cell_line_id,drug_id,response
RERF-LC-MS,135421197,1.554065103888189
OE19,3689413,2.2009145574363895
HCC1438,135421197,2.9315312537575124
KLE,107970,2.4969694624001546
TM-31,54626689,5.14649370502582
LUDLU-1,637858,2.984571557317574
COR-L88,9915743,2.6531314221419704
WM266-4,46907787,3.372133923169319
Hs 611.T,12003241,-4.3632527403619425
SW48,12003241,-0.9746028071684796
BT 245,135875424,2.904149434910518
PE/CA-PJ41 (clone D2),3689413,2.5059514962832536
TE-14,135398744,6.394251875306054
HL-60,168313016,4.321395169470036
DU145,44491742,3.929497920305024
Karpas-299,10302451,2.3096571602209655
JK-1,262093,1.0085892511994845
U-937,71466445,2.7910445117106515
HLF,262093,3.0135929063245324
KYSE-450,72967,3.7351940397417023
NCI-H1339,9936388,3.3861732240332314
SUP-HD1,11455910,0.2376646387177033
Karpas-422,637858,1.0915898497737888
GI-1,9903786,1.7362048371434178
TCC-Pan2,24180719,4.084025923645091
Hs 934.T,644241,1.8848101536179052
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
Caki-1,241158,5.557951612650369
NCI-H716,637858,1.7981928369747582
PaTu 8988s,6852167,3.1010868108448832
THP-1,selumetinib-JQ-1 (4-1 mol-mol),-3.8600862118998553
Panc 04.03,135875424,4.739147054003967
SNU-1066,136227924,3.4679855479635644
OUMS-23,168313016,4.4435991862403155
OCI-AML-5,5460769,2.0028479546764664
SNU-886,UNC0638-navitoclax (1-1 mol-mol),-7.5974579555081725
Panc 02.03,439501,0.4668648826805023
SNU-1,107970,2.0495206958344148
MHH-CALL-4,3689413,-0.1881082259185382
PF-382,107970,1.4805149558229411
MHH-ES-1,49766530,-2.35946817477404
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
LAMA-84,375860,-0.4537383385412094
Panc 03.27,10302451,2.8157600725630285
HCC1428,54596490,5.919134315186448
ST486,136227924,1.8715049257554837
Peer,73707398,-0.5421595453106686
COLO 741,24180719,3.1155658728119144
SCC-9,637858,3.7694424070181127
OS-RC-2,637858,2.270569811724511
NCI-H2122,135421197,1.54063176818906
SNG-M,168313016,5.345031475904297
HCC1569,262093,2.630898961991999
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
NCI-H2141,9903786,2.15851319161548
HCC1419,9915743,-4.40313771987628
Mino,135421197,1.5483687621841111
P31/FUJ,262093,1.035147161622815
A3/Kawakami,26596,-1.4802505010126563
AU565,46907787,3.197599854412173
23132/87,46907787,1.8335794476282232
Detroit 562,10302451,2.263442382574537
MIA PaCa-2,71466445,3.52941204584422
LoVo,135421197,2.0078610802467307
KCL-22,71466445,3.1103858035293235
HEC-59,241158,3.2385648758912904
BT 482,11455910,0.8854890707649536
LXF 289,4259181,0.8555931132792622
RL95-2,3689413,-1.8797416437850616
CAS-1,156414,1.815264077415652
Rh41,9936388,-5.1529677708174235
CJM [Human melanoma],375860,-0.5487520794387316
HCC1500,6852167,3.541859976914812
SNU-387,107970,2.231476947099596
HOP-62,11455910,0.5971366632673413
BICR 16,241158,4.494291631912356
JHOC-5,3689413,-2.3603805845843913
BT-20,selumetinib-JQ-1 (4-1 mol-mol),4.7209808702572
NCI-H1184,9903786,1.9169497440885477
NCI-H1944,136227924,3.273500409836235
NCI-H1838,3689413,1.1347617687317235
BT 232,12003241,0.7689860927775146
NCI-H838,136227924,3.210993191129446
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
A-253,262093,2.9926889319530736
MM1.S,BRD-K27188169-navitoclax (2-1 mol-mol),4.93691832790379
IGR-1,135421197,2.0618404907412473
VMRC-RCZ,644241,2.9068882426131313
Sq-1,BRD-K27188169-navitoclax (2-1 mol-mol),0.3707316901661518
SNU-1079,168313016,1.9938843500812935
RERF-LC-Ad2,439501,-3.088259445062755
Rh18,9903786,2.6471801174141625
JVM-3,71466445,1.609611139863367
PaTu 8988s,44491742,3.6400918872033343
YD-38,262093,2.9761292729070954
HeLa,9936388,2.2030969514797256
KP-4,11455910,-0.3156101411278702
EFM-192A,71466445,2.8191232050659463
JHH-2,135421197,1.6322230690261417
MOLP-8,9915743,0.5160575940701332
BT 139,168313016,5.38709248356601
TCC-Pan2,71466445,3.915793713203546
CAL-51,9936388,-5.638746232401389
KMS-12-BM,107970,1.2280769647153718
HDLM-2,375860,-0.88724972969489
OS-RC-2,9903786,3.8385821896684433
MOLP-2,637858,1.2784756867176654
NCI-H2126,444795,5.146791036292057
COR-L95,100016,6.620829555802918
NCI-H520,168313016,4.384348437846953
SK-MES-1,439501,-3.0675595474826194
DMS 273,9903786,1.811418424711566
BT 159,10302451,3.9427474616205527
HDLM-2,6852167,1.8499669564369137
TE 441.T,4259181,0.3231515403820576
M-07e,5460769,1.3910333770062682
SNU-626,5460769,3.7499472406611334
NCI-H1838,100016,6.459213557236613
NCI-H1341,136227924,2.213362476241057
HCC1806,327653,3.4854765950585453
H-STS,262093,1.3358664140686949
SNU-387,12003241,-1.416188991629313
KE-37,136227924,2.0912429237758796
SF295,241158,3.864746766488878
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
BT-549,156414,4.402880659642667
NCI-H2171,9903786,1.7901794952315444
P-STS,71466445,2.7514602087039792
TM-31,11396600,3.128698302220667
SEM,6852167,1.184676073870636
BT 271,135421197,1.2817550115075582
MDA-MB-468,9903786,1.7748497481459855
GSS,9877608,3.923769598981982
Hs 888.Lu,241158,5.055408917933412
A101D,12003241,-1.0986495828587448
TE-10,9903786,3.070607136357089
SNU-869,107970,2.357589135817321
Yamato-SS,11455910,2.3027203497268327
Kelly,12003241,2.7454811269637145
BT 330,644241,2.044782133454181
HMCB,46907787,2.4282883374132256
RPMI-8226,46907787,-0.7193366635471113
DU4475,9936388,-6.520654557034823
BT 147,6852167,3.4749398701378515
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
TOV-112D,6852167,3.8380412423876353
KALS-1,10302451,4.196627603085186
A-375,262093,2.9970202931790046
NCI-H2228,73707398,2.430231026946045
Hs 766T,10302451,2.1536955794158668
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
HPB-ALL,9936388,-8.275368871773662
SK-N-AS,9936388,-8.947501416398147
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
NCI-H2170,107970,2.6189429155295585
SF268,135999136,1.9538592313665253
NCI-H1694,375860,-0.3230504534344686
NB4,9915743,0.5883941664739625
OE19,135875424,5.148848479100124
NCI-H1184,5460769,-0.2786372914944621
NCI-H1563,262093,2.947853268609805
COLO 320,46907787,2.462485637898589
KNS-60,135999136,4.651096577413856
MKN7,11455910,1.138632994153518
MFE-319,26596,-1.024111788947852
NH-6,46907787,3.739922386901546
RPMI-6666,375860,-0.292497445502028
SCC-9,241158,3.962823581088113
YAPC,9915743,1.8269757962027744
HuNS1,375860,-0.6184479016387657
Mel Ho,135875424,3.73335713138188
D283 Med,11396600,2.9109671183024983
HCT 8,135875424,4.984268823368111
BT 139,73707398,1.451350595417811
IM95,136227924,1.5571875137371276
JHH-4,439501,-2.8819289141126596
OE19,9936388,2.0659697731662083
SK-HEP-1,9915743,2.4580731883892293
PK-1,12003241,-0.8622642153841519
SNU-5,9927531,5.646839183086857
OCI-AML-5,375860,-0.4377067020305437
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202
JHUEM-1,135875424,3.0885966905905433
TOV-112D,241158,3.7158318737048655
GCT,49766530,-2.994788722122755
SNG-M,3689413,1.102237357506899
Kuramochi,3689413,-0.3905926620288846
NCI-H1341,9903786,1.643545486774536
JHUEM-7,241158,3.726297808510672
HCC-56,135999136,4.45483812083689
RT-112,10302451,3.19729006739259
TE-1,262093,3.2367135010578134
D283 Med,439501,-4.70695325279779
KE-97,9936388,-5.867495812584186
KPL-1,selumetinib-JQ-1 (4-1 mol-mol),4.46971279886646
MOLP-2,9915743,1.124715317065168
HT-29,6852167,4.147335972225288
SNU-449,3689413,-2.168376107627999
SCaBER,262093,3.0352387860556824
NCI-H28,107970,2.518066551188869
Becker,54626689,5.068066609576423
PC-3,156414,2.5844798005435696
BT 330,10302451,3.8668829581904944
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
ST486,26596,-3.6953345637142063
NCI-H1650,10302451,0.6144197701725324
KP-3,100016,6.07483479536675
TE 617.T,6852167,3.448270243983474
EFO-21,selumetinib-JQ-1 (4-1 mol-mol),2.934977036652893
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
NCI-H1693,439501,-5.586339578501797
BT 228,637858,2.2538508050873016
SK-N-DZ,156414,1.5572743957350466
COLO 668,9903786,3.4728233461843745
TOV-112D,100016,6.758334848108728
KP-4,375860,-0.9518603940694028
NCI-H1869,9915743,-0.6149308552384661
A2780,135421197,1.3895584306244824
HuH-1,11455910,4.282125665148122
SNU-398,637858,1.1142411159722052
THP-1,644241,1.774267182932786
SaOS-2,46907787,1.5905885991562354
SR,4259181,-1.822920047050155
AML-193,71466445,1.808334525963911
NCI-H526,11455910,1.2336462288733878
HCC15,9936388,-3.3305479025951783
BT 422,11396600,2.1657946593546384
NCI-H1395,44491742,3.9607165302769514
IGROV-1,9903786,1.7387584479757865
KE-37,24180719,3.2256361204178714
MEC-1,100016,3.995806762220144
CMK,9903786,0.6507335736439642
MCF-7,73707398,1.774214442125948
SUP-B15,12003241,-3.8836552178144848
SNU-1041,3689413,2.0809742429378133
GDM-1,9929138,5.504057309727688
GP2d,73707398,1.3305042715968274
SNU-C4,3689413,0.8564713625003593
RS4;11,4259181,-0.6298577009855054
CAL-51,26596,-1.4638590943230956
NCI-H28,375860,-1.018176478830531
L-363,46907787,0.1133832024912023
TALL-1 [Human adult T-ALL],637858,1.0149454438397798
SNU-601,637858,2.21692805887622
KMH-2,136227924,2.758064098306969
BL-70,327653,2.5776654277541216
P12-Ichikawa,5460769,2.2031078708702196
CAS-1,9936388,1.0698428320732736
SNU-119,54626689,4.267759657725626
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535
CAL-62,46907787,-2.0222332374843
T98G,637858,3.480538395341526
YH-13,24180719,3.7478543768890136
A3/Kawakami,44491742,3.8621679307370953
HCC1419,9936388,1.8369004896717465
NU-DUL-1,637858,0.2470687054795695
JHUEM-3,11455910,0.589239225317042
U266B1,10302451,2.6421968842395938
NCI-H1355,439501,-2.6186321377113955
CAL-54,26596,0.8562356828634801
BT 224,262093,3.775565066976983
NCI-H1666,5460769,-0.3925578984877662
NCI-H1373,135999136,5.970731564912955
SNU-407,9936388,-6.677168792999783
PaTu 8988s,46907787,4.297293150577968
SaOS-2,54626689,4.533352391847383
SK-LMS-1,73707398,1.7151608604294482
BT 147,156414,1.567734128398706
OC 314,327653,2.3635468308659884
MM1.S,9915743,0.5251517896588939
RCH-ACV,135875424,3.077448855642363
U2OS,107970,2.3283737537932514
DU145,6852167,4.203979731076271
TE-1,3689413,2.462483014763608
SK-LMS-1,135875424,4.759949001069946
COLO 741,26596,-0.5200940435510158
SNU-1196,12003241,-1.2616769402260497
SK-LMS-1,4259181,1.6246211060463709
F-36P,26596,-3.451633292118186
MV4-11,9929138,5.135177780047251
RPMI-8402,46907787,-0.930500865109614
KMRC-3,136227924,3.033903598858876
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
UACC-257,11396600,3.5466245418165743
EB1,73707398,0.2172431300056034
Ki-JK,26596,-2.118639995094933
Jurkat,327653,3.0704554434178473
SK-MEL-31,135875424,3.140384739154431
JURL-MK1,10302451,-2.0701843125790993
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
CML-T1,10302451,-1.0288409878116755
IA-LM,73707398,1.4255919606814562
P31/FUJ,10231331,0.360402840185862
NCI-H508,selumetinib-JQ-1 (4-1 mol-mol),1.3063774876339054
CHP-212,9927531,5.318398541001747
HEC-59,6852167,2.4613827156801937
MHH-CALL-3,100016,3.61949081353442
Ri-1,135999136,4.203993475326129
H-STS,637858,1.1585331861261023
ST486,9915743,0.8352161269515779
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
SET-2,9927531,4.801393694643548
BT-12,135398744,6.373256605371206
KMS-21-BM,6852167,0.4278382768265162
TE-15,241158,3.84144022719984
Mino,UNC0638-navitoclax (1-1 mol-mol),-2.2285256214754647
CCF-STTG1,4259181,1.4943010127790817
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
SK-N-FI,9915743,0.2439816221510078
SNU-1077,selumetinib-JQ-1 (4-1 mol-mol),1.9000830670563744
SNU-61,327653,2.3439595497702985
ST486,135875424,2.429416484956845
SU-DHL-4,10231331,4.353604499482432
NCI-H526,26596,-1.5534394961181943
Panc 05.04,selumetinib-JQ-1 (4-1 mol-mol),1.2823810379914613
Calu-6,9903786,1.9563383465911224
RL,26596,-2.6100801443617336
RS4;11,637858,0.9565366734792956
ChaGo-K-1,637858,1.5063352286209188
SK-LU-1,135999136,3.760067607406658
HDQ-P1,12003241,-0.8789475866858393
MKN74,10231331,5.759039673812496
HCC95,9936388,-4.9854278423381135
LXF 289,637858,2.285720521187594
NCI-H2452,54626689,4.879011133008654
HEY A8,241158,5.048056534525615
RERF-LC-A1,11396600,3.681688949161253
BC-3C,5460769,2.335900284678582
TT,9915743,-0.2506861046068376
SK-CO-1,327653,3.1822308576162692
LK-2,135421197,2.2865264373163487
SNU-119,44489367,5.127022911687477
SNU-620,9936388,-5.286800591769548
JHUEM-3,49766530,1.26691736539767
DMS 454,26596,-0.4599730834169373
NCI-H1341,44491742,2.77003350871112
IST-Mes1,135875424,5.039969018342982
SaOS-2,11455910,0.8777485884783317
SW948,11455910,0.6774609071475187
G-401,327653,2.827166761380022
BT-549,4259181,2.4625999028961743
HT-144,73707398,1.5512400088188414
LCLC-97TM1,73707398,0.638027637531153
CMK,637858,2.2570785394012014
A-172,439501,-2.9680565651311723
BHY,10231331,5.244537153432119
Hs 683,9915743,1.4986187440690526
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
HCC366,375860,-0.8525905799274879
CMK,4259181,-1.112181067165922
IGR-1,46907787,-0.5222417136929179
P3HR-1,107970,3.4553561691501047
NMC-G1,135421197,2.4402756951086477
PE/CA-PJ49,3689413,1.6027869787622069
NCI-H211,135999136,4.1735993115728505
HCC78,135421197,2.5201678114483683
GSS,49766530,0.909441474448473
Lu-65,3689413,-0.1410308041132627
LS411N,12003241,-0.0946051023392001
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
SK-N-BE(2),selumetinib-JQ-1 (4-1 mol-mol),-1.8222666902203384
KO52,26596,-3.758446698642679
MHH-CALL-3,UNC0638-navitoclax (1-1 mol-mol),0.1946854000145928
ECC10,11455910,0.1106794798283132
EB1,49766530,-2.446229475307264
SW948,9903786,1.6902329933335576
JHH-1,73707398,1.6871204848292365
JHH-5,selumetinib-JQ-1 (4-1 mol-mol),0.6284460578622284
ZR-75-30,11396600,3.757449742584293
MCAS,9903786,3.9207216019302007
U-118MG,9915743,2.4267236248915753
HCC1954,375860,-0.3791480952403591
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
WM983B,241158,3.7381276806355537
HDLM-2,24180719,3.0339345159321818
RPMI-8402,637858,1.581832583062169
BT 112,49766530,0.144276899282749
LK-2,24180719,3.8589397068242106
RPMI-6666,4259181,-0.2234932602766142
DK-MG,selumetinib-JQ-1 (4-1 mol-mol),1.540298571322697
PaTu 8902,107970,2.826401466277882
ME-1 [Human leukemia],327653,1.5922481175926897
UO-31,100016,6.129898752942045
KP-4,selumetinib-JQ-1 (4-1 mol-mol),2.1555803314083635
SNU-398,135875424,1.4197381428119091
NCI-H1563,107970,2.7821488570698176
HPB-ALL,100016,7.357554409535215
CAL-120,136227924,2.519967645750226
KM12,54626689,4.2982875104975955
NCI-H2405,136227924,3.1304062683146747
JM-1,136227924,1.2038413750130548
TTC-709,9903786,2.3304378522453866
ECC12,3689413,0.1011873229267039
IGR-39,6852167,3.2260385180997044
KMRC-1,4259181,1.968851453570829
MEC-1,262093,1.0111827141937222
ACC-MESO-1,100016,6.4652465436588775
SK-N-AS,24180719,3.641877528230763
SNU-16,3689413,-2.4569670929316656
NCI-H1435,10302451,1.1445716606648535
CAL-54,5460769,-0.0866419988438866
HuT 78,439501,-3.2848313932186315
RERF-LC-Ad2,262093,2.9385372389092197
COLO 668,9936388,-5.811086467822447
SW1088,49766530,2.123366462001536
Hs 852.T,10231331,1.8356181415822297
BT 482,107970,1.7416732658347511
GSU,637858,2.527068624581838
AU565,12003241,-0.6235660341918571
COLO 829,637858,2.2097100379550936
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
A101D,73707398,1.1179774459813885
SK-N-MC,6852167,1.5726479412597263
JURL-MK1,73707398,0.1853305147735288
SYO-1,3689413,0.2165411688819273
Kuramochi,241158,6.3295579427674475
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
HCC1588,136227924,2.6333776491111585
U266B1,107970,2.068573563143244
Ki-JK,10231331,4.443580343542006
MPP 89,100016,6.902779011713528
SK-MM-2,241158,3.139397646648939
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996
NCI-H1573,637858,2.63768686790808
TF-1,9936388,-7.588879673689913
42-MG-BA,107970,2.2671831149956807
SW1353,4259181,0.2746350901066433
LOX-IMVI,12003241,-2.813518393614124
NH-6,637858,1.1461140723422587
HEC-265,136227924,3.2525592636436405
SNU-C2A,9936388,-5.314331610228823
Ishikawa (Heraklio) 02 ER-,375860,-0.5414643002476628
BT 340,6852167,4.842070078129686
EHEB,26596,-2.0876334457911727
NCI-H2444,46907787,3.4332033911522126
PaTu 8988t,375860,0.0559535091713014
LCLC-103H,135999136,4.479345177933151
BT 231,135421197,1.0763175924586934
SNU-886,3689413,-0.3695618539773043
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
HOS,26596,0.4724890056436647
HT-55,12003241,-0.758438477023311
DoHH2,9915743,0.0778019212938174
BT 271,644241,2.5391465532485564
COLO 320,3689413,-1.9916072658639432
Pfeiffer,100016,6.236222400968574
Hs 611.T,10302451,2.003286438841951
BT 340,10302451,4.165470025380085
OE33,241158,5.920302917932962
EFO-27,9903786,4.039986452778869
SNU-738,selumetinib-JQ-1 (4-1 mol-mol),5.597755741731593
HT-144,24180719,0.8110306594189328
NCI-H1915,9936388,2.519208351388662
SET-2,375860,-0.3203156821570778
RD-ES,12003241,-1.2305184687153958
NCI-H2052,135875424,4.438161541518592
NCI-H1734,46907787,-1.0284147677545927
OVISE,262093,2.7343448368987597
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
CCK-81,5460769,-0.0536611992608542
OCI-Ly3,46907787,-0.722061915015215
NCI-H460,107970,2.752075604137296
A2058,6852167,3.6639698934564175
HCC1438,3689413,-0.4859764672187859
NCI-H841,71466445,4.53794934837107
LK-2,73707398,1.838459164463507
HCC1954,9936388,-7.1027886366654585
SNU-620,12003241,1.204190065135074
LN-18,5460769,0.9939611818756712
Panc 03.27,136227924,3.110606575361216
Lu-65,168313016,6.388486365629365
HT115,241158,4.681808490608726
SW1088,46907787,5.3423839694958595
NU-DUL-1,24180719,2.3107351215495395
LS123,49766530,-4.7920009691109
NCI-H460,439501,-2.362377537788676
GCT,107970,1.7083698024056695
SK-ES-1,9936388,-6.72300625347337
MV4-11,156414,-0.848547238114129
BT 286,136227924,1.3356746395497436
NCI-H1869,11455910,2.924449694106302
AML-193,136227331,3.928096776967208
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
SNU-1079,439501,-2.542024376307003
SU-DHL-1,9903786,2.5464454731205777
NU-DUL-1,135999136,1.5798926430352824
SH-10-TC,156414,3.265122378656891
MV4-11,107970,1.817432876584402
KMBC-2,135999136,4.121225006171559
SW982,24180719,5.559505603215452
NCI-H508,135421197,1.875184072500521
PF-382,49766530,-3.617209334662046
SUP-T1,375860,-0.5976007782888901
NCI-H1581,241158,3.097187487045549
RERF-LC-Ad2,241158,4.786001291187356
SUP-HD1,100016,7.0046366432620735
SNU-878,10302451,3.582077732565662
JIMT-1,6852167,4.253888723725077
Ku812,71466445,2.9617943038056858
HCC-56,375860,-0.2290653983773377
NCI-H650,10302451,2.7441741696304223
OCI-M1,9903786,1.4970236133945398
KYO-1,10302451,-1.541615937925273
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
BT 172,selumetinib-JQ-1 (4-1 mol-mol),1.8042299289240984
COLO 741,107970,2.647977331260038
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
NCI-H1915,135875424,4.440187270311882
G-401,135875424,3.147536590476696
Daoy,100016,6.878604021612681
ECC10,11396600,2.3430961684425133
MOLM-6,3689413,0.3128747542373787
IM95,10302451,2.0980422588361143
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
GSS,9936388,-5.73118994601309
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
Hs 936.T,9936388,-4.507745146359587
A-204,136227924,2.1384474587970113
RCH-ACV,3689413,-1.349996625899334
LAMA-84,9915743,0.3935059145962964
BICR 18,9915743,1.102775446718332
JHOM-1,100016,6.419236010839144
GaMG,44491742,3.8685046453697383
WM88,375860,-0.1387933856952615
OCI-AML-3,262093,2.331975538333622
M-07e,24180719,3.310103046671316
HEC-108,375860,-0.0015834583996186
BL-70,107970,1.6369787903687438
KP-N-SI9s,26596,-1.674008327181718
IMR-32,9903786,1.34691800492683
NCI-H526,5460769,4.454179309152686
T-47D,100016,6.980531714745858
JMSU-1,4259181,-2.230603891690396
NCC-StC-K140,73707398,0.6748262049833047
T24,10302451,5.029855171051924
SNU-245,selumetinib-JQ-1 (4-1 mol-mol),-1.0935434340518932
M-07e,9915743,1.0767758822983564
Becker,262093,3.305929946624271
TYK-nu,9927531,4.342224808335168
LC-1F,4259181,-1.2761645262124546
NCI-H1341,6852167,0.0593600612593167
ChaGo-K-1,136227924,2.8574479872364247
MOLP-2,49766530,-0.7894264806393523
JIMT-1,9936388,-4.798396731889527
JHUEM-1,24180719,3.64667749132653
YD-10B,100016,5.941622042216757
COV362,439501,-2.4929175140704443
SK-MEL-5,375860,0.3634288608432608
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
OPM-2,6852167,1.7172653102666242
TM-31,135999136,1.8138767512848852
NCI-H2110,71466445,4.525976755285506
Namalwa,135875424,3.1964963879327355
Hs 578Bst,262093,2.4258150356441277
NCI-H2228,11396600,3.725847437407865
RL95-2,637858,1.629484037665391
BT 231,9915743,1.2683297871302317
REC-1,49766530,2.1728933829794395
BICR 56,9915743,-1.8480051060237024
HCC2108,5460769,1.78766929460534
Calu-6,11455910,2.638834676965617
Namalwa,100016,3.934978584241161
T98G,10302451,3.1795793433623634
Peer,5460769,2.3155061508829107
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
KNS-81,3689413,2.13740937168454
OCI-AML-2,136227331,6.356124272356354
BHY,9903786,2.1017831140065844
Ku812,11396600,2.326776145026828
JVM-2,24180719,1.7621393593103902
Karpas-422,241158,2.526232566496073
DB,12003241,-2.5818700415802107
NCI-H2291,135875424,4.231484066090065
SNU-840,44491742,6.442056780348467
NCI-H1666,9903786,3.302889272478758
HCC1438,637858,2.2625996667458974
HCC2279,375860,-0.2616514424513608
Capan-2,156414,1.6206965519092191
HCC44,9915743,1.8487357867630132
DU4475,100016,3.3182611876021157
EN,9936388,2.3210150451577394
MOLM-13,71466445,2.28410988708537
HCC1954,49766530,-2.49359957075404
BT 145,241158,3.5624759873716685
RERF-LC-MS,6852167,1.8897499878184068
LoVo,9915743,-0.8819018227786422
BT 286,26596,0.1662425719802319
KATO III,10302451,2.7485935005281736
F-36P,6852167,2.0711670211251016
HSC-2,262093,1.000516110359784
Mel Ho,selumetinib-JQ-1 (4-1 mol-mol),-1.885039449410358
KP-N-YN,262093,1.320292146111092
SNU-886,9927531,4.416743823533711
IGR-39,24180719,3.71185105486985
Hs 729.T,46907787,3.916533170347426
K-562,107970,1.9304513771469212
BT 245,135999136,1.3733623937615662
HCC95,4259181,-0.6650213112421581
SK-MEL-28,10302451,4.268902771891611
NU-DHL-1,24180719,3.951276464233685
BxPC-3,107970,2.2592769610294448
BT 131,10302451,3.8852877828195007
COLO 792,6852167,0.7381788864541688
T84,439501,-3.2363484717371964
NCI-H1373,9936388,2.083574695365507
VMRC-RCW,selumetinib-JQ-1 (4-1 mol-mol),1.8426593764457728
KMS-12-BM,327653,2.270237785805321
ESS-1,54626689,4.894766460355583
LNCaP clone FGC,637858,2.004669804836901
KNS-81,49766530,2.7158517560502293
MFE-319,9903786,4.166499809230756
G-402,3689413,-2.398883611420732
MFE-319,11455910,1.7600877604233616
NCI-H1299,10302451,4.027375771217026
HSC-3,439501,-2.291291548686292
LS513,136227924,2.4637797835127793
CHP-212,10302451,0.4952332551332477
MPP 89,46907787,6.057961616888675
TALL-1 [Human adult T-ALL],10302451,3.2797456534828364
NCI-H292,11396600,3.7365966834404225
SF295,439501,-2.4386536619135137
RPMI-6666,71466445,2.5937687881604106
ALL-SIL,644241,-6.056766449232899
MDST8,637858,1.7716899628344815
RT-4,3689413,0.3652230576391069
MV4-11,9927531,4.708512628737502
NCI-H1105,10302451,3.9440283019984985
OAW42,6852167,3.327110546741901
KHM-1B,44489367,4.908857615770495
MDST8,24180719,2.4870372971011374
HL-60,9927531,5.393037826630499
SK-MEL-1,10231331,-1.9528897384138784
UO-31,10302451,0.869987759961234
TM-31,637858,2.3445482610973767
KMS-26,100016,3.884140356330727
MDA-MB-415,selumetinib-JQ-1 (4-1 mol-mol),1.6369834680115742
JURL-MK1,262093,2.648959979850121
SK-UT-1,73707398,0.9883439046575164
ME-1 [Human leukemia],10302451,5.046375843615016
NCI-H1755,135875424,3.1335901028630393
BT-474,241158,4.261649055387228
JHUEM-7,327653,3.126202180618715
NCI-H1666,135421197,0.9962315776177934
HEL 92.1.7,54626689,4.464127217802394
RL95-2,375860,-0.928474794655752
HCC2279,3689413,-1.8306201481389968
Panc 04.03,9903786,4.611047286699123
HT115,71466445,3.3438481038223133
SNU-407,100016,6.489561303898527
THP-1,12003241,-0.95805458474302
NCI-H2029,439501,-1.7622660866331608
HuP-T3,44491742,4.372770131484514
SNU-216,UNC0638-navitoclax (1-1 mol-mol),2.629430823091792
BT 245,10231331,3.905394007999992
MOR/CPR,12003241,1.56456971518695
SK-N-AS,9927531,4.866192814831014
U-118MG,46907787,5.471659204774231
NCI-H2196,168313016,5.854117563388439
HCC1954,3689413,-1.9966165648344365
SNU-478,262093,2.3459041938371112
BT 504,49766530,1.1284892746391262
MIA PaCa-2,selumetinib-JQ-1 (4-1 mol-mol),-0.019734255481758
JHOC-5,6852167,3.0537905244245813
HuNS1,439501,-3.2381997907918447
JHUEM-3,12003241,-2.0090653802187197
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
OCI-AML-5,6852167,1.9136367887966896
SCC-4,9927531,4.977228114447549
RERF-LC-Ad2,135875424,4.566580865948674
SK-N-FI,11396600,3.485816734238302
NCI-H196,107970,2.3706951810586068
HT-144,10231331,-0.8863158661659762
DLD-1,136227924,3.626313463652563
OE33,9915743,2.242004758711727
Kuramochi,4259181,1.3483674721147798
Panc 08.13,241158,4.606670048460817
WM266-4,135421197,2.204314792506349
SNU-478,49766530,0.8968210676937323
A2780,54626689,3.943205764450006
KPL-1,135421197,3.0565693123686617
OAW42,156414,1.8124502035679988
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
SK-CO-1,135875424,3.678629656731489
M-07e,71466445,0.4211698315737406
NCI-H508,10302451,1.1228602001088863
RCH-ACV,327653,1.139116328551912
COLO 668,135999136,3.1755303775386654
NCI-H2170,135999136,4.479951445238564
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
SW579,241158,3.28708470010344
SK-MEL-24,135875424,4.490880969896708
TCC-Pan2,11396600,4.21456785581041
HCC1588,12003241,-0.4884151161938169
PE/CA-PJ41 (clone D2),262093,3.3360750662244443
HEL 92.1.7,9927531,3.309303309112431
NCI-H2228,107970,2.8314632132915207
WSU-DLCL2,BRD-K27188169-navitoclax (2-1 mol-mol),3.810557290062505
CAL-12T,136227924,2.605918242540546
KO52,11455910,0.9067852842316652
NCI-H1568,54626689,4.298451601405369
JHUEM-2,135875424,3.27601343648584
SK-N-SH,168313016,5.308215001668749
OVCAR-8,selumetinib-JQ-1 (4-1 mol-mol),2.9228351858434523
NCI-H1341,54626689,2.536149372334589
253J,6852167,1.19495327792042
NCI-H358,135421197,3.655226783621308
647V,46907787,0.8654746215037775
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
TE-9,135421197,3.747020112935066
NCI-H810,71466445,1.829191820836244
JURL-MK1,136227924,2.4264924164691135
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
SF126,637858,2.685608756713638
KHM-1B,54626689,4.681502909310955
COR-L105,49766530,-0.5480688242609842
ONCO-DG-1,100016,7.582922943410799
BHY,4259181,-0.4140726497204193
OC 314,12003241,-2.177807668538587
LN-229,135999136,5.508952384522358
LS1034,135421197,0.962643417558857
HSC-3,135999136,4.352393936185964
SR,135398744,6.424256669199728
NCI-H322,44491742,4.376212292863665
BT-16,375860,0.1512578525958123
CW-2,168313016,4.664259792388598
HOP-62,444795,4.062660222672805
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
HDLM-2,107970,1.9865274855394164
SNU-878,9903786,2.6270705473192644
OPM-2,5460769,4.223891374112808
C2BBe1,9927531,4.784416538426047
OVK18,26596,-0.4420601425641566
SUP-HD1,UNC0638-navitoclax (1-1 mol-mol),-1.9382538097314463
EM-2,10302451,-1.381197320031158
BT 340,439501,-2.6874072240019617
SK-MEL-3,439501,-0.9323794711246036
DK-MG,136227924,2.9692161266572707
KPL-1,73707398,1.7074726811570569
SK-MEL-30,107970,2.928613560405839
8305C,10302451,3.0116833270498677
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
KE-97,168313016,4.176662787294865
JHUEM-3,9936388,-3.506110274235372
IGR-1,71466445,1.9675328649104085
KP-4,327653,3.0161374219123727
KNS-81,UNC0638-navitoclax (1-1 mol-mol),0.7140378637358435
DLD-1,637858,1.8547650248451624
SK-CO-1,135421197,1.070123520764916
JIMT-1,12003241,-0.563362100663344
NCI-H1155,136227924,2.9905910988633653
BT 145,262093,2.5646715988074917
SNU-449,327653,3.836895463512291
COV644,107970,1.6396502941518332
WM983B,selumetinib-JQ-1 (4-1 mol-mol),-1.7690191358032856
SNU-1076,6852167,1.7947543105192023
HDLM-2,156414,0.7266431352631084
NCI-H146,49766530,4.81095512251176
TUHR4TKB,24180719,5.18513650177376
LS123,73707398,0.6654924685394674
KLE,136227924,3.154327848580928
ES-2,100016,6.579379467241575
RT-4,135421197,2.4643711937197756
HEL,262093,2.3252232523203995
CHP-212,44491742,3.750067652008212
OV7,24180719,4.527606490563011
PK-59,9936388,2.2614163852650377
NCI-H2122,9929138,6.815327786842329
NCI-H2170,44491742,4.021640872612266
WM88,49766530,-2.7931642846980336
COLO 829,10302451,4.0322248059619845
HEL 92.1.7,11455910,0.3548529299693889
SK-MM-2,46907787,-2.970047454600876
SU-DHL-4,439501,-2.4807393804308777
GOS-3,439501,-3.404828566068769
MV4-11,5460769,0.4038466040082859
SNU-182,73707398,0.3756320577757861
SF268,6852167,2.886787318838284
SF539,100016,5.965471494853995
SU-DHL-1,135421197,1.1384736779813156
KYM-1,73707398,0.8964699426689934
SH-10-TC,135421197,2.8631167309091556
OCI-AML-2,637858,0.7284581277155234
BT 172,6852167,3.7177159373997304
SK-UT-1,10302451,4.065117068717504
NCI-H2122,3689413,3.5396747143031497
HEC-1-B,100016,7.817681002018073
SW1990,241158,4.5746267223156085
NCI-H526,9903786,2.628275304590264
SK-MEL-5,6852167,3.3711794080976594
U-937,107970,2.3175497255146804
SNU-46,11396600,4.157992682582123
Kasumi-1,26596,-2.5055411121240705
SNU-1,100016,5.685360721271126
SUP-HD1,6852167,1.7259381822403246
JHH-4,135999136,4.26368824766702
BT 416,375860,-0.0898603200977126
PC-3,439501,-3.5165301870607903
SK-MM-2,9929138,0.5464010335439101
TOV-21G,135875424,3.093416550271537
ACC-MESO-1,11455910,1.4227308564953651
NCI-H1184,3689413,-2.309621936722181
GDM-1,6852167,1.5690648286355753
JVM-3,9915743,-1.1278742890902858
HCC1937,11396600,3.939286660836918
MDA-MB-157,439501,-3.062684000428755
DoHH2,BRD-K27188169-navitoclax (2-1 mol-mol),-1.5664711574800654
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
ST486,46907787,-1.2194061813967136
KCL-22,4259181,-0.343701000800128
JHH-4,9915743,1.3813494338537873
TUHR4TKB,439501,-2.4659071378458544
HPAF-II,637858,3.4206935967776135
HCC366,262093,3.5189758741975905
HuH-1,107970,2.4748588505404534
HuH-1,selumetinib-JQ-1 (4-1 mol-mol),2.1726097433834557
EBC-1,10302451,2.6602549654421765
Hs 888.Lu,9927531,5.408720252144841
CHP-126,BRD-K27188169-navitoclax (2-1 mol-mol),-0.343655574469369
VMRC-RCZ,9936388,2.3109640343405418
COLO 320,UNC0638-navitoclax (1-1 mol-mol),2.1878312985182604
KYSE-410,135999136,4.574182902915764
BT 333,9936388,1.082637149291879
HDLM-2,3689413,0.2567400255605154
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
DU4475,71466445,2.62010200109503
TALL-1 [Human adult T-ALL],44491742,3.807829450429648
HCC95,6852167,2.584252401921641
SHP-77,107970,2.2378803555447044
IMR-32,241158,1.87934561893452
NCI-H520,9903786,3.332228860924169
8-MG-BA,49766530,-0.054737716744796
Becker,107970,3.0116017692585406
Ki-JK,49766530,-2.8034891942597935
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
TUHR14TKB,107970,2.3416804561478464
COLO 205,selumetinib-JQ-1 (4-1 mol-mol),-0.3871952665597744
P-STS,135999136,4.20452870640474
SK-N-DZ,10302451,2.4315640963811496
JURL-MK1,6852167,2.5656057202015923
Karpas-299,6852167,2.12917908692066
769-P,3689413,-0.2029622109765157
Hs 294T,24180719,3.295536675647476
T24,375860,0.4075315384303163
LN-229,selumetinib-JQ-1 (4-1 mol-mol),0.9195048407927706
Hs 683,selumetinib-JQ-1 (4-1 mol-mol),3.498842094614085
SNU-81,9936388,-6.314751034125396
LXF 289,9903786,1.8485652979864533
GA-10,9915743,0.398325607555859
OAW42,241158,4.137379643985406
SJSA-1,BRD-K27188169-navitoclax (2-1 mol-mol),4.124284769561995
HEC-50B,10302451,5.618785073563312
Hs 852.T,12003241,-1.871479503201469
NCI-H1581,4259181,0.5053402023869984
NCI-H647,241158,5.626860272324237
IMR-32,439501,-2.4799025778743884
NCI-H460,4259181,-0.2054535095090753
SNU-620,4259181,-1.486057650268119
CAL-51,136227924,2.079284078064279
JJN-3,71466445,1.679403169347352
SNU-1,4259181,0.1990520766980941
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
KMS-12-BM,9929138,5.078790269314151
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
NCI-H2172,4259181,0.413697798920579
Reh,9903786,1.595846435725099
COLO 829,241158,5.392571054594158
PF-382,168313016,4.6371186800984745
NCI-H1299,49766530,-0.517142624612936
T84,136227924,2.5199027398538707
IM95,6852167,1.9087565501375077
HeLa,637858,2.5742998662874035
SNB-75,135875424,3.5358654963321556
VMRC-RCZ,10302451,3.843539163355995
NCI-H23,9915743,1.0695073587250767
NCI-H727,73707398,1.5620380856857303
K-562,6852167,3.2696177089982807
GSU,262093,3.0051612017045612
SW620,9936388,-0.3653098163020092
NCI-H1395,12003241,1.698262392733821
SaOS-2,262093,2.7398792490382244
KNS-42,439501,-0.277437282797495
KMS-34,168313016,2.8504854607247743
NCI-H1915,24180719,3.3856264137365666
SNU-387,10231331,2.753186261724594
HCC38,156414,1.3056275729955638
TOV-112D,107970,2.816191825989141
HuH-6,49766530,0.8339176615571017
HCC1395,135875424,6.03600729555728
Raji,12003241,2.533123505917396
NCI-H2172,6852167,4.795805811514927
SK-MEL-24,156414,1.646633050519371
HDQ-P1,9927531,5.7159143296477115
COLO 678,46907787,3.489005746708635
HT115,9903786,1.6808315283009525
Kasumi-1,10231331,0.7062321842333538
CW-2,3689413,0.3628565855877684
BT 271,135875424,3.267528631727611
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
Calu-6,136227924,5.658776934081175
RCH-ACV,9927531,3.1896486071629724
BT 504,3689413,0.2401102984502228
SCC-4,262093,2.191736984960853
SNB-75,9927531,5.402780165726325
RKO,9903786,4.184024439899693
HCC95,3689413,2.984270072976439
Namalwa,156414,1.5666485323210588
IM95,26596,-1.182221472210093
RPMI-7951,44491742,3.876790810560562
Rh41,71466445,3.306687548235661
Hep-G2,136227924,2.2133800896817304
NCI-H2126,4259181,0.5525556659927066
EoL-1,375860,-1.005222990918516
Granta-519,46907787,0.1510211143130647
OV56,6852167,4.1070527427791585
HCT 8,156414,1.6609441441146586
KYSE-70,135875424,3.720063911223788
NCI-H322,439501,-2.585087913028924
AML-193,UNC0638-navitoclax (1-1 mol-mol),1.223470800239613
Kasumi-1,135398744,7.461687299190896
HEC-6,439501,-1.45021451422316
KYSE-30,135875424,2.992970338382266
BT 159,selumetinib-JQ-1 (4-1 mol-mol),1.6689047126090906
HCC1833,327653,2.396591228489624
OUMS-23,100016,6.512546818056364
SNU-601,9915743,5.263014958216545
HEC-251,11396600,4.750561988154587
BT 416,9927531,5.009885250018842
HCC1195,439501,-1.494120316453499
BT 245,6852167,3.061843713920685
Kelly,71466445,1.8588223340604555
SCC-4,375860,-0.9454138707762751
OE19,107970,3.0665667847288103
Lu-99,644241,2.5747874241134476
Ri-1,UNC0638-navitoclax (1-1 mol-mol),-3.130813752237708
HEC-1-B,135421197,1.3262919275478138
NCI-H446,375860,-1.0573139189688194
MV4-11,10231331,-0.0666057003982483
TE-6,9915743,1.0725683226021352
KLE,12003241,-1.9975693903430911
TE-14,10302451,1.496270675992236
HCC2935,11396600,3.842906803447669
HT-1376,262093,3.325962410010009
LS123,100016,6.571994849278421
SNU-620,6852167,2.296006256931868
JK-1,5460769,-2.680332547756694
Calu-3,375860,3.536505764662041
COV644,9936388,-1.581655589979093
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
NCI-H2291,10231331,0.770730162794698
MKN45,3689413,3.361842209441358
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
F-36P,4259181,-1.8222583165697372
Panc 10.05,12003241,0.2449442349226892
253J,135875424,3.6390829141774934
L3.3,5460769,1.7814582708772182
NCI-H2452,12003241,-1.7557808561862691
SNU-449,375860,2.655390537146391
8-MG-BA,3689413,0.0230588346989354
SJSA-1,26596,0.7775759099492098
TUHR14TKB,9927531,5.242660147082698
BT 498,107970,2.860609306082874
TE-15,136227924,4.530652264188515
AsPC-1,135875424,4.124114476494282
LoVo,24180719,2.381979820549913
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
Yamato-SS,4259181,1.112549648652854
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
MDA-MB-453,46907787,-0.524764523127372
CAL-12T,327653,3.0974191705216794
YD-15,44489367,4.71886407548564
SK-MEL-1,156414,2.027107668574744
OE19,439501,0.2818425095827352
SNU-119,11396600,3.5657342992920547
BT 328,135398744,6.520469371663204
TE-5,444795,4.827182219857021
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
PK-1,375860,0.1836341615687206
Namalwa,327653,2.6135050132049167
SUP-T11,107970,0.8330523143812344
HT-1080,44491742,3.909011022661936
G-401,12003241,-2.103305079214356
HEY A8,327653,3.456207211282535
CJM [Human melanoma],44491742,4.278888606986291
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
AsPC-1,10302451,4.160835682979353
BxPC-3,4259181,0.1397018777458316
SKM-1,241158,1.623725861036911
TYK-nu,168313016,5.521300034207165
NCI-H1975,44491742,4.016351620338357
Mono-Mac-1,439501,-2.692243954974466
U-CH1,4259181,1.3998648787040493
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
A-253,9915743,1.8509292893724236
T3M-10,11455910,0.8263435212921274
647V,136227924,2.038450233147295
IPC-298,100016,6.58023685235314
KYSE-30,12003241,-0.1095696990749684
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
MOLP-2,327653,2.910106907615282
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
NCI-H2029,4259181,0.664419407815879
GMS-10,135421197,1.564647859858216
Rh18,54626689,3.4160557095461828
SNU-1214,135875424,3.75117609732274
MDA-MB-361,73707398,0.9595895200292788
TCCSUP,136227924,3.28330337763218
NCI-H650,262093,2.723348041118166
K-562,12003241,-5.632155645383806
PF-382,12003241,-3.7051147214471114
DU145,11455910,2.077410590950561
8305C,107970,2.244282047395896
G-292 clone A141B1,107970,2.7538669134691895
SW948,46907787,2.3709287142369555
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
NCI-H446,9927531,3.935868593657491
LoVo,375860,-0.1162329718395109
OCI-M1,136227924,3.580987744477365
HGC-27,637858,1.3770669368104775
SNU-119,12003241,-0.7435067493629696
SNU-119,5460769,2.8404840787101593
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
NCI-H520,46907787,1.4915843927881316
KMS-26,375860,-1.2821443043959098
NCI-H889,4259181,-0.8174872861875067
SK-N-SH,10302451,3.675886207337339
SCC-25,9903786,1.6185741180598072
BT 428,135398744,8.121810698450407
MKN7,156414,1.3312403404244495
ACHN,selumetinib-JQ-1 (4-1 mol-mol),5.066584749922726
P31/FUJ,135875424,3.622681212031297
HGC-27,44491742,3.7914350891371114
2004,135875424,2.8234839465542967
M059K,46907787,1.4659082225415776
HEC-59,107970,2.7080521474876353
BT 320,135999136,1.9088296274535188
HEL,11455910,0.7002369428142345
LK-2,135999136,2.017802061487894
U-118MG,135875424,4.484841768193188
SW1990,135421197,2.4673652362446887
BT 498,644241,2.2010744744476742
RCC10RGB,72967,3.7162805539485775
5637,12003241,-2.3897344760826775
HOP-62,135999136,4.132685432378933
TOV-21G,107970,2.735193282025734
JHH-6,107970,3.118262680815441
HuG1-N,11396600,3.640105128263337
786-O,327653,3.776777557893351
CHP-212,375860,-1.8839659810914688
MDA-MB-231,24180719,4.7034504904420595
PLC/PRF/5,24180719,4.127629216534508
KMS-12-BM,375860,-0.7808796284755947
TF-1,135999136,1.260535287279569
SNU-601,11455910,0.7913610206716569
JVM-3,100016,3.63486720200834
SK-MEL-31,49766530,-1.960215058686701
UM-UC-1,9936388,-3.585062742404864
CAMA-1,selumetinib-JQ-1 (4-1 mol-mol),1.6036689260374652
COR-L105,71466445,5.452991683251573
MSTO-211H,12003241,-2.79016034960529
AML-193,73707398,0.1090219362628487
PF-382,100016,3.957595275699552
NCI-H810,49766530,-1.6477038589154638
SNB-75,12003241,-1.444419761785008
THP-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.5130704139239983
TUHR4TKB,9903786,3.6038306258320425
Jurkat,10302451,2.000902365022557
TALL-1 [Human adult T-ALL],26596,-1.974209938729662
SNU-449,12003241,0.2005365129445947
BxPC-3,12003241,-1.7282705692868598
JVM-2,3689413,-3.874282045367449
Rh30,327653,2.580303479692579
KMS-20,156414,1.093109837922788
Hs 895.T,10302451,3.366157666522833
MOLP-8,11455910,0.4759456923848041
P12-Ichikawa,107970,2.3007298588505702
HCC1143,11396600,3.529486359294858
SUP-B15,241158,3.019550409629665
TCCSUP,637858,2.4470905671949996
WM983B,54626689,4.781491968938461
HEL 92.1.7,46907787,-0.7435733597095894
BT 428,10302451,3.296855722335022
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
B-CPAP,637858,2.2733284631239044
SNU-1079,637858,2.1328198031741494
Kuramochi,107970,2.378071782828113
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
Kasumi-1,46907787,-2.5065753473574786
BT 482,5460769,4.579365975157546
JIMT-1,327653,3.612061547111272
JK-1,49766530,-2.0838340114086047
8305C,241158,3.792534780111898
KM12,135421197,2.2620714252127336
YD-15,73707398,0.9589848117776284
KMS-26,444795,3.741445044808976
SR,24180719,4.53477547762416
P12-Ichikawa,135875424,3.359554329425199
SaOS-2,156414,1.509432711545826
JHUEM-1,9903786,2.799765938694702
K029AX,9915743,0.8984841793104903
TE-8,9936388,-6.617390334695402
CMK,241158,3.7264216380116193
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
NCI-H2342,46907787,2.1286860710526727
ONS-76,3689413,-0.2845128895134612
TE-1,selumetinib-JQ-1 (4-1 mol-mol),3.3703910260827374
NCI-H2170,46907787,3.956167889910436
HCC2218,262093,2.308676672701105
KMS-11,26596,-4.4422678730324465
NCI-H1105,262093,1.4948338370067744
PE/CA-PJ49,262093,3.242343498921695
NCI-H292,9915743,-0.4817131806939655
KNS-81,262093,3.063139326584166
JHH-6,10302451,4.243008176668727
786-O,46907787,3.0733456424852914
SK-N-DZ,136227924,0.9645463461515836
NCI-H2286,9915743,0.0711668307778549
RD,9903786,3.633793884549444
OE19,375860,0.3956315927623631
Yamato-SS,11396600,4.2294198024767145
NCI-H2029,136227924,2.308767464525173
Aska-SS,262093,2.4925778805334975
T3M-10,6852167,3.076618129408845
NCI-H2170,156414,1.4288887895689582
A-498,3689413,-0.327867250415736
SNU-840,637858,2.902104601766375
KM12,73707398,1.4036404190350429
BT 112,136227924,2.645928432247734
KP-N-YN,selumetinib-JQ-1 (4-1 mol-mol),4.653792080901046
NCI-H211,136227924,1.9167606171360705
BxPC-3,49766530,0.5943123243750338
KHM-1B,327653,2.4267430839124455
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
CMK,46907787,-1.0002189336263791
C2BBe1,46907787,2.8691428959141296
HDLM-2,9929138,7.073059321939057
SCC-9,9903786,2.6448761987997917
KO52,135875424,3.01966044425059
SBC-5,135398744,6.447254342428179
Ki-JK,136227924,2.2053195341815424
PSN1,44491742,3.787418780270154
BT 232,73707398,1.7633386245847071
NCI-H1651,107970,1.540473500145766
BT 145,44491742,4.062519071433911
KMS-20,10231331,-0.0376220922185321
OV7,135875424,4.527719161863161
Panc 08.13,12003241,-0.6066963298008116
MIA PaCa-2,UNC0638-navitoclax (1-1 mol-mol),2.8894676156365
MOLT-3,9903786,0.9925932748260368
CAL-54,44491742,4.012557158379019
AN3-CA,327653,2.9289784088078177
GI-1,73707398,0.9512925339176724
Detroit 562,241158,3.684460199981928
MOR/CPR,10302451,3.971849586071082
ChaGo-K-1,4259181,-4.05678240495267
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
22Rv1,49766530,0.7330336721208812
HCC1500,46907787,2.786329845885891
BT 340,5460769,6.248142012309782
RPMI-7951,71466445,5.865470046063986
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
NCI-H1155,5460769,2.4022459790155413
B-CPAP,44489367,4.992783705245297
HOS,10302451,5.257386528026884
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
KE-39,46907787,0.5111190203360444
TE-4,73707398,1.500912959299055
CAL-85-1,11396600,3.0340075631394248
HEC-151,54626689,4.464334654686751
KCL-22,168313016,4.264267423573641
GSS,327653,2.9951374094188172
ZR-75-30,135421197,0.9431769837232008
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
MCF-7,135875424,4.503633090652972
Li-7,10231331,1.7671950703678494
Caov-3,168313016,5.0841231575962
SNU-620,637858,2.5391555167189614
MHH-ES-1,UNC0638-navitoclax (1-1 mol-mol),4.348872164293784
RERF-LC-MS,327653,4.17889189356682
KYO-1,168313016,5.709011605678993
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203
SK-MES-1,10302451,2.5491443779150273
YAPC,54626689,5.597039319211252
Peer,selumetinib-JQ-1 (4-1 mol-mol),-0.7186159888699871
PE/CA-PJ15,156414,0.0244775870569668
TM-31,12003241,-1.3961411648113156
Hs 729.T,637858,2.029642877140948
769-P,637858,2.2738014282368324
SNU-308,5460769,2.0996672061045976
HuH-1,44491742,4.9230469745960255
NCI-H358,24180719,2.740482662953044
HCC4006,selumetinib-JQ-1 (4-1 mol-mol),2.3344862445657077
HCC1428,selumetinib-JQ-1 (4-1 mol-mol),2.208240466064499
JHOM-1,9936388,-2.304365188363062
KMS-11,168313016,3.7893432463065713
CAL-148,54626689,5.047267101365772
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
SK-N-MC,135421197,1.0109878230238314
KMH-2,12003241,-0.520398442259763
NCI-H2087,107970,0.9807530000225162
HEC-251,4259181,0.5128656675600579
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
JHUEM-3,637858,1.8218805135289704
BT 248,11455910,-0.0312737668402554
SNU-719,327653,3.2757208144159913
SNU-1,46907787,-0.7039913444865674
NCI-H2122,135398744,6.485849720689022
BT 340,262093,2.384282781054805
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
SW579,46907787,2.1305561791309273
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
MCF-7,4259181,0.4892707211739061
PC-14,54626689,4.5901854787123515
NCI-H2405,49766530,-0.8537478871049897
HCC1428,9927531,5.49162668491902
OVK18,3689413,-2.4624871166851965
EKVX,135875424,2.863023045597006
BICR 22,44491742,3.912327775797625
RERF-LC-Ad2,9936388,1.1598877099292195
L-428,135421197,0.7073965487557408
SK-MES-1,9903786,1.5074557756101594
NB4,136227924,2.0986844076590616
Daoy,6852167,2.893676835078427
NCI-H2286,100016,5.552985583261177
PSN1,54626689,4.576672218116635
BICR 6,3689413,-0.1381327952499849
DOV13,135421197,2.464750540362873
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
Raji,439501,-2.4044549184869872
Rh30,9936388,1.7390836835977532
HEC-1-A,107970,2.315887402815249
BV-173,3689413,-0.0500702145216063
MOLP-8,3689413,-2.303477592076259
SEM,44491742,3.581981402307046
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
BT 228,135875424,2.3307111472907263
RCH-ACV,selumetinib-JQ-1 (4-1 mol-mol),-0.4227837844361623
253J,selumetinib-JQ-1 (4-1 mol-mol),1.0702090152450077
COV362,9903786,6.486394788749974
SK-ES-1,11455910,-0.125480247265252
JMSU-1,107970,2.4999599660448664
RL,241158,3.0936457450366057
WM1799,135421197,2.490323876838408
MHH-CALL-3,637858,0.6194049407031013
Rh18,637858,1.8172408807578415
CML-T1,selumetinib-JQ-1 (4-1 mol-mol),0.8733678884698052
NCI-H1184,6852167,1.6538062359818173
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
SW1710,9915743,1.0949390608186476
RMG-I,3689413,-2.168245992738919
RVH-421,644241,1.9074274016396804
HCT 116,262093,3.0489861047493525
SNU-1079,9915743,-4.016291754559019
Kuramochi,6852167,3.266960226178628
YD-15,156414,-0.6443248940127515
Rh41,135999136,4.307553129612744
SNU-119,444795,1.2975403527774965
HCC1438,UNC0638-navitoclax (1-1 mol-mol),3.020359062628678
BT 245,375860,-0.1637313030055035
SU.86.86,UNC0638-navitoclax (1-1 mol-mol),3.1579288284093683
NCI-H647,10302451,1.873701044619417
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
RL,10302451,3.733722680982209
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
HCC1171,11455910,2.1800393678946395
T24,107970,2.9745778553622952
EN,73707398,2.277883684245818
Caki-2,12003241,-1.799336945217181
KMRC-3,10302451,2.024147098710192
ACHN,49766530,-1.8563203862098
MCAS,26596,-1.466898780296629
BT 187,4259181,1.3411496653636976
SKM-1,107970,2.3266449159028735
SF126,241158,3.967394683714564
TT2609-C02,selumetinib-JQ-1 (4-1 mol-mol),-0.0768064994283236
MKN74,5460769,3.534639533895065
ChaGo-K-1,444795,4.90712509154543
A-253,9936388,1.4333351862699826
Hep 3B2.1-7,49766530,-1.5968741678942395
KMS-12-BM,9915743,-0.3780298011492129
HEC-151,156414,1.2927614693415013
HuP-T4,241158,4.238157785514265
TTC-709,327653,2.2719221156396223
NCI-H460,11455910,1.4134750909778395
COV434,375860,-0.1612254056423543
LS513,107970,2.2797374940944284
ZR-75-30,3689413,-2.2209436804776805
MDA-MB-157,26596,-2.8480155125253623
SNU-478,136227924,2.019778672481118
MOLT-13,73707398,0.4538955993003755
NUGC-3,637858,1.9360146170624208
SNU-387,9915743,2.531778656004573
CAL-78,49766530,0.682857440978597
RS4;11,6852167,0.8313885928837619
LK-2,9927531,4.895223263990893
NCI-H1693,327653,3.096149325349242
Yamato-SS,439501,-2.9542074712794517
VM-CUB-1,selumetinib-JQ-1 (4-1 mol-mol),0.0299329512793566
22Rv1,107970,2.2797965792288815
HOP-92,3689413,-2.4488363425715076
MHH-NB-11,439501,-2.5352340677709404
ME-1 [Human leukemia],71466445,4.942504437994406
LOU-NH91,375860,-0.2088041582630222
KMS-20,26596,-2.568893435013116
IST-Mes1,135421197,1.925463420817299
DU145,241158,4.174318462840133
SUP-HD1,168313016,4.538999743906855
Lu-99,11455910,-0.2189814587074641
697,46907787,-2.1488861965501327
A-172,135999136,2.07127965150468
HCC2935,135999136,4.789223967226289
Hs 895.T,6852167,1.764938958894413
KLE,44489367,4.867561911603137
NCI-H69,44489367,5.517795091697192
CA46,107970,1.651382626144423
RKO,73707398,0.9128481241529548
FTC-133,241158,4.091507154193835
NCI-H1869,107970,2.0096354902950178
GB-1,3689413,-2.42348697309168
COV434,9903786,2.975082903645508
OCI-AML-5,46907787,-0.4591254686274671
RERF-LC-Ad2,6852167,2.3505226801926686
RKO,241158,4.5302703569847305
CA46,10302451,0.2515382956842912
NCI-H1299,135875424,3.7950147310792257
NCI-H1693,selumetinib-JQ-1 (4-1 mol-mol),1.8964870202087152
NCI-H196,156414,2.0892379474459037
GCT,262093,1.5309331416086709
OC 314,3689413,-2.4202845950234466
SU-DHL-1,44489367,4.533806271256096
MDA-MB-435S,9915743,4.554328214645058
BT 271,9936388,0.913255428649528
SK-ES-1,6852167,1.4651919042879715
KMS-26,24180719,3.7226536353071857
UACC-257,107970,2.211425151239531
JHH-1,10302451,1.603703322709363
SNU-407,73707398,0.6647043766298382
SNU-1079,71466445,1.115113066325304
LS180,4259181,0.5796574720850999
COLO 741,135999136,4.637543658362488
HeLa,26596,-2.0330393314508868
OCI-Ly10,135875424,5.106467369331284
YD-38,73707398,1.113777458655618
GP2d,439501,-1.2526235353612607
RERF-LC-A1,156414,1.959545548959112
IPC-298,selumetinib-JQ-1 (4-1 mol-mol),-2.676817535219498
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
HCC1143,10302451,1.8641137803790455
SUP-B15,10231331,2.8012447297266907
NALM-6,637858,-0.2798518560160861
Lu-99,54626689,4.41987072052993
Namalwa,3689413,-2.4943268400148715
BICR 31,6852167,2.001013365002547
LS513,9927531,6.189167828595346
COR-L95,637858,1.3348673917451612
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
P12-Ichikawa,24180719,4.307196041482238
NCI-H2106,156414,1.3861609981337029
NCI-H1792,262093,4.0169185554275915
ESS-1,9903786,1.7886366060040666
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391
NCI-H727,3689413,0.3749801507161196
DU145,9927531,4.922928089289864
SNU-1076,156414,-2.8336489406052037
NCI-H661,9903786,4.646166413465223
VMRC-LCD,10302451,3.928958385850413
BT 232,10231331,3.6027232306656933
Mel Ho,12003241,-1.328246141696159
K029AX,439501,-1.43360047701671
Hs 746.T,UNC0638-navitoclax (1-1 mol-mol),1.0511790307872622
PK-45H,11396600,6.037310564900793
SNB-75,6852167,3.854897598564988
MDA-MB-435S,107970,2.3053857954892742
MHH-ES-1,6852167,1.3235332252332372
SIG-M5,24180719,-1.1806497001291554
SW1417,54626689,5.0807582289879
KE-37,49766530,-2.520266355553242
22Rv1,135999136,4.349739635114316
GCT,24180719,2.9090175363690354
BFTC-909,136227924,2.3418993883842134
Kuramochi,BRD-K27188169-navitoclax (2-1 mol-mol),3.668553206374167
ME-1 [Human leukemia],BRD-K27188169-navitoclax (2-1 mol-mol),-1.1992290333774671
HEC-1-A,11396600,3.204796240985317
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
SNU-1,637858,1.0076801628048304
LN-18,selumetinib-JQ-1 (4-1 mol-mol),2.352155313347565
Detroit 562,9903786,2.622976915424344
HCC2108,selumetinib-JQ-1 (4-1 mol-mol),3.0515246299931205
LXF 289,12003241,-2.348837864712453
SET-2,4259181,0.1167213945949705
G-292 clone A141B1,73707398,0.1616989889265252
SNU-466,10231331,4.3204156342714715
JHUEM-1,9927531,4.870867049217503
HCC38,637858,1.176311415615167
RKN,10302451,3.971829298943927
BT 139,107970,1.8298356347130915
HSC-4,5460769,1.9290612526481368
UACC-257,156414,3.1876914879153984
BFTC-905,136227924,2.194418567728585
Mono-Mac-1,72967,4.124255908419064
A4/Fukuda,5460769,3.0365194168079572
SK-N-MC,135999136,1.3861351428117616
SW579,11396600,3.356641244231253
SJSA-1,439501,-2.834147074322405
BT 286,9903786,1.725049982792706
HuH-28,5460769,2.112533024093989
SU-DHL-1,4259181,-1.4222017445817885
KYSE-30,135421197,1.7734254693963984
AML-193,107970,1.008310161545622
EC-GI-10,71466445,5.620190449625078
KYSE-70,46907787,2.9670215892594793
G-401,262093,2.911602765721858
NCI-H322,9936388,3.3425282984485656
KYSE-520,12003241,-1.836986739794001
KO52,44491742,3.2759729423779103
HEC-1-B,136227924,3.6469104939920154
SK-N-BE(2),135875424,2.863964710968437
SNU-407,49766530,0.1037791929989153
NCI-H647,54626689,4.686941591996974
BHT-101,3689413,0.1910629182476014
BT 131,UNC0638-navitoclax (1-1 mol-mol),1.908727174025509
NCI-H929,5460769,1.81013287796662
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
SNU-1272,637858,3.0444768805463465
OE19,selumetinib-JQ-1 (4-1 mol-mol),4.339166063556634
SNU-685,439501,-2.253643843124453
HT-29,selumetinib-JQ-1 (4-1 mol-mol),2.436079004945063
HuH-1,439501,-2.8772683526572496
JHH-2,71466445,6.302834522641025
LoVo,100016,6.001395250082881
SNU-C5,327653,2.2876763505063566
HGC-27,selumetinib-JQ-1 (4-1 mol-mol),2.474282481636993
KMS-20,135999136,4.473937191041351
COR-L95,3689413,-1.01311028513846
JHOC-5,9936388,2.2786503857706593
M059K,12003241,-0.3753342750649466
YD-10B,135875424,2.966969780143732
RL,100016,6.4335673885856135
DMS 53,375860,0.9049082693788552
KYSE-410,375860,0.3539761529169563
TM-31,3689413,-2.3957166593643104
BT-474,12003241,-0.1629967020972257
KMS-21-BM,44489367,4.17704374385352
HOP-92,54596490,4.357567293340528
SNU-1077,9903786,3.350516769184116
JMSU-1,100016,3.921608363156487
SW948,444795,4.960330673315111
HCT 15,375860,-0.5583301050627271
HT115,9936388,-5.559170111556583
Kelly,637858,1.5339565907917991
RPMI-8226,12003241,-0.708602453849348
BT-549,262093,3.1295246575488354
Panc 02.03,100016,6.582809568040202
NCI-H460,136227924,3.925006850615035
COV434,9915743,-0.2434354150711091
K-562,24180719,3.2747438118023533
FaDu,4259181,1.098018003238
HSC-2,444795,4.293399719152513
TCC-Pan2,73707398,1.5554372616502647
IST-Mes1,selumetinib-JQ-1 (4-1 mol-mol),0.7556363714344752
LS180,375860,-0.0541765269880971
2004,3689413,-2.0950734579660417
NU-DUL-1,327653,2.423174804132232
TE-5,9903786,3.304893690679265
CAL-29,156414,1.0955099591770534
NCI-H647,156414,2.1873385810737043
NCI-H2126,6852167,3.4187540293096106
HEC-1-B,241158,4.361747370873768
GSU,46907787,1.9668852323778605
HOP-62,4259181,1.6890698920595109
BV-173,136227924,2.1412277594985816
HGC-27,54626689,3.6847810571078936
BFTC-905,9915743,1.39772044573247
EPLC-272H,156414,-1.0107061840170948
HCC95,selumetinib-JQ-1 (4-1 mol-mol),0.4273461795026718
KMS-18,3689413,0.1282967701093688
VMRC-RCZ,135999136,4.588924618132249
SEM,100016,5.238818929389881
SNU-620,11396600,4.54842563346304
OCI-AML-5,135875424,2.7043595166369694
NB4,327653,2.4394737339105452
TALL-1 [Human adult T-ALL],BRD-K27188169-navitoclax (2-1 mol-mol),-1.288900055854488
NU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),-0.9508883032540202
NCI-H1650,135999136,4.9140472114579365
LCLC-97TM1,375860,-0.9613247940016756
Hs 683,135875424,4.08610069423659
Peer,12003241,-2.4634872028083015
SYO-1,71466445,1.798579929211262
SNU-478,73707398,0.6264771931816725
KNS-81,9927531,4.88247851361275
RVH-421,73707398,1.5982063563026574
MKN74,44491742,4.321441779997771
HCC78,100016,6.366939598030235
MOLP-2,136227924,2.531478892468582
KE-97,327653,2.8684214732318094
AsPC-1,54626689,5.229882111208764
769-P,9936388,1.480470549487973
BT 498,135999136,3.3192669973744273
A-549,selumetinib-JQ-1 (4-1 mol-mol),1.5948722522654506
AU565,156414,-1.7188953203880928
HCC1588,637858,1.5531111300248248
K-562,135999136,3.657737204061429
KNS-62,9936388,2.361337776362267
NUGC-4,49766530,-0.8370280457407315
CA46,156414,1.2808873732328336
SNU-1033,4259181,1.0677542833514009
MKN7,44491742,4.213117229463602
SNU-8,49766530,-3.645853792041198
BICR 18,9903786,1.845690489746328
A3/Kawakami,49766530,-0.4479480669957117
KYSE-510,12003241,-0.1961434673469709
MIA PaCa-2,49766530,-2.3545367349028097
KALS-1,4259181,0.4925771943360276
KMH-2,135421197,1.1476668863331456
LoVo,262093,2.370412929490009
NCI-H1666,4259181,0.6541151201213545
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
MOLP-8,54596490,4.413151323823571
P12-Ichikawa,44489367,5.078588961067148
Raji,11396600,3.2888358336472496
8505C,135999136,4.3130615236691545
SNU-466,12003241,-1.792822949683991
K-562,327653,3.3038748071855175
HGC-27,6852167,0.8540634851742253
HCC-56,73707398,1.6052927593856017
NCI-H2106,71466445,4.59533809692137
TT2609-C02,46907787,0.4476463508004357
NCI-H1666,54626689,4.1000823545886895
SU-DHL-10,327653,3.666046340161681
22Rv1,73707398,1.1279645952785575
SNG-M,4259181,0.7093917409356426
BICR 22,46907787,3.4905986586009843
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973
TTC-709,637858,0.9125312609404584
SK-MEL-5,4259181,0.9764517115857632
Rh30,BRD-K27188169-navitoclax (2-1 mol-mol),4.056218450579192
CGTH-W-1,439501,-2.6325140773837012
Peer,135421197,0.5765613346520675
A2780,44491742,3.4077888459991774
YD-10B,136227924,2.2440881554064105
BT 232,637858,2.601842990384653
OVISE,4259181,0.909929291036465
SUP-T1,3689413,-3.2638224504497195
P-STS,46907787,0.2337438016095803
IGR-37,375860,-0.4375644933586405
JMSU-1,135999136,1.9983092293214295
TTC-709,3689413,-2.3273701449747985
HCC95,5460769,4.4862905703550355
NCI-H508,49766530,-1.9711369921584831
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
SF268,73707398,1.033344286819735
MOLM-13,135875424,3.721528356214304
HEL 92.1.7,26596,-1.1995167561269164
MCF-7,71466445,4.436792389060464
PaTu 8902,136227924,3.2072125986231117
NCI-H810,54626689,3.730467295425816
SNU-840,327653,3.6160038244402495
EKVX,262093,3.2676110256725712
MFE-296,135875424,3.004641901934104
HuG1-N,168313016,4.445071492240178
EBC-1,71466445,3.3244072972986807
OVCAR-8,73707398,1.0104900888646875
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
U-87MG ATCC,3689413,-0.5776108875278053
Lu-99,9927531,4.1215148534256105
SK-LMS-1,6852167,3.2249832474571893
AU565,71466445,4.046585104708946
BT 286,241158,3.931607244311501
COR-L88,9936388,-7.008316023847794
IGR-37,54626689,4.807071545239909
RVH-421,12003241,-1.8374248826372317
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
ONS-76,439501,-2.2755976390662163
NCC-StC-K140,375860,-0.6581555419852907
SK-MEL-24,11396600,3.3796631473976135
T98G,selumetinib-JQ-1 (4-1 mol-mol),2.813131207617802
KP-4,100016,6.84348879863886
DMS 114,6852167,2.821069829391007
NCI-H1299,73707398,1.237381568912588
BT 340,11455910,0.6869107925797121
COLO 684,135999136,3.371101164094913
697,107970,1.291277302319886
CAL-78,5460769,3.8399978594136193
HCC1428,6852167,3.9736083121297288
NCI-H1651,135421197,1.3042680543887686
HCC44,156414,1.2640813526571373
KALS-1,156414,2.413374739256189
GB-1,12003241,-0.733058723008687
HSC-3,26596,-1.4868403003967878
BT 239,9915743,1.0912084303287637
NCI-H1563,44491742,4.074873654245284
NCI-H2023,9903786,4.254062749563359
SNU-1,262093,3.13624265052581
SU-DHL-8,26596,-2.3999944738407257
NB4,3689413,-2.3833174829698085
Rh18,135421197,3.2073141034499577
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
PC-3,3689413,-2.1836829404040157
IMR-32,136227924,2.2103917598606326
OCI-AML-2,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2061375708820543
TUHR14TKB,262093,2.19350220661364
COLO 320,9903786,-0.1996043978745841
EB1,10302451,0.5796206365832764
ONS-76,100016,6.019166856387977
KNS-60,439501,-2.666798913296539
SYO-1,11396600,4.152528244885972
CAL-62,10302451,3.3988758724895076
HCC1806,375860,-0.04565763318165
IGROV-1,9936388,2.10108466287406
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038
WM983B,10302451,3.572135082387995
P31/FUJ,11455910,0.7543092217738059
HT-1080,9915743,2.579690358518253
NCI-H2196,637858,1.290993907845002
L-540,44491742,3.302641301804856
YH-13,selumetinib-JQ-1 (4-1 mol-mol),2.881387318518872
HEL 92.1.7,3689413,-2.453708704317935
COLO 678,49766530,0.1111976795656789
SCC-9,100016,6.423023301160456
RMG-I,327653,2.533792218134815
KMRC-1,637858,3.0556928718558707
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
MeWo,135875424,3.994936562823645
NCI-H2081,327653,2.703400517065932
HCC1195,10231331,1.190047667389913
LS513,10231331,-1.4270487616040106
A-549,4259181,-1.4635956785215285
HEC-151,44491742,3.809390131450424
MES-SA,439501,-2.264210619464941
EPLC-272H,439501,-1.68247015094151
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
SNU-423,24180719,4.009058877663273
COR-L105,241158,4.618729119434587
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
253J,4259181,-1.4081977312183471
RCH-ACV,9936388,-7.0347905205950765
Jurkat,9903786,1.902939896932713
786-O,4259181,0.4460597057437915
MDA-MB-415,135999136,4.973861835319697
KNS-60,136227924,2.463930704521007
SW579,135421197,1.841394745286318
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
KE-39,4259181,-0.84210776373342
AsPC-1,107970,2.236934549480267
SiMa,6852167,2.4572377935660037
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
FU-OV-1,262093,2.4810055989466018
THP-1,156414,0.8804557135559825
ChaGo-K-1,3689413,-1.075301905965469
SF539,11396600,2.4945499602014487
PC-14,136227924,3.162840410264972
WSU-DLCL2,3689413,-4.959446620100962
TCC-Pan2,9929138,7.681781953750215
U266B1,375860,-0.8204266898735075
WM266-4,49766530,-0.4074764037641682
F-36P,46907787,-0.7684715218448218
HuG1-N,9915743,3.4035980439406432
MOLP-8,44491742,4.067907034019371
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
UACC-812,9936388,-5.022392750910281
OAW28,135999136,1.5944266420299655
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
NCI-H1339,439501,-1.6994812988125017
Lu-65,46907787,3.3131734896161444
G-292 clone A141B1,637858,1.3689975755883457
HEC-1-B,637858,2.0958235368347293
HCC1195,4259181,1.5243000319349156
PK-1,11455910,1.3401068508197878
HCC78,73707398,1.3403643878686862
Panc 10.05,637858,1.877223323246833
HEL 92.1.7,selumetinib-JQ-1 (4-1 mol-mol),0.8853993447032109
NCI-H1792,10231331,1.4633013608252372
COLO 678,107970,1.689165488290766
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
VM-CUB-1,46907787,-0.1808741907084093
NCI-H1793,54626689,4.096575876998522
COLO 800,selumetinib-JQ-1 (4-1 mol-mol),-0.1854936037479787
MOTN-1,6852167,1.1725623710698938
Caki-1,262093,3.8219578030465033
LS123,12003241,0.0406446748290718
SW1271,12003241,-1.4062779923685875
HT,6852167,0.7668896132234709
KNS-60,46907787,3.1008858460670905
SNU-C2A,327653,2.894995491136924
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
LCLC-103H,71466445,3.510295389264131
TE-5,10302451,1.837949927472816
SW579,156414,1.6193105728841577
KYSE-180,9936388,-5.3897473887689
REC-1,selumetinib-JQ-1 (4-1 mol-mol),5.213062841516755
SK-MEL-1,107970,2.4240588929392715
LK-2,10231331,4.441960885168861
Pfeiffer,375860,-1.9122388106642976
SF539,637858,1.5175949767978318
SNU-407,3689413,0.4751617374249986
SW1088,9936388,2.2762478176067504
SNU-407,44491742,3.765091282887518
SF126,11455910,2.6986445536104138
YKG-1,156414,1.711503789054189
KE-39,24180719,4.116999771545502
SNU-1079,10302451,-0.8712691050913255
COV644,46907787,2.399255398547224
PC-14,9927531,4.079128694018213
L-540,9903786,1.612072273929478
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
Panc 05.04,9915743,-0.1908442283292951
BC-3C,44491742,3.863176048034213
ONS-76,26596,0.1332187247782509
Mino,375860,-0.5060371680285715
Ri-1,6852167,-0.591407289651703
PaTu 8988s,135999136,4.429569126789119
EHEB,375860,-0.9049347764221136
Kasumi-2,637858,0.3812755763700117
LS123,262093,2.2774181206163018
HCC2279,241158,5.839446783664071
NCI-H1869,156414,1.3059713748980704
NCI-H292,262093,2.9868554632365556
MDA-MB-415,73707398,1.5258742521817483
SR,73707398,0.885476765811656
L-540,107970,2.1674122993429252
NCI-H661,12003241,-1.8871798966926587
Calu-6,10302451,3.8675948224164873
NCI-H2023,10302451,4.238288673269683
NOMO-1,26596,-2.074766602044621
KNS-42,135421197,1.7884636185596865
KMS-34,12003241,-3.0064029669480528
LN-229,44491742,4.497083507897472
TCCSUP,241158,3.99107653461265
GOS-3,100016,7.242262816552233
Calu-1,135875424,4.2506874987837024
TE-11,12003241,-1.4991757511197057
GP2d,9903786,1.6186361299968774
NCI-H2286,54626689,5.416606874702902
HMCB,135875424,3.5183087899290686
KM12,156414,3.95208807087735
Calu-3,71466445,2.6015778955315407
L3.3,637858,2.497804094781357
A2058,73707398,1.8585898108228869
NCI-H1975,12003241,-2.295585009641022
WM88,11396600,2.133090606668807
A101D,49766530,0.6153321218578233
TF-1,444795,6.324567376805602
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
NCI-H1184,262093,1.9402045938209425
SK-BR-3,73707398,0.4064106830128078
A-549,6852167,2.2085984360403663
WM983B,4259181,-0.5261677537027811
NCI-H1703,6852167,1.7470383195809174
NCI-H2126,selumetinib-JQ-1 (4-1 mol-mol),1.9908852314747592
KYSE-70,135398744,6.338938630156892
HEL 92.1.7,9915743,0.818697547230163
SET-2,9903786,0.1058309934713531
NCI-H889,135999136,4.223038519760353
NCI-H69,4259181,-0.3416455237063791
DMS 53,10302451,3.896774436876792
Hs 895.T,3689413,-2.343534689562226
NCI-H2029,11455910,1.1545705407069018
CML-T1,241158,2.0968023336421227
U266B1,9915743,0.5964925492166065
HSC-2,11396600,2.2102241778250757
MOLP-2,444795,4.339225074199232
KP-2,12003241,-1.0131753515014823
TUHR14TKB,135875424,2.9544471921358944
NCI-H2405,11455910,1.6640905380907716
YD-10B,9929138,5.087034787927538
NUGC-3,107970,2.2870652507466156
DU145,49766530,-0.0443271676579987
SNU-668,9927531,6.94205854979306
OCUM-1,107970,1.812300160781112
SNU-182,262093,0.4168376562229068
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
CFPAC-1,12003241,-0.6323170147703681
NCI-H2228,136227331,3.956978031272767
RPMI-8226,11396600,2.661670578170676
KP-N-SI9s,135421197,1.130974840483334
HSC-2,9927531,4.076262005833891
YH-13,439501,-2.216859157731525
IGROV-1,439501,-2.1510551928674557
SK-MEL-2,11455910,1.0662653811839238
NCI-H1869,375860,1.5517292037743613
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
SNU-46,135999136,5.748534430136229
HMC-1-8,135875424,3.5952222830478364
HCC1428,439501,-1.870619220326862
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
MKN7,135875424,3.97567031740838
NCI-H2106,6852167,4.160945846818268
Mel JuSo,10231331,0.9125866595415298
KMRC-3,44491742,3.892317452433475
JHH-4,11455910,0.4294886649556081
Hs 888.T,26596,-1.257833689984314
EPLC-272H,selumetinib-JQ-1 (4-1 mol-mol),-3.103234599645093
IM95,44491742,3.8617516807929873
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
Rh30,11396600,3.5985518110360997
NCI-H1155,4259181,-0.3371626256760442
NCI-H1184,46907787,0.1164433785764037
BT 245,168313016,5.350977355116985
Fu97,6852167,1.3919958052442372
BT 179,375860,-0.2104297204099122
UM-UC-1,135421197,1.1725143747551234
EN,3689413,2.688418705808367
C2BBe1,10231331,5.91991778505206
639V,12003241,3.941533367074586
FaDu,9936388,1.704724007289382
BT 159,10231331,4.0293232500193845
HEC-251,107970,2.646140813822107
DK-MG,9936388,-7.3302132848609665
SUP-B15,135421197,1.049763554342806
JHH-5,9936388,-4.7805778905113705
BT-16,637858,2.509868277109157
CHP-212,644241,2.544720169894308
KMS-21-BM,4259181,-1.425243005712458
KE-37,73707398,-1.1916852271114504
K-562,135421197,2.032823128578147
2004,9903786,1.8272851025318924
TE 441.T,UNC0638-navitoclax (1-1 mol-mol),1.000062005612718
SNG-M,107970,2.3024806168242224
HEY A8,444795,4.655736917004839
SU-DHL-1,135875424,2.8587183873170847
ACHN,241158,5.588735274561884
NCI-H2171,71466445,1.378191899492029
DoHH2,3689413,-5.86508857802515
NCI-H647,9927531,5.004225610104877
MHH-CALL-3,5460769,1.3871224464271157
OCI-AML-3,168313016,3.888373508395693
HEC-251,262093,2.9573459973674985
OCI-M1,UNC0638-navitoclax (1-1 mol-mol),1.3490882330999483
SUP-M2,10231331,0.1284921122273066
Daudi,26596,-3.612902475241139
SW620,46907787,4.128718909991831
NCI-H647,10231331,3.723669651517376
SUP-T11,241158,1.0042355726441765
COLO 201,135875424,3.4896254753557354
SR,9929138,6.2909687425027405
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
NCI-H1792,107970,2.9959713760395763
NCI-H727,241158,6.115461447477091
M-07e,327653,2.415097194547363
J82,9903786,4.0002373465355054
SNU-626,12003241,0.7059762795421864
SW948,637858,1.5262532123254355
SCC-9,5460769,4.655053652221148
5637,selumetinib-JQ-1 (4-1 mol-mol),-0.7167442987429579
Mono-Mac-1,241158,3.016187818443372
NCI-H446,241158,2.8273295901889273
NCI-H1693,135875424,2.849397745802666
MES-SA,26596,0.3162950796632606
HT115,46907787,-0.537623842088779
NALM-6,439501,-2.425379213431436
OE19,10231331,4.637598127525754
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
MKN7,262093,2.224966476841938
NCI-H1568,4259181,0.5766231269303183
J82,439501,-1.5072353700594
NCI-H28,49766530,-2.0478449077556826
BT 179,selumetinib-JQ-1 (4-1 mol-mol),2.623374795423357
HuH-28,9936388,2.0438791197733632
WM115,11455910,0.9860510612095932
PF-382,24180719,4.536989460755837
NCI-H2196,11396600,3.4925760347357
Panc 03.27,135875424,4.313798765654786
NCI-H2171,136227924,2.167829841056951
NCI-H2023,6852167,3.239571554271464
NCI-H1755,156414,1.1123592928072572
NCI-H1105,54626689,4.494822335417732
NCI-H650,9936388,2.384400355821072
MOLP-2,262093,2.2971706880531757
Hs 895.T,49766530,-0.4019815670420401
JK-1,10302451,-2.112051383463461
TOV-112D,10231331,5.961074518530357
Hs 746.T,135999136,4.038871397264603
G-401,26596,-1.5666727843222663
HEC-1-B,135875424,4.054775379166637
BICR 22,135875424,4.925705128316808
HCC1806,selumetinib-JQ-1 (4-1 mol-mol),2.499092919245046
RPMI-7951,262093,2.547304876719483
P-STS,9936388,0.552871605050304
SNU-886,4259181,0.9120616711669954
JMSU-1,439501,-3.223216777280016
BT 232,4259181,1.35980761769268
MKN74,BRD-K27188169-navitoclax (2-1 mol-mol),3.3122214634660287
SCC-25,439501,-2.292727593069412
Reh,3689413,-0.3766335135286286
KMS-12-BM,156414,0.8404794203086158
WM88,73707398,1.223752817996938
MHH-CALL-4,637858,0.6402103133022878
UACC-257,136227331,4.461620315172803
SNU-761,156414,2.0745932616636664
NCI-H2052,135421197,2.7850999570051003
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
RPMI-6666,12003241,-3.2897330659592705
NCI-H1373,135875424,5.093925660594389
HCC2279,9903786,3.291578502930839
KMRC-3,46907787,3.1191324393866666
BICR 6,26596,-1.5869658496484045
SK-UT-1,637858,2.463996188946881
EBC-1,44491742,3.57682955784604
KYSE-520,9936388,1.4275069153979305
Caki-1,135999136,4.348933102663563
SNU-1041,9903786,3.9190312975923822
MKN1,9915743,2.5735660173658323
COLO 668,262093,3.0831926825612586
HeLa,107970,2.289164047292083
KG-1-C,135875424,3.0761511771820573
SUIT-2,11396600,4.33113824085374
YD-15,9929138,6.969661467519232
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997
JeKo-1,11455910,-0.102644590273409
TE-6,selumetinib-JQ-1 (4-1 mol-mol),2.8882267841059774
Li-7,26596,-1.7379173085827686
CMK,9936388,-7.015739641414748
8505C,9936388,-0.6863572564067597
SNU-16,71466445,2.4496252530891525
BT 340,644241,3.2445197760209505
BEN,9936388,2.3760143279303096
MOTN-1,637858,0.888223152245666
JMSU-1,136227924,3.0914793862161747
BICR 22,100016,6.157225392196351
OV-90,46907787,3.848595934568226
NCI-H727,9936388,1.6432072244848812
TE-6,UNC0638-navitoclax (1-1 mol-mol),3.0125565049053487
PaTu 8988t,73707398,1.170719580837983
COLO 792,637858,1.0332594159439463
HCC366,100016,6.086233690393214
NB4,12003241,-0.9132683604987908
HLF,100016,6.001250521147636
Daudi,46907787,-0.707382985228944
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
MDA-MB-157,12003241,-1.4339892472843776
8305C,46907787,-0.7427270894161048
JHUEM-3,135999136,3.851371077820259
EPLC-272H,327653,3.124560122706516
NCI-H441,241158,4.194222979464958
TOV-112D,3689413,0.2430902307838531
OC 314,44491742,4.454392522958538
EB1,439501,-3.6025033052563553
BT 428,11455910,0.0710771584645227
Hs 852.T,135875424,3.670536454912576
A-549,9936388,1.4749208650316612
TE-5,46907787,1.9285123682703753
KMS-21-BM,12003241,-1.038159466289584
KE-39,135999136,4.6219900849735325
U-937,12003241,1.6522375422653783
BC-3C,selumetinib-JQ-1 (4-1 mol-mol),2.3865928246681336
GCT,73707398,0.6993687906747118
KP-3,5460769,4.226589336768475
JVM-3,44489367,4.282453950749618
KYSE-30,selumetinib-JQ-1 (4-1 mol-mol),3.305713321992504
IGR-1,selumetinib-JQ-1 (4-1 mol-mol),-0.1009850774874795
ALL-SIL,6852167,2.025737624061405
BT 422,135875424,2.9816233876655387
BICR 6,327653,3.165378082168026
MHH-CALL-4,46907787,-0.722309996072336
HuH-1,9903786,2.716851853041897
NCI-H1693,10302451,0.2338111119921639
PF-382,44491742,5.368678247108403
A2780,135875424,2.703796648613349
HCC1500,4259181,0.9827468065480526
MOLT-16,71466445,1.8215054764803564
HOP-62,10302451,2.804324049095648
Granta-519,135875424,2.983761714085865
BICR 56,637858,2.3725324595184185
NCI-H196,11396600,4.033022120096851
NCI-H2122,26596,-0.3703174924227287
AGS,637858,2.5349975382958294
MPP 89,9927531,5.277486378374347
RPMI-8226,9929138,6.391388582144063
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
JHH-1,12003241,2.181152294070196
BT 164,selumetinib-JQ-1 (4-1 mol-mol),2.475873893186851
SCC-4,439501,-2.9533139403217397
NCI-H1184,26596,-3.790175824084468
NCI-H727,12003241,-0.657143782776601
KNS-60,9927531,4.453206768801637
NCI-H1734,24180719,2.363153806186681
Lu-99,9936388,-2.3280603077053317
Kelly,107970,2.1359224191736796
NCI-H146,644241,1.2089846023639548
ACC-MESO-1,3689413,0.4162012666414902
Rh30,168313016,5.331123133929558
PE/CA-PJ49,71466445,3.0052586534681645
NCI-H716,11455910,0.5118733249267832
NCI-H810,selumetinib-JQ-1 (4-1 mol-mol),1.3010994394801945
VMRC-LCD,241158,4.61265608430858
SF268,44491742,4.062737154124887
NCI-H322,6852167,4.306566159353396
MeWo,375860,0.0049768320304234
IA-LM,241158,3.7495123409873528
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
NCI-H1568,262093,2.8880881470868585
MFE-296,135421197,4.335521235356187
Lu-65,135875424,4.016301544047221
TE-11,11455910,1.33460610412381
TE-8,73707398,0.912270343350113
HEC-251,12003241,0.0135079560064688
TE-5,135875424,4.0614047836246
HT-55,107970,2.0894496787312313
NCI-H1869,49766530,-0.032716755694371
Hs 822.T,9936388,2.249829055538111
DMS 454,11455910,1.2938635688773483
A3/Kawakami,11455910,-1.104878748608077
EPLC-272H,9936388,-6.231113427915417
K-562,10302451,0.1323934402367818
BT 444,107970,2.33891923497999
A-172,168313016,5.106297252046059
Panc 02.03,107970,3.0394503344184214
HuH-6,12003241,-0.3879852820159472
CCF-STTG1,73707398,2.079175010578171
KLE,10302451,4.42053427640389
ME-1 [Human leukemia],135999136,4.558571069428398
HSC-3,73707398,1.0290894823159855
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839
HT-29,107970,2.4408786211606226
OAW28,327653,3.155680016062074
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
HPAF-II,10231331,1.5877031286420482
SK-N-MC,12003241,-1.5670005679110546
NCI-H2126,9915743,3.640256854727969
BV-173,11396600,2.9579324152439224
Li-7,selumetinib-JQ-1 (4-1 mol-mol),-7.070557349165433
EPLC-272H,73707398,0.7206305777931009
SK-N-FI,637858,1.275762804618504
SNU-840,107970,2.850093670381666
MDA-MB-361,156414,-0.6405149363792559
DU145,9936388,-2.7050109048591287
NCO2,5460769,1.276478801243687
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652
SNU-308,135875424,4.501679724510711
Panc 05.04,71466445,2.9988870085628165
HCC1954,262093,2.719302502923702
GI-1,49766530,-2.6650453503199776
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
NCI-H2170,100016,6.477443817994488
BT 164,12003241,-0.888203268787868
CAL-51,9903786,2.1849161121493847
EoL-1,71466445,0.1992433528179963
COR-L279,135421197,1.2327200147457915
LNCaP clone FGC,3689413,0.5325071990753445
RVH-421,46907787,3.7950027413321306
COLO 741,6852167,4.031174198198206
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
Hs 944.T,44491742,4.471544496147254
SF126,107970,2.3765754029032773
CAL-54,327653,3.490763598800991
NH-6,54626689,4.582553312129729
COR-L105,44491742,4.003695029376484
Kelly,10302451,3.349528438105202
SK-OV-3,107970,2.5604111984812152
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
HCC2279,4259181,0.9325870941028492
BT 422,135999136,1.6828969655433983
SNU-503,135421197,3.1341230661682125
MOLM-6,241158,3.2247883618399444
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
CCF-STTG1,6852167,4.451400297706149
HuG1-N,262093,3.534679932173412
Jurkat,44491742,-1.1697965410945943
UO-31,136227331,3.2031973353809833
MCF-7,9936388,1.4763358152049189
NALM-6,135875424,2.687254524498793
SEM,3689413,-0.1393923728957227
NCI-H211,11455910,-0.4390844400246115
DMS 114,11455910,0.636471074405143
Granta-519,49766530,-2.591856607816134
SK-MES-1,637858,1.374960774456644
VM-CUB-1,3689413,3.0900699567187013
OVCAR-4,241158,4.740656207396031
BICR 22,3689413,1.1307119933583345
HCC1833,10231331,4.172766842331065
SNU-626,73707398,1.6076526777595226
Caov-3,9936388,-6.651302664748808
EPLC-272H,135875424,3.5284269616389943
FTC-238,439501,-2.852234724495685
BL-70,241158,1.7812102764916156
SNU-216,100016,6.2010021575017085
SNU-407,444795,5.198512423866144
A4/Fukuda,3689413,-1.7998697854540155
Rh41,135421197,0.890799382686484
NUGC-3,73707398,0.756281056203992
BT 239,10231331,1.4016139195268935
BT 271,107970,1.5328862908650924
KG-1-C,UNC0638-navitoclax (1-1 mol-mol),0.3093766679731706
BT 228,11396600,1.874591390979962
AGS,5460769,2.317513443937506
JM-1,4259181,-0.0762731042787348
Capan-2,9903786,4.9592857340128385
SK-N-BE(2),168313016,5.114415680164609
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906
COLO 201,327653,3.050776662774606
8505C,327653,2.966511809444347
BT 248,644241,1.8454939937856112
SCC-4,UNC0638-navitoclax (1-1 mol-mol),-2.0380120299925433
SK-ES-1,5460769,0.8929417744322142
NCI-H841,26596,-2.5240216748283393
HEC-59,135875424,3.434837292372321
KMS-26,136227924,1.9705002365993127
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
HuH-6,73707398,0.8885405709685146
Hep 3B2.1-7,107970,2.24352532481949
K-562,136227924,2.737847329779252
EBC-1,UNC0638-navitoclax (1-1 mol-mol),3.6336601547096503
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
OE21,3689413,1.0863405783683666
SU-DHL-6,9903786,1.8029536633965553
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
Hep 3B2.1-7,439501,-1.9738642324779276
NCI-H1581,375860,-0.5344860443277677
DB,10302451,3.614342806330988
SUP-T1,selumetinib-JQ-1 (4-1 mol-mol),-0.508172798980745
Karpas-299,71466445,2.2248556118041956
U2OS,UNC0638-navitoclax (1-1 mol-mol),-0.5881639591710891
KMBC-2,UNC0638-navitoclax (1-1 mol-mol),-0.2443441372437479
KE-97,9927531,3.606406667936729
HCC1438,9936388,-5.250044991536538
SNU-C4,selumetinib-JQ-1 (4-1 mol-mol),3.2526553861224836
LNCaP clone FGC,100016,6.505127339133147
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112
RL,9927531,3.353152417945259
NCI-H358,44491742,4.317463726649291
NCI-H1105,selumetinib-JQ-1 (4-1 mol-mol),4.102386120760642
NCI-H508,73707398,1.2275898465257518
BHY,136227924,2.366046867351899
DU145,73707398,3.2547142234589126
YD-10B,9927531,6.486218545334236
EPLC-272H,9903786,1.2271384419186997
JK-1,9903786,1.7060026782988165
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
SNU-182,11455910,3.5316691934445372
HPB-ALL,262093,1.2966531532879173
HCC1937,6852167,3.606828986673197
OV-90,327653,3.1964593006491664
Hs 294T,241158,3.871652959751704
SUP-B15,46907787,-0.2691985239437229
KMS-20,selumetinib-JQ-1 (4-1 mol-mol),-2.1329666207384124
CML-T1,5460769,1.000954417912476
TALL-1 [Human adult T-ALL],644241,1.986860911521218
KMS-20,107970,1.4633641977001968
U-937,241158,3.3313730449185113
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
NCI-H1703,135999136,4.447228934762928
BICR 6,46907787,3.814885233730211
BT-20,4259181,1.436733914806858
JHOS-2,9936388,2.4979733354975773
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
IGR-37,136227331,4.32939216676153
JHH-4,44491742,4.756848275600054
SUP-T11,444795,3.188342205586965
SNU-1066,3689413,-0.3741974458844401
MDA-MB-453,10302451,3.3014196832790628
Hs 822.T,54626689,4.785695901624994
697,9915743,-1.2877511169277274
SEM,135421197,0.5141119166667375
LN-18,12003241,2.3352832275998927
KYO-1,439501,-2.3318531278707555
RPMI-8226,10302451,3.242830443900823
MDA-MB-468,6852167,2.5398355131679886
SNU-46,262093,2.777218393099506
MSTO-211H,11396600,3.2938939565791765
Capan-1,107970,3.0385955558587434
COLO 829,10231331,-1.138980901640988
TE 617.T,12003241,-2.151805000440827
F-36P,135875424,2.6086131482089363
HCC1143,3689413,0.0716522323698814
PLC/PRF/5,6852167,3.832431058074985
AML-193,375860,-0.9246349933126312
MCF-7,439501,-2.51567390987342
HL-60,49766530,1.1453309836966632
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
FTC-238,135421197,2.4336090665615115
SNU-1,9936388,-8.466890078347713
SW1088,6852167,3.083915220127574
NB1,selumetinib-JQ-1 (4-1 mol-mol),1.785319737848639
HEC-151,BRD-K27188169-navitoclax (2-1 mol-mol),2.581586549309544
TCC-Pan2,107970,2.8606881993885738
EC-GI-10,439501,-3.666361132208791
SCC-9,11455910,1.869884665357408
SK-LMS-1,selumetinib-JQ-1 (4-1 mol-mol),2.2731779644264645
HCC1171,135999136,4.43426569810154
DMS 79,11396600,3.318439325862458
OVTOKO,637858,2.365004868994971
COR-L95,9927531,5.207677506691081
HCC1806,3689413,2.70275971282259
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
COLO 829,3689413,0.7694296944480054
SH-10-TC,12003241,1.4218324467353134
JHUEM-1,selumetinib-JQ-1 (4-1 mol-mol),1.9844934160703236
M059K,637858,2.9375709273015533
U2OS,11396600,3.835959810142159
BL-70,135875424,1.380668609611053
NCI-H1155,UNC0638-navitoclax (1-1 mol-mol),0.5053861350195396
LCLC-97TM1,5460769,-2.8089441547625067
22Rv1,24180719,5.150551392077524
BV-173,9903786,1.323242877126727
TCC-Pan2,10231331,-1.6197179286660257
NCI-H1573,BRD-K27188169-navitoclax (2-1 mol-mol),3.4964989146437597
Panc 08.13,5460769,-0.1924357520120825
GB-1,156414,2.115103103424402
A-549,439501,-2.483005959928592
42-MG-BA,11455910,2.2214845082540813
BT 444,10302451,3.953897921649189
DMS 79,5460769,3.0772238606557623
SU-DHL-8,135421197,1.0706680615676138
IPC-298,637858,2.0731770893558954
Daoy,644241,2.9689041505015603
COLO 668,439501,-2.739607891151669
NCI-H23,selumetinib-JQ-1 (4-1 mol-mol),-0.1845846084913472
LCLC-97TM1,135421197,1.517750954289076
BT 416,135398744,7.827037669937473
SW1088,5460769,2.7590684048589025
HT-1197,73707398,1.1241151390025674
KYSE-140,9903786,2.4605743135261653
HT-1080,135999136,2.188985981446395
JHH-5,327653,3.1748835184568907
OCI-AML-3,327653,2.492530436962648
SCC-25,5460769,1.2990848940221191
TE-4,26596,-1.4080950714953673
ECC12,10302451,3.676093433206526
5637,637858,2.0145403224080347
DAN-G,262093,4.7024192027781435
LAMA-84,9903786,1.7036046577565669
KMS-34,54626689,2.584591756975835
MDA-MB-231,135999136,4.393925713686655
Ki-JK,327653,2.5576788593612076
NCI-N87,135421197,1.227136310912881
COLO 668,12003241,0.007541298710802
SIG-M5,UNC0638-navitoclax (1-1 mol-mol),1.9019832326670536
SK-N-FI,100016,6.445734787344034
OAW28,135421197,1.4901490212875883
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
HCC-56,135421197,2.032560895215065
SF126,262093,2.7341205400396418
TC-71,6852167,2.7255120299816684
OPM-2,262093,0.5720462757198622
DMS 273,4259181,0.4383145170351891
IGR-39,637858,2.3727831768497993
KYO-1,44491742,4.154466430935869
Jurkat,26596,-2.6358007271857216
NCI-H1703,46907787,1.9618105089969164
OAW28,71466445,4.188405368682896
Kelly,selumetinib-JQ-1 (4-1 mol-mol),0.3130303472508387
Rh41,11396600,2.905636505661568
TTC-709,26596,-1.3495496110855745
Hs 578Bst,54596490,4.55589845145933
NCI-H1944,168313016,5.996658186309284
TE 617.T,26596,-3.5782456619220246
NCI-H1869,3689413,-0.7267032921286074
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
NCI-H727,637858,2.2360670355510086
VMRC-LCD,135875424,4.154555639991533
NCI-H1184,4259181,-0.769318878882707
Panc 10.05,156414,1.819764158032316
TE 617.T,327653,3.0456722347172738
SNU-16,439501,-4.306216522257499
EoL-1,9927531,2.893857253769426
MOLM-16,46907787,-1.411428522933632
HuP-T4,135421197,1.5998853236041033
CAL-78,54626689,4.7118633904894205
COLO 320,156414,1.2064887269229854
A3/Kawakami,156414,1.7639181798832415
SKM-1,100016,4.336407790429152
KP-2,168313016,4.4737072284411115
Hs 944.T,262093,3.8646335441234823
MDA-MB-453,135875424,2.7753375231350104
CML-T1,46907787,-0.5465083296094366
SK-N-MC,5460769,1.627780458373646
FaDu,168313016,4.446637505899028
Sq-1,12003241,-0.6972908416742193
BT 216,73707398,1.0265344986941225
253J-BV,9915743,1.703363927754684
BT 416,49766530,0.2372877169340128
BT 330,UNC0638-navitoclax (1-1 mol-mol),2.829713529856627
KMRC-1,375860,0.0373834100132385
Karpas-422,327653,2.503082809882216
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
BT 231,375860,-0.0580384195874913
EKVX,12003241,-0.995524269330736
NH-6,12003241,-1.8219752869317325
A-204,637858,1.2825280617215151
G-402,375860,-0.0988535878122291
HeLa,4259181,0.2156486881613415
YD-10B,71466445,5.667780405427701
LUDLU-1,71466445,4.899023757250514
KYM-1,168313016,6.440512642028005
SNU-182,135875424,3.9739141814992056
HH [Human lymphoma],444795,0.0461881419908549
HCT 15,241158,4.134051598727554
BT 498,135421197,2.801881228152874
SEM,26596,-3.506968001766276
Kuramochi,10302451,3.780871192852023
KYSE-150,637858,2.0222292139148887
KNS-60,327653,2.1094204928561053
NCI-H1373,11396600,3.5940766248042495
LOX-IMVI,262093,3.0192087839524433
SF126,6852167,3.245971174452026
Kasumi-1,9915743,0.5863959367393617
SW948,11396600,3.556168564723583
M059K,49766530,-1.828446567556348
HSC-2,4259181,1.5437953657731505
LP-1,73707398,-0.084919728706542
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
CW-2,444795,4.148366741515224
EBC-1,26596,-2.071625704215017
697,444795,4.033454065777357
Panc 10.05,107970,2.288044652827366
EB1,135999136,3.88645183006867
BT 440,10302451,3.8215818132063233
NCI-H2023,selumetinib-JQ-1 (4-1 mol-mol),4.204121853439987
NCI-H520,54626689,5.006917649035428
HEL 92.1.7,439501,-2.540174469055436
HCC1395,5460769,2.101928934987084
NCI-H716,241158,3.477027636615277
KYSE-30,100016,6.190453384433256
LOX-IMVI,11455910,0.9161498134653596
HT-29,11455910,2.35614963734945
Mel JuSo,9936388,1.578964606957719
AGS,12003241,-0.4936842382500208
KE-39,327653,3.149148027412197
LK-2,54626689,4.482369415206183
HEC-1-A,9903786,5.533982095458378
SU-DHL-10,135421197,2.145200655725533
NCI-H2444,3689413,-2.223418972852252
Hs 888.Lu,3689413,-2.4401760719127092
Becker,375860,-0.5928207112259023
LN-18,73707398,1.4834861173786835
Hs 766T,12003241,-1.434019858151168
SNU-423,156414,1.5595439535021
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
HDLM-2,10302451,3.39330830228014
GSS,439501,-2.3619517329640782
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685
YD-15,136227924,2.6934840054154834
MPP 89,637858,1.2560615658967635
C2BBe1,24180719,3.6064230937282096
SNU-626,46907787,1.3860019611329613
HT-29,136227924,3.5079295938152706
NCI-H1563,5460769,4.309223313184859
A-375,49766530,-0.2051662663719206
LCLC-103H,3689413,1.9966381223526644
Raji,73707398,0.7917635742848352
NUGC-3,135875424,3.4631977650642396
C2BBe1,444795,6.194271713784543
253J-BV,73707398,1.865307102666125
Daoy,9927531,4.407816470136583
OCI-AML-2,11396600,1.0789992022533794
BHT-101,439501,-2.3771581779378828
Sq-1,54626689,4.3278148624962824
NCI-H1355,9915743,1.7324952444054351
COLO 684,136227924,2.900562305918871
NCI-H2405,5460769,3.951574866457585
LUDLU-1,107970,2.246008658957212
TCC-Pan2,262093,3.1215793064839903
BT 286,135875424,2.624951262486574
MKN74,44491742,4.321441779997771
SNU-16,12003241,-4.948615651726049
BxPC-3,135875424,4.118804534986376
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
Mono-Mac-6,100016,3.84240036835353
RERF-LC-Ad2,135999136,4.345961129852593
DMS 114,selumetinib-JQ-1 (4-1 mol-mol),1.888851191317842
NCI-H2286,11396600,3.697851476409739
JHH-4,3689413,0.1617777803735524
CAL-51,71466445,4.7818956768695715
JeKo-1,439501,-6.227788271417287
KMRC-1,136227924,2.9529226708788734
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
TE 441.T,46907787,3.123657521861764
PE/CA-PJ15,135421197,1.0415253026449975
KYSE-450,241158,4.285328470501583
SJSA-1,49766530,-1.4703185273344612
SNU-407,4259181,-0.1818409252805557
253J,136227924,2.473625062581448
JeKo-1,444795,4.544640897314401
A-204,135398744,7.3650683487349236
RD,73707398,0.8861107206817521
BT 139,5460769,4.859801196456228
HuCC-T1,44491742,4.260801380076742
Rh18,327653,2.9723981454496404
Hs 940.T,54626689,4.998784800534051
NCI-H1734,9877608,5.725584045619203
KMH-2,262093,2.330746095077634
BT 131,12003241,0.8855020405936681
KYSE-180,637858,2.310022745659766
CAL-120,135398744,6.432645448228996
MV4-11,71466445,1.1799710658743192
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
DEL,637858,0.5028649268417138
JHH-2,UNC0638-navitoclax (1-1 mol-mol),-1.9690924025630785
LOX-IMVI,375860,0.0693454409370285
MV4-11,4259181,-0.4542476315721023
MIA PaCa-2,135875424,3.180139545836177
769-P,11396600,4.3298717315530935
LAMA-84,5460769,3.9784862352409105
BT-474,73707398,1.0474698976362606
MOLM-13,3689413,-2.8005667715254017
SK-LU-1,44491742,5.866940990531296
BT 159,73707398,1.1635351268629908
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
SK-MEL-30,637858,2.477374564987187
NCI-H2029,3689413,-0.5548676180878093
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
BT-549,439501,-3.1266914034371567
PLC/PRF/5,100016,6.529147023700783
CADO-ES1,4259181,-1.6015743983343371
BT 428,100016,4.306836909333982
Hs 578Bst,4259181,1.388540800141387
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
BFTC-909,9927531,5.31835549136936
SU-DHL-6,439501,-2.4303946334698057
HCC95,44489367,4.846199338860998
GDM-1,100016,5.649529454604957
SNU-886,10231331,-0.2281959370366189
Panc 03.27,44491742,4.225898186806888
NALM-6,9929138,5.239590555889495
NCI-H2023,11455910,0.9302760696412364
A-549,135999136,3.721733527600953
BC-3C,637858,3.302055844369792
SKM-1,9903786,0.91314187591027
SNU-1033,136227924,2.5540912421490387
CAL-29,136227924,2.032112399542908
SK-MEL-5,262093,3.0272532373657848
SNU-1079,46907787,-3.0889383409725992
SK-HEP-1,10302451,4.165168773877425
SNG-M,241158,3.0909058026203144
Mono-Mac-6,73707398,-1.419752522473527
DBTRG-05MG,6852167,3.083762878407909
CMK,26596,-3.6157989534219497
SU-DHL-1,10302451,2.2731723403274535
TF-1,11396600,2.862627725963247
SJSA-1,4259181,0.2079005980889057
BT 147,136227924,1.9245142249128984
A-673,71466445,2.638210082463498
ME-1 [Human leukemia],375860,0.507532063957377
OCI-AML-2,71466445,1.8267840663953585
SK-N-FI,10302451,3.663337612290572
KHM-1B,241158,2.5921165995346565
JHH-2,73707398,1.105649662692389
EHEB,44491742,5.293750317448726
RMG-I,9936388,2.101682867932538
NH-6,262093,3.0659860570310995
SK-MEL-5,241158,4.170979949638567
SU.86.86,9936388,2.2696796585655
SNU-685,637858,2.5644844019805406
GSS,71466445,1.4608073960696302
MDA-MB-415,637858,2.2956366108360204
CAL-54,375860,0.076830899239988
COLO 668,375860,-0.2552898680870817
SEM,135875424,2.4848737039506426
SK-N-MC,selumetinib-JQ-1 (4-1 mol-mol),1.3987408852467555
RMG-I,46907787,1.7853253377364269
NCI-H226,637858,2.3908316426717375
SNU-1214,26596,-1.0463524319184982
ZR-75-30,11455910,1.1218208272028805
A-375,5460769,3.311565919469283
BICR 6,107970,2.2230750476194676
CAL-33,135398744,6.573384587063474
A-172,10302451,3.8410002428676737
Ri-1,439501,-2.801888786170529
NCI-H524,439501,-1.5131923813940935
NCI-H2286,135421197,1.3585015224229091
SNU-46,439501,-2.258414005891366
TYK-nu,selumetinib-JQ-1 (4-1 mol-mol),1.2226400408293931
Hs 895.T,11396600,3.5595368141538297
Lu-99,107970,2.570142525043538
DLD-1,26596,0.8453725223634535
WM266-4,3689413,-0.1379446477721048
COLO 320,selumetinib-JQ-1 (4-1 mol-mol),3.547549690422233
SNU-1,11455910,-0.8370004146214793
NCI-H1299,100016,6.953805951258825
RS4;11,168313016,4.934593266436089
ONCO-DG-1,44491742,4.983213967285157
Kelly,5460769,2.22696841800341
Hs 688(A).T,9936388,2.197824687815799
HOP-62,73707398,1.728110403283316
SIG-M5,10302451,3.7315924612449134
DU145,10302451,3.708227843551259
A-673,135421197,0.3124298336996849
Hs 852.T,439501,-1.3990443453800825
KMS-21-BM,26596,-2.3391795645360403
KMRC-20,241158,6.296391412542069
NCI-H358,439501,-0.5524451893811123
SNU-449,49766530,-0.9876450445747244
TYK-nu,26596,1.1864585547757855
KYM-1,UNC0638-navitoclax (1-1 mol-mol),2.797768732363665
EM-2,4259181,-0.3573100934145777
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
T-47D,44491742,4.391034289015602
HD-MY-Z,44491742,3.754375539988437
NCI-H2452,100016,6.6405878618594985
DEL,156414,1.3129358492392238
SW48,26596,-2.356334812614481
JHH-2,46907787,3.1927291980316506
MV4-11,11396600,-2.6796840852640966
KMS-21-BM,11396600,-4.473822501630397
SW1417,10231331,-0.4605053540659229
COLO 668,44491742,3.890577146633183
EJM,24180719,3.679957283710777
HCC44,136227924,2.988750330313465
Capan-2,9936388,2.515101489111694
SW579,9936388,-9.135357848638378
AML-193,156414,0.8692506520261336
HuT 78,4259181,-0.3142311669352864
TE-9,637858,2.7560592782365454
DMS 79,107970,1.6835351033356816
NCI-H1563,135875424,2.353629734666018
JIMT-1,selumetinib-JQ-1 (4-1 mol-mol),2.8828877731679667
ESS-1,10302451,3.294150768882909
SW620,444795,5.00121502031532
Capan-2,327653,3.5536187124726104
A-172,9915743,0.9354288818920024
HCT 8,4259181,-1.1037245280904695
Daudi,9929138,3.458684768924583
NCO2,327653,2.297487174577918
MPP 89,5460769,6.230455153292042
KP-3,107970,2.4048716428801677
NCI-H647,644241,2.820722009461978
NCI-H2126,46907787,2.1585150171474794
HCT 15,71466445,5.362396254264255
JHH-2,262093,1.5917989690275902
HuH-6,107970,0.8073577315762971
NCI-H1944,439501,-2.342776450648639
SK-ES-1,135421197,0.934110711885636
KE-39,11455910,-0.1151631297895284
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
Hs 578T,107970,1.821405074078983
T-47D,4259181,1.3653389737772716
CAMA-1,637858,2.0184779682033094
NCI-H660,3689413,-1.4753207784543096
Ishikawa (Heraklio) 02 ER-,selumetinib-JQ-1 (4-1 mol-mol),4.45456930685315
BHT-101,73707398,1.5852766214934897
BxPC-3,9903786,2.126136875029704
Hs 611.T,49766530,-2.7427307114148545
WSU-DLCL2,10302451,2.8814430152918717
KMRC-1,9903786,4.024109374851969
A-204,11455910,-0.408799298050112
CL-11,5460769,2.817673582837802
BT 139,selumetinib-JQ-1 (4-1 mol-mol),2.342972128639262
SNU-668,107970,2.4249439647555264
LC-1/sq-SF,439501,-1.6562365641481254
KMRC-20,3689413,-2.0293333018936877
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
KPL-1,9927531,4.948797048783531
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
MOLT-13,135999136,1.6862554581464335
SBC-5,49766530,2.674414744921775
P31/FUJ,49766530,-2.577046245506879
RKN,5460769,5.79272629497122
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
SNU-C1,24180719,3.313109061310517
Capan-1,26596,-0.6895285509385911
TE-11,135421197,3.0798207714757906
JHOC-5,9915743,-0.591005693368505
TT,12003241,-1.2151389854631975
FTC-238,327653,3.128570376507189
CW-2,439501,-2.020246340202773
CML-T1,262093,1.3151134240668207
HCC1937,241158,4.91326617468956
SW1417,9927531,5.165268920139929
JeKo-1,49766530,-3.0518255026052454
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
OC 314,9915743,0.9289282136331763
CAS-1,10302451,3.767754564688996
NCI-H1666,136227331,3.5475542812047873
NCI-H2170,135875424,4.845645858275147
SHP-77,135875424,3.698611964350599
HEC-151,10302451,3.224057282004677
OCI-Ly10,107970,2.8616762132018736
RERF-LC-MS,10302451,4.085913110869725
M-07e,73707398,-0.2805329031268003
SR,135421197,1.9567356952392363
WSU-DLCL2,12003241,-3.4791532779073373
MOLT-16,241158,2.157657324299802
KMS-20,6852167,1.0361135786452058
WM115,73707398,1.178086440828875
PaTu 8988s,4259181,0.1562419703255739
BFTC-905,262093,2.3947823917937017
BT 172,11455910,0.4137780640071803
NCI-H727,4259181,-0.7375001764594127
COR-L47,26596,-5.5673450877852995
RT-112,49766530,0.4682015340120261
HOP-62,135875424,2.89405317867683
RD,46907787,1.7054026101917616
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
NCI-H211,9915743,0.3286661494354852
HT-144,11455910,1.485095962050077
KYSE-70,11396600,3.829938839575827
NCI-H810,439501,-2.873270400537551
BT 444,135999136,3.658923915607091
TALL-1 [Human adult T-ALL],54626689,3.945964577280925
RCC10RGB,135875424,5.859031260595621
NU-DHL-1,135398744,6.409233084142903
JHOS-2,4259181,1.6951681410963
Hs 888.T,9927531,5.625894406785977
MV4-11,135875424,2.3295422515214717
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
NCI-H2172,3689413,0.3383001060602208
Hs 611.T,4259181,0.1161520407552913
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
Ri-1,375860,-0.316355066244252
SNU-685,11455910,0.9033032633285248
MDA-MB-435S,327653,3.1762289377434665
NMC-G1,26596,5.43387943202461
SW620,3689413,1.1437224923774536
EFO-21,5460769,5.67589124107342
MOLM-13,46907787,-1.536709398859376
DAN-G,11455910,0.9235983275094882
Calu-3,444795,4.6155350689818535
HL-60,9903786,1.6430909188137364
SW1271,135999136,4.614562085611917
IGROV-1,49766530,-0.195540678413639
MES-SA,9915743,3.475302692532233
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727
BT 239,444795,5.138852816460672
MOLT-16,9929138,4.3035507183563615
NCI-H23,71466445,3.4218295182871405
NB4,107970,2.06414667273963
Mino,439501,-5.730054140979018
SF295,135999136,4.283449365552917
MV4-11,375860,-1.038594146310439
KMRC-20,6852167,4.09361379982572
MOLP-8,9927531,5.438833274000949
MHH-ES-1,262093,2.803376777339923
EFO-27,9936388,3.039710224097925
CL-11,4259181,0.4150214368956425
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
K-562,26596,-3.6076758496321832
JM-1,49766530,-3.0151701370453794
L-540,136227331,3.8428800907354983
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
MDA-MB-415,9927531,4.701582574311918
CAMA-1,9877608,5.870182576067418
JHOM-1,12003241,-1.2744243269669069
OUMS-23,107970,1.9293400316395712
OAW28,11455910,2.4986666790908583
Kasumi-2,156414,1.0465549823430256
RT-112,241158,3.714911516167673
G-361,135999136,4.346430745109726
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
SUP-T1,11396600,2.9540043474610287
NCI-H660,73707398,-0.0968358716112526
BT 216,6852167,4.730740612520291
CAL-120,6852167,3.8186054907808344
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
GMS-10,136227924,3.0615637003217433
SNU-1196,5460769,1.0482928300242556
MKN74,3689413,0.9993219534405752
SNU-C5,9903786,3.1730161972997517
OV-90,100016,6.511633470460193
Jurkat,135421197,1.0042206438045034
Hs 578T,327653,3.3344882806614304
SNU-119,156414,0.2348404717120807
NCI-H1105,UNC0638-navitoclax (1-1 mol-mol),-2.607743956042822
TT,4259181,-1.5685992068812522
FU-OV-1,136227924,3.2834953568281597
TE-9,9903786,2.6320007696302894
SK-UT-1,49766530,-1.8212556826920157
NCI-H23,156414,1.2888959311526778
NCI-H1355,10231331,5.5582513930919255
Ci-1,5460769,3.784060470776022
EC-GI-10,6852167,3.17038059071199
MEC-1,241158,2.7058988737419787
SK-N-DZ,9936388,-6.025086835164752
TCC-Pan2,3689413,-0.1350455546392483
OAW42,9903786,3.91324183381597
A-375,100016,6.005492870785018
Hs 746.T,6852167,2.617948339328731
HCC4006,71466445,3.4609882866554695
Kasumi-2,135421197,0.8154486687594628
GA-10,637858,0.0748434639609226
NCI-H2085,12003241,-2.8100927731995924
DMS 53,136227331,3.826104197881878
LMSU,107970,2.329788160301069
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
SNU-201,selumetinib-JQ-1 (4-1 mol-mol),2.2194070686066936
Hs 839.T,262093,3.079390898816523
BT-474,107970,2.4195219689765266
KP-2,107970,2.7210126732046995
BT 504,135421197,2.466290644112219
CFPAC-1,136227924,3.3404294087361883
LUDLU-1,selumetinib-JQ-1 (4-1 mol-mol),1.0606041855234352
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
KYSE-140,12003241,-0.6057431237522657
YD-8,selumetinib-JQ-1 (4-1 mol-mol),3.141432259202229
CAL-51,6852167,2.546662292056567
NCI-H1573,46907787,2.7163703210354178
RT-4,9936388,-6.517969541343547
CAL-29,10302451,1.6338243981500025
SNU-398,11396600,3.339240330685363
Aska-SS,46907787,-0.8953027920417477
P-STS,UNC0638-navitoclax (1-1 mol-mol),-1.327662119160444
NCI-H1623,156414,-2.396664487331107
SYO-1,49766530,0.9236587906089132
SNG-M,46907787,1.3713068647337556
Daudi,24180719,3.437659555986817
RVH-421,107970,3.187164130309253
J82,46907787,4.254479025838574
CAL-51,439501,-2.444412450902406
HCC1500,26596,-0.8174609850015592
5637,5460769,-1.549780285334619
NCI-H322,9915743,-1.5185613747470492
TE-9,107970,2.565385085972178
RPMI-7951,10302451,2.662563983337758
SK-N-DZ,327653,2.3999084058011033
TE-1,439501,-0.5334953492440002
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
BT 245,5460769,4.174087021944073
MDA-MB-361,selumetinib-JQ-1 (4-1 mol-mol),0.7975844110985498
PLC/PRF/5,9936388,3.289212143502143
KE-39,100016,6.665188081944046
NCI-H2023,54626689,5.350772325710066
KNS-62,241158,4.309841254636907
NCI-H1869,5460769,3.405523512527605
Pfeiffer,439501,-3.463410019597594
JHH-5,10231331,1.5048057077981425
BT 187,262093,2.657149541546316
MDA-MB-435S,135875424,4.677381950528883
JVM-3,168313016,3.652022261873428
HCC1588,4259181,0.367831162449909
Jurkat,3689413,-0.8866590036526504
TT,262093,3.6842052963276406
MeWo,46907787,2.7349600019242963
BT-12,262093,3.0128893223100333
BT 245,selumetinib-JQ-1 (4-1 mol-mol),1.4299884719020757
A4/Fukuda,375860,-1.1918610484687095
JHUEM-7,262093,2.8461427698978197
NCI-H727,262093,2.950291125725139
GB-1,11455910,1.6376110278947926
MDA-MB-415,54626689,4.593942307999259
DMS 114,327653,3.6475394486968025
SNU-886,54626689,3.741397063281634
EBC-1,327653,3.757400762445518
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
HCC1438,107970,2.4795556192047874
KNS-60,3689413,0.5613903891454114
NCI-H2405,3689413,-0.5066399807315675
MeWo,156414,1.6220701053299502
8505C,9915743,3.019446627889447
JIMT-1,73707398,1.677314809441859
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
OVTOKO,49766530,-2.319379422934269
ME-1 [Human leukemia],3689413,-2.217252079013703
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
NCI-H661,6852167,3.3441449371697205
HCC1195,49766530,-2.234197173599504
KYSE-410,9936388,-3.552366403662026
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
CCF-STTG1,9915743,3.2198509615239024
WM983B,375860,0.0821681125114241
SNU-C1,5460769,4.252440714424883
Hs 888.T,9915743,0.1139967508569927
JMSU-1,12003241,-3.06340831413481
CMK,107970,3.0192567609790073
U-87MG ATCC,637858,3.3817655791628294
NU-DHL-1,135421197,0.761695548293036
H-STS,375860,-0.6907889018597777
NCI-H460,9936388,2.3098343611543415
SK-ES-1,637858,1.1648710207866575
MOLT-3,100016,3.7727587478901734
SR,375860,-0.3204889716997534
PK-59,135421197,1.5554330287724354
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
NCI-H841,54596490,4.447927326498449
SK-UT-1,9936388,-5.820733292214098
MM1.S,6852167,1.3787685421812157
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
BT 147,136227331,3.829920256470893
WM88,44491742,3.817934383194013
MDA-MB-453,135999136,4.2113637134750395
JHH-2,12003241,-2.42929005443543
GCT,6852167,2.315251879365214
SK-MEL-24,9903786,3.6296294578661494
KYM-1,4259181,0.2098724165428193
OCI-AML-3,54626689,4.470214284670753
Ri-1,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3048620858233484
MHH-ES-1,9903786,1.586022951185602
BICR 22,10302451,3.218470138701286
JHOM-1,4259181,2.459176547146831
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
SHP-77,26596,-1.5620029042215733
JVM-3,9903786,0.2351218463531885
COLO 800,168313016,4.811042364024057
LS411N,135875424,4.300305751936665
SNU-503,selumetinib-JQ-1 (4-1 mol-mol),0.4592551090177056
NCI-H1573,10231331,0.5929302495217658
NCI-H650,135875424,4.813541263439062
MV4-11,241158,1.6741528155317085
SF295,327653,3.6466695589164857
HCC1395,4259181,0.1311462895447667
NCI-H1341,71466445,1.3364768956830928
KYSE-70,439501,-1.7979650249976522
BT 328,107970,2.1571810870296333
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
PE/CA-PJ41 (clone D2),24180719,4.2890339364841505
QGP-1,241158,4.306884420889986
SW982,107970,2.5555367756868153
SU-DHL-8,49766530,-1.150122303282486
COLO 320,11455910,0.88882946750677
BT 145,54626689,4.322187645542722
Mino,107970,1.374067690004091
ECC10,644241,2.643631790579766
SK-MEL-2,241158,4.163944752728283
HCC1588,5460769,0.1168083541927539
SK-N-MC,168313016,4.334990427738434
MOLT-16,168313016,3.9383617008767295
42-MG-BA,46907787,2.9371087072278983
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
TE-9,136227924,3.0742454984310825
OV56,100016,6.603582199202106
SNU-878,12003241,-0.6657900217683382
SUIT-2,637858,2.948083302297865
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473
Ci-1,136227924,2.861978373437932
MDA-MB-468,100016,5.725845417349072
HCC366,selumetinib-JQ-1 (4-1 mol-mol),1.3799022063370607
Capan-2,135421197,1.2802517101193276
Daoy,156414,1.891767382024244
Hs 683,444795,5.839973604661916
BICR 22,136227924,2.105383482893856
CAL-62,100016,6.567555445612565
SNU-387,100016,7.682207014450764
HCC202,12003241,0.4259304556953664
TM-31,6852167,4.4813408273382
OCI-AML-2,136227924,1.951984345015637
DK-MG,3689413,-2.444320741118214
CAL-51,12003241,-1.2189714227076325
KP-2,49766530,0.3701885896643133
NCI-H2170,10231331,6.00292853605746
L-540,136227924,2.3931383545900524
BT 428,11396600,2.03305192481219
COLO 680N,262093,3.064075924679912
WM1799,73707398,0.8286664607249193
HD-MY-Z,UNC0638-navitoclax (1-1 mol-mol),3.0734625152158688
HCC-56,100016,6.404810900486153
EFE-184,6852167,4.373196332667482
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
LXF 289,73707398,1.5723760999376108
NCI-H1581,46907787,2.054614673663103
GSS,12003241,-1.231369265985878
MHH-CALL-4,136227924,1.8406000029443903
COLO 205,10302451,4.21417840913975
SNU-16,262093,3.1289538389821248
SK-BR-3,9915743,-3.880272444164353
MDA-MB-468,24180719,4.031775791207261
BT 320,439501,-1.927418392306892
A-549,637858,3.117280931983567
NCI-H292,9877608,5.923265260718527
BICR 18,10302451,1.8866317281326117
EFM-192A,49766530,1.9106564421036225
NCI-H2452,327653,3.049758242791241
SW982,262093,3.11351394040104
JHUEM-1,10302451,3.0563523137347386
LMSU,11455910,2.490355648913592
HT-1197,168313016,4.3878653913585985
NCI-H211,11396600,3.088009676720855
NCI-H889,11396600,3.5135706355172016
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
KMRC-2,9903786,3.847767222952075
BT-20,11455910,1.5364398716433951
PaTu 8988t,3689413,2.4784022576221836
Lu-65,9936388,-8.009646164485344
SW1088,54626689,4.770843115604433
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
BT 333,637858,2.533124120863436
LOU-NH91,637858,2.168731257760998
RKO,135875424,3.829354185480349
HCC1143,71466445,2.406598865609875
ChaGo-K-1,644241,2.384389937346898
NCI-H810,6852167,1.7168081280846608
Caov-3,135421197,1.5167281474841918
YD-10B,3689413,2.253033530854965
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
KP-3,3689413,-2.21572351958202
SNU-761,44491742,4.113182762091863
GCT,136227924,3.024645180957839
NCI-H1755,327653,2.97570867183818
HT-1080,637858,1.7356668622045788
YH-13,9903786,3.849279075978848
NCI-H2085,135875424,2.7505706963719243
DMS 273,107970,2.226748766743483
BT 228,9936388,0.9371184139441866
Daudi,9915743,0.3665260221427978
CW-2,11396600,4.1428337021020445
KP-2,135999136,5.367391673563159
BT 172,9927531,4.926572000473132
HCC78,107970,2.7946806041637933
SK-MEL-31,439501,1.7901681191985463
OAW42,44491742,3.912370337658794
BT 216,135398744,6.476974321326381
RPMI-7951,327653,2.8766150759858404
SW48,6852167,2.2630322871527913
NCI-H747,9915743,-0.7315863736844913
ONS-76,12003241,-1.3579895274230906
KMS-28BM,439501,-2.813687034658713
A-549,136227924,3.1395144761786486
Caov-3,9903786,2.8083030393929276
OCI-Ly10,241158,3.5075111900011664
SNU-1,11396600,2.945712911704453
HGC-27,135875424,2.7794180683242575
SF295,49766530,-1.8796707032595965
NCI-H2087,71466445,4.206842460124275
BT 164,100016,6.2228733531949505
KMS-27,241158,2.104620669820106
CW-2,637858,1.2989979987803284
CL-34,12003241,-1.25604782594079
VMRC-RCZ,73707398,3.8485182497894472
OPM-2,46907787,-3.368300500627006
MOLT-13,136227331,4.740160343609143
42-MG-BA,136227924,3.1509029182486845
SNU-878,637858,2.041946688300655
Kasumi-2,4259181,-0.4186991216348978
OCI-AML-3,4259181,-0.2993738011260952
Rh18,107970,2.2640428199879508
SK-N-AS,107970,1.6101479775889769
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
Karpas-299,107970,1.6107801137995834
RPMI-7951,26596,-1.730558618097036
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
253J-BV,5460769,4.4338655315193325
OE21,46907787,0.1329558963792394
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
NCI-H1693,UNC0638-navitoclax (1-1 mol-mol),1.0366545937598326
EFM-192A,9927531,5.058042989735013
Malme-3M,135875424,3.120735979829605
HT-55,11455910,0.5022530474255873
A-172,135875424,4.966488760073994
Hs 729.T,49766530,-0.2266090443337086
COLO 201,136227924,3.2878786819809105
KATO III,135999136,4.4010537882468785
MKN7,selumetinib-JQ-1 (4-1 mol-mol),3.0805078817781366
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
GCT,444795,4.405029687815304
HCC1143,4259181,-0.4991941409006941
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
NCI-H1395,100016,6.569605836811141
DEL,107970,2.0685567869118486
D283 Med,71466445,1.8844109066317911
Hs 611.T,156414,0.8748600228800256
HCC4006,135999136,5.063143439586622
TE-10,375860,-0.0930494370017834
BV-173,439501,-2.3365000657543415
COLO 668,644241,2.1375921936862627
Daoy,327653,2.9114644715771387
COLO 205,24180719,2.7622082317803653
JL-1,4259181,2.008998320795158
NCI-H1341,100016,3.8327529210726903
NCC-StC-K140,49766530,-0.6974859837361669
HLF,241158,4.258193705032094
OPM-2,26596,-3.75281027154887
MKN7,107970,2.1860197697313595
IGR-37,selumetinib-JQ-1 (4-1 mol-mol),0.4307789680425182
Granta-519,6852167,2.2648312753409887
HCC38,375860,-0.35863164801815
TE-5,156414,0.9303560194010824
Hep 3B2.1-7,4259181,-0.0551178259711273
NCI-H1581,11455910,-0.5870511913964108
SK-BR-3,11455910,1.4950616471057503
NCI-H292,241158,3.585722962787503
Hs 944.T,selumetinib-JQ-1 (4-1 mol-mol),-1.1784399840398554
RPMI-6666,9929138,7.502464828843475
NCI-H747,135421197,1.1053174645352293
Hs 888.Lu,262093,3.524644323966992
RPMI-6666,3689413,0.7706229516172245
Rh30,135999136,4.27956770229102
CML-T1,12003241,-4.650247315633356
NCI-H929,168313016,5.007996140484685
SNU-738,11455910,-0.0360600662579626
NCI-H1975,11455910,0.0232313677765091
ZR-75-30,selumetinib-JQ-1 (4-1 mol-mol),4.4940949952945575
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
OUMS-23,44491742,3.6829653315357818
BT-549,73707398,1.468839183930599
YH-13,327653,3.132127686900927
HEL,107970,2.2652057864285893
RS4;11,46907787,0.1973276065334859
VCaP,12003241,1.0138144203532238
THP-1,46907787,-2.1979745776426385
HCC-56,54626689,4.865631281272848
NALM-6,5460769,0.3419650871663187
SK-N-SH,12003241,-0.1782836435040178
MEC-1,73707398,0.8269388558464501
BT 504,10302451,4.044770274527245
G-361,6852167,3.18294861196672
BL-70,439501,-3.7904230490472623
SaOS-2,10302451,5.268852772808677
PE/CA-PJ41 (clone D2),4259181,1.7662808489331707
COR-L51,4259181,-0.0812090576856881
DMS 454,46907787,-0.5101535213897416
WM115,135999136,1.8466122948256136
SNU-1076,136227924,3.042119222699605
SNU-182,637858,1.6708222949269376
RERF-LC-MS,3689413,0.4263782886644774
SiMa,5460769,0.4503719492820418
SUP-T11,9915743,0.5825260386012178
BT 286,135421197,2.331823163871174
SW1353,10231331,4.64823511583987
A-549,6852167,2.2085984360403663
TOV-21G,UNC0638-navitoclax (1-1 mol-mol),4.683716239269286
HCC1395,11396600,4.211353464920311
OVSAHO,9936388,2.2943852117568944
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
NCI-H1792,135999136,5.2433356507887785
RT-112,12003241,-0.7712914992257113
BT 245,44491742,4.161467905313556
TTC-709,selumetinib-JQ-1 (4-1 mol-mol),2.9675969653518948
JIMT-1,11396600,4.3251237501633675
SNU-878,46907787,-0.6840421286217908
Sq-1,135421197,2.584547393194889
Daoy,BRD-K27188169-navitoclax (2-1 mol-mol),3.559722341306836
Hs 944.T,107970,2.3124347415373983
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
HSC-4,9915743,0.765957034876682
JK-1,71466445,1.5365502092012424
NCI-H2110,73707398,1.6375647309525496
HT-55,4259181,0.7351816138960287
JeKo-1,4259181,0.4142441656313368
253J-BV,156414,2.25351460742166
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
OVK18,135875424,3.840132228822679
NCI-H838,24180719,4.204137505892526
HCC1395,107970,2.2035026306442616
BT 239,26596,-0.3538471097190154
UO-31,439501,-2.964555924947922
8505C,156414,2.0308239491213693
SF268,156414,1.5872153411250456
PE/CA-PJ34 (clone C12),44491742,3.733326745267952
NCI-H522,156414,0.937566519659893
SNU-1196,selumetinib-JQ-1 (4-1 mol-mol),3.366894097169684
BT 428,135421197,1.0281432833092603
SW620,4259181,0.0662967794588152
SEM,439501,-3.163159816591066
BT 482,262093,2.2810025470588102
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
HPAC,9936388,0.8938610961333106
GDM-1,135875424,3.346620494935451
HCC827,selumetinib-JQ-1 (4-1 mol-mol),3.0068650568734396
SF539,10302451,2.624022513021108
CAL-62,6852167,2.7968041616377457
Hs 766T,100016,6.453782329995662
MG-63,9927531,4.972527766781062
KMS-34,9915743,0.841267495899617
WM115,135875424,2.968517855352779
HDLM-2,9915743,-1.1010684043189596
SNU-C4,135421197,3.0670219235957914
BT 131,73707398,1.1625406641587088
BICR 18,10231331,4.6040196689650905
CL-11,136227331,4.347611231682629
BT 131,156414,1.6229873238165975
RPMI-7951,637858,1.6619998861158691
SW579,136227924,2.120211379000796
MOLP-8,107970,1.7976582890286323
SNU-216,9936388,0.9315958331188322
LS513,selumetinib-JQ-1 (4-1 mol-mol),-1.0778434179028742
SNU-1214,46907787,-0.1476900319760525
HDLM-2,135875424,3.7112298908511017
RCH-ACV,9915743,0.3296075403381741
COLO 684,6852167,1.7245441218599669
DMS 79,10302451,4.069045121514552
OVCAR-8,439501,-0.7603560285089889
RERF-LC-MS,136227924,4.560045704487339
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
CJM [Human melanoma],9927531,5.046484804612069
ESS-1,9927531,5.52249907084491
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
JMSU-1,3689413,-0.0210585182318067
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
SNU-620,10231331,-2.4026146003872015
NCI-H1869,71466445,5.354012834432668
RERF-LC-MS,44491742,4.380479941679622
NCI-H146,9915743,-0.2957101551438801
COLO 678,12003241,-1.07618054300688
JVM-2,11455910,0.2677947916943763
PaTu 8988t,444795,4.288290341819835
HCC-56,10302451,3.7677535656973538
EoL-1,11455910,-0.8638634709362212
JM-1,637858,0.5231851777275447
SW1088,44491742,4.15883159123132
MM1.S,4259181,0.3083006728289762
NCI-H838,375860,-0.2970078399394082
Kuramochi,selumetinib-JQ-1 (4-1 mol-mol),0.801550139042012
ESS-1,136227924,3.049003867547222
WM793,6852167,3.317398724097228
SNU-478,9936388,-5.768985040086462
OV7,73707398,1.3742154881695552
SU.86.86,327653,3.751762966250303
NCI-H460,107970,2.752075604137296
TALL-1 [Human adult T-ALL],46907787,-0.546067260060498
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
MOLP-2,11396600,3.664107522761926
AU565,54626689,4.66017141288812
HOP-92,11396600,3.514379135780385
TE-15,168313016,4.315144290531877
2004,10302451,2.3376922055983957
NCI-H1339,9915743,3.628924415446368
SNU-668,9903786,2.616887117986772
OC 314,54596490,6.227091932870461
CAL-27,4259181,0.0205363318924195
NCI-H1734,4259181,0.3120141556341839
SNU-466,9915743,-0.0842203347342703
SCC-4,637858,1.987717752873236
Tm87-16,6852167,2.4211748884832813
COR-L88,UNC0638-navitoclax (1-1 mol-mol),-2.1535286194834966
SNU-761,9903786,5.568583080204817
PE/CA-PJ15,73707398,0.9467877501744384
NUGC-4,11455910,2.097041344071872
ST486,375860,-0.5687373512355877
KMS-11,241158,1.7607069914757574
8305C,26596,-2.120596559409719
HMCB,3689413,1.1423939419443525
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
SNU-466,46907787,-1.051542172508183
NCI-H2085,11396600,4.2540905152728845
769-P,71466445,4.666274253577678
Pfeiffer,9903786,-0.8773679724419216
253J,9903786,1.7805297403151377
5637,73707398,0.9897301208178872
MEC-1,71466445,2.7068349360844675
TCC-Pan2,12003241,-0.2350019856779653
BT 248,46907787,3.027762940742573
SNU-1077,73707398,1.6899308948113645
CAL-62,135875424,4.048990845421642
SK-BR-3,49766530,-0.361082625264213
DND-41,selumetinib-JQ-1 (4-1 mol-mol),-0.0339747112288985
A-172,24180719,3.644635065370508
SK-MM-2,168313016,1.868740784996341
MDA-MB-157,262093,2.565616950913742
CAL-51,4259181,-0.5132501801478601
NCI-H322,9927531,5.259442104255536
HuH-1,375860,-0.1259737357610563
A3/Kawakami,444795,4.277371495057248
HCT 116,439501,-2.291145672790816
CAL-12T,241158,3.629471544675429
KG-1-C,3689413,-1.7465014908016088
PE/CA-PJ15,107970,2.9199181042545175
HPAC,262093,3.184189581983291
HCC95,637858,3.1546972070247667
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
SNU-308,12003241,0.0879961923245038
SNU-719,46907787,-0.0717572497015621
Hs 688(A).T,73707398,3.3637618147673276
OVTOKO,3689413,-2.3162270386238735
MKN1,644241,2.5919310202302532
8505C,9903786,3.4608112423981874
BT 248,262093,2.0571072545208926
DB,UNC0638-navitoclax (1-1 mol-mol),0.9262699672486184
769-P,241158,4.142144552714684
SIG-M5,327653,3.3709040199841445
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
HCC366,5460769,-0.0088365115150554
SW1710,12003241,-1.2750404815852618
U-251MG,107970,2.2965569009527536
WM115,9929138,6.7694003006369226
T84,12003241,-0.2889439900128532
BT-12,9903786,4.28961947380918
SW1990,10302451,2.528677635613451
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
TE 617.T,136227924,1.63601430884803
COV644,3689413,-1.4992872949818017
VMRC-RCZ,54596490,6.225362497613279
CAL-148,73707398,0.7922411056874308
CAL-54,9915743,0.6596692010948818
NCI-H520,4259181,-0.9847708191101096
MKN74,54626689,6.992029114848977
BT 145,5460769,1.52442130287449
22Rv1,262093,2.6846165954285386
TT,637858,2.8122907208600676
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
CAL-51,46907787,3.297361866649883
TE-8,11396600,3.483213709023348
BT 159,644241,4.467530571865769
BT 248,6852167,2.795606288509473
OVCAR-8,375860,0.3753702766146815
VM-CUB-1,9903786,3.0676048433352268
OAW28,44491742,4.754653012158477
IM95,9903786,2.260707421178731
NCI-H929,135999136,4.255812797167961
CW-2,6852167,3.634155796835429
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
KMRC-20,73707398,1.7254732299327342
GDM-1,135421197,1.3394592190633656
NCI-H1339,54596490,5.682943703162134
OVK18,71466445,3.037286239647414
CFPAC-1,49766530,5.350694813461272
MSTO-211H,71466445,2.2675767772231024
NCI-H1793,4259181,1.6864937175392107
SNU-478,327653,2.5986094788996668
AsPC-1,439501,-1.6009280184427317
HuG1-N,135421197,1.5338215255875798
SUP-T11,4259181,0.0925220155978016
HLF,135421197,1.600730736912683
NCI-H1341,135875424,1.697371790785142
IST-Mes1,107970,2.9610434925705773
LC-1/sq-SF,9936388,2.2105374849729036
Kasumi-1,4259181,0.5778195803788477
G-292 clone A141B1,156414,2.3907012362809623
NCI-H1915,136227331,4.393848466029563
NCI-H460,46907787,4.3372157131836255
253J-BV,262093,3.2913693796929713
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
KM12,637858,1.7671311825333942
SNU-C1,10302451,3.924518569101239
OVCAR-5,262093,2.868361777233285
UM-UC-3,11396600,3.088705801401897
NALM-6,327653,2.2046348778532456
Ki-JK,241158,1.7863530369263578
GCT,9915743,0.92699998919311
JL-1,100016,8.572446789328106
SNU-899,10231331,-0.5861041210807778
RMG-I,262093,2.363268635735914
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
HEL 92.1.7,241158,3.844440784956009
COLO 668,49766530,-2.8242702060305818
SNU-423,selumetinib-JQ-1 (4-1 mol-mol),2.511686996120453
U-CH1,10302451,1.8015507562234312
SNU-119,9927531,4.042335314323924
HGC-27,107970,1.5990120472762
KMS-26,10302451,3.168611946824231
NCI-H2081,4259181,0.351932807704407
BC-3C,9927531,5.131139518306293
MOLT-16,136227924,1.8334417676190544
SK-MES-1,12003241,-1.463616091527542
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
KE-39,46907787,0.5111190203360444
RD,262093,3.0387065040185264
SK-N-DZ,71466445,2.103846907376585
REC-1,9903786,4.191167368609226
Li-7,9915743,1.173340818103225
SNU-685,9936388,-1.1795394282273874
JL-1,439501,-1.5766228751230973
OVCAR-8,637858,2.245893424159101
HuG1-N,375860,-0.3915682925509006
TE 617.T,46907787,1.8996212852232837
GDM-1,135398744,6.258827934702185
LUDLU-1,73707398,1.875547807805639
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
NCI-H2085,selumetinib-JQ-1 (4-1 mol-mol),1.6728919652680674
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
SNB-75,selumetinib-JQ-1 (4-1 mol-mol),2.6228425444296004
SK-LMS-1,11455910,0.8292842204783425
Yamato-SS,262093,2.7505818299570897
L-540,24180719,3.424167945886372
Caki-1,49766530,-2.8134564290994346
TF-1,10302451,4.088876235696949
BxPC-3,46907787,0.03250860780982
HT-1376,selumetinib-JQ-1 (4-1 mol-mol),2.138060477374947
A-673,11455910,-0.0977898825280259
Mino,6852167,1.220926429953778
A-375,9915743,2.060034252561476
SNU-466,241158,0.9825949083572648
SNU-175,9936388,-6.345283130310661
SNU-216,11396600,3.905215698607568
NCI-H1105,9903786,2.2828684981562013
FaDu,73707398,1.881650223785896
HT-1080,11455910,0.1997315897525516
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
Rh18,10231331,5.000034142038024
HT-55,439501,3.0049152055175377
MDA-MB-157,136227331,3.870321503168366
NCI-H1792,375860,-0.209110690878502
NCI-H2106,262093,0.7594772969687351
OVK18,100016,6.632788488948234
SBC-5,135875424,3.947045576812926
EM-2,11396600,2.356094145041023
HH [Human lymphoma],644241,1.8294339941253344
TE-8,375860,-0.3574304556846926
COLO 205,135875424,4.594078459695996
CHP-126,5460769,0.9651768958989126
RKN,4259181,0.9508926940780028
NCI-H810,327653,2.789807305040245
HSC-3,262093,2.860040873457059
JURL-MK1,168313016,3.946784557441632
P3HR-1,11396600,3.8940986796449946
EFM-192A,54626689,4.8183863327102205
BT 416,3689413,-0.9545304181237728
YH-13,6852167,1.959387815211575
CML-T1,44489367,4.494553632990814
PC-14,10231331,0.5461377223152567
VMRC-RCW,12003241,-1.0941298808716429
NCI-H1373,136227331,6.256455591315265
NCI-H446,9903786,1.878824600883621
TE-1,327653,3.068282437027353
A-375,9903786,2.3118659059614877
BT 428,9915743,0.3842410251142636
MDA-MB-468,71466445,3.782610959631592
HCT 8,71466445,2.03705487664743
SUP-T1,9929138,6.13855096958909
KMS-11,11396600,1.6057835101589155
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
SR,9927531,3.5947665035551113
SF539,156414,1.5385171897873895
NCI-H2087,135999136,4.85845906429525
HuH-28,3689413,-1.8867540967033527
TOV-112D,135421197,1.1317975787010155
NCI-H1694,6852167,2.1606813312691857
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
SUP-HD1,10302451,3.8687188160674912
CHP-126,135421197,1.2464718397024956
EPLC-272H,54626689,4.8265135136724675
BT-16,135421197,1.2495545603041716
LCLC-103H,73707398,1.1679839843019937
NCI-H441,637858,1.9230137221665495
IMR-32,10231331,3.825760806014001
KHM-1B,73707398,-0.6689954941559422
PE/CA-PJ34 (clone C12),439501,-1.4242244228812553
YD-38,26596,-1.5752818654632963
HSC-3,3689413,-2.2600837113951497
COLO 201,54626689,5.156495648319839
FaDu,136227924,3.658135500280057
LAMA-84,6852167,3.4194645624728257
HCT 8,44491742,4.525976447408572
HEY A8,100016,6.30003295297675
PK-1,6852167,3.144204149712558
TC-71,26596,-3.193308290167961
HMCB,100016,6.123582467992384
A2058,637858,3.1141521678001114
G-402,49766530,-4.676070864633351
NCI-H1623,637858,3.185553411157662
YAPC,107970,2.510985201601563
MDA-MB-231,73707398,1.1644092904893582
NCI-H1651,262093,4.029586538433741
NUGC-3,selumetinib-JQ-1 (4-1 mol-mol),2.244150108489299
SNU-216,10302451,1.428515381214255
Pfeiffer,44491742,3.3297086723950553
SNU-C2A,135999136,5.3185913230589925
KP-4,9903786,1.7495953596701077
NCI-H2342,73707398,3.0796988460505044
SYO-1,136227924,1.0009147925604558
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
Kasumi-1,262093,0.9096443237318556
Hs 888.T,9936388,1.4712772927415676
HEL 92.1.7,135875424,3.148841904096567
SK-LMS-1,439501,-2.6023396475730967
HT,135875424,2.176006504416359
NCI-H2452,9915743,1.4140850498548845
P12-Ichikawa,44491742,4.234271740927445
TE-14,46907787,0.3694296946140285
NCI-H2081,11396600,3.4950774921622174
Hs 944.T,10231331,-1.2019051656889153
Sq-1,46907787,2.10826946873895
GSS,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2560950768783368
TE-15,9915743,-3.4156269103241605
NCI-H661,135421197,1.0600684669241136
MES-SA,156414,-2.755878180461248
NCI-H647,135421197,2.605948730624533
COLO 800,262093,3.3147101233442196
PSN1,12003241,-0.8593243794123258
HCC1569,444795,4.941392474524884
G-402,135421197,2.1545147661375275
OVCAR-4,selumetinib-JQ-1 (4-1 mol-mol),2.7898739995965527
SNU-423,9915743,2.488155909988838
SK-N-SH,9936388,-5.065644908322296
Mono-Mac-1,375860,-0.4295713018664168
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
RS4;11,156414,0.6227944177183616
SNU-475,136227924,3.0898415955820715
BT 428,6852167,2.9431146688699275
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543
NCI-H889,10302451,4.256727329670886
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
CAL-148,46907787,0.1974742055175984
SCaBER,49766530,0.3491318819905442
SNU-398,6852167,2.173359087480046
Ci-1,10302451,3.7319108360157944
KCL-22,selumetinib-JQ-1 (4-1 mol-mol),-1.213906386428174
KMRC-1,44491742,6.09620831621162
SNU-1196,136227924,2.95634276982207
NCI-H522,375860,-0.630771500248647
OC 314,136227924,3.246361398875885
TOV-112D,168313016,5.522653694343065
TOV-21G,24180719,3.268358004210287
MeWo,241158,3.9599252474346502
VMRC-LCD,9915743,2.4183813584018616
SNU-C4,5460769,4.699419094889071
NCI-H2110,100016,6.079052375839209
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
Pfeiffer,135875424,2.9223731979657206
KMRC-3,9915743,1.1795230996835706
BT 232,11396600,3.2918989092466813
Daoy,444795,5.1441333345807685
EJM,11455910,0.7170091081693915
TOV-112D,UNC0638-navitoclax (1-1 mol-mol),4.5564386353746125
CAL-54,439501,-3.2230187997856308
Sq-1,49766530,-3.572585466463728
KYO-1,327653,3.22619937571039
NCI-H522,100016,6.692385014202011
BT 248,73707398,1.2475621750333084
BT 422,9936388,1.1526185364967738
GA-10,439501,-3.812594537001909
LN-229,10231331,4.08694802385181
EN,262093,3.594484397034306
OVTOKO,9903786,2.0414174754656544
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
NCI-H196,49766530,0.4460348160421952
GB-1,9929138,7.490130865110687
BT 239,135999136,1.6386300110242584
WM88,24180719,-1.3725016624195774
SNU-475,262093,5.097469804639549
HGC-27,100016,3.78981980973908
KMS-21-BM,241158,1.877362835227471
OVSAHO,44489367,4.926803870259274
A-673,3689413,-2.493408888485536
T24,9927531,4.8353414036700615
SW948,49766530,-0.6875988061214425
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
CAS-1,262093,2.1849008326659636
GA-10,327653,1.367223510616167
EoL-1,5460769,1.0165285119643896
FaDu,439501,-1.5866164776842138
OAW28,135875424,4.470041991889524
DoHH2,4259181,-0.0115593428473218
MIA PaCa-2,136227924,2.1731844460154743
5637,107970,2.2197251672380767
SNU-16,136227331,3.664519264936635
NCI-H2030,9903786,2.824655549380346
COR-L279,UNC0638-navitoclax (1-1 mol-mol),-2.0129718005483785
BHY,107970,2.2817797633490016
RS4;11,11455910,-0.9811499604134568
BT 187,241158,4.303810925937258
Hep-G2,4259181,-1.079856384384839
OAW42,107970,2.320375917331678
UACC-62,4259181,2.382328213158055
A-172,11455910,2.3992948402654095
VCaP,9927531,5.412919809162458
OV7,44491742,4.062871601608624
23132/87,135875424,3.8304583590646897
SNU-213,439501,-0.6838743591109449
WM88,136227924,2.639448330236639
BT 145,selumetinib-JQ-1 (4-1 mol-mol),0.9791242669222224
SW1573,9936388,3.0507391751654698
NCI-H211,439501,-3.5479428279050955
DU145,135999136,4.106502655585601
D283 Med,4259181,-0.2806940214967063
NCI-H1666,136227924,2.19834773760599
MOLT-13,637858,0.5697042946883438
NCI-H1694,UNC0638-navitoclax (1-1 mol-mol),-1.417470888611864
P12-Ichikawa,UNC0638-navitoclax (1-1 mol-mol),-0.6602743849013243
LOX-IMVI,135398744,6.429324407359154
HT-1080,UNC0638-navitoclax (1-1 mol-mol),3.1453657978309937
SNU-C4,9915743,0.291849772396667
CW-2,9915743,-2.027282933968592
LS123,4259181,0.5283924885744881
COR-L88,12003241,-0.20090693258686
IGROV-1,4259181,0.1937358171291443
IGROV-1,262093,3.169376516915595
SNU-119,135421197,4.049091304293704
PF-382,9927531,5.462558018035092
PLC/PRF/5,9927531,3.33785239114395
HCC1428,73707398,2.0353997361879625
NCI-H1581,3689413,-2.373014481120326
A2780,4259181,-1.27299012623329
KYSE-140,136227924,3.3753020930843065
Hs 294T,100016,6.337209257885702
M-07e,54626689,5.790335744168427
HT-144,46907787,4.841334264393981
RKO,5460769,5.660789679983863
HGC-27,375860,-1.0398325430166302
KE-97,107970,2.319431088510128
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
Karpas-422,3689413,0.6826110279753447
KMS-34,10231331,3.91366971805432
BICR 31,156414,0.5699919561712937
Hs 766T,24180719,3.121809599726509
Hs 936.T,375860,0.6750085464565785
NCI-H2342,262093,3.257524790305271
PC-3,72967,3.800120867156137
AML-193,46907787,-0.6702200808347925
NCI-H1838,73707398,0.6541596314038816
NCI-H2126,9936388,-6.844961041738704
BT 248,327653,3.4402013175237394
HEC-1-A,9927531,4.872071430147468
KP-2,375860,1.4529528337868778
HSC-4,156414,0.4374127066870092
Calu-6,73707398,1.205682955793124
KLE,UNC0638-navitoclax (1-1 mol-mol),-2.745432149551299
SNU-685,6852167,3.0753896768893028
Rh41,107970,2.277335866720587
647V,135421197,1.6081071378201617
BT 286,6852167,3.4826351863854295
BT 145,135421197,2.030859989245954
HPAF-II,241158,5.361464672847053
MeWo,9936388,-4.455184723751584
HCC2218,100016,5.089450081937329
JJN-3,9936388,-8.876764475546423
TUHR14TKB,UNC0638-navitoclax (1-1 mol-mol),-4.287202344436747
Hs 895.T,439501,-3.8668511324468664
KMRC-2,4259181,1.2333196545111071
PK-1,9903786,5.672212413868687
LAMA-84,168313016,3.970773961757139
NCI-H196,4259181,0.9744150084112732
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323
BL-70,44491742,3.343909693711406
Hs 940.T,136227924,0.9830608526546036
Calu-6,375860,0.1574070397224094
BT 286,selumetinib-JQ-1 (4-1 mol-mol),-1.4917661989890287
HDLM-2,637858,1.3890823822291447
COLO 680N,135999136,4.301915358812356
Ki-JK,5460769,-2.8439091816710707
RL,168313016,4.727767126002517
HCC44,10231331,-0.2249435110927301
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
GMS-10,4259181,-1.3122250193343967
OPM-2,73707398,-1.391957592490296
BT 224,135398744,6.495060752655371
5637,375860,-1.1046178739161925
HCC1937,44491742,5.446943100232909
MKN45,107970,3.2436851115973035
SW1783,9927531,4.46381053918724
HCC4006,439501,-0.4255324495628316
SK-N-BE(2),375860,-0.3438904708611859
NCI-H1755,24180719,1.4034438865982524
SK-N-SH,3689413,0.7530548018951405
COV362,9927531,5.782280660469085
A3/Kawakami,107970,2.2225148018694254
VM-CUB-1,135999136,4.744134082695585
COLO 800,9915743,1.5977279916979588
GaMG,3689413,4.2258406300802145
SK-LU-1,6852167,4.189762356624802
MeWo,100016,6.619977613887792
SK-CO-1,4259181,-0.2853622975740302
JHH-2,4259181,1.4792964046898105
Calu-3,10231331,2.145606244915116
5637,11396600,4.421550522360851
TE-5,11396600,3.2450913131710957
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
BT 422,11455910,1.0713128287987654
CA46,26596,-3.5845712744961324
HCC1438,136227924,3.0530124683265725
Ku812,9927531,3.686533687467188
HEC-1-A,262093,2.5793359656763784
NCI-H2009,73707398,1.4628489872410333
HCC2279,135875424,4.219637022812179
HuNS1,selumetinib-JQ-1 (4-1 mol-mol),0.1641694525405924
SW1271,9903786,4.005340236032604
SW1353,10302451,4.375388652736272
OCI-Ly3,262093,0.61539030331268
YD-8,10231331,5.266552071230695
JVM-3,439501,-2.5078633176007803
CW-2,135421197,1.1852786816312322
NCI-H1184,444795,4.437911221112586
HSC-4,11396600,3.0766488056466104
A4/Fukuda,168313016,2.0147776130358253
NCI-H2196,44491742,4.104688837740398
JHH-5,44491742,3.8169087988503705
SiMa,10302451,2.75637165309626
MOTN-1,439501,-3.3199671011375913
NCI-H2444,9915743,2.889982162911787
HCC366,73707398,2.815770937960961
U-BLC1,10302451,-0.4891280402389555
FaDu,262093,2.775295689369596
SNU-8,73707398,1.2983083910911808
A2780,100016,4.757543521992015
RVH-421,135421197,2.7493093312166534
SK-LMS-1,135999136,4.540087324054403
IGR-1,4259181,-0.2884937988554064
TCCSUP,444795,5.142441230913875
Ci-1,262093,2.7870589391035443
CML-T1,107970,1.8137988275945616
MV4-11,100016,3.584878230644963
EB1,4259181,-0.1411659668037445
WM88,3689413,-2.428480680194512
769-P,26596,-0.9592747509105644
BT 245,439501,-4.061461225365729
MDA-MB-453,44491742,4.088527945953042
JHH-1,241158,4.182258020404446
NCI-H2023,107970,2.443634681904435
KMS-21-BM,9877608,6.031837359251096
VMRC-RCW,637858,1.774740761381287
MM1.S,5460769,2.129502129742311
MOTN-1,107970,1.2324851180704943
NCI-H28,9927531,4.6016482528028515
NCI-H2126,10302451,3.9683881221380495
WM266-4,9936388,1.925680740660873
HLF,12003241,-1.5273612308967348
KMRC-20,439501,-2.469138258710991
Malme-3M,selumetinib-JQ-1 (4-1 mol-mol),-2.351283247335257
JM-1,375860,-0.4977027167273706
DLD-1,44491742,4.025001948780805
KNS-62,135875424,2.885043849551813
MHH-CALL-4,26596,-1.7349356502662407
RERF-LC-MS,262093,3.104487938727744
Hs 895.T,54626689,4.6957746440195
KMS-12-BM,439501,-2.5993845366115016
G-361,9915743,0.2147475804393018
SF268,4259181,0.1615840122785245
DK-MG,6852167,2.7662965247819056
ZR-75-30,135875424,4.922735562927052
SNU-46,UNC0638-navitoclax (1-1 mol-mol),1.5330694735080217
RL95-2,26596,-0.9803054302492492
Rh30,selumetinib-JQ-1 (4-1 mol-mol),0.2603507581444004
HCC15,3689413,0.3467742153458734
P31/FUJ,327653,2.543614095842417
Hs 888.Lu,6852167,2.0167944321765914
MIA PaCa-2,156414,1.6924569137824248
DBTRG-05MG,9936388,2.4654274854338505
Lu-65,10302451,3.851828229272266
A3/Kawakami,644241,6.313721804681679
DAN-G,5460769,3.6980093078585594
BICR 6,135421197,2.188693589086808
SK-N-AS,selumetinib-JQ-1 (4-1 mol-mol),-0.8317042212420149
NU-DUL-1,selumetinib-JQ-1 (4-1 mol-mol),-1.3712165783966237
P31/FUJ,168313016,4.690131242833582
KNS-81,54626689,4.933838460637069
EC-GI-10,26596,-3.5687172078755087
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
DMS 53,5460769,5.120342551697822
NCI-H1703,439501,-1.5312988936027676
OV7,11455910,1.3702614621166394
GP2d,107970,1.8153419418648105
23132/87,100016,5.572734576179291
KMRC-2,136227924,3.1141635996197183
HD-MY-Z,9936388,-7.089387661668647
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
COLO 800,156414,1.5989345686547471
KMS-34,26596,-3.9045844155365304
Daoy,135875424,3.817686781191165
Aska-SS,11455910,2.343634234167196
SNU-503,4259181,2.077412365798562
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
H-STS,26596,-2.569417697964928
Pfeiffer,637858,0.795813698485305
KYSE-180,12003241,-0.805265861116592
T84,327653,3.0918014670068654
HT,241158,2.254595813400616
NCI-H1184,135999136,3.0982974136589143
HEC-1-A,135875424,2.7872654410751148
G-402,107970,2.1842851966179304
TE-14,107970,2.304242218577071
SK-MEL-28,107970,3.16887671769628
NCI-H520,26596,-1.7163548151943342
RL95-2,46907787,0.5712988396817201
ChaGo-K-1,135421197,1.864105940411698
FaDu,54596490,4.6794450616255805
PSN1,selumetinib-JQ-1 (4-1 mol-mol),0.8634237269595101
BT 231,327653,3.38465300707193
KMBC-2,49766530,0.6316468025143787
BT 498,selumetinib-JQ-1 (4-1 mol-mol),4.316550369510256
8305C,10231331,2.2947891246385983
NCI-H889,135421197,1.0362826511717604
HT-1080,49766530,-3.575770083541022
Kelly,4259181,-1.3379091263134828
T84,46907787,1.7674761870685007
SNU-840,135421197,1.1283252272940862
CGTH-W-1,135421197,2.895305047489035
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
A-204,107970,1.8649971930452791
HCC1395,136227924,3.3223803208690135
SNU-61,10231331,-0.1396530061474971
BT 112,5460769,1.283415330936559
Capan-1,4259181,0.8226555222701868
SK-N-DZ,4259181,-0.3656613292065959
HLF,24180719,5.040452636951483
NCI-H716,26596,0.0248584598201427
SW1353,3689413,-1.8577928934605696
VMRC-RCZ,9927531,5.06353509308392
Aska-SS,439501,-3.4608963825976686
COLO 800,241158,3.8394116886094
KMS-26,4259181,-1.695112614082753
L-428,selumetinib-JQ-1 (4-1 mol-mol),0.3703912930912235
BT 416,11396600,2.2118594965797147
BT 224,9936388,2.154938052183267
ST486,262093,0.8785422298451224
OVCAR-5,UNC0638-navitoclax (1-1 mol-mol),0.9443819478994296
HCC1171,4259181,1.5327045600391374
Lu-99,439501,-2.3036425217634395
KO52,100016,6.24417827042609
SBC-5,9936388,-5.234314033557506
KNS-60,9915743,0.9849454355481576
NCI-H2052,10231331,0.0369259699577181
LN-229,9929138,5.025043627599637
SUP-B15,4259181,0.1387948880885041
HCC1569,9929138,7.033632026458537
HEC-251,375860,-0.1403385126276384
JHUEM-1,4259181,0.4565714749709281
MM1.S,327653,2.336208515323047
DEL,9915743,3.429632007483548
UO-31,262093,2.5027892995722674
BT 333,136227924,4.6219554593863075
Hs 839.T,100016,7.045878686884313
KMRC-20,136227924,3.298573049161518
BICR 31,9927531,5.661036072082279
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
CHP-212,241158,4.019379918122575
LP-1,4259181,0.3929382473497618
HPAF-II,4259181,1.9900492431716317
NCI-H1105,135999136,3.2946052044715737
GP2d,26596,-1.9076944219866043
RCH-ACV,11455910,1.239951006790748
NCI-H647,11455910,1.3155768042278373
HCC4006,9927531,5.0093588349321125
DBTRG-05MG,135421197,2.57791349467794
NCI-H2170,136227331,4.269339943775955
SNU-C4,136227924,2.9928621999202467
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
RL,UNC0638-navitoclax (1-1 mol-mol),0.9240725003614388
PF-382,26596,-2.06856872789975
JHUEM-2,5460769,-3.615295030871829
WM793,9915743,2.18814480431127
SK-N-FI,26596,-3.6176410664455374
IGROV-1,6852167,1.5305143027352028
RD,10302451,3.748222452512195
OAW28,10302451,2.68651474445359
BICR 6,5460769,0.6237785323656337
KLE,49766530,-2.017018761794788
DK-MG,4259181,0.7593257500018887
JURL-MK1,5460769,3.622430112813927
NU-DUL-1,375860,-1.5029992457223036
LoVo,439501,-1.7683171506776545
RPMI-8402,107970,2.195898791012078
NCI-H929,11455910,1.7265755247991157
U2OS,3689413,0.3310874452746708
HEL,439501,-2.350875236844296
Li-7,135421197,2.8637872744317763
MOLP-2,135875424,4.772032025808402
HCT 116,135421197,1.1800274219002476
CAL-78,selumetinib-JQ-1 (4-1 mol-mol),1.9841734317141573
LOX-IMVI,9936388,0.4128358081832157
NCI-H1395,10302451,4.201114377039751
SNU-1272,9903786,4.921324329124853
Panc 02.03,10302451,3.706546166543765
SNU-466,49766530,-2.375695720565105
BT 145,73707398,0.9276611953602932
SNU-886,644241,2.771156867357371
L-428,439501,-3.0695670825388848
RT-4,12003241,-1.8542714118634884
ES-2,11396600,4.145090695204245
EN,selumetinib-JQ-1 (4-1 mol-mol),5.845147422589704
KE-37,44491742,3.673383181125235
KMS-12-BM,135875424,3.5247186168283453
OCI-M1,73707398,0.9723798314394978
Yamato-SS,327653,2.703551871712419
HCC95,9903786,2.343121552943665
NCI-H526,10302451,4.161847197543937
DU4475,3689413,0.1265439413603304
HuG1-N,327653,3.6334081946843506
L-363,439501,-2.2383513664350394
HuNS1,5460769,0.1719707153677664
Hs 578T,3689413,-0.3709013801718254
Karpas-422,11396600,4.033756538148708
PSN1,135875424,4.38320892941454
JHUEM-7,11396600,4.730722840017514
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
EoL-1,637858,0.3936490265761631
EM-2,12003241,-5.8745734353402534
Ishikawa (Heraklio) 02 ER-,24180719,4.095355158461072
KHM-1B,11396600,1.492899305921399
KE-37,9915743,-1.0787732351752954
HSC-3,375860,-0.7997603409835673
MDST8,73707398,0.930898424190815
HCC1171,3689413,-1.743559773321706
Hs 888.Lu,168313016,5.717641132644131
Li-7,44489367,4.441999897912582
U-251MG,11455910,1.7912494784014348
HCC-56,44491742,4.146730174017219
23132/87,5460769,0.87100881863978
TUHR4TKB,262093,2.707007825366508
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
Calu-1,100016,7.639038839177244
Panc 08.13,375860,1.3164486030027225
NCI-H1581,selumetinib-JQ-1 (4-1 mol-mol),2.3344397438111404
MDA-MB-157,9915743,0.9957990206413116
BT-16,12003241,-1.8198494997272787
BT 328,selumetinib-JQ-1 (4-1 mol-mol),3.8675980198640465
Hs 578Bst,637858,1.5469526457433171
OS-RC-2,135421197,5.318093622175408
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
L3.3,9936388,-5.444309252993802
KP-N-YN,9936388,1.912535006220544
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
JHUEM-7,49766530,-0.0352390480057696
QGP-1,3689413,0.2348303758640308
NCI-H1838,637858,2.13193146153693
NCI-H1563,12003241,-2.3981612742304614
COLO 201,637858,2.4512804408988393
JIMT-1,241158,4.281994950904064
KYM-1,327653,3.3203819587904757
HCC2935,54596490,4.468988893625454
COR-L105,107970,2.936160881286492
MOLP-2,9927531,5.358514182418203
YH-13,73707398,1.2587835012572517
KMS-34,46907787,-0.9505734854402896
G-401,107970,2.0352708529532824
MOLT-13,10231331,-1.0231086705106536
KYSE-520,5460769,2.8497133103495713
SK-LMS-1,71466445,5.876102346203037
8305C,168313016,5.620124632794436
NCI-H226,11455910,1.847807065010321
SF539,262093,2.0596515913386786
HDQ-P1,9915743,0.2716921146551485
SK-HEP-1,135875424,4.97106166770821
HeLa,241158,4.038975399720051
PL-21,375860,-0.8908022550999798
Rh30,71466445,3.123064034579754
NCI-H810,3689413,-2.3374294855019566
NCI-H526,44489367,4.205938255149825
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
SW620,11396600,3.2226280594878145
OE19,327653,3.724127212615087
TALL-1 [Human adult T-ALL],9929138,6.59900307589284
42-MG-BA,11396600,3.992983938802259
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
Mono-Mac-6,5460769,2.7333685745073457
RERF-LC-MS,49766530,0.7744144603938863
NCI-H650,327653,3.3544160833227337
COLO 678,10302451,3.4236206649832797
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
NCI-H1694,444795,3.723692799249934
Tm87-16,241158,4.326282231261254
HCC2108,73707398,1.1119632364432313
KNS-60,10302451,3.3900395940904464
8505C,135875424,3.698353328169634
EJM,9927531,5.060130602494636
JHUEM-3,10302451,0.6588208189074596
MDA-MB-415,49766530,3.102282172182342
EFO-21,9936388,3.018454857449296
BT 498,9927531,5.612738328284819
SNU-308,439501,-2.437759024379206
U-87MG ATCC,selumetinib-JQ-1 (4-1 mol-mol),4.879492377756021
HCC44,241158,3.9136091411622345
SW948,5460769,-0.6640669541383749
DEL,selumetinib-JQ-1 (4-1 mol-mol),1.5220162631855352
GaMG,9903786,4.966976399953102
SW1783,selumetinib-JQ-1 (4-1 mol-mol),4.8105600035571126
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023
NCI-H2023,135875424,5.909688089564903
BT 330,439501,-3.680620250809701
BICR 56,UNC0638-navitoclax (1-1 mol-mol),2.815412644303643
KYM-1,9903786,3.7679848907863738
SNU-1214,10302451,0.3178594253094901
NCI-H1693,5460769,1.1417796185034783
NCI-H2029,135875424,4.350194062307378
BEN,6852167,3.945016619736351
Rh41,11455910,-0.4442712184273157
EJM,UNC0638-navitoclax (1-1 mol-mol),1.2280431327330104
JHUEM-1,6852167,1.554254101027855
NCI-N87,24180719,3.957157119616887
KMS-27,168313016,5.514189836939729
CAL-29,54626689,4.505758602956094
NCI-H23,637858,1.0149973634937457
Lu-65,44491742,4.485926174539046
SK-CO-1,46907787,4.316773762169295
647V,10302451,3.4005631351647807
NCI-H1568,9915743,-0.8427224057935273
SNU-1077,100016,6.64200464659652
GDM-1,136227924,3.363011715884638
WT2-iPS,327653,3.084686550525322
HCC1419,12003241,0.329008083865116
NCI-H69,444795,4.095513261024057
BV-173,9936388,-7.205824957487243
TE-5,107970,1.5256811386739602
EN,107970,2.920021617709282
HLF,107970,2.1682422311433123
SET-2,12003241,-1.37504024910663
WSU-DLCL2,6852167,0.3992644477087519
ES-2,73707398,1.4813259801983545
BT 359,26596,-1.128901879166228
SK-MEL-3,73707398,1.6754793187128854
Caki-1,439501,-1.3714154371315346
T-47D,49766530,-0.4213805978343772
Mel Ho,9936388,1.523642966825596
JURL-MK1,135421197,2.4135031491286285
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
NCI-H1563,46907787,3.500140375056612
PF-382,11455910,1.1839598995526908
IGROV-1,135398744,6.402844237905131
SNU-5,135875424,3.5820845007608555
KMRC-2,selumetinib-JQ-1 (4-1 mol-mol),3.693514223055559
NCI-H1975,26596,-2.5930273814391196
IGROV-1,327653,3.667792542405671
KYSE-410,12003241,-2.1155115062785805
OVISE,327653,2.506626214633075
LMSU,135398744,6.91211293627059
AsPC-1,24180719,3.701309063973522
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
LN-18,135421197,2.222908154028884
HPAF-II,262093,2.839576376925405
697,selumetinib-JQ-1 (4-1 mol-mol),-0.8612370024069985
RPMI-8402,4259181,-1.5890412699882153
KP-2,10302451,4.044083771623064
SNU-1,12003241,-2.3799966933109262
GDM-1,241158,3.4116054847688857
Rh41,327653,2.4549598700342
HOS,439501,-2.316181578495001
L-540,100016,3.9234848652304097
NCI-H1155,439501,-2.4258947741424572
EBC-1,10231331,-0.5164847757495455
TUHR4TKB,9936388,-4.816282931741809
LS411N,3689413,2.701640891749041
OE21,54596490,5.298200205444942
AN3-CA,375860,-0.4575105157706771
PC-3,UNC0638-navitoclax (1-1 mol-mol),3.298344799073772
HCT 15,9903786,1.9585182501172609
KNS-42,4259181,-0.17232882278181
BEN,10302451,4.117279782065388
Ci-1,439501,-2.567904110965142
KYSE-30,107970,2.3754255446432935
SNU-387,241158,4.027101114870974
HSC-4,644241,2.6183127396598262
EHEB,262093,2.39806678929768
YD-15,4259181,-0.9565744428001864
HMCB,444795,4.365001038195376
T-47D,11396600,3.840733614966456
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
OVTOKO,262093,5.058822079580486
SK-MEL-3,9927531,5.047514354060135
BV-173,11455910,0.1396519641049683
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
BT 498,136227331,4.544114350665722
OVK18,262093,2.4244937883691287
SNB-75,107970,2.331230517757488
LNCaP clone FGC,375860,-0.5963987861231773
KE-97,11455910,0.2852885194409614
NCI-H1944,262093,3.0559716202604834
SNU-61,439501,-1.3808373898758073
G-401,9915743,0.7240748800691799
Hs 936.T,107970,2.841992044005918
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
CJM [Human melanoma],156414,1.7180992271166762
KYSE-410,44491742,3.6208474241241473
COLO 668,73707398,0.8001176213586483
NCI-H1355,10302451,3.9139868052709303
HH [Human lymphoma],11455910,0.005551580985779
DMS 273,375860,-0.4468381354972334
JHUEM-7,9903786,1.8726211891462523
HCT 116,10231331,2.3806251587463567
NCI-H522,136227331,5.948504593030567
MG-63,11396600,3.547749871707555
RPMI-7951,12003241,-0.9511728924240472
NCI-H1573,3689413,-0.5514389876644209
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
BL-70,26596,-3.7588271568583953
MKN74,327653,3.1147590669580847
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
WM983B,156414,1.573204920480929
GA-10,100016,3.803284916821312
SF539,375860,-0.4378698388059482
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
B-CPAP,375860,-0.8507879875115774
HCT 8,5460769,4.645297134954857
NCI-H1650,644241,2.6556304890705618
HCC1428,44491742,4.031952184974023
Hs 683,10231331,6.307100182412671
HuP-T3,10231331,2.6811135289001236
WM793,12003241,-0.659721194491695
NCI-H441,9903786,3.5452366409305887
HEC-151,439501,-1.7100799573978192
HD-MY-Z,136227331,3.950603619388181
TE 441.T,107970,1.1503901417213285
COLO 680N,107970,2.2694661867181565
DBTRG-05MG,135875424,3.4879962097655057
B-CPAP,135421197,1.178862358485884
SK-MES-1,6852167,2.1535089151807796
GA-10,444795,3.886732538639244
HCC78,71466445,3.2271775960204465
WM983B,6852167,3.582375315492635
COLO 741,54626689,4.398469167012791
NCI-H1915,46907787,2.8693661385266
FaDu,156414,1.172585611043198
MDA-MB-231,6852167,3.6519005073230217
HT-1197,262093,2.0088485136907575
LP-1,26596,-1.5638632087078823
CA46,241158,1.6221144264981358
NCI-H2052,100016,6.8923960055757805
SNU-407,9903786,2.2079678485918977
CMK,12003241,0.0052049395185332
IPC-298,11455910,1.6404749147186584
CA46,49766530,-5.499020578204802
COLO 800,135398744,6.478150217692287
COLO 668,UNC0638-navitoclax (1-1 mol-mol),1.041904598510707
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
8-MG-BA,439501,-0.5992510337528919
RPMI-6666,241158,2.9721894035721546
KLE,327653,1.7943752773136603
OE21,11455910,0.3483153837156987
SH-10-TC,135875424,4.945714860516567
J82,135999136,4.85981653793685
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
769-P,9915743,0.5554140720620152
SUP-HD1,439501,-1.483428569132062
Mino,11396600,2.601097362695862
Hs 578Bst,136227331,4.283595415699579
NCI-H2286,73707398,0.5411682012342772
SK-N-FI,262093,0.9859061166754924
IGROV-1,5460769,1.6083174601829917
HT-55,262093,2.6396601461162588
SNU-1033,135875424,3.081818614002125
COLO 680N,5460769,3.8284698218745055
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
NB1,135421197,1.388835024026268
KMS-26,44489367,3.4322137837504254
LS123,637858,0.8552062768357409
J82,12003241,-0.1407716325694316
SNG-M,11396600,4.011470573491779
MOLM-6,439501,-2.481235369301624
BT 286,UNC0638-navitoclax (1-1 mol-mol),1.4427957482860168
TOV-21G,4259181,2.223736423310248
DU145,375860,0.0587895300626014
NCI-H2106,644241,2.236152490037656
Calu-3,439501,-2.024926202935107
SK-OV-3,49766530,0.1985460846164677
NCI-H2087,6852167,3.953337173011455
SNU-16,5460769,1.4244737217539871
NCI-H810,UNC0638-navitoclax (1-1 mol-mol),1.050373409146072
NCI-H647,3689413,0.6953623673111984
C2BBe1,241158,4.815582884845346
SF268,selumetinib-JQ-1 (4-1 mol-mol),3.3872094498347063
NCI-H647,9915743,2.3861555081982035
U-118MG,73707398,0.952210463272118
KMS-20,262093,1.6065117070445694
ES-2,135398744,8.06870751291861
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
NCI-H526,444795,4.168802704831755
HSC-4,46907787,5.727789952108257
OCI-Ly3,439501,-3.305238194936377
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
Mel JuSo,12003241,-0.8749256028494242
NCI-H292,156414,1.4083938325335852
OVK18,4259181,-0.6799661458777646
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
DU145,241158,4.174318462840133
SNU-489,12003241,-0.3449149032803904
TE 441.T,selumetinib-JQ-1 (4-1 mol-mol),4.709536906442107
BT 216,327653,3.657240159217869
IST-Mes1,9903786,2.7623614356082458
LC-1/sq-SF,44491742,4.404829993178961
SCC-4,11455910,0.5911512823156414
AN3-CA,4259181,-0.2663396960548074
TF-1,100016,6.442708110888471
NCI-H1568,439501,-2.6831567396736022
HGC-27,24180719,2.7787963276057046
NCI-H23,54626689,4.77499641111419
NCI-H2110,11455910,0.8455410267883708
SNU-869,3689413,-0.5659806105186423
HCC1954,44491742,3.88484853713588
SK-ES-1,156414,1.5792793420660831
NCI-H2170,9915743,-4.0730094679521125
TF-1,4259181,-0.4142995072345916
OV-90,9903786,3.9551127291738424
A-172,375860,0.131110300908506
Yamato-SS,5460769,4.640105648822845
Hep-G2,73707398,1.4703050959367814
HCC1937,9936388,1.6949856124341256
NCI-H211,168313016,4.627432995908626
EKVX,4259181,-0.1949078091115229
KYO-1,54626689,4.750050156879417
NCI-H1869,168313016,4.348765145343562
ME-1 [Human leukemia],46907787,1.000894546616175
U-251MG,UNC0638-navitoclax (1-1 mol-mol),2.869129939531875
JHOS-2,136227924,2.6850771580880783
GaMG,107970,2.2843601112217535
JHUEM-2,9903786,1.0264930895087971
BT 340,136227331,4.417429547624524
HGC-27,439501,-3.477587502070629
EFO-27,54626689,4.866384531477491
MDA-MB-157,71466445,-0.8161407888171323
KE-39,6852167,2.989668764419295
G-402,11455910,-0.05437779259868
BT 239,49766530,0.6116447613594903
SNU-8,327653,3.195636469676862
SW620,9915743,1.1918924065742125
BT 245,107970,1.8345714144721337
NCI-H522,327653,3.011425661783578
SK-LU-1,11455910,1.7364253174007704
HuNS1,46907787,1.7038689762215966
NCI-H2110,46907787,2.692877404772462
HCC1954,6852167,1.7323424520522626
HCT 8,136227924,3.7452024891634785
NCI-H226,3689413,2.4864282663543302
DU4475,262093,2.0152969052094725
SNU-1196,3689413,-1.8376731206647552
BT 330,72967,3.756952070615194
UM-UC-1,375860,0.751139865228237
22Rv1,637858,2.0333625515444353
Li-7,9903786,1.4917500852360135
DMS 53,54596490,4.264908888356617
SNU-840,73707398,1.0622976409805671
NCI-H889,439501,-2.793088249368423
HCC1588,375860,-1.1262838478639452
SNU-761,46907787,2.564900222072361
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
HuH-6,375860,0.7275713697842162
HuH-1,10302451,3.651882936765564
Hs 888.Lu,12003241,-2.029150250693523
SNU-C5,73707398,0.424759818514952
JeKo-1,135875424,3.073704073284497
ChaGo-K-1,44491742,3.5931231049771126
NCI-H929,6852167,0.2588908385559714
SNU-620,136227924,2.4539673197881444
SCC-4,54626689,4.693008388350228
HEY A8,10302451,3.339170922140571
OE19,136227924,3.1692952710595557
MDA-MB-157,54626689,4.568687551235484
JHOM-1,54626689,4.954636933631071
SNU-407,11396600,4.026955307306754
NCI-H2029,26596,-1.020700117051714
BC-3C,135875424,4.794032428578798
KYSE-150,135875424,2.978740895797715
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
SCC-4,12003241,-1.1287847624263156
SNU-1077,135875424,3.798963502018643
SUP-B15,54626689,4.446287186845001
OAW28,5460769,4.044755256654475
RCC10RGB,73707398,3.9170227295506304
SNU-1076,439501,-2.344859624762999
Mono-Mac-6,9936388,-1.750888467590725
SNU-16,44491742,2.438228727906927
SK-N-SH,637858,0.7787528931707683
NCI-H716,selumetinib-JQ-1 (4-1 mol-mol),-0.1504205000857164
NCI-H2405,637858,2.527704826903145
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677
BT 147,107970,1.8049375369032488
NCI-H2087,46907787,0.6289755590874684
NCI-H2342,135421197,1.9083443664668167
SNU-410,444795,5.209490058147456
JJN-3,135398744,6.34309809291168
COV434,12003241,-2.0451557846060537
NCI-H2228,44491742,4.2440053782675555
MDA-MB-361,241158,4.008394347858686
CAL-78,327653,3.706712543295155
UO-31,4259181,0.6677925094271252
A-549,11455910,0.2975953497649719
LOX-IMVI,9903786,2.476339692878584
GMS-10,439501,-2.5226384823579404
OVCAR-5,156414,1.505266249063237
EPLC-272H,44491742,4.296380741364786
TUHR14TKB,156414,1.545939775410448
GSS,168313016,4.309710891894579
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
QGP-1,107970,2.847415715373979
PE/CA-PJ34 (clone C12),49766530,5.059286998332617
SNU-620,46907787,-0.9958322433999224
JK-1,24180719,2.9465858444087183
LXF 289,262093,3.4150141342974605
TCCSUP,9903786,3.558837088709428
COR-L95,11396600,3.695258257335492
ZR-75-30,49766530,-1.248821284043819
A2780,136227331,3.7351205807719863
KP-N-SI9s,10231331,1.7797766908392143
Karpas-299,5460769,1.8174425760442317
NCI-H2228,136227924,2.998313400459559
NCI-H929,9903786,1.9183912305018265
NCI-H460,9903786,4.057661845653794
SKM-1,9929138,6.747336348801134
2004,327653,3.3458019142742734
NCI-H196,44489367,4.4813360413597705
BT 228,107970,1.7919397546621243
KMS-26,241158,1.8879300052760837
Karpas-422,439501,-2.968319248514649
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455
AU565,9927531,4.912755977802547
BT 112,3689413,-2.4519950955667764
SNU-626,49766530,-0.2308457798178905
HT-1376,3689413,2.4091899536551264
SNU-1077,637858,2.311785541808234
SW1353,46907787,-0.2143520062248116
Ku812,4259181,-1.0914400455544095
KMS-28BM,637858,-0.0987535237113853
NU-DHL-1,11396600,1.7686570539993816
NCI-H2444,444795,4.943179746981843
TC-71,168313016,4.509628867413136
8305C,73707398,0.8416094140918434
SK-N-BE(2),46907787,-0.3861436275691191
KMBC-2,135875424,3.177506278142116
BDCM,439501,-2.7334853290513497
MFE-319,selumetinib-JQ-1 (4-1 mol-mol),1.6766813591617562
HOP-92,5460769,4.612763799526671
SU-DHL-8,107970,1.6318568157956992
BT 147,135875424,2.90044056464114
Ku812,135999136,1.6073024160366625
U-251MG,4259181,1.0740354308159887
SCC-25,100016,6.900174579464034
KMS-27,6852167,1.4833276189220757
DND-41,241158,3.5371394102308646
SK-LU-1,49766530,-1.2707580776234786
BV-173,156414,1.1309234349715926
KMS-26,46907787,-2.97816119814664
NCI-H647,24180719,3.874894669402666
T98G,439501,-1.9696613143180952
SK-UT-1,135999136,1.6451873526214251
NCI-H146,71466445,0.6815814889300492
MHH-ES-1,107970,2.3247175730314757
U-937,9936388,-6.425883937752082
RPMI-8402,10302451,2.410020049442099
BT 228,73707398,1.4280479826464054
IGR-37,9927531,5.0345741970674975
NCI-H2196,262093,1.390749456679199
DK-MG,439501,-2.8000262894493653
PE/CA-PJ34 (clone C12),135999136,4.2559270335643955
ME-1 [Human leukemia],135875424,3.754856170927667
LS180,9936388,-5.017955750811216
Hs 611.T,262093,0.9776083871947168
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408
JHUEM-2,136227924,1.8669676160402808
LS411N,9903786,3.6806866285220017
EoL-1,73707398,-3.0491075359956508
MEC-1,49766530,-2.6442058003130806
KMS-28BM,9915743,0.6729564679567067
TE-8,439501,-2.6420993562145925
CA46,9915743,0.7447060154867644
ACC-MESO-1,44491742,5.613898283692527
VMRC-LCD,107970,1.7842693363117308
FaDu,3689413,2.633100488394503
HCC827,5460769,2.7975928374001104
HCC1833,BRD-K27188169-navitoclax (2-1 mol-mol),0.005806850934129
BICR 18,5460769,1.6305268231033057
MHH-CALL-4,168313016,3.901082293744531
TF-1,136227924,2.8858592548660766
KG-1-C,selumetinib-JQ-1 (4-1 mol-mol),-0.1781764139854267
HCC1428,71466445,3.8149114243044817
SUP-T11,135999136,4.940178246919182
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
Kasumi-2,46907787,-1.0712711351942366
UACC-62,644241,2.9986317152485307
NCI-H526,9915743,2.0217278226524606
HuG1-N,100016,5.877444193140431
PE/CA-PJ15,10302451,1.647301447843495
Daudi,10231331,6.134507235467236
KNS-62,637858,3.1526441291678737
Lu-99,26596,-1.1176086778994336
SNU-175,439501,-1.724461019506839
SET-2,73707398,0.747643412090769
AU565,107970,1.9067452119355752
MDST8,3689413,-1.6812703512916511
SK-MEL-3,107970,3.0007282894696967
CAL-29,26596,-1.7040802846973448
KYSE-180,4259181,-2.278337111185809
VM-CUB-1,6852167,2.222312161566665
EB1,375860,-1.1817069193066
GA-10,24180719,3.6610141975018937
RERF-LC-Ad2,4259181,0.9500738030007112
HCC1143,100016,7.122041956726765
SEM,168313016,1.967017226052083
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
SR,12003241,1.5749280257994038
Capan-2,5460769,2.6167760530795654
GI-1,4259181,0.0748069509367487
BICR 31,135421197,2.236076370585341
UM-UC-3,9903786,3.957731160225435
42-MG-BA,9929138,6.505508084195067
SW1353,26596,-1.2000741302841849
8505C,444795,4.497569251932835
Panc 04.03,11396600,3.73844061007523
NCI-H1435,262093,2.8121009793990046
Lu-99,637858,1.7809926728554546
SNU-410,439501,-1.2001719961376376
Fu97,168313016,4.435663214514425
EFO-27,644241,3.241988529302909
HCC44,9936388,-7.032744443363015
EoL-1,10302451,-0.9784650240234488
L-540,9929138,3.361491533267478
Ishikawa (Heraklio) 02 ER-,135421197,3.044962376223266
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
A101D,3689413,0.2698790344581709
L-363,54626689,5.096204751862005
KMS-28BM,136227924,3.12099798130619
MOTN-1,11396600,3.137567702451298
DU4475,9929138,2.965218723675565
MHH-ES-1,9915743,1.9071670198037491
MOLM-6,26596,-3.738191164501696
LXF 289,168313016,5.746715572468322
NCI-H211,12003241,-0.3344728899219033
NCI-H1623,10231331,4.737119210946733
MOLT-16,49766530,-2.0330031999498255
Ri-1,46907787,-1.1077031577889345
MDA-MB-435S,12003241,-1.2560113103811834
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
SNU-840,9936388,2.507111845662591
DMS 454,73707398,0.7615831708776919
BT 359,6852167,4.533677121834974
MOLM-13,637858,0.5048034575879493
MKN1,135421197,0.9793646210495068
SNU-899,135875424,3.6622876573155336
Becker,71466445,4.307879847711241
PaTu 8902,4259181,0.9791956381618654
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
KYSE-410,135875424,4.192963545953549
HCC1428,12003241,3.752026929973328
CAL-148,444795,5.084246191247904
SCC-25,136227924,2.958495944269512
NCI-H1105,11396600,3.854794582402416
COLO 684,10302451,4.647371569023228
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
CHP-126,selumetinib-JQ-1 (4-1 mol-mol),1.2519618903386895
SNU-449,9903786,3.696408358539977
Calu-3,5460769,-0.6817561012415637
SW1417,262093,3.3040552673447907
NCI-H1092,UNC0638-navitoclax (1-1 mol-mol),0.7964927017699627
MOTN-1,135999136,4.458023817111403
COLO 205,439501,-0.8424951249003566
JHH-5,UNC0638-navitoclax (1-1 mol-mol),0.713308672539544
BT 444,46907787,3.76954091799178
KYSE-150,71466445,6.21700221694018
NU-DUL-1,9915743,-0.5036069794958961
ONCO-DG-1,262093,2.6022952770143197
SCaBER,10231331,0.960032427399654
GP2d,637858,1.5344934743402423
PE/CA-PJ49,9927531,5.215467759359
SF268,9936388,0.7736528995107874
KMS-34,10302451,3.7054012110712464
Hs 729.T,107970,2.3122831170597475
DU4475,11455910,-0.5137096491730787
MOLM-13,135421197,0.945680487717708
RPMI-8226,9936388,-6.980714667404577
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576
MFE-296,9927531,4.364597960371392
FaDu,241158,4.6777977803464745
WM1799,241158,3.9311325613420394
Fu97,selumetinib-JQ-1 (4-1 mol-mol),0.2124672849949502
MHH-ES-1,71466445,3.4244975863031755
HCC15,10302451,3.767869991537956
NCI-H28,135875424,3.040618130997964
MEC-1,637858,0.8953416902336931
NCI-H226,439501,-0.8440362022647064
JHOM-1,selumetinib-JQ-1 (4-1 mol-mol),4.373142511310138
HCC2935,9936388,1.1235911387260256
HCC1500,637858,1.1010846881251866
LS513,6852167,2.449303940636612
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
Hs 578Bst,107970,1.8349384981697157
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
COR-L88,49766530,3.4984546409835016
JHH-4,10302451,2.056735539702947
NCI-H1184,439501,-1.2905593318516702
OCI-AML-5,135999136,3.783330102557352
JHH-2,3689413,-2.478608277030538
PL-21,4259181,-0.9263969170856944
Hs 888.Lu,135999136,4.915312211386622
HMC-1-8,9903786,2.873770542760651
SW1271,444795,4.935671262335122
NCI-H2029,selumetinib-JQ-1 (4-1 mol-mol),2.795337882414602
KM12,71466445,5.496348766161868
BT 145,11455910,-0.1698312216802191
SK-CO-1,26596,-2.200264316257102
SNU-1076,5460769,2.5468440002865895
HEC-6,168313016,4.325832160543922
Karpas-422,6852167,0.067435343224215
KATO III,46907787,3.3838937790978165
LN-18,10302451,3.663631196190854
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
KHM-1B,439501,-2.4289183886287535
PK-1,73707398,1.4410973874230182
LUDLU-1,375860,-0.1285972370265223
SK-N-FI,135421197,0.4390653325388048
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
D283 Med,100016,3.728925578699804
SaOS-2,327653,4.165382989627235
PE/CA-PJ41 (clone D2),135421197,1.2532047663272594
JHUEM-2,107970,2.1315490396390793
Hs 688(A).T,3689413,-1.8044012386941577
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
PaTu 8902,9936388,2.1491039356268966
BT-549,3689413,-0.9397914335397376
Hep 3B2.1-7,10231331,1.1707245730964018
NCI-H211,241158,5.257469500310299
NCI-H1105,44491742,3.93837449237457
HSC-3,100016,6.558832951826536
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
WM1799,10302451,3.849791642303361
SH-4,4259181,0.97599802103587
SU-DHL-10,637858,1.1094204456021386
D283 Med,444795,-3.2845998018022775
IMR-32,11396600,2.686072598374917
KNS-60,136227331,3.7348276766396986
NCI-H1944,71466445,5.389376015988457
DMS 79,262093,2.040295424440088
NCI-H747,10302451,1.853109889502639
DMS 454,135421197,0.7906856651766786
8305C,262093,3.034489216194041
MCAS,241158,4.420825214389376
HT-1080,10302451,3.8413298591430247
FU-OV-1,439501,-0.5556149973103641
NCI-H69,11396600,3.636933869724233
OCI-AML-3,135421197,1.1151677608997974
BICR 56,4259181,1.025220358351184
KP-N-SI9s,135398744,6.4391278360731246
HCC4006,10231331,2.028448781487259
KYO-1,9915743,0.2540895185471781
UO-31,49766530,-5.258539330368952
PF-382,444795,3.785413836559396
OVSAHO,4259181,0.7848451227911502
Panc 05.04,327653,3.66844152859248
NOMO-1,637858,1.0893367728071195
SW1573,135875424,1.8143158468632437
EoL-1,9903786,-0.1437472034571408
COV434,9929138,5.510182738323978
PC-3,644241,3.438318735013137
L-1236,selumetinib-JQ-1 (4-1 mol-mol),2.8513697754529947
MOLM-6,10302451,-1.8333818669362472
Panc 04.03,73707398,1.757833710000806
SK-MEL-2,10231331,1.800532200590708
EC-GI-10,44491742,4.525033675313585
NCI-H520,135421197,1.6066426721545042
MEC-1,135999136,1.4630893356395394
IMR-32,375860,-2.054219262250898
NCI-H841,54626689,4.108843484642347
COLO 792,444795,4.800217468318623
LS180,5460769,0.3293841533128088
KMS-20,136227924,2.296093636743899
JHOC-5,10302451,1.853023270405576
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
A2780,444795,1.1255727490438436
A-172,selumetinib-JQ-1 (4-1 mol-mol),3.279588036343396
L3.3,168313016,5.4672449278411595
HEC-1-A,44491742,4.152626069309694
SW48,4259181,-1.8199657809061969
NCI-H1944,44491742,3.732177387700191
GMS-10,444795,4.9652539058226175
HCC1419,4259181,1.0183716467529351
L-428,26596,-3.3648892390526144
2004,100016,6.70935199674954
NCI-H1355,9927531,4.199887735428921
KMS-26,9927531,3.4485802259646703
Calu-1,10302451,5.51693152602978
KYO-1,12003241,-5.7976599099380595
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
D283 Med,107970,1.5899675113879286
RCC10RGB,71466445,4.397911896340776
SKM-1,selumetinib-JQ-1 (4-1 mol-mol),-3.5716961442559496
WM115,444795,4.375682835505768
Karpas-620,9936388,2.8279791192492088
BT-12,135999136,1.8612722925490397
BT-474,6852167,2.8360260364208707
PC-14,107970,3.287444237855521
G-401,5460769,-1.872739736028161
KYSE-30,9927531,4.7729245028370055
BT-16,71466445,5.064611089812396
RKO,135999136,6.045591123054076
GB-1,73707398,1.1867709251238034
SNU-466,135875424,2.3489478767532868
Hs 611.T,3689413,-2.7004104072546133
Capan-2,637858,2.3526238536580224
NCI-H526,439501,-2.4772740458578983
JeKo-1,9903786,1.7626830163965443
MKN45,73707398,3.4688255593209596
NU-DUL-1,4259181,-1.762578833655516
KYO-1,9936388,-6.33783178095698
EN,439501,-3.211149849796052
Hs 944.T,73707398,1.0226628760817618
ONCO-DG-1,4259181,-0.0855284825830974
T-47D,439501,-2.5781176863157524
NCI-H1838,9927531,5.140983076545055
NCI-H1581,44489367,5.128966425345989
KYSE-450,637858,3.2826178661178003
ECC10,136227331,5.843658104512461
BT 320,11396600,4.5560356349666
BT 440,selumetinib-JQ-1 (4-1 mol-mol),1.436759754366273
Panc 02.03,241158,4.402915180139186
22Rv1,54626689,4.606144843606004
Detroit 562,9915743,0.7221649172673843
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
L-540,11455910,-0.1938391362250027
OV7,4259181,0.7460960676293698
SK-UT-1,3689413,-2.3572164451465105
HT115,262093,2.8442241689305123
CAL-29,9927531,5.397915625533194
BT 504,136227924,2.4961671253802957
EJM,100016,6.634092198961092
TE-4,11455910,0.4087808216227429
NCI-H2029,46907787,2.4460673221548443
DMS 79,BRD-K27188169-navitoclax (2-1 mol-mol),-0.118411912541611
SK-MM-2,10302451,2.9274692632191543
HT115,444795,4.63817892392484
UO-31,11396600,1.978530758998764
BT 232,262093,2.843383638859083
SNU-466,168313016,4.749596387848816
KYSE-70,54626689,6.762622459467938
IGROV-1,10302451,0.4135234554742116
RERF-LC-A1,637858,2.1829548820407165
SNU-466,107970,2.321869103591275
SNU-C2A,54626689,5.282972840372123
LS180,26596,-1.3053249122689552
GA-10,135421197,0.1177808721156358
BT 359,3689413,-0.0229882443129298
MIA PaCa-2,54626689,4.534739947118546
639V,241158,4.254110598517854
MHH-ES-1,241158,2.9486895199136876
Hs 852.T,4259181,0.4038883720534522
NCI-H1568,135421197,1.29303587511011
JHH-1,71466445,1.5476660922212682
NCI-H1869,327653,3.4253692354840197
SNU-601,9936388,-4.393234947072901
RL,9903786,3.83184195533614
COLO 699,73707398,0.3893821784676728
HT-1197,selumetinib-JQ-1 (4-1 mol-mol),0.9011980112854324
COLO 320,73707398,1.0538483346288248
EFO-27,71466445,6.412452895571818
RPMI-6666,444795,4.6852375773815975
Hs 940.T,12003241,-1.8353600585061816
RS4;11,100016,4.815282587104974
YD-38,375860,-0.9666963323879848
CCK-81,327653,2.928466613082437
RS4;11,135999136,1.6580439823649238
SNU-449,156414,1.8120811787876097
M-07e,444795,0.671881702750201
HT-1197,135875424,3.754015840236683
TE-10,444795,5.4304564593052085
IA-LM,262093,2.9896562434219627
BT 340,327653,3.529753308565155
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
HOP-62,6852167,3.1179431190301226
SBC-5,6852167,3.965917526242172
NCI-H647,46907787,2.2999063461602716
NCI-H1563,11396600,3.5189077710115244
BICR 16,selumetinib-JQ-1 (4-1 mol-mol),2.075716785292983
LUDLU-1,439501,-1.4236131557498473
HT-1197,136227924,5.329383648142769
SNU-407,10302451,0.9943081022244468
SU-DHL-1,375860,-0.8487932986720208
T-47D,11455910,1.56267041367126
SW620,6852167,3.2674299159277753
HCC366,10302451,2.822890976985495
HEC-265,439501,-2.385481236661946
JHOS-2,49766530,-2.972328777920352
NCI-H2405,439501,-2.240122833517123
SU.86.86,439501,-1.025939576051134
OPM-2,107970,1.3408908225452507
G-292 clone A141B1,439501,-3.0998279845902723
Rh18,6852167,1.9644324701038989
KNS-81,6852167,4.651561825132848
NCI-H889,UNC0638-navitoclax (1-1 mol-mol),-2.669944065758076
JURL-MK1,11455910,-0.1674344407672636
M059K,3689413,-2.3612434015729336
Rh18,71466445,2.179125629800487
Peer,46907787,-0.6755973461446936
KMS-28BM,262093,1.4261672899079032
DU145,12003241,-2.0135691280208876
NCI-H1869,selumetinib-JQ-1 (4-1 mol-mol),1.6697033595632398
TE-1,6852167,3.8311272087264814
U-87MG ATCC,49766530,-0.4723901829194296
SW579,54596490,4.948848003277673
EFO-21,375860,0.3291343721988856
TYK-nu,5460769,2.633431315912765
Hs 578Bst,46907787,3.9294981488620366
BV-173,46907787,-0.9372629276794407
LCLC-103H,262093,3.3068425344063326
EB1,26596,-3.5599614403908264
YD-10B,9915743,-4.675964091727352
SF268,135875424,2.548556170220251
LP-1,439501,-3.639573627473922
SU.86.86,11455910,1.5020597787375292
YD-15,241158,3.805397573173429
HCC2108,49766530,-2.150620999142696
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
CAL-51,262093,2.862241975448649
BT 440,9936388,1.094365580931073
NCI-H1734,3689413,-2.032752334102639
NH-6,375860,-0.5773523787871093
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
H-STS,135421197,1.21674084203813
SUIT-2,135421197,1.9421505415119584
T24,44491742,4.439042191378119
TE-4,24180719,3.647594082859593
Hs 839.T,24180719,3.944911214885226
NCI-H1373,6852167,3.4417503249951737
U-118MG,9927531,5.792159501722103
Mono-Mac-1,444795,3.2832788866841573
A-204,156414,1.2120783499508014
KE-37,135875424,3.024504733607955
L-428,44491742,3.8287631756244944
RT-4,10302451,0.2321939311866163
Mel JuSo,375860,0.1137765747437233
GB-1,10231331,4.4589377550912745
ESS-1,6852167,2.0941643944902055
BDCM,12003241,-3.7863516552935415
RVH-421,11396600,3.585263708085467
Panc 10.05,135875424,4.82827544995575
MJ,5460769,-0.0196671860810318
SUIT-2,439501,0.993663636668041
Caki-2,selumetinib-JQ-1 (4-1 mol-mol),4.273304003635038
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814
OCI-Ly3,9929138,5.257531923381126
YD-15,11455910,1.434316032947977
KMS-21-BM,9915743,0.1101239094873029
WM1799,11396600,3.8068565686639273
BT 416,24180719,3.1133029562660353
CHP-126,6852167,2.3577769718395825
JHH-1,439501,-0.896844817014076
HLF,444795,4.996858415004705
MIA PaCa-2,12003241,-0.7993036743010778
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
Hs 944.T,375860,0.0810180917289278
NCI-H716,135398744,6.457168364956761
TE-10,9915743,-1.7671163693014442
MFE-319,444795,3.938376988705715
KE-37,9936388,-6.941921188286439
HPAC,100016,6.325474069382135
HCC827,135875424,3.772761345205915
MOLM-6,73707398,0.517152915565168
SK-MEL-3,10302451,3.716398360245668
BT 333,44491742,4.348369839159046
NB1,168313016,4.537464228593661
OVCAR-5,49766530,-1.816533160659826
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
BT 231,156414,0.9770079511825466
GSS,9915743,0.3423445319525382
MM1.S,262093,0.96316485237803
U266B1,439501,-2.1640561417805686
Hs 746.T,262093,3.2071255403244097
PE/CA-PJ41 (clone D2),10302451,2.698134533156883
Capan-1,135999136,4.351414780537385
LN-18,44489367,5.059559200275477
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
TE-15,262093,3.281434334474844
PE/CA-PJ49,44491742,3.950119634705539
BT 422,107970,1.7481064478345374
COLO 205,44491742,4.914749097396915
SK-LU-1,46907787,2.3105401780799917
SNU-C2A,9903786,2.8672741986738193
SIG-M5,6852167,1.5544573482245505
SNU-668,10302451,1.5008708259848218
BICR 18,135421197,2.040633770246715
RPMI-8402,11396600,3.4463493734861186
SNU-685,71466445,4.2836215001071185
DK-MG,73707398,0.9326213981846314
SNU-46,100016,6.6556000707540095
GP2d,241158,3.714880329185931
L-363,9915743,1.0748185712665137
Caov-3,11396600,3.9486242065815738
Calu-3,637858,1.8527277636987496
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
DEL,9927531,3.262771629290843
WM266-4,UNC0638-navitoclax (1-1 mol-mol),4.921786401804959
OPM-2,241158,1.7102591321182437
DOV13,9936388,-0.6150425956780249
KMS-12-BM,9903786,0.6537757100604409
OCI-AML-3,5460769,2.571994692264208
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
SUP-T11,46907787,1.0254127656245202
SNU-245,6852167,3.4758123608320983
WSU-DLCL2,135421197,1.3366887647242718
SNU-201,9936388,2.3725441363874236
NCI-H1373,9903786,3.0736149101448893
HPAF-II,73707398,1.96583699059278
697,156414,0.8194955479278566
MDA-MB-453,327653,2.9444810987281533
OVCAR-5,73707398,1.79782058395096
P12-Ichikawa,637858,1.4527984508245164
KE-37,439501,-2.40992471859013
EM-2,24180719,2.561541498353381
TALL-1 [Human adult T-ALL],135875424,3.2199979097840905
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945
Hs 852.T,262093,1.3766639413412267
BT 172,135421197,1.393069790953409
MHH-CALL-4,71466445,1.6335508440746371
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
RKN,9929138,7.419607622812729
HT-1376,46907787,2.915425637626166
ME-1 [Human leukemia],444795,6.159578889589608
PC-14,100016,6.551425062945198
HH [Human lymphoma],439501,-4.820803116801483
HCC827,44491742,3.1413058075131746
DB,6852167,1.6575256705815002
BT 333,46907787,6.1383675954590835
DMS 53,136227924,2.35473496791988
Caki-1,12003241,-1.8863162536101896
NCI-H810,11455910,-0.6368425988840776
GaMG,644241,2.451949741066743
T24,100016,6.183675550900896
LN-229,49766530,-2.6497370695255857
BT 224,136227924,4.003699925469014
SW1088,262093,4.334823497952687
RS4;11,selumetinib-JQ-1 (4-1 mol-mol),0.0937059974096374
SK-MM-2,637858,0.0064684499737818
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
GP2d,135421197,2.1727622250503607
Hs 294T,9927531,5.24007707651297
GP2d,327653,2.337916149275068
YD-10B,selumetinib-JQ-1 (4-1 mol-mol),-1.9634991051981487
MM1.S,selumetinib-JQ-1 (4-1 mol-mol),-0.6106024148084398
NH-6,71466445,4.601031445785075
HOS,12003241,-0.4852200240623472
TE 617.T,11396600,3.161779711193339
FU-OV-1,12003241,-1.039273875540509
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
BV-173,10231331,4.511463225160437
GSU,136227924,3.064976264970486
COR-L88,11455910,2.1470995526848258
8305C,5460769,5.099577444912903
HGC-27,327653,2.307850951814526
BT 428,327653,2.894003003794866
NCI-H1385,24180719,3.5899417956097075
NCI-H2081,26596,-1.5856459484869678
HT-1197,44491742,3.769562948559888
KYO-1,107970,2.531973304775865
MDA-MB-361,9927531,5.403888941869855
TUHR10TKB,46907787,3.6384939383070662
SUP-HD1,44491742,5.1977387021810255
Kuramochi,136227924,3.2782581577037964
SK-MEL-1,9903786,3.576716533884559
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
Tm87-16,9903786,3.2568482334104587
RPMI-8402,5460769,1.919918299685469
RERF-LC-MS,26596,-1.2372341703529914
CAL-51,5460769,1.3780575552768597
BICR 56,73707398,1.0454469872982766
SNU-899,selumetinib-JQ-1 (4-1 mol-mol),2.409462633962382
K029AX,73707398,1.096607124396172
SNU-878,11455910,0.0025920112250637
Fu97,637858,1.7613524415247008
NCI-H747,3689413,-2.2954703648292605
KP-4,11396600,3.580302793635078
U-937,26596,-4.272350751013951
D283 Med,selumetinib-JQ-1 (4-1 mol-mol),1.653180962560337
NCI-H522,444795,5.191031194563041
EC-GI-10,107970,2.2401004276751997
NCI-H2030,262093,3.6307250181599215
OVCAR-8,54626689,6.165412281282488
KNS-62,136227924,3.1878911405001236
Fu97,12003241,-1.5366115434948442
NCI-H2171,46907787,0.7633638606493435
BT 482,9936388,1.0428737774764048
SCC-9,9915743,1.0040050158500469
NUGC-3,439501,-0.8687930764506365
EBC-1,444795,4.731018118480506
EHEB,439501,-2.4217048608799097
GI-1,262093,2.614529868805307
DoHH2,9936388,-6.050878325143338
647V,107970,1.6847508381936895
HCC78,637858,2.2955589210250773
HCC1438,375860,-0.6408911339583222
COLO 684,637858,1.1934197712616614
SK-MEL-5,44491742,4.058095878540579
KP-4,10302451,4.244768589994227
NCI-H1755,BRD-K27188169-navitoclax (2-1 mol-mol),-1.5046970174914764
JHUEM-7,26596,-1.8551798961299688
SNU-C1,26596,-0.0671330439663034
OCI-AML-3,49766530,-3.0415372602627375
KMS-11,73707398,0.4989267515733416
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
DMS 273,3689413,-1.7704206659692223
FU-OV-1,4259181,1.2776952629591818
Mel JuSo,26596,-0.7227371785697827
TE-1,135875424,3.5778077934437658
EBC-1,136227924,2.637152829802991
MOTN-1,71466445,1.6583879973363078
SNU-46,12003241,-0.9132341104689335
KMBC-2,11396600,3.805651469243142
CHP-212,5460769,-1.533156489217473
TF-1,6852167,3.4840592939536097
IGROV-1,11455910,-0.2792640061206097
JeKo-1,637858,1.1914802653668115
L-540,9936388,-1.294007802651234
HCC1171,73707398,1.2245906470205266
CAL-62,9927531,5.042893811802322
Aska-SS,3689413,-0.2828072846638814
COLO 320,100016,4.196375737127383
HuNS1,3689413,-2.2730227081216787
KMRC-2,10231331,3.7445529235865895
SUP-T1,26596,-4.2216278033342105
IPC-298,3689413,3.077795295387571
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
SYO-1,439501,-5.087995993751375
HuT 78,71466445,0.6237805812301164
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
SNU-761,73707398,0.8313669811057733
PF-382,135999136,1.3874167482573283
LP-1,5460769,5.634254198515754
NCO2,24180719,2.363595427996926
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
SNU-C4,439501,-3.0543903815418547
HuH-6,71466445,1.898975323859935
KMS-20,44491742,3.719914001289463
PK-59,11455910,1.1021180024981292
PF-382,11396600,2.839145334831077
T84,100016,6.649554415164183
EBC-1,135398744,6.3334705093468235
KMS-28BM,46907787,-0.0548327067626499
NUGC-3,6852167,3.3889998350800608
BT 428,156414,0.1234393926344954
SK-N-SH,444795,4.912607426917253
SK-OV-3,9936388,2.038842599711319
HEC-108,136227924,3.134071919213167
BT 286,3689413,-0.1900658377643967
NCI-H2342,107970,2.0946828835513793
Mono-Mac-6,3689413,-1.766017033423464
KU-19-19,12003241,-0.0608702413973226
SU-DHL-1,49766530,-4.824875359994143
IGR-1,262093,3.048494446765652
EBC-1,24180719,5.0552104743424096
RCH-ACV,136227924,2.5365542828193957
CAL-148,71466445,3.5849271130179448
HSC-4,6852167,2.6632521076475446
U2OS,241158,0.4177230113185624
NCI-H650,241158,4.216893236896897
CAL-51,3689413,0.5709426612715743
LN-229,241158,4.166915058651339
NCI-H1155,BRD-K27188169-navitoclax (2-1 mol-mol),0.8887988434342636
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275
SW1088,BRD-K27188169-navitoclax (2-1 mol-mol),3.869262910505179
HuH-6,3689413,1.6433341745909646
KMM-1,6852167,5.031362845213915
NCI-H810,637858,0.7916088156813487
G-361,135875424,3.221019513636021
BxPC-3,10231331,0.6961573218104748
SNU-886,241158,1.2144772988451973
NCI-H2342,241158,4.482197649882829
NCI-H889,375860,-0.3028496531572372
Hs 729.T,136227331,4.519931514074803
Kuramochi,9936388,1.4592676990765918
IGROV-1,9936388,2.10108466287406
NCI-H358,135875424,4.435153990168911
JM-1,100016,5.094244415703564
SYO-1,327653,4.254978893518193
OCI-AML-5,11455910,0.2167444305252664
SNU-1105,4259181,0.7884836359109508
C2BBe1,49766530,1.671103573384802
SK-N-BE(2),44491742,3.960613770840922
NCI-H1869,241158,5.0819681903137806
SK-LU-1,selumetinib-JQ-1 (4-1 mol-mol),1.493691888542625
SK-ES-1,444795,4.571799247087775
Li-7,46907787,-1.2636759008098706
RS4;11,136227924,1.742872720779967
TCCSUP,11455910,2.681471740921846
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
SNU-16,10302451,3.753496060515648
Hs 688(A).T,10302451,3.7061911654839816
NCI-H2106,135421197,0.6471538236638695
G-401,637858,0.5800115670130345
ChaGo-K-1,9936388,-4.876543253304364
BT 328,136227331,5.061934875267611
LK-2,26596,-1.655987263184575
UM-UC-1,135875424,3.037930773608268
NCI-H2106,439501,-2.192418172555811
SHP-77,375860,-1.0648061224217071
SNU-869,100016,6.487538118719535
WM266-4,5460769,5.368369623882124
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
NCI-H1355,9936388,0.5035386429798234
GA-10,10302451,1.250963043335676
DMS 53,9929138,3.8205898252518393
SCC-9,136227924,3.721677265331546
HCC95,135999136,5.011624687002968
NCI-H661,9915743,-0.8538809858854721
NU-DHL-1,4259181,-0.8877351143250455
NOMO-1,100016,4.546215242968586
EFO-21,11455910,1.6034546526861042
COLO 680N,100016,6.604594090356929
EC-GI-10,168313016,5.76408308969352
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
HCC1195,262093,3.0706321230019635
AML-193,9915743,-1.3116324914766342
PE/CA-PJ49,135421197,1.7245990786454344
Mono-Mac-1,10302451,2.661721795389531
RL,24180719,5.058068464344177
HCC-56,637858,2.8571937872562407
Calu-6,4259181,-2.1681015531295027
NCI-H520,12003241,-2.710304641181941
CGTH-W-1,44489367,5.286932871572645
KE-97,375860,-1.25859838989695
SNU-16,100016,4.136425652163891
DV-90,6852167,0.5997436806483085
TE-4,9903786,1.7247018760374746
BFTC-909,46907787,2.3649992203474515
L-363,10302451,3.481450543195112
SK-N-MC,439501,-1.9559444468392349
TE-6,439501,-2.719069941795036
SNU-503,10302451,4.344629987884854
MeWo,24180719,4.402084052292052
EKVX,11455910,2.049892638783207
AML-193,selumetinib-JQ-1 (4-1 mol-mol),-1.0603244627842072
NCI-H2286,4259181,0.1165074944182298
SUP-T11,UNC0638-navitoclax (1-1 mol-mol),1.5876304129762722
HCC1806,439501,-1.846359042641554
OVCAR-5,54626689,4.126454939451351
NCI-H146,11455910,-0.4209962248823531
SNU-398,135421197,1.394943523979563
LS1034,11455910,0.6573376137938117
Mel Ho,107970,2.382821676365672
NCI-H650,9915743,1.7401502562987152
MOLT-3,9929138,4.064754061766862
NCI-H716,168313016,4.474917633369443
WM983B,107970,2.073106798570593
JM-1,241158,1.7269305863155773
NCI-H1395,24180719,5.770511312321668
HT-29,9936388,1.7022736774811322
SK-HEP-1,3689413,-2.4602386660304143
GSS,100016,3.718199006522657
OAW42,375860,0.01569674815874
HCC827,9936388,-1.46620375683839
KMS-20,UNC0638-navitoclax (1-1 mol-mol),1.0394785462110392
CAS-1,UNC0638-navitoclax (1-1 mol-mol),1.8136943980639495
Jurkat,107970,2.2627318872269733
RPMI-8402,71466445,1.5277227120720451
MHH-CALL-4,100016,6.461754156645112
CAL-27,375860,-0.618101771298289
NCI-H1339,637858,2.289025775873357
BT 416,136227924,3.4255307271180726
KMS-18,11455910,-0.1916352786292855
QGP-1,135875424,4.81787572087767
Detroit 562,9936388,0.4800991198944179
HEC-251,5460769,6.090602801092177
8-MG-BA,262093,2.906826185305208
SU.86.86,3689413,-0.2101757274961018
IST-Mes1,3689413,0.9013533734229402
COLO 668,327653,2.9984375660201037
LK-2,4259181,-0.1712437938177803
WT2-iPS,73707398,1.5963579815560645
JHH-5,12003241,-2.221894796534897
L-363,3689413,0.386026439105166
A-172,46907787,3.7359554398784978
SNU-182,100016,8.076902029611453
PL-21,439501,-2.414753232425099
WM793,135875424,3.1604105075223656
JHUEM-1,11396600,2.4949940260593872
OAW28,71466445,4.188405368682896
TT,11455910,1.6357775292121417
GB-1,49766530,-2.426410648312405
HCC1588,44489367,4.371183486636218
CGTH-W-1,24180719,3.2237497601440266
BT 330,11396600,1.7759393171748088
OAW28,5460769,4.044755256654475
SNU-407,9929138,5.973449763391868
WM793,637858,1.8553013176450457
HCC1806,9915743,1.1947371643854778
HCC1143,11455910,1.411815978618001
253J,168313016,4.386063736521232
Ki-JK,135875424,2.2623198423416255
SK-N-BE(2),3689413,-2.1106889399644273
Raji,327653,2.879098254460797
HCC202,6852167,2.3722949143697076
SK-N-DZ,46907787,1.653220614467886
ZR-75-30,9927531,5.796828878545894
EC-GI-10,11455910,2.357666913009647
SNU-387,9903786,4.748130611639421
SK-MM-2,439501,-1.9347764023362728
SNG-M,selumetinib-JQ-1 (4-1 mol-mol),1.4036596659631748
SW1573,107970,2.0608182724975266
NCI-H2172,11455910,3.487096997214958
COLO 201,107970,1.868619980747979
MOLT-3,54596490,4.074964853764077
C2BBe1,UNC0638-navitoclax (1-1 mol-mol),0.9522227757619474
769-P,10231331,6.35987842726323
BT 328,156414,4.0443464949872645
MIA PaCa-2,10302451,3.7253784601245945
NCI-H358,107970,2.533765359070406
Hs 888.T,49766530,-2.634429263371643
NCI-H1869,327653,3.4253692354840197
697,44491742,3.706087965098128
NU-DHL-1,12003241,-2.4677988287748915
OE19,5460769,4.447133624333207
YD-10B,46907787,-0.6754469582299863
HEC-6,71466445,2.328482360164493
MCF-7,24180719,3.686974231893429
CCF-STTG1,135875424,4.233748796461769
RPMI-8402,375860,-0.8555405736756128
HEL,71466445,1.5745300131733593
NCI-H2171,135421197,2.0026019926205185
Kuramochi,637858,2.821656022109006
IM95,107970,1.6852534939866826
NU-DHL-1,439501,-3.591448694271343
SNU-1079,9936388,-2.1340211532610636
BICR 6,73707398,1.1329966454047338
GP2d,71466445,4.352014639159245
SET-2,241158,3.0184145193600807
BT 179,135999136,1.6190851622776896
RERF-LC-Ad1,262093,3.285321037103647
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
NCI-H838,135999136,4.446245852167806
TE-4,9915743,-1.938588144911124
THP-1,44491742,3.722381012581274
A-549,9936388,1.4749208650316612
NCI-H747,11396600,2.4515221760153603
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
NCI-H1915,644241,1.9378779435175135
KYM-1,3689413,0.9025287359400416
Panc 02.03,262093,3.467425891303458
HuCC-T1,439501,-1.791859675505955
BT 482,644241,2.486810185249483
AsPC-1,9915743,1.396378280260739
A-253,439501,-2.336084390723404
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
SNU-1214,262093,2.99372726902227
BT 224,73707398,1.7036083579889874
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994
KCL-22,26596,-1.6030605550543997
DU145,5460769,5.167808415466422
SK-HEP-1,6852167,5.53454213252302
NALM-6,375860,-0.5746489324982738
IGR-37,9915743,1.4211592255405934
MOLP-2,9903786,4.729359936369518
NCI-H1975,6852167,1.190480480339929
NCI-H441,12003241,-0.5712831750055372
SJSA-1,637858,2.1617157587953133
JM-1,26596,-2.491901301923365
TE 617.T,5460769,-1.488012889612994
A3/Kawakami,375860,-0.4676935312596571
DMS 273,439501,-3.5888564067388633
BT 187,selumetinib-JQ-1 (4-1 mol-mol),2.145503415351022
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194
SNU-738,241158,6.033903166025284
OVCAR-8,12003241,-0.599857829959187
Hs 746.T,644241,2.8412475305578786
DMS 273,100016,5.677769516399485
NCI-H2122,107970,2.8025359770355047
GCT,4259181,0.217188934537872
JURL-MK1,UNC0638-navitoclax (1-1 mol-mol),-6.663169619788907
JM-1,10231331,5.343116821873739
KMS-34,9927531,3.5487000216351277
KNS-62,262093,2.8892264309510014
OVCAR-4,49766530,-2.103044081091216
NCI-H2106,UNC0638-navitoclax (1-1 mol-mol),-0.2261787168491973
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
IST-Mes1,241158,4.374014389295604
2004,9936388,0.7178208617873092
KYSE-140,439501,-2.2036133964389446
HL-60,11396600,3.4352516220498215
253J-BV,10302451,1.5827039358802202
SNU-475,49766530,3.8108218409500063
NCI-H69,12003241,2.7316245717871572
COLO 668,6852167,2.8709029977726717
Capan-1,9927531,5.621022347820903
HLF,327653,3.1143570229746653
NB4,10231331,-1.99869835268962
BICR 56,54626689,5.63048504264984
IM95,54626689,4.926227185678869
SNU-899,44489367,5.367213552801788
DLD-1,11455910,2.1228676329479397
NMC-G1,9927531,6.6210082677754984
TYK-nu,12003241,-2.574649573149326
LCLC-97TM1,644241,3.02487415997038
ChaGo-K-1,9915743,2.151950733066917
639V,selumetinib-JQ-1 (4-1 mol-mol),4.561629835608233
KYSE-140,9915743,-1.963321476047282
SF126,644241,2.527931632106116
BT 172,241158,4.245378972557845
SNU-1033,6852167,3.058956873768391
SNU-1,9903786,3.1259833622650315
BT 159,12003241,-1.7931625060077818
NCI-H1581,262093,2.2413159684739905
HCC1806,44489367,4.442774319912779
NCI-H2452,4259181,1.4154165902225178
NCI-H647,439501,-1.4518848962069395
K029AX,156414,5.338524173167653
NCI-H2228,6852167,4.0498001150674225
PF-382,9936388,-6.688930185968071
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
IA-LM,637858,2.795809218533269
HeLa,135875424,4.463353648372455
Ishikawa (Heraklio) 02 ER-,262093,3.584751515027739
HCC2935,4259181,1.139501635941419
SH-10-TC,6852167,3.183522893329415
PE/CA-PJ15,11396600,3.3444318017760986
ESS-1,73707398,0.9452333213652502
KE-39,73707398,1.3252144554958445
NCI-H69,241158,3.5376406535699543
L-363,156414,1.591955840690862
SU.86.86,135875424,4.152288157211863
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
EM-2,9903786,1.526711348749508
HGC-27,156414,1.4531209246757668
SNU-1041,135421197,3.0593389422379293
HOP-62,46907787,2.3496891847816905
BT-474,11396600,4.260974029786902
A-375,71466445,4.407690807388674
TE 441.T,135421197,0.4096443090762519
GMS-10,9915743,1.3582856861071526
P12-Ichikawa,12003241,0.1281153302005317
TE-15,5460769,-0.6910051691918724
PC-14,46907787,2.390406251773133
NCI-H1373,9929138,7.584401812075051
GSS,135875424,3.760188013536636
BxPC-3,241158,3.755569293331497
NCI-H1435,439501,-0.9104784538070396
TOV-112D,4259181,-2.185686568259274
SK-UT-1,26596,0.4182972999713699
EBC-1,4259181,0.1391394165733286
TE-5,136227331,4.141551967030233
SNU-119,637858,2.7399101747630867
Ku812,327653,2.6105949863285436
BT 131,4259181,0.5995842251057973
HSC-4,135421197,2.1482643592466495
KMS-26,44491742,3.93722038391691
NCI-H1355,644241,1.8672307897255656
NCI-H1341,156414,0.9119467847999114
A-172,9903786,3.6235991814079545
GA-10,71466445,1.994023479253392
NCI-H716,107970,2.192898211455521
HEC-1-A,12003241,-1.9132267433224897
Hs 578Bst,11455910,1.5492426268686
NCI-H1339,12003241,0.6707609457385758
NCI-H23,9903786,3.588944874892838
OPM-2,49766530,-3.767684481967312
BT 164,10302451,3.8869135930428063
KYSE-30,3689413,-2.4041486305877497
HCC-56,5460769,4.347795399558133
COV644,10302451,3.712338518023003
PL-21,11396600,2.4757103369664084
SK-N-MC,444795,4.620519937789042
HCT 15,9936388,-4.893709722395259
IST-Mes1,44491742,4.903550558956352
JHOC-5,327653,3.2802952976184723
SNU-478,439501,-2.527106469117114
NCI-H1373,107970,2.3684164881001584
NMC-G1,6852167,3.88532849006431
NCI-H2030,241158,3.7184725002314183
NCI-H28,54626689,4.460186125757267
T24,11396600,3.350791028009117
TTC-709,241158,3.209768010669518
OAW42,11455910,0.9169740584979637
COLO 678,selumetinib-JQ-1 (4-1 mol-mol),0.2945638397547896
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
NCI-H1793,46907787,3.6705160121721736
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
HLF,10302451,3.786681722046504
SK-MEL-24,49766530,0.9936370719790436
WM88,156414,1.6850419616886465
D283 Med,26596,-3.592310964496019
JHOM-1,49766530,1.1391722298569036
ONS-76,5460769,1.8809234095271896
TE-1,54626689,6.966022100980541
SNU-C4,135999136,6.328379982006613
TUHR14TKB,11455910,2.317206369851234
PE/CA-PJ49,136227924,2.4190721025981987
KYO-1,4259181,-0.6060384488599356
OCI-AML-3,241158,2.768035371877761
MM1.S,107970,1.483055719195773
SK-MEL-30,4259181,-0.1828887975932634
TE-5,selumetinib-JQ-1 (4-1 mol-mol),1.7443513942912756
F-36P,selumetinib-JQ-1 (4-1 mol-mol),-1.0872575264771165
NCI-H1341,11455910,-0.2175400116786661
DU4475,24180719,-0.5971261701053152
TE-5,241158,3.735323756350085
SK-N-AS,644241,2.0495505337377393
NCI-H1755,73707398,1.4659899774236258
NCI-H929,44491742,4.424394304638718
RT-112,26596,-1.382463026117804
HMC-1-8,11455910,0.6557155975266148
SNU-213,637858,2.227184287849749
EC-GI-10,100016,6.57909581265972
SNU-1041,6852167,3.3738029338506093
H-STS,3689413,-4.4758570940331515
YAPC,71466445,6.285156806731666
EoL-1,11396600,0.6541827154317742
KE-39,10231331,4.477976749120646
HCC1806,46907787,0.9728149371858936
OVK18,selumetinib-JQ-1 (4-1 mol-mol),1.011508135908241
AsPC-1,10231331,1.7826677656602696
P12-Ichikawa,168313016,4.634165787184027
HPB-ALL,3689413,0.032224825554501
SiMa,9936388,-4.904679848632844
RL,73707398,0.8668689445518878
RS4;11,49766530,-2.8590033120735767
LXF 289,135421197,2.6553019911408056
BICR 22,107970,2.71438120007047
COV434,107970,1.1877633129771374
JURL-MK1,12003241,-5.793080967465335
HEC-151,11455910,-0.546024976491568
Sq-1,327653,2.3606693919052737
SW1271,11455910,0.4702460968788743
RVH-421,5460769,4.814862206766451
OV56,4259181,1.5870297119020984
NCI-H1395,135875424,3.644181585171065
HuH-28,6852167,2.4785220942658137
SK-OV-3,4259181,0.9080230343390464
THP-1,3689413,0.1739337887776562
Ri-1,10302451,1.5393417915178893
OVCAR-5,327653,3.1617926735061737
BT 159,6852167,3.668845452982651
BT-549,5460769,6.35928800843138
C2BBe1,selumetinib-JQ-1 (4-1 mol-mol),1.7438038372946627
BT 428,71466445,5.17114192317244
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251
TTC-709,135875424,2.6743897511272454
RT-4,9903786,1.1299984693284726
TE-14,73707398,2.073714083306327
NCI-H1573,9936388,0.6973837947866425
HEC-1-B,49766530,0.5619128655889829
M-07e,12003241,-1.0456216878354962
KG-1-C,46907787,0.4611136549096399
NCI-H1975,9915743,-3.928107410623461
A2058,12003241,1.9511247747481215
NCI-H747,107970,1.6995080105584164
OAW28,168313016,5.164256635335989
SNU-C2A,136227924,3.0438027551295352
SBC-5,439501,-2.4874901722547977
Hs 578T,135875424,3.578631345262118
KALS-1,9929138,7.477924351122795
BC-3C,73707398,1.995912944947898
NCI-H810,156414,1.380169056406662
SU-DHL-4,241158,2.7367495479709194
NCI-H292,135875424,4.14052752249008
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
MKN74,439501,-1.7547166912858625
NCI-H1385,11455910,-0.7459134175942048
HMCB,4259181,-1.3658440890199388
8-MG-BA,9936388,2.9775871054225256
HEL,73707398,1.0006953763352662
OCI-M1,135999136,1.5304010424247585
KMS-12-BM,73707398,0.3620923628880652
MSTO-211H,49766530,-4.866552298919663
HCC1395,375860,-0.7550225265126825
BHT-101,637858,2.210357872554675
JHH-6,11455910,3.965766048623887
NCI-H1339,4259181,-0.3541173382827977
SW1710,156414,5.813264772050665
SF539,327653,3.3770394007544953
CAL-27,262093,3.248965473833737
NCI-H889,327653,2.919177288427523
HCC366,4259181,-0.2253216072179903
CCF-STTG1,24180719,5.187179011089803
DAN-G,9915743,1.9935074421825545
SK-MM-2,BRD-K27188169-navitoclax (2-1 mol-mol),-3.608862706116632
OPM-2,168313016,3.5498730155612863
OCI-Ly19,135999136,4.140438011573843
A-673,44491742,3.844993574977925
IM95,4259181,0.4193994056923691
HCC2935,71466445,4.339835405663117
NCI-H460,6852167,4.590065962834362
PK-1,107970,2.4622131815620834
MHH-ES-1,168313016,4.916028116367523
TE-4,156414,-0.7706955367597111
NB4,11455910,0.3286835470988328
YD-8,UNC0638-navitoclax (1-1 mol-mol),2.814214671394628
YH-13,107970,3.012104980277858
HuNS1,54626689,4.810315002739711
HDLM-2,444795,4.905725806732837
A-204,UNC0638-navitoclax (1-1 mol-mol),2.407510176104919
HEC-1-B,11396600,5.535370939543194
BICR 16,5460769,4.333999441494942
OE33,71466445,3.9319707229949703
YD-15,6852167,1.5234266215850325
AN3-CA,637858,1.3761527435149865
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
HOP-62,241158,4.371363298737313
Panc 05.04,107970,2.819973093119505
TTC-709,135421197,1.6212603414567397
GB-1,9903786,2.9752485766111936
KU-19-19,49766530,0.1366302187334878
PaTu 8988s,10302451,4.079091129858146
RS4;11,135875424,3.0879856704694313
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
Daudi,44491742,3.5549145676591314
KYSE-450,9936388,-0.9236320595886032
MSTO-211H,46907787,2.574686905184434
KMS-34,4259181,-0.3254253333461033
MOLT-16,4259181,-1.509104113024461
NCI-H1703,5460769,1.9042192719561193
BT 330,135421197,3.0606427160011433
Hs 729.T,375860,0.4901141915771287
SW1990,9903786,3.346032701157222
Rh18,241158,3.650001682729563
LNCaP clone FGC,73707398,1.3422598428306614
SUP-T1,241158,1.808139416871087
Karpas-299,12003241,-0.4647539333721411
SF126,49766530,-2.4401287268273135
PE/CA-PJ49,12003241,-1.496755728928347
BT 330,4259181,0.5985885076364172
8505C,644241,2.1327575450913727
ACC-MESO-1,73707398,1.5001086563583304
BT 187,10302451,3.7784364345624666
8505C,24180719,2.2536556029037644
RS4;11,24180719,4.150358441008597
NH-6,136227924,2.082013315983653
Hs 888.T,9903786,1.8376079408341344
RMG-I,10302451,1.8334248355675016
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
MKN1,262093,2.3312380194672353
BT-20,49766530,-3.0336116964226076
IMR-32,100016,6.43791059275997
LP-1,327653,2.8727954788037575
KYSE-150,107970,2.435161948690566
Lu-99,5460769,-0.1107532404571854
KYSE-410,71466445,4.5751159315788055
NCI-H2286,24180719,2.8145127753915196
KMS-11,71466445,1.8143007153609576
COR-L51,135421197,2.6598803683271965
NCI-H2110,241158,3.1912359933366465
KPL-1,UNC0638-navitoclax (1-1 mol-mol),2.89421490403249
NCI-H2126,168313016,5.941518060923545
Hep 3B2.1-7,73707398,1.151761195316654
HEC-108,241158,3.683911292843857
PK-59,71466445,3.6462946515492423
Kasumi-1,375860,-0.4619360100102614
Li-7,24180719,2.592427026723636
SU-DHL-8,9903786,1.70511202729143
KATO III,439501,-0.4584208934437059
SK-MEL-30,10231331,-2.3294138551278643
COLO 800,100016,6.663651406564157
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755
Lu-99,46907787,0.2214274327488097
NCI-H522,644241,2.1349742590503427
LNCaP clone FGC,241158,3.9934021722066784
LMSU,637858,2.7447242272748924
Li-7,3689413,2.782987463580999
SNG-M,12003241,-1.3269427590967688
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
Malme-3M,135421197,3.050817856383808
HCC44,26596,-2.4855427767458735
ZR-75-1,135421197,1.3077773564492
BT 271,241158,5.625981584697921
SNU-C5,12003241,-1.9279387541899935
Panc 10.05,49766530,2.44365810580744
DND-41,46907787,-0.7130087499349617
NCI-H1299,12003241,-0.9760038754339474
Caki-1,selumetinib-JQ-1 (4-1 mol-mol),4.356213501153114
SiMa,439501,-2.281270120889317
SU-DHL-10,439501,-2.5547095883933975
AsPC-1,135875424,4.124114476494282
AM-38,46907787,2.780926012910743
HD-MY-Z,11455910,0.2534017769980389
JVM-2,10302451,2.502537821329635
SNU-1105,439501,-2.4533098010215024
VM-CUB-1,100016,6.234028822794693
Kasumi-1,135999136,3.6917766554725175
NH-6,24180719,4.08977726634613
SNU-899,9936388,1.721308391499284
SNU-81,26596,-2.2143193215677925
BT 131,49766530,-1.5740647020909493
HL-60,73707398,0.8677907289632488
NCI-H1650,UNC0638-navitoclax (1-1 mol-mol),1.4354883086402157
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
KHM-1B,262093,0.9728016968076376
A-375,5460769,3.311565919469283
MHH-CALL-4,327653,2.3339923757908028
BHT-101,100016,6.007811941047966
SNU-5,11396600,3.811291488960962
HEC-251,439501,-2.223367930628925
NCI-H2052,327653,2.777948843960099
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
A-549,10302451,3.5203591354698016
SNU-466,5460769,0.9969525340042612
GB-1,6852167,3.2720023248760293
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
OCI-Ly19,12003241,-2.2360327877915545
KATO III,12003241,-4.840637368540689
MCAS,6852167,1.7021529696000626
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
COV362,44491742,3.68091331789624
COR-L88,46907787,2.262713166355046
WSU-DLCL2,135875424,2.114413324161352
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
MKN7,637858,1.847380474134536
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
RERF-LC-A1,107970,2.429814394867771
CAMA-1,9903786,5.004529624345284
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
SNU-489,107970,2.9829628021045975
BT-474,11455910,3.140407546934709
SUP-M2,49766530,-5.163044789903349
RERF-LC-Ad2,637858,1.7897797033938452
SNU-16,135421197,0.9463670972041712
HT-55,9903786,2.6159451586769156
SEM,5460769,-1.0690415880949575
MKN74,637858,2.2619901111682768
EFM-192A,24180719,3.6489339283030953
RPMI-7951,136227924,2.219680452566263
K029AX,11455910,1.0219454107172774
LOX-IMVI,6852167,2.751037556623792
BHY,135421197,2.210170489791885
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
BT-549,12003241,-0.9663956127583828
NCI-H1155,135999136,2.1142509404842147
CMK,10302451,4.010237102082258
Kasumi-1,327653,2.8937710692107688
A2058,3689413,3.023224690588694
NCI-H1155,26596,-2.1815551982286885
BT 504,10231331,4.750172866148794
KCL-22,644241,-4.057206367955216
BT 112,10302451,3.727610987508193
M-07e,135875424,2.6099381217800897
NH-6,11455910,0.8097778679046014
OVSAHO,136227924,3.9451154225840783
PC-3,5460769,3.04554817499368
HMCB,54626689,5.696553588626368
U-937,156414,1.3451910574911532
HLF,135999136,5.433599477864868
HCC15,439501,0.3030845703669018
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
Hs 294T,49766530,-1.3950088307868331
HCC2108,9903786,2.237017286795856
253J-BV,136227924,2.6085874458601066
NCI-H69,10302451,3.5556757771647653
HCC202,107970,1.9120205179375371
MOR/CPR,11455910,1.2367157670420523
A-253,11396600,3.687595077759593
DMS 454,327653,3.1848583000561215
SUP-M2,135999136,4.670916241507474
DAN-G,44491742,4.1375495021288
T3M-10,49766530,1.7153212560254725
JHH-2,241158,1.694333135831791
BT 444,UNC0638-navitoclax (1-1 mol-mol),1.869451456428048
SYO-1,11455910,1.1491108391479796
IGR-1,9927531,6.184289140362073
ES-2,439501,-2.264854435064497
NCI-H2172,9903786,4.970438346504575
HuP-T4,107970,2.3366903299299935
A-375,135398744,6.486116496095493
HuG1-N,135875424,4.4582955762312055
CAL-120,10302451,4.646213124669908
BT 147,637858,1.9745023824878931
DV-90,9915743,0.0761455851411662
SW1353,12003241,-1.0641088251163675
LS180,10302451,1.4669812473297774
SNU-216,44491742,4.347867819055225
Panc 10.05,4259181,0.030271279252648
KALS-1,49766530,-2.069599194374988
HEC-6,9929138,7.579418638994079
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
EBC-1,46907787,-0.0936261851935095
OCI-AML-3,644241,1.351301385486736
MOLP-8,5460769,1.8843864880791628
769-P,54626689,4.819979512091467
HD-MY-Z,26596,0.1075810605234112
SCC-4,135421197,1.85399046640426
FTC-238,444795,4.083922601699021
SCLC-21H,439501,-2.4331226834497612
MKN1,11455910,-0.2869953117882883
JHOC-5,107970,2.549485059999082
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
A-375,9936388,-2.2482939434629223
LOX-IMVI,6852167,2.751037556623792
RERF-LC-MS,5460769,5.094680634820597
HCT 15,54626689,4.64310350979775
PC-14,9903786,1.3474672632704163
OAW42,644241,1.8292706332656063
BT 340,135999136,1.7458658328692
JJN-3,4259181,-0.711865550445762
KYSE-410,136227924,3.831866760516254
Hs 688(A).T,12003241,-0.4220829795676687
LK-2,100016,5.670732740144693
BT 239,12003241,-1.4894008844853184
M-07e,4259181,-1.9035117365658276
SK-MEL-5,135421197,1.8346447693413537
NCI-H661,10231331,4.850159308010921
GB-1,4259181,-1.4082863988824423
JHH-5,54626689,4.053403083016556
KMRC-1,24180719,3.956198558970242
SNU-685,135999136,4.652702404642394
EB1,5460769,0.545957183213574
NCI-H1299,10302451,4.027375771217026
MDA-MB-157,100016,3.517936084480814
A-673,135999136,4.231524255529223
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
SW620,327653,3.021193441393605
RL,135875424,2.9597814982763753
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
OCI-Ly19,439501,-4.390923092151438
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
SNB-75,73707398,1.9157922187543075
NALM-6,44489367,4.649410879482371
P12-Ichikawa,135999136,0.868328937682989
JHUEM-2,439501,-3.5756847183572704
CAL-85-1,107970,1.6693076027868323
HT-55,135421197,1.3327520491863434
VCaP,71466445,2.453363509035087
EFO-21,9927531,5.470218663007946
JHUEM-1,54596490,4.836153565936757
SF295,11396600,4.282405011310363
Hs 940.T,UNC0638-navitoclax (1-1 mol-mol),0.3265341030867644
RMG-I,11455910,3.4870876000849704
CHP-212,4259181,-0.6960023833337013
SNU-407,327653,3.0225030327462017
SKM-1,11455910,-0.0252675410510007
CAL-33,10302451,1.3669984318824204
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
NCI-H1568,375860,-0.3746562160702436
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
SNU-C4,9936388,-0.0983600900121806
HMCB,135999136,1.9344485879492248
SK-N-BE(2),439501,-3.274978008142144
NCI-H1944,637858,3.157092426362052
HEL 92.1.7,73707398,1.0106494633423595
ES-2,9936388,2.136137651865657
NMC-G1,136227924,2.469359539544405
LXF 289,3689413,0.4542816941401804
MSTO-211H,5460769,-2.0887143253822615
SNU-886,327653,2.660863736494067
TE-11,107970,2.9500167329306692
KE-39,6852167,2.989668764419295
KYSE-410,644241,2.1966590431724
RERF-LC-Ad2,100016,6.703705933143471
EM-2,156414,0.7048874875207918
MFE-296,3689413,0.1325691008190123
HSC-4,327653,3.5197711195347434
TUHR14TKB,327653,1.6819178430584345
HuG1-N,136227924,2.3836679865505332
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
SW1417,241158,4.352874922061946
SK-ES-1,135875424,2.8714720771033297
JJN-3,439501,-3.1655591002540864
NCI-H1755,11455910,1.1406081050587142
JHH-4,49766530,0.9310698609536
DU145,10302451,3.708227843551259
Hs 934.T,UNC0638-navitoclax (1-1 mol-mol),0.9424865340845288
NCI-H716,135421197,1.426114705682071
BT-474,selumetinib-JQ-1 (4-1 mol-mol),0.4588027273781878
LOX-IMVI,327653,3.424274817584711
P-STS,9903786,4.008586814147432
SU-DHL-8,73707398,0.7589420989008208
AGS,241158,4.254131157773437
BT 232,107970,1.965995572624395
HCC1588,107970,2.234641750507031
TTC-709,135999136,2.269842230246662
SK-MEL-24,9927531,5.248971858061216
GP2d,4259181,0.2488799202775051
NCI-H1395,selumetinib-JQ-1 (4-1 mol-mol),2.8235760807369177
WM1799,4259181,0.910290049923774
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
BT 271,156414,1.5805031871042805
NCI-H1573,10302451,3.1946799190013815
HL-60,6852167,1.3769451533529364
RVH-421,135999136,4.306974775879162
SNU-C4,4259181,0.9751508347932162
OCI-M1,262093,1.0880796533665364
Panc 05.04,135875424,4.70222110000058
SW1783,46907787,3.9046818317286944
HPB-ALL,12003241,-0.6872291231969794
SEM,107970,1.646444978651256
Hs 944.T,46907787,2.1367942885767786
COLO 829,135999136,4.936325381606469
SNU-16,9929138,2.9075870655199836
TE-1,71466445,2.6353487820633847
PE/CA-PJ34 (clone C12),4259181,0.3767954059641493
MKN74,73707398,1.2954691116779045
COV434,26596,-1.4572205446145876
NCI-H1435,637858,1.608648555542635
WM266-4,10302451,4.017909136506136
Ku812,135421197,1.6654017400601815
VMRC-LCD,262093,2.9924485884433496
MCF-7,262093,3.511527860265079
A-673,644241,3.265724898737132
Calu-3,136227924,3.506459850502243
SCC-25,637858,1.5386898989204256
NCI-H1435,9903786,1.8372314189682823
MHH-ES-1,46907787,0.0189081093783337
A3/Kawakami,UNC0638-navitoclax (1-1 mol-mol),3.0447804722614764
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
WM793,54626689,6.182066538200824
KMBC-2,327653,3.602242571352684
JHH-5,10302451,1.996624845120403
ECC10,135875424,2.912404124811061
NCI-H2122,12003241,-0.1228144224546952
BT 112,107970,1.504371825071881
ALL-SIL,49766530,-2.347000417785464
COLO 680N,9936388,1.5299770165572488
NOMO-1,6852167,1.234836949550939
BT 145,12003241,-0.8369227670207208
NCI-H1573,439501,-2.416114223913521
NALM-6,241158,2.1531208223375
BT 286,46907787,3.635470224586541
BICR 6,136227924,2.7894508880651485
Hs 611.T,9903786,0.3508528062947837
HEC-265,9936388,-5.092900256875076
SF295,637858,2.706804834358429
BT-12,327653,3.045855605227353
SW1573,49766530,-2.79322841384178
PaTu 8902,44491742,4.263402068757711
MOLP-2,73707398,0.4787083071687479
ALL-SIL,100016,4.099229681419155
SiMa,136227924,1.9858625956320377
Hs 746.T,168313016,4.639079207564439
253J-BV,26596,-1.8629561826944263
G-361,3689413,0.7888420983212308
HT115,136227924,1.4968152830691424
U-BLC1,262093,2.6001367621084306
Kasumi-2,100016,5.973936097539331
NUGC-3,168313016,5.1272078558334915
HOS,54626689,5.640278689372571
NCI-H1693,241158,5.606232618136794
NCI-H1650,439501,-0.6894352308557807
NCI-H2122,9903786,2.7991091527294216
NCI-H522,9915743,1.083108246388964
KMRC-1,241158,4.823138037217212
T84,73707398,0.224073795276098
NCI-H358,26596,-1.6094838950604715
SET-2,100016,6.077577626399248
LN-18,439501,-2.51749540441962
Peer,637858,0.987077054262488
ECC12,12003241,-0.4991552447723122
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
Peer,9915743,-0.353266525071404
GDM-1,439501,-2.0864895468216846
CAS-1,46907787,2.098776455360669
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
A-673,24180719,3.918829940752815
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
BT-20,24180719,3.806383373160612
NCI-H1703,107970,2.219056559870104
BT 112,439501,-2.896282798681624
UACC-812,9915743,-6.921665690083625
BEN,4259181,0.1509293562542142
Ku812,10231331,-1.9439726513116764
AMO1,46907787,-0.6708551712557594
CAL-33,11396600,3.937699926815987
SK-N-FI,9936388,-7.982723182575795
SW982,3689413,-0.7945580289517821
NCI-H2405,262093,3.3162860948220714
LAMA-84,26596,-2.1995969037049936
MDA-MB-157,168313016,4.249309770188466
KE-37,168313016,4.401025656704106
DU4475,10231331,-4.248158187501236
KMBC-2,637858,2.3795290977842014
SNU-1079,107970,1.8696204302707973
A3/Kawakami,selumetinib-JQ-1 (4-1 mol-mol),2.7324114698986373
CAL-27,9903786,1.9830233496778105
KMBC-2,44491742,4.484748547607026
BT 187,156414,1.5104615677540767
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
SW1088,156414,2.9727036283929644
KMH-2,3689413,-1.7619354335242607
TE 617.T,71466445,3.56672644929392
DV-90,26596,-3.568331067432308
PaTu 8988t,135421197,1.788370067257354
F-36P,100016,3.924028764616067
LCLC-97TM1,9915743,-0.0836077976930932
COLO 668,26596,-1.2429093822877924
NCI-H1838,54626689,4.5314844392205655
VMRC-RCZ,24180719,3.909696719725047
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
TE-10,26596,-0.9876255141372016
A-375,135421197,1.9818816716343688
Toledo,4259181,1.5062320886092213
OV56,3689413,-0.2367136689985935
VM-CUB-1,375860,-0.8530802496201679
VMRC-LCD,9903786,1.8330708335593808
A-498,73707398,1.745059470984177
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
CAL-51,9936388,-5.638746232401389
NCI-H69,439501,-2.497311288560019
NU-DUL-1,241158,0.4554147177079873
Kelly,135421197,1.3669012525071198
ONS-76,11396600,3.887590392789339
BT 239,46907787,1.748010103728736
RERF-LC-A1,9936388,-6.729312283369553
CAL-78,10302451,3.609429190813552
SK-LU-1,9936388,2.205073285427917
SK-MES-1,73707398,1.2846012994899838
RVH-421,439501,-0.8524727848852272
Mono-Mac-6,168313016,4.302379406609043
NB1,107970,2.3226504043825287
ML-1 [Human thyroid carcinoma],327653,3.144384021244803
SUP-T1,135875424,3.316622158258836
IGROV-1,9929138,6.483056540257463
EFM-192A,135875424,3.7105346659107834
GA-10,135875424,2.5269087035880844
K-562,3689413,1.0071697658281389
Hs 611.T,54626689,4.8749619996750475
SK-MEL-5,107970,3.0501102581579977
SNU-216,135999136,4.192311948123392
COV434,444795,5.643905455381125
HOP-92,6852167,3.546901057497169
PK-45H,selumetinib-JQ-1 (4-1 mol-mol),0.8986544638640594
NCI-H841,49766530,-1.6257988824506011
KE-97,262093,2.317138698505635
SNU-1214,135999136,5.40108770784267
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
HCC1395,9936388,-7.459318644951684
UACC-62,9915743,3.9206443408409455
JMSU-1,26596,-1.1755063311173417
DND-41,12003241,-0.2098098510645495
SNU-719,73707398,1.6522942539342995
NCI-H526,12003241,1.2765702668014436
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
NU-DHL-1,11455910,-0.2130419418137634
NOMO-1,3689413,-2.5325178418163174
Panc 08.13,9903786,3.5519515597880646
SK-CO-1,10231331,-0.7210930575000714
JHH-5,135875424,3.15748575614029
CL-34,selumetinib-JQ-1 (4-1 mol-mol),-3.160070646459842
NCI-H1869,6852167,3.74490947977495
NCI-H1693,46907787,2.3875684863362445
HSC-4,241158,3.797905223062241
OAW42,444795,4.960287089839776
TALL-1 [Human adult T-ALL],9915743,0.282075897468642
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
SNG-M,73707398,0.9251887702431444
Hs 688(A).T,439501,-2.959985011333181
SNU-C5,26596,3.4561899708021175
SIG-M5,26596,-1.691579811002482
OUMS-23,9936388,1.0481650973608996
697,26596,-3.738264049294864
AML-193,44491742,3.5122021187729184
OV7,262093,3.0286714339572542
T98G,9915743,3.11701457310986
G-402,11396600,2.964823639578594
OV7,49766530,-5.15064199643512
DU4475,11396600,2.471584986754413
HuH-28,46907787,0.1056590544791841
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
Hs 888.T,156414,1.6153983574814628
KMRC-1,439501,-2.7889227637684773
P3HR-1,444795,4.927433768581791
JHUEM-3,241158,4.29308217340487
Calu-3,4259181,0.5687129223574867
HEC-265,107970,2.6838155458007753
BT 248,11396600,1.9236183524788075
SUIT-2,10302451,3.8519201138639
OV-90,107970,2.0662633791311635
NCI-H1395,6852167,3.4323108551980748
KALS-1,375860,0.6178760797597267
L3.3,44491742,6.349276489474054
U-BLC1,24180719,3.264940033062701
TE-5,262093,1.0368633823540545
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
SK-MEL-24,UNC0638-navitoclax (1-1 mol-mol),3.0441510128296456
MOLT-16,439501,-2.6339721487362775
PC-3,9915743,3.040450489306842
Hs 294T,46907787,3.712635526652043
Hs 611.T,241158,2.625430045012582
CAL-33,44491742,3.945687581773722
AML-193,26596,-1.9434141476174296
NCI-H522,11396600,3.374818989992459
TCC-Pan2,11455910,2.002854110835051
HEC-251,3689413,-0.622023028283223
NCI-H1650,107970,2.2663913645375846
SW1990,637858,2.6354229615266447
2004,444795,5.087849305555533
Tm87-16,5460769,0.8511670833811608
42-MG-BA,4259181,0.1313298908519999
8505C,135398744,7.128245503588914
JURL-MK1,439501,-2.5160318205813432
NCI-H1341,135421197,1.8518080327886164
CHP-212,12003241,-2.3110623292084695
ONCO-DG-1,9915743,0.2840854953845789
LN-18,9903786,3.1734737643120696
SW1990,327653,3.573318417462307
ES-2,4259181,-0.5646450757791253
LNCaP clone FGC,12003241,-1.977151768552247
NCO2,73707398,-1.0010123602704273
KYSE-410,49766530,0.2031131423748078
BV-173,5460769,1.1539249163538905
TE-14,439501,-3.001573063863178
SK-MEL-5,9936388,2.3503506475790816
Tm87-16,10302451,4.036013672489342
HCT 15,135421197,1.319827384864071
JHOC-5,71466445,4.945491447820873
BT 239,selumetinib-JQ-1 (4-1 mol-mol),1.637299005229072
A-549,selumetinib-JQ-1 (4-1 mol-mol),1.5948722522654506
Hs 940.T,4259181,1.2767093386920751
Mel JuSo,73707398,1.4621510495455972
YD-10B,10231331,-3.2666005565013183
HEC-265,5460769,4.34119097814152
SNU-878,9915743,3.52259328044215
OCI-Ly19,49766530,-0.0820002075595115
Malme-3M,9936388,1.1290902894019168
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055
TE 617.T,44491742,3.9684227449531697
OAW28,11455910,2.4986666790908583
A-673,73707398,-0.4228078892765429
NCI-H2023,5460769,4.150302713550692
SK-HEP-1,107970,2.7276242080982405
NCI-H1666,12003241,-2.860788946487449
HPB-ALL,107970,2.29047871440167
HuP-T4,26596,-2.6464216672474783
TE-9,262093,4.268741263772325
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
LS411N,46907787,0.8939335106347707
ZR-75-1,107970,2.995397749509407
JHUEM-2,73707398,0.772116909696958
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
LCLC-97TM1,44491742,4.237702230509644
SUP-B15,11396600,3.1558477769861892
MeWo,135999136,4.477003311279449
IPC-298,327653,3.3909286727424552
G-402,12003241,-1.3833657940583168
JM-1,73707398,-0.8556338999048841
PSN1,637858,1.3005438922518275
RKN,11396600,3.670395083293249
Rh18,9936388,1.9794921916079815
NCI-H2196,9927531,4.117400803944708
THP-1,11455910,-0.1573617764654806
HCC95,46907787,-0.2787376325383735
PK-1,3689413,-0.025358625846968
MOLP-8,439501,-2.9296652389863267
OV-90,10302451,4.13641008716836
Karpas-299,73707398,0.3259263898696366
CAL-78,3689413,1.0903536033822472
Mel Ho,44489367,4.690545380949643
SNG-M,9903786,2.9432381601198427
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
MCAS,100016,6.4909883414165135
Mono-Mac-1,BRD-K27188169-navitoclax (2-1 mol-mol),0.3663100658261126
NCI-H1734,10302451,1.8692313112057235
EBC-1,135421197,2.252820006275089
D283 Med,5460769,1.125938178392905
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
TE-15,11396600,3.8567248680954056
HuP-T4,375860,-0.2953279197993684
JHUEM-1,44491742,3.7957056019779345
LoVo,168313016,4.599216339831628
TT2609-C02,4259181,1.5094867892449766
Kelly,11455910,-0.435640272884412
SUP-B15,262093,1.7420921581554918
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
Pfeiffer,54626689,2.394994402389365
SK-BR-3,6852167,1.9054876714905489
MDA-MB-435S,24180719,2.2243848427113
NCI-H322,26596,-1.3562395131244265
BT 271,5460769,1.6664418058692942
UO-31,6852167,2.94948623576417
COR-L95,135421197,1.4504202802892363
SNU-119,10302451,1.573205462567535
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
OV-90,5460769,5.624374105443753
HCC15,24180719,4.303391195547382
LAMA-84,24180719,2.689401486606494
KNS-42,11455910,1.3943687177837636
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
HEL 92.1.7,637858,1.114692071831855
IGROV-1,9903786,1.7387584479757865
MOR/CPR,637858,2.5605522078351854
HT-1197,156414,1.5339590025962693
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
Lu-99,135875424,3.620221919582757
BICR 18,107970,2.433210640100899
TUHR14TKB,136227331,4.279193413134127
YH-13,10302451,3.810654470358069
P3HR-1,262093,1.7726417290278578
QGP-1,10302451,4.783649693632775
LCLC-97TM1,107970,2.3018486004849907
Ki-JK,168313016,2.304395905335515
KMS-12-BM,11455910,-0.5978210432128618
OC 314,135421197,2.0874935264790646
U-118MG,375860,2.698493959590529
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
SK-N-AS,UNC0638-navitoclax (1-1 mol-mol),2.763969623467532
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
COLO 699,135999136,4.420900898288184
HSC-4,262093,2.780665409693215
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
KLE,439501,-2.1797784747958477
CAL-27,107970,2.069516948439653
T98G,135875424,5.101346341382456
TE-10,44489367,4.752075299000312
FTC-238,46907787,2.062040520622944
Hs 852.T,UNC0638-navitoclax (1-1 mol-mol),-0.1509084775003549
MDA-MB-453,9936388,0.6028011486270662
WM983B,135398744,6.927047773444745
YKG-1,439501,-3.197548465236136
Yamato-SS,10302451,2.7279296260988284
YD-8,262093,2.4929271706284433
NCI-H1355,73707398,1.7830398779702854
COLO 741,375860,0.428863043923301
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
SF126,135398744,7.810596319596066
CJM [Human melanoma],6852167,2.90088058805864
HuH-6,9936388,0.7826739866684046
HCC1588,9915743,-0.589938249140678
SW982,135421197,2.997806489210206
IGR-39,26596,-2.1240544281705955
MHH-ES-1,9936388,-6.403533054534267
HuCC-T1,9927531,3.6522633748640487
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
BT 271,11455910,0.6743644259938443
KYSE-150,156414,1.6424559188451335
RCH-ACV,26596,-2.407585357799557
KYM-1,241158,2.885537975342422
A-549,9936388,1.4749208650316612
HT-1197,3689413,0.4105522735593818
Karpas-422,UNC0638-navitoclax (1-1 mol-mol),0.995215523956661
Peer,11455910,-0.1315414365833526
IGR-1,9915743,1.9511711316311544
NOMO-1,135875424,3.068632733482165
KP-3,46907787,2.5590188315760956
NCI-H1666,6852167,2.1099138170473384
HCC1833,135999136,4.219025793158123
YD-15,107970,2.3819608381605097
SJSA-1,100016,7.674645652371816
SK-N-FI,375860,-0.8042006203726739
HH [Human lymphoma],9929138,3.344278516856126
SNG-M,439501,-1.900276797941319
A-375,12003241,-1.2978704743837648
KE-97,11396600,3.2423162434671293
K029AX,4259181,-1.2018440065990823
TT,9903786,2.2571281683889253
COLO 792,selumetinib-JQ-1 (4-1 mol-mol),-0.9796050035167326
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
KLE,9936388,-3.639802417260702
NCI-H1755,10302451,1.3931824559347357
HT-55,444795,4.735697190261942
NB4,135999136,1.7804254957800154
SK-N-BE(2),10302451,4.064544845875673
RPMI-7951,49766530,-2.0352614049405178
NCI-H1944,4259181,1.4344113288675724
EFO-21,24180719,3.9985907504935048
JHOM-1,10231331,4.4768538272834375
BICR 6,135999136,4.273525232508699
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
NCI-H2122,selumetinib-JQ-1 (4-1 mol-mol),1.880665568287093
Karpas-422,12003241,0.4573968210074843
CAL-148,136227924,1.0972662327382037
TE-6,9936388,-6.304125795740003
HL-60,26596,-1.7556952568708522
HCC1937,439501,0.0308528134887005
NCI-H661,375860,0.2037463104187888
TE-5,135421197,1.4018767750008558
SNU-1105,637858,3.0144066830582172
SW48,100016,6.031440310304127
BT-16,9936388,1.3930931201421013
OVCAR-8,10302451,4.012280315973911
Calu-3,10302451,0.1750089967931517
SK-N-SH,135875424,2.927968967811746
SNU-466,selumetinib-JQ-1 (4-1 mol-mol),0.5207583733853219
Hs 683,54626689,4.697975786794028
BT 248,135875424,2.546043839111523
Ki-JK,135999136,4.148473540945428
HuG1-N,54596490,5.177857055291183
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
CAL-51,241158,3.781489879449518
Ri-1,9915743,-1.2170005610109595
NCI-H2081,135421197,1.057518505455496
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
NCI-H2170,UNC0638-navitoclax (1-1 mol-mol),0.9818039893917144
U-937,24180719,4.95025506775169
ONS-76,262093,3.354802573562099
HCC2218,73707398,1.2835282527544178
NU-DHL-1,44491742,4.098367852004394
RPMI-6666,10302451,1.9523998069896955
OCI-Ly3,135999136,1.7797204950280945
KMS-21-BM,10231331,-2.04952218948576
SU-DHL-1,9927531,2.969590320438058
COV644,73707398,1.004277448975642
HMC-1-8,135421197,3.069266594691258
Hs 611.T,107970,1.3823074139293197
SCC-25,71466445,2.1328221809706336
CAL-51,5460769,1.3780575552768597
CAL-33,107970,2.1111978025436797
REC-1,6852167,4.364510532165473
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
ECC12,375860,-0.8615166178906869
RERF-LC-Ad2,107970,2.022505659566407
BFTC-909,100016,5.8134150302243865
UACC-257,9915743,3.2321822894615546
A-375,10302451,4.088422063006118
BT 131,327653,3.395185423161247
Calu-6,327653,3.0403330128886306
Raji,100016,6.465762715187829
SUIT-2,selumetinib-JQ-1 (4-1 mol-mol),3.2290404930384637
SNU-C4,49766530,2.185419725240328
SNU-387,262093,3.304396146111304
UO-31,9927531,3.0316635123485693
HCC366,9915743,1.377762778734198
A-549,46907787,5.023259811787708
NCI-H1792,135398744,6.377997167001959
NCI-H2342,selumetinib-JQ-1 (4-1 mol-mol),2.310038447385045
SW620,100016,5.873144490676751
NCI-H226,9936388,2.9750619483400467
HCC827,3689413,-1.9670372316713456
BT 224,439501,-1.0305399865987015
HCC44,644241,2.1964993568144244
MOLP-2,26596,-4.180731486004902
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
PE/CA-PJ15,136227331,4.888188791536357
Calu-6,107970,2.3483200205763106
5637,135875424,2.9776269402245092
SW948,6852167,2.188206161672083
WM793,262093,3.640026682877067
RVH-421,6852167,3.1482110171534297
EFE-184,BRD-K27188169-navitoclax (2-1 mol-mol),1.6135654545629603
NCI-H1581,11396600,3.1540391346849015
HPB-ALL,9903786,2.3044154759834847
SNU-5,327653,4.191247706787995
MDA-MB-361,135875424,3.2859719831181176
BT 245,135421197,1.3239460835535384
NU-DUL-1,135421197,1.0938833376467747
GDM-1,11455910,2.236688406286894
HCT 8,637858,2.1347621147598206
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
NCI-H2126,11455910,1.7285212021483076
BT-474,3689413,-0.6944310513118788
ESS-1,54596490,4.349195883265103
Hs 852.T,10302451,3.071934801488988
FU-OV-1,9915743,0.5010130642537969
G-292 clone A141B1,12003241,-1.351842997684689
NCI-H1694,11396600,2.3248952404491976
42-MG-BA,9903786,3.3707760791071184
SW948,71466445,3.954398511848749
RCC10RGB,107970,3.009214725762471
CAL-85-1,9936388,-7.895376476927265
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
CAL-29,262093,2.679093479440611
COLO 684,73707398,1.0044196671057204
Capan-2,135875424,4.579171720877857
P31/FUJ,12003241,-0.93015536828776
IGROV-1,5460769,1.6083174601829917
LCLC-103H,136227924,3.302464114309801
NCI-H2172,11396600,4.171717068415809
MSTO-211H,54626689,2.3486455994654767
NUGC-3,46907787,3.024654204411081
KMRC-3,375860,-0.2834215688720704
SNU-668,44489367,4.717080750297381
5637,9903786,1.5217427141278097
Mono-Mac-1,4259181,0.0400691688405866
TT2609-C02,439501,-1.3899506791900362
WM88,100016,6.2407728308576
BC-3C,3689413,4.931170730107947
8305C,375860,-0.9705370224824008
GSS,26596,-1.5813697443428234
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
SNU-478,375860,-0.8852245456595869
DAN-G,24180719,3.702330549508382
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
SF539,9915743,0.9219479584552366
DMS 454,12003241,-0.401739549188604
Caov-3,26596,-1.3429927330101894
Lu-99,327653,3.062690908551929
COLO 684,UNC0638-navitoclax (1-1 mol-mol),2.88576239527898
Ishikawa (Heraklio) 02 ER-,4259181,-1.51348893728215
OVSAHO,262093,2.313375156215166
KMS-26,9915743,-1.9616830637475051
HEC-251,6852167,3.664993078516629
HPAC,12003241,0.9185778330779416
HCC1438,4259181,-1.3511895743455689
NCI-H841,12003241,-1.6250883775981226
UM-UC-3,135421197,1.7291544564806811
HeLa,10302451,4.286472451875936
Peer,135999136,0.4527960183796846
SW948,107970,1.650733689507072
SNU-475,3689413,0.7678171361213897
Calu-6,241158,1.6946113745445348
Pfeiffer,136227331,3.814394552258677
SNU-81,10231331,-2.370371712203436
Karpas-299,327653,2.737482841251175
A-172,44491742,3.879269865010821
42-MG-BA,73707398,0.9751037110279231
JHH-2,100016,7.043022520962564
SW579,49766530,0.2032240599458712
BT 112,4259181,0.804943209632055
NCI-H522,9903786,3.9217135447784783
MHH-CALL-4,439501,-2.5308829551991168
PaTu 8988s,5460769,4.375147735669684
HT-144,135875424,4.403596226349448
COLO 792,46907787,1.9326545670415696
LOX-IMVI,4259181,-0.9241838451669104
JeKo-1,26596,-2.667287216238713
RPMI-7951,375860,-1.2606970188300772
PK-59,3689413,-0.088836641292159
NB1,49766530,-2.158662190283236
HPB-ALL,156414,1.6473060747549009
KMS-34,327653,1.2067417719719684
Ri-1,5460769,1.1375471412538625
Caov-3,5460769,3.7832431235533903
SEM,54626689,4.433727990073252
HT-1080,375860,-0.4805820776579086
SNU-216,241158,4.2881581162179305
SU-DHL-8,5460769,1.8345696055083096
HCC1588,135875424,4.102110498165806
HCC38,11455910,0.8868705732454679
SEM,241158,3.04470395214072
BT 159,11455910,0.815831828499024
MDA-MB-435S,9903786,3.3965750050470356
HCC1954,71466445,4.2589101297816
MCAS,selumetinib-JQ-1 (4-1 mol-mol),0.5693027943347815
OCUM-1,54626689,4.911583456650553
NCI-H2452,136227331,4.192235498443636
SCC-25,107970,2.0623920721619564
SW1573,12003241,-0.6702221198842615
CAL-120,46907787,4.080879277011309
MSTO-211H,156414,0.8242215144670997
MKN74,6852167,3.3368691353125604
769-P,46907787,0.4584238337470808
MV4-11,11455910,0.2618062537213718
Panc 04.03,107970,2.70125557955606
MOR/CPR,107970,2.4232948215338355
KLE,9903786,3.130074514321622
DU4475,54596490,4.235795189278402
A-549,637858,3.117280931983567
GCT,44491742,4.460609521265373
NCI-H526,49766530,-2.411772965733929
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
JL-1,375860,-0.015048095510899
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
BICR 31,3689413,0.760898743899782
CAL-120,262093,3.3293434401415847
2004,4259181,-0.1301142592462394
BT 131,637858,1.8330567448634565
Detroit 562,49766530,-0.0466351352244022
42-MG-BA,12003241,-1.3085155086024562
LNCaP clone FGC,44491742,3.7255423914895776
LN-18,262093,3.730786897618696
Caki-2,9936388,-5.25151724619499
COLO 678,11455910,2.071395728825759
Hs 944.T,637858,1.7134302577668823
SW620,135398744,6.387116600988426
NCI-H524,637858,1.0517398150644477
Capan-2,4259181,1.3752260367329712
BT 498,6852167,6.0420041098120985
CAL-51,439501,-2.444412450902406
Li-7,136227924,3.3307357238068818
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
HT,107970,2.098069233579563
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
MDA-MB-361,46907787,1.0050799963168924
JHOC-5,135421197,3.377612264303829
SNU-C1,637858,2.363835438412207
NCI-H1341,26596,-1.5435661996164969
NUGC-4,375860,-0.1996539544596114
Hs 746.T,12003241,0.0057336203254279
GSS,selumetinib-JQ-1 (4-1 mol-mol),-3.114554328810234
MOLP-2,11455910,1.1959894171141363
L-540,71466445,2.156563541822822
SNU-C1,44491742,3.3879999967260717
LOU-NH91,12003241,-1.4006618643370652
SNU-398,439501,-1.0670786880866563
HCC44,10302451,3.4411011911559193
NCI-H2052,637858,2.2400258514896967
SK-HEP-1,49766530,-2.8567737760804324
BT 444,73707398,1.807025337873425
KP-2,241158,4.417297726606118
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
697,11455910,-1.5843121483230655
SNU-620,9915743,2.3587879241072227
HPAF-II,9936388,2.7106140569939097
SW982,49766530,-0.9510465454534272
SK-N-SH,73707398,0.8722989575210444
JHH-1,44491742,4.550943997135646
HGC-27,3689413,-1.6532214726359813
SNU-407,5460769,0.640220508180195
NCI-H520,136227331,4.183046250285636
ME-1 [Human leukemia],135398744,6.466274911980868
KYSE-410,11396600,3.754375595740645
ZR-75-1,selumetinib-JQ-1 (4-1 mol-mol),3.094728167218718
HCC15,6852167,3.485797740848402
HEC-151,26596,-1.920762353069635
JHOM-1,375860,0.4553478964552023
KATO III,637858,2.9571239735822696
RMG-I,439501,-1.0670769936155349
786-O,100016,5.342252836782742
NCI-H647,100016,4.3873613110575045
NCI-H2141,UNC0638-navitoclax (1-1 mol-mol),0.371334188919835
RERF-LC-Ad2,9927531,7.758899930646885
CAL-51,26596,-1.4638590943230956
PC-14,439501,-2.395737625467809
SNU-620,439501,-2.3713510132267923
ECC10,9915743,-1.3646312579395177
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
MES-SA,10302451,4.142527408006535
BT 444,11455910,1.1196809594429316
HuT 78,9927531,5.1568522769540674
SK-MEL-3,136227924,3.573502388362414
EFO-21,262093,3.250428911213388
VMRC-LCD,44491742,4.573213718781489
COR-L279,439501,-3.5163381606181243
KNS-62,12003241,3.5800547148534165
NCI-H69,637858,1.6270818041098434
ECC10,100016,5.627610035010204
TCCSUP,4259181,1.0116551093848198
NCI-H520,9936388,-7.179601192363118
RL95-2,49766530,-1.414659307229874
PL-21,135875424,3.3109880797567595
RL95-2,327653,3.1108836073008868
MM1.S,71466445,1.6605389329514368
Hs 944.T,24180719,3.481271240163357
PC-14,12003241,-2.6584563263219203
KYSE-520,439501,-3.151478653175136
OPM-2,9903786,2.6412283094975657
AN3-CA,3689413,0.1719288482065274
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
WSU-DLCL2,9927531,3.1454575318264495
NCI-H1651,11455910,1.357904809543347
NCI-H146,3689413,0.5626872136369616
OCI-AML-2,107970,2.189664943492832
Rh30,3689413,-2.408934939466004
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
NCI-H810,73707398,-0.5650291058326256
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
SNU-478,selumetinib-JQ-1 (4-1 mol-mol),-1.2725800627795898
SiMa,73707398,0.5176109846337434
8505C,3689413,-3.9181742012691143
NCI-H2444,49766530,-1.881288849348997
COV362,262093,3.3118588999816008
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
BICR 56,3689413,1.5922116280396923
SW1116,73707398,1.201154114814001
ST486,UNC0638-navitoclax (1-1 mol-mol),0.2279596514699741
GDM-1,9936388,-9.102246983309657
TC-71,9903786,2.1601140442915736
SK-N-DZ,UNC0638-navitoclax (1-1 mol-mol),1.0761547272216332
LOX-IMVI,135421197,1.985626548385356
SW1088,637858,2.4464344152719817
MHH-CALL-3,135398744,6.205129646453742
Ki-JK,375860,-1.0279195490213373
HT-1080,100016,6.676268064255503
KYSE-140,9927531,4.387230999589902
KMBC-2,46907787,3.4975434896929674
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
SW1353,637858,2.400898572711613
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
SNU-449,107970,2.557902386411369
L-428,136227924,2.9759698761374795
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
NCI-H1792,4259181,0.0387421076392515
COLO 205,135421197,2.4843493589992125
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
ONCO-DG-1,9936388,-5.057642902396516
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783
SU-DHL-10,375860,-0.3702588226637646
NCI-H1693,3689413,-3.280819080207211
TOV-112D,73707398,1.216080457841962
RD,49766530,-0.4768486017330388
KYM-1,11455910,1.0218934269529627
SF126,439501,-2.7774123769651315
KYSE-450,135999136,4.777760732357945
KYM-1,637858,0.9207105078433748
NCI-H2081,241158,4.1289817617864575
NCI-H889,107970,2.493650179224298
SNU-308,3689413,0.3406956707675037
NCO2,644241,3.59504052771079
SUP-B15,9927531,5.1368052730530955
8305C,9915743,0.0007928276495739
BT 422,136227331,4.344086098247262
Lu-65,9927531,5.027796470849251
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
HL-60,241158,3.40829183459634
OAW28,6852167,2.294169410796982
PaTu 8988t,4259181,-1.3402011211504403
KM12,6852167,3.682699732019613
LUDLU-1,44491742,3.9054426641243873
HEC-1-B,4259181,-1.3712023171307914
HuH-1,136227924,2.959438331398248
SU-DHL-10,100016,5.73425222116556
HEL 92.1.7,6852167,2.2795499395639536
TUHR14TKB,10231331,4.228729010809842
Karpas-620,46907787,4.212982028495631
BT 239,135875424,2.359781873979594
NCI-H69,135875424,3.823328505000576
A-375,selumetinib-JQ-1 (4-1 mol-mol),1.0912668350631578
L-428,54596490,5.475491625110064
253J,241158,3.97219194312285
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
G-402,44491742,3.86820580626592
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
Becker,637858,2.787561829247156
CAL-33,135875424,4.580844092260986
MDA-MB-231,9936388,2.201115810933066
RD,selumetinib-JQ-1 (4-1 mol-mol),0.3868599896227363
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
U-251MG,71466445,4.8077443194093705
Mel Ho,24180719,-0.2700978118958237
HH [Human lymphoma],100016,3.957825935624259
Hep-G2,46907787,3.3643071732848
CCK-81,135421197,1.1239650919721589
SNU-1272,135875424,4.314381098584833
SNU-478,9915743,-2.1915037699834863
Kelly,135999136,1.6211634256627956
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253
DU4475,6852167,2.0552679553733215
COLO 668,11396600,3.0895910074964856
CAL-54,107970,2.162008035980813
SNU-478,9927531,5.143977185818116
YH-13,135875424,4.585935280505426
NCI-H2444,107970,2.840600883147425
BT 328,4259181,1.754792833603723
NCI-H1838,12003241,-1.140669133543194
EoL-1,54596490,3.971496787644092
NCC-StC-K140,100016,6.431860837963816
IGR-1,375860,-0.2003147634116378
BT 333,11396600,2.8942593651334567
FaDu,24180719,4.023385296253764
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
SNU-1033,156414,1.6354285292334745
RCH-ACV,375860,-0.3160075920060057
KMS-21-BM,135421197,0.9217420053482288
TE 617.T,439501,-4.266247423790402
HOS,6852167,3.572559775208279
A-253,46907787,4.065025553631924
SW620,262093,2.830381572601645
Ci-1,11455910,-0.0933169767027184
KP-N-SI9s,10302451,3.2446889985836265
HCC15,54626689,4.436341034968849
HCC1395,12003241,-2.06138866466857
OUMS-23,49766530,1.123776679749195
HuG1-N,10302451,3.905861877386106
NCI-H1573,156414,1.4271496349272998
SNU-46,136227924,3.2751090842747637
Hs 944.T,BRD-K27188169-navitoclax (2-1 mol-mol),2.8439154149697266
SNU-407,12003241,-0.5168922712641052
YAPC,135421197,1.6415717791988456
IGR-37,9936388,-3.744387709560832
MHH-CALL-4,9903786,1.9013313990407976
NCI-H2029,262093,2.84677790575948
NCI-H526,4259181,-1.5556471073891744
LS180,44491742,4.531352051294965
NCI-H322,444795,6.421299597347825
LCLC-97TM1,4259181,-0.2611730486969081
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641
BV-173,selumetinib-JQ-1 (4-1 mol-mol),-6.492404008680617
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
786-O,73707398,1.0800079367026778
HCC1806,9936388,-6.293878706667742
HCC366,12003241,-0.2149977364985454
Reh,71466445,1.6116548168850549
NCI-H2009,46907787,0.5680124512944033
BICR 56,135875424,5.509002498442888
HSC-3,6852167,3.108712764007485
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
KMS-18,49766530,-2.077336380213563
WM88,9903786,2.087799458877892
COLO 201,100016,6.515418099212221
SCC-9,10302451,2.205114392498864
SK-CO-1,9936388,-6.4137542305703015
HCC827,6852167,2.3379035713359904
KYSE-180,241158,4.333679160826191
TC-71,262093,3.008445971803391
RCC10RGB,327653,3.228661308812885
SCaBER,10302451,1.638511810966576
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
OVTOKO,241158,4.780065273335938
BT 159,9915743,2.235896124208317
Becker,327653,3.7069027046220024
KG-1-C,9936388,2.2222312234871957
RERF-LC-MS,73707398,2.0319367406190483
BT 498,9936388,2.0435440687928614
MOLM-6,selumetinib-JQ-1 (4-1 mol-mol),-0.8995054444130357
CAL-78,10231331,4.497903897116711
NALM-6,9927531,3.382690661986343
LAMA-84,selumetinib-JQ-1 (4-1 mol-mol),-1.7222369046637322
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
SNU-449,44491742,3.9284370838515903
KYO-1,100016,4.086276175586104
ONCO-DG-1,327653,3.0746646431128655
BT-20,44491742,4.162819949257598
HEC-1-A,73707398,1.278227831135503
COLO 201,10231331,-1.1140410692145708
Panc 03.27,11455910,0.4781856768651555
MDA-MB-468,46907787,3.086871495075205
FTC-133,46907787,3.491897677971775
HCC1419,156414,-1.6616800850124382
NMC-G1,10302451,5.170100461056351
HSC-4,54626689,4.284935050666877
SCC-4,selumetinib-JQ-1 (4-1 mol-mol),0.7097382019229815
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
NCI-H2171,4259181,0.2390230285316857
RT-4,10231331,3.499380927126235
Hs 852.T,107970,1.793411000541102
OVISE,439501,-2.343202219776273
FTC-133,3689413,-0.3036251064519336
OV-90,12003241,-0.4315626967505086
HEC-1-B,10302451,0.3109333075515339
SUP-T11,54626689,4.242369080519398
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
WM115,241158,3.4880777915567496
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
DMS 454,9936388,1.3137576899177168
OVCAR-4,136227924,3.1468518699477097
COLO 800,10302451,4.008038630888801
SNU-8,10302451,3.487044127075749
KYSE-30,73707398,1.0667429400266626
SNU-61,241158,3.885428513145571
SNU-1196,262093,3.697852439265109
JVM-3,4259181,-1.842202711980964
SNU-16,10231331,4.660588677927323
HOP-92,135999136,4.381843912128879
SF126,73707398,1.606269734820819
TE-6,11396600,3.777010025535689
Hs 895.T,107970,2.9764537428543516
NOMO-1,71466445,1.8310961714544176
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984
BT 440,135875424,2.9900391536065354
HPAF-II,44489367,5.767004660036691
LN-18,3689413,-0.4753252169993508
NCI-H2087,10231331,-2.7002323257150636
Raji,46907787,-0.4930919590495862
Karpas-422,9903786,1.5566107707645094
HOP-62,9915743,2.3333223593469947
Hs 852.T,26596,-1.3645726938327003
ChaGo-K-1,136227331,4.028131370047934
ESS-1,26596,-1.5335330182559344
NCI-H1915,156414,1.5545026473918255
SNU-466,262093,-0.0016542197274145
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
MDA-MB-231,9927531,7.115369189993137
Reh,327653,2.319625668296167
NCI-H2087,168313016,4.712660554948847
SK-BR-3,12003241,-1.7425302549890949
SUP-T1,327653,1.5396768902081992
Namalwa,135421197,0.8963594643304925
MFE-296,11396600,3.78613722040272
DND-41,156414,1.129076362273066
Pfeiffer,54596490,2.754630117745776
IMR-32,selumetinib-JQ-1 (4-1 mol-mol),0.7090363184607439
YD-38,444795,4.9688300992603
SW948,262093,3.1804911198162036
PC-3,135398744,6.536880900821883
LoVo,9903786,0.6551100591729495
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213
NCI-H28,10231331,1.6918864459680945
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
UACC-257,54626689,4.832062373284329
HCC4006,644241,2.5673666310720336
SNU-387,UNC0638-navitoclax (1-1 mol-mol),1.7391468001573358
OVISE,107970,3.0608588072726444
ChaGo-K-1,5460769,6.469611673758945
ONCO-DG-1,241158,3.197101697830666
SNU-503,11455910,1.6883627644278838
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
HEL 92.1.7,168313016,4.428707161449081
NCI-H716,3689413,0.3516381459827891
KMRC-20,44491742,5.411645351023098
LS513,9915743,-0.1928520394279614
RPMI-7951,241158,3.4568590473726273
Kasumi-2,54626689,4.779746030866953
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
TC-71,637858,2.1337665442095664
NCI-H2196,24180719,3.828260421215232
THP-1,10231331,-2.0055855111768697
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
KP-4,156414,1.731574968381172
KMS-21-BM,9903786,1.778157023990249
8-MG-BA,12003241,-0.0474192028844215
AU565,9936388,-7.122590364363415
PaTu 8988t,10302451,4.044762571435361
KYSE-30,10231331,0.8678234440350742
HCC2279,9936388,-5.134625350026444
NCI-H520,10302451,3.2587774106229146
SJSA-1,135875424,4.854723891945684
RPMI-8226,241158,0.7857834855258714
LCLC-97TM1,136227331,4.3740550996774745
TUHR10TKB,44491742,4.130919607533437
SNU-878,73707398,1.334014436236399
WSU-DLCL2,637858,0.5051604368629126
NCI-H1703,327653,3.173271174813216
LP-1,9915743,0.8947745693738212
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
KE-37,11455910,-0.4991335198758184
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
KYSE-450,9903786,5.350068255808832
WM266-4,136227331,3.760867873542347
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
OAW28,73707398,1.2451215877479735
SNU-1214,9929138,6.834852342367116
H-STS,9927531,5.457961831541725
SNU-899,262093,2.8321925614753116
KP-2,9936388,2.471423235540368
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
SHP-77,24180719,3.876468111980974
CAL-85-1,54596490,4.44350849938878
LXF 289,5460769,3.06478422280727
DoHH2,637858,-0.5339503780013348
L-428,3689413,-2.385530955592741
C2BBe1,637858,2.175277981120109
NCI-H660,444795,4.054546774998577
ONS-76,6852167,3.4771955261396252
YD-38,9936388,-5.278764060182601
SCC-4,6852167,3.546394346660464
SNU-503,UNC0638-navitoclax (1-1 mol-mol),1.8536750772324864
JURL-MK1,9927531,3.9851065784934945
BT 328,135875424,3.085389187382682
IGR-37,5460769,4.3562687129012625
A-549,136227924,3.1395144761786486
SU-DHL-8,262093,1.173912345187794
SW1271,3689413,-1.2412691685690602
ME-1 [Human leukemia],262093,1.5767156474221262
NCI-H2009,439501,-2.087429471182781
Daudi,10302451,1.2926011902861492
BHY,selumetinib-JQ-1 (4-1 mol-mol),0.0066768595340859
JJN-3,9929138,7.196831688264381
Reh,24180719,3.874399894133451
Namalwa,241158,1.6214493925930429
SW1990,100016,6.759971253936254
HCC1500,439501,-1.4156205398968564
NCI-H226,9927531,4.418189277296578
Hs 611.T,135999136,3.4823204763051487
SET-2,44491742,3.5989743077742387
EPLC-272H,11396600,3.8096472633651106
SK-ES-1,54596490,4.536683455406273
Li-7,107970,2.3347606129628056
JHH-1,135421197,1.7316230199472116
NCI-H661,26596,-0.5563822784391794
BICR 18,44491742,4.057400353675569
LMSU,327653,3.6010830884894824
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
COLO 699,10302451,3.829088600781648
PC-3,262093,3.07605084151026
SR,26596,-2.2070280953319283
A-375,46907787,5.129812217042003
Rh18,11455910,-0.2112753889424844
AN3-CA,11396600,4.58709626361668
COR-L51,9927531,4.484495617917877
SW579,9915743,0.8612316643696222
SNU-61,44491742,3.859456688826312
SUP-B15,selumetinib-JQ-1 (4-1 mol-mol),0.3382807042409725
SNU-387,73707398,1.5803373697858054
NCI-H292,11455910,1.285235050416197
TT2609-C02,135875424,5.0022625641084755
SNU-601,46907787,1.4332715707381218
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
P12-Ichikawa,71466445,1.784342730653087
NCI-H929,637858,-0.3950607584941885
SNU-466,71466445,6.314226176026475
BT 359,100016,6.547217450499836
YH-13,262093,3.0071094341497826
CAL-78,44491742,4.7670188278775605
OC 314,11396600,2.739817011792775
TCC-Pan2,135875424,4.2350171007948685
SF539,9927531,4.183842431586729
B-CPAP,selumetinib-JQ-1 (4-1 mol-mol),2.8675411473634917
LUDLU-1,49766530,4.558190853315777
COR-L88,439501,-1.6986263045412435
Ku812,644241,-5.729959790836442
5637,46907787,-0.5455038235860961
SU-DHL-10,6852167,0.7392191200589763
NCI-H2110,9927531,4.774812830583443
Hs 839.T,637858,3.1071442354117473
LCLC-97TM1,54626689,4.751501808909531
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
NMC-G1,4259181,1.051938223963876
KE-39,10302451,3.0941257531868858
K029AX,selumetinib-JQ-1 (4-1 mol-mol),0.2286983759000624
OCUM-1,9903786,1.5374110288154037
MV4-11,9915743,-1.3857936300638058
TE-5,10231331,5.100118375291916
HuP-T4,135875424,5.011521901574996
BT 239,327653,2.683807943934812
P31/FUJ,11396600,3.188193103342261
NCI-H2085,327653,2.044327509419636
Aska-SS,136227924,2.71481465035111
IM95,637858,1.184914734198418
EPLC-272H,5460769,1.6244755024215547
DV-90,439501,-2.858386639088026
NCI-H460,100016,5.855223104671776
NCI-H2023,241158,4.443142725107179
CML-T1,4259181,-0.9247208790621684
RPMI-8226,4259181,-0.2249156450925163
BFTC-905,11455910,3.497810765417644
ALL-SIL,637858,0.2842777242368783
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
CAL-148,selumetinib-JQ-1 (4-1 mol-mol),-1.2852398724483811
MOLM-13,241158,1.7093626682651633
HOP-62,136227924,3.3249367186884564
KYSE-180,46907787,3.816228061036196
EFO-21,54596490,5.632352941512187
EKVX,9927531,4.418248493855361
HMC-1-8,375860,-0.2146762631480129
A-172,26596,-0.1948539739463346
SW1353,135421197,2.4746920364366813
NCI-H211,644241,1.4591617185883057
HCC2279,9915743,1.7630274974109628
MDA-MB-231,11455910,1.414181949063077
KP-N-SI9s,100016,6.171993249574907
KP-2,135875424,4.758790844331061
SNU-449,24180719,3.8016565421464072
WT2-iPS,46907787,4.256789061062823
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
Kuramochi,327653,3.5969647053028297
NCI-H446,135875424,2.863790721987945
LAMA-84,9929138,5.193234250593021
CAL-12T,9936388,-2.4849922514623417
SNU-449,5460769,0.9117409452183444
HEC-108,439501,-2.3418750446111347
NCI-H196,9927531,5.55374615852481
OCI-M1,6852167,3.793961103000983
JHUEM-1,439501,-3.414887087046791
HGC-27,9927531,3.8749849093672744
SNU-16,9903786,1.405581496282783
KYSE-510,46907787,4.415386026929367
Caov-3,9915743,1.9155459693646115
BICR 6,10302451,3.560909556549929
COLO 829,262093,3.4773152453847715
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
SBC-5,262093,2.1741934315953726
HuP-T3,3689413,-1.422602865458103
LAMA-84,136227924,2.847754951874779
HCC1428,3689413,0.0072798037629334
NCI-H1092,135875424,3.039549904779009
NCI-H1092,10302451,4.171918094429464
KP-4,26596,-2.006035898797214
BT 286,10231331,-1.310629484482038
RCH-ACV,135421197,1.024054023197644
SNU-668,10231331,2.5432829605574296
RVH-421,11455910,0.1784528957020075
JL-1,10231331,6.305660182558998
MHH-NB-11,3689413,1.2467762283849737
OCI-Ly19,46907787,-0.6661147236567055
L-428,5460769,3.644532278593977
MIA PaCa-2,136227331,4.243512473772355
TUHR14TKB,selumetinib-JQ-1 (4-1 mol-mol),1.836081106756344
Tm87-16,12003241,-0.0978800802816917
KYM-1,10302451,3.948612855520952
PL-21,9936388,-7.198492921849207
HCC1438,selumetinib-JQ-1 (4-1 mol-mol),3.080440327517642
SK-N-FI,73707398,-0.4639317195303371
MHH-CALL-3,9903786,1.8198372830428096
HPAF-II,54626689,4.6353285905370925
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
NCI-H2030,4259181,1.1105893163636829
PE/CA-PJ15,4259181,0.664963818132981
OCI-AML-3,9936388,-8.90406813186184
L-428,46907787,-0.6484055986243037
SNU-8,637858,2.315225412035183
HCC1143,10231331,3.1675049490504943
NCI-H322,135421197,2.22865477281611
LUDLU-1,4259181,0.5420742085137419
RT-112,5460769,3.4890381868117712
KNS-62,136227331,4.203841276745653
SCC-25,73707398,0.6106904052422437
BICR 6,241158,3.789279687880277
SK-LU-1,10231331,3.230997250694965
HuCC-T1,54626689,4.801198538933309
COLO 699,11396600,3.859625290158775
JHUEM-2,24180719,2.542214228790043
BT 498,73707398,4.023335284833002
DBTRG-05MG,241158,4.845918295723135
KMS-27,46907787,-0.4980850656291734
VCaP,4259181,0.5963848512304438
SNU-398,4259181,0.6622148934831026
OV56,135999136,4.60647934251061
NCO2,71466445,2.6517435517023284
Hs 729.T,156414,1.628436706068538
A-375,24180719,4.11900133605722
SW579,9903786,2.7100621017301516
PE/CA-PJ49,46907787,3.401972170810614
BT 187,6852167,4.060958892704537
KALS-1,637858,2.4646285747552747
WM1799,5460769,2.2209273724490335
SU-DHL-1,10231331,2.149159497852676
MOLT-16,444795,3.4331824193930176
SKM-1,11396600,2.556560537938587
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
JHOC-5,73707398,1.509837676483666
SNU-668,11396600,4.182067548365165
SNU-475,135875424,5.230711078177573
T24,135999136,5.239460804430351
VCaP,3689413,-1.1358537127375183
MHH-CALL-4,107970,1.5226905124680885
JHOS-2,262093,3.1807395255548463
BT 139,439501,-2.1565169223075062
KYSE-180,6852167,3.0076808179282213
A2780,46907787,0.387414270491788
Kasumi-2,135875424,2.5938758238859494
HT115,10231331,0.3575794941006647
HCC1588,9903786,2.112519242014298
IM95,327653,3.5986348195863957
NCI-H28,44489367,4.707672227756053
JVM-3,156414,0.7783914285135163
PE/CA-PJ49,156414,1.3413488116629748
DB,73707398,0.5293823110528094
VCaP,439501,-3.1099303166106087
CL-11,156414,1.7503846149108115
FTC-238,135999136,6.041478317142046
CL-11,46907787,0.9755252779091432
SNU-1,73707398,0.9345704256403632
PK-1,135421197,2.4270856926792947
Detroit 562,44489367,5.574573056186899
NCI-H1651,44491742,4.212944602241969
SU-DHL-10,26596,-1.8221428143230487
SH-4,135421197,1.5292272501013058
SEM,12003241,-3.075217153076431
BFTC-909,262093,3.5924629632259792
OE19,6852167,3.959491189600183
BT 147,9936388,1.2294480842266318
OC 314,156414,1.5893694322605127
OCI-AML-2,26596,-2.6744696757916215
P3HR-1,241158,4.4514160234357725
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
GB-1,selumetinib-JQ-1 (4-1 mol-mol),4.142934403640131
SW579,73707398,1.013024116730033
RD,6852167,2.8800606360455228
BT 416,135421197,2.461654603646364
M-07e,156414,1.4173221971225267
L3.3,107970,2.7957953106701305
TE-1,9936388,1.4235089598374957
SIG-M5,9915743,0.6121664403334032
PLC/PRF/5,135875424,4.546560112708509
COLO 668,11455910,0.5026800479718163
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496
NCI-H2029,241158,4.340377347526191
BT 147,10302451,3.751322201692566
NB4,6852167,1.4864413822511506
RERF-LC-Ad1,49766530,-0.8755533009144216
SW1990,selumetinib-JQ-1 (4-1 mol-mol),1.814683670817831
NCI-H1395,49766530,-2.8850236043305792
SW1088,644241,2.51934073419526
GOS-3,136227924,2.1351760440562533
G-361,9903786,2.8296470400432296
MIA PaCa-2,241158,2.0398577340537587
TC-71,136227924,2.205314859996721
SNU-410,46907787,3.7701283534171894
TE-1,241158,4.508480195004466
KNS-42,637858,2.408422862210767
BxPC-3,9915743,0.4274244099837221
LOX-IMVI,100016,4.319089113839007
HCT 8,262093,3.680435821837603
U-937,9927531,3.434526864785126
NCI-H1568,73707398,1.0000031751048108
JJN-3,375860,-0.479807677724239
BT 147,135421197,1.4134853513564778
EHEB,135999136,1.8833962574329148
KP-4,136227924,3.1314573836961235
SU-DHL-1,9929138,3.6810672504095385
SNU-1076,327653,3.6653466863942903
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
LS123,3689413,-2.2814901809462467
253J-BV,9936388,1.8223967711781484
HuCC-T1,71466445,-5.737741283929361
SNU-398,9936388,-6.365933460277143
Lu-65,135999136,6.05207061737822
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
CML-T1,9903786,2.526700219209825
EB1,327653,2.3886030622482566
UACC-62,11455910,0.399778260959969
HT,5460769,1.55908415219926
K029AX,6852167,3.6050393182388225
Panc 08.13,136227924,2.4171431229910265
TC-71,11455910,0.3179864486303165
COLO 205,49766530,-2.229597593802736
KU-19-19,4259181,2.3072251676522835
GA-10,6852167,0.8612474487872448
RPMI-7951,644241,2.388085399534529
HH [Human lymphoma],135421197,1.0671301978035626
HT-1080,46907787,3.15683670670671
SW1573,4259181,2.0061423198913766
VMRC-RCZ,selumetinib-JQ-1 (4-1 mol-mol),2.1702511953372974
MCAS,10302451,3.470287420983729
PK-59,9903786,2.9850600541065764
NCI-H1651,4259181,-1.783038847618123
Fu97,241158,4.729687986093483
LoVo,10302451,1.0215583424111876
OVCAR-4,107970,2.404125658896095
MDA-MB-157,156414,1.5733069512528617
COLO 320,135398744,6.463011253269961
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
LOU-NH91,327653,3.620861790086289
SNU-213,100016,6.954868306659309
HCC2108,9936388,-4.897775231329417
SNU-685,9903786,5.039547940758868
BV-173,44491742,2.039629297457472
PSN1,11455910,0.0826195354078685
G-292 clone A141B1,3689413,-2.069808730051662
SNU-719,49766530,-1.9010790195453584
PK-59,327653,2.872249707318676
CGTH-W-1,5460769,2.937857230001596
SK-MM-2,107970,2.4881899297299057
A3/Kawakami,9903786,0.9564213610990896
PE/CA-PJ41 (clone D2),644241,2.3238637219547904
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
NCI-H1355,9903786,1.6922210610733373
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
BT 416,135875424,2.581275175967605
NCI-H1105,444795,4.226557988602367
NCI-H2081,107970,1.5324597930931985
DMS 454,156414,1.5492997606467644
QGP-1,9903786,2.781324092534045
WM1799,9915743,1.2587525193703504
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
HSC-4,637858,2.398043952194309
Hs 729.T,54626689,4.911570422092128
KYSE-150,241158,3.925608446446452
WM1799,49766530,-0.3108809621459331
LXF 289,11455910,1.909862916296106
HH [Human lymphoma],UNC0638-navitoclax (1-1 mol-mol),1.1119627302728434
T24,135875424,4.724253336521634
KM12,375860,-0.5085253136640141
U-BLC1,73707398,0.5348084909882532
Panc 05.04,9936388,2.125359461331759
EM-2,168313016,4.389317398313489
HOP-62,637858,3.261273294662145
NCI-H2106,10302451,3.9378582499714576
IGR-39,135875424,6.243999816524794
SNB-75,11396600,3.7273557083084583
LoVo,26596,-4.043483931746528
LC-1/sq-SF,136227924,3.5583860131764835
NALM-6,136227924,1.937403591420271
JHH-5,9927531,4.499670785521202
KMRC-2,262093,3.029643780288338
KYO-1,375860,-0.0649576326848778
HOP-62,5460769,2.443615735481444
HCC2279,12003241,-1.0560673565017786
NCI-H1734,9929138,5.157080013193966
NCI-H2196,5460769,6.02637664184288
CCF-STTG1,136227924,3.7108552267199504
Calu-1,54596490,4.459626115799054
NMC-G1,44489367,4.2984501703001605
NCI-H1869,241158,5.0819681903137806
EFO-27,3689413,-2.375877948841856
NCI-H650,5460769,3.805855578074832
HEC-6,262093,2.3423105964881414
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
HEC-1-B,9903786,3.578370658582295
KYSE-70,9903786,2.353212274658888
RPMI-7951,3689413,-1.832371720912868
A-549,3689413,0.7236603744186211
KYSE-410,10302451,1.6161895544560456
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
HCC4006,136227331,3.713774396347732
CGTH-W-1,11455910,1.5970205272466635
TE-15,135875424,3.16520710682736
NCI-H841,10302451,4.064570970847571
Hs 822.T,262093,2.2664804620168693
NCI-H358,10302451,1.3117331281372162
SH-4,11396600,5.060968167282413
JHOC-5,241158,4.073008861380035
SNU-308,262093,4.9932279379660764
MOLP-2,46907787,3.434010090351403
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
SNU-449,9927531,4.924705078398161
MPP 89,9903786,4.435706117930943
Toledo,9936388,3.05226126712226
CL-11,637858,1.4070270256293935
HEL 92.1.7,262093,2.5840863683898885
LS180,9903786,2.2166672873522857
T98G,73707398,2.1109141148348254
SNU-886,11455910,-0.4283095081187237
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
SF126,44489367,4.5936497391935625
NCI-H1155,444795,4.055241272148919
BC-3C,4259181,1.463523509527546
769-P,107970,2.68737921958017
TT2609-C02,10231331,2.507453069849083
HEC-59,5460769,4.548370162463851
LXF 289,11396600,4.152956454399736
NCI-H1944,11396600,2.88322672555981
KP-N-SI9s,9915743,0.2181439527436794
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
JMSU-1,135421197,1.367458661118936
TC-71,4259181,-1.3693696367229935
J82,262093,3.090491521434039
SNU-423,136227924,3.242018782370702
KMS-11,3689413,-0.1519254071205927
Granta-519,136227924,1.3333863896282263
KO52,6852167,2.1234945146220645
NCI-H1299,12003241,-0.9760038754339474
SYO-1,135421197,1.7778335849280964
JMSU-1,11396600,3.5882148906168254
NCI-H1563,327653,3.2472621502852985
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
SaOS-2,439501,-2.8243657156627724
M059K,107970,2.205521615137292
DMS 114,135421197,1.272483451000873
NCI-H1694,107970,1.634233191518056
NCI-H1650,241158,3.702855511233096
SUP-M2,9929138,3.6762665629700177
MKN74,4259181,1.058479464010789
NCI-H358,9936388,-5.546440676880145
A-549,168313016,6.463391576466817
HEY A8,135999136,4.500439967266887
HCC44,327653,3.1372767049709296
OV7,5460769,0.8621725528933663
SK-N-DZ,241158,1.6286594691564176
NCI-H1915,444795,4.8987813871468795
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
SK-LMS-1,241158,4.676834411951693
NCI-H146,135875424,2.9115600315347057
BT-16,107970,2.1571455528855665
JVM-3,BRD-K27188169-navitoclax (2-1 mol-mol),0.3272263070571534
COLO 668,136227924,2.7222662640570356
ES-2,9915743,3.6243790068274384
KALS-1,644241,2.759278664699006
NCI-H1339,100016,8.285361450373896
NCI-H1568,3689413,-2.0602171008804935
SH-10-TC,11455910,0.8075465879192946
HEC-251,49766530,-1.4787018176624072
BT 228,11455910,0.8628346849534536
BT 164,107970,1.5974999178888267
IGR-39,4259181,1.0118736726180315
HPB-ALL,241158,3.2053071979746344
KNS-42,135875424,5.020750527542343
PC-3,168313016,4.45670900548214
MDA-MB-231,10302451,3.1258043295368285
MOLT-13,3689413,-2.356450494712317
SNU-216,26596,-1.178501170162628
MKN1,135875424,4.434731625885322
LC-1/sq-SF,selumetinib-JQ-1 (4-1 mol-mol),1.9783005635841648
NCI-H522,54626689,4.6269731577498066
UACC-62,44491742,4.3464910230211755
BFTC-909,107970,2.2861723254681774
P3HR-1,637858,1.45691685095597
MOLM-13,168313016,3.5509192860421592
Kasumi-1,241158,1.872306915049785
MDA-MB-157,135421197,1.265960780615991
BT 422,12003241,1.9442582460098417
CML-T1,10231331,3.71504818577299
BT 231,44491742,3.9496827176131384
LS1034,9927531,5.052618610074112
KMS-21-BM,9936388,-8.048894686182319
NCI-H1693,375860,0.3039564435298386
KO52,12003241,-1.0632598943321483
SNU-C4,11396600,4.202175701473822
NCO2,6852167,3.0522218001812114
SK-N-SH,241158,3.663182891539546
VMRC-LCD,71466445,3.0345394698478647
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
RD,4259181,0.4253037663567937
HCT 15,10231331,5.105409369900083
Kasumi-2,241158,2.967162139629707
WM88,4259181,-0.1240754339586
A-204,49766530,-2.4739709349642083
KHM-1B,4259181,-0.2095303903157825
JHUEM-1,241158,3.61852207918387
KNS-60,375860,-0.5601238085225673
ChaGo-K-1,UNC0638-navitoclax (1-1 mol-mol),3.3725673517370662
TE-11,46907787,3.0827761276743346
Mono-Mac-6,selumetinib-JQ-1 (4-1 mol-mol),-2.958594774349443
KMS-12-BM,11396600,1.1666466615999174
CW-2,9936388,-2.7633080589769885
SUP-M2,100016,3.7473632933772394
OCI-AML-5,71466445,1.573445404531825
Reh,10302451,3.67985775333445
RERF-LC-A1,5460769,2.531170153978
Hs 611.T,73707398,-1.1602307486634975
MV4-11,24180719,2.443056688922552
RMG-I,9915743,0.3310978387400572
OCI-Ly3,11396600,1.20620750211381
OCI-AML-5,9903786,1.179944382770948
KMS-20,9903786,1.7377090782754483
VCaP,107970,2.076938857757041
SNU-182,375860,-0.5806496982631392
MDST8,54626689,6.955475194588027
SUP-T11,11396600,2.6585567591139245
LNCaP clone FGC,10302451,3.7109646115457418
COR-L88,100016,6.409850176158066
SK-MEL-30,168313016,6.2335475928263255
NCI-H1339,selumetinib-JQ-1 (4-1 mol-mol),2.2666299614605143
EFE-184,3689413,0.8995807831619225
H-STS,107970,1.855553720240211
SNU-175,selumetinib-JQ-1 (4-1 mol-mol),-0.1305665077886403
SW1463,10231331,-1.1566445252598772
WM115,9927531,5.125567810288171
SNU-81,439501,-1.707157001292212
HSC-3,327653,3.9955925666561263
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
P3HR-1,4259181,1.18334464722064
HCC2218,selumetinib-JQ-1 (4-1 mol-mol),1.4456076234612698
SW1271,10231331,-0.1974856956768426
KE-39,3689413,-1.8420159541718293
ONS-76,10302451,3.399700001459874
TALL-1 [Human adult T-ALL],6852167,1.670387367472753
DAN-G,135421197,3.0058015912267475
BICR 18,4259181,0.3399206996622695
NCI-H1792,73707398,2.4293633915980535
SNU-308,9915743,-2.1849760358615296
M059K,9936388,1.0319872180787746
5637,6852167,1.734170154500971
Panc 10.05,100016,7.2735240015579645
ST486,156414,0.7820846211489824
NCI-H2444,73707398,1.4354113747623178
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
RPMI-8226,9903786,1.7655422214301637
SUP-M2,3689413,-3.139623723794694
A-204,24180719,2.7582827211078245
DU4475,54626689,2.443152896424325
MOLT-13,71466445,1.1714755088017548
BT 172,637858,1.9723791445737595
Reh,26596,-2.983938152417055
TE 617.T,241158,3.7218678617090046
A-549,107970,2.6370788506586345
BICR 6,135875424,4.583907142773698
TYK-nu,444795,4.785149640817898
HEC-1-A,135999136,4.326266563149784
HuP-T4,10231331,-2.2405949766532935
HSC-3,637858,2.0652307033731097
HCC202,156414,2.264042370468709
IGROV-1,107970,2.287061680908213
KMS-34,637858,0.6996482331075263
Ki-JK,selumetinib-JQ-1 (4-1 mol-mol),-0.3683128688059284
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
MFE-319,46907787,6.309736161106018
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371
NCI-H211,73707398,0.5175001919026392
K029AX,135398744,6.420759462552213
BT 428,10231331,-0.1978015197872311
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
TE 617.T,637858,1.1275370402381546
SNU-308,168313016,4.41321855315878
GOS-3,26596,5.630360863540023
Mel Ho,4259181,-1.9031340337885552
HeLa,135999136,4.338563749387071
SW1271,9927531,4.558020454092029
MOLP-2,439501,-3.1752212130018163
WM983B,637858,2.6617865393922906
SNU-620,selumetinib-JQ-1 (4-1 mol-mol),-4.433730050654808
BICR 56,10302451,1.081670718064007
SW48,10231331,-2.95597966611556
YD-38,135421197,2.8276318584619022
NU-DUL-1,73707398,0.3699002098172852
KE-39,327653,3.149148027412197
SNU-423,9927531,5.196680575825113
HuH-28,637858,2.0135028750477275
Fu97,24180719,3.1268724134983916
U2OS,73707398,0.2432624867397234
HOS,11396600,2.933584432278509
Hs 683,49766530,0.8674069188410214
Ri-1,44491742,3.935960320926185
T98G,11455910,0.2544044244043033
NOMO-1,46907787,-1.215006340822028
WT2-iPS,11455910,0.3504555455596581
G-401,10231331,2.894718734978725
HT-144,107970,1.7664193063263929
PF-382,9915743,0.1930622386086079
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
U266B1,11455910,1.3573355580969808
NCI-H661,46907787,3.1119891404607083
HuH-28,9903786,2.984330186348554
NCI-H1869,54626689,4.973681232735932
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
UACC-62,selumetinib-JQ-1 (4-1 mol-mol),-0.661389948081571
SNU-1077,9936388,2.8901032001990954
KO52,10302451,3.962918157421803
NCI-H2110,9915743,1.734073577383887
CAL-62,107970,2.231851938620399
SK-N-BE(2),100016,5.117046374692038
Mono-Mac-6,46907787,6.013710561092881
HEL,637858,1.821308587756956
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
UM-UC-1,6852167,2.5979148138945094
NCI-H1838,9915743,0.3872640032202238
SNU-1033,135421197,1.1443309651958211
JL-1,262093,4.749807355253156
SU-DHL-1,136227924,2.1802521862386395
NCI-H211,637858,1.4615716709012136
Mel JuSo,107970,2.345847448694836
EHEB,3689413,-1.930959129148268
SNU-8,selumetinib-JQ-1 (4-1 mol-mol),-0.3445187438421354
P3HR-1,135421197,1.4692220072432751
NCI-H1385,46907787,0.0996622150705552
MPP 89,4259181,0.6927128674187937
CL-11,BRD-K27188169-navitoclax (2-1 mol-mol),3.059787296703186
LS513,439501,-0.8485123993452164
PaTu 8988t,9936388,-7.900053622036252
WT2-iPS,262093,1.0416118497469489
NCI-H1581,156414,1.3302428949057634
PK-59,4259181,0.3924216394548331
SNU-81,46907787,-1.0582449369350613
TE 617.T,9927531,4.756324122053051
HCC1171,9936388,2.426947381666507
VMRC-RCW,4259181,0.791876678188995
DMS 454,3689413,-0.1217907891040976
EC-GI-10,24180719,3.7128141318799006
BT 359,637858,2.5273498695616627
SK-N-DZ,44491742,3.9840069294663025
NCI-H1341,241158,3.623594083926393
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
SW1417,46907787,1.724855594045881
Mono-Mac-1,54626689,3.913673897382288
NCI-H2029,73707398,0.5003927400842891
AML-193,9903786,0.8964959082150169
MOLT-16,6852167,0.1209526940764007
EN,4259181,-1.2410580135175182
BT 159,9936388,-6.930864213478757
5637,71466445,3.813254816409256
B-CPAP,100016,6.506572981316216
SK-UT-1,262093,2.998836933826174
OE33,327653,3.4722328346839246
TE-14,11455910,0.8853432614856256
K-562,9927531,3.3022164605184763
CA46,375860,-0.5712781411665353
OV56,327653,3.693872160162438
Pfeiffer,135999136,1.352929794196776
NCI-H1339,26596,-1.3893901381267089
MEC-1,4259181,0.1927330879761474
VCaP,selumetinib-JQ-1 (4-1 mol-mol),0.3069804526516825
JIMT-1,26596,-0.816309459972074
OPM-2,444795,4.04932788863876
JHUEM-2,241158,3.3547536689663904
A4/Fukuda,4259181,-0.5702867723998835
MOLM-6,135875424,3.809731266515376
BT 333,3689413,0.756626575903668
GA-10,107970,0.8863840463858195
IMR-32,3689413,-3.464498060379514
SW948,135875424,4.663257041681152
AM-38,11455910,0.8170455923888418
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
DK-MG,11455910,0.6874488483397508
BT 164,4259181,0.8270070515242077
Kasumi-2,11396600,2.2579616248243495
COV434,262093,2.1356582362370897
RS4;11,11396600,2.516092176764727
SNU-761,136227924,3.0890701215325085
MDA-MB-231,12003241,-1.774974219486486
TCC-Pan2,327653,3.0100478974076585
GCT,637858,1.0385345002534945
SK-N-AS,9903786,2.5201816871089653
IM95,selumetinib-JQ-1 (4-1 mol-mol),0.2831662508837702
BT 131,439501,-2.852207869991737
MKN7,9927531,4.538796074024755
KHM-1B,136227924,1.9174951940989704
HT,24180719,3.691178600872326
JHH-5,73707398,1.459059572393258
KMS-27,9903786,2.0838522642379216
SK-MES-1,10231331,1.6852843396336314
BT 245,136227331,4.251360717375094
SW1710,49766530,-2.0180793579471183
BT 330,135875424,2.80821579250056
ZR-75-30,12003241,0.0052055629667129
NCI-H747,241158,4.314424044876157
TF-1,selumetinib-JQ-1 (4-1 mol-mol),-0.1446879756721995
LS513,3689413,-0.047571492296106
F-36P,637858,1.1543782344326252
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
YKG-1,46907787,4.9363681806831075
SK-MEL-30,3689413,3.4376299216272685
BT 232,327653,3.71280727706233
Hs 746.T,73707398,2.6800461507251634
ACC-MESO-1,135421197,1.1131712845559925
NCI-H2228,24180719,5.281914992621932
JHUEM-2,9929138,6.79897920922461
BT 248,241158,3.909930885156875
PL-21,6852167,0.788666382413097
Hs 822.T,11396600,4.268177594859087
HEC-265,100016,5.251492285111922
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
HSC-2,11455910,0.978871234646886
MG-63,10302451,3.049772862204908
22Rv1,9936388,-6.447034824270601
PaTu 8988s,73707398,1.72539191163247
DU145,46907787,4.026240658586575
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101
Calu-6,135999136,4.2599356901260865
NCI-H747,262093,2.550683117249541
HEL 92.1.7,135999136,1.6323653290095597
OV56,135875424,4.815096584327211
HuT 78,selumetinib-JQ-1 (4-1 mol-mol),-4.078257117596482
KE-39,71466445,5.518940973386278
G-402,6852167,2.090716330092647
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
JJN-3,10231331,5.266258686816633
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
DU145,9936388,-2.7050109048591287
EJM,9915743,0.880814312418276
8-MG-BA,73707398,1.972925261503962
Lu-65,262093,3.3965218788249407
KMS-27,9927531,4.171626738694902
A-549,6852167,2.2085984360403663
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
Reh,9929138,6.102767885928958
MOLT-13,9936388,-7.171381917175865
Hs 839.T,135875424,5.214579617970531
Hs 852.T,46907787,1.758090813443025
QGP-1,73707398,1.9620866624858488
COLO 741,439501,-2.122340896395585
BT 232,11455910,0.0350412788633053
TE-6,644241,2.3482267869305904
FTC-238,100016,6.441740826290021
OCI-M1,100016,6.862784368685653
LK-2,107970,2.4057924006239317
TOV-21G,10302451,3.5434423725456092
PL-21,46907787,0.2459511356880181
TE-5,9929138,7.538066804414881
DV-90,9929138,3.266607070409867
NCI-H460,136227924,3.925006850615035
TE-8,637858,1.4873668702699938
CML-T1,637858,1.454745710944211
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
MDA-MB-435S,9936388,-7.051147394229912
NCI-H441,327653,3.4037680370042276
NCI-H1299,107970,3.021193234232078
EM-2,46907787,-1.6373715361565755
MDA-MB-453,12003241,-0.9610578830621354
Panc 08.13,46907787,-0.8528546674908809
SNU-182,44489367,4.36916945125797
Panc 03.27,49766530,0.7469851659716551
SK-UT-1,241158,3.8222099850046054
AGS,selumetinib-JQ-1 (4-1 mol-mol),0.7685834389081105
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
L-363,12003241,0.3787290467646389
22Rv1,135875424,4.290538379246911
TE-11,44491742,4.693263805058857
SK-N-DZ,5460769,3.5679680619882617
Caki-1,168313016,5.868880738665532
KE-39,100016,6.665188081944046
KMBC-2,241158,4.749872704815576
NCI-H1581,BRD-K27188169-navitoclax (2-1 mol-mol),3.4839314108036015
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
LS411N,107970,2.4864618038552724
DU145,11396600,3.556301760853191
COV644,9903786,3.8438435409952456
TCC-Pan2,9903786,4.661219913833123
SNU-C2A,3689413,1.145907285408548
SK-HEP-1,54626689,5.252317432323977
Hs 294T,54626689,4.642173496982852
SH-4,46907787,2.8458594611775947
BT 416,136227331,3.8203373209104425
NCI-H1792,10302451,2.867241366253955
NCI-H358,11396600,3.567926614566842
HT-1197,9936388,2.7630776748899746
Kasumi-1,11396600,3.073022183075244
NCI-H2286,107970,2.345269043808208
JHOC-5,46907787,0.6133782496345309
BICR 22,73707398,1.4183060149157571
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
KYSE-140,selumetinib-JQ-1 (4-1 mol-mol),2.3172835703962686
KATO III,44491742,4.678429550063523
Kelly,136227924,2.280835674454857
MDA-MB-231,107970,2.4334474009984186
GDM-1,71466445,4.505903550249394
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
KMS-18,54626689,4.081071154079752
MHH-CALL-3,9915743,1.3835239256634295
MJ,10302451,4.214297869660198
KP-3,10302451,2.012637643935689
WSU-DLCL2,5460769,0.924781789272552
TT,44489367,4.439043009737822
Hs 940.T,3689413,0.3650733663514719
KPL-1,9929138,5.414616490149542
AsPC-1,327653,4.351823995090995
CAL-85-1,46907787,0.5241273269532959
SU-DHL-8,46907787,-0.7946943870210552
KNS-60,selumetinib-JQ-1 (4-1 mol-mol),2.416041251074975
MKN45,637858,3.657706213668147
UO-31,44491742,3.8837342350027377
NCI-H747,11455910,-0.1344323307423927
ES-2,241158,4.7150295600490235
NCI-H1155,9936388,-5.221468348115442
Mino,135999136,1.739858930997736
Ku812,136227924,2.6493599225721742
DK-MG,24180719,3.651633572345493
SNU-46,4259181,1.2898600996653962
BT 498,UNC0638-navitoclax (1-1 mol-mol),2.7043329045361393
WM793,3689413,0.565505634508756
BT 320,9936388,1.7913306244505192
WM115,10231331,-3.458943295987183
KP-3,44489367,4.890538998734305
SNU-423,375860,-0.141425947999252
HMCB,73707398,1.3368186639169768
SNU-423,644241,4.521136945345214
NCI-H2009,136227924,2.9896301065010933
BL-70,6852167,-1.1490016051859089
HCC1806,156414,1.552269130109232
SK-ES-1,439501,-3.332679382402903
ECC10,4259181,0.1069108144174364
BICR 56,6852167,2.49326983244998
Hs 934.T,12003241,-1.701018905102148
KE-39,156414,4.025830312298652
KE-39,637858,2.1285067674718374
Rh30,136227331,4.257101028878693
RKO,54626689,4.750442055573677
HD-MY-Z,327653,3.7321262442272567
MSTO-211H,439501,-1.1644309958543906
COR-L51,9903786,2.9541793607693267
Calu-6,136227331,4.4599645259954555
OV56,241158,3.916258648740272
SNB-75,54596490,4.4312268703898825
A3/Kawakami,9929138,3.117210627279925
MDST8,241158,1.799926141571129
WM793,136227924,4.7819042035619255
HGC-27,5460769,1.1785967516378393
DAN-G,6852167,3.417213289559001
NCI-H2405,100016,6.531050125500204
SNU-601,4259181,-0.4833088686637755
MHH-CALL-3,136227924,2.519521666896543
LS513,44489367,4.489684382655126
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
RKN,135875424,3.6230459419726526
KE-97,selumetinib-JQ-1 (4-1 mol-mol),-2.3334311692640184
Panc 08.13,637858,1.5616639635325589
SNU-182,6852167,1.4866247167817654
M-07e,241158,4.092457424530606
23132/87,136227924,2.929197271565677
HEC-108,3689413,1.021712931431184
Hs 888.Lu,637858,3.046602589688793
Ku812,44489367,4.131127961346879
MKN74,9915743,1.5544684592006026
NCI-H1623,73707398,1.8898657972875643
NCI-H2452,10302451,4.286596307748033
MG-63,262093,3.0447141305088614
WM115,12003241,-3.303596686294694
HOS,24180719,4.2411336343126536
MHH-ES-1,selumetinib-JQ-1 (4-1 mol-mol),0.1854105188393836
JHUEM-2,135421197,0.9907591998948792
PC-3,11396600,3.5715694520968
CW-2,46907787,1.2539554927641257
SNU-1,24180719,3.367943220423491
NCI-H1573,UNC0638-navitoclax (1-1 mol-mol),2.6425968514400715
GDM-1,73707398,0.4445585345149614
HCC44,3689413,2.49151375476088
KMBC-2,54626689,4.121176613845106
NCI-H2085,107970,2.2340000781597844
NCI-H929,26596,-1.2167182000669836
SNU-886,26596,-1.4881272997493236
NCI-H1869,5460769,3.405523512527605
OAW42,135875424,4.816412015133948
L3.3,135875424,3.974579804692541
NCI-H441,3689413,0.4936421850915237
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
TYK-nu,100016,5.6630271022409495
DU145,54596490,4.798915584619797
MOLP-2,241158,2.025769717996406
NCI-H1299,4259181,-0.5610817863206101
HCT 116,selumetinib-JQ-1 (4-1 mol-mol),4.796768877675462
SNU-503,9927531,6.946018069076572
COV434,100016,6.159872289007743
COLO 699,12003241,-1.6460659518938752
2004,107970,1.5686946490439204
BL-70,49766530,-0.8526727850489186
BT 422,4259181,1.564610339660692
COR-L88,73707398,0.9556404513556984
MOTN-1,46907787,-0.6742316988150437
HEC-1-A,3689413,-1.724337097738872
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
LCLC-97TM1,11396600,3.6456493290211425
HCC44,11396600,3.8855375571171846
SBC-5,156414,2.5142262290401516
Ci-1,3689413,-2.5186366363641293
JURL-MK1,46907787,-0.3234597989905174
OVCAR-5,107970,2.223801029553332
NCI-H1869,439501,-1.575584272947446
MJ,439501,-3.472446137047906
NCI-H2141,49766530,-3.0033448616594174
Hep-G2,9936388,0.9252852669938214
NCI-H1793,135875424,3.2087606409419087
SNU-61,637858,1.6436621136217924
Hs 822.T,UNC0638-navitoclax (1-1 mol-mol),1.6925354489393756
KP-4,73707398,1.2219624501401705
THP-1,9915743,0.7907463858245806
TC-71,10302451,3.884014223654917
HCC1954,135875424,3.784549105915095
TE-8,444795,5.184133125926738
D283 Med,44491742,3.738153910971064
GDM-1,54626689,2.5806073729204906
Rh30,5460769,3.928559830912204
NCI-H929,49766530,-2.4737600180853385
Rh18,11396600,3.2185471746223975
RPMI-8226,71466445,1.9270357841709371
KM12,26596,0.910782273652732
786-O,9903786,3.782252181935989
RKN,9936388,2.306220468641662
BC-3C,9903786,3.0556905946174537
BT 428,12003241,-1.1639537703903158
JHH-4,375860,-0.101060239455863
P12-Ichikawa,439501,-2.449202945881867
JHH-6,6852167,4.148791687912657
BICR 22,4259181,0.3497439952553443
KP-3,135875424,4.114191182933948
KNS-81,46907787,4.401803452784797
KMRC-3,26596,-1.545617580729079
EHEB,46907787,0.323033594148826
KO52,49766530,-2.9689315906411413
BT-12,107970,2.322047510455146
NCI-H1915,439501,-4.1452565317565995
HPB-ALL,49766530,-0.2881554297817815
NCI-H2110,439501,-2.2349143195011583
OCI-AML-5,637858,1.7330578787515938
LS180,9915743,2.834892961755663
NCI-H650,3689413,-2.023136862594463
NCC-StC-K140,selumetinib-JQ-1 (4-1 mol-mol),-0.4329404408477834
SW620,135421197,1.4472362766412623
639V,135421197,3.226794865257896
647V,327653,3.5723030126799475
MDA-MB-231,9903786,4.774872525437021
OUMS-23,selumetinib-JQ-1 (4-1 mol-mol),2.2362069327324128
BT 340,4259181,1.6823623787475968
ECC10,136227924,2.5549710603978366
SNU-398,selumetinib-JQ-1 (4-1 mol-mol),2.57940367072891
AsPC-1,73707398,2.3690176063372888
SNU-407,selumetinib-JQ-1 (4-1 mol-mol),-1.4031529042241262
HGC-27,UNC0638-navitoclax (1-1 mol-mol),1.547939825071545
TCC-Pan2,637858,2.213784354871656
MOLP-8,9903786,1.299688823902182
BT 416,selumetinib-JQ-1 (4-1 mol-mol),0.8110934532138555
OCI-M1,241158,3.69055500632508
DOV13,71466445,6.3474763334075615
SW982,327653,3.5055694306340484
HCC2108,262093,2.915848941362045
HMCB,241158,3.538321708116031
CMK,3689413,0.9967323135888336
SH-10-TC,9927531,5.280985634466932
Rh18,UNC0638-navitoclax (1-1 mol-mol),-3.466450646619238
SCC-25,135421197,1.688972609410465
U2OS,9903786,2.225601394928473
Panc 03.27,11396600,3.3574447393288547
U-937,BRD-K27188169-navitoclax (2-1 mol-mol),-1.0925994306637552
LOX-IMVI,168313016,4.96467141821942
SW1353,6852167,2.5995387617408388
HEL 92.1.7,100016,4.201358504841771
Raji,107970,1.9902567284357284
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
BICR 31,46907787,2.190433361645711
TCC-Pan2,46907787,2.449998645601034
Capan-2,44491742,5.038963412977017
JHOC-5,12003241,-1.1087899100302334
NCI-H1838,UNC0638-navitoclax (1-1 mol-mol),0.5563197288031422
HSC-4,9936388,2.361545024779824
42-MG-BA,9936388,2.1836082954328644
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
T84,selumetinib-JQ-1 (4-1 mol-mol),0.2360248997526779
MOLM-13,439501,-2.531564352317227
NCI-H1373,439501,-1.5059395530242756
GaMG,241158,4.746833057174428
BT 440,100016,6.480442369798277
SET-2,135421197,1.735218850040683
HSC-2,44491742,4.345443441235533
TF-1,3689413,-2.3947116127493797
PSN1,375860,-0.0527401494130232
SW1463,10302451,2.197754569420114
NCI-H1385,12003241,1.7057998630948272
SW1783,44491742,3.6997355499837217
NCI-H2106,241158,2.9302091646352526
42-MG-BA,262093,4.0294491331177715
WM115,24180719,-0.1236916700903925
SNU-410,11396600,6.23981949111421
HuH-6,156414,1.109377454710629
SK-MEL-31,73707398,1.4524538881276303
CFPAC-1,9903786,2.8562781406669653
SNU-46,9936388,3.201545334866413
BT 159,135999136,1.5002095290775506
UM-UC-3,12003241,-0.2552051516294621
NCI-H1341,12003241,-1.9101542939935303
NCI-H661,241158,4.406370209729512
SNB-75,637858,2.6086368841985608
KMS-26,6852167,-0.4011200581134632
MDST8,10231331,0.2022855962524302
CGTH-W-1,327653,4.251940578984738
BT 286,375860,0.1606437193581575
SHP-77,327653,3.224710785820069
CA46,24180719,4.114109141176105
GMS-10,49766530,-2.0823399026837888
Hs 852.T,24180719,3.4184445538285835
B-CPAP,9903786,2.2781712830719316
LNCaP clone FGC,10231331,4.305884734347832
RKO,3689413,3.093382349703003
KMBC-2,10302451,4.200978616748967
BICR 56,71466445,2.0273239202254985
YD-38,241158,4.218003156068375
NCI-H2087,5460769,-1.5102005910697154
G-361,selumetinib-JQ-1 (4-1 mol-mol),-0.122250953270649
HEC-1-A,10231331,6.402874161063355
OVTOKO,100016,8.078720974707625
IGROV-1,46907787,2.182756719431072
THP-1,10302451,3.9077455908783856
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
DEL,54626689,3.9669826807108577
CGTH-W-1,selumetinib-JQ-1 (4-1 mol-mol),1.2775145909700567
PLC/PRF/5,11455910,0.2914890015755099
HT115,156414,-1.6734320997584922
OPM-2,9929138,4.40255967212205
HCC-56,3689413,0.2080037745541134
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
BT 147,327653,3.2470694295501925
U-118MG,71466445,5.975471047496491
Ku812,26596,-2.18380806647072
SK-MEL-1,327653,3.0009528841881283
KMS-18,136227924,4.439422503928272
HuCC-T1,6852167,2.8530776188641926
NCC-StC-K140,9915743,-4.061475008678285
YAPC,6852167,3.757016833172803
EC-GI-10,3689413,0.4203199772849357
CAL-120,73707398,2.482636408608758
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
MIA PaCa-2,644241,2.2485281362376677
OV7,12003241,-1.6318982026296969
KMS-12-BM,136227924,1.841540408480291
U-251MG,9903786,4.913889261363981
Kasumi-2,135999136,3.771420948620172
ECC12,6852167,3.3957553977851194
OE33,4259181,0.9178629586058104
NU-DUL-1,6852167,0.3945833512314752
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
HMC-1-8,73707398,1.3647287690832346
HCC1806,107970,2.3006774774871444
BT-16,135875424,3.384825931248148
AsPC-1,49766530,-1.5554439905221051
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
NCO2,439501,-2.4046294895536446
BT-12,3689413,-1.6226385767572318
PaTu 8902,73707398,2.5949502925816397
SK-MES-1,107970,1.6078502223677542
HCC38,262093,3.049385257949274
CML-T1,439501,-2.361432010025089
PE/CA-PJ41 (clone D2),11455910,-0.0174306689930347
HCC95,439501,-2.2206191561813537
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
COLO 829,5460769,5.712006369948703
KNS-81,4259181,0.9523122682170628
MDA-MB-468,637858,1.3196114478937917
SK-CO-1,10302451,2.4520332675877605
SU-DHL-8,BRD-K27188169-navitoclax (2-1 mol-mol),4.223436962245127
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
EJM,327653,3.072072044008088
BT-20,9927531,4.105614320548644
OCI-Ly10,327653,2.9834360685132073
NUGC-4,4259181,-0.8315529215214057
Peer,26596,-2.3725099322734193
MFE-319,49766530,0.80428041774597
HCC1171,637858,2.0193293251273587
PLC/PRF/5,44491742,4.0953370325315355
SW982,26596,-1.3061424276940652
HEC-1-A,UNC0638-navitoclax (1-1 mol-mol),1.5450110805841195
PaTu 8902,156414,2.7243668654536206
T3M-10,637858,3.395991608767305
Detroit 562,100016,6.391000104824681
EM-2,375860,-0.8639645436146182
MDA-MB-468,10302451,2.6008680877418286
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
SNU-398,156414,3.5585517115959395
8-MG-BA,241158,4.128580176104645
TE 441.T,10302451,3.78756460057488
DB,3689413,-2.3561309099852448
PE/CA-PJ34 (clone C12),262093,3.186494210920842
RVH-421,54626689,4.549894578548201
DU145,136227924,5.593457102459236
HT-144,12003241,-2.1434131709855215
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206
NCI-H1793,107970,2.8613850617942114
NCI-H1666,3689413,1.2654271755000104
T3M-10,5460769,3.3157316369773926
CHP-126,444795,3.714617722830771
CA46,9903786,1.650432742323398
Mel JuSo,637858,2.3077535969243343
SNU-626,54626689,4.772100003109828
BT 159,135875424,2.5273091114985777
IM95,135421197,1.82803770659542
NCI-H69,3689413,-1.5363030352959728
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
LCLC-97TM1,135875424,3.9585615026829823
JHOS-2,6852167,3.022922211254124
LS123,9936388,0.5461115096373947
SNU-685,24180719,3.799836504821154
OE21,107970,2.067715024549662
BT 147,4259181,1.073603835274746
LS513,9903786,1.9994254947829608
OV56,262093,3.284870427010587
YD-10B,9936388,-5.330714776422858
CAL-12T,6852167,2.1618229054744997
EoL-1,54626689,2.476018203222032
KMS-21-BM,46907787,-2.184676378105775
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
ChaGo-K-1,49766530,-1.5426741425236086
23132/87,44491742,4.505625737535984
SNU-201,4259181,2.400409530902911
MKN1,49766530,-2.302116655830655
Hep-G2,10302451,3.0105378640601037
BT 359,11455910,0.3970564809620578
U266B1,6852167,2.66755364409151
HCC1419,6852167,1.0857417323628011
SU-DHL-8,327653,2.6008762420868425
CHP-212,11455910,-0.0664645017636666
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
HeLa,135875424,4.463353648372455
HCC1500,241158,4.347158152842418
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
PK-45H,12003241,-0.6609061403409452
BT 498,10302451,4.23204741279201
SW948,439501,-2.1692174321648174
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
AU565,262093,2.3992948308197093
CCK-81,9903786,2.4008516567284848
MKN74,375860,0.5646140741524153
HCC78,11455910,2.0518993583639182
HCC1395,9915743,2.6383057789400746
Hs 822.T,4259181,1.579664777569875
DND-41,10302451,2.791919082066888
Capan-1,10302451,2.5563331533364373
BICR 31,439501,-2.4499261286992007
MeWo,136227331,4.002976901142853
BT 228,262093,2.371515805144491
HEY A8,11396600,3.7173618063092246
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
NCI-H2081,12003241,2.480414390654569
42-MG-BA,24180719,3.6653917584215567
TOV-21G,11455910,0.2385703250097463
RS4;11,9927531,3.90062082158746
Calu-3,selumetinib-JQ-1 (4-1 mol-mol),-2.481326472415344
JURL-MK1,637858,1.598414572100692
KE-39,135875424,3.891762591841876
BT 179,439501,-2.97680380093877
PaTu 8988s,selumetinib-JQ-1 (4-1 mol-mol),0.3498739449396179
YD-15,439501,-2.3800052899031985
Pfeiffer,24180719,2.2416081825437546
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
NCI-H1373,10302451,3.0942478784962693
WM983B,135999136,4.467967668661813
HEC-1-A,136227331,4.058497716463453
NCI-H1734,10231331,0.3591189863863598
NUGC-3,26596,-0.5443807488000636
SIG-M5,71466445,2.546223661997516
A-204,644241,0.4255610904978891
SK-ES-1,3689413,-2.1650070700779582
NCI-H1105,46907787,2.551008749749465
MOLM-6,637858,1.0239222762950713
JURL-MK1,44489367,4.76869283376435
NALM-6,11455910,-0.1269393441174446
NCI-H2030,107970,3.119598892281485
UACC-62,9903786,5.03427767143789
NCI-H1944,9927531,4.180597511578871
HCC-56,12003241,-1.1028800957118954
COR-L51,375860,-0.9911369939793973
KMS-34,6852167,-0.2545428449161299
8505C,46907787,1.2029484173632825
SNU-C2A,637858,2.233207186626609
MOLP-2,168313016,6.050723195700108
RERF-LC-MS,10231331,0.9954911948227504
HEC-108,44489367,4.45975641268053
NALM-6,9936388,-6.74372502576803
KMS-11,selumetinib-JQ-1 (4-1 mol-mol),-2.59830306895456
JHOS-2,9903786,4.753698085205414
Hs 683,10302451,3.704535359284315
KNS-42,241158,5.1081489530944015
CAL-85-1,5460769,4.15135857015067
JHOM-1,262093,3.378036000941939
KALS-1,10231331,5.286218838371379
SH-4,44491742,3.636684434382026
VM-CUB-1,156414,0.5841257025928078
JHOM-1,241158,3.6386964384932137
Detroit 562,637858,1.8443507539386277
TTC-709,10302451,3.507934781987639
CHP-212,UNC0638-navitoclax (1-1 mol-mol),3.0960304898677973
LOX-IMVI,637858,1.7619736168396252
COV362,327653,3.663360057056847
Jurkat,9936388,-5.914965617519404
Kasumi-1,136227924,1.874085610777816
RPMI-8402,3689413,0.0751031286751058
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
NCI-H196,11455910,1.326317749713535
BT 416,135999136,1.7385922508955245
SK-UT-1,9903786,5.78516391020833
SUP-M2,11396600,1.284411602276366
PE/CA-PJ41 (clone D2),637858,2.8065176462831034
MeWo,11455910,-0.0610908401405663
NCI-H460,46907787,4.3372157131836255
COV644,439501,-3.4357426903027273
CCF-STTG1,10231331,5.780092265996196
NCI-H1435,UNC0638-navitoclax (1-1 mol-mol),3.6159705037693217
P-STS,4259181,0.7192752907491521
Panc 10.05,11455910,2.05873127969748
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
TUHR14TKB,136227924,3.4575547117836836
DOV13,5460769,1.9787074160604587
HH [Human lymphoma],71466445,1.7610041408250423
NCI-H520,4259181,-0.9847708191101096
A-498,135421197,2.4500558267656873
LoVo,10231331,-0.6826574775964468
JHUEM-3,10231331,1.902547404227762
Fu97,375860,-0.1420045444279083
BT-12,6852167,4.120873835163926
769-P,73707398,1.168379286742932
BT-474,262093,2.736655857570439
WM793,5460769,5.840780592325561
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
HCC44,439501,-2.457856090784354
BT 416,9929138,7.415658440710529
SUIT-2,241158,4.373615531607702
JVM-2,9915743,-2.5513470723309095
BT 328,73707398,2.390014521827579
HCC1143,327653,2.9245812810780745
AsPC-1,136227924,3.2025742465891938
REC-1,107970,3.403139793728704
SNU-16,637858,0.5041964685707029
IPC-298,10302451,3.9740679982268583
RL,375860,-0.2985027186247951
BFTC-909,6852167,2.133526407129769
TCCSUP,5460769,3.7572024912117103
SUP-M2,44491742,3.782473940408551
Hs 294T,9936388,0.7679572566977205
WM983B,3689413,0.8501817874784955
SNU-1272,135421197,2.338787330458388
COLO 792,4259181,0.9728594463326096
HCC15,49766530,0.5190445493569186
NCI-N87,12003241,-2.470820657410725
NCI-H1915,6852167,2.88069410899598
IGROV-1,11396600,3.99372654279783
SYO-1,375860,-0.5330917141994846
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
DAN-G,71466445,4.655647233867882
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
DMS 53,135875424,3.815847763190564
CAL-78,439501,-1.7848444921283717
Li-7,5460769,-0.8720138445783291
786-O,3689413,-2.4095930887688546
Tm87-16,3689413,-0.2220957395853978
MDA-MB-435S,100016,6.42664314163943
NCI-H1694,327653,2.2817152980884265
NCI-H1341,24180719,2.9217382703534134
Hs 944.T,439501,-0.9410683695438108
CMK,9915743,0.8633678445268913
SK-ES-1,10302451,3.444765090684361
NCI-N87,135999136,4.294797881105147
Hep 3B2.1-7,135999136,2.2984722485990567
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
HCC1195,selumetinib-JQ-1 (4-1 mol-mol),2.3126527462305955
NCI-H2106,637858,1.632566617574699
KHM-1B,135875424,3.3101852288443276
PE/CA-PJ15,135875424,3.5762101924458585
KMS-21-BM,100016,3.297202365361246
KMS-18,73707398,0.4352882147281803
HCC2935,9927531,5.26637836845999
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
HCC4006,11396600,3.4330968627911425
Daudi,644241,1.4114598324864769
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
HuNS1,136227924,1.7771734051898846
KMS-21-BM,107970,1.3348974715071786
LCLC-97TM1,327653,3.202975625508304
MCAS,135875424,3.596680652923431
COR-L105,46907787,0.7742744471044445
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
BT 112,11396600,2.640188999201151
U266B1,241158,2.766625072392717
CJM [Human melanoma],637858,2.4545545863502314
SK-BR-3,4259181,-0.0321422954421751
KNS-60,9903786,2.981782520240843
KYM-1,46907787,-0.5999039132788315
Panc 10.05,5460769,2.1730903163441444
647V,9903786,2.919786568637495
SK-MEL-3,262093,2.386841982025131
LS1034,selumetinib-JQ-1 (4-1 mol-mol),-0.292584359399862
COLO 792,107970,1.4461618436680284
SNU-119,46907787,2.5271615138386054
HMCB,9915743,1.6080279846600372
LK-2,9915743,2.752054960797746
OE33,439501,-1.244619642300935
Mino,selumetinib-JQ-1 (4-1 mol-mol),-0.0896875125298877
TE 617.T,24180719,3.6567645960116497
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672
TE-11,439501,-2.6156568819541435
42-MG-BA,49766530,-1.7138070922942703
MG-63,54626689,4.58773041441284
Kasumi-2,9927531,4.453654232617923
U-937,135421197,1.66797552132573
LOX-IMVI,4259181,-0.9241838451669104
CAL-78,4259181,0.9156565377024688
SK-N-BE(2),6852167,2.849776055810666
KMRC-2,444795,5.142588115774172
SIG-M5,375860,-0.3879584489386603
LMSU,selumetinib-JQ-1 (4-1 mol-mol),3.5274573633732773
SNU-245,4259181,1.448365127133337
CAL-120,44491742,4.283004570772673
L-428,100016,6.045371287660442
Hep-G2,71466445,2.837099504530813
HCC2218,135875424,1.4940742692763715
CAS-1,9915743,1.3093689847422858
SNU-410,3689413,1.1161257107979303
DLD-1,12003241,-0.215038024432674
SUP-T1,444795,1.0883115007500728
PK-1,9927531,5.928994406522703
NCI-N87,156414,-4.435299577962505
NCI-H1703,135875424,3.0256597823887725
MCF-7,3689413,0.894647662863142
NCI-H520,9927531,5.647411307076465
CAL-62,9936388,-6.3411138463637
NCI-H810,168313016,3.527700584911011
AsPC-1,3689413,-2.062701377390924
A-204,9903786,2.6800363782821517
Caki-2,135875424,5.110553141792517
BHY,44489367,6.340314331461489
NCI-H810,444795,3.9825694306913086
JHH-2,10231331,1.680867095557431
A-549,44491742,4.437272986024
G-402,26596,-0.4180942485240064
2004,262093,1.3904438006170303
MCF-7,10302451,6.463530538408448
IA-LM,107970,1.9308025720075177
NCI-H660,UNC0638-navitoclax (1-1 mol-mol),-2.199385544669957
MDST8,135421197,2.23565927197073
Ki-JK,9915743,-0.1988023014574486
NCI-H716,9936388,-4.976580043871955
HOS,637858,2.229714845567401
SR,100016,4.130694890660373
NCI-H2170,4259181,0.296825515381287
KP-3,241158,4.0882665535753375
OPM-2,10231331,0.6444733525039235
BT 504,241158,4.311533589367548
HEC-251,9936388,-5.1528411757611465
Peer,375860,-1.18299630263261
HCC1419,5460769,4.36793897247466
SNU-899,107970,2.6525131600787293
KMM-1,3689413,1.9155128689282703
SW579,375860,-0.3689240744334486
K-562,262093,3.1056763935044813
NCI-H2029,637858,1.7994577186451293
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
DEL,11455910,-0.2144903394891009
SNU-761,10302451,2.865362622311559
HGC-27,12003241,-2.439316929165163
MDA-MB-361,11396600,3.700077553751832
Aska-SS,241158,3.805565217473049
SF539,9903786,2.8297220739955993
SNG-M,49766530,1.2190782800499038
MDA-MB-157,44491742,3.772080854170876
MDA-MB-361,49766530,-1.160190626946109
Hs 936.T,73707398,1.47923152976858
BT 216,44491742,5.368329526940575
SCC-25,26596,-1.8912501387828335
MOTN-1,10302451,3.257929179100611
HEC-6,135875424,4.1138725556721685
TTC-709,46907787,1.4773024325483866
GA-10,9903786,1.0626395044563215
HDQ-P1,439501,-2.3169119812080794
HMC-1-8,637858,2.1501243127898064
GCT,9927531,4.599543435598106
Calu-3,135421197,0.9816420613117603
Reh,241158,3.1279755149580213
BICR 31,107970,2.625018410874988
ECC10,168313016,3.3239878993756684
LC-1/sq-SF,135421197,3.695638130955798
OAW42,selumetinib-JQ-1 (4-1 mol-mol),3.6330242229616694
Rh18,46907787,2.4292480291627214
EFE-184,49766530,0.8289691461992541
KMRC-2,46907787,4.616997253710001
Calu-3,12003241,-0.8682368391192625
OC 314,selumetinib-JQ-1 (4-1 mol-mol),0.4980964574783434
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
BT 416,439501,-5.114778373309692
TUHR4TKB,11455910,2.848253003917055
NCI-H2452,3689413,1.184555113675537
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
JeKo-1,46907787,2.135239462505942
TE-5,11455910,0.4645654676747968
CFPAC-1,4259181,0.9556133546094158
TYK-nu,10302451,3.5311892845206123
HCC1395,6852167,3.6940482841079647
UACC-257,135875424,5.07127694251911
Toledo,selumetinib-JQ-1 (4-1 mol-mol),4.9688453289491115
Pfeiffer,241158,3.156782665894997
HCT 8,135421197,1.352992198121239
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
H-STS,9915743,1.4562053378516668
BT 179,3689413,2.324623273227175
HT-144,10302451,3.8668226201155873
HD-MY-Z,54596490,4.535330665629844
COLO 699,637858,1.990442060212899
BL-70,136227924,2.857298369944604
Capan-1,5460769,0.8848211247496085
RVH-421,3689413,0.478404210346996
P31/FUJ,46907787,-0.8407426122417735
RPMI-8226,135421197,1.9475796731003323
WT2-iPS,100016,6.129452507999119
OVCAR-8,107970,2.979884143831386
NCI-H1581,644241,2.2407150929255453
KYSE-410,46907787,2.6604064739007804
Hs 839.T,54626689,4.989143838240461
Ci-1,26596,-1.6175201482887698
BT 231,11396600,2.44608853396947
L-428,9903786,1.2681458902985745
RERF-LC-Ad1,12003241,-0.821513059069255
JVM-2,49766530,-4.705274253962015
ST486,135398744,6.173673764709001
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
CW-2,72967,3.734001222623639
SK-MEL-28,73707398,1.5724586228934123
TC-71,9927531,4.177938465440418
CAS-1,9927531,5.442580925984542
LNCaP clone FGC,136227924,2.6855023326383387
T84,10302451,1.5341654621205278
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
NCI-H727,10231331,-2.105430518957453
SNU-C5,241158,1.6968578329684194
SK-N-SH,selumetinib-JQ-1 (4-1 mol-mol),2.2586391294611974
ChaGo-K-1,241158,4.201927221282135
CAL-54,12003241,-2.3491200847554103
NCI-H1573,107970,2.295055793405493
NOMO-1,11396600,3.3888037624860674
LS1034,44491742,3.738346956467245
Lu-65,9903786,2.0553359532496875
TCC-Pan2,4259181,-1.5549335256713654
Reh,107970,1.8822362327686308
Namalwa,9915743,0.490557645352366
MOR/CPR,3689413,3.3711926349807797
Hs 822.T,10302451,3.767077439801767
T-47D,262093,1.970232832851439
SNU-1079,327653,3.396967278535857
Calu-3,11396600,4.335639453655832
SNU-16,73707398,0.8336482871010481
SF126,11396600,4.209455624849945
697,135999136,1.259492439714956
NCI-H28,9936388,-6.07130459443066
LN-229,262093,3.033286890634207
JHH-6,9927531,5.6306250844291075
SK-MEL-2,6852167,4.028362425471942
NCI-N87,9936388,-5.070095106907016
CHP-212,49766530,0.7165809127280346
CHP-212,26596,-3.74720846369554
Lu-99,10302451,3.8598080136614463
UACC-62,135421197,3.0810150127011773
TUHR10TKB,637858,1.682299707905914
LXF 289,10302451,1.735451917587997
PK-59,136227924,3.43326158684526
NCI-H1155,9927531,3.8709301895195023
KYSE-510,135875424,3.1467699489442182
CMK,135999136,1.26133129608494
Mono-Mac-1,135875424,3.0350686584049473
HCC2218,135421197,0.9685735875874713
HCC1428,637858,2.210735769602794
Calu-6,54626689,5.692610695033436
Ri-1,selumetinib-JQ-1 (4-1 mol-mol),-0.2329470107135907
BT 224,135999136,1.5656128801524771
RPMI-8402,135999136,1.132884235732898
HCC1833,9936388,0.4384818253571875
TF-1,135421197,2.0817745254871216
8305C,637858,1.993620328425992
OCI-AML-2,9936388,-7.199814294099559
HCC1195,12003241,-0.4871999069137717
LS411N,4259181,-1.386635238211632
SNU-C1,10231331,-3.0598130215217285
Panc 08.13,10302451,2.252874393046268
HCC1428,49766530,1.5674588812368278
KE-39,73707398,1.3252144554958445
BT 416,327653,3.217588277124403
Panc 08.13,3689413,2.756509749646428
SJSA-1,10302451,4.357577903208362
OVCAR-4,3689413,-2.062187861989016
GDM-1,327653,1.6980121732900797
SK-MEL-31,107970,2.6492337066565033
ZR-75-30,9936388,2.0011388860463373
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
MOR/CPR,11396600,4.52695838854887
HeLa,9915743,4.03760238390019
NCI-H1155,24180719,4.465305710206081
LN-229,44489367,4.384213219290705
MCAS,11396600,3.718076439368648
OCI-AML-2,100016,4.069849166636085
OCI-Ly19,24180719,3.872538261077388
CML-T1,BRD-K27188169-navitoclax (2-1 mol-mol),1.24494098413804
J82,135421197,1.0520459695592828
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
Hs 683,637858,2.5544628931589166
SNU-16,UNC0638-navitoclax (1-1 mol-mol),1.1266318716416923
HSC-3,444795,5.012644187656376
Panc 05.04,10231331,1.446733345878993
HCC366,439501,-0.4382794174763856
SNU-1076,375860,-1.1254156508705129
BT 224,9915743,3.066397544250084
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
NCO2,9936388,-6.28064659559562
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
Panc 05.04,4259181,1.0154249000610034
SR,10302451,3.219855694871582
Yamato-SS,73707398,1.2225276782354235
OVSAHO,6852167,2.379314950322878
KYSE-140,637858,2.3149924463818534
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564
LOX-IMVI,327653,3.424274817584711
NCI-H2085,6852167,3.1183079346322
EoL-1,100016,3.3783759894754795
KMRC-20,262093,3.714553986632731
HuP-T3,136227924,2.888640375816574
PL-21,12003241,-0.83006256212438
MeWo,54626689,4.69360095158586
Ki-JK,73707398,-1.0738345642120612
NCI-H1734,71466445,2.259055905852919
ECC10,444795,2.5610873462217687
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
NCI-H1734,107970,2.5124626074074405
PaTu 8988s,156414,1.7268071269453409
SNU-61,107970,2.0644711824277757
HCC1195,136227924,3.859466477996048
AsPC-1,12003241,0.1897400127907629
RCH-ACV,637858,0.8093595227428888
KYSE-450,3689413,-0.3124621453247139
NCI-H1299,136227924,3.5346618762414392
HuP-T4,BRD-K27188169-navitoclax (2-1 mol-mol),0.4964751270758175
Hs 936.T,262093,3.786495505346027
TT2609-C02,5460769,3.053476613598646
PK-59,5460769,5.2141758944681635
JHH-5,46907787,2.46563567325675
AN3-CA,11455910,0.3745394880525272
NCI-H1755,9936388,2.296070393599244
SNU-1079,10231331,-1.013778330631948
SUP-T11,selumetinib-JQ-1 (4-1 mol-mol),1.513032323882754
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
CAL-33,9936388,-7.915687157978736
HEC-50B,241158,5.355916764847489
CJM [Human melanoma],9903786,6.367293868352352
NCI-H322,selumetinib-JQ-1 (4-1 mol-mol),1.745335379225679
NCI-H1105,136227924,3.5995085606393955
HCC-56,439501,0.1637931010538502
SK-LU-1,3689413,-0.1029638587908799
SNU-407,11455910,0.0868474536937429
Ki-JK,107970,0.4876893584938715
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
BCP-1,135999136,4.224263765271161
BT 164,262093,1.918525006614416
WSU-DLCL2,136227924,1.92257757824623
M-07e,168313016,3.928570731388112
NCI-H2444,UNC0638-navitoclax (1-1 mol-mol),3.249927198416822
SW1088,11455910,0.1121601149091921
BT 239,156414,-0.3891739105228405
SF268,135421197,1.2829440642017702
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
SW1990,262093,3.247926984778252
A-673,241158,1.6738540084680422
NH-6,6852167,2.540209707487907
HCC2218,241158,2.2086061733116615
ACHN,73707398,1.6311925065880293
COLO 699,262093,2.601705972340985
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
COLO 205,9936388,-5.293351176311716
NCI-H727,6852167,3.356078560596427
Mel JuSo,241158,4.124736524200029
OE21,9915743,-2.7713034399639
MSTO-211H,9936388,-4.464575449065994
Kelly,135875424,1.72735348015212
NCI-H1838,135421197,3.0892223680095077
LNCaP clone FGC,4259181,1.1537445787746927
KP-2,444795,5.129804419457869
BL-70,156414,-1.981902345453731
DMS 273,637858,1.5802330029013405
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
MDA-MB-361,11455910,0.4388713413004988
LS411N,73707398,1.3643081745247092
HuT 78,6852167,0.2624976594092375
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
MDA-MB-468,44491742,4.175044772115959
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
KMRC-3,3689413,-1.603340065722176
A4/Fukuda,136227924,1.9204852137512072
HCC44,6852167,0.644523823911665
SF268,444795,4.01418198594817
SK-MEL-2,9927531,5.603550958927875
253J,54626689,4.340507469274858
Kelly,9915743,1.2517863913865832
NCI-H2087,9927531,4.212541441573842
BT 159,327653,3.49992313005632
THP-1,241158,2.136965411928187
FTC-238,107970,2.130291511736535
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
WM115,262093,2.5199436905866905
TE-14,12003241,-0.291419040743519
KMS-18,10231331,3.978934052597739
KMRC-3,UNC0638-navitoclax (1-1 mol-mol),2.633297765474324
NCI-H1869,156414,1.3059713748980704
HeLa,135999136,4.338563749387071
EoL-1,3689413,-2.5778346492897266
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
A-375,3689413,-0.7182003405560186
BT-16,100016,4.275534033025709
NCI-H716,46907787,-0.166954561973427
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
SNU-869,9903786,4.230852859752073
AU565,135875424,4.732736146663846
A2780,9927531,3.2712332494904226
SNU-685,9915743,3.119233801889696
ECC10,107970,2.546230477639249
Kelly,54626689,4.905487020799352
KMS-27,107970,2.0805071505254107
HCC2279,5460769,5.144403730026711
SET-2,5460769,3.4880653417656022
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
MOLT-13,375860,-0.4970846647186875
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697
MOLP-8,73707398,-1.5200522985211378
MOLM-6,9903786,1.0024208305438098
SIG-M5,439501,-3.273907668571148
NCI-H446,644241,3.4620716948259123
Lu-65,439501,-2.896459054469027
HCC2935,44491742,3.357572958697748
NCI-H2342,10302451,3.274408295183184
Jurkat,73707398,0.9750698244222464
HEC-1-A,168313016,5.702351892024658
HLF,135875424,3.96007520843582
KYSE-520,73707398,1.862286341397532
U-937,9915743,1.290945765650766
JHOM-1,135421197,1.641458342897405
GA-10,241158,1.1347612436603682
U266B1,100016,6.458228016262307
L-540,637858,1.6045529162646237
JHOC-5,49766530,-2.297129087448997
SNU-601,6852167,2.808936985877374
SNU-1214,168313016,6.364459074383153
KP-3,327653,2.831253990169757
HEY A8,73707398,1.040881676923852
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
MOLT-3,11455910,-0.1695088627496582
SNU-213,3689413,0.5464532854962126
KMS-18,156414,1.6699936447003676
OAW42,71466445,5.313769340389005
MOLM-6,71466445,1.8070039893626304
KMS-20,241158,1.964058176771948
MV4-11,selumetinib-JQ-1 (4-1 mol-mol),-3.212734853192351
ME-1 [Human leukemia],136227924,3.8385097232305103
NCI-H1395,241158,4.2689573120798165
K-562,644241,-4.86229706466587
JHOS-2,44491742,4.089494767364973
MG-63,44491742,4.049642181579157
TE-14,136227924,3.1216716097465365
KMS-20,24180719,3.3038292759957404
HCC366,49766530,-0.9103930727197836
GOS-3,6852167,4.136996914293619
786-O,136227924,4.54082640186513
Tm87-16,135875424,5.622886388921831
TE-11,100016,3.880053912311749
JURL-MK1,49766530,-0.182637071574771
BT 330,10231331,3.9874659396467793
OAW28,6852167,2.294169410796982
KMS-21-BM,24180719,3.968248733018151
BT 504,6852167,5.8705785953298255
DV-90,4259181,-1.0070098224756132
WM115,54626689,3.4845925362433
DV-90,73707398,0.6212142210484521
8305C,135875424,4.357413208917153
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
KYSE-70,6852167,2.2981101713941814
SW982,selumetinib-JQ-1 (4-1 mol-mol),3.3517984322180383
TE-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.912232615684107
JHH-4,12003241,-1.7562385090138668
NCI-H1694,241158,2.045684471014548
NCC-StC-K140,5460769,0.9709750837193912
SH-4,100016,6.480724052638794
T24,135421197,1.5767187843599464
MOLT-3,46907787,-1.1708174424731892
BT-16,11455910,0.4164616318960097
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
BT 139,9903786,4.553274987644657
U266B1,4259181,-0.6063493010445111
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
SCC-25,12003241,-2.271238083973026
COLO 678,9936388,0.9023900644309476
THP-1,73707398,0.2816477508362379
8305C,44489367,5.521143258806751
ESS-1,262093,3.0427773228942057
DU145,9927531,4.922928089289864
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
BT 444,136227924,3.5279486847576886
MOTN-1,UNC0638-navitoclax (1-1 mol-mol),1.0336260327177484
TE-11,375860,-0.5681056358976869
MCAS,3689413,-1.1400919247426515
NCI-H2081,3689413,-0.989992552174664
RERF-LC-Ad1,107970,2.434538597740863
BxPC-3,6852167,2.5268139587107754
LNCaP clone FGC,168313016,4.233748238876194
SK-LMS-1,5460769,5.744937264039862
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
Karpas-299,136227924,2.4546473500331576
AU565,73707398,1.1644887368044523
JHH-1,6852167,3.051302168376451
HeLa,439501,-2.848382287027866
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
RD,439501,-3.401030731559912
BT 239,44491742,3.7318422225870753
SNU-1,439501,-3.7780257252431126
NCI-H838,107970,3.016331313127053
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
NCI-H1694,11455910,0.2193513858726209
JHUEM-2,11455910,0.0999331855360444
RMG-I,selumetinib-JQ-1 (4-1 mol-mol),0.9170400407627758
RL95-2,10302451,2.0027308413664735
DMS 53,9936388,-3.9040655164911686
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
MIA PaCa-2,5460769,2.8270884799697833
MV4-11,168313016,3.2115112435982356
SNU-886,9936388,-5.3251547250946825
Capan-2,10302451,3.148442090803562
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
NCI-H1838,9903786,2.204739159527363
SUP-M2,26596,-3.767571298105125
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
NCI-H2110,136227924,4.625762146403413
HuP-T4,11455910,2.9391845361778532
CAL-120,9915743,1.5300357462743028
HPAF-II,5460769,4.759612134982938
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
K029AX,136227924,2.929460109593454
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
CA46,11455910,-0.2967360934235351
GCT,11396600,3.3936538094375317
CL-11,327653,3.118050165737185
COV362,637858,3.021486989132716
NCI-H1792,12003241,-0.2343490439085071
NCI-H1793,262093,3.818681600610628
SK-MM-2,9936388,-2.43514787246578
NCI-H1666,241158,3.305487854480141
SK-ES-1,46907787,2.445669024708645
LP-1,444795,7.002761969822617
U-937,44491742,3.930782705930826
ONCO-DG-1,439501,-2.5478488812484015
MOLT-16,44491742,3.707485326024471
NCI-H1944,5460769,2.8815728712933533
MIA PaCa-2,26596,-1.1158295610303952
HPAF-II,439501,-2.2531231348817715
Kelly,241158,3.0916607727606333
COLO 792,12003241,-1.2493881793514412
U2OS,136227924,2.232158663555595
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
Daudi,135999136,4.063293138043838
EFO-27,107970,2.9901836608736883
BT 440,11396600,2.3245110777445728
OCI-Ly19,156414,2.045097094802914
Fu97,10302451,2.984278073549712
NCI-H747,6852167,2.2192552845643148
BxPC-3,262093,3.443903516481154
HOP-92,156414,1.5048646511910324
253J,100016,6.267948749211356
BT 416,71466445,4.968371844164254
SNU-503,3689413,0.9941235992839832
MDA-MB-157,4259181,-0.4671059045276012
BT 444,selumetinib-JQ-1 (4-1 mol-mol),0.8524514153938803
HCC1806,26596,-2.125787428122878
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
KCL-22,44489367,4.535057133024572
F-36P,136227924,2.476842028434826
SK-MM-2,9927531,3.423086236737343
ALL-SIL,73707398,-0.324762560862376
BT 330,9915743,0.5029117023680005
HPB-ALL,644241,3.355304143351822
OCI-AML-3,637858,0.7817011573177973
HuP-T4,selumetinib-JQ-1 (4-1 mol-mol),-3.5462201060588714
IGROV-1,73707398,0.8848064516600974
IGROV-1,375860,0.7731558163124775
NCI-H1693,49766530,-2.9408096951220384
SCC-25,11396600,2.765145835118827
TE-14,262093,3.712272001874861
BT 359,4259181,0.9043427030240666
OV7,9936388,0.389883949605854
NCI-H526,241158,3.603489043441015
KO52,444795,3.710694398794004
KALS-1,241158,1.844994871137429
SNU-119,BRD-K27188169-navitoclax (2-1 mol-mol),3.038273734124671
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
VMRC-LCD,11455910,1.1166938549694674
G-402,9936388,3.284430890401921
LCLC-103H,12003241,-0.4608233539243975
PaTu 8902,136227331,5.567107594748722
FTC-238,44491742,5.664145193267726
BICR 6,637858,2.1920881342545773
OS-RC-2,3689413,-2.40669101710066
DAN-G,selumetinib-JQ-1 (4-1 mol-mol),2.3069493601380056
L-428,10302451,3.6101692915617303
SH-10-TC,3689413,0.5157614607297105
SH-4,136227924,2.5718168505003693
NCC-StC-K140,44491742,3.703030524506224
SNU-1076,73707398,1.2464040742464415
DV-90,327653,2.8172961812508057
OVSAHO,46907787,1.5644430729796035
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
KYO-1,262093,2.3511585107741286
OV56,637858,2.2925900158017747
KMS-20,11455910,0.7957422642794928
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
HCC827,49766530,-2.1224128504974207
KNS-62,10231331,3.3757174650978534
CAL-33,637858,2.2822409220674085
COLO 678,6852167,2.6711614029982265
SNU-869,135875424,4.845035654060252
HPAC,135999136,4.37957376504402
JHH-4,262093,3.0993355303406305
U-BLC1,selumetinib-JQ-1 (4-1 mol-mol),-1.24963956980548
IGR-39,UNC0638-navitoclax (1-1 mol-mol),4.155621356761579
PLC/PRF/5,135421197,1.8500736721187756
A-549,49766530,0.1688758689952186
DOV13,136227924,2.864785745195549
BT 330,11455910,-0.0355958099114693
A3/Kawakami,11396600,1.9424572968751193
BT 216,46907787,3.9063812539976386
G-401,6852167,1.9492633511801831
SNU-398,10231331,-3.488148641094839
Hs 683,3689413,-0.4207741938701824
BT 482,12003241,-1.3288470463834767
KP-4,444795,4.300956807365333
TTC-709,11396600,2.7906512267667325
CAS-1,135875424,5.317066072752183
COLO 668,107970,1.5128822355273368
SNU-1214,3689413,-0.7711373431609502
AN3-CA,46907787,4.249089743528786
NCI-H2085,49766530,1.4049840507927902
DK-MG,49766530,-2.542495237652574
L-1236,9936388,2.483385835901907
LN-18,136227924,2.6730717807576347
KALS-1,46907787,2.274678241554836
NCI-H2110,5460769,2.6451142093153326
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
REC-1,4259181,2.258839706285654
NCI-H2291,4259181,0.9093114252123392
KYSE-520,10231331,4.442298950853209
U2OS,49766530,3.607044221214865
Daoy,73707398,0.9018089005014748
SK-MEL-28,4259181,1.166453283270818
A2780,10302451,4.067201499125142
BT 139,135875424,2.659641868559938
DU4475,107970,1.5675398019585955
ECC10,BRD-K27188169-navitoclax (2-1 mol-mol),-2.5242626143168234
HGC-27,73707398,0.4589955363470999
SK-MEL-31,46907787,2.8803714607156707
ES-2,12003241,0.0508402342945085
HCC1395,49766530,0.1887726422432668
EPLC-272H,135999136,5.477096530832568
OCI-AML-3,135999136,4.040843396784286
PE/CA-PJ41 (clone D2),168313016,6.324441458081494
NCI-H211,3689413,-2.259187530744643
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
L-363,100016,4.553463106890726
OAW28,439501,-0.9322268226633188
EFO-21,637858,3.247378970072765
JeKo-1,10302451,3.7878208830718862
8-MG-BA,107970,3.159598521099513
MM1.S,73707398,0.3713750235386087
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
TE 617.T,49766530,0.7219936029633269
HT-144,44491742,3.9121735247647127
MKN74,4259181,1.058479464010789
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
NCI-H1563,4259181,1.88971359243236
NH-6,136227331,4.3480381735805365
T24,241158,4.612211727096444
NCI-H727,107970,3.133468251114326
NCI-H1155,156414,1.1883560015419388
NCI-H358,135999136,4.377326657668253
DMS 273,168313016,5.378851860414917
Hep 3B2.1-7,6852167,2.3004574615198656
NCI-H441,100016,5.015174861435744
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
HSC-3,5460769,0.5796773846600773
LOX-IMVI,46907787,-0.948054839108756
Rh41,10302451,3.6529049739678983
TE-6,9903786,2.448917190367821
OC 314,4259181,-0.1098665144334052
TF-1,12003241,-0.8942649772523563
HEC-6,327653,3.024082416501414
SNU-213,135421197,2.2792835673188687
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
BT 147,9915743,2.5746757141413887
SNU-878,107970,2.6977452614918507
OE33,3689413,1.522493576982794
SR,5460769,1.487017062685354
EFE-184,644241,2.502750657538877
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
IGROV-1,46907787,2.182756719431072
Ri-1,71466445,1.3498732213426647
NCI-H1568,637858,1.7833024505225796
NOMO-1,136227924,2.5449106490851263
U-937,135999136,3.69419410967262
HCC-56,4259181,1.2024907271901706
NCI-H1092,44491742,3.604656167614849
SW579,selumetinib-JQ-1 (4-1 mol-mol),2.10914043341792
SK-MEL-5,71466445,2.1269711311282373
M059K,444795,5.032881715947493
HuG1-N,73707398,1.3800802205290363
PK-45H,135421197,3.006684170238441
HT-55,11396600,3.0966663667884595
HSC-3,selumetinib-JQ-1 (4-1 mol-mol),1.0715718666689311
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
ZR-75-1,4259181,0.5908023263806823
NCI-H2081,136227924,2.7498424735477913
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854
Mel JuSo,4259181,-1.462450394836602
MOLT-3,24180719,3.6183770994691553
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
HCC1195,107970,3.035088271235786
NCI-H841,5460769,2.2001101436907984
L-540,selumetinib-JQ-1 (4-1 mol-mol),1.2043338237829615
TE-14,3689413,2.902593123647125
IGROV-1,71466445,2.3758001916617797
BICR 6,selumetinib-JQ-1 (4-1 mol-mol),1.6625006001600495
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
Hs 936.T,4259181,0.7907782963904789
SF268,71466445,4.871894724490201
SK-N-BE(2),54626689,4.321914900057883
WM1799,327653,3.531373142867038
HCC95,73707398,2.1605697712261263
Rh41,49766530,-2.538268095723461
UACC-257,24180719,0.7888376417050607
GI-1,241158,3.946291763915852
BT 179,73707398,1.5883061850934768
NH-6,10302451,3.668750555789657
NCI-H2029,71466445,4.409186865297714
SCC-25,4259181,-0.0888101612247617
SJSA-1,156414,2.20247372262641
SK-N-AS,156414,1.537017755514308
PK-45H,49766530,-0.0429860028998506
DBTRG-05MG,24180719,1.884339703884815
A-204,46907787,0.8434762218045947
KE-39,262093,2.516325504276674
KMS-21-BM,262093,1.4735879820093536
B-CPAP,5460769,4.36425483182296
OCI-AML-3,10302451,3.3891751896775655
NCI-H1339,10302451,4.201130344992501
NCI-H2170,135421197,1.5856670633650565
KE-97,26596,-2.711610546447418
NCI-H2141,44491742,3.797452560506029
HuH-28,4259181,0.9633418141408334
SNU-C2A,selumetinib-JQ-1 (4-1 mol-mol),1.4067421274631011
KMRC-20,10302451,3.571501385736242
CAL-85-1,54626689,4.572937409511515
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128
SNU-C1,3689413,-0.1776191587992591
BT 131,3689413,-1.953613680223501
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
MeWo,107970,1.9752107373732688
NCI-H211,444795,1.3932572861204826
NCI-H2228,11455910,0.4514463057977056
SUP-HD1,375860,-0.581820779838327
NALM-6,3689413,-1.8173610448442752
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083
SNU-1079,4259181,0.5490184048770516
KYSE-410,selumetinib-JQ-1 (4-1 mol-mol),1.899201390217913
Pfeiffer,107970,1.4317635231254673
NCI-H2228,9927531,4.856676083567804
KM12,439501,-0.9697085854354284
SNU-1196,4259181,-1.0865264109218773
TTC-709,5460769,-2.125391207652167
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386
SNU-1079,136227924,2.5648904820695693
BHT-101,136227924,2.4401355841785173
SNU-C1,9936388,1.0138657245137583
SNU-387,9936388,2.7868328011584924
Hs 934.T,262093,2.035260189129304
Hs 888.Lu,49766530,-2.122811696802074
DU145,54626689,4.459868591961446
A-375,135398744,6.486116496095493
TOV-21G,444795,4.92534522275514
TOV-112D,11455910,-0.1683002015136989
Karpas-422,107970,2.1264000948746555
LOX-IMVI,49766530,-3.939815107547984
TC-71,54626689,4.535760169083424
NCI-H650,73707398,1.320339059501373
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
WM793,11455910,1.0189470974054349
Hs 578T,12003241,-1.9219753364875385
NB1,26596,-1.7417489155233454
JeKo-1,24180719,3.9921486226338536
Karpas-422,135999136,3.6937273176122294
ST486,44491742,3.1941323124879393
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
SUIT-2,12003241,-0.3419407469483631
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499
NALM-6,107970,1.8699252038348184
DU4475,9927531,3.2558531780718507
SaOS-2,136227924,4.496792726095474
COLO 792,10231331,-1.289578148322008
SNU-C5,136227924,3.8791329718590264
KYO-1,444795,4.725029182648668
KM12,262093,3.385023533358405
SNU-761,327653,2.9832598132977495
MFE-296,136227924,3.1639946768284672
KP-2,54626689,4.554618285215139
NCI-H2452,73707398,1.4673083704761625
HOP-92,10231331,1.6069626352375108
KYM-1,selumetinib-JQ-1 (4-1 mol-mol),-0.2216165227125683
P12-Ichikawa,100016,6.391056060940552
SW1990,54596490,5.639139126471044
BT 330,444795,4.463557334125424
TE 441.T,6852167,2.229580798352396
DND-41,9936388,0.9439294041019026
UO-31,327653,3.5092493872896666
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
TCCSUP,11396600,4.109332889227832
SNU-601,49766530,0.5786542106679428
647V,9915743,0.3723955679086398
OPM-2,11455910,0.7503761469114726
LN-229,439501,-1.7560244035844634
NCI-H1703,375860,-0.6025431335029626
Kelly,11396600,2.808288398090548
SCC-25,241158,3.0649196018080653
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
NCI-H211,9929138,5.380776985298909
MKN74,9915743,1.5544684592006026
C2BBe1,72967,3.7345422437876254
CAL-51,71466445,4.7818956768695715
RMG-I,4259181,0.9732462035277308
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
B-CPAP,11396600,0.7084279408075309
SNU-1105,241158,4.64343596184443
Hs 729.T,9927531,5.3265551472820425
OE21,136227924,2.0991161235844404
BL-70,11396600,2.443517551582617
OAW28,24180719,4.377592888188756
TE-15,selumetinib-JQ-1 (4-1 mol-mol),0.3530631195710951
DMS 454,168313016,5.4433694832060775
NCI-H2087,4259181,-0.0076353302505686
LN-229,73707398,0.9368457509516706
KALS-1,135875424,3.665008490823154
SNU-216,135421197,1.0326096520006542
NCI-H1734,12003241,-3.2634619258307644
TYK-nu,4259181,0.6188832613269896
P12-Ichikawa,135421197,0.8700527660051071
SNU-398,375860,0.3424290745203647
SNU-449,439501,-4.772752939359215
SK-CO-1,168313016,6.229837204453753
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
OE33,6852167,2.347290735103793
KMS-18,135875424,3.1558215727233208
BICR 18,24180719,3.746417357849833
NCI-H1155,11396600,2.7094100495435165
SIG-M5,46907787,-1.5125615192651995
NCI-H747,10231331,-2.435318484527335
JVM-3,9936388,-6.226344313547517
SNU-601,100016,6.491707225104745
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383
TE 617.T,3689413,-0.0312016851133043
MDA-MB-361,4259181,1.4337162255627849
LOX-IMVI,107970,2.2116293322990264
GMS-10,327653,2.705235188100399
SF295,6852167,3.343016827643526
TC-71,11396600,3.405164109661843
KCL-22,135875424,3.663318576460465
SW1417,6852167,3.2987198824651105
COLO 320,44491742,4.01582606797262
NALM-6,135421197,0.6704764022840549
HDQ-P1,UNC0638-navitoclax (1-1 mol-mol),2.4376644367097917
KMS-20,54626689,3.7959086868633016
AsPC-1,4259181,1.083384461798112
ONS-76,136227924,2.542073211711186
BL-70,3689413,-1.0284037004933524
SR,107970,1.7321639087061549
IST-Mes1,136227924,2.313131576565863
DK-MG,135999136,2.1309073421912075
WM1799,107970,2.5287793754876464
Hs 944.T,3689413,0.6165521340275051
B-CPAP,107970,2.366266521836174
Hs 940.T,156414,1.05658076311892
NCI-H292,54626689,4.661071465435288
IGROV-1,9929138,6.483056540257463
OAW28,168313016,5.164256635335989
SK-ES-1,375860,-0.8114646343622277
HCC4006,3689413,-2.273135078427732
Calu-1,54626689,4.5858763156654065
SNU-398,262093,3.8749654719100186
CAL-78,6852167,2.8425857780730936
NCI-H647,6852167,1.3113478854499263
OVK18,11455910,-0.0430501401536957
SCC-9,4259181,1.940043087837339
BxPC-3,135421197,1.4419000032460958
CCK-81,3689413,0.410216547608945
DEL,26596,-2.2766928538396916
KYSE-70,4259181,-4.187670573846372
MOTN-1,3689413,-2.530735206047899
SH-10-TC,107970,3.078551044723764
A4/Fukuda,11396600,-8.215434514364686
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
A2780,439501,-2.4090624878410316
NCI-H1694,262093,1.281080897473335
Ci-1,375860,-0.2191044108092374
T-47D,135421197,1.1997772280694294
BT 187,100016,7.76208292164505
BT 320,107970,2.3152930812829497
HT115,10302451,-0.0451065093220725
23132/87,12003241,-0.6974968916735146
Raji,241158,1.7953871388242486
GI-1,3689413,-2.447824191080865
LC-1/sq-SF,262093,5.279467675468132
HEC-251,637858,1.281363109758873
Hs 766T,11396600,4.535282068757712
OE21,24180719,4.795188480973195
CMK,73707398,1.0162249456833987
MKN74,135421197,1.917095385489804
MV4-11,26596,-2.2629821538239576
EPLC-272H,24180719,3.216245725397228
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
TALL-1 [Human adult T-ALL],135999136,1.718285852306641
G-361,375860,-0.1039366462277599
MOLP-8,10302451,3.559537910744256
ACHN,12003241,-1.5952093864502457
KYSE-70,135999136,5.194226724950964
KE-37,107970,1.5802988637404825
Li-7,10302451,2.1466540090014994
NCI-H1581,12003241,-3.141909657100737
A-673,136227331,4.241984110268528
PLC/PRF/5,9903786,4.947267974127204
SNU-308,10302451,1.9995275040024083
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
NCI-H747,73707398,1.0948410901239818
DOV13,6852167,1.6285837488742436
BT 239,6852167,2.2833850419098116
Panc 03.27,637858,2.5511694826514204
TE-10,439501,-2.523220580930317
PLC/PRF/5,4259181,1.1684219933563562
RMG-I,135999136,4.313972565447826
PC-14,26596,-1.584314299248499
OVCAR-8,135421197,1.5864277094483568
A2780,71466445,2.121500658196736
SEM,4259181,-0.7975863762048068
MOR/CPR,46907787,3.5743081695315255
KG-1-C,107970,2.049328219906487
SNU-182,4259181,-0.711046785415259
KATO III,selumetinib-JQ-1 (4-1 mol-mol),2.3824011664462117
LK-2,selumetinib-JQ-1 (4-1 mol-mol),2.330503945113565
OCI-AML-2,439501,-2.945157705835344
KATO III,71466445,4.418751574312434
SW1417,439501,0.2964546756721697
CFPAC-1,9936388,2.1130645315651444
NCI-H1915,4259181,1.4857184154845886
42-MG-BA,135421197,1.023186017239741
Mel JuSo,selumetinib-JQ-1 (4-1 mol-mol),0.9282438421968175
NU-DHL-1,9903786,2.0090459538270298
NCI-H146,4259181,0.4591034911128469
REC-1,3689413,1.860618150322578
SNU-466,9903786,3.45397809087946
LN-18,9929138,4.994470479876054
NCI-H1838,selumetinib-JQ-1 (4-1 mol-mol),-0.1713397125245971
NUGC-4,3689413,0.1501840734639977
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
NCI-H1341,168313016,4.195064479213196
VMRC-RCZ,49766530,0.1680653140003736
EFE-184,11455910,1.1766265020277265
CAL-29,241158,5.118479967388945
UM-UC-1,9903786,1.5514700820318568
IGROV-1,9915743,-0.4757488934941289
K-562,4259181,-0.7813149193344907
NB1,4259181,-0.7936923568602017
NCI-H1355,11396600,3.5209515786022156
NCI-H292,10302451,3.577296661602114
F-36P,135421197,1.230502256000523
647V,UNC0638-navitoclax (1-1 mol-mol),4.619302704924987
TF-1,9927531,3.351583098746858
NCI-H1792,439501,0.6605330204311965
F-36P,9927531,3.277951098444252
UM-UC-1,327653,3.640505495969521
PaTu 8988t,637858,2.5993481939897314
EBC-1,9903786,3.237672392939453
OPM-2,135875424,2.796643273298537
SNU-C5,9915743,1.1022150159535518
K-562,11455910,-0.068399521398108
SK-N-DZ,6852167,3.0525681043394055
BT 228,49766530,0.5150432807946567
COV644,136227924,2.3380958896938147
AML-193,100016,3.9854178308912074
SYO-1,637858,1.9757755479199952
SK-N-DZ,12003241,-0.5399118336559388
A-172,3689413,-0.4114318334262174
Hs 936.T,241158,4.073902447809716
MFE-296,107970,2.24229394331556
HEC-1-B,9936388,1.5004168586274125
NCI-H1435,9929138,6.22270971673178
Rh30,12003241,-2.0054573943466876
OAW28,9915743,2.8675584787684456
PC-14,10302451,-1.9208505295158915
CHP-212,135421197,1.019713131092093
Jurkat,241158,3.2047640771704953
SNU-685,135875424,4.288569640305719
BT 340,10231331,4.137603645680791
Karpas-422,262093,3.033308575813637
BT 145,11396600,1.7169241977244534
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
Karpas-422,71466445,2.788648588655379
OPM-2,439501,-4.648238189793765
HT-29,135875424,4.223622397781982
HCC1171,10231331,1.1298251907359
HEY A8,12003241,-2.767500133031125
OVCAR-5,selumetinib-JQ-1 (4-1 mol-mol),-2.399030765208003
SU-DHL-8,375860,-0.3507557955455605
SNU-1,UNC0638-navitoclax (1-1 mol-mol),2.6940797475374874
IGR-1,54596490,6.338760759181102
SEM,9929138,6.8273209917060145
NCI-H661,11396600,4.301216087095742
BT 239,3689413,-0.6991113979789645
HCC1833,135875424,4.246764438360678
NU-DHL-1,73707398,-1.134131669743868
RMG-I,12003241,-2.7782598646997414
LOU-NH91,6852167,3.2671273023515934
Granta-519,241158,3.1692083740262373
UACC-812,49766530,0.2629782697340875
G-292 clone A141B1,9936388,-5.3493608745804515
NCI-H2110,375860,0.2017557628381111
JK-1,637858,1.1553498236077802
OAW42,135421197,2.0874020814941643
OCI-Ly10,637858,2.6828928934608176
BT 286,107970,1.9511501669936515
YKG-1,9927531,5.706988241233545
EFO-21,107970,3.0231101472169186
NCI-H1341,439501,-2.6104164072221168
RERF-LC-MS,54626689,4.221264321270605
SNU-1076,3689413,-0.3890418815015654
T24,262093,3.3703165306256353
CJM [Human melanoma],241158,4.277707149827287
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
NCI-H2141,9915743,0.5832119024567368
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
NCI-H1341,UNC0638-navitoclax (1-1 mol-mol),-1.6565118719167296
SNU-182,241158,3.9105215752620457
KMS-21-BM,637858,0.4852193372876609
SUP-B15,9915743,0.9578532779585308
Namalwa,637858,0.9589719241333216
639V,4259181,-1.1387945846031091
OVSAHO,10302451,4.086009367153599
NCI-H1339,46907787,4.303951587914797
SNU-16,136227924,1.93853165721534
MOLT-13,107970,2.070591581633897
Caov-3,10302451,2.9252761280004513
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
A-172,637858,2.4052176402069514
BHY,6852167,2.688170131060443
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
Panc 02.03,5460769,1.6540560754425335
MFE-296,156414,1.6336035535804103
LP-1,375860,-0.2769324190070452
SYO-1,73707398,0.9065821405188256
EJM,156414,1.801807158025587
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
NCI-H211,9903786,1.4038112191361545
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
KMRC-2,11396600,3.609897485717139
MOLP-2,107970,2.110185420834163
Hs 578Bst,327653,2.576828219762845
VCaP,46907787,-0.7712669618246023
SK-MEL-24,135421197,2.6941455652105852
JHUEM-7,46907787,-0.7019339701280191
NCI-H1299,439501,-2.475221299124019
Fu97,262093,3.1812015946879924
SUP-B15,637858,1.0348461342218127
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539
Li-7,9927531,4.31523724383209
AU565,4259181,-0.781957409712965
JHH-5,644241,1.6912278541244328
PaTu 8988s,241158,4.442566432866993
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
NCI-H2286,10231331,3.958797115295856
RERF-LC-Ad1,9936388,2.559895364863056
NCI-H838,46907787,4.142158924634486
DAN-G,26596,4.046660448506208
BV-173,54626689,3.8645614476813406
MCF-7,136227924,2.325387172028071
OCI-Ly3,136227924,2.2750950031645885
P12-Ichikawa,375860,-0.9657726988428024
BT 216,100016,6.740671439747835
NCI-H526,100016,5.298819017471169
KP-2,262093,3.513459327352711
GSS,11396600,2.8148513524153005
Peer,71466445,1.396276268518125
LS123,46907787,4.6171834590437015
SCC-25,selumetinib-JQ-1 (4-1 mol-mol),-1.3511560119840642
HuG1-N,637858,2.4963852514993268
GOS-3,49766530,-1.0492623989714644
BT-20,54626689,4.5259843221506655
KP-3,12003241,-0.3092638329597765
HDQ-P1,135875424,4.477728258448439
SNU-668,637858,2.2358105014096914
KMS-27,327653,2.9836297632664905
BT-20,439501,-1.326762104121763
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
KP-4,107970,2.3974989228996586
HCC1833,439501,-1.5774129771640248
SU-DHL-8,9915743,1.1928625100006218
SET-2,107970,1.5950786133470078
Jurkat,375860,-0.5267502714106769
GDM-1,9915743,-0.2522404028033351
BICR 18,26596,-0.934766780366006
A2780,644241,1.9281614760038184
BT 145,168313016,5.801537598068537
RL95-2,5460769,2.3147567331395753
HCC827,12003241,-4.000089472829944
BT 248,107970,1.564508535325896
SH-10-TC,54626689,4.603655677944001
COV434,44491742,4.086933897953946
HCC1143,168313016,5.718985268806146
U-118MG,5460769,3.4252823056372845
HCC1833,selumetinib-JQ-1 (4-1 mol-mol),2.357049659281798
NCI-H1373,3689413,-0.1033910947263759
MOTN-1,4259181,0.2801438460901613
LS123,135421197,1.188222873463802
Hep 3B2.1-7,327653,3.179957662955071
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
ECC10,10302451,3.62041349864807
NCI-H1373,135398744,6.356905852078599
HSC-2,241158,3.065705859569923
OCI-M1,637858,1.0895726887378772
CAL-27,637858,1.966992675721693
GDM-1,375860,-0.386730724119011
CHP-126,26596,-2.268724327317824
YD-8,135999136,6.481795126986557
HD-MY-Z,644241,1.5083011664495825
HT-1080,136227331,3.9777239464002223
SNB-75,9936388,1.911669139874388
L3.3,135398744,6.452563021638662
HuP-T3,9936388,0.6940852338085793
SNU-1,444795,5.8199745249535635
EHEB,BRD-K27188169-navitoclax (2-1 mol-mol),5.0776573503309
8-MG-BA,135999136,1.4343313230693755
CJM [Human melanoma],439501,-2.3505582983790076
F-36P,10231331,0.4784045802967716
PK-1,637858,2.636074428434348
EFM-192A,46907787,2.276348372522029
NCI-H2291,UNC0638-navitoclax (1-1 mol-mol),0.0684358892424717
TE-14,11396600,4.264622215416366
IGR-1,327653,3.4717478303608655
JHOS-2,637858,2.236950440158482
NCI-H1092,439501,-3.60207444945155
SW1088,327653,3.9714894457937566
RPMI-6666,327653,3.501914206867195
NCI-H1869,46907787,2.861559973778754
WM983B,44491742,4.283339353588083
DMS 273,262093,2.141936221481062
Malme-3M,637858,1.926036953910112
SUIT-2,4259181,1.8331520084863369
J82,100016,6.509431143115434
NCI-H2087,BRD-K27188169-navitoclax (2-1 mol-mol),2.996002246582284
SKM-1,135421197,1.6359213938027426
SW1116,9915743,-1.8123899004443464
KHM-1B,9903786,1.5275790345873377
SW579,26596,-1.623870534815972
SW1417,135421197,1.3555171655865843
NCI-H322,100016,6.362238943247445
SW1417,9903786,3.296338786408906
MKN1,444795,6.668552685441613
NCI-H1650,49766530,-2.350106011815308
KE-37,3689413,-1.780022958661614
OCI-Ly19,6852167,0.0969280373931757
KYSE-180,136227924,3.113518519432139
SNU-738,135875424,5.435883526808027
NCI-H226,11396600,3.8487542891861697
MV4-11,135999136,3.817952088116468
TC-71,135875424,2.7755794314588105
T98G,107970,3.0789596512237978
CML-T1,3689413,-2.671933251411637
KMS-27,49766530,0.6819698946698491
YD-10B,6852167,1.0320503365922948
NCI-H1355,49766530,-0.7127402307257245
NCI-H322,3689413,3.1405279208224086
HCC2279,6852167,3.124713547621625
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
SU-DHL-1,3689413,-2.511818154735677
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
SCC-25,10231331,0.4590527217191406
NCI-H1105,9915743,0.8862915101567481
GSS,44491742,4.082096433494501
SU-DHL-8,6852167,1.4339874618826112
NH-6,3689413,-2.319645843981955
SK-N-MC,136227331,5.402807013617019
MV4-11,637858,-0.472794507161154
SNU-489,9936388,2.9211262102294246
KG-1-C,11396600,4.230481509625587
NCI-N87,327653,3.392428289503534
J82,10302451,4.267907491334314
SNU-216,46907787,3.852045832322763
Toledo,9927531,3.803347409887559
Granta-519,26596,-3.6955660538224784
HCC1954,136227924,3.208934620428715
KMS-12-BM,4259181,-0.5634255522920182
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
RL,9915743,1.6730730266381315
Daudi,4259181,-0.0890599021012781
OVCAR-5,4259181,0.5065591256292203
CFPAC-1,46907787,2.402933014882264
SNU-119,6852167,1.9740525769719148
22Rv1,100016,5.084356097831624
DEL,9936388,-6.471933624576076
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
IGROV-1,168313016,4.807199318661473
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
NCI-H1915,10302451,3.466946799076096
Hs 766T,6852167,2.9738525518639425
NCI-H526,327653,2.6188673903561805
U-BLC1,12003241,-2.3919609664555543
KP-2,6852167,2.748552445152737
NCI-H226,73707398,1.9043471909706144
NCI-H1573,11455910,2.1224271669039902
NUGC-3,262093,3.0230092898812484
TC-71,UNC0638-navitoclax (1-1 mol-mol),4.936257961765979
Hs 729.T,241158,3.68166010418192
HEC-251,135875424,3.4387509729179913
RL95-2,136227924,2.901366933043705
TE-1,107970,2.027205986063941
MDA-MB-361,UNC0638-navitoclax (1-1 mol-mol),1.8233267611349624
AMO1,9903786,2.4699152046705253
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
BT-549,136227924,3.266068806496957
NCI-H1838,9936388,2.03456358859775
RPMI-8226,26596,-3.5550255900749623
H-STS,327653,2.5353230161110014
Hs 729.T,4259181,0.497890264731072
DEL,9903786,1.8347897300097875
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
MOLT-13,241158,1.68385615274184
Pfeiffer,selumetinib-JQ-1 (4-1 mol-mol),-0.1055669472599887
TCC-Pan2,135421197,1.46026769574307
BT 228,135999136,1.184789757824171
HL-60,375860,-0.428675793220051
HCC1428,11455910,0.3865695172976586
EB1,136227924,2.1314721571590876
DEL,241158,1.6743881940862215
DAN-G,3689413,2.9814511815134943
YAPC,4259181,0.8211273757017798
PK-59,637858,1.5777202295297317
HT115,4259181,-1.337170717880476
COLO 792,UNC0638-navitoclax (1-1 mol-mol),-0.6661800226482624
HOP-62,100016,6.313498249886369
BT-549,9915743,2.34179420613382
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
TE-5,9927531,4.466928464790859
NCI-H2444,44491742,4.369311972266699
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
UO-31,375860,-0.3911745062364136
PE/CA-PJ41 (clone D2),11396600,3.63156445822279
SF539,6852167,2.369096859709367
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
OCI-AML-3,71466445,1.081217761566199
OV7,9915743,1.7839177837721256
KYSE-150,11396600,3.904935557523132
NCI-H522,168313016,4.366007701234683
SaOS-2,135421197,3.6760992974277817
KMS-28BM,12003241,-1.6881209255451883
EN,9915743,1.169812706824078
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
DMS 454,71466445,4.510372203594112
NALM-6,100016,5.173644166821544
BT-16,168313016,4.373316472356694
AsPC-1,136227924,3.2025742465891938
Capan-1,135875424,5.030307204242131
BV-173,12003241,-5.971697113356734
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
RT-112,6852167,3.1370975355387825
KYM-1,100016,6.934049900113359
A-172,135421197,2.0454281917849357
OCI-AML-3,73707398,-0.3023697675289024
SK-MES-1,375860,-0.2426900588796581
NCI-H2172,9929138,5.835125788077067
NCI-H2196,9936388,1.3718542945695429
HCC1569,135875424,2.981320238705361
SUP-B15,73707398,0.0543063600854058
SNU-16,375860,-0.954947659547355
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
EPLC-272H,11455910,1.2178341739631082
Hs 766T,262093,3.5846417811943514
HPAF-II,107970,2.753042652639578
LCLC-97TM1,9927531,5.703886109604247
NCI-H1693,11396600,3.0020537778987286
HT-1197,46907787,2.8838222010198975
CAMA-1,24180719,3.6789207527484127
BT-12,375860,0.1600757407844332
MOLT-3,12003241,0.5652275410160802
KE-37,5460769,2.542918791182312
SCaBER,4259181,0.8939054398138756
EHEB,107970,2.1350318268920776
SNU-1196,107970,2.4988255258778764
KYSE-450,439501,-3.185322034462323
CAL-51,12003241,-1.2189714227076325
COLO 205,107970,2.370802122352658
SNU-899,637858,2.6573033243386948
NCI-H929,12003241,-1.2414676879861424
COLO 205,9903786,2.133695985637416
22Rv1,375860,-0.0627055235915324
CAL-85-1,73707398,2.240426052352089
OUMS-23,4259181,0.3066462533812187
G-361,444795,4.573428611348007
NCI-H2444,54626689,4.646993110224464
NCI-H1650,3689413,-2.359636469082647
BL-70,9903786,1.6201088809137068
8-MG-BA,135875424,3.2007214055219144
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
SNU-213,24180719,4.112073754783821
PE/CA-PJ15,12003241,-2.2005242909151668
ST486,9936388,-7.5497220296798275
Peer,9936388,-7.0845020379788375
TE 441.T,637858,0.3313302982061412
DMS 53,11455910,0.8364370230272622
OVCAR-8,9936388,2.326713990957197
LoVo,4259181,0.2045859597859785
JHH-2,24180719,3.6723733137319705
SU-DHL-8,44491742,4.1577476289633
B-CPAP,444795,4.737983928137852
HuT 78,241158,3.345962703014529
NALM-6,12003241,-1.6085171342218008
KYSE-410,54626689,4.470007741978822
SNU-869,9927531,5.42388661469149
ST486,3689413,-2.784671548878338
SNU-1214,327653,3.7315085171271742
MHH-CALL-4,44491742,5.077124852247723
RERF-LC-A1,135875424,3.889170235593284
SUP-B15,10302451,1.4777499767205602
KYSE-150,100016,4.009775484830176
SK-MES-1,136227924,2.193847007439744
GSS,136227924,2.0459518542117983
NCI-H2122,9936388,-2.3512808318812555
SUP-T11,6852167,1.2603138165512704
HCC2108,327653,2.5162191828052713
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
WM1799,selumetinib-JQ-1 (4-1 mol-mol),-1.4889485752316562
TE-10,49766530,0.4613217391985113
Daudi,107970,1.216737596928884
KYSE-510,54626689,4.821893470864067
COLO 741,637858,3.389953316236187
NCI-H526,9936388,-5.702236125397588
LoVo,637858,1.5179613366947162
Hs 578T,73707398,0.3948619170486216
SK-MEL-30,10302451,3.898557203634669
NCI-H1155,6852167,3.411422238563504
JHUEM-2,375860,-1.6699040750668208
DMS 114,49766530,0.1100604585503799
TE-10,10302451,1.870187527499395
IM95,168313016,5.381835335975214
BT 187,12003241,-0.5243066739913107
NCI-H358,44489367,4.681687495519541
NCI-H929,135875424,3.2591057623275006
HT-1080,54626689,4.476122296465383
DK-MG,26596,-1.5409696775062258
G-401,168313016,4.483065775660181
KMRC-1,9915743,1.4003501061845525
UM-UC-3,24180719,4.462811800098747
HEC-6,49766530,-2.047471555214632
BT 498,241158,4.164187123770961
DOV13,9903786,3.8407513521100975
HCC2935,327653,3.691870307618831
JK-1,107970,0.6168366370340178
JeKo-1,54626689,4.515438698631472
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
NCI-H1385,644241,1.6107924420900666
IM95,73707398,0.9480066923155336
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
MOLT-3,644241,1.5823178433410596
SNU-886,262093,3.428603865365944
CAL-62,135999136,-5.204307291938572
BT 416,156414,1.0194631441188509
5637,10231331,4.7519859123848285
EoL-1,24180719,0.9933546408071084
SW48,637858,1.3097623359774897
HCC827,156414,3.2121505716961134
G-402,54626689,5.308319288518875
BT 286,5460769,1.8515527065353563
YD-8,12003241,-1.7142863629727714
NCI-H1105,9927531,4.896971855718655
HT115,327653,3.079050830894509
Rh30,6852167,1.7191526949253222
COR-L105,9903786,2.948812050867326
JHH-4,135875424,4.647713249642841
RPMI-7951,135421197,2.3107830834906324
MCAS,54626689,5.742619105162711
U-937,262093,2.270631541359052
NCI-H1623,12003241,-0.4868602659209724
SNU-878,49766530,0.7388609615880275
NCI-H841,327653,3.296188109973884
NCI-H2286,9936388,-4.7248658959842
A2780,168313016,3.896841135664639
SNU-407,637858,1.71460298771488
NCI-H727,439501,-2.2848783314382133
HGC-27,9929138,5.812966492872734
IM95,375860,-0.4736196030119515
HEC-1-A,46907787,1.2689818779824844
Caov-3,12003241,-2.5094220970195136
KP-N-YN,11455910,2.456468445716411
Rh41,4259181,-0.3079102815907465
OS-RC-2,135875424,4.485922096178854
DV-90,9903786,1.7610541097937376
NCI-H358,4259181,1.2799951568169998
BT 231,241158,3.4112394985232517
LN-229,11396600,3.892523581558088
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
BT 147,UNC0638-navitoclax (1-1 mol-mol),1.916043415549889
TE-11,selumetinib-JQ-1 (4-1 mol-mol),1.5412110979956997
DMS 273,73707398,1.2764695344106731
CAL-148,44489367,5.301812328348802
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178
HCC1588,46907787,1.4873763939478983
EJM,107970,2.184437882167209
TALL-1 [Human adult T-ALL],12003241,-0.6623785293924347
KYSE-30,9903786,5.462463083669851
COLO 678,136227924,3.6500617296173288
BT-20,156414,1.6027842834064494
HCC-56,6852167,3.667817096482301
LS180,135875424,4.384751932486372
KE-37,9903786,1.3543500174719385
SK-BR-3,46907787,0.432844981405334
NCI-H1155,46907787,-0.1423458632521134
JURL-MK1,3689413,0.8778438710921479
CAL-33,11455910,1.2995904735860209
COLO 684,49766530,-2.0010350026906787
OCI-M1,12003241,0.3090538594406519
CA46,9927531,3.0223750820915978
Becker,49766530,0.5239013848654858
JHUEM-1,327653,3.274496077374958
COLO 680N,241158,5.284652832624782
SW1271,11396600,3.626770708484224
SK-N-BE(2),10231331,-2.0949368191083466
SYO-1,444795,5.48455213311621
NUGC-3,5460769,1.9333841225118369
HuNS1,9915743,0.7777068121651658
SiMa,9903786,1.5237540856212457
TUHR14TKB,4259181,1.635938781538023
8-MG-BA,637858,3.771770795308391
DMS 53,135999136,1.9411901601516004
L-540,10302451,2.597758054262249
LS513,135421197,1.126111149798444
A-375,444795,4.8572215879040925
DU145,54626689,4.459868591961446
KPL-1,3689413,3.184676645737856
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
SNU-410,9936388,2.1346646723856444
Daoy,4259181,0.1994205747840131
253J-BV,6852167,2.333510642923989
MDA-MB-415,3689413,0.9318118886316789
A-549,4259181,-1.4635956785215285
KYSE-410,4259181,0.334687441755604
DMS 114,168313016,4.429758921545856
BT 159,44491742,4.231002554874911
HCC1500,5460769,5.1304942195737935
KMS-20,168313016,2.502907983030332
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
Mel JuSo,9929138,7.586814417068839
HCC2935,136227924,3.4382607017764473
IST-Mes1,12003241,-1.7187710036837192
GI-1,6852167,2.008297234106824
BT 231,100016,7.4946101776766385
A-549,4259181,-1.4635956785215285
EKVX,156414,-0.4483754981833144
BT-474,10302451,1.6230602382563992
DOV13,49766530,-2.036556412816105
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
BT 248,9927531,4.7076279917818225
HEC-251,73707398,0.8821727990853683
U-BLC1,327653,3.5649632216548897
YD-8,327653,2.805787909326678
HEL,3689413,-2.191477482826257
A-204,135875424,2.7744609418453887
SNU-8,135875424,4.308406363333984
HCC15,44491742,4.47716804785037
PLC/PRF/5,10302451,4.036530527642544
KYSE-70,11455910,0.6771697782379181
HCC38,UNC0638-navitoclax (1-1 mol-mol),1.0044709258096385
EBC-1,375860,-0.2967621546856999
HEL 92.1.7,327653,3.068543405394667
EFO-21,12003241,-0.6894261883426276
COLO 792,10302451,3.8709383103233095
NCI-H1563,10302451,2.8247496437227473
ECC12,26596,-1.2680544811101384
NCI-H1650,54626689,4.822116690237369
LUDLU-1,241158,4.349073004115051
KMM-1,71466445,4.780709751917369
SNU-410,54626689,4.39404629791552
ST486,637858,0.4034485852671179
Hs 895.T,4259181,1.7875337393373951
KYO-1,24180719,2.7868862192381516
GCT,3689413,-2.349685112754086
Rh30,11455910,-0.173986116803538
HEL 92.1.7,5460769,3.8355782077499248
F-36P,156414,1.5553832514314012
SNU-738,9903786,3.5811355233288773
L-1236,10302451,4.314783956287455
DMS 53,UNC0638-navitoclax (1-1 mol-mol),-1.494402322167808
Hs 895.T,9927531,5.651415148698969
T84,10231331,0.9685449870961756
AML-193,49766530,-0.6507980760292754
OVCAR-5,11455910,0.5140465150742446
JHUEM-7,73707398,0.8849918098478027
KNS-62,49766530,5.605619598661556
KALS-1,BRD-K27188169-navitoclax (2-1 mol-mol),4.937746414126266
GDM-1,46907787,1.561453615533633
BT 444,439501,-3.015846554822595
T-47D,327653,3.493418775441787
NCI-H508,44491742,4.239299300064597
Kuramochi,9927531,6.027141313400392
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912
MSTO-211H,327653,2.467891014920142
WM983B,9936388,-0.2926482048121987
RERF-LC-MS,637858,3.156110522031532
SNU-761,9927531,4.19360542314586
PF-382,3689413,-3.8661032289286488
EFO-27,26596,4.577324640946523
HCC2218,12003241,-0.1021817446699859
Hs 683,73707398,1.2895938784946597
NCI-H2085,9915743,0.6026125220601625
Hep-G2,444795,7.091940765135057
HCC44,49766530,3.18026268339199
A-375,637858,2.049731474801189
HEC-6,9903786,3.848299658438586
MKN7,24180719,3.8906800220593434
OVCAR-5,100016,6.797399029850292
DMS 273,135999136,4.8097980755766505
OC 314,439501,-2.7228413581115105
VMRC-LCD,3689413,-0.1897073669297062
G-401,49766530,-2.7444300270308113
LUDLU-1,9915743,0.4461040293600573
A-549,135421197,2.4799819746704075
A-673,375860,-0.5094320760358009
HT-1197,241158,3.8644992212078617
OUMS-23,10302451,4.74180958679891
TYK-nu,156414,1.6431806946886447
SH-10-TC,10302451,4.984172634394984
SK-LMS-1,327653,3.1438411129584933
COLO 684,375860,0.4583693277008406
Hs 729.T,136227924,2.3598946894515014
639V,9903786,3.738179934930431
NCI-H2052,156414,5.289728467553055
MEC-1,439501,-3.41979967464108
T-47D,156414,1.5833515843485626
K-562,9915743,1.457381054045144
HOS,444795,3.8858541661854775
SNU-216,5460769,1.6923637113112366
CCK-81,26596,-1.410251638303959
JIMT-1,100016,6.5721980857327935
NCI-H1869,262093,3.2234761574881485
Hs 940.T,107970,2.2449201121582236
MOTN-1,44491742,2.9342913777963555
MOLT-3,241158,2.733568382877171
PE/CA-PJ15,136227924,2.633948596133963
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
LS513,262093,3.104156650593673
SU-DHL-8,168313016,3.815239771277497
MES-SA,135999136,1.8012434168872604
WT2-iPS,12003241,-2.3723982156624057
OVCAR-4,11396600,4.545943819655395
PK-1,9936388,-3.885789608116406
HEC-108,10302451,3.916028655528669
BT 139,11396600,2.700615833267889
KG-1-C,10302451,1.8404484115585815
L-540,327653,3.067159538807824
HCC1438,12003241,-0.2782249625748692
SNU-1079,262093,2.756274169770221
T98G,4259181,0.7418471761834453
G-402,9915743,1.3194896557677194
EC-GI-10,136227924,3.398194138185936
SCC-25,9915743,-2.46733650734929
HCC1419,3689413,0.4398043880767979
KMRC-3,135421197,4.3103204050054345
NUGC-3,135999136,4.702707449703542
OE33,73707398,1.4892412668396968
COLO 800,135421197,2.3295817527143243
8-MG-BA,6852167,4.146273302746602
RT-112,selumetinib-JQ-1 (4-1 mol-mol),2.905178034325965
TE-6,4259181,-1.870862501193427
Hs 746.T,135421197,2.8198811275725206
SW948,10302451,4.082058519290096
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
BT 159,156414,2.2120697636728353
WM266-4,637858,1.0594560796680337
RCC10RGB,9915743,0.9759946846108524
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
BT 498,46907787,4.416353779526344
A-549,135421197,2.4799819746704075
RD,135999136,4.200113448993708
HSC-2,26596,0.6802273350911279
BT 159,107970,1.8106388402335116
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
EJM,262093,1.353461350978494
NCI-H446,10231331,4.291786486557435
OVSAHO,selumetinib-JQ-1 (4-1 mol-mol),3.5066947205839236
SNU-869,262093,3.5484440490505738
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959
SK-LU-1,10302451,0.6542414788556885
HD-MY-Z,11396600,3.2182854001324768
BICR 6,9927531,3.2709369283144674
SaOS-2,12003241,-0.699813042979073
HT115,9877608,5.791889645309291
NCI-H526,11396600,3.7053245475874785
WM88,11455910,0.2100258474381383
SW948,44491742,3.910317363967626
NCI-H1395,168313016,6.368341181188219
LoVo,46907787,0.5340804086119918
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
BT 416,10231331,-2.083820485023427
SEM,135398744,6.34358667151958
LN-229,327653,3.598788059447135
HCC15,4259181,-0.5021574884501439
GI-1,5460769,1.3544320917610908
ECC12,136227924,3.114580380384796
SUIT-2,136227924,3.4861054974924133
BT 328,11396600,3.7528560222461858
MOLT-3,3689413,-1.814335700031944
KMS-12-BM,44491742,3.489197811217823
Yamato-SS,644241,4.451249478679348
SU-DHL-10,444795,4.65789408600245
NCI-H23,136227924,2.7523480468192254
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
KYSE-150,44491742,4.452704490333977
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
MeWo,4259181,-1.000732445958145
SK-MEL-31,262093,3.561171585686889
DND-41,6852167,1.828834613140458
HPAF-II,selumetinib-JQ-1 (4-1 mol-mol),2.1871956092647404
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
OPM-2,4259181,-0.0185783035827133
LC-1/sq-SF,5460769,2.491763650512152
JHH-5,26596,-1.3669217407356802
MCAS,BRD-K27188169-navitoclax (2-1 mol-mol),3.9772772002243353
KMS-34,11455910,-1.0188772923185183
L-363,327653,3.0030098417967883
CAL-27,24180719,3.98072492665334
HCC202,24180719,4.265713695992528
BT 359,135999136,1.778359502307078
NCI-H2196,327653,2.664873729838991
Panc 10.05,54626689,4.8438884977610135
Capan-2,136227924,3.162135891621308
ONCO-DG-1,10231331,3.502059620603748
HT,49766530,-2.438744411324034
SK-MEL-5,439501,-0.7759362068872153
KE-39,107970,2.31854003043047
YKG-1,637858,1.419948249294149
BT 216,11396600,1.9603911758569217
B-CPAP,9936388,2.314754665986152
HCC1171,439501,-1.4214133435338303
SCC-9,6852167,2.7106856908699255
HCT 15,26596,-1.5306161018190547
NCO2,49766530,-4.92824321728858
SW579,107970,1.6244987565976912
SNU-1079,44491742,4.118848224044972
SNU-1033,439501,-2.7458935942411085
HuP-T4,71466445,2.7537575678736452
BICR 22,156414,1.4774483319728589
NCI-H2029,327653,3.052005292522305
L-540,12003241,-2.1812715398766844
MSTO-211H,24180719,1.9210037149309027
NCI-H1581,135875424,3.5038022021338415
OAW28,637858,2.2776250733597085
D283 Med,6852167,1.541783481002512
IGR-1,44491742,3.995353370886831
786-O,49766530,-1.7436393019266725
BT 504,444795,4.894377759650745
NCI-H1339,73707398,1.5517116600994163
OCI-Ly19,327653,3.3059226153173835
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
SNU-738,327653,3.802831984914698
OCI-Ly10,375860,0.5230976360665899
JK-1,168313016,3.280810167382389
BV-173,241158,2.5742615925336856
BT 179,262093,3.0912681706054492
Daoy,9936388,-5.3939036036909656
A2780,24180719,2.9021439553303026
SNU-175,100016,4.815284438481943
NCI-H520,9903786,3.332228860924169
OCI-Ly3,54626689,4.4880223831039086
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
JHUEM-7,5460769,0.024222502884872
SNU-869,49766530,0.4790816119449209
SNU-8,26596,-0.6710039843025739
TALL-1 [Human adult T-ALL],100016,4.020437007073488
Sq-1,3689413,-2.2869880122730755
SNU-475,100016,7.606290519099935
IMR-32,44491742,3.818890533402266
BT 232,136227331,4.34663354921091
TE-6,135999136,5.897939938855362
MOLP-8,375860,-0.9263291950812266
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
Hs 944.T,100016,5.802201252997301
BT 245,4259181,0.4559580659670063
RT-4,9915743,2.2914033994891847
BT 232,439501,-1.8419260323239657
JK-1,73707398,0.3515563744907511
DMS 273,9927531,4.953960158421894
SR,3689413,0.3714575249004426
NCI-H226,selumetinib-JQ-1 (4-1 mol-mol),4.20163198876541
OCI-Ly3,UNC0638-navitoclax (1-1 mol-mol),-0.8261929635354904
HDLM-2,9936388,-6.699544688001925
Mono-Mac-1,136227331,4.247854438913471
PaTu 8988s,9915743,-0.0886276947358788
RL,135421197,1.8322990483714552
EKVX,241158,5.164302158965644
BT 359,73707398,1.6798691675714814
KPL-1,11396600,3.5604078040671796
NCI-H2170,73707398,2.2436003573271046
U-937,375860,-0.6351957865306692
HCC1588,100016,6.591658390404969
BT 187,9915743,2.9672609424813
23132/87,9929138,5.470109790622619
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
RPMI-6666,26596,-1.6823570129437355
KMH-2,11455910,1.2516447842889498
HCC1171,12003241,-1.936475523579036
TCC-Pan2,5460769,4.19565263219897
P31/FUJ,156414,0.8249508749632878
KMS-21-BM,9927531,3.894276575541364
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
GA-10,73707398,-0.3686666371597158
G-361,439501,-0.9249859922186838
SNU-1,135999136,4.2258569764915395
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
RERF-LC-Ad2,136227924,3.207411157267862
CJM [Human melanoma],26596,-1.4087486748108544
LMSU,375860,0.9440264058556476
COLO 800,439501,-0.358926557493619
Panc 05.04,135999136,4.919832850968504
SNU-8,262093,2.9266150824116877
BT 498,135875424,3.150429417088691
Hs 895.T,12003241,-1.2157135831587602
PE/CA-PJ34 (clone C12),54626689,4.8339545787356215
MFE-296,44491742,4.423113386396404
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
KYO-1,46907787,-0.6673337091305744
MHH-CALL-4,10302451,3.4549917451264376
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
LOX-IMVI,439501,-2.207275092585139
NU-DUL-1,12003241,-3.7698079605480257
NCI-H2444,637858,2.7890642864609525
Kelly,168313016,4.119393264383737
2004,26596,-1.025080107658215
SNU-423,46907787,4.032406628203726
P-STS,selumetinib-JQ-1 (4-1 mol-mol),1.951618016482338
YAPC,439501,-1.3344819600707327
5637,9936388,-5.346129703335208
Kelly,6852167,2.334031930420637
CAL-54,135875424,4.317349634986473
HCC2935,107970,1.7323238719492455
TE-4,168313016,4.782755227329567
PE/CA-PJ34 (clone C12),6852167,2.080023831418778
CHP-126,3689413,-2.431147866907691
SNU-182,9915743,-0.6528575435960152
OCI-AML-5,156414,1.749799487205322
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735
SU.86.86,46907787,2.7876095981228044
NCI-H1573,9915743,0.8618655163621424
Rh30,46907787,2.5511013191395913
NCI-H647,9936388,1.0931922000405532
HSC-4,3689413,2.5472025828962055
NCI-H1581,100016,6.5572943300427795
PSN1,135421197,2.7573404072547327
OAW28,327653,3.155680016062074
ECC10,9927531,3.415986585333862
LNCaP clone FGC,6852167,3.159871073492599
A-204,12003241,-1.8688427044932845
U-251MG,selumetinib-JQ-1 (4-1 mol-mol),5.468916065595192
BICR 6,156414,1.5223204989206929
HEC-1-B,3689413,0.3558591242375798
U-118MG,44491742,3.985342348777434
QGP-1,135999136,1.7470686183555435
EJM,54626689,4.594595753018125
Kasumi-1,637858,0.8254828437519408
OS-RC-2,9936388,2.9973803425590733
Caov-3,637858,1.6331589021286677
L-363,11396600,3.444833933433015
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
SUP-B15,100016,6.907261874504965
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
253J,11455910,0.0349890570981946
KMS-26,327653,1.2405471954530771
RPMI-6666,9915743,0.6394902381719043
NCI-H1694,135421197,1.1346758741878853
RKN,11455910,3.815213247766997
AN3-CA,241158,3.592519055568355
COLO 699,3689413,3.029151035827229
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868
HCC1419,241158,4.325671093419114
MKN74,9936388,-0.1480822399843773
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
NB1,241158,3.7390057768995257
A3/Kawakami,9927531,2.786138883968946
NCI-H1650,9936388,1.5331586238984851
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
Hs 611.T,439501,-3.691204716302381
HDLM-2,49766530,-0.915068926729708
NCI-H2444,9903786,4.235157669098579
SK-BR-3,5460769,4.927732708716518
MOLP-2,6852167,2.4581845144067853
G-402,54596490,5.430260999889079
LoVo,12003241,-2.8621949377385465
T3M-10,135421197,3.6176522796441546
Capan-1,3689413,0.3362458713829924
U2OS,439501,-2.693554795919347
KYSE-450,selumetinib-JQ-1 (4-1 mol-mol),2.8795541061049104
PC-14,11455910,0.0459407670906722
FTC-238,135875424,3.1896552091997603
HEC-6,107970,2.5203665838349036
NCI-H1581,10302451,4.243802408751907
BT 482,135999136,2.0696310473297768
JHH-2,10302451,2.423935123229122
MKN74,11455910,0.5314790476879293
BT 139,135421197,2.718205377140928
BT 231,439501,-3.8677572824685913
Hep-G2,262093,4.425755335049499
HPB-ALL,9927531,5.02886546731598
KMBC-2,6852167,2.897354350199853
IMR-32,6852167,1.9156173636084908
NB1,9903786,2.052998466280315
SNU-738,262093,2.5728208753018285
CAS-1,49766530,-0.5285201098219467
TE-10,5460769,3.091987508758681
BT 139,10231331,4.592628649226856
Hs 683,12003241,0.8693905406704602
MDA-MB-435S,73707398,0.6150300416812977
DMS 114,262093,2.4519702544281436
NCI-H841,9903786,1.3953234404083057
HCC366,44491742,5.047439553601353
KE-37,241158,2.42379613610841
UM-UC-3,262093,2.408651217666756
LCLC-103H,44489367,4.479979959570128
EFO-27,262093,3.0007323703470896
SW1417,11396600,4.42518333755826
A-375,24180719,4.11900133605722
KYSE-520,3689413,3.1364277290203986
SNU-119,9877608,5.864690809801913
HCC1143,24180719,4.266131781804432
JHOC-5,262093,3.0668349870794542
OAW28,11396600,3.5740319462685535
SUP-HD1,156414,1.2814810366686893
PE/CA-PJ34 (clone C12),11396600,3.27217842552133
CAL-54,UNC0638-navitoclax (1-1 mol-mol),2.525711366860768
ESS-1,44491742,4.277473074701454
M-07e,136227924,2.437184343955499
MOLM-13,136227924,1.704251401840426
IGR-1,10231331,1.9861104383183457
PK-59,9929138,7.561658238332544
Capan-2,262093,3.612001970240134
SNU-1214,73707398,0.3322136890505088
HCC1195,73707398,1.556886983624434
SNU-61,9936388,-6.308071034865157
HCC38,49766530,0.1078777234170871
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
Ri-1,168313016,3.43203331304281
BICR 31,136227924,2.8140968842668923
NCI-H1341,262093,2.9706231896058823
IGR-1,73707398,1.4805521909749868
SNU-182,49766530,-3.329297087517195
Daudi,262093,0.7533038243356376
CAL-148,9915743,1.3006857721800915
SNU-C2A,UNC0638-navitoclax (1-1 mol-mol),4.411481357734303
DU145,136227924,5.593457102459236
WM88,135875424,3.748879677238851
BEN,637858,3.568953434975905
OVSAHO,49766530,-1.4771294887146182
HCC1143,73707398,0.6963565440176983
Raji,11455910,3.338513112420112
NCI-H1339,11455910,0.5713481488212533
GOS-3,135421197,1.697146176044067
OCI-Ly10,9927531,5.366378866921267
SW1353,selumetinib-JQ-1 (4-1 mol-mol),1.7746405965747805
HCC1806,135421197,3.3559114199150697
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
Mono-Mac-1,49766530,-2.16205133655403
NCI-H524,11455910,0.6737102909376176
BHT-101,9936388,2.229649251743914
HMC-1-8,241158,5.5321321838758335
HD-MY-Z,9927531,4.2813620085195625
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
SNU-407,135421197,1.3307309137808745
Granta-519,5460769,2.1422187145203897
HuT 78,44491742,3.833204810123411
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
SW982,439501,-3.0027408627821934
PK-1,selumetinib-JQ-1 (4-1 mol-mol),1.9861622648896295
NCI-H1915,12003241,-2.138789855422618
HD-MY-Z,100016,6.5820470291511555
FTC-133,5460769,4.281031552964228
OVCAR-8,9903786,3.64408364733759
LC-1/sq-SF,3689413,0.5159232922556106
SNU-503,73707398,2.541804283502416
NCI-H1693,107970,1.7337077857992298
TE-15,3689413,0.9912236496957668
BICR 18,71466445,3.286830230491617
Mino,54626689,2.826693695384345
SNU-869,11396600,4.186989660644326
LCLC-97TM1,637858,1.4157632634757724
MDA-MB-453,11455910,-0.0078824359576409
HD-MY-Z,24180719,3.4052482299900224
Mel JuSo,6852167,2.9551227658662103
Peer,24180719,2.2373111977936255
G-402,24180719,3.3362847751975884
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971
Yamato-SS,49766530,-1.529274305649153
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823
IPC-298,262093,3.133705488563506
HOP-92,73707398,1.019832404417608
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874
CW-2,135875424,-5.260207779048425
SNU-869,selumetinib-JQ-1 (4-1 mol-mol),2.584496248279929
NCI-H1838,11396600,3.9087571666656222
TE-9,11396600,5.486103652826923
HT-1197,135999136,4.533058673840764
OCI-M1,9927531,4.777784518044042
UM-UC-3,5460769,6.395850795756177
SJSA-1,136227924,3.1619398784526176
MKN1,44491742,4.1588945650125355
SNU-1076,26596,-1.989905852137358
RPMI-8226,24180719,4.46850622531289
BT 232,6852167,4.665057754555266
DB,9903786,1.8629742307315609
DU4475,26596,-2.6903175915045305
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
Ki-JK,6852167,1.5180827510613648
DOV13,107970,2.938310681769946
JeKo-1,135421197,1.3904667144592064
SNU-C1,107970,1.526415841578502
MOLT-13,9903786,1.350785557130732
HOP-92,46907787,2.9516486383279488
Hs 852.T,selumetinib-JQ-1 (4-1 mol-mol),1.1151349056672275
WM983B,10231331,-2.8464070849273755
SK-UT-1,100016,6.311695779547894
RPMI-8402,327653,2.524650226639341
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
NB1,439501,-2.2993360738685604
BT 271,439501,-3.3712164407205916
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
B-CPAP,241158,3.71370211344078
NCI-H1703,49766530,-3.0493553752695783
SUP-T1,46907787,-1.0799760028641845
SET-2,11396600,3.171295781716927
SNU-869,10302451,3.2820222285741134
IPC-298,439501,-1.1668969195749603
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
HOP-62,9936388,2.1829443174265997
OVCAR-8,135875424,3.0307558865901285
SNU-119,107970,2.4008728686512617
8505C,107970,2.375571587180646
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
COLO 680N,24180719,4.791215319697758
BHT-101,135421197,3.464281402199008
SNU-685,5460769,1.3668159641558515
BT 179,156414,1.740196699219975
HCC1428,9915743,2.613420698751445
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
NCI-H727,327653,3.8552398443183193
NB1,11396600,3.5328020412692376
NCI-H358,637858,1.9740293300552516
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
COV644,262093,3.243932148063393
NCI-H1666,168313016,4.852809935193056
NCI-H322,5460769,4.726933223287107
P31/FUJ,73707398,-0.9687174770786582
UACC-62,136227331,3.8337503750077175
JK-1,26596,-2.9056009254184247
A-549,49766530,0.1688758689952186
SNU-1105,12003241,-1.0789157776023728
KM12,11455910,1.6759446540932372
BT 179,12003241,-1.00247586074096
SNU-C2A,439501,-1.0520759407127591
NALM-6,73707398,-1.133432091638796
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
Hs 888.T,327653,3.5406754693481153
697,3689413,-4.592685729606217
SW1990,9927531,5.3345214594202695
OCI-AML-3,9915743,0.4173420308342337
AU565,6852167,0.824199435407992
TALL-1 [Human adult T-ALL],439501,-2.6089794339614256
DMS 79,136227924,2.929954381299975
WM793,9936388,1.3359302595984517
NCI-H1563,49766530,0.5577612729828542
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
HEL 92.1.7,107970,2.1393634980619622
KP-N-YN,9903786,5.5444671223667825
LOX-IMVI,73707398,0.9274850481113778
JHH-5,107970,2.0070201087005457
GSU,12003241,-0.2864311193180854
YD-10B,107970,2.4548970149913187
OE21,5460769,0.0529032243874579
Jurkat,selumetinib-JQ-1 (4-1 mol-mol),-1.978152478321326
A2058,439501,-1.4813488072157313
CAL-85-1,439501,-2.788056668623063
Hs 746.T,327653,2.7924805493418567
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
OCI-Ly10,3689413,2.738747600587094
ALL-SIL,439501,-2.349752310116714
647V,241158,4.253529022731219
HuT 78,73707398,-1.0733102034167783
Panc 03.27,selumetinib-JQ-1 (4-1 mol-mol),2.6440242769241338
HGC-27,135999136,4.659278272182858
Calu-6,11396600,3.718739877278185
Caov-3,262093,3.252230981856776
H-STS,11455910,0.6438795438543947
BFTC-905,637858,2.2129577853608757
MKN74,135421197,1.917095385489804
IGROV-1,26596,2.910298792762654
DB,9927531,3.16097275010185
DV-90,107970,1.4314124171332838
MOTN-1,375860,-0.5275856656168855
EKVX,46907787,3.5587951033471112
NCI-H441,4259181,1.2625810441667016
A-253,12003241,0.3953648973902781
MHH-NB-11,637858,1.0838908575180757
A4/Fukuda,6852167,0.513003696591474
42-MG-BA,156414,2.3078841237771073
HSC-2,49766530,-2.22152995059399
COV434,selumetinib-JQ-1 (4-1 mol-mol),1.350650078825728
KLE,135875424,3.394401628511705
253J,10302451,0.4667603068204772
KP-4,135999136,4.290505195277357
SET-2,24180719,3.6007624988079696
Calu-1,262093,2.8993991941012704
HCC-56,135875424,5.1003791094232085
EB1,241158,1.457261035728942
NCI-H1355,107970,2.284866170992536
Ki-JK,UNC0638-navitoclax (1-1 mol-mol),0.2574517035947892
SNU-1105,9903786,3.6171667561714056
AU565,3689413,0.8257687517728082
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401
T3M-10,156414,2.016640265656968
NCI-H2030,73707398,1.6875070689591785
SF539,5460769,-0.1125532875886319
NCI-H2081,49766530,1.2305991234309177
OVCAR-4,439501,-2.2754472098367855
SNU-398,107970,2.587748005247781
AGS,4259181,0.9678254613735656
BEN,135421197,5.032233949916212
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
L-540,135421197,1.2106932508822246
OCUM-1,168313016,4.182572572603023
A101D,637858,2.3382819963464967
SNU-1066,4259181,0.2629374761746411
SW1088,4259181,0.6363648282246106
SF539,UNC0638-navitoclax (1-1 mol-mol),2.2023146643666323
BT 416,10302451,2.165106846355265
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
LOU-NH91,107970,2.5070848864255093
M059K,375860,0.2487548899979027
OCI-Ly10,10302451,2.566014120606711
KMS-12-BM,46907787,-3.5146066785265746
OCI-Ly10,73707398,0.9871539697416232
SW1116,107970,1.8262752967373983
KCL-22,107970,2.3450086604567195
U266B1,9903786,3.1119057024478094
SJSA-1,6852167,3.504637342801869
Hs 944.T,6852167,2.6502457950936837
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215
BT 440,135421197,3.1509992040487074
Capan-1,439501,-1.7438578400457687
SCaBER,439501,-1.925365534311937
JURL-MK1,26596,-1.965499498470982
L-363,9903786,1.2649504106242235
SCC-9,3689413,-0.5284639903905319
HGC-27,136227331,3.820430594188932
HT-1197,637858,1.1987341905705466
HCT 8,selumetinib-JQ-1 (4-1 mol-mol),0.8650339041398372
NCI-H2106,BRD-K27188169-navitoclax (2-1 mol-mol),0.1617044566198489
HuT 78,444795,-1.7173791831946914
HCT 8,73707398,1.7500112780012191
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
HCC1428,107970,1.710707773894572
23132/87,444795,5.5054846626834735
BT 232,135875424,3.043961791838538
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
KLE,11396600,3.656351561000123
Kuramochi,73707398,1.772910417031626
REC-1,54626689,4.088202914478188
IGR-37,44491742,4.84582247034579
SNU-423,4259181,1.1208846332757925
HPB-ALL,BRD-K27188169-navitoclax (2-1 mol-mol),-1.293174020586246
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
KM12,100016,6.486077549174115
MHH-CALL-4,72967,3.718598415166011
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
SNU-449,135875424,4.841371934548395
SNU-8,100016,6.375529183181613
BT 147,24180719,4.465367792138847
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
BT 271,selumetinib-JQ-1 (4-1 mol-mol),0.8721966521481374
SK-N-BE(2),262093,1.809319637639724
A-204,54626689,4.088786658405886
SHP-77,241158,1.951017341248196
NMC-G1,439501,-2.0387411188020024
HSC-2,156414,-0.6500382909370143
A-253,9927531,5.71272933596785
KE-39,12003241,0.559414259019648
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
NCI-H526,71466445,3.4428380122826736
UM-UC-1,73707398,1.4812492573397609
NCI-H2009,26596,-1.5885219134108934
SR,11455910,-0.2292707717843843
SNU-423,12003241,-1.4382544514663564
NCI-H520,6852167,1.505656389836919
TC-71,100016,6.681443396825605
BICR 31,9915743,-0.3251640044425866
NCI-H1703,73707398,0.963485701318702
D283 Med,168313016,4.168522701530026
JMSU-1,10231331,2.1189745433064515
IGR-37,135875424,3.259806736853938
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
PE/CA-PJ41 (clone D2),9927531,5.176178802230399
PaTu 8988s,262093,3.243938357884203
SW948,3689413,-2.2648112033429824
NB4,375860,-1.341920340962159
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
BT 340,107970,2.016731313243945
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
SU-DHL-6,26596,-1.882707371112463
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
KU-19-19,439501,-2.2192304341921205
SF268,100016,6.377468220379779
23132/87,107970,2.492254606799978
BT 482,241158,4.269412013532964
ACHN,327653,3.2830997989663566
T3M-10,241158,4.470503510456402
DND-41,327653,2.6177902685494834
KE-97,9903786,1.2492215046339803
KLE,9915743,0.4681181116614699
SK-MEL-1,11396600,3.732963338182352
Capan-1,12003241,-1.403867722449874
M059K,6852167,3.122777995706041
YD-10B,9903786,0.9692609848682356
COV434,11396600,2.8403888234500663
CAL-12T,375860,0.2281009293347852
SNU-16,26596,-3.716787103027543
OVCAR-5,9927531,5.160514110518488
MHH-CALL-4,9915743,0.0855702351312573
HH [Human lymphoma],375860,-0.7625107237877107
PC-14,4259181,0.4148318229863006
COLO 829,49766530,1.364396620526625
HCC38,241158,4.477022319117719
SNU-601,selumetinib-JQ-1 (4-1 mol-mol),0.5711471073512734
CCF-STTG1,135875424,4.233748796461769
TE-5,439501,-3.2949389532726867
NCI-H1694,637858,0.3995039534325592
CAL-51,168313016,5.819136604546001
SJSA-1,54626689,4.902956028453571
TE-5,73707398,0.9909489120421338
UM-UC-3,26596,-0.252554246147762
UACC-257,136227924,2.920939130155667
LUDLU-1,9903786,3.064378057627616
NCI-H1568,44491742,3.692908194165655
SW948,9915743,1.1952390119197474
UACC-257,135421197,1.9290983247334992
BT 286,10302451,3.989436421266635
WM983B,73707398,1.4395905386733596
KMS-34,644241,0.6843791574877399
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
JHUEM-2,71466445,5.178747074886277
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
HCC1395,135999136,4.391261806083376
CAL-33,selumetinib-JQ-1 (4-1 mol-mol),1.717482821229556
BT 504,644241,2.5369130082852234
MOLT-3,327653,2.355499733998213
NOMO-1,5460769,4.769752092364765
KPL-1,10302451,4.018734113992757
NCI-H2126,107970,2.363943051390716
HuP-T3,5460769,4.291069487745317
SNU-C2A,9915743,0.5240422710487646
NCI-H1184,637858,1.2845311841937697
SNU-668,3689413,0.4740443403911467
HOP-92,9927531,4.8467416959319625
CAL-51,49766530,0.4609697007955676
WM266-4,9915743,5.517914495108045
NCI-H1155,644241,2.1023649798666937
SK-N-DZ,444795,-2.5083972815041577
HGC-27,49766530,-2.870861488456396
TE 617.T,UNC0638-navitoclax (1-1 mol-mol),1.3072146472034474
Panc 05.04,9903786,4.601199939689659
KU-19-19,73707398,1.7453733414385195
ChaGo-K-1,9903786,4.114689259573735
RPMI-8402,9927531,3.4344708783390856
HuH-28,44491742,4.601953674704061
VMRC-RCW,46907787,1.4182502903454035
TUHR10TKB,5460769,4.601270489376953
CMK,375860,-0.825698439326878
PK-59,11396600,3.5699719356694573
Lu-99,73707398,0.9944479975381392
HEC-108,637858,2.449708151119433
CAL-148,6852167,2.1626646060240367
SK-CO-1,5460769,-0.7722931098274061
CCF-STTG1,54626689,5.020869139068369
NCI-H358,327653,3.0661628388292623
NCI-H23,327653,2.841152187489534
MKN74,135875424,3.2262010711942484
SUP-T11,644241,2.523966392128261
Panc 10.05,73707398,0.9040448931915048
DBTRG-05MG,135999136,3.6182651515935302
KP-3,9936388,-3.794861235698215
BT 328,9936388,2.1535847087745386
NCI-H1092,3689413,-0.2231155414175143
NCI-H2106,3689413,-2.547861084772001
B-CPAP,10302451,2.5954421947302344
NCC-StC-K140,444795,2.80174580023504
HT,375860,-1.0285235345603876
NCI-H1734,439501,-2.4852115396408436
WSU-DLCL2,4259181,-1.5160973088782748
DAN-G,637858,2.982118454285325
SNU-449,135999136,4.264029635041134
JVM-3,3689413,-1.6537581501619123
HD-MY-Z,262093,3.0364164526237807
CAS-1,4259181,1.2102737727072803
MOLT-3,11396600,3.214493659676048
SK-N-DZ,54626689,4.736690060896422
HEC-1-A,9915743,1.9800038677829928
L3.3,selumetinib-JQ-1 (4-1 mol-mol),7.047753882053292
DMS 454,9927531,4.138491843589823
KYSE-510,9927531,4.748041591600806
U-BLC1,54626689,4.734211145760804
NCI-H1755,439501,-3.104182815210806
Calu-1,73707398,1.2133176360224152
LN-229,9927531,7.375456166440614
AU565,49766530,1.448288738772077
COLO 678,135875424,4.367651695561652
COV644,11396600,3.2739624799588505
Hs 766T,9936388,1.7778445616458998
NCI-H358,73707398,1.1537520848201694
LN-18,241158,4.2473346445945594
JHH-4,241158,4.032336391203072
ONS-76,4259181,0.68334491499701
C2BBe1,54626689,4.865008072126087
COV362,11396600,3.1783397213372293
SNU-685,107970,1.9143619661744995
NCI-H460,9936388,2.3098343611543415
NCI-H1734,375860,-1.150619884530698
Hs 683,UNC0638-navitoclax (1-1 mol-mol),1.040409655043311
BT 147,12003241,0.4037100837513208
CAL-33,54626689,4.511938993638908
KNS-62,9927531,5.413841173671558
KPL-1,44491742,4.061678740812618
BT 271,9915743,1.1851402962233049
KP-3,49766530,-2.4187443119050904
OVCAR-5,637858,2.2396981147097903
AN3-CA,135999136,1.6085173592108284
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
WSU-DLCL2,9915743,0.1660660253888135
OV-90,135421197,1.209947389883954
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
RKO,100016,5.817852214634293
LOX-IMVI,44491742,5.895851784959737
Mel Ho,9903786,4.6138306230888615
NCI-H1651,3689413,1.2718647351965997
KMS-34,9936388,-7.578544661125487
SW579,644241,1.6147011533525324
Ki-JK,4259181,-0.8442803156053552
PE/CA-PJ49,637858,1.923825301062206
Calu-6,9936388,-7.509028566007479
HCC1833,136227924,3.0159379881399895
Hs 611.T,375860,-0.3365508956402739
Hs 936.T,71466445,3.3475399187974384
SK-LU-1,BRD-K27188169-navitoclax (2-1 mol-mol),4.132612583217379
RL95-2,9936388,-5.708399699553936
VMRC-RCZ,54626689,4.668269774215583
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
NALM-6,26596,-2.8659414702792128
Mono-Mac-1,UNC0638-navitoclax (1-1 mol-mol),0.713076461951265
T84,6852167,2.3607700783512686
SCaBER,9936388,-6.596808157772059
NCI-H1155,12003241,0.5053452290511842
A-204,168313016,4.364596621658886
MDA-MB-468,54626689,5.57850642495249
NCI-H209,9936388,1.6716697805480627
NCI-H520,9915743,1.4167224147327635
KCL-22,375860,-0.4876859015099881
SK-N-SH,9903786,1.912941590488841
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
HCC78,439501,-1.472903672264699
TCCSUP,46907787,2.977323633088547
Granta-519,11455910,0.302072347623865
Daudi,3689413,-4.376822515219121
HCC44,24180719,3.308697106148532
LS1034,262093,2.9969405069392963
OVCAR-5,12003241,-2.4332289606556903
NCI-H1385,UNC0638-navitoclax (1-1 mol-mol),-3.5851944113716923
NCI-H1693,4259181,0.7986342395932161
TE-4,46907787,0.034405481319533
U-BLC1,241158,3.6969065198741378
EBC-1,135875424,4.611810630126507
Fu97,3689413,-0.2126169445323924
BT 147,135999136,2.0385519129868443
NCI-H23,5460769,-1.0672070635340756
IPC-298,135421197,1.9910993623388888
MV4-11,44489367,4.434615022030146
HCC2218,11455910,0.1685104412294276
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
MKN7,9915743,1.455342343306638
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
NCI-H661,49766530,1.1318827683023138
OE33,10302451,2.926424279202946
HCC38,9915743,2.4807170857977865
BICR 16,UNC0638-navitoclax (1-1 mol-mol),3.2045768686697684
SF539,107970,2.309030481029931
Li-7,100016,6.9157107863456915
TE-10,46907787,0.1921390892100071
ECC10,9936388,-3.931527167718931
SK-N-FI,135999136,4.105674452216523
HEC-151,444795,4.8159070538718245
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
CAL-120,107970,2.6681262489073716
CAMA-1,135999136,1.755447111331727
MOLP-2,BRD-K27188169-navitoclax (2-1 mol-mol),2.125156198588138
NCI-H2196,6852167,2.8747705894098488
PC-3,49766530,-1.3415324716004575
PE/CA-PJ15,241158,3.6544935074881586
TE-5,12003241,-1.2234174090075007
BT 145,135875424,2.9417434414875374
A-204,26596,-0.948226132815995
KCL-22,11455910,1.070847957925647
DB,644241,1.3416700671632733
SK-MM-2,49766530,-2.0965316269775816
KYSE-150,73707398,1.088609979945698
IM95,UNC0638-navitoclax (1-1 mol-mol),1.2778255958828686
HeLa,439501,-2.848382287027866
A-253,6852167,4.173153374285914
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
Mono-Mac-1,9929138,7.711944602530317
HCC2108,135875424,3.411556630339189
CAL-51,3689413,0.5709426612715743
SK-BR-3,10302451,2.9491683435141045
JeKo-1,6852167,1.633510922803868
SK-N-SH,24180719,3.49542412809488
ES-2,107970,2.4145055108152262
SK-BR-3,11396600,4.1222338228644695
SNU-308,9936388,-0.5886369856263455
Caki-1,107970,3.065617455859658
LS513,46907787,0.9651727941211948
SNU-182,9927531,4.620682064232075
K029AX,637858,2.158003562439808
TE 617.T,11455910,0.3917461009813664
KYO-1,73707398,0.4233642273318134
Granta-519,262093,1.5974758737964725
CAL-148,375860,-0.9253661566101976
NCI-H2342,9903786,5.089610325302681
RMG-I,444795,6.5483017268808545
KO52,241158,3.6727095918533
NCI-H2196,4259181,0.8420736929714187
ESS-1,135999136,4.050088319286221
BT 216,439501,-3.37474066613204
SNU-410,107970,2.3255659679492378
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469
Mel Ho,73707398,0.8984627578429711
RPMI-6666,46907787,0.0524007873085762
EFO-21,10302451,4.310388254749294
MCAS,375860,-0.3499242525784914
SW1990,10231331,2.104617413508516
NCI-H841,73707398,1.141940549320864
A-673,637858,0.7164978632133837
DMS 454,107970,1.7006864411159697
SNU-182,9903786,3.6716358007160546
NU-DHL-1,262093,0.667372891927881
KYSE-30,241158,4.2154926555372
Panc 03.27,9927531,5.182143526242967
KE-37,26596,-2.2525665271951527
PE/CA-PJ34 (clone C12),135421197,2.056271924404355
NCI-H522,5460769,0.5614535105182378
JHUEM-3,136227924,3.0400208358424243
BT 359,107970,2.0114219051470887
SUP-M2,327653,2.3610903124957336
C2BBe1,12003241,-0.6014753337621667
NCI-H358,49766530,1.9873941918959552
SU-DHL-8,3689413,-0.1983897447219186
NCI-H1975,637858,1.41679582909573
OVISE,241158,2.9923875981017134
DV-90,49766530,1.92724859659278
FTC-133,135875424,4.265925786122884
JK-1,12003241,-7.790720782549377
BxPC-3,11455910,2.77826122800999
SNU-182,BRD-K27188169-navitoclax (2-1 mol-mol),2.6103315008965953
SW948,156414,1.6424995325300082
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
CAL-12T,73707398,1.4913099506647278
NCI-H2081,262093,2.026605801788383
TOV-112D,selumetinib-JQ-1 (4-1 mol-mol),2.629482004155843
MDST8,327653,3.1544218347658375
RPMI-7951,135875424,3.929226739625062
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
BT 145,107970,1.590370979602365
BT 245,26596,-1.3254238494846824
KYSE-410,9903786,4.00816844948711
Lu-65,73707398,1.7319675343544505
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
SNG-M,10302451,2.428061040966125
BT 444,11396600,3.072900716227824
SK-CO-1,262093,3.1807391377127376
OE19,135421197,2.291572889832539
ESS-1,9936388,3.356877818481439
MCAS,9936388,-6.436874065356807
Hs 888.Lu,44491742,4.101401149351862
NCI-H1734,136227924,2.5893506458509634
U-BLC1,9927531,5.132450103816796
SUP-HD1,9915743,0.8948687265051912
HCC4006,241158,3.3479342168717694
EFE-184,241158,4.6559218833737095
HCC366,107970,2.271123549663536
L-540,241158,1.8161298182367036
TE-6,44491742,4.129891650576595
KMBC-2,262093,2.431705852322835
NCI-H211,135875424,3.0832009645931073
TE-4,11396600,3.940884116586543
B-CPAP,9929138,3.6088246512600457
CAL-62,136227924,2.2921842664772996
OCI-Ly19,selumetinib-JQ-1 (4-1 mol-mol),-1.2560093436498458
HEC-151,644241,2.1605297615214716
647V,4259181,-0.0179068575968908
SNU-1,5460769,1.879573497334996
Yamato-SS,241158,3.6414110842673386
Sq-1,156414,1.0754801574574806
HEC-108,168313016,6.1351198054698575
UACC-257,11455910,0.2602701775607313
PSN1,11396600,2.760096793353625
KNS-62,439501,-2.644603626195061
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806
KYO-1,selumetinib-JQ-1 (4-1 mol-mol),0.0180906147444378
SaOS-2,135999136,4.306712196094447
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
SNU-503,49766530,2.995521329492969
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
HEC-1-B,327653,2.8877285088820694
BT 328,12003241,0.43959296828198
Karpas-620,49766530,-1.8063473095000468
PaTu 8988s,135421197,1.1460063606701134
MDST8,4259181,0.8851574645315519
DMS 114,135875424,2.926439690209593
LCLC-97TM1,9929138,5.774162864206733
SNU-8,9936388,-5.172305126613517
MFE-296,12003241,-1.246731028560956
SU-DHL-10,73707398,0.8499866155658562
SNU-16,107970,1.3948454573250222
EFM-192A,107970,1.699878245077743
MHH-NB-11,156414,0.3603526018764347
HCC202,4259181,0.8134665998363166
UACC-257,UNC0638-navitoclax (1-1 mol-mol),3.0893651600544096
YD-8,44491742,4.162245932134171
NCI-H1838,49766530,5.619169884682744
A-549,168313016,6.463391576466817
VMRC-RCZ,637858,2.5558948315535757
SW1088,136227331,5.532811982625497
RT-4,73707398,0.8448009736616658
MOLM-13,9903786,0.7109980532390177
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
HuG1-N,4259181,0.6205305384183885
COV362,644241,2.4663572011502457
NCI-H69,26596,-2.134877782649339
KYSE-150,4259181,1.17340557634434
EFM-192A,6852167,1.4625394744980325
IGROV-1,10302451,0.4135234554742116
PE/CA-PJ15,5460769,-0.4178373813349113
HuNS1,6852167,0.9722710028853416
NCI-H524,6852167,2.748516407102372
DK-MG,44491742,5.623663094967997
TE-4,637858,2.2506365452063295
SK-CO-1,11455910,1.152685438196598
SK-MEL-5,168313016,6.194351632392148
HEC-265,135421197,3.07473850340402
HCC2218,11396600,2.588416382808436
HCC1438,11455910,1.641191029153792
NCI-H1694,46907787,-1.0476402710384092
NCI-H2228,selumetinib-JQ-1 (4-1 mol-mol),0.712413787162595
TE-15,12003241,-1.6215722433150963
SW620,73707398,1.7654578320686287
KYSE-510,10302451,5.138407368996928
SaOS-2,9927531,5.410264314347966
COV644,49766530,0.2349932620082565
NCI-H2141,9927531,4.975438094968349
COR-L51,11396600,3.4123493157330027
SKM-1,73707398,0.3700517012219515
BT 359,375860,0.0667828963411476
SUP-HD1,71466445,3.198564934424997
RPMI-8226,100016,4.270983790022636
T84,375860,-1.0611721246965713
SK-N-MC,24180719,3.744362662869468
OS-RC-2,439501,-0.684202622279705
Hs 688(A).T,selumetinib-JQ-1 (4-1 mol-mol),5.275991754201655
MDA-MB-435S,6852167,3.3926503317081873
NCI-H1734,9936388,-4.869160721724045
Granta-519,135421197,0.2234065586927925
HCC1833,107970,2.3243441845600517
SET-2,54596490,4.331118205930631
ZR-75-1,637858,1.8695576554878648
Hs 944.T,135875424,1.9575051690352112
NCI-H929,100016,3.8135603062591
8505C,54626689,4.062735308937117
SF126,26596,2.229943441766346
LXF 289,9929138,7.38651684018349
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
Calu-3,135875424,4.098138876247088
BFTC-909,26596,-1.7437210940555867
WT2-iPS,6852167,4.7114285575150765
RPMI-6666,637858,1.2318801416926508
BT 482,135421197,2.625315115733885
ChaGo-K-1,11455910,-0.3769194241823518
JHUEM-2,12003241,-3.1995756847172108
NCI-H508,136227331,4.38758043299591
PC-14,375860,-0.4543940661648492
HEC-108,26596,-0.981636576627464
SNU-478,12003241,-2.4220393479516025
WM1799,262093,3.074804588152201
BT 271,135999136,1.6268785370862404
HDLM-2,selumetinib-JQ-1 (4-1 mol-mol),1.4826251454250057
BT 286,136227331,4.205096233968031
OVSAHO,637858,1.8290217705007763
NCI-H446,156414,1.4806898091900922
BT 164,637858,1.0928281047696768
RS4;11,107970,1.6679413535699257
SK-MM-2,UNC0638-navitoclax (1-1 mol-mol),-2.9286271637501806
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
COLO 320,107970,1.828420426524412
BV-173,168313016,3.577674079165387
GOS-3,135999136,4.682109520485855
NCI-H810,10302451,3.713085374892607
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
DOV13,4259181,0.7388628793294447
DBTRG-05MG,135398744,6.409074750923468
NCI-H2405,135875424,3.4546844746128476
OCI-Ly19,UNC0638-navitoclax (1-1 mol-mol),0.6251807252163226
HOS,3689413,-0.1573622709293647
NCI-H1573,24180719,3.1860388048083603
SaOS-2,6852167,2.181246544986129
HCC366,46907787,0.88765268675736
SNU-C1,49766530,0.3403545416536475
ACC-MESO-1,107970,3.0129300087399744
SNU-878,262093,4.410693672921156
JHH-6,73707398,1.7993372824385652
MIA PaCa-2,262093,3.1147038686055812
NCI-H196,135999136,4.3823476311898855
MDST8,46907787,1.4338285439483007
SK-MEL-5,5460769,5.96903783579764
NCI-H226,156414,2.826440859061599
LOU-NH91,241158,4.097895358021133
G-402,selumetinib-JQ-1 (4-1 mol-mol),1.4151237701172463
SNU-8,136227924,2.992589463119238
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
U-251MG,10302451,3.867935268510184
LAMA-84,135875424,3.803439858623824
NCI-H2291,107970,2.284745408670311
NCI-H2405,4259181,-0.9091972697869036
Caov-3,6852167,1.75620045611788
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
ECC10,439501,-2.678077063421273
SNU-761,135875424,3.262050115513109
NCI-H1573,9903786,2.787588976876453
RPMI-6666,selumetinib-JQ-1 (4-1 mol-mol),0.5297817690201579
SK-MM-2,4259181,0.7170509806722623
ALL-SIL,9936388,-6.364749169872344
RCH-ACV,135999136,3.734219341327072
SCC-4,327653,3.2036873464171003
TE-1,9915743,1.1903317834538285
KNS-60,644241,2.4844336494007706
Rh30,135421197,2.937313489864044
8505C,73707398,1.096799488168713
B-CPAP,168313016,4.426367892913076
DMS 53,9915743,0.9976254394471727
SNU-201,135875424,3.4476242027363715
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805
OS-RC-2,9915743,1.7303629724196847
IM95,46907787,1.2487466118215294
5637,136227924,2.876940542257041
EoL-1,6852167,-0.9141942843071824
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
U-CH1,24180719,3.645067118877854
KHM-1B,375860,-0.460638651136882
RERF-LC-MS,241158,4.36087401910034
HT-1197,4259181,1.1662801512055228
SNU-119,10231331,4.363406465804169
SNU-C1,168313016,4.005521663397634
NCO2,107970,0.4926308981227985
GA-10,156414,-0.0566742081865969
JHUEM-3,439501,-2.1632963006772075
A-673,9915743,0.6829950735134661
VCaP,168313016,4.030935975123804
SJSA-1,3689413,0.2987109884776379
BL-70,5460769,4.3376670104082455
647V,73707398,0.9172695307391888
NCI-H838,135875424,4.377927908580301
U-CH1,5460769,3.546164006563716
KMS-12-BM,644241,2.605305599492216
Panc 10.05,136227924,2.25248962667623
BT 428,444795,3.9327551144919584
JURL-MK1,4259181,-1.935656248556129
DEL,46907787,0.775499404701727
NCI-H69,11455910,1.576050849827518
COLO 684,100016,6.373471933627605
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
KP-3,262093,2.764663205540099
OCI-AML-3,9927531,5.116735976562035
CHP-212,135999136,3.677189987225608
LS123,107970,2.423370198781075
SW48,11396600,3.829401994456863
SNU-668,262093,3.825984415177203
OAW42,26596,0.2521816339620648
OVCAR-4,327653,2.6970207290226136
T24,9915743,2.484963977138841
RL95-2,12003241,-0.4521887729146946
NCI-H1703,241158,3.8145496221130464
SK-MEL-3,11455910,1.2991192016646154
NCI-H810,46907787,-0.1951086170067281
Caki-2,49766530,0.634494181094052
NCI-H1693,9903786,3.776760773308461
REC-1,24180719,5.326289522106428
HEL,26596,-1.8679385890512872
Sq-1,71466445,3.0659362414230795
HEC-151,262093,2.667137080366997
NCI-H661,327653,3.5614910429728295
HEL 92.1.7,UNC0638-navitoclax (1-1 mol-mol),-1.3520489193994385
HuT 78,12003241,-1.0527217193191982
BT 179,54626689,4.864817799699987
HOP-92,100016,6.879559613863246
COLO 201,5460769,4.015779319815586
LC-1/sq-SF,73707398,3.503978721535421
JMSU-1,9903786,1.2487858864951975
MFE-319,135875424,4.6574477212915015
OVSAHO,135875424,4.354044130900052
NCI-H1568,135875424,3.0063280878885967
U2OS,9915743,-1.5669717520878548
NCI-H1734,5460769,-3.3513439751679983
HCC1419,73707398,1.4255015605860972
Rh30,135398744,6.322590827161508
MCF-7,241158,3.9263571249685874
SNU-886,49766530,-1.8017914460493445
HEL,136227924,2.725456875957553
NCI-H2196,3689413,-2.371911217935783
Peer,136227924,2.1160969435978303
BICR 56,168313016,4.673512744968894
BICR 18,9927531,5.5562254884624895
OC 314,9927531,4.337134005776663
HuP-T3,262093,3.018266583248783
SNU-423,71466445,3.7020222675723646
BV-173,135875424,3.775066116863956
NCI-H1395,135421197,1.2810683988074232
PK-45H,107970,2.275385985235783
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
NU-DUL-1,49766530,-3.828248490513479
NCC-StC-K140,24180719,3.6527660288257415
RKO,24180719,5.308193040989237
Calu-1,241158,5.139545731518775
U-87MG ATCC,135421197,3.5274943050860874
SUP-T11,136227924,2.659905722722051
HCC366,44489367,4.343333435745529
NCI-N87,375860,-0.928197184659684
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
TE-1,135999136,5.1786705831528055
T84,54626689,4.466094804413681
BT 216,UNC0638-navitoclax (1-1 mol-mol),1.86314072706696
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
SNB-75,136227924,3.131186635449868
Panc 02.03,6852167,4.143336119644561
SNU-869,11455910,2.0379647800047813
Malme-3M,6852167,4.778936783077254
BICR 16,3689413,1.5183083645706292
MOLT-3,selumetinib-JQ-1 (4-1 mol-mol),2.6811661525029904
NCI-H196,73707398,1.4930546062583872
COLO 668,4259181,-1.074551036430991
DMS 53,135421197,0.687232619284389
KO52,UNC0638-navitoclax (1-1 mol-mol),-2.0411974213550965
OAW28,46907787,2.388022074777516
NCI-H211,135421197,0.3603373283624291
COLO 201,3689413,0.7393302797479664
MDA-MB-157,241158,1.407364121620741
KYSE-410,UNC0638-navitoclax (1-1 mol-mol),2.9728532369388425
LS513,135875424,4.138794062430469
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
SU.86.86,9927531,4.197811757313418
OCI-M1,44491742,3.801673396413645
CAL-12T,439501,-3.605636550997873
KE-97,9929138,4.212063934652932
NCI-H2081,9915743,0.926591953046768
SK-MES-1,135875424,4.094460625120135
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789
RERF-LC-Ad2,10302451,4.090867148457294
NCI-H1623,327653,3.600793829240414
NCI-H650,107970,2.390821588287009
RPMI-7951,73707398,0.5772291594495476
HEC-6,73707398,1.1585131254296075
L-540,6852167,1.4633456510076597
OCI-M1,9915743,0.9472890233124052
Ku812,24180719,2.5562197151601413
BT 145,637858,1.269457721746569
SNU-626,107970,2.4650135190130817
NCI-H446,46907787,1.4439556704022858
SK-MEL-1,24180719,0.1393206335004591
YD-10B,11396600,-4.483822340213775
HuCC-T1,262093,2.7118122084105374
HuG1-N,26596,-1.6967804623376053
MDA-MB-453,49766530,3.3081056054922064
TE-11,3689413,2.9978037995561126
KMS-11,4259181,-0.7092027923860437
A-375,241158,3.5865598480759413
Capan-1,327653,3.1248384671803353
NCI-H460,6852167,4.590065962834362
NCI-H2122,6852167,2.6058424993180247
NCI-H1184,107970,2.059526895608455
NCI-N87,637858,1.7879892218708664
Hs 766T,46907787,-0.1882915719944492
MOLM-16,241158,1.7712175579783012
SK-N-SH,11455910,2.5268556232530868
DEL,71466445,3.114463975482827
OCI-Ly10,46907787,0.036156791402413
OVCAR-4,4259181,-0.8572472959044465
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
SNU-1077,241158,4.367473186933375
EM-2,UNC0638-navitoclax (1-1 mol-mol),-0.3416252714331361
NCI-H446,11396600,2.9015736046433607
NCI-H28,10302451,3.4627926284269503
HT-144,100016,6.638904024373049
Hs 611.T,11396600,2.963461604358696
JM-1,107970,1.4704012549786991
SNU-761,644241,2.361328799023618
8505C,4259181,0.207440893124338
SU-DHL-1,637858,0.6782178889909583
P31/FUJ,135398744,5.7727848933678
LS411N,6852167,3.3651093558735035
Ki-JK,439501,-2.4258748646441624
SW1353,49766530,-0.8162034464098388
RT-4,selumetinib-JQ-1 (4-1 mol-mol),2.9367807248544233
WM793,241158,3.83369214528036
MHH-NB-11,5460769,0.1822518013387546
SNU-410,73707398,2.675607708519287
OUMS-23,UNC0638-navitoclax (1-1 mol-mol),4.271209740622461
HuG1-N,135398744,6.4115232793077235
LS180,135999136,4.321194581518088
HCC2218,9936388,0.977315225187753
HEC-59,10302451,4.030247099665508
Rh30,10231331,3.76900481174906
769-P,136227924,4.180099818093012
CCK-81,46907787,-0.7254087381657865
CAL-12T,9915743,-1.8110199185247196
IST-Mes1,10302451,1.9071808976959603
P-STS,439501,-3.4977273473127632
NCI-H2087,9903786,2.3520196427400717
EKVX,44491742,4.084576713807475
MDA-MB-453,26596,-1.0726693130426117
T84,637858,0.2956840752422291
MOLM-6,262093,0.6748168893327547
MHH-NB-11,241158,4.0313756433900885
BT 164,10231331,4.691772823179407
NCI-H520,6852167,1.505656389836919
EKVX,UNC0638-navitoclax (1-1 mol-mol),2.6417819929880126
G-361,12003241,-2.5867066735550623
HEC-151,12003241,-1.83751972949174
SKM-1,4259181,-0.1122232838107409
NCI-H747,54626689,4.597091193033005
SNU-61,100016,6.106397388471953
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
KE-37,4259181,-0.5515633382074134
EC-GI-10,12003241,-1.9756752078564588
WM266-4,135875424,3.043976656542822
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
CAL-29,5460769,2.8970816736671416
SNU-308,9903786,2.008516122429012
NCI-H1838,107970,2.381888048616505
MDA-MB-157,49766530,-2.405889714389838
NCI-H2081,9927531,2.933726437844289
HEY A8,262093,2.6286127201317835
HEL,375860,-0.4243086466742362
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
SNU-1033,12003241,-0.6294445516416565
DB,26596,-3.691509767021521
Sq-1,9929138,7.093151024107166
COV644,44491742,4.3354697105959055
ChaGo-K-1,12003241,1.029111103028103
COLO 320,4259181,0.6482581902948412
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
VM-CUB-1,9936388,-1.2208910173981742
SNU-886,9915743,1.7822621128192635
KO52,54626689,4.497055456581237
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
PC-3,9936388,2.7801122668619738
BV-173,24180719,2.8991745630687986
NCI-H2087,11455910,0.3125785540763442
TT2609-C02,135999136,6.167464859374325
BT 145,49766530,-0.5681033515253969
KE-37,10302451,3.144943536566891
MOLM-13,6852167,0.0474303723036755
OS-RC-2,241158,5.89413073451188
JURL-MK1,375860,-0.9544947155395412
BT-12,135421197,1.7013160656627575
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
VCaP,49766530,-0.3741263874855742
U-CH1,107970,1.9849994578449
SNU-1,54626689,4.406316252118573
HuH-6,6852167,2.719206575723939
HCC44,4259181,-0.6862286642496935
NCI-H28,9915743,1.3436778069227204
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
SK-MEL-1,9927531,4.509159168037888
Granta-519,135999136,4.28714374371566
HCC44,100016,5.500199899639815
TT2609-C02,241158,6.14247238841205
ONCO-DG-1,3689413,-1.9285483999998865
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
HT115,11396600,3.748253613191512
LMSU,54626689,4.479048602124445
Capan-2,selumetinib-JQ-1 (4-1 mol-mol),1.8393844312735137
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
HCC827,9903786,1.5312362888468285
SNU-C5,4259181,0.2951385005953514
NCI-H1869,136227924,3.4575085361719955
NU-DUL-1,9927531,4.217714200280878
Lu-65,4259181,-0.4284059095013066
NCI-H322,10302451,1.3901154750786564
OC 314,107970,2.3630132830347343
U-937,46907787,1.778074875045128
Hs 888.T,135421197,-0.1341748338568028
NCI-H1299,9936388,-0.1781231784373126
TE-10,6852167,2.690583082482836
SNU-423,135875424,3.328445896940313
SNU-899,5460769,1.25373521066823
CAL-27,3689413,-0.5192231908073464
OE33,selumetinib-JQ-1 (4-1 mol-mol),2.2373751377171938
KMS-27,439501,-2.6111087383065597
NCI-H650,4259181,-0.4685648042874594
OCI-M1,11455910,0.9199836560966144
SNU-475,9903786,5.095134957133182
NCI-H2110,9903786,2.318107893964858
ME-1 [Human leukemia],11396600,3.0194011260213824
CHP-126,136227924,2.2251507312000576
KO52,262093,1.2878327274871448
KE-39,9929138,5.605001473491643
HCC202,136227924,3.1235993915196723
F-36P,9915743,0.3844593263484804
RERF-LC-A1,49766530,-2.6105960143319487
NCI-H2170,9903786,3.56987053348202
COLO 741,327653,3.3444058509126076
NCI-H1838,4259181,0.6400249787419052
NCI-H1105,3689413,0.7120747688732703
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
RCC10RGB,637858,2.3286326267725084
U-CH1,262093,3.1428300622202014
L-1236,444795,2.729490341854986
CAL-85-1,10302451,1.9167496661673895
NCI-H1944,selumetinib-JQ-1 (4-1 mol-mol),0.9541404535319424
U-118MG,327653,2.9357126354671363
647V,12003241,-0.2300893498058843
CJM [Human melanoma],selumetinib-JQ-1 (4-1 mol-mol),3.328512112066071
YD-8,49766530,-2.0839194852213976
WM1799,375860,0.5990452165912616
D283 Med,46907787,-0.0797634926932206
MV4-11,3689413,-0.1876256430889787
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
MOLT-3,135421197,0.6925394528870177
H-STS,10302451,3.908664464224374
OCI-AML-2,9929138,5.333806393496855
EKVX,136227924,3.396888883126824
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
HEC-50B,439501,-2.0612919893622084
KO52,selumetinib-JQ-1 (4-1 mol-mol),-1.2096541805376022
BT 164,9915743,0.6934008137449594
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
TE-4,375860,-0.3741121439305557
LP-1,selumetinib-JQ-1 (4-1 mol-mol),-0.0299849732495822
OS-RC-2,107970,2.550901736917197
Hs 688(A).T,156414,1.563615855647258
KMS-21-BM,71466445,2.8050552373531694
647V,49766530,0.7545140228303677
PE/CA-PJ41 (clone D2),44491742,4.176291442698054
SCC-9,107970,3.0149180037966095
Karpas-299,241158,1.626419354952072
CHP-212,10231331,-5.947772300553975
NCI-H2122,11455910,1.0821419204732732
KMRC-3,6852167,2.76779483892737
MOLM-6,135999136,3.668986326514268
BT 444,9936388,1.54368416560238
RPMI-7951,9915743,0.6767769344324703
Hs 895.T,644241,2.271304651362579
CAL-51,136227924,2.079284078064279
KO52,5460769,4.4327211318187745
SNU-C2A,12003241,-1.200287436461147
BT 333,107970,2.568042136344133
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
DU145,11455910,2.077410590950561
OCI-Ly19,135875424,3.926549898319096
NCI-H510A,46907787,1.6646540248102413
IPC-298,73707398,0.9731823872438464
KP-N-SI9s,135875424,2.000984128197718
KP-4,637858,2.2303750130637163
FTC-238,375860,-0.2933892047161701
COLO 680N,12003241,-0.3137141462022448
GOS-3,9936388,2.12022290506738
HT-1376,4259181,-0.3817300080320475
Hs 294T,439501,-2.312914558527944
Capan-1,71466445,6.280411506729028
CAL-85-1,100016,6.683113656599713
JHH-1,10231331,4.365919080349219
BL-70,54626689,2.3891090820704894
EHEB,9903786,1.657877258917439
OVCAR-5,136227331,3.878676395565833
Reh,12003241,0.0982187894519585
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
SK-UT-1,selumetinib-JQ-1 (4-1 mol-mol),5.500503252581381
SK-N-MC,46907787,0.041820408065543
SNU-201,439501,0.2163207704150155
COR-L95,44491742,4.146782751375218
BT 333,6852167,3.960179900726511
NCI-H1105,11455910,0.5219957952901316
L-428,11455910,-0.1426546871205822
KMBC-2,selumetinib-JQ-1 (4-1 mol-mol),1.4650712581947256
HT-1197,136227331,4.1686832896523685
CAL-148,9929138,4.85675773122561
MOLM-13,10302451,1.7245492330691454
Li-7,73707398,1.3993074762120628
Calu-6,selumetinib-JQ-1 (4-1 mol-mol),2.1275623712302454
PC-14,73707398,2.0324483303809666
EFO-27,46907787,4.067144836646944
SK-UT-1,11455910,0.1513173468225572
COR-L95,6852167,3.112371536345172
JHOS-2,10302451,3.465482157276917
CAL-33,6852167,1.8112207544736203
COR-L95,262093,1.2094317801688714
HL-60,135875424,4.0116269121044015
SW982,12003241,-0.7831418604360746
JHH-1,637858,3.237981035954196
JHOM-1,135875424,4.80614919695595
SNU-16,135875424,3.101421210140047
SNU-308,107970,2.9327058246303483
HT-1376,135875424,3.6702822969792193
EFO-21,49766530,0.1419770754491262
NCI-H508,107970,2.3621486723726126
HuP-T4,46907787,-0.6151499250248685
NCI-H460,135875424,3.211754300989152
BHY,11396600,4.25848737272748
JHUEM-1,136227924,2.224041693066133
WM793,10302451,3.996584762768067
BT-549,637858,2.0216713295762614
G-292 clone A141B1,49766530,-1.892767942202222
SNU-C5,selumetinib-JQ-1 (4-1 mol-mol),1.2815948498049754
EC-GI-10,135421197,2.6554260651885944
HDLM-2,135421197,3.3057353966925613
SNU-478,11396600,3.7061070175674904
SNU-410,44491742,4.2778322604140815
EC-GI-10,637858,3.0023579305682953
Hs 294T,71466445,3.938194222071139
U-BLC1,71466445,2.8221839412497864
ChaGo-K-1,262093,3.038007559777189
COR-L105,10302451,1.2881684147693646
WSU-DLCL2,44491742,3.7672171779194983
DMS 79,49766530,-1.9641825285331105
SF268,12003241,-2.0418893916572243
COR-L95,241158,4.468160037389037
BICR 31,10302451,2.0763164615496232
BT 504,4259181,0.909538881723855
MDA-MB-468,3689413,0.3907824455820104
TE-5,9915743,-0.2115886110471379
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
5637,135421197,1.1694761088255747
SNU-1272,UNC0638-navitoclax (1-1 mol-mol),1.3009701153803632
NCO2,241158,1.6159541696435746
NOMO-1,135421197,1.2386186938920458
HuH-6,9915743,1.4192862158653652
MHH-CALL-4,5460769,0.3846301145612474
HCC202,selumetinib-JQ-1 (4-1 mol-mol),2.9874459844488315
NCI-H2342,24180719,4.665288727484187
8505C,262093,2.08540105499643
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
NCI-H1435,selumetinib-JQ-1 (4-1 mol-mol),2.795744930742413
SK-N-BE(2),73707398,0.4235514927917171
A2780,9929138,3.988043631552867
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
KNS-42,9936388,1.888318570516148
HT-1080,71466445,2.000268821259553
MV4-11,9936388,-6.825137915729416
HCC1195,UNC0638-navitoclax (1-1 mol-mol),4.3671706235216465
MIA PaCa-2,10231331,2.934704407633453
KP-N-YN,9927531,3.406811023385209
Mel JuSo,439501,-1.0789226024470335
DMS 273,54626689,4.997985813086497
BV-173,9915743,0.6416286379608698
PaTu 8988s,3689413,2.020164099747706
G-292 clone A141B1,135398744,6.65861915049708
PSN1,9927531,4.910271279543014
HCC4006,262093,2.439333720308208
HCC1588,6852167,2.2560831218356583
SCC-9,439501,-2.6581193485563737
REC-1,46907787,4.0420421547178975
HEL 92.1.7,136227924,2.7818707499809188
BICR 22,5460769,-1.4539525700949456
Lu-99,44489367,6.260129637386264
MDA-MB-231,10231331,2.949013721621845
MeWo,637858,1.1064250861176543
KCL-22,262093,2.312361441448963
SKM-1,10231331,-2.5704839701228117
L3.3,241158,3.9670067644952702
SW1271,49766530,-1.8216621121390524
SUP-HD1,49766530,-3.081720899400098
P31/FUJ,375860,-1.2092771030706315
SNU-398,3689413,0.8860664930016563
KMM-1,44489367,3.94610724381061
NCI-H1184,241158,3.551679636073963
T3M-10,selumetinib-JQ-1 (4-1 mol-mol),1.5480323853814495
CL-11,10302451,4.255690428034535
KMS-27,71466445,4.755423613019404
GMS-10,3689413,-2.2812112324373057
TE-4,9927531,4.138970102101572
T84,49766530,-0.5596671678676561
SNU-620,9903786,1.530835439194961
SUP-B15,135875424,3.3386210567856462
TUHR14TKB,10302451,3.933491064202245
MKN7,10302451,4.64665224424522
LC-1/sq-SF,637858,3.634884010371685
253J,44489367,4.176368567094206
CJM [Human melanoma],3689413,-1.0332065150817793
A-549,73707398,2.11945224002363
JHUEM-1,156414,1.11415290016218
OVCAR-4,135398744,7.790531663529689
NCI-H1355,375860,-0.2835588127763641
COLO 680N,10302451,2.7755387285317266
WM983B,135421197,2.3980917008752725
RD,637858,1.496545007024156
SHP-77,selumetinib-JQ-1 (4-1 mol-mol),1.1256176667196132
EC-GI-10,9915743,-1.6990033620090657
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
EHEB,327653,2.436506136039934
HEC-1-A,54626689,4.33879506199334
PLC/PRF/5,71466445,4.409191653894859
JJN-3,73707398,-0.471172401917679
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
NUGC-3,9915743,-0.9717204559547163
T84,135875424,3.2008335504024963
RCC10RGB,54596490,4.957303932772775
SNU-119,439501,-2.3303537311085143
HEC-1-B,selumetinib-JQ-1 (4-1 mol-mol),-0.661425337744121
RKN,375860,0.0559819210079563
SNU-620,135421197,2.4250401955395984
RL,136227924,2.481613482211788
NCI-H2342,6852167,3.4879830506373817
23132/87,637858,2.155811558126407
OAW28,4259181,0.9119817479539226
VM-CUB-1,10231331,1.4888918847331971
IA-LM,3689413,-4.432004355370191
IGROV-1,44491742,4.406671418311328
NCI-H1838,241158,4.182638843798734
MOR/CPR,100016,6.350482300205422
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
TT2609-C02,26596,5.442135867718664
BT 228,439501,-2.264868941994625
LS180,73707398,1.191690395470446
GSS,10302451,2.0776350865742623
NCI-H460,135875424,3.211754300989152
P12-Ichikawa,241158,2.9729795131964063
BT 248,44491742,4.160095989296475
COLO 678,241158,4.15604357395598
COLO 792,327653,2.8843710408539964
SNU-16,9927531,3.2030544942563317
Hs 822.T,49766530,-2.239699786404697
NCI-H838,4259181,1.813760126667212
HCT 116,12003241,-0.2623292503702257
HT-55,5460769,6.100853443002961
SNU-1076,4259181,0.5064465956182325
SNU-761,262093,1.8734688668170425
DOV13,241158,3.7297667131482335
HT-29,4259181,1.101372694592505
SK-HEP-1,5460769,6.10306620405049
COLO 699,26596,-1.9597259723317009
SNU-1196,73707398,2.467226592979981
SNU-869,637858,2.513376946079908
TE 617.T,54626689,4.601521502493687
NCI-H841,selumetinib-JQ-1 (4-1 mol-mol),3.1374958176608603
KYO-1,11455910,-0.2516095405982875
JHH-4,4259181,-0.2871438619353636
NCI-H520,135875424,4.041449952679746
SNU-216,54626689,5.715021569760538
NCI-H1341,11396600,2.1149833327737615
SNU-738,637858,2.247136359045344
MHH-CALL-4,selumetinib-JQ-1 (4-1 mol-mol),-0.4835284848569625
NCI-H520,262093,2.5616079053074787
YKG-1,24180719,3.9983429760657265
PE/CA-PJ49,26596,-2.486533753867605
HT-1376,107970,2.532514719500574
GaMG,136227924,2.741790754216058
A3/Kawakami,5460769,1.7157310456182762
OVISE,3689413,-2.3316050545360136
NUGC-3,241158,4.199647797705153
MKN74,444795,4.813746668426388
HPB-ALL,9929138,6.3136934521225445
Hs 888.T,6852167,1.984642924657964
HCC15,168313016,4.627209757330862
Raji,71466445,2.2613596218999295
BT 504,9903786,2.1257740171546717
KYSE-70,73707398,2.029692143461395
NCI-N87,10231331,4.183605147658756
BT 440,46907787,5.667511206840828
HEC-151,637858,1.4744237971842309
NCI-H1650,9927531,5.159202312794284
SNU-407,135875424,3.3406481823919627
SNU-761,3689413,-0.7506907427890448
8305C,9936388,-4.900292137873706
HCC1500,262093,2.85046563878574
NCI-H2030,3689413,1.2400324738328432
A-673,4259181,-0.6373852614685119
JHH-2,156414,1.429842756041678
NB4,241158,1.760612084671808
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
HuT 78,168313016,3.837657248427472
HCC1833,44489367,4.329044594834159
TOV-112D,375860,-0.3825926571920917
SU-DHL-10,107970,2.4723265497575397
BT 131,11396600,1.7130676585109468
SNU-213,6852167,2.322505898014435
HD-MY-Z,54626689,4.2520115750124345
SNU-685,100016,6.855109756647912
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
BT 231,49766530,0.2532028472914431
AML-193,135875424,2.8839431116482803
MeWo,selumetinib-JQ-1 (4-1 mol-mol),0.1566106193221408
KMRC-2,6852167,1.9056104142520949
SNU-466,444795,3.973309413484701
CCF-STTG1,6852167,4.451400297706149
SK-MEL-1,6852167,3.260361139868282
RKO,44491742,4.905526099010324
NCI-H2122,10231331,1.1462222888418094
LCLC-97TM1,439501,-2.367039612081251
NCI-H1703,12003241,-1.7949432370006393
HOP-62,54626689,3.8543822457381687
OPM-2,44491742,3.727542800888903
HT115,135875424,4.178256004737694
NCI-H524,135421197,1.1654489956873584
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
BHY,135875424,4.814173497924925
NCI-H1869,73707398,1.8797199164844864
DB,136227924,2.1225886217744376
HSC-2,selumetinib-JQ-1 (4-1 mol-mol),1.4656219122240142
SNU-410,72967,3.703184158128847
KYSE-510,26596,-0.7866712659714874
HL-60,444795,2.82308006165913
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
NCI-H2052,9903786,2.0027287626066297
CAL-62,262093,2.299935005581277
BT 147,11455910,0.0190221125535866
MOLT-3,44491742,3.801093183463652
MOLT-3,135875424,2.964820433196679
Hep-G2,637858,2.4710681435790747
Hs 888.Lu,9936388,3.0019673480858455
NCI-H2087,100016,6.366125554898137
SK-MEL-24,selumetinib-JQ-1 (4-1 mol-mol),-1.505467160134209
JHUEM-3,46907787,-0.2270381387910647
697,135421197,-0.0099062080038934
SNU-182,168313016,5.05876054110742
SYO-1,46907787,-0.8384354430594259
IST-Mes1,73707398,1.324483483158502
SW579,262093,3.2995610578191683
HEL 92.1.7,375860,-0.1874438560569251
Karpas-299,9929138,6.330957122742023
NCI-H1915,11455910,3.6924393637334703
COLO 680N,73707398,1.0530287264392622
P12-Ichikawa,54626689,4.071904833007741
COLO 741,selumetinib-JQ-1 (4-1 mol-mol),-0.2608627934385684
CCK-81,11455910,1.1979404959065163
COLO 699,439501,-0.4708312711011941
LS1034,9915743,2.2707321419893094
HCC1438,5460769,1.743757679133544
COLO 201,10302451,3.777843454625055
HCC2108,24180719,3.7452058347449033
HCC15,46907787,1.7788170946404287
SNU-182,46907787,0.3516168249380413
MeWo,135421197,1.5459550604441452
MKN74,327653,3.1147590669580847
OUMS-23,136227924,2.42742246798026
NCI-H28,9903786,3.2913179081195776
ONCO-DG-1,168313016,4.429383977943416
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
AGS,135421197,2.7162637897993123
SNU-620,135875424,4.164173792833431
CAL-33,46907787,3.1182368809636487
SNU-C5,107970,1.938594575048687
OCI-Ly19,54626689,4.591922542094535
UO-31,UNC0638-navitoclax (1-1 mol-mol),1.0830521696478217
COLO 205,73707398,1.5350438237256383
CCF-STTG1,12003241,0.9586959919868534
MHH-CALL-3,156414,0.7888389372381419
TALL-1 [Human adult T-ALL],49766530,-2.2368967155466586
BT 131,9927531,5.2651806903181235
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
DB,241158,2.7771018526302056
SJSA-1,11396600,3.615139997245977
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
JHOM-1,UNC0638-navitoclax (1-1 mol-mol),-1.7781569058579632
EFE-184,156414,6.238077429363588
HEC-1-B,439501,-2.327113074925545
SNU-387,135421197,2.3985099297623815
NCI-H1299,46907787,1.4375849802030871
HCC4006,637858,1.3165870232425092
CGTH-W-1,71466445,5.8893630337243446
LAMA-84,644241,-4.93711557474261
HuP-T4,9936388,-6.160630678520688
SK-CO-1,6852167,2.111498553552754
MOLM-16,439501,-2.4166934958345476
CAMA-1,6852167,3.8047331998506526
SF268,3689413,-1.0049822928368335
SU-DHL-8,24180719,3.8548274906185793
HuG1-N,9927531,4.775383733857977
SNU-466,135421197,3.5326251478471877
NCI-H1568,11455910,-0.0792581795853734
NCI-H1694,54626689,4.576851136016779
LCLC-97TM1,71466445,2.7974721848465025
EFM-192A,9903786,5.377742197319564
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
HCC1806,136227924,2.6306602850580387
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
BV-173,327653,3.1495796349784477
KMS-34,9929138,4.716780019482296
HCC1954,327653,2.7726038968609847
Aska-SS,327653,3.2557442863738033
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
MOTN-1,135421197,1.3703744240022513
WM1799,136227924,5.317137472440357
SUP-T1,10302451,2.7674350059847344
NUGC-4,12003241,-1.4802161759010128
Li-7,44491742,3.4427957124518325
253J-BV,9927531,5.275278966830564
GI-1,327653,3.210184617717175
Kasumi-1,644241,-2.415467387593779
BT 428,262093,2.2051737857299547
HCC15,71466445,3.952377160133232
CW-2,241158,3.8389238376142822
DoHH2,12003241,-3.729445034849217
SNU-1214,5460769,-0.9519860634538546
LS1034,4259181,0.5645346336831063
NCI-H292,136227924,3.1886204590132654
EBC-1,73707398,0.9440582877963352
Mino,444795,1.9878842537418735
TT,11396600,4.947180830424627
JIMT-1,135999136,4.503963053903458
Hep-G2,107970,2.033740391106035
NCI-H358,3689413,0.3269344418253172
HuH-1,3689413,3.5538877505923097
2004,375860,-0.4306769141118115
BT 428,5460769,2.5146871392563845
VMRC-LCD,136227924,2.9641387298533868
DB,10231331,4.346778551144196
KM12,4259181,0.925682230598446
KCL-22,100016,3.971728515649248
JHH-4,444795,4.954557242601277
LS180,135421197,1.2375553911833763
CMK,327653,3.684751642752481
Hs 936.T,10302451,3.751378963953563
HuP-T4,262093,3.072428366481475
SIG-M5,5460769,1.4726407580947376
Capan-1,11396600,3.9695297031649384
GSS,11455910,-0.448056775545068
SEM,10302451,1.800985187016429
A-253,135999136,4.704597459303478
WM793,107970,2.3599025930331368
TALL-1 [Human adult T-ALL],136227924,2.458144705929413
CAL-27,49766530,0.710892933347092
DMS 273,11396600,2.9821670224503025
CAL-54,54596490,6.393585920661526
HuP-T4,10302451,-0.1170952178700548
A4/Fukuda,49766530,-0.1813275565198268
NCI-H810,241158,3.83353914911485
HCC1500,11396600,2.707080690171913
BT-549,100016,6.139281322747303
HuT 78,3689413,-1.8719775604380453
MKN74,selumetinib-JQ-1 (4-1 mol-mol),1.7394351663824423
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
VMRC-RCZ,11396600,4.06764978038785
ECC10,73707398,0.3199143694659382
BT 428,9903786,3.72207082245763
OVCAR-4,9929138,6.8802220195172525
DU4475,selumetinib-JQ-1 (4-1 mol-mol),-2.9281799022987234
RT-4,107970,2.3841738823851255
U-BLC1,5460769,1.2363713333826207
HCC1500,375860,0.1348683063529126
HH [Human lymphoma],24180719,3.0043474911652375
KMS-26,439501,-2.394060102049288
OV7,9927531,3.7573149322821937
YD-8,4259181,0.3383272267042485
BxPC-3,71466445,4.819923879864087
YD-15,46907787,-0.7954794802454365
RKN,262093,2.5285063130840344
MOTN-1,12003241,-0.0935669928398487
SK-MEL-1,9936388,1.368356716964437
HCT 15,11455910,-0.2039943057976136
Hs 683,439501,-3.4221859538690467
SNU-C1,241158,4.295259005445246
TE-8,4259181,0.2121873060682536
Panc 03.27,3689413,-0.1085312900774309
EFO-27,6852167,4.289895730200754
MJ,73707398,1.2722011507797648
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
NCI-H1581,9927531,4.312096995742435
Rh30,4259181,-0.0513529873152824
PaTu 8988s,136227924,2.43354349220747
NCI-H2126,71466445,2.8907750872786404
OPM-2,156414,0.898749748032719
RL95-2,6852167,2.7207432389099395
A2780,9903786,1.372407357095215
NCI-H1623,107970,2.966658693868389
Aska-SS,11396600,4.186494523446212
NCI-H661,3689413,0.5447440822016135
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
Namalwa,12003241,-3.0032452893334596
SNU-5,168313016,6.260174128040875
TE-4,9936388,-6.469304697668828
M059K,26596,-1.203189408299565
Karpas-422,375860,-0.2340212994929422
Mel Ho,10231331,-2.0849495719271927
ACC-MESO-1,44489367,5.824107451823484
Pfeiffer,9927531,3.43317918273791
P3HR-1,10302451,3.345429510731406
MIA PaCa-2,46907787,-0.2565491752841508
YH-13,637858,2.290172126875016
SIG-M5,44491742,3.8291239619503905
HH [Human lymphoma],4259181,-0.4800103115462393
MeWo,262093,2.898334268827345
MES-SA,135421197,2.6547553279335543
SW1783,5460769,4.078393209152703
HCC4006,4259181,2.039618139148504
A-498,107970,3.0044685679861054
Rh18,3689413,-2.3361578419795843
SNU-46,3689413,0.3621274861005061
U266B1,73707398,-0.6379528045224374
SNU-8,439501,-2.494664293068585
SNU-1079,73707398,1.1905051072298996
Hs 934.T,10302451,3.3765537918569812
BT 131,46907787,3.719666358571709
KYSE-520,4259181,-1.1472347902805615
UM-UC-1,10231331,0.2237903001677945
MKN74,12003241,-0.9650452844715884
SNU-61,135875424,3.609444893060012
YAPC,9936388,2.1810367621372095
AsPC-1,11396600,3.3240147605355506
Kuramochi,9915743,0.8375201089369183
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
A-253,444795,4.639406715254548
DMS 114,135999136,2.324166381403774
TE-15,107970,2.289738953976788
SUP-HD1,9903786,1.2830576514216323
NCI-H1838,262093,3.1825262883222836
HEL,12003241,-0.3954740832299299
SNU-1,9927531,3.402077148066899
JK-1,439501,-2.3094568759097265
GCT,10302451,2.4573372812580354
WM266-4,9903786,4.44287748208762
JVM-3,6852167,1.039296799861209
MIA PaCa-2,73707398,0.9717738640313962
A2058,10302451,3.911777548937271
NCI-H1734,241158,4.904474400938833
NCI-H1395,11396600,4.124168749082167
SNU-1,327653,3.07634731524816
BCP-1,439501,-3.5020472552151904
PE/CA-PJ34 (clone C12),9915743,-2.2300833448892985
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
RPMI-8402,12003241,-0.4088888603650127
TF-1,11455910,-0.5944245496950694
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
Mino,156414,0.9048152948855052
KMBC-2,24180719,5.106392241669845
CAL-33,9915743,-0.5523572938486134
MIA PaCa-2,9936388,-9.05612896602556
HuP-T4,439501,-0.5281906022533748
NCI-H2291,12003241,-0.3481975958318299
COLO 205,262093,3.276906461196508
K-562,168313016,4.482960220744853
KYM-1,135875424,2.5463366788137427
MKN74,375860,0.5646140741524153
HMC-1-8,9936388,-5.4088494773522395
OE19,637858,2.3590283739366145
SNU-119,241158,3.4983662079339295
DMS 79,439501,-2.1979819291914224
OVISE,9929138,5.66720682434708
AMO1,241158,1.849274294802101
DK-MG,156414,1.729290001800195
RT-112,10231331,2.3318477678961367
HT-1376,11455910,0.3601219062444335
SET-2,168313016,3.716090786123575
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
BT 248,156414,1.4948422332158926
GSS,9929138,2.058801232137709
SUP-M2,4259181,-1.314414971411119
U-251MG,136227331,3.886496175618068
SNU-899,9877608,7.308498444418231
PC-3,54626689,4.828583340763222
CADO-ES1,5460769,-0.4724140531139457
NCI-H929,4259181,0.6476848617762108
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
NUGC-4,9915743,-4.1416967256258275
TOV-112D,9927531,5.049724327124321
CAL-54,10302451,-0.9489487854638172
ECC10,12003241,-2.873030940363692
PF-382,4259181,-0.6205773881868614
KO52,135421197,1.227280721989531
HMC-1-8,10231331,-0.5576269220838886
KYSE-510,100016,5.186546688011686
CCF-STTG1,10302451,5.711005870244634
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
KYM-1,5460769,0.1657624677468328
SNU-719,9903786,2.245774395512323
NCI-H1915,262093,3.400332041553307
OAW28,24180719,4.377592888188756
WM115,439501,-0.2667789802830004
TF-1,241158,3.865318341041154
FaDu,9915743,0.0595730562348672
OPM-2,644241,1.6900050339542656
NCI-H727,10302451,3.178772538514987
HCC827,10231331,5.207740808728872
P31/FUJ,135421197,1.0144502005310674
Kasumi-2,107970,1.3663131605888186
OV-90,637858,2.6658344204605275
MDA-MB-415,10302451,4.0233818677308735
KP-3,637858,2.0723058540314945
SF539,44491742,4.105649274647132
ECC10,selumetinib-JQ-1 (4-1 mol-mol),0.1905940904726353
SW1088,135999136,4.543955103595509
NCI-H1694,100016,6.457618599357896
KMS-12-BM,6852167,1.232935409292076
DMS 454,6852167,4.1609541401682755
NCI-H650,12003241,-0.6460655528270789
SW1088,135875424,2.929496932080149
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
FaDu,selumetinib-JQ-1 (4-1 mol-mol),1.1902235075273182
NU-DHL-1,6852167,1.5672236440525231
KMH-2,selumetinib-JQ-1 (4-1 mol-mol),-2.0810705685207265
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
NCI-H520,9927531,5.647411307076465
NCI-H211,71466445,2.8294314838648473
MDA-MB-468,136227924,1.762243520931147
NOMO-1,9936388,-6.523282887173488
RCH-ACV,9903786,1.555646026251057
HCC2279,10231331,5.2502746127917925
HCC1395,9903786,3.009593050669707
EM-2,5460769,2.512608661279844
SNU-410,49766530,1.0142633339399836
HEL 92.1.7,4259181,-1.2698112333682838
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
NCI-H460,100016,5.855223104671776
SNU-886,135999136,4.094662341834861
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
BICR 56,9936388,-4.960855402776582
KP-4,4259181,0.4203041141920705
COLO 668,9927531,4.694789725560254
C2BBe1,327653,3.1461118239439183
SNU-626,9936388,2.473476131438239
Peer,168313016,3.2061836639817094
SBC-5,135999136,5.333154079184271
LoVo,107970,2.0597080136849795
KNS-81,637858,2.7069879492405313
A4/Fukuda,24180719,2.900503133545593
BICR 16,637858,2.469326044218029
Ki-JK,12003241,-1.478318359413444
ONCO-DG-1,136227924,3.186548860778023
BT 245,49766530,0.0902413739193597
SNU-308,UNC0638-navitoclax (1-1 mol-mol),1.6647275742348495
NCI-H810,26596,-3.4871956530659927
WSU-DLCL2,11455910,-0.3356389260792345
SW1990,6852167,2.6280721153803843
NCI-H226,9903786,4.103639248775795
COLO 205,100016,5.963233409359241
SNU-478,44489367,4.364697701310285
NCI-H2228,12003241,-0.7511130172017173
A-375,46907787,5.129812217042003
MHH-ES-1,135421197,0.9821303635644922
NCI-H2141,26596,-3.569863113976208
TE-9,241158,4.967863865822489
JVM-3,46907787,-0.7519440596115978
HT-1080,439501,-2.2877487074012026
NCI-H1573,73707398,1.66643290760046
DEL,4259181,-1.3760879211511634
MDA-MB-157,3689413,-1.567220624306923
T3M-10,9936388,1.68149243193284
HT,262093,2.3474073826292265
LAMA-84,11455910,0.4620694061975223
NCI-H446,107970,2.2153976675650777
C2BBe1,73707398,1.453704181016527
SCC-4,135875424,3.69532319714556
SK-MM-2,375860,0.1183568668528984
WM266-4,73707398,1.4628063646321043
SCaBER,107970,2.2401170615425676
LXF 289,100016,7.121965810949268
OPM-2,54596490,4.128803973627264
CAMA-1,10302451,4.701896381708503
Kasumi-1,107970,1.9349338275651868
OV7,6852167,2.904721816278503
PK-59,241158,4.280180443060871
Toledo,3689413,1.25181961816846
SUP-B15,168313016,4.060589167875257
GI-1,637858,2.098296851941244
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
SK-MEL-3,54626689,4.613351990823583
NMC-G1,24180719,4.260476623253757
SUP-T1,73707398,0.2441086723916535
KYSE-450,10302451,4.575458638647607
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805
M-07e,9903786,0.8629482504426611
ME-1 [Human leukemia],10231331,-1.3974711314743906
SK-ES-1,9915743,-1.1737874171427145
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
HCC1438,156414,1.65905389006548
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
GP2d,168313016,5.68534337088213
DEL,3689413,-2.5284347391762583
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
K029AX,107970,2.970679690534556
CA46,135875424,2.985562686352135
RMG-I,241158,3.956223740645626
MCF-7,selumetinib-JQ-1 (4-1 mol-mol),2.4423640678398413
NCI-H1385,156414,1.4779200200526772
KNS-62,54626689,4.751862971217072
IGR-1,156414,5.315978843201624
BL-70,73707398,0.9826136409699476
BT 416,11455910,-0.2427833720473563
HCC366,3689413,-0.7247636162337553
RD,107970,2.2653970087336313
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
T98G,6852167,2.9321470861606533
SNU-216,3689413,1.0802163076061988
SHP-77,262093,3.3265672360163374
KP-2,9903786,4.272294010971456
BV-173,71466445,1.7673516880901483
SK-MEL-1,12003241,-1.7363712573149035
DMS 454,136227924,3.2899111891910424
Rh41,26596,-2.117854193038536
SNG-M,54626689,4.575857021173439
NCI-H1693,26596,0.3286565515580511
COLO 668,54596490,5.118300220706665
HuH-1,24180719,4.001541004184732
SK-OV-3,9903786,2.611217845094376
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391
CL-11,9936388,-1.838606364908758
SNU-201,107970,3.0289309781280287
HOP-92,327653,3.5254813835673633
Lu-65,54626689,4.680171395498018
EFO-27,444795,5.488221670965637
A4/Fukuda,10302451,3.353566161735505
SUIT-2,262093,4.049104877248936
LNCaP clone FGC,49766530,1.5259250948267933
PK-1,9915743,1.3307464414908754
HT-1080,168313016,5.65627248206995
BT 145,327653,2.8678553441980386
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
PLC/PRF/5,135999136,4.161588438871366
T84,9927531,3.2336753080400933
PE/CA-PJ15,100016,6.230779358531284
Calu-3,54626689,4.413713967520506
NCI-H2122,71466445,3.71055721858648
SK-MEL-3,9903786,4.6944360721993545
HT-1080,5460769,3.028756475221219
COLO 699,selumetinib-JQ-1 (4-1 mol-mol),3.535800123966137
Hs 888.T,262093,2.531155754559327
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
NCI-H2228,262093,3.7725646248304447
8305C,49766530,-2.6247792402938086
HSC-3,241158,3.419773075540372
JHH-2,49766530,-3.049401978968413
EJM,selumetinib-JQ-1 (4-1 mol-mol),1.9175380074632984
LOX-IMVI,136227924,2.635687863612288
LMSU,4259181,1.0604093757007595
Calu-3,644241,2.2382913836957576
KMS-27,4259181,-1.1469286160575058
GB-1,444795,4.7060044385424735
LoVo,136227924,4.6796674015936075
TUHR4TKB,241158,3.690536318141575
HPAC,73707398,1.2360196797474063
NCI-H1563,439501,-2.9827403425963492
NCI-H1581,44491742,3.702285088658523
IMR-32,10302451,3.1192672729398407
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526
SR,135999136,1.8410476011891763
HH [Human lymphoma],135999136,4.178944962809741
RKN,241158,3.8611150596916577
U266B1,3689413,0.1413723785410366
KYSE-510,135999136,4.6232522957296736
NUGC-4,107970,2.3784134624007436
Rh30,49766530,-2.324710777710102
SNU-878,375860,-1.032056104840677
BT 320,6852167,5.054396580410171
NCI-H522,6852167,2.4506568165817777
T98G,46907787,2.563671389341863
SET-2,6852167,2.1824189534016556
SNU-478,107970,2.28578695983555
KMRC-2,156414,1.7005569347395115
CGTH-W-1,3689413,-0.6568714259027654
KMH-2,637858,0.9367437449814346
YD-10B,73707398,1.1278990449683126
Ishikawa (Heraklio) 02 ER-,11455910,1.4574745929250947
Hep-G2,10231331,-0.8368419788063003
NCI-H322,156414,-3.694752457878393
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
MOTN-1,73707398,-0.2089189057600323
BFTC-909,9936388,1.702123766125507
SNU-1033,11455910,1.238389627301748
SNU-1076,100016,6.986031941643801
Ri-1,26596,-3.083821338619051
IMR-32,9927531,3.188320479836116
Ci-1,135421197,1.276790754576014
DEL,135421197,2.352546042439028
WM115,46907787,1.8634039559333693
KCL-22,3689413,0.1679864473503304
NMC-G1,54626689,4.889759047851804
NU-DHL-1,9927531,5.134600574788464
NCI-H727,5460769,4.510942150258337
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
MOLT-3,637858,0.8565038735884491
NCI-H1581,9915743,3.627185987098802
PE/CA-PJ49,135999136,4.298011402376219
MFE-296,637858,1.569825687785107
NCI-H23,73707398,0.5781793163548435
COR-L279,4259181,1.4928439848867712
COR-L105,637858,2.3247583240908405
SK-ES-1,12003241,-1.52997414629941
D283 Med,3689413,-5.066385831563446
PF-382,71466445,1.9189761436188
Daoy,136227924,3.329647267316264
Rh18,168313016,4.6958558766338045
TALL-1 [Human adult T-ALL],UNC0638-navitoclax (1-1 mol-mol),-2.996993812021711
KHM-1B,49766530,-2.233986045015649
BCP-1,54596490,3.9190164950711313
KYSE-140,107970,2.5158058197499384
NCI-H2023,9915743,3.985285977542264
OCI-AML-2,135875424,3.3371422768909857
TT,selumetinib-JQ-1 (4-1 mol-mol),1.1402175654992766
VMRC-LCD,49766530,-0.8677922390975771
SNU-878,10231331,1.1758793721918113
MOTN-1,135398744,7.842138367791958
LN-18,135999136,4.29684161962908
Capan-1,637858,2.0066289365913588
LMSU,439501,-3.1304465735998153
A-204,10302451,2.421522636520457
Kelly,327653,2.684571007540684
DBTRG-05MG,5460769,5.967153987898797
SNU-668,135421197,2.8470371844107274
BHT-101,10231331,0.5195362214151683
BT 239,UNC0638-navitoclax (1-1 mol-mol),-3.437137028059637
KU-19-19,5460769,4.3332822587900255
SK-MEL-28,46907787,3.835105129876131
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
KMS-21-BM,10302451,2.292063608939571
F-36P,49766530,-1.869404688444432
NCI-H1299,136227924,3.5346618762414392
Ku812,9903786,1.763683139425592
MG-63,135421197,2.3239487693953627
BT 498,11455910,2.7063920015971084
NCI-H1105,6852167,3.8396171518707023
Kuramochi,49766530,0.1496678654084536
MKN1,4259181,1.0548548306280776
NCI-H23,135875424,3.011059427080452
DV-90,selumetinib-JQ-1 (4-1 mol-mol),-1.1774042966543188
NCI-H2196,selumetinib-JQ-1 (4-1 mol-mol),3.899366542869125
EM-2,26596,-2.2140652847735027
EoL-1,168313016,2.0659145537185792
YD-8,10302451,2.519210773741685
JJN-3,12003241,-0.0138977078234466
NCI-H841,241158,3.877248650806591
LOX-IMVI,9915743,1.7866984805438202
Rh30,136227924,4.165333500464175
GDM-1,26596,-2.9755879350812964
SNU-5,241158,4.938861844841369
GSU,10231331,1.2076140731561538
OE33,9927531,5.791665708309609
BV-173,107970,2.273734627744329
SiMa,10231331,3.4625935909833583
JHH-6,4259181,1.7336593544042438
SNU-16,24180719,3.1323605363274516
KYSE-410,9915743,-1.3205440456701116
GA-10,UNC0638-navitoclax (1-1 mol-mol),1.4796624390436783
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
DOV13,54626689,4.592497291259624
KMH-2,46907787,0.3409672144404854
DU4475,136227331,3.920684597845916
MES-SA,49766530,3.67980126905318
SCC-9,49766530,0.4117706354329887
BT 286,9929138,6.547331402872382
COV644,12003241,0.3541041054737522
ACC-MESO-1,selumetinib-JQ-1 (4-1 mol-mol),2.43285066252002
JHOM-1,439501,-1.2372155535522604
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
NCI-H841,444795,4.067288283451541
A-549,10231331,2.044831055629592
NCI-H1299,100016,6.953805951258825
JIMT-1,135875424,5.902712544312733
WM793,24180719,3.9443550279133186
Ri-1,12003241,-5.9425936829646435
NCI-H1105,9936388,-6.252003030821692
GMS-10,6852167,2.636274185388478
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
ST486,11396600,2.643350967918509
L-363,637858,1.4329368390332162
BT 179,4259181,0.8094186534058477
22Rv1,46907787,1.6905939183269825
FaDu,46907787,3.7880775071647377
SW1417,9915743,0.7399869758043424
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
Hs 611.T,637858,0.871054087636222
Namalwa,49766530,-1.8902019897608628
KO52,439501,-3.705469726802315
BHY,100016,6.773898116669002
OVCAR-5,644241,1.8863081548750864
BT 232,3689413,-0.4723000491663335
IGR-1,3689413,2.7517007326117957
TE 441.T,49766530,-1.0459972469347878
Daoy,26596,-2.0962215675601024
HT-1080,selumetinib-JQ-1 (4-1 mol-mol),0.5061126238331859
HGC-27,444795,2.4083732799097395
COLO 320,136227331,6.064515235330745
RT-4,4259181,0.4956946540898031
SNU-216,4259181,-0.1596508841879307
HCC366,9936388,-5.702122369307378
NCI-H1703,10231331,6.407882764214753
NCI-H838,73707398,1.6319007245831227
CAL-51,6852167,2.546662292056567
MKN74,262093,3.405035629450505
LMSU,49766530,-0.1291663690745916
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
Caov-3,135999136,5.456324561190912
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
Peer,9903786,1.0379810938538272
TCCSUP,73707398,0.9718071298936178
Mel Ho,637858,1.519372506019662
CAL-51,107970,2.299284460939792
HCT 15,11396600,4.026693260912133
YKG-1,selumetinib-JQ-1 (4-1 mol-mol),2.6528510984038864
NCC-StC-K140,156414,4.00821298519003
YD-8,3689413,-2.153430400522153
VMRC-LCD,375860,-0.2754019641455896
NCI-H520,375860,-0.3875820486223135
A-375,9929138,5.4250105922665375
HCC38,4259181,0.7320315366357028
SET-2,46907787,-2.0840425279846553
GMS-10,24180719,4.030352948191557
Mono-Mac-6,156414,0.1379269816160407
WM88,26596,-3.3679469356752465
OAW42,4259181,0.8701798956954508
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
Hs 888.Lu,9903786,2.210543303670434
Daoy,135421197,1.0307479494466607
NCI-H1568,327653,2.9538763640308403
A3/Kawakami,100016,3.999978023882096
DLD-1,107970,2.55803516550686
786-O,5460769,2.250547826623791
Ri-1,136227924,2.363884089308993
Hs 944.T,327653,2.9907406502537817
CAL-78,73707398,0.878307672243771
OUMS-23,73707398,1.567830139530049
LN-229,9915743,-0.4123038394428829
HCC15,11396600,3.725702968544969
COV362,135999136,4.490973640630612
NCI-H2009,5460769,1.3316086312624285
KMS-34,3689413,-2.478307053017587
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
RERF-LC-Ad2,9915743,1.500109019763864
SHP-77,3689413,-2.4730953136867297
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
BT 422,135421197,2.465319301073433
SNU-C4,156414,0.7755904610848084
JURL-MK1,107970,2.4390351360082954
VMRC-RCW,6852167,3.4570004694788965
NCI-H2085,135421197,1.1751521107550191
UM-UC-3,54626689,4.485744634467296
JHUEM-2,10231331,3.01921809921647
B-CPAP,136227924,3.258845757188781
ACC-MESO-1,136227924,3.807440016829928
L-428,9927531,4.649182566177492
SW579,10231331,4.122750326545354
NCI-H211,6852167,1.2921457601331006
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
BT 145,6852167,3.1517365583575496
BICR 6,11455910,1.839661874011414
SK-N-DZ,135999136,1.9403718347768153
HCC827,100016,4.431453048958875
HMC-1-8,262093,2.6952463235362414
HEC-6,6852167,2.7812009481164894
KMRC-20,49766530,-1.4976923868030616
MFE-296,54626689,4.55025566417521
Calu-3,26596,0.6204289833771246
A-673,9927531,4.216692000672551
DB,44491742,3.5309759894848747
BT-20,46907787,4.606441667420873
F-36P,375860,-1.097600146187803
SW948,375860,-0.5776308885037049
BV-173,73707398,0.4212435272473835
LOU-NH91,73707398,1.1540810865513749
KE-39,637858,2.1285067674718374
HEC-251,135999136,1.694007404717233
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
T24,73707398,1.720352175395374
GI-1,UNC0638-navitoclax (1-1 mol-mol),1.5277702622089633
NCI-H747,168313016,4.938874545890276
EBC-1,11396600,3.453174926041772
ZR-75-30,46907787,5.6188651676565655
TCCSUP,135421197,2.510598154952076
647V,26596,-2.3148144516989184
Daoy,3689413,-2.377724406680773
NCI-H2342,4259181,1.1305245498799386
LMSU,6852167,2.6209493875982277
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
ChaGo-K-1,156414,1.5604886005920922
OS-RC-2,6852167,2.6750903805779833
NUGC-3,375860,-0.2148572525752654
DMS 114,9929138,6.976557704238316
Hs 683,11455910,0.4733989942514576
QGP-1,135421197,1.134586890713183
HEL,241158,3.370113308144609
PE/CA-PJ41 (clone D2),73707398,2.4931970679708972
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
ES-2,10302451,3.824196852311708
NOMO-1,9927531,5.049638663441057
NCI-H647,11396600,2.927909062901915
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
VMRC-LCD,4259181,-0.0718042548985789
SCC-9,375860,0.1694000381305893
OC 314,644241,1.747205449465236
A4/Fukuda,9915743,-0.3554458205966057
DMS 273,241158,3.177272786345067
DMS 53,3689413,-1.7302649812310384
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
BT 286,9915743,1.1038828678808648
8505C,12003241,-1.423942083306862
Rh41,44489367,5.218410162477889
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
Sq-1,637858,1.6916403508982327
HMC-1-8,3689413,0.9110162890999955
DK-MG,9903786,4.148261806293546
SK-MES-1,168313016,3.674631178203009
MEC-1,selumetinib-JQ-1 (4-1 mol-mol),0.0562917055128989
MKN1,107970,2.535523742229024
COR-L88,44491742,3.2658502599700188
KMS-21-BM,136227924,2.0166655260293487
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
SNU-C1,375860,0.032690159170556
SW1990,9915743,2.956888864284862
COLO 699,168313016,4.7973091734297855
Karpas-299,46907787,-0.0391332663516403
A-549,100016,7.181380121169662
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
SK-OV-3,12003241,-1.2313805329375749
BT 498,439501,-2.816531814980934
A3/Kawakami,3689413,-2.523189913009787
JHUEM-3,135875424,4.829807561587815
SNU-61,135999136,5.618921387112628
SK-ES-1,selumetinib-JQ-1 (4-1 mol-mol),3.2551720376366022
SNU-C4,107970,2.5216503815906375
HDLM-2,439501,-2.3355243460723747
SYO-1,262093,2.864571024942669
AN3-CA,135875424,2.655467292479818
TUHR14TKB,11396600,3.8849450559075343
KMS-20,637858,0.4496747428654858
KP-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.6878999698692776
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
HCC1438,73707398,1.5624217708956756
5637,10302451,0.7873719567933962
SU.86.86,9903786,4.655147385880342
KNS-60,637858,1.3304723346285807
Toledo,49766530,2.126888986810566
SCC-4,26596,-2.628163319920325
Yamato-SS,6852167,0.5276701137747644
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
MOLM-13,24180719,3.226510234308061
Hs 936.T,10231331,-0.3842903211878899
OCI-Ly3,107970,2.241121524741462
NCO2,3689413,-3.837216983883232
TT,136227924,2.992692937715844
SNU-1077,10231331,3.484337251970082
KYSE-150,3689413,0.7938684230504212
AsPC-1,135421197,1.8824248695595285
UO-31,9903786,3.174003298065322
BL-70,4259181,-0.5589889707355735
NCI-H661,4259181,-1.4326329693308524
NCI-H28,46907787,-0.1803088776787751
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
DMS 454,10302451,3.267964851725962
A3/Kawakami,135421197,1.197973904783629
RPMI-8402,135398744,6.9217830210823434
NCI-H2085,3689413,-0.2448228197387998
MDA-MB-231,selumetinib-JQ-1 (4-1 mol-mol),1.533786837540601
Peer,3689413,-2.558911360370697
HCC15,136227924,3.0147456858017923
ST486,54596490,5.2508906493958625
EJM,135875424,3.8151689174566665
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
SW1710,107970,2.8501029800719744
NCI-H1395,327653,3.4863341416729847
DLD-1,4259181,0.6000897890539907
A101D,439501,-0.9695989482214274
MDA-MB-361,3689413,-1.8803084883549792
COLO 699,327653,2.3345928950143597
MDA-MB-415,135875424,2.557894559104866
KYSE-510,49766530,3.99865541167158
BT 147,439501,-3.335486008920962
YKG-1,135875424,4.553579428376037
TE-14,44491742,4.678720015809428
SNU-685,375860,0.2053793820891022
SW1271,262093,2.7991981503454495
LS1034,637858,1.918496292413477
HCC1438,100016,5.852637802531623
KNS-60,444795,4.769163680647293
TUHR4TKB,10302451,3.4604204193373387
NCI-H1755,3689413,1.3270015579538552
Rh41,selumetinib-JQ-1 (4-1 mol-mol),0.1512506116205909
KYSE-180,107970,2.4041035075192196
BT 330,selumetinib-JQ-1 (4-1 mol-mol),4.150840661532534
TOV-21G,3689413,-2.863324096900296
HL-60,4259181,0.2304044272519446
GI-1,135421197,1.6519040465788966
LOU-NH91,9915743,1.51930479588737
Ku812,5460769,3.1615206717567608
LS123,439501,-0.5553663251516828
BL-70,9927531,3.241092589782463
HuP-T4,327653,2.942842262184186
HPB-ALL,9915743,0.6969273375453205
SW1271,168313016,5.582938604018868
PE/CA-PJ15,375860,-0.3600146700827705
769-P,49766530,-0.8828677111325465
KMRC-1,49766530,-0.1675164065777726
RD,100016,6.5954800872388155
NCI-H1666,24180719,3.162843399055042
NCI-H1373,637858,2.695780471176255
YD-15,327653,3.7258295405325814
Hs 683,9927531,5.316569157291169
23132/87,327653,3.3687565906187387
GA-10,54626689,2.543732489563001
Hs 294T,107970,1.788602892415094
TCC-Pan2,selumetinib-JQ-1 (4-1 mol-mol),-2.1073076371814667
BICR 56,136227924,3.153782585129781
OE21,9927531,4.992848693668257
SNU-C5,439501,-1.612847853644416
NCI-H810,10231331,4.27940972162908
Hs 888.Lu,136227924,2.7652519196534304
NCI-H1563,136227331,3.8731399869875167
F-36P,327653,3.3003434117548105
A-204,44491742,4.019063545989705
C2BBe1,9915743,2.975671813944452
BHY,9915743,-2.760312091830137
5637,9915743,-2.6589939523871347
HCC2108,10302451,4.138705922344902
A-172,73707398,0.9336261150356991
KNS-62,11396600,3.6666207328470217
HCC2935,262093,3.2004499429644704
Calu-1,12003241,-0.3445186674692038
MES-SA,54626689,4.598798704363495
IGR-39,selumetinib-JQ-1 (4-1 mol-mol),2.11462186606363
G-402,136227924,2.8538202085088185
ST486,6852167,1.0597481979076584
OE33,100016,6.493432597771833
KYM-1,54596490,5.194094726606244
COLO 800,6852167,3.2462624682071493
SNU-C1,73707398,1.1462047039633347
OPM-2,24180719,3.7347961717129383
HSC-2,107970,2.953096914146704
DMS 273,135421197,2.3407622077730035
WM793,11396600,4.503186389543736
HOP-92,49766530,-2.5153256499879517
BT 172,4259181,1.1172021573082116
COLO 741,10231331,0.6549411878869091
HSC-2,73707398,1.5445224580033434
KYSE-150,54626689,4.974861573345204
Kasumi-1,selumetinib-JQ-1 (4-1 mol-mol),-0.6942072614799009
WM115,136227331,3.7917327546536983
BT 164,136227924,2.714674644422482
Hs 888.Lu,73707398,1.7025083015610414
NCI-H1734,11396600,3.6622911845899817
NCI-H1703,4259181,0.0989323208657525
BHT-101,10302451,2.8227142275442993
TE-14,135875424,2.9954156144381203
RD,327653,3.3022408948964306
M059K,73707398,1.2235502285517177
NCI-H322,10231331,3.754211694454943
HCC1806,4259181,-1.395545790075546
OAW28,3689413,-1.4375749125930504
NCI-H1623,9936388,-4.968103162812744
JM-1,9915743,0.8499678141273637
NCI-H1573,6852167,3.160970212714405
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
NOMO-1,327653,2.81345515165661
NCI-H650,49766530,-1.7972837938587842
KMS-12-BM,9936388,-7.442749057312851
CAL-54,3689413,-3.5113381718602756
KCL-22,135421197,1.194260119901322
A-673,439501,-3.092013019617277
BT 139,44491742,4.209444035840443
SK-MEL-31,3689413,0.7932345609098049
BT-12,73707398,0.9835944574465368
HOP-62,44491742,4.640090000896823
SNU-182,327653,2.4311558058235443
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
SK-MEL-31,637858,2.2737617331848807
HT-55,9915743,-1.6854357534662117
HEC-108,262093,2.510970460452122
SK-N-SH,262093,1.5021437515873324
VM-CUB-1,73707398,0.9598904700080856
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
KO52,46907787,0.3317813334576328
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
NCI-H1703,3689413,-2.562471575946014
BICR 16,6852167,3.083582887744423
HCT 116,3689413,3.301731662910047
VMRC-RCZ,4259181,0.656084510348254
TT2609-C02,136227331,4.484463069653878
KYSE-30,54626689,4.463155066843435
Hs 940.T,9915743,0.0875879000353744
TUHR10TKB,4259181,1.0185659270480565
BT 224,135875424,2.9965213302921816
WT2-iPS,3689413,0.8966057482922113
NCI-H661,136227924,2.7818959309662183
MHH-NB-11,135421197,1.028464988751559
Kasumi-2,24180719,3.447908092121991
SNU-1077,49766530,-1.9738465664800544
HT-1080,3689413,-2.4389842103983583
OVCAR-8,3689413,0.7986129838675038
RL,262093,2.402242412116004
MOTN-1,241158,2.7455766578845564
SR,241158,3.3851919568331765
FU-OV-1,9903786,2.8592788804010936
MHH-NB-11,375860,-1.167115758317035
JVM-3,26596,-2.348515642559758
NCI-H2170,644241,3.042503926939871
EKVX,selumetinib-JQ-1 (4-1 mol-mol),2.1173577222029643
BT 428,UNC0638-navitoclax (1-1 mol-mol),0.5798906424997637
PaTu 8988t,9903786,4.140175125497243
NCI-H716,375860,0.0273336501108971
SNU-685,262093,3.0570612245027027
WM115,9936388,-1.175666523167262
G-361,10302451,3.636127166828417
NCI-H2110,54626689,4.627241982556493
NCI-H1651,73707398,1.6677013766470885
OC 314,11455910,0.0768833443632768
SNU-869,5460769,1.7157786407903552
HPB-ALL,327653,2.9231212258836696
SNU-466,3689413,-2.151085855485809
MFE-296,71466445,6.167390306969204
CL-11,9929138,5.374540786580353
UO-31,136227924,2.530889708332206
SH-4,49766530,3.958821770259228
YD-15,100016,6.01418803247364
BT 239,136227924,1.4188260158561712
SF268,49766530,0.574843558236966
UO-31,5460769,0.456698735836774
NCI-H1975,11396600,3.468451084221391
U-87MG ATCC,439501,-1.3147544227486891
A4/Fukuda,12003241,-4.192136354440014
Panc 08.13,6852167,2.816659852155705
NCI-H2110,3689413,0.5131338822863976
697,UNC0638-navitoclax (1-1 mol-mol),-1.742714330372107
SNU-719,136227924,2.577096412948206
FTC-133,439501,-1.0725688155870328
GaMG,135421197,1.593389235572815
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
JHUEM-7,24180719,2.9437043979916413
MOLP-8,327653,2.384727852533787
BFTC-905,46907787,3.862219767298802
SNU-601,107970,2.326433259827754
NCI-H2106,9936388,1.6529338103280846
LCLC-97TM1,46907787,1.8795083111860824
BT 320,375860,4.032556785404055
Kelly,46907787,1.489260374833201
CML-T1,9936388,-6.3994005254305995
KALS-1,107970,3.013495125773725
NCI-H1339,262093,3.4716839644219246
BT 444,9927531,5.530041138420047
OC 314,637858,1.1559909710813434
MCAS,637858,2.160945503625874
VM-CUB-1,9915743,0.0251855246366983
SF126,BRD-K27188169-navitoclax (2-1 mol-mol),2.340861713590995
LN-18,375860,-0.7642172179373815
RCC10RGB,9936388,2.3235560801623465
THP-1,5460769,3.8427937277030497
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
U-118MG,4259181,0.1154579425878505
NCI-H1666,71466445,3.492343929395081
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804
SUP-B15,54596490,4.39372018561384
Hs 839.T,selumetinib-JQ-1 (4-1 mol-mol),2.4784871545769094
Caov-3,241158,3.40549720249276
TOV-112D,26596,-2.3004297516066927
CAL-51,375860,-0.3577134594482877
OCI-AML-3,107970,1.3143182352551162
Hs 839.T,9927531,5.8565553238540655
SNU-423,11396600,4.403909661334611
CHP-212,11396600,2.9941835804811507
RPMI-8226,135398744,6.232374281438443
Raji,136227924,2.5188827267380116
HEC-1-A,10302451,3.536868477856568
P31/FUJ,5460769,2.718083541162644
B-CPAP,26596,-2.034534215785694
LP-1,3689413,0.1149626145640583
EJM,375860,-0.4454409247993169
HCC1937,49766530,-0.8756565380330879
JHUEM-7,135398744,6.411220982649173
Hs 746.T,4259181,1.0284627919078262
2004,49766530,-2.057712290576902
TE-8,9903786,2.2578315560817432
NU-DHL-1,54626689,4.007312828770784
Hs 888.T,3689413,-2.4304159299205215
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538
PF-382,439501,-2.5741395884768377
HCC1500,54626689,4.657243866783195
TE-4,54626689,5.034184861733729
Peer,262093,1.208995800009143
COLO 829,9927531,5.213552390265391
TE 617.T,135421197,0.8388775868881587
OPM-2,11396600,1.8817984525619431
SW1783,9903786,4.362374850125049
TE-8,136227924,2.7469773037217715
SKM-1,10302451,3.713731670018531
EBC-1,3689413,0.3969440473796213
PE/CA-PJ41 (clone D2),selumetinib-JQ-1 (4-1 mol-mol),1.3944144559858256
NCI-H524,135875424,1.583285673103297
NCI-H520,107970,2.0234591709207397
U2OS,12003241,-1.2814871357228934
Yamato-SS,136227924,3.1022512927874444
NCI-H2110,637858,3.1754566169961005
HCC2218,9915743,-6.199285187365854
GCT,26596,-0.460153915776305
PaTu 8988t,136227924,2.49705731140334
JHH-5,3689413,-2.062402723839909
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304
MOTN-1,5460769,0.7518419346698605
PE/CA-PJ49,9903786,3.1609136015972847
KCL-22,327653,3.1814248646460603
SF126,156414,2.7219935651000395
NCI-H1155,241158,3.784258278156689
MOLT-16,100016,4.920795787487072
SNU-C1,6852167,0.1423090557165161
IMR-32,135421197,0.1202799185207932
SU-DHL-1,439501,-2.3864560258185916
Mel Ho,262093,2.800747953988144
UO-31,26596,0.4742942530113579
KYSE-410,637858,1.774325597801251
T24,4259181,1.5292017727719016
MKN74,3689413,0.9993219534405752
OVCAR-5,10231331,0.2169812398707243
BT-20,5460769,5.85454688440853
FTC-133,637858,3.731185140297224
OCI-Ly19,10231331,0.2879784016430623
RT-4,637858,2.2211102524324717
NCI-H322,54596490,5.659488455835274
ECC10,49766530,-0.6021024707846206
OCI-Ly10,100016,6.418038918193145
JHOS-2,46907787,4.960219995115103
ECC12,9936388,-4.873950021290679
Hs 746.T,439501,-2.632583453917954
NCI-H716,135875424,3.9271515423817047
DND-41,11396600,2.425122364939696
SW579,637858,2.218521302325827
BT 245,11455910,0.6053339220870597
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
HuH-6,26596,0.8914215652548961
HT,9929138,4.348342572684797
KNS-60,6852167,2.5006125988541203
NCI-H520,644241,4.472644159305388
BV-173,6852167,1.2212853775314485
KCL-22,241158,3.680884772603812
VMRC-LCD,73707398,0.967348855291882
FaDu,10302451,3.713000367024148
Panc 04.03,3689413,0.3957464459941977
NU-DHL-1,3689413,-2.5727806443741836
HCC1500,135999136,4.086589117257826
JVM-2,107970,1.541422040439992
SK-BR-3,135875424,2.976147465835477
MG-63,12003241,-0.4675070550973023
KHM-1B,5460769,1.8331932839616616
NCI-H1155,71466445,4.659482632283621
ECC10,44491742,3.5514188140431644
KMS-18,135999136,4.8693780005592595
BFTC-909,644241,3.062866082016443
NCI-H1694,4259181,-0.9016234434199344
ES-2,262093,2.44906158082759
EB1,9903786,1.1512361945239595
HCC95,11455910,1.9982111231876976
SK-UT-1,46907787,3.5849510733980265
OCI-AML-3,9903786,2.1236549190588097
LS123,11455910,1.1940798457620236
JL-1,136227924,2.288232757655929
MOLM-13,26596,-2.2068545341754295
Hs 852.T,9915743,-0.5396545081507467
IST-Mes1,135999136,4.360333625305844
GSS,4259181,-2.284174243977743
HOP-62,156414,1.5376490539390024
HCC4006,12003241,-2.6394477245029355
U2OS,71466445,4.273731678378128
DV-90,168313016,4.073202068254718
BICR 31,262093,3.397835562493394
SW948,12003241,-1.7903806895013192
BEN,107970,2.561102930550366
CAL-78,11455910,2.8056640629270766
SNU-899,71466445,4.515368703204169
KMRC-1,262093,3.6313310555506817
SNU-201,241158,5.535356896703898
BT 245,10302451,3.8870647023268448
RERF-LC-Ad1,selumetinib-JQ-1 (4-1 mol-mol),3.573516405475977
NCI-H358,54626689,4.446929751520876
CAL-51,73707398,0.7053044464230985
KYM-1,26596,-1.5759790260808906
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
NCI-H1299,6852167,2.875213655534043
MFE-319,262093,3.9047520178061856
23132/87,4259181,-1.287795100395303
HOP-62,644241,3.1135369440994767
HEC-59,135421197,2.778714880666289
KP-N-SI9s,24180719,3.3137524211821945
HCT 116,10302451,4.1839510650516365
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
DU145,46907787,4.026240658586575
EC-GI-10,241158,3.603755758520639
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
HCT 15,6852167,3.660532698855016
COV644,54626689,4.74251726997751
RVH-421,71466445,5.483453670429095
OPM-2,54626689,3.88605573030338
MM1.S,9936388,-7.097218801181761
A-375,637858,2.049731474801189
L-428,4259181,-0.74991169769426
U266B1,71466445,2.059013324665234
G-402,135999136,4.750055175062071
786-O,168313016,4.441158744193567
ChaGo-K-1,selumetinib-JQ-1 (4-1 mol-mol),2.371471699435725
G-361,262093,2.334861127155717
OCI-Ly19,375860,-0.4899216845678457
OCI-AML-3,135875424,2.9827106176181735
KNS-60,73707398,0.4331789831099927
COR-L51,71466445,3.319982023980898
COLO 320,439501,-3.5765221681419805
Hs 839.T,3689413,-2.374647409552807
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
A-673,49766530,-3.0139632371957705
JeKo-1,241158,1.9415728140254451
BT-12,136227924,2.3126118312621404
OVK18,9915743,2.5814540538306012
U-251MG,9936388,1.7501129357253542
NCI-H196,262093,3.244471483790871
A4/Fukuda,9903786,0.7546004224414102
RMG-I,9903786,4.466562574504816
SUP-T11,135875424,3.130261828756196
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826
AML-193,637858,1.3897000366082406
PE/CA-PJ34 (clone C12),156414,-2.3095911483351004
SNU-478,444795,4.74563569018297
BT 422,444795,5.024437809909507
KE-97,136227924,2.279256150432482
KYSE-410,439501,-2.4284024166032365
TCCSUP,9927531,4.77726983491798
BV-173,644241,-5.8284711205476025
HOS,49766530,0.1670768985244303
SU-DHL-1,327653,2.51842673185387
VMRC-RCZ,135875424,4.757952332015436
LS123,10302451,3.382571500430193
SEM,46907787,-3.1211446232519178
Pfeiffer,UNC0638-navitoclax (1-1 mol-mol),1.0211462635075932
NCI-H23,49766530,-2.8295631960670735
COV434,5460769,0.4340369587181126
Rh41,100016,7.167579216403683
NCI-H1915,107970,2.322652332824797
MHH-CALL-4,156414,0.8136129124457091
Hs 944.T,49766530,-0.7107074816486109
DB,100016,4.066938426663746
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
VM-CUB-1,637858,1.6949759456767477
EHEB,100016,6.596024177667571
HCT 15,135875424,3.2134473566688726
TM-31,24180719,4.235800537371256
RCH-ACV,100016,4.052738843081589
A-549,54626689,6.037159882780096
IM95,241158,4.0998965911685605
A2058,107970,2.3458450243640026
HCC2279,11396600,5.494062372014229
YD-8,46907787,3.160935680087681
OCI-AML-5,241158,3.967364233011896
COV644,168313016,4.295385194423968
BT 422,6852167,4.1385741646892145
PE/CA-PJ34 (clone C12),107970,2.3192518543827476
Lu-99,241158,3.0745673307990375
KMS-12-BM,10302451,3.4855488172991924
SNU-16,9915743,0.7177446910868589
Hs 683,5460769,1.3545224877290158
SK-MES-1,9927531,5.425786603716899
SUP-T1,12003241,-2.125139255884817
NCI-H2106,9903786,3.304741679115025
EPLC-272H,637858,1.4524809101407783
CL-11,selumetinib-JQ-1 (4-1 mol-mol),-3.72089292117095
TYK-nu,BRD-K27188169-navitoclax (2-1 mol-mol),3.566274948346332
SK-CO-1,107970,2.4721550322855843
NCI-H522,54596490,4.410611853984333
GA-10,11396600,1.0536432572837295
HL-60,12003241,-0.948434817183572
2004,637858,1.3330020321957723
CAL-12T,11396600,4.498308812674723
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383
LOU-NH91,136227331,3.865245001267085
J82,3689413,2.7361853242444045
SW1710,73707398,0.971226143057924
NCI-H1666,156414,-3.939657296511655
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
OCI-Ly19,4259181,0.058208585019133
JHH-2,11396600,2.878978251675123
MDA-MB-453,444795,4.759998515464953
KP-N-SI9s,375860,-0.3225844332082871
COV644,135421197,2.2912269565469936
DU4475,135999136,4.276034607772466
DEL,BRD-K27188169-navitoclax (2-1 mol-mol),3.547668304221524
NCI-H841,262093,3.0633638010395927
NCI-H1694,44491742,4.026754305354829
KNS-60,54626689,4.622075671984031
A3/Kawakami,135875424,3.019357204965879
SNG-M,44491742,4.516771250419383
Hs 746.T,9936388,2.9301322002426393
KYSE-450,11455910,0.6287655004796859
EPLC-272H,10302451,2.306832599815418
PaTu 8988s,9903786,1.8009975173036927
MSTO-211H,637858,1.3984482263345202
LS123,9915743,1.0126339899264374
U-BLC1,644241,1.7323634588350438
CA46,46907787,-0.8110179268567884
RERF-LC-Ad2,3689413,-2.3718681179327143
C2BBe1,10302451,1.7353429150256774
OCI-M1,375860,-0.3208113625803119
SNB-75,135999136,4.820409920697815
Pfeiffer,5460769,3.50798965945468
SNU-C4,11455910,3.771721357690206
IGR-1,6852167,3.681437464404636
CCF-STTG1,100016,6.985278157575169
A4/Fukuda,10231331,-0.0070700765814584
SK-MEL-5,46907787,3.947667418966643
BT 333,5460769,4.50385990816769
A-375,241158,3.5865598480759413
SH-10-TC,44491742,3.905889235687173
Jurkat,439501,-2.365566126578654
MOLT-13,12003241,-0.6419644689091649
MV4-11,6852167,0.3226146559681107
KYSE-150,46907787,4.608870266464791
Hep-G2,241158,4.703758837360285
EM-2,9915743,0.5726352403116545
CAL-51,9915743,1.1260994347217144
SiMa,71466445,2.534593277399028
KU-19-19,9903786,4.470072542277405
NCI-H1915,136227924,2.449863082820113
HCC1438,6852167,3.7274636692401297
SF295,107970,2.6813754727325203
DMS 53,644241,1.4928462905360964
SNU-886,73707398,1.147330182406101
YD-38,135875424,3.801699719504721
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554
U-937,54626689,6.77401943581697
IGROV-1,135421197,1.96820638017286
NCI-H1573,168313016,4.64136690416913
NCI-H446,136227924,3.5012378178100487
Yamato-SS,637858,2.139067108128219
HDLM-2,12003241,-2.9289857152710344
YD-8,637858,2.173572899934862
Rh41,9915743,0.4194124468243376
MHH-NB-11,12003241,-1.5354599516868075
U2OS,327653,2.21685850175056
SK-MEL-2,4259181,1.4036951416401309
UM-UC-1,49766530,3.4095372136602147
VCaP,9936388,1.4949429315009104
HuNS1,135999136,1.7858791194050956
SNU-407,156414,0.885459521528447
NCI-H1869,49766530,-0.032716755694371
HT115,439501,-2.40828737906019
SNU-1105,6852167,2.7622264784385444
SW620,44491742,4.4130085164157125
CFPAC-1,135421197,3.4833112622431357
CCF-STTG1,selumetinib-JQ-1 (4-1 mol-mol),4.9623301985248265
SNU-245,439501,-2.452660264273032
LAMA-84,135421197,2.406961444006632
KYO-1,241158,2.959045378118942
Sq-1,73707398,0.934201736655557
OCI-Ly3,9915743,0.6097478926104294
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
PF-382,637858,0.850873658302796
SW1353,73707398,1.600430045495041
HT-144,9915743,2.253768741240734
UM-UC-1,10302451,3.891085801991747
MOLP-8,46907787,-2.434163875600539
KE-97,12003241,-1.757079073884842
NCI-H1435,9936388,0.980131608638386
CHP-126,71466445,1.938697583088702
RPMI-8402,9936388,-6.946099895647247
Hs 746.T,107970,2.1679941354436196
VCaP,100016,6.449384825808392
EPLC-272H,9915743,-3.018922536526067
LOU-NH91,9936388,-6.294191236399446
BV-173,9929138,5.5371919710520325
MSTO-211H,107970,1.929708493397844
KO52,3689413,-4.063517257373306
HCC78,5460769,-0.5347925527973022
HT,9903786,3.804202680432086
HSC-2,9915743,-1.4415795953156172
42-MG-BA,637858,1.2732883958955747
BICR 18,12003241,0.2549770836209779
EFO-21,10231331,4.759276702825322
GaMG,375860,0.0243101951979654
COV434,156414,1.5374263935363748
GCT,375860,-0.0653979815404537
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
NCI-H1341,49766530,-3.266288365391744
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
NCI-H1869,135999136,1.6552462790975504
MM1.S,3689413,-0.3922685663675629
SNU-1272,49766530,0.1675221070029884
NCI-H841,107970,1.8401087857571516
NCI-H747,5460769,2.4677950435240814
NCI-H2087,439501,-1.341118756842812
NCI-H23,3689413,-2.6057234529472098
IST-Mes1,637858,2.1376990366589905
SNU-886,6852167,1.7356740395835049
NCI-H660,54596490,4.247861500478792
TE-10,73707398,0.9916706156447608
SK-N-BE(2),4259181,0.1964139282456021
BT-16,136227924,2.1772162484418924
SNU-201,49766530,0.2558718668414946
TE-9,439501,-2.406207557642534
JeKo-1,135999136,1.7054412351562194
SW1710,9929138,6.751654764196259
L-1236,9903786,-0.7492109399697982
HGC-27,26596,-3.243081069551806
SU.86.86,10302451,2.9439020975191315
LOX-IMVI,10231331,1.7536207323976525
OC 314,46907787,-0.3791723220517189
RL,3689413,-2.4285945149334185
HT115,selumetinib-JQ-1 (4-1 mol-mol),-0.8127871371839009
NCI-H2110,54596490,5.001361284562202
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
HPAC,9915743,0.7621805259187995
NCI-H1155,135875424,3.2409208598380466
LUDLU-1,135875424,4.724968330377738
KP-N-SI9s,6852167,2.328525910487029
IGR-1,168313016,4.4632549660929195
OAW28,46907787,2.388022074777516
BICR 22,10231331,2.1949493731732095
HEC-59,73707398,1.404942401725486
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
NCI-H661,637858,2.3544841299222927
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
NCI-H1694,selumetinib-JQ-1 (4-1 mol-mol),0.438004270294335
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
NALM-6,71466445,2.5967465437674537
NCI-H508,9903786,0.5730721211303239
JM-1,327653,2.4402793258430786
HOP-92,44491742,4.695490745837731
NCI-H1568,107970,1.680617581032042
VMRC-RCW,262093,3.5147146159266174
RERF-LC-Ad1,10302451,4.5263361411635366
NCI-H2141,241158,3.8240614308547327
Hs 294T,4259181,-0.3023864007652443
Hs 729.T,11455910,1.0467944276793937
SUP-M2,637858,0.6632556191760942
YD-38,168313016,6.308402556942436
KYSE-30,44491742,4.262990240897069
OCI-Ly3,26596,-3.73515804460265
SCC-9,44491742,4.764074483400304
MDA-MB-157,135875424,2.7117106005077276
PK-59,9915743,1.423625885080464
NCI-H1666,44491742,3.401457772249809
TE-5,24180719,3.924549413967206
GSS,107970,2.2178092034727954
BT 224,6852167,4.53858021347583
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
KNS-42,11396600,3.114434674778827
HuCC-T1,10231331,4.5361574010300805
EFO-27,49766530,-2.657964166176686
OCI-Ly10,44491742,5.232515428740167
IGROV-1,327653,3.667792542405671
LUDLU-1,9927531,4.97566245035899
FTC-133,9936388,3.0046059879710363
KMRC-2,9915743,0.8631489276658242
NCI-H2405,73707398,2.099759783776834
KG-1-C,4259181,1.5706679551779288
NCI-H1373,12003241,-0.7849764131433078
SHP-77,135421197,1.1078063098339157
NCI-H1944,444795,4.357606071770019
23132/87,24180719,4.1620662541644595
HCC1937,135999136,4.749692180944621
HSC-2,644241,3.1908860621612254
KYM-1,9927531,4.58392682790106
SNU-16,327653,2.968666215032176
SW1088,11396600,6.290027933724405
MDA-MB-453,136227924,2.410345496671846
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
769-P,selumetinib-JQ-1 (4-1 mol-mol),2.569867947443669
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102
NCI-H2081,6852167,2.954622232439069
647V,444795,4.052159403101229
KMS-11,9915743,0.4869298751458265
CCK-81,10302451,-0.3624920421217548
COLO 678,9915743,-1.0812060080075532
VM-CUB-1,12003241,-0.6809659848466374
SNU-1196,49766530,-0.055725374284701
MKN45,135999136,1.8479400978167373
GSS,6852167,1.3969716760302158
LAMA-84,10302451,-1.004459316754453
DMS 114,UNC0638-navitoclax (1-1 mol-mol),2.3153747752746834
RT-112,9936388,-6.676830833959952
EB1,11396600,2.2409379442223134
RERF-LC-A1,26596,-2.038549310603685
SK-N-MC,44491742,4.171908823838076
NB1,6852167,1.7522276332147415
KMRC-3,439501,-3.150982817952844
BT 139,6852167,2.565632709988516
NCI-H1944,26596,-1.3994203937624
NCI-H196,71466445,5.320372938858583
NCI-H2029,6852167,3.404847034659949
DB,327653,2.4976994881662176
COR-L105,9915743,-1.8659407955600968
NCI-H1105,71466445,2.8775637842759583
SU-DHL-1,73707398,0.2992121771474305
ACC-MESO-1,9936388,3.1205070846652374
BL-70,135421197,0.854508793534898
COV362,5460769,5.303432014507575
Mino,73707398,0.350796804562992
NCI-H1623,375860,-0.2497324332058591
HT,selumetinib-JQ-1 (4-1 mol-mol),1.0457933075353667
CA46,327653,2.398308016277815
COV362,3689413,0.2449279899544521
CHP-212,selumetinib-JQ-1 (4-1 mol-mol),-3.8376268074181312
SK-MEL-31,9915743,2.191298837926563
NCO2,637858,0.6185034167656125
NCI-H1623,3689413,0.664737487618683
A2780,375860,-0.912616297645574
FTC-133,4259181,2.1331002918337925
BT 440,637858,2.6000641094082635
MV4-11,46907787,-2.893360076838023
NALM-6,BRD-K27188169-navitoclax (2-1 mol-mol),0.2444749160324902
CW-2,9927531,5.678325078717316
MM1.S,168313016,2.515366642859788
OVCAR-4,73707398,0.9342396451955234
SW1783,10302451,4.263014004956648
KYM-1,71466445,1.4464310394768298
KYSE-410,6852167,1.749610623919313
Caov-3,73707398,0.8005567181272054
OVK18,10231331,2.741626907853192
LOX-IMVI,135398744,6.429324407359154
EHEB,241158,3.817598938948392
MPP 89,375860,0.3862595177296635
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
A-498,637858,3.4757595298108974
HEC-1-A,4259181,0.5667735233157607
HPB-ALL,54626689,4.5734485079773
OE21,100016,6.577886119924336
Detroit 562,73707398,1.0205294862246352
Detroit 562,327653,3.5229256866831955
TC-71,49766530,1.0136455106007916
PE/CA-PJ15,439501,-2.069757641280327
Lu-65,637858,2.878442664173332
NCI-H460,637858,3.384702960830197
NCI-H211,107970,1.1174938440677993
BT 271,9927531,5.398706995408204
NALM-6,135999136,1.471573545820229
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
NOMO-1,439501,-2.35226533453039
SNU-61,262093,2.836545473910542
KYO-1,136227924,2.5889716651569614
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
BICR 18,637858,3.015698204447704
NB4,5460769,1.5499271806248969
HuCC-T1,156414,2.9876112232007515
KNS-60,4259181,-1.0001238912945338
RPMI-8402,44489367,4.889305564658811
Caki-2,637858,3.3027688951039953
NCI-H2085,4259181,0.4906519027073793
DEL,375860,-1.0252775108428016
OVCAR-5,136227924,3.2070295394145782
Hs 729.T,73707398,0.8195691589926136
BV-173,135398744,4.1083578998819945
TUHR10TKB,73707398,1.629534927817398
A101D,241158,4.125404634521497
KE-39,4259181,-0.84210776373342
CAL-51,46907787,3.297361866649883
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
NUGC-4,73707398,1.4695211141371651
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935
NCI-H810,54596490,5.063126061474121
RPMI-6666,73707398,1.0548607195564614
OE21,9903786,3.8183922804943298
HCT 116,11455910,1.427750976717415
Hs 729.T,9936388,1.6599440767787133
NCI-H2452,9936388,2.1806204942966803
SNU-1079,9903786,0.8372132722803839
SW1990,5460769,2.4608974418371017
Panc 03.27,4259181,0.909110974092044
HuCC-T1,4259181,0.6983061177841803
LN-18,46907787,1.895990025484258
NCI-H1869,107970,2.0096354902950178
SK-MEL-24,241158,4.25425778982335
NUGC-4,637858,2.002597662326331
Reh,135421197,0.7565283422785475
SW579,10302451,1.116201799162962
HCC1833,3689413,0.395553245761409
SNU-869,156414,1.5646436752769155
NCI-H322,241158,4.940934801994881
TCCSUP,12003241,-0.9458347981681208
NCI-H810,44491742,3.3983932232685756
OVCAR-4,10302451,5.517030030405602
NCI-H1568,241158,1.943489424131273
LMSU,262093,3.167641110749879
NCI-H2087,375860,0.2532519276094911
MIA PaCa-2,9903786,3.251255785633491
HCC827,241158,3.909716950172797
NCI-H1155,73707398,0.8186433878121172
Tm87-16,9929138,6.73537704561969
WSU-DLCL2,107970,2.0978783908634537
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
JIMT-1,44491742,4.195591062798884
HEC-1-B,107970,2.166435384493281
RCH-ACV,49766530,-4.0327200092354305
LMSU,168313016,4.430377140485892
SBC-5,11455910,0.8715920005264659
LK-2,44491742,3.8692951916642353
HL-60,262093,1.12595796571635
BT 245,73707398,1.0043109985849346
HEC-6,4259181,0.4272977056155777
MDA-MB-157,637858,0.0650158223638603
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
MKN74,241158,4.664529497930215
AGS,10231331,1.2929786798210765
ALL-SIL,327653,2.0915878780614623
Detroit 562,46907787,-0.4268141433892927
RERF-LC-A1,136227924,2.978723056085531
K029AX,262093,3.0004551512416957
NH-6,5460769,1.427769870137193
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
BT 131,136227924,1.4796003986288269
NCI-H1581,24180719,2.8599644133571105
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
SK-MES-1,9929138,3.12327700271694
EoL-1,241158,0.7802478350206956
Calu-3,262093,2.6683793293156204
NCI-H841,11396600,2.6632446224517454
TE-14,637858,2.3337222437177454
PE/CA-PJ49,135875424,3.843300837205347
COLO 800,10231331,-1.3489383760666889
RCC10RGB,46907787,5.224507823938942
COLO 205,637858,2.2798809149356223
G-402,9927531,4.821419019473558
GDM-1,3689413,-2.3976693518494208
UACC-62,UNC0638-navitoclax (1-1 mol-mol),3.345693266997061
SiMa,3689413,-0.4508724532834644
MOLM-16,10302451,2.1186807134276795
BT 245,241158,3.5873529093746828
HCC78,selumetinib-JQ-1 (4-1 mol-mol),3.3730165762035567
NCI-H889,12003241,4.506379405890452
IA-LM,49766530,-3.412847117105243
COR-L51,156414,1.7388629163468807
HLF,375860,-0.0399029193144341
JHH-5,241158,1.8373368397822012
C2BBe1,11396600,3.438018426982882
SNU-C1,439501,-1.3608922935267702
LoVo,444795,4.8141558651213145
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
CL-11,3689413,0.4065181450870009
ECC10,10231331,3.4361664003584824
SNU-398,12003241,3.2060207303790924
LXF 289,10231331,2.4249622135671824
KM12,selumetinib-JQ-1 (4-1 mol-mol),2.4684544152911334
CJM [Human melanoma],24180719,3.589113424402915
HT,46907787,-0.9086366382873644
SNU-16,11455910,0.0764254411475756
KE-39,9936388,1.1689372039333712
HuP-T4,135999136,4.980263470840169
HuG1-N,UNC0638-navitoclax (1-1 mol-mol),1.1274185196104751
SNU-840,262093,3.393401871162564
NCI-H2291,46907787,1.4824694863138157
DB,156414,1.1616934223159214
KMS-11,136227924,2.4847849493179406
SK-N-MC,327653,2.919056740223589
TE-11,54626689,4.665624874587401
BT 139,72967,3.761856387021038
CAL-12T,11455910,1.8992809146905865
TE-8,168313016,5.127856732185798
HCC1438,54626689,4.507842033684473
SKM-1,375860,-0.6747488513339966
SCaBER,73707398,1.3236589923807338
BT 498,327653,3.5489603001727477
SNU-61,9915743,-0.5579526190142376
OC 314,71466445,3.8450252260882105
JHH-1,11455910,0.6944106748858588
TE-4,selumetinib-JQ-1 (4-1 mol-mol),-0.2694684145255028
SNU-1214,12003241,-2.886982661469118
ECC12,73707398,1.5263893558271446
NCI-H1650,12003241,-2.181878019620055
RCH-ACV,168313016,3.0928889111886337
DV-90,9927531,4.273842148602971
CAL-85-1,9903786,2.154153676778314
MOLM-6,9929138,4.00608246192175
OCI-AML-3,10231331,-4.326304119674098
NCI-H23,439501,-3.080706529891667
HMCB,107970,2.4632765451158356
BT 330,6852167,3.461733809833727
NCI-H23,26596,-3.72229415651004
TE-6,3689413,3.2359405444130473
JL-1,49766530,2.587242207366064
DoHH2,26596,-2.141975510207564
MKN7,241158,3.770372619506397
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
TE-5,5460769,-0.4523281217111792
MHH-ES-1,10302451,2.7656001788565283
SNU-685,selumetinib-JQ-1 (4-1 mol-mol),2.4989886652623357
MDA-MB-231,135875424,3.845545280720972
J82,44491742,4.20149606168553
CAMA-1,49766530,0.0581457358273481
SH-4,10231331,-1.6536047980695794
TF-1,54626689,4.40910092549892
EFM-192A,11396600,3.5001558011372045
NCI-H446,439501,-2.615106266936583
OCI-Ly10,439501,-3.3893615276573783
P12-Ichikawa,6852167,1.2288649311061628
253J,26596,-1.986846221842857
GI-1,135875424,4.168860245999812
639V,3689413,3.093093365439167
LOX-IMVI,168313016,4.96467141821942
UM-UC-3,327653,3.3553409260124827
CAL-54,9927531,5.326263652959217
CAL-27,156414,-2.8765071974836753
Panc 03.27,135421197,1.6982326506072338
SYO-1,168313016,4.463038136814232
SNU-478,637858,1.5237047093622371
HuP-T4,49766530,-2.034879085363831
BICR 22,9927531,5.395078942533075
SKM-1,5460769,2.732858525958475
VM-CUB-1,5460769,-0.9631116017936964
LOX-IMVI,3689413,-4.023880524547255
WM983B,135875424,3.018238153031043
CAL-29,644241,2.799007464040423
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
SK-MEL-1,100016,6.470813601542051
J82,54626689,4.895570516775903
GI-1,12003241,0.5382171766517799
KG-1-C,11455910,4.990169857060823
SYO-1,10302451,3.63681748537988
MKN7,71466445,4.862191582132044
KMS-20,9936388,-8.248983770505305
RERF-LC-Ad2,24180719,5.168983190689386
TYK-nu,54626689,3.6530802518025536
KYSE-450,135875424,4.8684130020868235
HT,44489367,5.014009989445673
Panc 04.03,4259181,1.0934261994249337
TCCSUP,262093,2.756857712955527
JHH-4,637858,1.967758508296358
Detroit 562,5460769,3.1492937743842724
MFE-319,3689413,0.3953423105508483
DMS 273,26596,-2.1961333269229173
KMS-21-BM,375860,-1.2608056103151717
T3M-10,44491742,3.8541069254264566
NCI-H716,156414,5.804018273165498
SK-MEL-24,637858,2.0909048277426683
RPMI-8402,241158,3.030815815171316
NCI-H650,selumetinib-JQ-1 (4-1 mol-mol),2.4482139208893674
GA-10,136227331,3.9402947188121793
PLC/PRF/5,12003241,0.8244509806325866
SNU-466,10302451,3.698428690338159
YD-8,241158,4.108189803137544
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
GSU,9903786,4.148563338701872
NCI-H2009,71466445,2.5164920571758036
IGR-37,9903786,4.593363058361211
EFO-27,12003241,-1.7336155023360622
Namalwa,10302451,0.420511059814922
EFM-192A,327653,3.185830081020507
NCI-H2452,11455910,0.7111396076654327
HDLM-2,135999136,4.831194178567747
KNS-81,10302451,3.4109366208206904
SNU-601,73707398,0.8838750132106912
UO-31,644241,1.6075210452191253
MHH-ES-1,73707398,0.6255428046106257
SKM-1,46907787,-1.5658410471483666
PC-3,135999136,1.552966926323613
BICR 31,637858,2.611871003184785
SUP-M2,24180719,3.210910968066848
PK-45H,9936388,1.8966458551256495
Karpas-299,439501,-2.5701669510398717
BT 131,9936388,0.7125118165046622
KMS-34,24180719,2.9385746618628774
P12-Ichikawa,3689413,-1.803795844399087
TE-5,637858,0.9454052445962788
NCI-H226,241158,5.093875853874048
MOLM-13,9915743,0.7456385275428815
AN3-CA,107970,2.2532094276604115
KLE,241158,1.9293702793301108
JeKo-1,5460769,3.2700758729193526
DAN-G,54626689,4.490154479486038
P31/FUJ,9936388,-7.166815071220185
HCC38,5460769,2.8026336362460307
NCI-H2141,11455910,0.8457435139245203
TT2609-C02,9936388,3.168099243698234
NCI-H2286,11455910,3.2712794680477173
GI-1,44491742,3.8147677768435497
SUP-HD1,5460769,1.3370486215581097
HT-55,637858,2.07232626492922
COLO 678,637858,2.34286662480737
HDLM-2,4259181,-0.5875112476137577
SNU-119,73707398,0.7345911888158907
EB1,136227331,3.874508283981952
WM115,637858,1.77843641117838
GDM-1,10302451,2.035200695060817
TE-4,3689413,3.3768605304218036
MHH-CALL-4,6852167,1.516764811863356
NCI-H522,49766530,-2.92412408259348
BT 333,262093,2.471436519213189
SNU-601,54626689,5.422473558508191
OV-90,135875424,4.80016944702245
Hs 683,644241,2.1182711597047277
KMS-11,327653,2.770747014844883
Daudi,11455910,-1.173613913103254
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
A-375,444795,4.8572215879040925
SU-DHL-10,168313016,3.668325026898756
BC-3C,12003241,-1.7584420473179934
SF268,241158,3.9832812003151834
KMBC-2,11455910,1.9151529363040984
Hs 294T,73707398,0.8837453626165415
NCI-H69,9915743,1.0136854730638705
MES-SA,444795,5.074827680340431
THP-1,135421197,0.9721009186640236
KE-39,9927531,6.019185228760376
UACC-812,439501,-1.4243957864326813
BT 239,375860,0.789468692413804
PSN1,439501,-2.156746892791343
TE-6,375860,0.2137179943255964
SNU-449,46907787,4.480861537403045
Hs 578Bst,156414,1.2276952270662207
BHY,439501,-2.5036111867595823
BT 286,4259181,0.6646990868644945
SK-MEL-24,327653,3.7561333766375817
SCaBER,375860,-0.5997691554859326
COV362,10302451,3.875331140880436
NCI-H2342,135875424,4.000102704356125
COLO 741,9915743,3.842124253309565
NCI-N87,73707398,0.9429301881187698
NCI-H2106,11396600,2.567316038119924
MHH-CALL-4,135999136,4.260034737485126
BL-70,UNC0638-navitoclax (1-1 mol-mol),1.3205011863889164
OCI-Ly10,5460769,4.307631470824749
Kuramochi,5460769,4.70110979591698
LAMA-84,49766530,-2.2840485371109907
SUP-M2,5460769,0.4100409038325726
A-204,73707398,0.8872141377599841
NU-DHL-1,241158,2.9356865238845313
CAS-1,6852167,2.849454489855759
CAL-120,9877608,5.792965508852075
Malme-3M,156414,1.628797695516341
SNU-601,11396600,4.148994335946169
NCI-H841,9915743,3.2736348589608606
Aska-SS,100016,5.454856815374324
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
NOMO-1,4259181,0.2459758371125145
Karpas-299,9936388,-6.586031756730676
GOS-3,168313016,4.456848917287458
DMS 53,73707398,0.3652360376283804
Panc 05.04,5460769,1.7514561399814712
NCI-H841,136227924,2.950651455010232
HEC-251,9903786,4.825179909690824
NCI-H292,637858,2.5198155256882813
5637,9929138,6.240532566215687
BT 239,73707398,0.5313402889199192
JHUEM-3,3689413,-0.6367758327679763
AML-193,327653,3.166198380644303
K-562,73707398,1.1020172598138147
SW620,135875424,2.207867824891832
NUGC-4,71466445,3.986101296043148
OVCAR-4,46907787,-0.5848382539691691
Hs 578T,4259181,0.6901225496008685
SNU-119,9915743,-0.9461018440857424
8305C,24180719,1.6054111298172622
PC-3,24180719,3.782483083792295
Hs 729.T,3689413,-2.0906347621795076
Hs 895.T,135875424,4.928152538117819
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
NCI-H1944,136227331,3.877742239943195
Panc 04.03,6852167,3.6951209581653743
NCI-H2122,5460769,2.4268150631675067
BHY,11455910,2.7739554462043112
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
YD-15,135421197,2.516828006554414
CGTH-W-1,241158,3.697852979444439
JJN-3,6852167,2.0043505861675706
Kasumi-2,UNC0638-navitoclax (1-1 mol-mol),-2.8195604802601197
BC-3C,11396600,2.927390282149192
PF-382,10302451,0.8944755236764494
TTC-709,71466445,4.102542258005533
L-428,6852167,2.25091130507535
NB4,9936388,-6.659724835082886
OVSAHO,3689413,-0.988138970272714
NCI-H929,241158,1.4883272197282302
Calu-1,9927531,5.244935764908175
TE-11,71466445,5.070538866030301
HCC1833,168313016,5.722800305180265
SNU-407,6852167,2.953427937237118
MDA-MB-453,9929138,5.862527790185705
EoL-1,136227924,1.175653355009707
NCI-H211,26596,-3.016523907085459
LOX-IMVI,135875424,4.258043031810949
BT 330,73707398,1.1643905844402598
CAMA-1,107970,2.77221313938515
JHH-4,10231331,1.1955508274143107
NCI-H2030,selumetinib-JQ-1 (4-1 mol-mol),3.0704561739948737
SUIT-2,107970,2.9350948745745966
LOX-IMVI,9903786,2.476339692878584
Raji,4259181,-0.4985032966889935
KYSE-450,262093,3.266752988649651
A-204,444795,3.9482496369859392
FU-OV-1,73707398,1.0047751906041116
MFE-319,10302451,3.878997082885385
MHH-ES-1,3689413,-2.44734032949193
Caki-2,107970,3.093308869295807
PLC/PRF/5,73707398,1.7771083987685936
GI-1,26596,-0.9174030047278064
KE-97,135421197,1.12759931417641
HT-1376,439501,-0.8291876191032579
ECC10,156414,0.8829858531470315
8505C,136227924,3.0385484032115215
OAW28,107970,2.4537130721494105
CAL-27,135875424,4.567542159153124
PE/CA-PJ41 (clone D2),6852167,3.048314493941667
NCI-H1703,100016,6.215140096774371
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372
BT 187,135999136,1.2876624032070751
639V,6852167,4.510121924990905
NCI-H929,327653,2.3561667456594986
HEC-1-B,6852167,2.27935850479613
HCC2935,UNC0638-navitoclax (1-1 mol-mol),1.7958098433458678
BICR 22,135421197,2.0438055763788556
KYM-1,135421197,2.2292481943308906
NUGC-4,9927531,4.1074548867853045
NCI-H1092,5460769,5.922318384562557
SU-DHL-10,262093,2.40427265358065
SKM-1,6852167,1.599440768743568
NU-DUL-1,9929138,4.2318151055504165
SNU-8,3689413,-3.353074674655615
SF539,4259181,0.2869057369152892
HMC-1-8,9929138,7.281868070980933
Rh41,24180719,3.317809188705979
SW620,10231331,-3.895026934403506
KP-2,327653,3.783815914238096
BT 112,26596,-1.3919420546275056
PF-382,375860,-0.9454794315487792
U-937,9903786,1.2748798795403693
NCO2,10302451,-2.218182882660743
CW-2,375860,1.657135931795828
SNU-719,4259181,-1.3711079243063935
NCI-H810,644241,1.7813212984436453
NCI-H1703,10302451,1.82214372973452
AU565,54596490,4.681317358630495
MOR/CPR,375860,-0.6619931812165856
HMCB,644241,4.490422282614611
CHP-126,9903786,1.6217083088403044
JHUEM-7,3689413,-2.2301251225415255
SNU-46,107970,2.926961098317302
PK-45H,9915743,1.737886794631877
HSC-4,71466445,6.061667629347064
T-47D,107970,2.340422447326511
Hs 611.T,46907787,1.0011001882698198
SW1990,107970,2.5044307368694687
Yamato-SS,9936388,1.5578978605453773
SNU-81,10302451,3.60256279960024
NCI-H2291,168313016,6.023429526313328
SNU-840,9903786,4.945950711370254
BT 112,10231331,5.608675026595674
YD-38,11396600,4.074151932666014
SNU-466,4259181,0.976739173619952
MV4-11,439501,-2.384651174177473
TE-5,49766530,-3.388201082645815
JK-1,135421197,1.447193045378296
AGS,135875424,4.083494996873591
CA46,4259181,0.0375174782651609
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
TE-11,26596,-1.418568182466745
MHH-CALL-3,262093,1.7879800250632032
G-402,327653,2.539319278350871
Becker,135875424,4.35709039626534
Hs 888.Lu,4259181,1.7811754959132586
NCI-N87,241158,3.56045646229574
PL-21,135999136,3.272294699588802
NCI-H1573,135875424,3.6449998804885064
JIMT-1,46907787,4.113382124971396
NCI-H1944,73707398,2.546148379079913
U-118MG,12003241,-0.1852675851464418
HLF,9915743,2.207816370136927
LoVo,54626689,4.759845357486115
NUGC-4,156414,-3.830513888497556
NCI-H526,73707398,0.1268432403684528
SNU-1041,9936388,0.8457601319500153
U-251MG,637858,2.3102483718241382
OCI-AML-5,136227924,1.61818972770755
HuT 78,156414,0.7736660521630903
CW-2,10302451,1.0482757335808135
MG-63,73707398,1.4753017703355924
WM266-4,135999136,1.7774722318734697
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
HCC2218,6852167,2.7413890151562543
SK-OV-3,637858,3.830307013284548
HCC1171,262093,3.491139872179752
EFM-192A,156414,-2.907944851521074
KCL-22,73707398,1.053432785971903
SKM-1,136227924,2.5339244468963407
HDQ-P1,4259181,0.9497481254036038
COLO 201,71466445,2.22674921872856
RL,135999136,1.4689449879319691
F-36P,5460769,6.312488647887553
OAW28,262093,2.853078829548121
SK-N-AS,44491742,3.868464169325176
NCI-H146,5460769,1.8747395178404
Pfeiffer,644241,3.575811031828958
BT-549,107970,2.9169966931039113
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
MSTO-211H,26596,-0.5653018529577997
BT 504,637858,1.8465103710961657
NCI-H2291,11396600,4.122894095421017
A-204,selumetinib-JQ-1 (4-1 mol-mol),1.7277465059670114
ECC10,46907787,-0.2077218323322306
SK-N-MC,10302451,3.713832355063549
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117
HCC1500,73707398,0.9868057798362108
MFE-319,4259181,1.4040440632214766
NCI-H2228,49766530,-0.2388260531706088
TTC-709,262093,1.587813672786524
RPMI-7951,439501,-2.4869379045692313
NCI-H1105,5460769,2.617523266083722
YKG-1,9915743,1.478165176900873
TF-1,73707398,1.4165981550195783
LC-1/sq-SF,107970,3.0387693559151754
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
KMS-28BM,11455910,0.2155476441980809
TTC-709,375860,-0.1104220027434393
MDA-MB-157,24180719,1.846017762198611
697,9903786,0.9408007056276604
A-253,73707398,2.5977351568738825
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
BT-549,6852167,2.654575121453327
SW1088,3689413,0.8885196557801914
HEC-265,UNC0638-navitoclax (1-1 mol-mol),-0.4693446779328366
GCT,5460769,3.4482432173572644
MEC-1,9927531,3.3122365402427816
L-363,BRD-K27188169-navitoclax (2-1 mol-mol),4.233005650808416
SU-DHL-1,100016,4.0163007651424945
NCI-H650,100016,5.632760623979546
HEC-6,9936388,1.177360441508745
SH-4,135875424,4.59145070139426
OVCAR-5,44491742,4.010152953024954
BT-474,136227924,2.4914554847870187
YD-38,selumetinib-JQ-1 (4-1 mol-mol),-0.3338451182587707
Rh30,107970,2.354219446763589
GCT,UNC0638-navitoclax (1-1 mol-mol),2.4775147083922
WM793,4259181,0.9321312927301734
JHUEM-7,637858,1.2462680133442194
HeLa,26596,-2.0330393314508868
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
MOLT-16,11396600,2.170033155162838
OCI-AML-5,26596,-1.736130608355082
NCI-H1355,135875424,3.7219654105807622
BT 224,4259181,0.9395634525168084
OVK18,375860,0.1054743479549769
HCC1428,54626689,4.9686582045118755
KMS-12-BM,444795,2.0247311602920415
HCC2218,46907787,2.570368749578335
WSU-DLCL2,444795,3.9682152316651496
SK-N-AS,327653,3.714692783839888
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
DMS 454,UNC0638-navitoclax (1-1 mol-mol),-2.3468627747637685
HEL,6852167,2.7971477189216207
MOR/CPR,9903786,3.5279183844640305
GB-1,262093,2.1332737171644913
JURL-MK1,156414,1.0073583637706065
EKVX,9936388,2.132401654750859
GSU,4259181,1.034622044405449
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
KMS-11,107970,1.1628859556901452
COLO 680N,6852167,3.889885977774019
HCT 15,100016,6.694419225032017
BT-474,135875424,5.915453425364125
L-428,49766530,-2.874438748279996
H-STS,12003241,-1.720451684377523
SNU-410,selumetinib-JQ-1 (4-1 mol-mol),4.312736206352891
NCI-H1299,107970,3.021193234232078
TYK-nu,10231331,1.3626302869635751
JHOM-1,10302451,6.059670218544928
NCI-H2030,135421197,3.075513669205883
Lu-99,156414,1.6009276932034684
UO-31,selumetinib-JQ-1 (4-1 mol-mol),1.0804888438509763
COLO 205,12003241,-1.1256209046349093
LS180,3689413,1.3392854552239355
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
NCI-H1563,637858,2.0351568858397355
Li-7,241158,4.1355969929783045
NCI-H1568,49766530,-3.205306991379519
SNU-869,44491742,4.0762801195520675
U-BLC1,135999136,4.0618059262308615
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
L-428,73707398,0.6270222273710352
HSC-4,12003241,-0.0373048915881231
COLO 792,262093,2.2000430142721736
NCI-H1975,135875424,3.5608641934024843
TC-71,135999136,1.4901332353785983
SNU-C5,5460769,3.868586295292914
Hs 766T,10231331,-1.1212004968621416
RERF-LC-A1,439501,-2.669244370935075
SHP-77,49766530,-2.4195879391735216
TE-9,6852167,3.2217086715952488
Detroit 562,107970,2.26172258664431
UACC-62,136227924,3.255935919058072
A-375,9903786,2.3118659059614877
THP-1,6852167,0.7768028422680426
LS123,327653,1.7087867319352237
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
Lu-65,24180719,4.093355084092675
A-172,136227924,1.9508876589720905
SNU-449,10302451,2.626140201612578
NCI-H889,9915743,1.0430914945054055
JMSU-1,49766530,0.5298615958954185
NCI-H1666,UNC0638-navitoclax (1-1 mol-mol),2.2678241552011498
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
SaOS-2,71466445,4.363709574185696
A-204,54596490,4.718810668338487
JHH-4,73707398,1.0578897556038087
LOU-NH91,26596,-0.8372049149458933
NB4,71466445,1.5990398825459642
HEC-251,241158,3.0567288983724135
L3.3,12003241,-0.3315333583144895
CW-2,4259181,0.7022652209474797
U-118MG,11455910,0.7446076183130194
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245
OVCAR-4,262093,2.934935020789089
BT 482,327653,3.2285900790212607
NCI-H1568,26596,-1.690126811671561
NU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-2.039060237587124
PaTu 8988s,439501,-3.8776790772528864
MDA-MB-361,6852167,1.7520699616345732
SK-MM-2,3689413,-2.3519138228022367
A-375,9929138,5.4250105922665375
KNS-60,44491742,4.18434599527296
HCC44,9903786,0.5279756391305372
SHP-77,12003241,2.3628262056689384
LS1034,107970,1.4253135653766993
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
KMH-2,49766530,-1.67617119568669
639V,49766530,3.725635459384192
KMH-2,9903786,1.3660293069385576
PaTu 8988s,9929138,5.293231117903689
P31/FUJ,439501,-2.3575947617146475
HEC-265,10231331,6.423898204800826
HuH-28,24180719,3.69351158523283
ECC10,UNC0638-navitoclax (1-1 mol-mol),-3.3170539937927876
JJN-3,100016,3.8434142095984303
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
BT 145,9903786,2.2676133006053965
LAMA-84,73707398,0.8554564674159427
SK-BR-3,selumetinib-JQ-1 (4-1 mol-mol),2.4200828967398995
NCI-H2170,49766530,5.350715427478364
NCI-H28,5460769,-1.4379241893426098
SNU-1077,12003241,-1.4220834787906382
HCC1195,46907787,3.546738673188822
MDA-MB-468,375860,0.2372575740208442
KE-97,24180719,2.1176271045398742
KMS-34,selumetinib-JQ-1 (4-1 mol-mol),-0.3341202517618857
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
SUP-HD1,444795,4.9983836585041015
RERF-LC-Ad1,73707398,2.698751964761458
PK-45H,73707398,3.18492419186588
PF-382,327653,2.393380485895892
CJM [Human melanoma],4259181,0.5717203642017457
MKN74,24180719,4.121555152871541
Mono-Mac-6,10302451,3.81015516051213
KMS-27,12003241,-0.3161890721272481
NCI-H1435,135875424,4.380789148010153
NCI-H2171,3689413,-2.7117222930063867
CFPAC-1,439501,-1.9750103172149232
MHH-ES-1,135875424,3.469224275097477
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
NCI-H522,73707398,0.7434005611154502
HT-1376,135421197,1.3113029615588312
THP-1,262093,2.4428888686996237
NU-DUL-1,5460769,0.0650786105857349
BT 231,136227924,3.1954768658582378
COLO 668,46907787,2.3006610001201584
MHH-CALL-3,11455910,1.7272986441128235
C2BBe1,5460769,5.889347981048802
BT 231,135875424,2.2081545391597728
BICR 22,9903786,3.2901982519836213
SW48,136227924,1.7122170056378203
Calu-3,9936388,1.0811796684163033
SF268,644241,2.0955453774449055
MOLM-6,6852167,2.1278340646476654
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
Rh18,9915743,1.1636262664119963
T-47D,24180719,3.970410948496811
Lu-99,BRD-K27188169-navitoclax (2-1 mol-mol),3.735758153011721
HCC1954,9903786,3.647576872659031
NCI-H520,135421197,1.6066426721545042
WM266-4,54626689,4.339330674247134
HCC1171,9927531,5.509897026708257
NCI-H2023,637858,3.168017601469802
ChaGo-K-1,10302451,4.275291921166029
PLC/PRF/5,5460769,4.572267252029585
HEY A8,4259181,0.4571473783124858
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
NU-DUL-1,UNC0638-navitoclax (1-1 mol-mol),-0.5183888778396748
NCI-H2228,54626689,4.547933757432327
MKN7,135999136,6.1524703702506915
SBC-5,3689413,-0.1482568941323282
NCI-H1395,375860,1.7808246881173873
D283 Med,11455910,0.6480749902472364
22Rv1,11396600,4.6208981896393215
HEL,9929138,6.278460484472286
Ki-JK,24180719,3.0037994579334755
NCI-H446,26596,-3.841011502431018
NCI-H1373,4259181,0.2366885194586986
KMS-27,10302451,3.849053848839269
MOLM-6,135421197,0.9867364446858986
HEC-108,6852167,3.774395558261256
Hs 940.T,44491742,4.308619589326881
YD-15,9936388,-5.281829985034155
KLE,6852167,2.751103786046217
SNU-626,135421197,2.600343807362106
G-361,24180719,0.5505455431390868
THP-1,100016,3.892329450898836
HT115,5460769,1.7158101929675542
AGS,9936388,-0.8886821418021683
COV434,46907787,1.741111624081942
MDST8,9915743,3.1722151191536607
EKVX,9915743,0.527963418662055
BT 504,107970,1.546603565945837
NCI-H1975,9936388,-7.660165830996957
HSC-2,135421197,2.289170573267479
JJN-3,135875424,2.965307149294294
HCC1428,24180719,4.492989973949783
SW1783,9936388,2.9056540363277796
Aska-SS,5460769,3.7674682150871552
SNU-175,12003241,-1.252002444372071
KNS-62,73707398,1.7190535741641355
SET-2,26596,-1.642607786787168
MEC-1,136227924,1.9415739350117864
IGR-37,4259181,-0.1199354810210708
WM266-4,439501,-0.5871270471596414
COLO 320,327653,2.2113040618920596
BHT-101,5460769,1.8781791917401816
RPMI-6666,5460769,0.788563204465766
COLO 678,439501,-1.1365168855313783
MDA-MB-361,439501,-3.0458993456169168
HEC-59,71466445,5.0373269237544465
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
YAPC,135999136,4.461108174764027
GA-10,12003241,-5.009664542431325
DK-MG,9915743,1.7937332394851484
IGR-1,637858,2.3337050705342453
HT-1376,73707398,3.190908649969745
MIA PaCa-2,44491742,3.8709962970987464
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
EN,9903786,3.730384858671513
KE-97,4259181,-2.1334519305493647
KMRC-2,637858,2.4993405738331216
GSS,9903786,1.9234294660474929
MKN74,5460769,3.534639533895065
SIG-M5,135421197,1.947558909075972
NCI-H1755,241158,2.7309585381924024
HT-1080,12003241,-0.8718791582683669
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
Sq-1,107970,2.3768765562541527
L-540,156414,1.45352527783077
HuH-28,156414,2.1488017743760586
Daoy,46907787,4.334387972090441
NCI-H660,135875424,2.723331707113997
SJSA-1,9927531,4.886165341408575
LCLC-97TM1,11455910,0.6647050862050086
RCH-ACV,156414,0.8173746965984037
ECC10,26596,-3.5060948128404874
SNU-1,49766530,2.1666853303349245
BT 172,9903786,4.891040343072455
UM-UC-1,11455910,0.1775144921107808
SK-MEL-1,637858,2.061096838595509
639V,637858,2.8155963626279767
22Rv1,3689413,0.3571323215452703
SK-N-DZ,135421197,1.275457172430967
5637,4259181,-0.6992610249902801
ES-2,9929138,5.3077403629794
Pfeiffer,6852167,-0.1757451201496154
SNU-840,156414,-0.1270098171116787
HuCC-T1,637858,2.046776139114269
SW1573,135421197,1.3915330004591782
MES-SA,9927531,4.955649444081026
KYSE-140,6852167,2.934032084850076
SUP-T1,9936388,-4.413014724970872
JHOS-2,11396600,4.0221153186085905
OCI-Ly10,12003241,1.0181729921478868
HEC-1-A,439501,-2.768971793153046
CW-2,327653,2.4435241851356646
RPMI-8226,375860,-0.5400266159154646
HPB-ALL,6852167,2.8304771744370543
HCC44,9927531,3.2754168004895328
Kasumi-1,156414,1.0680106868971504
NCI-H446,6852167,1.7003239210515226
SEM,156414,0.3224280721453019
DB,24180719,2.9132672827023014
P3HR-1,136227924,2.9304577514896466
SET-2,71466445,1.5490156865471134
HT-29,3689413,-0.0079740382830798
Daoy,selumetinib-JQ-1 (4-1 mol-mol),1.1027213311180792
MIA PaCa-2,107970,1.625165459581556
NCI-H2452,24180719,2.8480667171601852
WM115,107970,1.780812210779262
HGC-27,168313016,4.744843210420601
FTC-133,107970,3.2744864550719126
BT 245,637858,1.8554051464132844
NCI-H1568,46907787,2.5747387573296425
BHY,5460769,2.8101975648917468
NCI-H28,241158,2.3012533117747664
Ki-JK,10302451,2.4926538669178977
IMR-32,71466445,2.852327940242344
HCC1937,135875424,4.325388188219658
EFE-184,71466445,4.052816246542502
Fu97,4259181,-0.4565347445839081
COLO 678,10231331,0.1251543587047796
K029AX,10302451,3.727811549907541
U266B1,11396600,3.5687128062577447
FTC-238,4259181,-0.2851243695387588
BDCM,selumetinib-JQ-1 (4-1 mol-mol),0.9833737053487288
NCI-H1563,UNC0638-navitoclax (1-1 mol-mol),0.5431037192141
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
T-47D,637858,1.866222886405254
ONS-76,241158,4.846225597872182
Hs 940.T,135875424,6.668178474722678
NCI-H446,49766530,-2.3059028658542116
MHH-CALL-4,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2869255563318425
HCC1395,9927531,6.948950349672662
HEC-59,439501,-0.4694388725326887
SF126,9936388,2.3000981317136433
NCI-H2141,439501,-3.4118873833208676
NCI-H1563,6852167,1.693143094788934
SUIT-2,9936388,2.2499280975506393
TOV-21G,49766530,-3.499964939979177
Hs 578Bst,644241,1.8272145958520527
NCI-H929,9915743,0.0759555072139175
U-937,168313016,5.149453664972447
697,12003241,-3.737782369602395
Ci-1,327653,3.316118649157309
KE-97,44489367,4.494657179212553
TUHR4TKB,637858,2.0327500822977154
Hs 852.T,9936388,-8.265529958895947
MDA-MB-468,26596,-0.798846302362186
RS4;11,444795,3.789506011302555
SCaBER,136227924,3.000538162090115
COLO 800,135875424,4.447518165388321
SW1271,637858,1.8302889918552376
TE-11,10302451,1.4712971313049523
KP-4,262093,2.717667187094357
NCI-H1581,26596,-0.8859288398475073
CAL-33,375860,-0.476811057349919
RKO,12003241,-0.2410566552434749
BT 328,100016,6.778172011931934
CAL-120,selumetinib-JQ-1 (4-1 mol-mol),1.9222647739332688
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
OCI-AML-2,12003241,-1.1091047572975106
HT-144,156414,1.6783717188308007
BT 159,637858,2.201222965192923
SCaBER,3689413,-2.276836963642964
SNU-1079,135875424,3.1645684861148977
NCI-H2009,9903786,1.8298580590992315
TUHR4TKB,44491742,4.24148356171105
SCC-25,11455910,2.801880341049824
KMS-12-BM,9927531,3.2870919606414963
NCI-H2444,135999136,4.625303018501703
HuH-6,135875424,3.823839910626804
OVTOKO,selumetinib-JQ-1 (4-1 mol-mol),4.12243300561417
L-363,selumetinib-JQ-1 (4-1 mol-mol),0.5037270825872936
MHH-CALL-3,327653,2.339703359599371
RVH-421,4259181,1.1736255747855893
SNU-213,4259181,0.9824949084518934
Daoy,439501,-2.3347693323407195
SNU-8,241158,1.5874400033719902
HLF,11455910,2.0760137944141355
MEC-1,107970,1.5620945400659931
YH-13,136227924,2.93381240838723
Karpas-620,262093,2.9084914265438164
AML-193,11396600,2.463856517722703
COLO 792,73707398,0.9576418558919108
Panc 02.03,4259181,2.0313571914007604
MOR/CPR,439501,-2.2142939555112484
L-1236,241158,1.444995384465227
SHP-77,46907787,1.21959073146431
SUP-T1,9915743,0.2147589739019727
SF539,135421197,1.037431947377599
OAW28,135421197,1.4901490212875883
Lu-99,6852167,2.317139161663513
HMCB,262093,2.6900614407313355
CA46,100016,3.773189878640827
P3HR-1,4259181,1.18334464722064
DMS 114,375860,-0.2775891558908802
WM115,156414,1.595819692541897
CW-2,9903786,2.9588284510461733
SK-N-BE(2),135398744,6.372852995200929
UM-UC-1,637858,2.9353042937749745
MDA-MB-453,439501,-3.002845657836036
HL-60,44491742,3.945358906065035
NCI-H2106,12003241,4.508121614525734
RPMI-8226,6852167,1.5516188067482786
NCI-H1792,136227331,4.237356132647452
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
SNU-466,9936388,1.636304731108846
NALM-6,46907787,-2.3948812362942964
U-937,100016,4.26159584690163
HPAC,439501,-1.2049246371580666
Jurkat,136227924,2.4803602069258712
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
NU-DHL-1,10231331,-1.2748802736904843
SK-MM-2,444795,-2.647397105058285
BT 340,9927531,6.379921104021661
KALS-1,72967,3.838723057282731
SNU-1077,439501,-0.9206139201693064
KHM-1B,26596,-2.1296194509234576
G-402,10231331,3.752227949163232
JHUEM-7,selumetinib-JQ-1 (4-1 mol-mol),0.2978252775763586
SiMa,9927531,3.724506882989752
SW1783,11396600,4.918648417758992
NB1,100016,5.984902151942781
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
SW1710,44491742,4.487431108260269
Calu-3,BRD-K27188169-navitoclax (2-1 mol-mol),1.4704463411828776
HCC-56,9936388,-7.462492097738726
SET-2,136227331,4.340141921453115
COLO 829,44491742,4.1867442642539725
BT 440,12003241,-2.6320772698218793
A-549,3689413,0.7236603744186211
HL-60,439501,-2.5264411138407836
NCI-H28,44491742,4.1731257553412116
KP-N-YN,73707398,1.440636079440376
HEC-151,selumetinib-JQ-1 (4-1 mol-mol),2.04219566232124
Becker,168313016,4.48609238913996
L-1236,6852167,1.1111947927360797
Ci-1,71466445,4.362793002044996
CAL-51,44491742,5.152478206660974
BT 164,439501,-4.366983118458045
D283 Med,135999136,3.641764348590375
BV-173,637858,1.2819525113051429
8505C,439501,-2.435831139874658
HuH-1,135875424,4.883016404001769
IGROV-1,49766530,-0.195540678413639
PL-21,9929138,5.81570058531176
BFTC-905,9936388,0.1811780464508788
BT 145,136227924,2.723434550490864
Kasumi-1,439501,-2.487116457098306
MSTO-211H,6852167,2.890925130180435
YKG-1,26596,0.9408189524000934
CAL-148,11396600,3.115756586832573
IGROV-1,135875424,3.3275053166921347
KLE,9927531,4.8057879583658405
ZR-75-30,9915743,-8.763917050030939
SNU-601,168313016,4.9872270729910255
NCI-H1755,4259181,1.0124007009100535
HOS,135999136,1.413572307289402
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
SNU-C2A,46907787,-0.3001977853137419
KMS-11,9903786,1.9090096011276083
HCT 8,54626689,4.527600703141773
CMK,6852167,2.302921040135064
JeKo-1,44491742,3.7422814982420056
EFO-27,73707398,1.1269975883077623
NCI-H2052,241158,4.256087222388137
JeKo-1,3689413,-2.4394197066593835
BDCM,11455910,-1.5577309500226444
SU-DHL-1,241158,1.6235055790866513
CAL-51,444795,5.053001195278548
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
Kasumi-2,5460769,1.467216518279754
Lu-65,selumetinib-JQ-1 (4-1 mol-mol),-0.4610963672816198
KYSE-140,9936388,1.9603983153875792
NCI-N87,444795,4.906796024963376
CL-11,11396600,3.643774231055674
U266B1,selumetinib-JQ-1 (4-1 mol-mol),0.6265067373447608
SNB-75,10302451,4.014625860461939
CCF-STTG1,136227924,3.7108552267199504
DU145,135421197,3.2080942542888056
SNU-1077,11396600,4.998092576249027
SCC-25,156414,-1.9517374046491416
SF295,262093,3.7346493602329462
Panc 05.04,12003241,-1.2094626899686458
BT 172,54596490,4.427470913675516
DAN-G,135875424,4.48447178949668
NCI-H1092,107970,1.8386309101568237
Daudi,444795,4.05018196872557
SNU-8,11455910,1.7503640063904615
FaDu,327653,3.4598790914984017
MJ,26596,-3.924273415415616
NCI-H1693,9915743,0.8308025375292787
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
NCI-H211,10302451,3.113222756869034
NCI-H889,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3007309952892117
QGP-1,262093,3.244803388046988
NCI-H292,135421197,1.1571557888211337
NCI-H1623,4259181,0.7011384719609343
HCC202,135875424,3.830240155533794
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
MES-SA,46907787,4.094732434863112
TE-4,72967,3.69473331553554
NCI-H1694,9903786,3.3065111756665564
NOMO-1,9903786,1.612481289648159
SNU-1214,9903786,2.1258190574569955
GaMG,168313016,5.769923785934136
T84,4259181,-0.5082694903070305
SUP-T1,71466445,1.8491194915279467
SNU-869,46907787,4.403742227184192
NCI-H1944,54626689,4.347082601964867
NCI-H520,54626689,5.006917649035428
SNU-1272,6852167,2.886842068916118
VMRC-RCZ,262093,3.1107535398689747
SU.86.86,644241,3.4785053193371716
HH [Human lymphoma],3689413,-2.48685445642347
CMK,439501,-2.5697505618969547
IGR-37,46907787,3.599816729005436
SNU-449,168313016,5.914877518762689
TE-11,11396600,4.3576491196249565
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
SNU-423,54626689,4.589502893592808
DU4475,135875424,3.0079145369477827
RCH-ACV,439501,-2.6930538101979575
A4/Fukuda,26596,-3.7061252239164553
VCaP,26596,0.7732068358688922
NCI-H2029,5460769,4.253529576580681
SNU-1066,107970,2.4636875537817433
SW1783,107970,3.037635999927972
SNU-489,241158,3.8247990570864703
UACC-62,637858,3.1015028924179164
SNU-668,11455910,1.1110208427049713
HLF,3689413,-1.4235179966835771
OC 314,375860,-0.387180019727141
MKN74,135875424,3.2262010711942484
Ci-1,44491742,4.040597879597693
KYSE-450,6852167,3.693304163934065
MFE-296,9936388,-7.084516673626579
MHH-NB-11,135999136,1.0169938700078396
CCF-STTG1,100016,6.985278157575169
A-549,10302451,3.5203591354698016
HT-144,71466445,4.558955973709899
TUHR14TKB,9936388,1.5897685475960623
L-540,4259181,-0.830522797129625
SK-LU-1,73707398,2.0384137453818316
KYSE-520,6852167,2.563750102501921
EJM,9936388,-8.624056137584708
U-118MG,9929138,7.614097012433896
KMRC-1,135421197,2.781168744821282
SW579,6852167,1.90487015320506
Li-7,135875424,4.067344810022126
NCI-H522,107970,1.611650854248594
SNU-761,9929138,6.284127493402678
Rh18,12003241,-2.237967131461188
SW1271,136227331,4.376300443457216
L-540,375860,-0.5429152411185477
HCC2935,644241,2.068249364643198
COV434,135421197,0.3873638415100381
SU-DHL-10,136227924,2.6642941314249327
OAW42,100016,6.607597097790758
AML-193,439501,-3.193215284595587
SNU-182,12003241,-2.036673656339672
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
NU-DUL-1,107970,1.631619301271972
OCI-Ly3,327653,2.887990377015542
COLO 829,12003241,-1.833925982592443
NCI-H2009,9936388,-6.076047204085024
LS1034,6852167,3.8807120807574784
BT 112,135999136,1.34167975240954
BT 164,135875424,2.686622551466718
EM-2,644241,-5.5059587558621965
TE-14,135421197,1.7423329869648043
Caki-1,UNC0638-navitoclax (1-1 mol-mol),1.2572218654888876
EB1,44491742,3.4704982889402545
COLO 205,375860,-0.9474772906288528
U-87MG ATCC,4259181,-0.4824960484366338
JHOS-2,107970,2.2743990130812173
SK-N-SH,439501,-1.8318448964157588
OCI-Ly19,9927531,5.466722325400782
HEY A8,3689413,-2.2125181580464592
SNU-5,49766530,-2.0910598582068776
SK-N-SH,10231331,6.160386015509348
HEC-151,3689413,0.5850952885102259
PF-382,156414,0.6060441396240198
TE 441.T,327653,2.387297951651056
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
MOLT-16,46907787,-0.6616446970476906
G-361,100016,5.501390716782531
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
BT 482,3689413,0.1224003168777627
BT 112,327653,2.6431646979441012
SUIT-2,135421197,1.9421505415119584
KYSE-180,3689413,3.064535959483158
EHEB,4259181,-0.3918316132670805
Hs 944.T,4259181,0.8815824268316962
NCI-H23,46907787,-0.1743912151849711
PK-1,262093,3.4724760266373087
NCI-H650,44489367,4.4348799803356025
SNU-1214,selumetinib-JQ-1 (4-1 mol-mol),-0.4737134364925926
BT-20,12003241,1.693784137841815
BT 216,selumetinib-JQ-1 (4-1 mol-mol),3.07268372456456
KNS-81,BRD-K27188169-navitoclax (2-1 mol-mol),1.1818015014003955
WM793,10231331,2.277080944837622
SNU-478,241158,3.0431805013253252
RT-4,6852167,2.0895706527990376
SW1573,73707398,2.4757839790774123
BT 440,4259181,1.1118800854766548
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
SK-N-AS,375860,-0.8530557147031617
SNG-M,9929138,6.049726158148494
BT 139,9915743,2.3473723766604833
BT 416,262093,2.6479795412008937
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
HCC44,selumetinib-JQ-1 (4-1 mol-mol),-1.8271790904045608
C2BBe1,156414,1.1308711604086286
COLO 829,54626689,4.670000135009869
MV4-11,444795,-2.88363162511681
Caki-1,11455910,2.5342429467421144
CMK,135875424,3.145736210165476
NUGC-4,6852167,2.041234695282504
Kasumi-1,3689413,-0.2693105089834908
22Rv1,12003241,-0.1253815141985464
Raji,9903786,2.8365362494251394
KMS-26,selumetinib-JQ-1 (4-1 mol-mol),-2.213502870233135
NCI-H2342,71466445,4.327526370836878
JHH-1,9903786,3.3314474186941987
BT 359,12003241,0.8363622600991807
ME-1 [Human leukemia],73707398,0.5585508807159069
Ri-1,54626689,4.174115404148546
SH-10-TC,9903786,4.254901914328344
Tm87-16,73707398,1.1462148062827904
SNU-387,4259181,1.2933701792403325
COLO 668,444795,5.2717518651707875
BT 232,10302451,4.010899903190945
MEC-1,11396600,2.4763898883602384
JHUEM-1,9915743,0.9861539346224674
GaMG,12003241,-1.1621616673389346
T24,12003241,-0.6434481559725229
NCI-H1975,9903786,1.3990648437170825
SNU-423,135421197,3.0122188559971725
P12-Ichikawa,11455910,-0.4653341655184377
Hs 766T,439501,-3.031090708237588
Ri-1,444795,2.8789748064532823
LC-1/sq-SF,4259181,1.283274293242228
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
ST486,439501,-3.700540877794945
CL-11,44491742,4.051585264115174
Namalwa,selumetinib-JQ-1 (4-1 mol-mol),0.0869925670736783
B-CPAP,6852167,2.612580501807676
GB-1,135875424,3.7799523392029593
NCI-H1869,73707398,1.8797199164844864
SK-MEL-2,439501,1.1166422747690987
ALL-SIL,11396600,2.960335319566646
ChaGo-K-1,73707398,1.0973603524165894
MDA-MB-435S,11396600,4.912452343589747
Fu97,11396600,5.862463296841975
WT2-iPS,10231331,-2.6099308614640417
Tm87-16,49766530,0.8637146059158625
SK-MEL-30,262093,2.857601335601776
YD-10B,135421197,0.9932980294986136
RPMI-6666,136227924,2.5880592922669097
MHH-CALL-3,135421197,1.4359965769543697
Ri-1,637858,0.8978114122705031
Pfeiffer,11455910,-1.170722455400671
CAL-54,4259181,1.011746502902974
BT 224,10302451,3.953686323960311
NUGC-3,12003241,-0.6366922027749422
G-361,46907787,-0.7380617933880704
JVM-3,5460769,-4.534057079586897
Namalwa,11396600,2.5581294543218616
BT 482,9903786,3.918124147791562
MOLT-16,11455910,-0.4766797538258427
CAL-51,156414,1.13799157004995
Granta-519,9903786,1.2937892753152922
NCI-H1944,46907787,2.618124377747688
HT,136227924,2.3517784191427613
TE-6,6852167,1.7770458307223695
BT 112,12003241,0.1954695576836523
MeWo,10231331,1.6242684117210484
SK-MEL-30,9936388,2.3653955391527575
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
HuP-T3,54626689,4.821166418142214
Mono-Mac-1,107970,1.267448776766495
LP-1,49766530,0.7133399832547254
HEL,100016,4.260371486080393
Ki-JK,9903786,1.8002187553993072
HT-1197,327653,2.757208589680578
RVH-421,637858,2.415713547012104
U-118MG,6852167,2.9671585976275385
SNU-1,3689413,0.5302948396087109
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
GCT,100016,6.941224948418202
Hs 888.Lu,439501,-6.314665191885066
SF539,136227331,3.3252279599925085
KALS-1,selumetinib-JQ-1 (4-1 mol-mol),1.151640151549291
BICR 56,107970,3.0717922125106405
BT-16,11396600,4.325514003074736
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
DBTRG-05MG,10302451,3.813801584534872
LAMA-84,637858,1.7001422847979093
P3HR-1,71466445,2.8786541215857264
U-BLC1,11455910,1.1815633788614182
CML-T1,44491742,2.876043803936746
RS4;11,73707398,0.131215442193938
NCI-H69,9903786,3.032908802365876
BL-70,selumetinib-JQ-1 (4-1 mol-mol),2.011932316177293
HOP-92,24180719,4.50522386688255
BC-3C,6852167,1.631200387252669
SK-MM-2,11455910,-0.2856161246837256
NCI-H1299,262093,2.920458315101783
BICR 22,637858,2.779101364791116
SK-N-DZ,375860,-1.0583156634000266
TE-8,54626689,4.536608130193031
253J,46907787,2.2087478748262597
SEM,375860,-0.9031870337732496
NCI-H1792,100016,5.097619126157972
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351
COLO 205,26596,-2.0120712396922475
HuH-6,644241,1.7181445887888465
NCI-H2452,9903786,2.1501841215173396
NCI-H292,135999136,4.360218039072087
MCAS,71466445,2.5533694020857163
MOLP-2,644241,3.111768413323115
BT 271,46907787,2.4034092441644597
WT2-iPS,9903786,4.00311264543886
SU.86.86,selumetinib-JQ-1 (4-1 mol-mol),2.491154829564457
KE-39,439501,-0.0752815835977172
SW579,24180719,3.509454387023944
SK-LMS-1,135421197,1.8226321341170344
C2BBe1,375860,3.403726092342882
JURL-MK1,9936388,-6.026953880051591
JURL-MK1,135875424,3.956954247189128
U266B1,135421197,2.0671733343036247
BT 440,73707398,1.96751487315396
DMS 53,6852167,2.392011330045594
CAL-12T,3689413,0.6503456712736767
LNCaP clone FGC,135875424,3.855348592559951
A-253,241158,3.928835071598182
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
MKN7,73707398,1.285732603925907
LoVo,71466445,2.646256567071358
SNU-475,24180719,3.61335526116337
LOX-IMVI,10231331,1.7536207323976525
Hs 729.T,26596,0.627655143965394
SNU-16,46907787,-1.0299263396915046
697,637858,0.646057758109665
697,644241,1.6492796316111564
CHP-126,135875424,3.887160554276878
SET-2,11455910,-0.0425011411311434
G-292 clone A141B1,262093,2.200248075467667
MeWo,10302451,3.531260082767252
MCF-7,9927531,5.854182634805009
LXF 289,135875424,3.2815298243266553
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316
MOLT-13,327653,2.351844946347274
LS513,49766530,0.4821695528273116
TF-1,439501,-2.265040568492349
JK-1,46907787,0.9440267753612736
Hs 822.T,444795,5.019849007849625
NCI-H841,9927531,4.161760245261401
SK-MEL-24,644241,2.0343401267094925
SW1990,44491742,4.13198674266079
HEC-1-B,12003241,-1.9447585975595445
HOP-92,12003241,-2.2936384439521156
EKVX,10231331,2.2534490436168766
SNU-1,10231331,2.0066448846643743
BT-474,439501,-3.058225040966164
RL,637858,1.0832577787514124
DLD-1,9936388,-0.5378287493970375
A2780,26596,-4.32263985415392
HT-144,5460769,5.183826263672234
C2BBe1,136227924,2.0906474270390656
HEC-265,135875424,3.9538578477076136
SNU-719,107970,1.9431075169363972
NCI-H520,73707398,1.1778124455658596
OCI-M1,107970,2.5617440742117794
KYSE-520,107970,2.991610825069756
SNU-620,168313016,4.089156987985177
U-BLC1,49766530,0.1451945306283898
SK-N-MC,73707398,0.55519642478783
SNU-16,644241,1.522235534594242
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
BT-549,241158,3.5488750117076484
KMS-12-BM,10231331,5.965261420703939
BT 245,12003241,-0.4272477548788383
NCI-H526,6852167,2.93402855712139
786-O,71466445,4.288313305391022
NCI-H838,3689413,-2.1672294024388106
PK-1,4259181,0.605699115942288
HuCC-T1,11455910,0.6774191240252393
SK-MEL-1,UNC0638-navitoclax (1-1 mol-mol),-0.6906136435096342
KMH-2,26596,-2.508510760962814
HD-MY-Z,5460769,0.4985347726770217
HGC-27,10302451,1.8923411487775068
U-BLC1,9929138,7.10057481888197
SK-MEL-24,9936388,-2.668445536248577
NCI-N87,439501,-2.2970478950560715
LUDLU-1,262093,4.588998578428556
SK-MEL-24,10231331,-1.7228498103629468
NCI-H446,135999136,1.8364057437274477
SUP-HD1,3689413,-2.4864416841895727
BFTC-905,107970,2.4913440657651496
JJN-3,UNC0638-navitoclax (1-1 mol-mol),2.7939555874700845
Karpas-299,9927531,5.423795277339213
SUP-B15,375860,-0.4986384951202697
BT-16,10302451,2.960014135095809
CMK,444795,5.729401774716638
OCI-Ly10,54596490,5.381670584410645
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
JHH-1,100016,6.434861287132587
BT 139,24180719,5.457784024295298
BT 416,4259181,-0.2167278617462421
RPMI-6666,6852167,1.0949232019863977
COV362,4259181,0.4253063174036923
697,11396600,1.1442486142510078
BT 333,12003241,1.72597197998683
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
COR-L279,5460769,2.2116692629451338
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783
Calu-3,9903786,3.8990782508172495
YD-15,5460769,-2.912025087128814
A4/Fukuda,71466445,1.4546499284121797
KMRC-1,73707398,1.5458693028147192
KMS-12-BM,selumetinib-JQ-1 (4-1 mol-mol),-0.820838989236415
SW1088,selumetinib-JQ-1 (4-1 mol-mol),2.946061724217482
EM-2,262093,0.7558915053093321
GP2d,375860,-0.4187362187145614
SU-DHL-4,26596,-1.8970615023372663
SU.86.86,11396600,3.58919118666286
Calu-3,241158,5.835885626166657
P31/FUJ,241158,2.9181679480161997
SR,439501,-3.204976665793822
BICR 16,4259181,0.912961687518015
OCI-Ly3,selumetinib-JQ-1 (4-1 mol-mol),-0.0066498103237673
KE-39,11455910,-0.1151631297895284
BT 248,3689413,-0.3734654016267222
Kelly,9903786,1.651293069080272
TE-8,46907787,2.122097927546814
COR-L51,9915743,1.408034977719198
PC-3,4259181,2.3252170813684763
QGP-1,637858,2.459344583911319
LOX-IMVI,10302451,1.9959018084394209
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
NCI-H2126,12003241,2.692479485403981
Kasumi-2,49766530,-3.7396811929647513
COLO 699,135421197,0.9619259452362175
Hs 746.T,156414,1.629229892534377
KO52,375860,-1.0348961069797258
KMS-11,12003241,-2.8887213513956147
PE/CA-PJ15,3689413,2.6755130574722767
A-253,327653,3.6566862144122374
ECC10,24180719,2.258488342196553
22Rv1,136227924,2.1207718843699
TE-15,54626689,5.678962222931802
BT 333,135875424,3.156129563480943
HCC4006,54626689,4.387604349302092
KYSE-30,637858,2.0597026776790544
CML-T1,327653,2.5732071532781866
NCI-H146,156414,1.153076826996135
NCI-H1105,135421197,0.5397494538103206
ECC12,444795,5.615613038326261
Hs 888.T,12003241,-1.970204906844497
Hs 936.T,selumetinib-JQ-1 (4-1 mol-mol),1.8156081078118131
NCI-H526,375860,-1.1255684965626964
NCI-H2009,4259181,1.0344432117954978
MKN74,444795,4.813746668426388
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
SCC-25,24180719,3.13778330208101
CAL-33,136227924,2.366373998099427
NU-DUL-1,136227924,1.961051427269065
TM-31,262093,3.077046279014693
JHH-5,9929138,4.293254911583093
BT 328,439501,-3.1360046964577983
HCC1500,136227924,2.675203690625814
SK-N-BE(2),637858,0.7979005670073629
KP-N-SI9s,49766530,-2.2767545360017407
NCI-H2170,10302451,1.7626824552831668
HCC15,135999136,4.472611779685761
TE-10,136227924,2.8479301717793435
SNU-478,46907787,0.0593244213587615
SNU-1272,107970,2.7088030141342383
Rh41,444795,-0.0086850409743929
SaOS-2,73707398,0.8491853151273433
HOP-92,54626689,3.9009772387198702
JURL-MK1,71466445,3.07345032592258
NCI-H460,262093,3.3627537421549314
BT 224,100016,6.546386559669457
ONS-76,10231331,-2.145918525616272
NCI-H2009,327653,3.1880644035572825
FTC-238,9903786,3.4467406025771705
G-402,637858,1.1376865921728858
IST-Mes1,9936388,2.2275468363886763
SK-MM-2,9915743,1.9327552948519848
HGC-27,11455910,-0.7196123988614116
CAL-51,135999136,4.2132345103647015
BT 231,12003241,-1.271590527231957
BT 232,49766530,1.9852556236627383
TE-8,49766530,-2.1976290152657114
MOLT-13,439501,-2.4259548935745348
ES-2,71466445,5.483195455605914
EB1,46907787,0.9817237925855196
G-361,73707398,0.7623357185652524
SUP-T1,100016,6.229647258472745
KMRC-2,107970,2.5476750010931446
OVTOKO,168313016,5.682190141491144
KMS-27,135421197,2.249002810195298
OCI-AML-3,selumetinib-JQ-1 (4-1 mol-mol),-2.716692997206964
PC-3,327653,3.578414834441837
NCI-H520,637858,1.8177885969386705
KMRC-20,100016,7.210629640241846
697,49766530,-5.010660235197008
SNU-1033,10302451,2.931783952664607
SNU-503,5460769,2.419581709530207
SNU-C5,11455910,0.7223735264442241
AsPC-1,5460769,5.795061807453513
NCI-H522,24180719,4.104291025168841
MC116,9903786,4.909292458120856
PE/CA-PJ15,selumetinib-JQ-1 (4-1 mol-mol),2.840123680248533
HCC366,9903786,2.568010100247165
SK-N-DZ,11396600,2.4748866696759113
ALL-SIL,12003241,-5.746631994241774
L-1236,637858,0.7270189908659739
Hep-G2,selumetinib-JQ-1 (4-1 mol-mol),-0.7772498513580158
MJ,49766530,1.2980181747447994
YD-15,3689413,2.243668996765499
CAL-85-1,UNC0638-navitoclax (1-1 mol-mol),1.0364537191058536
TUHR10TKB,6852167,3.670922279136049
YKG-1,UNC0638-navitoclax (1-1 mol-mol),2.987622235126213
MHH-CALL-3,439501,-2.5206189278952325
Reh,439501,-2.4165922655956407
YD-38,107970,2.360175771455579
OVTOKO,136227924,4.392974848141837
Panc 08.13,262093,2.9271884425048404
A-549,11455910,0.2975953497649719
JJN-3,49766530,0.5555169127000841
EPLC-272H,241158,3.6471551151035135
MKN7,12003241,0.0513011107794011
YH-13,11455910,2.765771134789071
NCI-H1915,10231331,2.410169333798645
HCC1588,9936388,-4.959177530840856
BT 422,46907787,4.821420374408007
EHEB,136227924,2.586993854279513
BT 164,11455910,0.017477073320278
SUP-T11,100016,5.673603064365157
BT 112,375860,-0.4292821848483891
JHOC-5,100016,4.009706795291197
NUGC-3,11455910,1.6597314376827883
HT115,9929138,5.341285159279084
BxPC-3,637858,2.219072546092823
Mel Ho,6852167,2.564669459332006
SNU-C2A,10231331,2.052823285789936
SNU-119,9936388,-1.2994148300283177
RPMI-8402,49766530,0.2151937728897686
Hs 294T,10302451,3.786077352821612
NCI-H2444,6852167,3.117687231513562
SK-MES-1,3689413,0.2897315368024132
23132/87,6852167,2.0137400124986713
OC 314,6852167,2.8554025378636587
JURL-MK1,241158,2.6830481572048255
KE-39,262093,2.516325504276674
BT-16,439501,-3.235694513476061
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
SH-10-TC,439501,0.97642019578469
BT 428,73707398,0.9802493689904498
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
KP-4,3689413,-2.736369445880075
Hs 578T,375860,-0.1045522991963771
LOX-IMVI,9936388,0.4128358081832157
Mono-Mac-1,644241,2.275828690099689
KMH-2,10302451,3.711688985022062
HPB-ALL,11455910,0.3446196457259795
BT 482,637858,2.0886989886626335
SiMa,26596,-2.340944971406374
RERF-LC-A1,BRD-K27188169-navitoclax (2-1 mol-mol),3.6651265228354855
HEY A8,selumetinib-JQ-1 (4-1 mol-mol),1.3172129019958227
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
AsPC-1,12003241,0.1897400127907629
NUGC-3,327653,3.534710126050335
A-375,4259181,-0.8072558556065395
COLO 800,3689413,2.0885075938315576
MKN1,156414,2.004674973176418
Kasumi-1,9903786,0.9129411943023928
GA-10,9927531,2.891443375149746
SNU-620,73707398,1.5869525584401722
Hep 3B2.1-7,selumetinib-JQ-1 (4-1 mol-mol),1.068007517221539
Daudi,54596490,4.948926549609605
BT 164,73707398,0.8970000363309636
TT,9927531,4.594242153757871
JeKo-1,11396600,2.6042135230770325
SNU-C1,4259181,0.4442529184524438
SR,156414,1.2315139202463783
MFE-319,24180719,4.375964654470909
VMRC-LCD,327653,2.851210955556481
KCL-22,439501,-2.3189522381647194
JIMT-1,439501,-2.416769885537428
QGP-1,9936388,-1.1142521734336477
PC-3,241158,4.501131440200892
SW1271,54626689,4.884226988721356
Panc 03.27,24180719,4.985905389709271
T84,9929138,6.3577776039121465
A3/Kawakami,327653,2.708987247942638
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
MCF-7,46907787,-0.1248384989436528
F-36P,241158,2.4015613346017113
BFTC-909,11455910,1.958059547603208
SNU-46,637858,2.6211038154237833
COLO 829,11396600,3.5925898800882856
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
NCI-H747,9936388,1.1116037034519244
BT 112,9915743,1.837502115717176
HCC1806,54626689,4.669002357556094
A2780,3689413,0.5219259729031659
Hs 839.T,439501,-1.1818140450451011
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
SNU-601,136227924,3.114119824082727
HCC1428,135875424,3.1301464909874546
SK-UT-1,136227924,4.460190875137593
MCAS,46907787,1.67067233253558
FaDu,637858,1.7950412976824095
KPL-1,9936388,1.598306973451347
Kelly,444795,2.997154071611722
ES-2,135999136,4.341769517673809
Hs 611.T,UNC0638-navitoclax (1-1 mol-mol),0.5214150649691321
NU-DUL-1,156414,0.3562766461235795
Hs 940.T,136227331,4.452644003789645
DU145,135421197,3.2080942542888056
TE-6,46907787,1.386672545327742
NH-6,135999136,3.2691781476001744
EHEB,5460769,-1.3281679410072365
SNU-46,11455910,2.77319640879208
NH-6,327653,2.9210802264449445
SK-N-MC,26596,-3.660625750775288
JHH-5,49766530,-2.9566039137212137
MOLT-16,73707398,0.2866580301768925
A-375,6852167,3.704250523230319
AU565,26596,-1.0644098452654434
SW1990,71466445,5.525497338974383
PL-21,24180719,4.236296326656865
EHEB,71466445,3.460498363916868
NCO2,44489367,3.401256271865541
Calu-1,4259181,1.7629989147872749
NCI-H196,9936388,-3.664647197542574
SNU-C5,156414,1.5922286954824516
KE-97,5460769,-1.2505802220316746
KP-N-SI9s,327653,3.066152107627383
Calu-1,327653,2.6340275004388856
KCL-22,11396600,5.105155728417937
SH-10-TC,100016,6.555483038363527
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
SK-N-SH,107970,2.0186521104376904
TE-15,439501,-2.48025284068881
RT-112,327653,3.237746861222672
Panc 04.03,11455910,2.454958233695195
NCI-H1563,selumetinib-JQ-1 (4-1 mol-mol),4.213181825361553
HCC1419,135875424,4.5952897384359215
DMS 454,49766530,-1.744731880816356
THP-1,136227924,2.5094113505430737
KMS-27,9936388,-7.881651109846528
T84,156414,0.0682461753591611
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
KE-37,100016,3.280443906920473
UM-UC-3,9936388,2.2420800599378325
Hs 822.T,327653,3.4451810935599925
NCI-H1755,UNC0638-navitoclax (1-1 mol-mol),-2.483337609520519
SNU-1079,12003241,-2.81102043929997
Raji,135421197,1.3656726509446273
NCI-H1355,26596,0.1615668606609613
Daoy,637858,2.1279349928795455
LOX-IMVI,73707398,0.9274850481113778
SK-MES-1,11396600,3.1861183641425823
TYK-nu,UNC0638-navitoclax (1-1 mol-mol),4.545157348775277
UM-UC-1,9927531,4.732850009488004
KP-N-SI9s,637858,1.6021781453279658
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
TE-8,11455910,0.8822945282493246
HOP-92,135875424,3.091462315962494
NB4,4259181,-1.8381008527339011
LS180,327653,3.1909584751660973
SNU-387,9927531,5.201038765097566
NCI-H2444,644241,2.901364953707021
SNU-878,241158,4.120703520920855
IGR-37,156414,1.774854831406992
SNU-449,11455910,0.8938620280411973
HCC1171,241158,3.854682403921552
SNU-423,73707398,1.089223560310694
SK-MEL-1,73707398,1.2021958708063876
NCI-H1092,73707398,1.109051456829637
NUGC-4,100016,6.130178573368833
IST-Mes1,262093,3.164571948045499
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
OCI-AML-3,136227924,1.3599145322416812
NCI-H1105,135875424,3.000418011762545
LOX-IMVI,71466445,3.3061273768946737
SW579,44491742,3.723441369263322
ST486,135421197,0.3717374472748143
TC-71,44491742,3.7748114564226407
DK-MG,12003241,0.4512209867473665
BICR 56,selumetinib-JQ-1 (4-1 mol-mol),1.4514445246280927
SUP-B15,156414,1.1180314683979184
RPMI-8402,9915743,0.1468401173271679
BT 333,439501,-2.413365908020449
DV-90,241158,4.253592582656695
KP-2,selumetinib-JQ-1 (4-1 mol-mol),2.520383276264048
TALL-1 [Human adult T-ALL],168313016,5.087698576043886
TT2609-C02,44491742,4.381647170405731
NCI-H446,3689413,-2.437056347343706
A2058,135875424,4.909286996355865
ChaGo-K-1,24180719,4.090680478392621
MDA-MB-468,241158,2.89506441485498
BT-474,637858,2.300118260965066
Rh30,135875424,2.415792825604233
SCC-25,44491742,4.077227537084196
HuG1-N,49766530,-0.3535010251675565
OCI-Ly19,637858,0.9883844033130186
OC 314,135999136,1.5511353326033843
BT 112,100016,6.504213631006025
Lu-65,241158,4.2277525357675705
NCI-H2106,168313016,4.030575020699663
SCaBER,9915743,-1.392407899834092
JM-1,262093,0.3077511100871351
NCI-H1568,135999136,4.3721543597322405
OVSAHO,375860,3.0148853739241495
MOLT-13,46907787,-2.224127501302228
MDA-MB-453,156414,0.9469838239648454
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
Hs 294T,135421197,2.57319967501113
DU4475,9903786,2.594571624962549
NCI-H2228,637858,3.1749317104999673
VMRC-LCD,135398744,6.4569642970049
HeLa,375860,-0.2411971223696274
T84,UNC0638-navitoclax (1-1 mol-mol),2.4353508898299245
PL-21,327653,2.987235766281407
SNU-308,4259181,0.5010319397561465
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
HEC-50B,9903786,4.880358665703779
NCI-H28,6852167,2.1577543799864403
SNU-213,136227924,3.1812992174761696
WM88,10231331,-4.286644172681502
NCI-H2444,10231331,5.176218450399146
NCI-H2286,135999136,4.916000985263414
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
NCI-H23,11396600,3.42598990187636
NCI-H520,135875424,4.041449952679746
HCC-56,selumetinib-JQ-1 (4-1 mol-mol),-0.6003400771432926
COLO 792,135875424,3.9911927217813385
KMH-2,9936388,-5.258192279265897
Kasumi-2,44491742,3.800345149395397
NCI-H1573,4259181,-0.9431239264425192
BICR 6,100016,5.983099357165641
Rh30,24180719,3.9836617255243
U2OS,9936388,-2.745672898623292
Caki-2,6852167,3.1041521694647103
SF539,241158,3.806550538894245
SNU-478,10302451,0.1456730012173813
HCC1143,444795,4.803024181226615
KMS-26,49766530,-5.317731060061128
COR-L95,49766530,-0.268325836176492
HEC-108,135421197,3.884784600125324
G-292 clone A141B1,375860,0.1163688023411329
LOU-NH91,49766530,0.361985362717411
AsPC-1,6852167,3.622461858977091
MM1.S,375860,-0.3099552941005813
KMS-26,5460769,1.6781754946124072
IGR-1,107970,1.916732154292642
SH-4,9915743,0.7789394097193199
GCT,12003241,-2.363961173456096
NCI-H2291,262093,3.0616783331233197
DoHH2,49766530,-6.954726736729235
WM1799,10231331,-0.6781881841650482
MPP 89,UNC0638-navitoclax (1-1 mol-mol),1.0683509046590218
NCI-H2029,100016,6.638892611020326
SK-ES-1,73707398,-0.3273653393975521
TE-5,4259181,-0.2224269562564943
OAW28,135875424,4.470041991889524
Hs 822.T,637858,3.031541188164114
LS123,135875424,3.499213265654359
MPP 89,selumetinib-JQ-1 (4-1 mol-mol),2.3199890701471295
JeKo-1,375860,-0.4106112996091592
Ku812,262093,1.3423418533813145
UACC-257,12003241,-1.8114895383547025
KNS-42,3689413,-0.7849742988075888
NCI-H1694,168313016,4.033797833146115
Panc 03.27,327653,3.706156295956661
HCC1395,444795,5.464087524782881
NCI-H446,24180719,3.785701536509419
SK-MEL-5,11455910,0.3432757840716531
GI-1,135999136,4.223499836748494
PaTu 8988s,100016,6.475282567189534
JURL-MK1,644241,-5.066770527926198
BFTC-905,5460769,4.235583914088274
NCI-H1299,241158,3.1343803063940996
EJM,73707398,0.7642029358076543
HSC-2,10302451,2.789258636905671
SK-LU-1,54626689,6.771949064483641
EFE-184,262093,3.462409565200508
SNU-886,46907787,3.408086497020091
BT 416,241158,3.719071622577502
NCI-H1341,9927531,3.217953728153189
RVH-421,135875424,4.136589484266176
JHUEM-7,6852167,1.350724801432494
G-292 clone A141B1,9915743,4.37083604289579
AN3-CA,6852167,1.7401945713297349
HEL,49766530,-2.395534265113236
RS4;11,26596,-3.6621242440749766
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
NCI-H2196,135999136,3.7154561762942353
HEC-1-A,241158,4.656372705051137
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
LXF 289,107970,2.2922723928752307
SNU-1076,12003241,-1.173823716137647
MV4-11,327653,2.3639439459269935
DBTRG-05MG,49766530,0.0162384250619963
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
NCI-H661,439501,-2.903837615768139
KE-97,UNC0638-navitoclax (1-1 mol-mol),5.143602126758789
ChaGo-K-1,11396600,3.1968353669128637
TT2609-C02,73707398,3.611682023187072
CAL-148,9936388,-7.397165329324112
NCI-H211,9927531,3.644928626875117
PL-21,135421197,1.4240798978799187
NCI-H1650,9915743,2.357354883780035
MHH-CALL-4,49766530,-1.9452729400457551
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
BL-70,71466445,1.4229248120179192
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
COLO 668,135421197,1.2477515484477224
Ri-1,9936388,-7.695738985409057
HMC-1-8,12003241,-0.3368702938294806
COLO 699,44489367,4.329963608371918
BT 482,10231331,-0.950028925069568
MKN74,24180719,4.121555152871541
U-118MG,9936388,-3.83393648054696
HCC-56,107970,2.461083510474252
TE-15,9903786,2.5325936452806723
BT 504,375860,-0.0376175483747626
CAL-27,12003241,-1.271388336497811
TE 441.T,44491742,3.759624787095016
BT 231,73707398,1.611870726926167
MDA-MB-468,73707398,0.8500080149823163
SNU-1033,46907787,1.4215977745383968
EFM-192A,262093,3.3016365369190614
GSS,262093,2.371550442394459
YH-13,26596,-1.6020780091570677
KMS-12-BM,3689413,-2.359728446736426
BFTC-905,439501,-2.3282671970513524
KM12,11396600,3.711398908201269
EFE-184,10302451,2.785285352409803
PE/CA-PJ34 (clone C12),5460769,-0.2838566207500756
WT2-iPS,637858,1.311477651994295
GB-1,136227924,3.951727784027331
TCCSUP,168313016,5.913828803978875
MFE-319,439501,-2.2775311995949035
NB1,135999136,1.5175720637935213
COLO 829,11455910,1.5093587467864735
BL-41,9936388,3.270630647985179
G-402,46907787,0.192686346076504
647V,439501,-2.3476085577035506
Mono-Mac-1,3689413,-2.253738856829829
NCI-H2081,10302451,3.961972444166296
ECC12,107970,2.974178840344196
NCI-H2196,107970,1.7459552506758529
SNU-216,439501,-2.844909600692544
HuH-6,selumetinib-JQ-1 (4-1 mol-mol),2.3851782535908628
ALL-SIL,4259181,-1.3200126273341632
KMS-26,135999136,2.070918369097562
L-428,9936388,-7.639006974415921
SF268,9927531,3.0957828421568396
NCI-H889,6852167,5.2304269420890535
BT-12,49766530,-0.9440868950031468
KYSE-510,262093,2.791157701495768
NCI-N87,11455910,1.6652699053284308
DOV13,selumetinib-JQ-1 (4-1 mol-mol),5.706841821977817
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
BT-20,3689413,-3.3374276278199972
Tm87-16,327653,5.240333301807643
VMRC-RCW,9936388,-1.838517301167892
SNU-899,12003241,-1.150293591999144
NCI-H1299,135421197,1.297843636132371
HD-MY-Z,73707398,1.0247944682443757
A2780,107970,2.1177540249197246
A-673,5460769,1.3883868162718005
SK-N-DZ,26596,-3.5191168188453603
EJM,135421197,1.4211538659692204
SH-4,637858,1.8209494990164508
SNU-869,241158,5.826918581124776
BT 422,selumetinib-JQ-1 (4-1 mol-mol),3.270814227900577
VMRC-LCD,439501,-2.2001056287042715
HOP-92,136227924,3.2563886907656725
EFE-184,439501,-0.6930526838136172
SK-MM-2,9903786,2.9629309693480983
FU-OV-1,107970,2.0514231206369686
RS4;11,327653,2.354289829060074
NCI-H929,11396600,-1.497885086375298
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
MM1.S,11396600,2.9620457472616533
TOV-21G,6852167,3.9528622196071335
GMS-10,9936388,1.763954811977491
HOP-92,4259181,1.0738738060955595
YAPC,3689413,3.09003195173071
NCI-H1568,9903786,2.4011050725962115
NCI-H2052,136227924,3.050038230910341
SW1271,107970,2.3235168881670285
Hs 852.T,3689413,-1.1635573957116976
REC-1,136227924,3.1866861789415855
OVCAR-8,9929138,6.802229697599492
COV434,439501,-6.307025719899454
Toledo,11396600,3.3426369304139825
COV362,73707398,3.674207870915267
JHH-4,6852167,2.8954393352869383
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
NCI-H1581,73707398,1.105308404191274
A101D,9915743,1.230916500554605
KMS-26,11396600,-5.248360616459154
YD-38,10302451,0.2221462011029107
KMS-27,26596,-2.324040117520084
Yamato-SS,46907787,0.3625913303778602
HOP-92,UNC0638-navitoclax (1-1 mol-mol),0.3347977995164087
SNU-410,BRD-K27188169-navitoclax (2-1 mol-mol),4.230533690826982
Caov-3,375860,-0.325299744991378
KPL-1,107970,2.5494857724802813
KATO III,9903786,1.8271137188030744
MFE-296,262093,2.4223872491935077
TE 441.T,439501,-2.08185324910289
PL-21,71466445,2.5925493312215053
SW1710,637858,1.7303422952388878
HPB-ALL,637858,1.3214508999864645
EPLC-272H,107970,2.2048649006361623
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199
BICR 6,11396600,3.532608369106794
HCC78,135999136,4.338544211633957
OVCAR-8,11455910,1.074074633675783
TOV-21G,71466445,4.3182150687628695
NCI-H2087,73707398,0.8336025649851103
Mel Ho,327653,3.195481244425943
BICR 18,11455910,2.028324794320248
LN-18,4259181,-1.3558758274682057
HCC1171,54626689,4.823529273802999
Reh,135875424,2.5875056879374307
SU-DHL-10,9903786,1.7653767834986365
A101D,selumetinib-JQ-1 (4-1 mol-mol),0.6301447985237953
CAL-148,100016,6.461133409351435
KCL-22,10302451,0.4054501902818456
NCI-H1755,135398744,6.361982871837632
MHH-CALL-3,9936388,-0.8161492964940873
U-251MG,49766530,1.0855724910741882
ONCO-DG-1,375860,-0.8365182552714027
BT 179,135421197,2.7508543391500875
Mino,3689413,-3.624730843514525
JHH-6,selumetinib-JQ-1 (4-1 mol-mol),5.125843437299189
SK-MEL-5,3689413,3.463644790263917
OCI-AML-2,9903786,1.7653976313293729
CHP-126,375860,-0.7056712843598286
LN-229,9936388,-1.4821904886179738
EFO-21,6852167,4.52142922121983
HEL 92.1.7,10302451,3.8368515417641142
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
SK-HEP-1,241158,4.116654148222159
EM-2,73707398,-0.1284556019091807
GSS,46907787,-0.800523617648134
LNCaP clone FGC,5460769,1.4769173176739367
AM-38,262093,-6.35735494896705
HEC-251,10302451,3.1386971099878065
YH-13,375860,-0.5335760796053879
MSTO-211H,241158,2.290519528489604
A-172,9936388,-2.441923795647272
NCI-H2286,10302451,3.84942208037586
RPMI-6666,11455910,2.3485395047161783
GDM-1,11396600,3.1168819453439895
HEC-108,107970,2.8725679938480817
COLO 699,9936388,-4.155221111232459
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
GA-10,9929138,4.091985168387067
OCI-AML-3,100016,6.665392900980702
VM-CUB-1,107970,2.31350526197513
MPP 89,135875424,5.105268273979739
U-937,11455910,-0.571974283584222
Granta-519,327653,2.833903719231272
UO-31,135421197,2.4256878664158443
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
SNU-423,49766530,-2.309056121887604
HEC-6,637858,1.941267423049059
PL-21,9915743,0.5916230612831309
SYO-1,135999136,1.963149298158808
MOLP-2,135421197,1.9402190230236491
HuCC-T1,9936388,2.1654759502470755
SNU-216,11455910,0.3573804688779068
SNU-1,241158,3.738411168906105
WM115,135421197,2.9135607351561883
Pfeiffer,10302451,-0.0352778784259099
BHT-101,4259181,0.1634706521315197
NCI-H211,262093,1.1438689543119294
NCI-H2452,156414,1.7996451609117237
NCI-H1792,6852167,3.9268827346397264
JHH-5,5460769,1.8419810692418657
NCI-H2286,439501,-0.7884333546830701
NCI-H2052,3689413,-1.081433417665549
BICR 31,73707398,2.635299985295534
BT 245,100016,6.42627295768896
ME-1 [Human leukemia],9915743,0.9546590301314803
TE-14,26596,-1.531582993203474
UACC-257,262093,3.003704805776171
NCI-H2087,UNC0638-navitoclax (1-1 mol-mol),2.07313942878803
NCI-H2452,135999136,4.5117873079445205
TT,107970,2.344052320065365
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
NCI-H520,156414,1.990276073985292
BT 228,6852167,4.103615495734906
HCC1438,46907787,4.671733521099006
OE33,136227924,2.987067512543954
AsPC-1,637858,2.8111542457272605
Hs 822.T,11455910,5.717819116017218
NCI-H522,135421197,1.9700795220087195
TE 441.T,644241,1.5282801612003003
NCI-H2291,136227924,3.7471032532575457
TM-31,135875424,4.624744892996729
JHUEM-1,11455910,-0.2565923916493475
SBC-5,107970,3.247043743319875
JHH-1,26596,-0.7682069189838904
IGR-39,136227924,2.6355333557661167
Hs 683,44491742,3.840304182439804
NU-DHL-1,5460769,0.1990382783266381
UM-UC-1,11396600,1.80390855748595
Calu-3,100016,7.471917827082483
SET-2,637858,1.0371530211435662
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
MOLT-3,10302451,0.2519809929726158
MOLM-13,12003241,-3.578107028375036
C2BBe1,6852167,2.3555235675705934
Hs 688(A).T,4259181,1.1112083370906582
Panc 04.03,10302451,3.874200048588579
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
HOS,selumetinib-JQ-1 (4-1 mol-mol),3.1878483028080673
TT,10302451,1.8777264782629384
PSN1,107970,2.763803123998224
Hep 3B2.1-7,136227924,5.40641673036814
NCI-H520,26596,-1.7163548151943342
SNU-475,637858,3.1810222277694535
MCF-7,9903786,3.2865331154211743
KYO-1,135875424,2.9941253538881925
KMH-2,439501,-2.384989575251817
L-540,135875424,3.4045526292316017
BFTC-909,44491742,4.0640318167931255
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
SUP-M2,46907787,-1.6457394871000364
AN3-CA,262093,3.1058426937478036
SUP-T1,54626689,6.947205003270078
ONS-76,44491742,4.314760532803232
COLO 668,156414,1.3268968619485253
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
Namalwa,5460769,2.4239066035753054
P-STS,73707398,-0.0870893043837352
GP2d,12003241,-2.636823152177336
EFM-192A,73707398,1.3646305784605928
SUP-B15,6852167,2.250730006351081
Caov-3,11455910,2.963871199363813
OE19,4259181,-0.6372302154044356
Hs 852.T,375860,0.1239369223393283
BT 504,12003241,-1.3815102310326015
Panc 03.27,107970,2.945998932112281
HeLa,6852167,3.9174873228525353
A101D,4259181,-1.780447840165833
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
DMS 454,135875424,4.8848557327736115
HuG1-N,selumetinib-JQ-1 (4-1 mol-mol),2.3210955713963672
RCH-ACV,5460769,1.517415725106548
HuCC-T1,241158,4.215812511929855
ME-1 [Human leukemia],168313016,5.223278335467516
BT 172,9936388,-4.290165173398555
G-292 clone A141B1,5460769,2.9316291773021095
COR-L88,5460769,4.328731747643338
RPMI-8402,44491742,5.171904167752256
UACC-257,44491742,4.3075324328228275
NCI-H1355,BRD-K27188169-navitoclax (2-1 mol-mol),3.0033185433354985
SK-MM-2,327653,1.9835737572628724
SNU-C5,BRD-K27188169-navitoclax (2-1 mol-mol),1.5541280257877843
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
CAL-120,BRD-K27188169-navitoclax (2-1 mol-mol),1.0394968689624224
SaOS-2,9903786,2.3206358959344264
SNU-1076,135421197,2.6867393428940107
SR,11396600,3.1743105813803085
42-MG-BA,10302451,1.5465274092689412
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
CJM [Human melanoma],135999136,4.708181973943208
JHH-1,46907787,3.3100024597454674
Hs 852.T,100016,3.86747930561629
Pfeiffer,262093,0.9483544228261476
SUP-T11,73707398,0.4533846882446893
Capan-1,156414,1.6052662486376672
M-07e,135421197,0.940164437961766
UACC-257,9936388,2.2230563753853754
UO-31,46907787,1.771308845530738
COLO 320,54626689,3.403277233554932
WSU-DLCL2,24180719,3.102276053536735
MDA-MB-361,71466445,3.6959978776465414
COLO 668,9915743,2.0243501166827924
LCLC-103H,241158,3.440238106244061
SUP-T11,49766530,-4.92791110390187
HT-1197,24180719,3.8565119139724544
Capan-1,49766530,2.9089609583789535
2004,135421197,1.2984734830690137
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
Li-7,54626689,4.207813357392459
OPM-2,10302451,3.176323712036339
Daudi,9903786,1.3988461789185107
Panc 03.27,5460769,1.9093660486325057
NCI-H1693,156414,0.918301243900346
DBTRG-05MG,9903786,2.261180783210366
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
TE-11,637858,3.1102345821229673
LCLC-103H,135421197,1.2256317024766628
BT-12,72967,5.032821091249338
CAL-29,46907787,4.132082272537132
VCaP,136227924,2.2790218879563255
IGROV-1,12003241,-2.0122972114546904
MES-SA,11455910,-0.2253675731239214
DMS 454,11396600,3.1958001986957143
OE19,12003241,0.3915460727280876
CGTH-W-1,107970,2.906028593305823
SK-N-FI,168313016,4.337326261772598
CHP-212,71466445,1.0770121742472976
SNU-C5,44491742,3.683316121476328
GOS-3,4259181,0.7347951046145877
WSU-DLCL2,44489367,4.191778449138372
T98G,262093,3.081379180281475
HCC1419,selumetinib-JQ-1 (4-1 mol-mol),4.191406953790356
HCC95,107970,2.8523791542380095
OCI-M1,26596,-2.6046335322938927
T98G,12003241,-0.2247982599387034
BT 330,262093,1.7469148441543585
T3M-10,9915743,3.0037354208599996
TTC-709,444795,4.010443492718726
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
CFPAC-1,3689413,3.8323467943354337
NCI-H647,73707398,1.965831350411136
GaMG,73707398,1.764890273720185
COR-L105,136227924,2.729950058152846
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
SUP-T1,168313016,4.416252700819181
VMRC-LCD,100016,6.5149453048399515
TT,168313016,4.280600681021949
NCI-H2291,10302451,3.44442862522121
NCI-H2106,44491742,3.3894720811903976
A-673,12003241,-2.2168793422392103
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
T-47D,9936388,1.741664063669155
NCI-H1435,73707398,1.0591696361842406
NCI-H522,637858,0.9732265340904396
SNU-5,3689413,0.3799296763624849
LAMA-84,107970,2.224975468533932
NU-DHL-1,327653,2.351197542951544
697,54596490,4.316781960045189
NCI-H23,10231331,0.2640956714926077
Hs 895.T,selumetinib-JQ-1 (4-1 mol-mol),4.223259606319089
COLO 684,11455910,-1.3406228718579627
TOV-112D,135999136,5.136012887417667
RPMI-8402,135421197,0.8834932639167268
PE/CA-PJ41 (clone D2),12003241,-1.240840898142407
JVM-2,12003241,-4.468160768320854
HPB-ALL,11396600,3.1053872858307225
BT 286,156414,1.5712991446224744
SU-DHL-8,100016,4.106875584244309
SW982,136227924,1.7454954285641082
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
SK-N-AS,135421197,2.9463042299637645
TYK-nu,24180719,3.6184551231091784
PaTu 8988s,637858,2.70031319298971
SK-N-AS,10302451,3.6948168438870583
LK-2,11396600,3.577744596051322
KU-19-19,262093,2.7281718696395303
CHP-212,107970,1.5459012913024066
EoL-1,9915743,-0.0181598036434267
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
MOLT-16,UNC0638-navitoclax (1-1 mol-mol),-0.9307408191355994
MOLT-3,107970,1.5374571301913311
NCI-H2023,9936388,2.0021755277076045
VMRC-RCZ,46907787,2.9652136995689315
HT115,135421197,2.47112158690729
PSN1,9936388,-1.558535767626658
BFTC-909,4259181,-0.0277162117211437
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
MFE-319,241158,3.887445302538144
AGS,136227924,3.766909782373439
Kelly,26596,-1.7791948075234636
KYSE-70,262093,3.701785722517592
OVCAR-8,10231331,5.783202418816481
DOV13,12003241,2.698298225737835
SW579,135999136,4.040780810793802
GI-1,107970,1.763597971813926
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
HCC1395,73707398,1.348655515938351
OV-90,6852167,4.1070875772110185
MDA-MB-231,9915743,4.40604807158467
NCI-H1563,136227924,3.549094897051017
HCC202,9915743,-1.8631873030547408
OCI-AML-3,46907787,-4.468250501398446
SR,9903786,1.863499016732126
CAL-12T,12003241,-2.021983796416415
2004,241158,4.247713330929997
KYSE-180,439501,-1.6605779697575254
PK-45H,3689413,-1.0199295796729335
NCI-H1563,135421197,1.4749525017569085
FaDu,107970,2.22410543491943
DV-90,375860,-0.9488117357311476
PE/CA-PJ15,54626689,4.686002745759547
RKN,439501,-1.5558449248177562
MPP 89,439501,-3.0783668430470574
BICR 18,136227924,3.2249717702756486
TE-6,54626689,4.669827412944223
UM-UC-3,6852167,1.955849338539072
A-204,9927531,4.116017775807866
RERF-LC-Ad1,3689413,-1.7788688033713365
A2780,637858,1.382423379201008
COR-L95,9936388,1.0197606854481494
OVISE,49766530,-2.0570642495309004
HT-55,73707398,1.0598769485898192
SNU-1272,71466445,5.534293199033029
NCI-H524,375860,-1.0954179632346426
TE 441.T,241158,4.026754207652904
SNU-5,439501,-2.355283147047071
BT 228,136227924,3.2498510190278314
CCK-81,439501,-0.4641982207624705
A-375,107970,2.3829956966560664
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
MHH-ES-1,100016,6.165620846351705
FaDu,9927531,4.819445610620238
NCI-H1650,selumetinib-JQ-1 (4-1 mol-mol),2.519916667602708
SNU-685,327653,3.6761409517937698
ACC-MESO-1,4259181,0.8154176587876882
PC-14,11396600,4.745127634228124
LCLC-97TM1,12003241,-0.8351557307101188
ES-2,9903786,4.393151500832027
NCI-H2110,10231331,4.807632795755959
IGR-37,136227924,2.9944260233382667
HCC1833,100016,6.427561679501585
DMS 454,selumetinib-JQ-1 (4-1 mol-mol),2.137011851517838
HCC2279,10302451,2.443076216566613
COLO 320,135999136,4.1679659514892435
SNU-1041,439501,-2.4187407213181085
COLO 829,135875424,4.104169116255948
OCI-M1,selumetinib-JQ-1 (4-1 mol-mol),-0.1559464569185333
VMRC-RCW,135398744,6.359457324257638
T-47D,241158,4.377516241825195
AU565,135999136,4.178255303593246
HCC1588,49766530,2.4669861757295832
Calu-3,49766530,-1.5198016619838384
CAL-78,637858,1.6758422163434077
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
PF-382,73707398,0.3361294473850881
253J,71466445,2.845552651770213
MES-SA,262093,3.4311342236601567
Hep-G2,12003241,-0.7040118985216451
HCC1195,100016,5.060252338886612
SU-DHL-1,135999136,4.730243036337901
DV-90,135421197,0.8587381868219376
HSC-4,107970,2.304506496588027
KYO-1,135999136,1.771053497047969
SCaBER,12003241,-1.3613478880946173
NCI-H1944,375860,-0.3513719404528298
NCI-H2085,24180719,4.367351187700946
HT-1080,24180719,4.333661562765805
Peer,135875424,2.778289251682957
BICR 16,156414,1.6425914491549127
SK-MEL-5,637858,2.5788242810991537
SK-BR-3,168313016,5.907534707953531
LUDLU-1,46907787,0.7163750513556869
KYM-1,72967,3.725186297986206
SR,46907787,0.4720796190205829
BT 172,10302451,4.033913731030382
BC-3C,54626689,4.469550899506127
MKN1,BRD-K27188169-navitoclax (2-1 mol-mol),3.65775160677675
HEC-1-B,46907787,-1.260685398577055
SNU-5,6852167,3.310074767427802
Mono-Mac-1,73707398,0.6980623217810987
JM-1,44491742,3.590859136704876
Kasumi-1,71466445,1.0139160827846212
Karpas-620,637858,2.7118075848946583
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805
NCI-H2196,46907787,3.906560872378596
SNU-869,135421197,2.4475958723974944
JIMT-1,136227924,4.112902711551938
GCT,136227331,4.154263248782668
YH-13,4259181,0.5149162893859401
NCI-H2081,54626689,4.922665584817983
OCI-AML-2,5460769,1.9036049524164391
SK-MEL-3,49766530,1.022989661604762
HEC-151,136227924,2.850288220591168
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
CGTH-W-1,136227924,3.107802787848976
HCC2108,6852167,3.7271551469098583
SUIT-2,73707398,2.4448376326021313
SH-4,10302451,3.573247418595864
COV362,135875424,4.673498463439342
DoHH2,439501,-2.792554896141067
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737
CMK,49766530,1.0776761429399353
U-118MG,241158,4.2243210279093
BT 330,49766530,-1.7517349908544686
NCI-H2228,135875424,4.666656797632995
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
G-401,4259181,0.5796012369716917
NCI-H929,107970,2.2964601738289687
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
CAL-12T,4259181,-1.3475002263625786
RT-112,107970,2.3361930126733785
LS411N,10231331,0.2083934704449227
COV362,11455910,3.2611382384479186
OCI-Ly10,UNC0638-navitoclax (1-1 mol-mol),0.9404785966426684
EJM,9903786,2.5710642236856818
HMCB,26596,-1.2966092010554455
MOLT-16,9915743,-0.2771679442099183
A-375,262093,2.9970202931790046
HEC-265,9903786,3.4431873939131536
U-BLC1,4259181,-0.0351960911080245
BT 187,46907787,3.607814599945456
Detroit 562,71466445,4.974965129813821
NCI-H1563,24180719,2.7565513890340023
LMSU,24180719,3.8300426500348177
KMRC-2,54626689,4.800851370562855
H-STS,selumetinib-JQ-1 (4-1 mol-mol),1.7397587853483405
P3HR-1,5460769,3.3454995233869957
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
TUHR4TKB,46907787,4.198282991293648
LS411N,44491742,5.693616041532359
SK-N-AS,3689413,-1.598597846908754
SK-N-MC,3689413,-2.3816652298923873
CAL-54,11455910,0.6457231079325149
Mono-Mac-1,6852167,1.1013775883292647
P3HR-1,107970,3.4553561691501047
SNU-16,49766530,-2.8368517260847304
MDA-MB-361,327653,3.3179134221439344
NCI-H520,9936388,-7.179601192363118
BT-16,4259181,-2.0652151566273687
SF539,26596,-2.288089999638428
MOLP-8,136227924,1.5113872866650588
HGC-27,241158,3.1465337742819135
AU565,136227924,2.2371309282915184
8505C,9927531,4.3206227244137745
NCI-H1092,135421197,1.379439810077043
SR,135875424,2.4827533420158376
NCI-H1703,selumetinib-JQ-1 (4-1 mol-mol),2.399515856711348
23132/87,135421197,1.295481545457509
DV-90,54626689,4.0297430446630065
L-428,71466445,2.253432696874775
SNU-761,9915743,0.9081807401116692
TCCSUP,107970,2.506866971737107
SUP-T1,11455910,0.2462561508535602
PaTu 8988s,54626689,4.835984760777768
Hs 578Bst,3689413,-1.7241892879585388
Hs 294T,6852167,2.030444131876515
SKM-1,9915743,-0.8868720134451151
HLF,9903786,4.061487019079308
BT 131,241158,3.979093045578545
TE-9,135999136,4.639285967377416
SW1710,3689413,-0.3418925228905715
JHUEM-3,selumetinib-JQ-1 (4-1 mol-mol),0.3995235416963141
G-292 clone A141B1,135875424,3.061063292473857
JHH-4,selumetinib-JQ-1 (4-1 mol-mol),1.29938759958363
KYSE-140,135421197,1.0055598212916683
EM-2,54626689,4.479552823135875
MOLT-3,9927531,3.2112573350362372
HCC44,637858,1.942113190267318
BT 330,3689413,-2.329423623315505
ACHN,54626689,5.12205838838052
769-P,262093,3.4485358488357867
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
HEC-6,135421197,3.631820052963688
SNU-1105,135875424,3.163533063025223
EHEB,637858,1.5977612521222773
DoHH2,5460769,1.245270036002789
BHT-101,24180719,2.99424617899874
RKO,107970,2.3673735748138265
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
MOLP-8,135421197,1.7506124789909805
HCC1500,107970,1.6380228058856745
SW579,4259181,-0.0150146553014248
Panc 05.04,439501,0.2716766298535532
SNU-478,100016,6.124719500368946
Mono-Mac-6,444795,2.051246828353319
Ki-JK,135421197,1.017420564830507
COLO 678,156414,-0.6332509558751841
NCI-H2228,156414,2.8304851039328565
NCI-H660,637858,0.9020207680443736
COR-L95,327653,2.664763845896721
SNU-182,24180719,2.2806214449962323
BT 147,241158,3.953049776749466
OVSAHO,9903786,3.817356196338304
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316
Hs 683,6852167,1.768664782954411
SNU-119,9903786,3.393165032525661
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
SK-MEL-31,selumetinib-JQ-1 (4-1 mol-mol),2.462947302888872
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
OVK18,637858,1.5297854885562336
CAL-33,5460769,2.348968888608987
42-MG-BA,54626689,6.775302884946697
AGS,46907787,1.8516291073486968
SNU-1077,107970,2.607215080284504
JeKo-1,9927531,3.3417502019075473
L-428,11396600,3.243581020285636
CMK,71466445,1.4196244832729643
EFE-184,54626689,4.499420138638496
HCC1500,327653,2.623652361439541
KE-97,49766530,-2.2252000601337456
BT 440,6852167,5.5047187061926035
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
SEM,49766530,0.1216347460182048
BT 440,644241,2.739700914223042
YD-10B,156414,2.388242081473774
PE/CA-PJ34 (clone C12),10231331,3.045773235767836
CCK-81,6852167,2.8199787349778553
HCC202,439501,-1.9855042257832605
CHP-212,439501,-3.066647647836344
JJN-3,156414,1.5641574452872378
MCAS,11455910,0.7655577193657753
NCI-H1299,46907787,1.4375849802030871
SUP-HD1,135875424,2.9213239436654908
NCI-H2087,selumetinib-JQ-1 (4-1 mol-mol),-5.600268685370347
HCC-56,168313016,4.911744541698628
EBC-1,12003241,0.7952037321943549
PL-21,136227924,2.3397761554923413
DB,136227331,5.354479486577142
OVK18,6852167,1.7942608404325415
SK-UT-1,439501,-2.663904937582399
MOLM-16,9903786,-0.0890634921772537
SNU-1076,107970,2.385093319314459
HCC827,168313016,6.229726215184129
KMS-12-BM,241158,1.5195082823857844
NCI-H647,49766530,1.518533488741799
HH [Human lymphoma],49766530,-3.061520130360288
KMS-21-BM,54626689,2.4877028849611977
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
MOR/CPR,136227924,3.350851412370925
SW1116,selumetinib-JQ-1 (4-1 mol-mol),-1.5718709944273437
JHH-1,375860,-0.0865260995882469
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
DB,135398744,6.337933152850909
RKO,439501,-1.8401322759847645
KMRC-3,12003241,-2.293511180564156
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
SET-2,262093,0.9752595476876692
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
OCI-AML-2,135421197,1.0650932399576858
DB,135999136,3.730789319227476
OVCAR-5,444795,4.301907976555397
NCI-H1395,9936388,2.8582059793440964
EM-2,107970,2.208998012653241
SK-N-BE(2),156414,1.4719636932362017
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693
M-07e,375860,-0.7306719237293631
P12-Ichikawa,136227924,2.6176590952299477
NCI-H1650,327653,2.4203242647198153
697,135875424,2.464322234177451
AsPC-1,6852167,3.622461858977091
JJN-3,135421197,1.2672654970884558
HeLa,100016,5.8653655502295
IGROV-1,26596,2.910298792762654
CAL-62,UNC0638-navitoclax (1-1 mol-mol),2.629188723486929
KYSE-520,637858,3.405755919690514
NCI-H1693,11455910,0.7254587825692573
MKN7,54626689,4.5064665795650765
HL-60,UNC0638-navitoclax (1-1 mol-mol),1.0635413421585809
HCC38,439501,-2.3943608626526536
JM-1,11396600,1.6173586604508372
GSU,6852167,3.634612073118843
Kelly,135398744,7.079466503802849
SNU-410,262093,2.9879613961382363
VMRC-RCZ,9915743,2.338225361528291
EC-GI-10,375860,-0.5151206248138002
JHUEM-7,375860,-0.5506223236134746
HLF,5460769,2.8126856105883355
IGR-37,73707398,1.5804639662381832
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096
NCI-H2087,156414,0.9461657177021514
A4/Fukuda,262093,3.0357368226896178
RT-4,439501,-1.136247834932354
OC 314,73707398,0.9395818266377978
HPB-ALL,444795,4.0041475034544325
L-1236,46907787,2.216652350556167
Hs 888.T,135875424,5.931085085521744
BT 139,4259181,1.714008353576017
UACC-257,46907787,5.925125259909612
CHP-212,156414,1.607333676424714
MFE-319,135999136,3.968795924273322
KMRC-3,49766530,-1.4126043666581272
KMH-2,100016,3.8705403745512017
WM983B,UNC0638-navitoclax (1-1 mol-mol),4.930439890956027
LOX-IMVI,selumetinib-JQ-1 (4-1 mol-mol),0.1243957473600749
2004,11455910,0.701648674397756
OE33,135875424,4.864853081585439
SNU-410,26596,4.2924060391829935
NCI-H2122,46907787,2.248014576758407
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208
NB4,439501,-2.5545682554076805
KMS-20,46907787,-1.3444114814530854
KP-N-YN,241158,4.193334687339578
HCC1171,49766530,-2.294988687179399
U-CH1,135875424,4.885628111434567
OCI-Ly19,73707398,0.0896254246290502
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
SNU-1077,6852167,3.093534637774652
LP-1,107970,1.8011925115015095
KMS-11,100016,4.183673123455152
U-CH1,9936388,3.1396417887347017
Namalwa,4259181,0.072491305186228
Mel JuSo,9915743,2.4580846898357547
SNU-16,241158,3.7925495758268286
MG-63,375860,-0.4723696527252595
BT 228,10302451,3.762994795422787
KYSE-410,156414,-0.3480069289117364
23132/87,241158,3.5006717835026713
HEC-6,selumetinib-JQ-1 (4-1 mol-mol),0.8521985876067439
SNU-899,136227924,3.189426259363562
ChaGo-K-1,135875424,3.8110724271208656
HuH-1,135421197,1.8778683670700504
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
A3/Kawakami,12003241,0.0304416634107028
PE/CA-PJ34 (clone C12),11455910,0.5657744918990928
SW982,10302451,5.246123536863423
HPB-ALL,UNC0638-navitoclax (1-1 mol-mol),-0.420170411701019
647V,262093,3.044497646509944
CL-11,11455910,1.292205129341028
DOV13,156414,2.3224096962852325
KATO III,107970,2.4596354159707827
SNU-61,12003241,0.1572719330395487
HDQ-P1,6852167,3.4525559906926793
HCC2935,135875424,5.111767291831502
IST-Mes1,9915743,1.0557522455188102
JHOM-1,24180719,4.1291119275964965
LN-229,107970,2.219765317659143
NCI-H292,439501,-2.469830491210978
NCI-H1568,11396600,3.496587037401377
NCI-H1693,24180719,4.6196215448166456
NCI-H2106,46907787,3.0584015724155904
COR-L105,444795,5.02091820523187
BT 286,9927531,5.383522650777723
DMS 273,11455910,0.4737958394902512
COLO 699,9929138,6.696462829183714
Kasumi-2,10302451,2.501538159290375
NCI-H1792,selumetinib-JQ-1 (4-1 mol-mol),1.508077627842721
Peer,6852167,1.672414064872
KNS-62,3689413,1.1853258222695242
Caki-1,135875424,5.125575206992357
Becker,26596,-2.013233579681989
U-251MG,644241,3.0245187520411694
KMS-18,262093,1.4721662513603355
BFTC-905,4259181,-0.5196077824853107
IGROV-1,135421197,1.96820638017286
KPL-1,9915743,2.2588912198208595
SNU-503,10231331,4.23088232579893
BT 228,327653,3.1357639702509865
HuP-T4,9903786,1.2000554865922293
MeWo,44491742,4.0764207569550255
VMRC-LCD,selumetinib-JQ-1 (4-1 mol-mol),1.7266079975134632
RPMI-6666,439501,-2.7068928395348935
BT 248,10302451,3.817813130063646
HEC-59,49766530,-0.0916228108387451
CAL-54,11396600,3.3062490005536467
NCI-H2196,375860,-0.2759858226988109
NB1,637858,1.5809621716939124
HCC1833,11455910,1.7776428599570322
BT 333,241158,4.43002656195282
Calu-1,44491742,5.4818200754646
A3/Kawakami,637858,1.0589616094349
COR-L105,4259181,2.2372065992854133
TE-10,637858,2.2669165845620887
CML-T1,168313016,4.15358640853123
MDA-MB-435S,26596,0.461113315638288
MDA-MB-231,4259181,0.3992270922523126
HCC1395,637858,2.957827547978506
ACC-MESO-1,6852167,4.128939666891623
KP-N-SI9s,135999136,3.2804622409589252
SW579,54626689,4.651382339589695
HeLa,4259181,0.2156486881613415
OCI-Ly3,49766530,-2.896711539543773
DAN-G,107970,2.4101634443904727
BT 216,644241,3.0724583671092236
KMS-28BM,24180719,3.7004949029064704
BT 428,644241,1.7841818020413711
PE/CA-PJ41 (clone D2),135999136,4.2765037519460565
Capan-2,9927531,4.988385726182681
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
KMRC-3,241158,4.146314213470915
T84,26596,-1.9747226822057509
P31/FUJ,4259181,-1.476581151251805
SW1990,11396600,4.084870548965884
CJM [Human melanoma],11455910,2.204115994538186
SNU-175,10302451,-1.3432217773837662
Hs 578T,637858,1.2517408441018556
LN-18,9936388,-1.1399684434607444
HCC1833,24180719,3.7123111048651225
KE-39,9929138,5.605001473491643
SNU-886,637858,1.4418078006770565
NCI-H1184,135421197,-1.5924558307630432
Panc 05.04,135421197,1.7241772934352249
WM266-4,24180719,1.3327982596344865
PE/CA-PJ34 (clone C12),10302451,1.6517506382371558
BT 159,100016,7.101052412805122
SW948,73707398,1.7510146080607218
OCI-AML-3,12003241,-2.086986892339566
H-STS,135875424,3.212810522479317
SNU-449,6852167,2.6501635563943977
BT 498,136227924,4.389685115045935
KYSE-520,9915743,1.755136902967863
LS123,6852167,1.8176468580104257
HD-MY-Z,6852167,3.895273061647595
RPMI-8226,135999136,1.3758652810772145
MPP 89,44491742,4.112850541914658
HEC-251,135421197,1.306349279370071
BEN,439501,-2.2680431594189727
HCC1195,9903786,3.7437324544379487
NCI-H716,6852167,2.05149641213453
HSC-2,5460769,0.0073733744403826
COLO 684,3689413,-2.2674920306130764
NCI-H647,9903786,3.1378024767973827
KMS-28BM,11396600,2.8366519547889357
MDA-MB-468,selumetinib-JQ-1 (4-1 mol-mol),2.286033970917834
NCI-H747,327653,3.3601935070997264
MKN74,107970,1.5556994313686008
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
L-1236,107970,3.0094874946662165
SNU-C4,73707398,1.213067519189312
CAS-1,44491742,3.9814120844096386
SNU-8,4259181,-0.24228140638784
JHUEM-3,44491742,3.947686960056495
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
Mono-Mac-6,6852167,2.351301964226235
NCI-H2228,135999136,4.356643456755604
SW1353,9936388,-5.283221475424073
NCI-H2291,24180719,3.5666768149805184
BT 112,156414,0.8059624645319847
NOMO-1,136227331,3.913043208951298
LUDLU-1,100016,6.796390484470128
MPP 89,9915743,2.161327298254378
BC-3C,375860,-0.2868729036934795
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
SU.86.86,262093,3.327893877156399
CAL-51,9903786,2.1849161121493847
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
OC 314,135875424,2.7859307759569467
OCI-AML-5,11396600,3.436150065828036
HuP-T3,49766530,1.2218451996302029
KE-39,49766530,-2.0647642539816715
DU4475,135421197,0.912129000759155
SIG-M5,selumetinib-JQ-1 (4-1 mol-mol),-2.937192443891954
HL-60,10302451,4.087381229377661
CW-2,156414,-1.1793376368039696
AML-193,262093,1.541807961893536
HCC1419,9927531,5.21935192048334
PK-1,241158,4.411269356882099
AsPC-1,9936388,-0.8199656713038528
NCI-H1581,9936388,-5.169397744708478
NCI-H1568,24180719,2.911739165396745
Karpas-299,4259181,-0.4823463002937178
BFTC-905,44491742,3.9351753124000073
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
BT 440,3689413,1.7448809021086664
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
BT 428,135999136,1.4549412998786355
T-47D,10302451,3.768986766263313
COLO 320,135421197,0.8671243277775497
Hs 940.T,9903786,1.9949918440372123
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
TE-9,9936388,-5.179827441506514
YD-38,156414,-3.156839755481009
NCI-H1869,11455910,2.924449694106302
SNU-449,637858,2.172600125936458
NCI-H838,168313016,5.9902874418125425
JVM-3,107970,1.9172884284374956
Lu-65,12003241,0.1595843887204832
VCaP,44491742,3.83752183909955
TC-71,46907787,1.352087076315588
Kuramochi,11396600,4.221456275944083
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
G-402,73707398,1.1492190990464957
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
SK-CO-1,71466445,5.862416915369376
MDA-MB-415,4259181,1.0953651491998988
SW48,135875424,3.469184081134181
COLO 680N,637858,2.3166033820088368
EC-GI-10,262093,3.0638768709018795
Hs 688(A).T,262093,2.411815084878299
NCI-H1650,46907787,2.274323665886221
OVTOKO,4259181,0.8127160476513252
NCI-H1299,10231331,4.726273361560379
MDA-MB-435S,637858,1.7685528665824608
SNU-886,135875424,2.126718157354228
SF268,54626689,3.339026850454045
SUIT-2,107970,2.9350948745745966
OCI-Ly10,26596,-0.6290463214568307
HCC827,375860,0.1070945405661363
T84,3689413,-1.5299599275494418
HeLa,100016,5.8653655502295
HSC-2,100016,6.282703144403752
COR-L51,26596,-2.461438053418328
THP-1,444795,2.529502673160271
SNU-668,5460769,3.895439916502409
LK-2,241158,4.352486881371655
FTC-238,10302451,4.1572624644011
CAL-29,6852167,1.5867412061088535
RERF-LC-Ad2,5460769,6.029186520623905
NCI-H1651,11396600,5.109965211899371
TE-1,168313016,5.403982565301054
SCC-4,4259181,1.7871165076569986
JHUEM-3,9903786,2.091612721233031
SW1417,73707398,1.4333921611241789
AsPC-1,107970,2.236934549480267
Hs 895.T,135999136,4.261728173473695
SNG-M,375860,-0.2212162005851632
MM1.S,135421197,1.5136201913497214
P-STS,107970,1.9935688507494205
Mel JuSo,135421197,1.941691146031138
JHH-2,6852167,1.881711410942769
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322
SK-N-DZ,168313016,4.271968521443649
HGC-27,9903786,1.5115157472800849
BT 216,9936388,1.282590182354356
DEL,262093,1.2345626785360508
OCI-Ly10,9936388,-5.832060635266597
TUHR4TKB,6852167,3.6957006227457168
OCI-Ly19,100016,6.584850236816641
Jurkat,168313016,4.063506111710871
M-07e,11455910,0.9135610826931194
NCI-H1755,135421197,1.7196206530846876
NCI-H196,637858,3.0093076834066923
TUHR4TKB,UNC0638-navitoclax (1-1 mol-mol),0.4628598930276774
JL-1,107970,3.007452583664889
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
MDA-MB-468,5460769,3.9216030050456023
JVM-2,9903786,-0.0734034903257133
Hs 944.T,136227924,3.55320847384718
SNU-8,12003241,-0.8120802877527198
HPAC,4259181,0.8473544462478222
JHUEM-3,73707398,1.3541053482659346
A-204,136227331,3.914790015372966
LC-1/sq-SF,9903786,4.361015168836896
HCT 15,44491742,3.7262724808810295
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
WM266-4,4259181,0.7940608146362106
DMS 273,444795,4.3404236236698495
A-375,100016,6.005492870785018
OC 314,24180719,3.913488245203202
SK-MEL-31,44491742,4.695235381351794
MHH-ES-1,11455910,0.3888631975426587
TE-4,12003241,-0.733911012282654
RD,71466445,3.6816034975249474
TE-15,11455910,-0.076849872958893
PK-45H,135875424,5.088820558877691
SF126,54626689,4.4806961176575095
SK-N-DZ,9903786,2.0344840639265787
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
MHH-CALL-3,73707398,2.0420485735176883
ZR-75-30,54626689,5.091860544438209
P-STS,156414,3.8931257076797623
HCC1833,637858,1.485454068401974
RERF-LC-A1,73707398,1.0933643071146293
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
JHUEM-1,10231331,4.962562844927884
697,5460769,1.383858776744359
NCI-H2196,10302451,3.953927189909324
HH [Human lymphoma],44491742,2.6350452695028888
A-172,49766530,0.1361021615856843
L3.3,100016,6.042484334243821
JeKo-1,100016,6.219930850058466
PL-21,3689413,-0.2817982428361766
NOMO-1,135398744,6.340708200805823
HuNS1,9903786,1.9338093787028072
Daoy,9903786,4.877795508066272
IPC-298,107970,3.0209130478833477
HT-144,375860,0.9202284793115426
OVTOKO,439501,-1.8305159910800708
BT 328,637858,2.786285777963434
RVH-421,49766530,0.507430038024508
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
BT 172,439501,-3.021522386524776
KNS-60,11455910,1.2653119972070106
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
HCC1428,9936388,2.06453548249226
Mono-Mac-1,262093,2.3689622956108107
NCI-H2087,49766530,-1.9829819346209112
DU4475,46907787,-0.6348556248692606
MKN74,46907787,3.0385379880903542
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187
NUGC-4,135421197,0.9656923984345016
HEC-108,100016,6.393272881400893
HCC-56,11455910,0.944400073561266
NCI-H2052,4259181,-0.2621110612765442
WSU-DLCL2,241158,2.532275707975188
SH-10-TC,49766530,2.645691737420763
BT 179,11455910,0.244595682570849
L-428,107970,1.6404690434145903
ECC10,135999136,4.34093313955728
2004,73707398,0.939674633435561
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103
HuP-T3,10302451,3.3244038223924868
SK-LU-1,12003241,-2.6616586719339725
HCC15,156414,2.365134958139565
SUP-HD1,12003241,0.3285815834035863
786-O,135875424,4.398795427398002
RCC10RGB,262093,2.8343922904091134
WT2-iPS,10302451,5.794873655301564
HDLM-2,262093,2.5590696667733908
KALS-1,73707398,0.9491392932530416
NCI-H1869,439501,-1.575584272947446
TM-31,73707398,1.0107205954441807
UM-UC-3,135875424,2.7438914646322106
TE-11,10231331,4.736086886941046
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
697,375860,-1.6013192541839316
NCI-H446,11455910,-0.4036414129969405
KYSE-410,9927531,5.048506934315496
HEC-6,12003241,-1.1839534104512932
KP-N-YN,UNC0638-navitoclax (1-1 mol-mol),0.0470016406930417
SNU-466,54626689,3.7822354566553167
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
COLO 741,241158,1.01148903945962
KE-39,156414,4.025830312298652
HT-1080,135421197,1.6974023477762936
IGR-37,3689413,2.8374772536506407
KP-N-YN,3689413,-0.8084843339395943
AU565,375860,-0.7785666069738753
NCI-H1155,100016,6.5684025185087505
SNU-685,12003241,-1.0976198055590074
NCI-H2342,3689413,-0.4986291797575011
EB1,3689413,-2.432787849324627
KP-4,6852167,2.7219764725227753
KMRC-2,44491742,3.971638428490517
KMH-2,135875424,3.335950960073661
HEL,327653,2.969363674974165
NCI-H2009,10231331,-1.9302715463885551
OS-RC-2,136227924,4.587923384885118
GB-1,135999136,1.7433537147277611
NUGC-4,26596,-1.113746804335536
SNU-878,5460769,2.876812490154217
OS-RC-2,49766530,-2.9436814262452144
TT2609-C02,9927531,6.514577910597335
BT 179,46907787,3.881061843357654
HCC1588,327653,3.013772565246454
BT-549,135999136,1.9798336492119424
Calu-6,168313016,6.238498419183306
Aska-SS,107970,1.9510492684161391
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
DMS 454,439501,-2.8107075635854866
HSC-3,49766530,-2.4571890524447553
HOP-62,UNC0638-navitoclax (1-1 mol-mol),2.4690733929057385
NB4,46907787,-0.9478840081863982
KLE,4259181,-0.0203780302150134
NCI-H2196,439501,-1.9043844138508108
Panc 03.27,9903786,3.06546007586267
DND-41,375860,0.0527896767876526
YD-10B,11455910,1.0221520098708106
KMS-21-BM,135999136,1.2444015260094663
OCI-Ly10,49766530,5.527943462019326
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
KYO-1,136227331,5.147481927043426
FU-OV-1,9929138,5.415072941349914
CL-11,6852167,3.2346326297754833
KYSE-510,136227924,3.267869272747249
A-253,10302451,3.496494704914602
Mono-Mac-1,327653,2.35680812589116
UM-UC-3,73707398,1.0664316005493033
BT 216,12003241,2.6409098560740243
HOP-62,168313016,4.593663167068175
HCC1143,135999136,4.602247958833588
MOLT-16,9936388,-8.915282355135908
VMRC-RCW,49766530,-1.510963658016383
SNU-503,107970,2.9918086587664514
BT 428,439501,-3.4900182991978936
NCI-H28,selumetinib-JQ-1 (4-1 mol-mol),-5.691526050173684
SCC-25,3689413,-0.8116745291609476
A-498,4259181,1.547873530266754
OAW42,9915743,3.0067264030666907
SCC-4,71466445,3.670270473572402
NCI-H2106,9915743,2.062061101089789
WM266-4,11396600,1.7325332738125347
GaMG,637858,3.26037697579532
HT115,100016,5.804685245268015
Panc 04.03,135999136,5.549073334475873
NCI-H2405,6852167,3.038556010393465
SK-MEL-28,selumetinib-JQ-1 (4-1 mol-mol),-0.6682697886543986
CAL-62,11455910,1.9126970012437423
NCI-H1915,71466445,2.9548789565379576
SNU-878,54626689,4.420173919907976
JHUEM-1,136227331,3.9088223702445526
AN3-CA,44491742,4.617223070127138
ALL-SIL,26596,-3.0181503922951674
COV644,5460769,6.215803603541286
HCC202,49766530,0.0708249995809799
HeLa,12003241,1.4760559160729645
KHM-1B,12003241,-0.9345261470540068
BC-3C,46907787,1.9222116024183311
BT 131,262093,2.390336920502222
SNU-213,9903786,2.2891232968098887
Kasumi-2,262093,1.7604912977671856
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
PE/CA-PJ49,54626689,4.62395369924922
GB-1,439501,-2.3945114258909532
OVCAR-5,9915743,0.3174164391419692
HPB-ALL,135999136,1.8548730425081073
SF268,24180719,3.690683122172715
SW1783,54626689,3.693361817042254
OS-RC-2,73707398,1.5913521541277962
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
RPMI-7951,100016,4.945357769827656
JHUEM-2,49766530,-1.5038121113070972
DV-90,136227924,1.3959750608222408
MHH-NB-11,44491742,4.127844347820601
COLO 201,135999136,4.934648698657588
SUP-B15,9903786,1.6008803071908635
JM-1,439501,-5.872076466297635
Namalwa,9927531,3.1365070733929663
Kasumi-1,24180719,3.14435877906002
U2OS,135875424,4.905688284770679
UACC-62,6852167,3.6947813963338656
COV644,11455910,3.873776923883242
A-549,168313016,6.463391576466817
KG-1-C,24180719,2.346577016341169
KP-N-SI9s,136227924,1.797924144791439
IM95,12003241,-0.6158272527459553
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
U-118MG,136227924,3.3662867602003006
8-MG-BA,444795,4.950662878119513
JM-1,135875424,2.019666731209586
MEC-1,375860,-0.4118266375234574
NU-DUL-1,10302451,1.4160930813102384
FaDu,12003241,-1.459997114195287
SK-MES-1,9936388,1.0310687201713455
CA46,3689413,-3.563387503989764
YD-8,9915743,1.4308611377432014
NCI-H1373,5460769,2.0630814106312543
SBC-5,54626689,4.608121703383126
GA-10,136227924,1.4612725021832749
LS513,11455910,1.3682876788708345
EFM-192A,241158,4.32002704513449
SNU-1196,637858,2.876047341050798
EFO-21,73707398,1.8103187924362223
KYSE-150,327653,3.2544951668748845
MOLT-16,12003241,-1.273061825596023
JL-1,135875424,5.193306419898844
CML-T1,9927531,3.1672020542525674
SK-MEL-2,10302451,4.273835624093029
K029AX,241158,4.250115815507947
Caki-2,UNC0638-navitoclax (1-1 mol-mol),0.6386694909249623
NCI-H1869,12003241,-1.5114527115730307
NCI-H211,4259181,-0.6668256447017947
NCI-H2029,9936388,-1.4677878209950324
YKG-1,107970,2.756113266406284
MKN74,12003241,-0.9650452844715884
GP2d,9915743,-1.6456174019811347
HCC1954,5460769,3.202561874283659
DEL,644241,2.6875101037764892
OCI-AML-3,375860,-0.5721607544660736
NCI-H508,9936388,-6.267876365775133
NCI-H2126,9903786,3.129084376626642
LP-1,135421197,1.2171511840038625
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
Ri-1,135421197,1.0934360104975305
EFM-192A,4259181,0.6735686495327354
EJM,11396600,3.800195279839431
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
Hs 294T,3689413,-2.200259258980444
Becker,3689413,0.4493271202500121
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
MOLT-3,9915743,2.149590681460773
Mino,168313016,3.695449207711372
AM-38,9936388,-6.913644192260965
OVCAR-4,9936388,-2.136102412732439
U-937,73707398,0.2560795072809404
HCC1937,4259181,0.8390392659445921
HT-1197,135421197,1.673772932436652
OAW28,107970,2.4537130721494105
SNU-245,10231331,1.5636115973451816
UACC-62,262093,0.8846336077087198
Ku812,107970,1.4051912271786118
PF-382,136227924,2.0859082008018084
KE-97,3689413,-2.1029735471074225
BT 239,4259181,0.729080593858997
BT 416,12003241,-2.2907483254938774
Ku812,637858,1.0891915977996414
BT 172,12003241,-0.4866452668331515
VMRC-RCW,100016,5.733604538717687
A-375,49766530,-0.2051662663719206
OE21,156414,-3.0417448997848857
VCaP,241158,4.103874762457962
NCI-H1869,6852167,3.74490947977495
HT-1197,9927531,4.678863685283018
KP-3,375860,0.992773842660452
SNU-1076,10302451,0.3385976785731625
KE-39,9927531,6.019185228760376
MCAS,44491742,4.8173197109659
HEC-1-A,11455910,0.0025723571677065
PK-59,10231331,3.699323619498394
KP-N-SI9s,241158,3.863624288459924
CL-11,71466445,3.717903191169583
HCC2108,136227924,3.562843531024723
NCI-H1299,4259181,-0.5610817863206101
SNU-216,6852167,2.5800071539870846
Hs 294T,44491742,3.9125649468331383
RVH-421,selumetinib-JQ-1 (4-1 mol-mol),-0.1901819182148017
RERF-LC-Ad2,71466445,6.028378172033726
EBC-1,9929138,6.205761956690981
HCC2279,327653,3.624968533475722
SNU-685,3689413,-2.422498805139559
Hs 729.T,100016,6.726636381823557
EKVX,6852167,3.4116684246666913
PSN1,71466445,5.775525837190175
SW1116,9936388,1.5004696743438164
BT 416,46907787,1.2743651659496544
SK-N-MC,4259181,-0.9619910881284685
Calu-1,135999136,4.366294064672552
KMS-26,156414,1.0739071723028757
NCI-H2342,327653,3.668550441144792
PE/CA-PJ49,11396600,3.5050583522874637
IM95,644241,4.4124367091719865
NCI-H2342,11396600,5.770432473059626
EB1,6852167,1.278793864374466
NCI-H661,10302451,1.6315200392387812
NB1,73707398,0.8206064026989972
HT-144,9927531,5.124270234210206
Ishikawa (Heraklio) 02 ER-,637858,2.5781304421684847
Mino,9915743,-0.1014414753917248
Mono-Mac-1,11455910,1.2371744705316827
U2OS,637858,0.295840107326967
G-401,9927531,4.9703255494446035
KM12,135875424,3.0557052091310357
NCI-H1385,135421197,0.1924120036443515
OE19,156414,6.025174328305522
HuT 78,54626689,4.7254586853376175
PaTu 8988t,12003241,-0.7673639150441187
HMC-1-8,100016,5.583587343649554
SNU-886,12003241,-3.694795257520175
SKM-1,71466445,1.6319589215508703
SNU-601,135999136,4.32642211604744
NCI-H211,46907787,-1.4290062563896933
SNU-685,241158,4.033832085823602
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
HCT 15,73707398,1.1959193392458622
YD-38,5460769,0.587016845611175
BT 428,637858,2.1785026029472454
EB1,107970,1.4399846214228276
CAL-62,4259181,-0.4453978178523717
Ri-1,11396600,2.305014362827753
MKN74,156414,1.3103031812830657
NCI-H1734,262093,2.5864421448130632
NCI-H1666,637858,1.967161556580531
Mono-Mac-6,135875424,2.7965119530378906
EC-GI-10,135875424,4.9830420551116985
SF126,9927531,4.99089280929888
LP-1,637858,1.1984002374597165
YAPC,135875424,4.215334227700636
SNU-489,73707398,1.821217019007182
RMG-I,49766530,-2.064948903327457
SNU-1105,73707398,1.718813701968452
Reh,11396600,3.042988610167451
SW1353,241158,3.9499039254187105
SUP-M2,11455910,-0.9872443510940216
NCI-H508,637858,2.102679611900147
HEC-59,375860,0.0781671745466512
BT 422,73707398,0.9682269368808664
A-253,375860,1.496704811763376
BT 245,11396600,2.7099317658056927
Ci-1,46907787,3.828892244852044
COLO 205,6852167,3.347119164765525
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
KMS-18,644241,1.1242955523524518
TALL-1 [Human adult T-ALL],107970,1.1259426564073174
SNU-8,107970,2.3224728440298814
PE/CA-PJ41 (clone D2),10231331,2.737757357175731
TE-11,136227924,3.028335758763499
NCI-H1734,637858,1.7593522393628591
GI-1,9927531,5.508249375264951
T-47D,6852167,3.1829025639617723
BT 333,10302451,4.227428623189883
NCI-H520,71466445,4.442767515504577
SNU-387,49766530,-0.0337981818562327
BT 333,4259181,1.6387622911370845
EoL-1,26596,-3.796383365572035
NCI-H508,3689413,-2.320337530403156
AsPC-1,4259181,1.083384461798112
BT 504,5460769,2.119344247070391
Caov-3,100016,5.7781449283056645
MV4-11,49766530,-2.278829084327519
A-549,49766530,0.1688758689952186
NCI-H441,9936388,1.8164232394185744
Becker,241158,3.23499622526182
HuT 78,135421197,0.0616295171222303
ONCO-DG-1,637858,2.0012277986291527
COLO 205,327653,3.1447698331614857
Rh18,44491742,3.876019031257375
AML-193,135421197,0.7876033807150744
NCI-H841,135875424,3.023154313740163
JHUEM-1,262093,1.0562191495276867
GDM-1,4259181,0.8180452048094571
HuH-6,UNC0638-navitoclax (1-1 mol-mol),1.0136391182455402
Calu-1,3689413,-2.465191800637427
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
L-363,241158,1.721361208612377
MHH-CALL-4,241158,1.661305159450415
CML-T1,49766530,-2.849769761760908
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
COLO 668,241158,2.3162244242092815
NCI-H889,46907787,3.7493893467815527
MKN45,136227924,3.646033724215572
BL-70,54596490,5.069667260483249
LK-2,6852167,3.0492440780711605
OV-90,241158,4.35659665315252
RD,54626689,5.184276956151369
KYO-1,26596,-1.5121743902030458
NALM-6,10302451,2.2736336019353147
Lu-99,3689413,0.965763177110082
EFO-27,11396600,3.826824277303455
ZR-75-30,439501,0.5523338496996666
JJN-3,168313016,4.2235817825732225
THP-1,327653,2.1571810935411313
NCI-H929,73707398,-1.1294071073635834
PE/CA-PJ49,73707398,0.9781921467778038
BCP-1,26596,-2.6141791098451934
SUP-T11,637858,1.0076857486222597
KYSE-70,5460769,2.831605222646697
BT 216,54596490,4.353678237582666
YH-13,10231331,5.93947704147761
GI-1,10302451,3.8681627903392792
SNU-1079,3689413,-2.2789240635037182
OCI-M1,9936388,-5.157124392155609
Panc 08.13,selumetinib-JQ-1 (4-1 mol-mol),-0.0835546726356045
CAL-85-1,12003241,-1.401340141763049
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
M-07e,44491742,3.818170293843834
U-937,5460769,3.0065623514388298
OCI-M1,439501,-2.6275325883029135
769-P,4259181,-0.9555012683593715
G-361,135398744,6.4148171061967645
TUHR14TKB,46907787,0.2152940597768577
SNU-719,12003241,0.0299382028109862
NCI-H1341,3689413,-3.76878307288409
NCI-H292,107970,2.31632347859771
GaMG,54626689,4.819246218906471
ZR-75-1,6852167,1.974149453818777
A101D,135999136,4.499329757784453
RERF-LC-A1,46907787,1.7386055738310746
TE-14,156414,0.150817369290719
Mono-Mac-6,54626689,2.415454912070549
BT 359,46907787,3.734412578013872
OPM-2,375860,-0.7230228450862618
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
D283 Med,135875424,3.0041212409823053
HLF,UNC0638-navitoclax (1-1 mol-mol),2.5473541790811347
NCI-H1299,135875424,3.7950147310792257
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
SK-MEL-1,439501,-2.4358325657169035
SNU-407,107970,2.3692041371322494
Granta-519,73707398,-0.348610297970246
KMRC-2,10302451,2.956766072446153
HCC1143,262093,2.740628946324062
NU-DHL-1,54596490,5.416894183216897
B-CPAP,262093,2.8121848345775784
Panc 03.27,262093,3.23349895733636
HEC-6,3689413,-0.7278233112149324
BT 440,107970,1.846754761569568
Capan-2,73707398,2.506465722260324
P3HR-1,selumetinib-JQ-1 (4-1 mol-mol),3.656805781248008
MOTN-1,156414,1.1092606915389736
MOLT-13,136227924,1.9107910741830303
A-375,9936388,-2.2482939434629223
TE-9,26596,-1.3406326261923425
KLE,73707398,0.4840000511633914
NCI-H1651,46907787,3.508622378093426
UM-UC-1,241158,4.206004961628962
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561
WM88,439501,-1.2543537382039465
SF268,637858,2.030315050805783
HCT 15,selumetinib-JQ-1 (4-1 mol-mol),1.4588191826561598
KYSE-150,262093,2.5847717064108657
LS123,9903786,4.141854621966089
SNU-620,3689413,0.413852643898191
Panc 02.03,73707398,1.687012904299387
TALL-1 [Human adult T-ALL],9903786,1.5190576712457438
NH-6,4259181,-0.1363698113178426
DOV13,262093,2.5740309324045327
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
CML-T1,135875424,3.5304182343940935
U-937,3689413,0.9938277330138956
RL,11455910,-0.0595035434135363
MOLM-6,168313016,3.368219114502854
NCI-H2286,9903786,1.3981147995547691
HCC827,107970,2.348665730800901
BT 147,644241,1.928241008057233
ALL-SIL,375860,-1.552794194023853
IST-Mes1,439501,-2.4971864822052767
BT 147,73707398,1.4314799151310398
Hs 611.T,327653,2.4585049182672525
HCC4006,49766530,-3.027931972438472
KE-39,3689413,-1.8420159541718293
UACC-62,241158,4.23511002277846
WM88,54626689,4.526788093765302
LCLC-103H,9936388,2.1573494470182593
KLE,262093,2.3874885119076668
TUHR4TKB,4259181,0.882373605987028
GB-1,9927531,4.312258679101311
IST-Mes1,46907787,2.643041583848796
Hep-G2,9915743,2.3547256655946542
NCI-H1793,637858,3.697458536286102
SK-ES-1,54626689,4.430682649586796
TE-15,73707398,1.075655915251324
WM115,6852167,1.3860811523021286
SJSA-1,12003241,-0.348535560110424
Ri-1,9927531,3.385054072969868
Kelly,100016,6.527674974645037
KYSE-140,44489367,4.3269137896614955
BT 428,107970,1.3396670576098808
KMH-2,6852167,2.5301856007997348
LS513,4259181,0.279340511847143
KMRC-20,9915743,2.261900740642606
HOS,241158,3.8448261010276674
Karpas-620,107970,3.3214718336794484
MOR/CPR,10231331,5.9387462777056115
COLO 829,4259181,0.3719311087420013
HuP-T4,12003241,-2.8459442311528154
G-292 clone A141B1,6852167,1.22729598496685
SNU-1214,439501,-2.3459859921965793
BT-16,6852167,2.8490153723252227
COLO 678,24180719,3.99237652342475
OE21,4259181,-0.2444735464140802
EBC-1,135999136,4.328547073399329
TC-71,3689413,0.4216372127873143
23132/87,selumetinib-JQ-1 (4-1 mol-mol),1.331252033045766
AML-193,135999136,1.7506715164272186
Toledo,156414,2.776303134779206
TC-71,12003241,0.7010514965491693
EM-2,44491742,3.7753697950117897
SUP-M2,71466445,2.643802810982145
JHH-2,9936388,-4.808151862711936
SNU-899,241158,4.245209655205581
OVTOKO,12003241,-1.0973416897014734
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
BT-20,9903786,4.2067479925704925
KYM-1,44491742,4.6632878215143405
WSU-DLCL2,135999136,1.771587640268099
HuH-6,11455910,0.6602078622110275
SNU-466,6852167,4.01396121923117
SEM,9915743,-2.2587042117517284
M059K,241158,4.804659473259962
RCH-ACV,10302451,2.577047280767927
NCI-H1184,10302451,3.191848520716454
KMS-12-BM,168313016,3.5287146199889805
A-204,11396600,3.09168738174324
NCI-H838,262093,3.692579673956935
HEY A8,135875424,4.032445855238006
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
CAL-33,135999136,4.312581278342569
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
JHOC-5,4259181,0.5152500246672413
CAL-85-1,241158,4.439596779386476
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
LMSU,73707398,1.6424339360302744
KE-39,11396600,3.848773124810753
JL-1,12003241,-1.4801638152381718
OCI-AML-2,135398744,6.3440072866172965
HEC-151,375860,-0.8046156329798803
SNU-466,11396600,3.3990634673304707
Hs 852.T,241158,3.502588858838865
GB-1,BRD-K27188169-navitoclax (2-1 mol-mol),3.626110273785182
KYSE-180,73707398,1.6922150122396675
DV-90,12003241,-1.148500998331207
SW1990,24180719,3.37776868647363
HCC2108,12003241,-1.7779849182593923
OVISE,9936388,2.6758567859836826
GP2d,262093,3.014356837300259
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
BT 440,9903786,3.1498376271679533
HCC1954,637858,1.5173302564464135
SNU-1066,12003241,-0.4993915951512702
BT 248,135999136,1.3787773380664552
MDA-MB-415,71466445,4.189951151964875
HPAC,24180719,3.1450066824835705
TF-1,44491742,3.716758320980523
Calu-1,selumetinib-JQ-1 (4-1 mol-mol),6.8446491124721085
SNU-C1,135421197,0.9147895752646428
HCC1569,9936388,1.7160045234798948
C2BBe1,135875424,3.7823394766863863
NH-6,selumetinib-JQ-1 (4-1 mol-mol),2.318236461290304
CGTH-W-1,46907787,2.2159861154913516
EoL-1,136227331,3.409385468978638
LC-1/sq-SF,135875424,4.887954422220303
MCAS,10231331,-0.2141548705956653
LS513,375860,-0.922608188487365
HEL,135999136,1.6019096984193502
SNU-C1,100016,6.347812039507436
SNU-1105,107970,3.082321397183302
ACC-MESO-1,637858,3.0332515622117016
SUP-B15,71466445,3.754478245783766
SNU-387,6852167,2.3914256143726433
HCC78,241158,5.586971952243853
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
FTC-133,44491742,4.538470926749077
Pfeiffer,327653,2.2333046287861
HCC1937,10302451,4.416854871626928
SUIT-2,12003241,-0.3419407469483631
HEC-1-A,136227924,3.4085098693584603
WT2-iPS,selumetinib-JQ-1 (4-1 mol-mol),-0.2269056443543759
639V,BRD-K27188169-navitoclax (2-1 mol-mol),3.946335862254824
HCC1833,11396600,5.135041940263416
DU4475,439501,-1.9980477376201553
NUGC-3,100016,7.160996607387645
BT-474,327653,3.3375355192094025
DU145,4259181,1.409412257624231
NCI-H23,11455910,0.0561940780927377
SNU-61,156414,1.6812768260110038
COLO 678,54626689,4.5576374661099734
SU-DHL-8,136227924,2.244700910858823
SBC-5,135421197,2.079587314097717
DLD-1,5460769,4.378806727859053
IGR-39,262093,3.5414544189999035
KALS-1,12003241,-0.678278256964916
GCT,9936388,-4.326749507903357
G-401,54626689,4.421186382617726
TUHR4TKB,9915743,2.327900585898517
OC 314,49766530,-1.543055424188454
UACC-62,49766530,1.0622286299463806
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
HT-144,9903786,5.3539912005761705
SNU-503,135875424,5.104819930335823
RPMI-8402,136227924,2.2526718879349694
CAL-29,4259181,0.3499471492641841
MOLM-6,375860,-0.9334754341312836
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
HuH-28,107970,2.16988663827051
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
Ishikawa (Heraklio) 02 ER-,26596,-0.9802171650937824
LOX-IMVI,44491742,5.895851784959737
AsPC-1,637858,2.8111542457272605
NCI-H2126,73707398,1.9031907027928148
G-361,49766530,-1.5432487194919586
KYSE-150,49766530,2.5375392775981913
NALM-6,9915743,-0.4248933620675649
HuP-T4,100016,6.7159168289197915
UM-UC-3,637858,2.079800276505731
KYM-1,375860,-0.0864025501236097
HCC1806,637858,2.071766835745825
DV-90,156414,0.1906274562396029
NCI-H1341,4259181,-4.062950123550263
SNU-601,10231331,3.365304175447414
LN-229,3689413,-2.3108318382356248
MFE-296,10302451,3.5887459847705996
RT-4,262093,3.3301279648450985
Hs 888.T,136227924,1.939793098771597
CAL-51,135875424,4.33643967165441
NB1,10302451,3.721240237409207
NCI-H522,12003241,-1.5672925136718587
Mino,24180719,3.160868152372625
Pfeiffer,26596,-3.7585498657816414
SaOS-2,49766530,0.3706728408995327
Caov-3,selumetinib-JQ-1 (4-1 mol-mol),1.5904337767004495
BHY,10302451,1.481147701409921
SNU-398,5460769,0.8679915096242241
RCH-ACV,107970,1.9405981464406723
ONS-76,9936388,2.029236983033262
Hs 729.T,644241,2.251936411171052
SNU-475,12003241,0.1195420556659512
SNU-840,49766530,1.025296962572851
YD-38,10231331,-1.3870760442434895
BICR 6,6852167,3.11548661722106
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
SNU-1,136227924,2.7041604085298205
Mono-Mac-1,9903786,0.9536797288397608
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
786-O,44491742,5.035169002663678
CGTH-W-1,12003241,-0.9249574155092228
BT 239,9903786,2.77679173166366
Panc 03.27,6852167,2.678417934109474
SU-DHL-10,12003241,2.591682900303347
SKM-1,24180719,1.95578575443114
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629
HuP-T4,24180719,2.171737705010422
CL-34,4259181,-1.074921358474701
BT 340,135875424,2.9922583399282163
Granta-519,644241,4.377614733152813
SNU-61,375860,-0.3575080218905608
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363
ONS-76,107970,2.339276188405755
MIA PaCa-2,327653,3.0320730676471572
TUHR14TKB,12003241,-2.6792741920200815
FaDu,6852167,4.667127824779662
NCI-H522,4259181,-0.2456063667287351
JM-1,71466445,1.831003524042788
SK-ES-1,136227924,2.7143313352480143
CAL-51,135421197,1.6266864976107616
KYM-1,262093,2.2176284666013366
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
NCI-H1105,644241,5.119219602350766
KMS-18,9903786,2.604638475406196
F-36P,3689413,-1.7757563129439584
HuP-T3,107970,2.2315719384591133
NCI-H1184,9915743,0.6883439734891695
Hs 578T,UNC0638-navitoclax (1-1 mol-mol),0.8451308474744694
M059K,135875424,4.531925541014952
NCI-H1299,135421197,1.297843636132371
CAL-148,637858,1.8040983358368403
NCI-H1435,71466445,2.4195354882991547
KP-3,4259181,-0.2815852402422203
NCI-H2286,5460769,0.0147592339119179
CHP-126,49766530,-2.0764650765443817
OVSAHO,107970,2.430589701222164
KYSE-150,10302451,5.770989993718531
A-253,135421197,1.6531350819497892
HCC2108,107970,2.525568270617478
23132/87,9936388,-5.399700035064151
MHH-CALL-3,26596,-0.8027776235461769
GSS,375860,-0.7667011218707456
ESS-1,selumetinib-JQ-1 (4-1 mol-mol),2.1651949829821353
Daudi,637858,0.7785119720749748
BT 164,54626689,5.6581897281778435
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
HCC1937,107970,2.351096424930394
PE/CA-PJ49,9915743,0.4153900299925456
NCI-H2291,9936388,1.6916444639385806
2004,46907787,0.0998644602240742
BT 482,135875424,3.0321936879214846
HCC44,107970,2.2740758908973766
Daoy,262093,1.456980228501706
HSC-2,637858,1.3679707411899185
HCC1954,10231331,3.3840036108796525
KE-39,71466445,5.518940973386278
MM1.S,12003241,-0.8577985614667851
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
COV362,444795,4.975026489361351
SW1417,11455910,2.2970669346586168
SK-MEL-30,73707398,1.6777957621098678
BT 239,262093,1.5843139145133054
SNU-761,UNC0638-navitoclax (1-1 mol-mol),2.3659172139386975
NCI-H747,444795,5.119508258323706
MDA-MB-453,54596490,5.641262539800198
OVCAR-4,9903786,4.586941705699431
GP2d,135875424,3.142612243202518
NCI-H28,327653,3.1152294532579523
PL-21,100016,4.334695208074886
SK-CO-1,44491742,5.1736211152382285
IGROV-1,9915743,-0.4757488934941289
HeLa,9936388,2.2030969514797256
DV-90,11396600,2.8019083313135553
ZR-75-30,327653,3.117084253257466
SNU-C1,262093,1.2400206335619155
G-361,71466445,3.559474212214759
HPAC,71466445,3.833476052590533
SaOS-2,241158,3.6917409878316136
RPMI-8402,73707398,0.6686223698322713
Mino,44491742,3.5991371763887616
NCI-H1915,9915743,0.3571601745148741
NCI-H1703,262093,3.0674943510667334
OE33,12003241,0.2230817721074321
5637,327653,3.080656495363518
COLO 678,3689413,0.0140701655611088
KP-2,637858,3.1748941243834103
MDA-MB-361,12003241,-1.091645986643679
HCT 8,11396600,3.8842790603170023
OE19,100016,6.21408400033578
LoVo,5460769,-2.1468642890382412
TUHR14TKB,637858,1.156941849061993
Mel Ho,136227924,2.792099034627563
JHH-2,11455910,2.202317711271985
KNS-42,107970,2.850114382105987
NCI-H1693,100016,7.64063251702684
PLC/PRF/5,327653,3.1034760000853994
VMRC-RCW,9915743,1.0689932165793572
Granta-519,375860,-0.9367901929922506
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
BT-12,11396600,3.9879207117312943
SNU-1076,selumetinib-JQ-1 (4-1 mol-mol),1.5511529799006534
SNU-46,135875424,4.168499733284657
KLE,11455910,3.332048563725763
Raji,24180719,5.292771843313121
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
Hs 746.T,241158,3.344811066724749
Li-7,12003241,-1.919504874807884
SNU-407,439501,-0.9775272958011642
SNU-61,9903786,2.1391845181717373
NALM-6,262093,0.7865180544621748
MCAS,9929138,6.918248380879042
CMK,100016,5.771362707779288
KE-37,71466445,2.2362370567819863
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
COR-L95,9915743,0.942320604231091
HLF,6852167,3.9661239452653088
LP-1,44491742,3.686326414227543
SNU-899,73707398,1.7017712409022585
SNU-1066,selumetinib-JQ-1 (4-1 mol-mol),2.1861844384259377
YD-10B,168313016,4.69452362713008
Hs 294T,UNC0638-navitoclax (1-1 mol-mol),3.1993320257548796
NCI-H1693,12003241,-2.0700110042259072
BC-3C,439501,-3.6854661122428896
SF539,135999136,1.70209400272594
BICR 22,11455910,2.0554057071158303
NCI-H660,136227331,5.940989847463471
COLO 792,3689413,1.4913457514232935
Lu-65,9915743,2.050551276197927
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
KG-1-C,9915743,2.9302265350196315
HeLa,637858,2.5742998662874035
SW1353,136227924,3.029116785491403
JHOM-1,73707398,2.0512902795527856
NCI-H1869,9915743,-0.6149308552384661
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
JHH-6,439501,-0.5793275995059294
KNS-60,156414,1.4823692521947065
MOLM-6,44491742,4.372818024610458
SK-N-DZ,73707398,0.4769509189536381
SK-N-AS,5460769,4.709590087634428
NCI-H1299,selumetinib-JQ-1 (4-1 mol-mol),1.4480114642409152
NOMO-1,11455910,0.2303469505827257
LS180,12003241,-0.6460664270988897
HT-1197,71466445,4.752167556586409
MFE-296,6852167,3.968241432358567
K-562,135875424,2.7247406179323055
VMRC-RCW,439501,-1.1623161811429144
NCI-H446,327653,2.68114451363679
LUDLU-1,136227331,4.9346482061859875
CAL-12T,5460769,3.2968044881057734
DMS 53,107970,1.762888041904688
NCI-H2286,12003241,-2.840007028807547
NCI-H1755,selumetinib-JQ-1 (4-1 mol-mol),1.244878912686623
SUIT-2,10231331,3.5504785260208473
HCC1500,9936388,-2.5304598124234365
DV-90,5460769,-1.416729974856236
KMS-20,100016,6.235059528000449
SK-N-SH,4259181,0.0308340137854706
Panc 04.03,262093,3.918875507815306
LN-18,49766530,0.2968190625783926
JHH-4,100016,6.356907567320683
CAL-51,241158,3.781489879449518
MFE-296,439501,-3.0642012902552
KHM-1B,637858,1.18497480261582
NCI-H661,135875424,2.4725937826628006
Daudi,241158,1.9180708700138325
SNG-M,135875424,3.588544936048006
5637,11455910,0.64521724418638
8305C,4259181,-0.8520805569418024
NCI-H1650,136227924,4.84526698521074
TE 441.T,135999136,1.6397829738151082
SUP-T1,135421197,0.9840092633419462
PK-1,439501,-1.8745947720441176
HSC-4,135875424,3.4627713632233537
SK-CO-1,637858,1.8597515079418403
SNU-410,9915743,1.505425413193383
HT115,26596,-1.779298311907341
GSS,5460769,0.9437954326098514
NCI-H358,262093,2.755416882784921
HOP-62,selumetinib-JQ-1 (4-1 mol-mol),-0.1175997595945407
NCI-H1944,10231331,3.941339928718522
Karpas-422,168313016,4.1332698119868265
OVTOKO,9936388,2.2599066716722707
GB-1,9936388,0.1084454809521914
COLO 320,637858,0.981357097050842
RPMI-8226,44491742,4.60819314657813
U2OS,26596,-1.797685053172872
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
LP-1,262093,1.1866363383040155
HEC-108,9936388,-4.887528080420867
KM12,9927531,4.5473811141762965
BT 228,12003241,-1.6653206714884845
NCI-H2110,12003241,-0.2811614102315782
253J,9927531,4.121406347708415
NCI-H446,444795,2.983412688059999
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569
BT 139,262093,2.8481987129285256
RPMI-6666,UNC0638-navitoclax (1-1 mol-mol),3.657204919876549
SNU-761,241158,3.6921089683840265
HEC-1-A,375860,1.1545449877423215
T84,262093,2.390395114942932
LNCaP clone FGC,9915743,0.7205657109253502
AsPC-1,9936388,-0.8199656713038528
LK-2,375860,-0.3436710653987513
SK-CO-1,11396600,4.255124433433546
PC-3,135421197,2.1784840639419154
DOV13,73707398,1.2640838378303083
DU145,11396600,3.556301760853191
UACC-62,9927531,5.07743176976165
SK-MEL-1,46907787,0.0749929399397362
SNU-1214,4259181,-2.0986949595329527
KP-2,644241,4.234611919960947
HCC366,241158,4.236615889952433
Karpas-620,selumetinib-JQ-1 (4-1 mol-mol),4.807986755393626
KMRC-2,135999136,5.684896477141993
CCK-81,100016,4.4296308435579554
BT 440,10231331,0.8389226179977666
Hs 888.Lu,107970,3.001005642322468
TE-6,107970,2.2926230294608776
BT 172,73707398,1.3761444311807098
NCI-H1623,135421197,3.7764453326534855
EKVX,3689413,-1.7429314171810966
Ri-1,24180719,3.165444216400886
SNU-478,10231331,-0.4380556767393462
VMRC-LCD,12003241,3.8307047822357343
BICR 22,9915743,0.3047863731286212
OVTOKO,10302451,1.7851365810334463
DBTRG-05MG,selumetinib-JQ-1 (4-1 mol-mol),1.400104516992479
SW48,156414,-3.5613148313114293
SF539,136227924,2.8154987155907905
NCI-H838,49766530,-0.8492681792296649
IGR-1,12003241,0.2975109917194724
LS513,26596,-1.0957721063054122
EN,6852167,3.8351993338589496
UM-UC-1,54626689,4.318149764179219
BT 440,168313016,5.661072033234367
SNU-8,168313016,4.339041813764209
Rh41,262093,2.4502999940067225
NCI-H2087,9936388,0.7446762448927194
OAW42,12003241,1.2884936123543242
IGROV-1,10231331,1.9104831176724932
A4/Fukuda,439501,-3.252400391503616
JHH-2,26596,-0.057413924712861
NCI-H358,136227924,2.8821870791202873
MJ,375860,-0.5648982341601144
HSC-3,4259181,0.6256880265153872
SHP-77,9915743,3.2387614248812984
NCI-H810,135421197,1.5773346723196464
EBC-1,107970,2.1957803762133725
MDA-MB-468,12003241,1.1497525105309832
OVCAR-5,9936388,1.186466547849794
CCK-81,136227924,2.050553135971544
RKO,26596,-1.341584325458414
SNU-C4,54626689,5.039491649570443
SW48,46907787,-1.5740012638710297
TC-71,107970,2.798539733238077
BT 286,439501,-3.2145304071914844
A-549,44491742,4.437272986024
MOLM-13,44489367,5.70063080501961
Granta-519,54626689,4.523537450364534
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
BT-549,135875424,3.804392758634582
OVSAHO,439501,-1.6237946984233838
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
JK-1,444795,3.5125605826433244
Panc 08.13,327653,3.3508049940900437
SK-N-AS,135875424,4.067320794930689
ST486,327653,2.3248651822642734
SBC-5,73707398,1.6541333685248465
Daudi,135421197,0.2989842149032058
BFTC-905,135421197,2.6921264103177
KE-39,10302451,3.0941257531868858
BT 286,444795,5.07961620697437
MDA-MB-157,6852167,3.8998726158787007
BICR 22,168313016,4.910867780923905
OCI-M1,168313016,4.404992087327789
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
U-251MG,9915743,2.5124314599198407
HT-1197,54626689,4.141422873724605
SUIT-2,11396600,4.33113824085374
NCI-H929,10302451,2.7551907478934465
MeWo,327653,2.8778071428357612
KMS-11,135875424,3.01982766210033
CAL-51,44491742,5.152478206660974
LAMA-84,135999136,1.3679633920686491
SNU-719,262093,3.356379511241945
P12-Ichikawa,49766530,-2.0130843351151437
BICR 16,9936388,-6.204978757825023
TE 617.T,9903786,3.301651498076641
PK-45H,4259181,0.9843809610373756
HCC1806,10302451,1.9356856115865475
TE-9,168313016,6.046508255391066
P31/FUJ,6852167,1.016015239887951
BICR 22,439501,-2.4052901035443
KMRC-1,46907787,3.729545872280723
HEC-59,9903786,2.2541518083702172
KMBC-2,4259181,1.3883022744442572
OVISE,9903786,4.69480560533159
COV362,136227924,2.2847413829349947
CMK,168313016,3.8240747199409975
KMS-18,24180719,4.058774531063792
CMK,262093,3.0450317567550154
SNU-1,135875424,2.684613740830041
HEC-108,46907787,5.113191551513952
Tm87-16,11455910,1.895109547469087
HOS,375860,-0.0507320978080906
MDA-MB-468,135999136,4.546911980308586
SIG-M5,4259181,0.1435014224884159
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676
MEC-1,327653,2.805783862154475
HCC4006,9903786,3.3433056456258585
F-36P,135999136,1.2589377775362909
Ishikawa (Heraklio) 02 ER-,107970,3.1744092198805136
TALL-1 [Human adult T-ALL],156414,0.6536773010311714
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
RPMI-8402,135875424,3.838035457399833
SK-BR-3,26596,-2.188814054378237
SUP-HD1,262093,1.1594795274119565
YD-8,136227924,3.733712180219105
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
MOLT-13,9915743,-0.4312567007691435
NCI-H1341,selumetinib-JQ-1 (4-1 mol-mol),2.3331984343698045
TALL-1 [Human adult T-ALL],selumetinib-JQ-1 (4-1 mol-mol),-0.8847007543917196
EBC-1,selumetinib-JQ-1 (4-1 mol-mol),-0.5998354334946902
RVH-421,9927531,5.089842816937553
SNU-601,327653,3.505640392145212
JHUEM-7,156414,1.092092573669373
RPMI-7951,9936388,-2.1957578683042205
KP-4,135421197,2.59268452027494
TM-31,26596,-0.9336571735173056
LS123,241158,1.4761560714556368
MOLT-16,selumetinib-JQ-1 (4-1 mol-mol),0.56687932569694
JMSU-1,73707398,1.0584772481895266
HSC-3,12003241,-1.4285198417789524
SNU-1066,44489367,4.747246553376864
HuG1-N,44491742,3.596787790528333
SF539,49766530,-1.8483208282069583
BT 359,262093,3.411602907811722
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
COLO 320,9927531,3.3062100750903594
PSN1,73707398,1.4306111569949278
SNU-C5,644241,2.256907978098841
MJ,135875424,3.3337154689139914
BT 139,12003241,-0.7824976089919207
BHT-101,selumetinib-JQ-1 (4-1 mol-mol),-0.8861655403353532
CAL-85-1,637858,1.5106736758760393
HOP-92,9936388,1.480575569609934
NCI-H226,136227924,3.4351319272724585
HCT 8,46907787,1.4188037679805106
RCH-ACV,11396600,2.874378489903408
EFE-184,107970,2.9508712394784826
U-251MG,9927531,5.06166571476347
KP-3,11455910,1.1515388808863225
JHUEM-7,168313016,6.3518310954698824
SW620,9929138,6.470174413186685
SF295,4259181,0.2902320947492574
OVK18,444795,4.809227288639882
COLO 668,5460769,2.9607897533404244
BT 159,262093,2.588782521087668
SNU-308,100016,6.582722131637771
NCI-H2110,6852167,2.8025502977558165
MHH-NB-11,26596,-2.2895666937918673
WM266-4,327653,3.1683064460628603
DMS 454,644241,1.5281678593249242
JHUEM-7,9915743,2.288162918918336
SW1417,10302451,3.631964421069336
Hep 3B2.1-7,637858,2.0545585773513517
Capan-1,11455910,2.2189515930780312
OCI-Ly3,241158,1.7687975312544326
NCI-H889,selumetinib-JQ-1 (4-1 mol-mol),4.19134386436801
T24,3689413,-0.672605759999641
HEC-59,4259181,0.197589789871654
LoVo,135999136,5.7154474843469565
KE-37,135421197,0.0656333668327355
NCI-H211,selumetinib-JQ-1 (4-1 mol-mol),-1.7857534849869647
MOLM-6,5460769,2.737785033090413
SNU-1033,9915743,1.252454153580825
NCI-H2087,44491742,3.6695473170739583
BT 359,9936388,-7.804167889982691
DoHH2,46907787,0.1864391937598248
DMS 273,9915743,1.912374780622189
NCI-H1666,107970,1.4066957803626672
JMSU-1,262093,2.8828462460891444
NCI-H1155,49766530,-2.3327778818126244
Fu97,156414,3.415711676319674
WSU-DLCL2,71466445,2.0995254728091304
CAMA-1,73707398,1.6048081837673416
22Rv1,10302451,3.5915895791665746
KYSE-520,9903786,4.522923988599173
DAN-G,46907787,4.341199528724315
BICR 56,241158,3.5079507073020153
HEC-59,44489367,4.567961623859816
BT 216,262093,2.591664883123623
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117
NCI-N87,11396600,3.282772907192936
Mono-Mac-6,637858,-0.2655990256126367
Rh30,241158,3.625038807076232
MDST8,9903786,2.958137426904596
HCT 15,439501,-2.431117301372995
SaOS-2,4259181,-0.1317601722396107
SNU-719,9936388,-4.601692458666014
THP-1,135875424,2.9650391263515057
LS411N,262093,3.2594677855419456
BT 224,11455910,0.6330255553599808
EJM,9929138,6.263891211273599
KMH-2,5460769,1.5529919827376786
A-204,9915743,1.0041843523053866
FaDu,644241,3.1108112382917814
JHH-4,46907787,3.5638190245783687
KALS-1,262093,3.291549071505813
SNU-1066,9915743,2.3115456271865664
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
L-363,26596,-1.5549208071756957
HuP-T3,135875424,4.261865095251217
SNU-182,26596,-1.9870021319207585
NCI-H2009,10302451,1.2105403110698565
BHY,9936388,1.458207941803915
OCUM-1,4259181,1.1079950036965132
SF126,selumetinib-JQ-1 (4-1 mol-mol),2.532720151276387
Hs 888.T,644241,1.6748162418135606
PaTu 8988s,12003241,-0.9111494781164662
NCI-H1694,49766530,-3.246574682514139
HCC2108,100016,5.291323338255078
HPAC,135421197,1.2085727097221448
JJN-3,241158,1.8370439799329683
KMRC-3,262093,3.093643058080816
DMS 454,4259181,-0.0206188051189722
NCI-H520,12003241,-2.710304641181941
Hs 729.T,135875424,4.346118730396158
OC 314,5460769,0.7455149919957782
NCI-H647,135398744,6.542739498462596
TF-1,135875424,3.0732861246211005
NCI-H2030,100016,6.672614959068411
OV56,10302451,3.128852101084234
HCC1588,73707398,1.1440243133842154
A-549,10231331,2.044831055629592
TOV-112D,262093,2.6540269134796213
JHUEM-1,5460769,1.70749298340363
TF-1,46907787,0.4244045030022794
LS411N,9915743,2.8294092926119028
TE 617.T,9915743,-4.6063841978227
OV-90,10231331,-0.2658989715006121
SK-MM-2,11396600,-5.924315206412897
SW579,12003241,-1.7693862144500747
QGP-1,11455910,1.8508501526124652
REC-1,73707398,3.9738319614180666
NCI-H841,439501,-5.095559559459305
TE 441.T,375860,0.1054494227896346
SK-ES-1,135999136,1.927716812239529
NCI-H1666,135875424,3.51211447124405
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
CAL-85-1,136227924,2.9828253747888067
OVCAR-5,3689413,-2.1267579766056297
RL,156414,1.6345695399688598
TUHR10TKB,3689413,0.0025132381526345
TUHR10TKB,9936388,2.290376539920044
HuH-28,327653,3.326177611407744
P31/FUJ,10302451,4.186780329312711
Mono-Mac-1,11396600,1.2647728617805982
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
BV-173,135999136,1.7763340204720903
PC-14,135875424,3.4913396696572523
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
HPB-ALL,10302451,3.903129824192939
NCI-H1155,107970,2.2957080194510437
EHEB,9936388,-5.642934540589324
A4/Fukuda,73707398,-0.4328093310020208
AML-193,241158,4.142634503453859
LOX-IMVI,5460769,1.2475955137176375
HCC1954,135421197,1.006556252272656
TTC-709,12003241,-2.491438610606954
Ku812,135875424,4.708872885868404
PaTu 8988t,262093,3.2462588578894587
LP-1,46907787,-2.0895710134477063
Tm87-16,107970,2.1756790823624987
MOLT-16,24180719,3.035314461984268
LCLC-103H,10302451,4.471526391535591
ECC10,262093,1.4663563613449744
OV-90,4259181,0.8863073345893967
BT 172,3689413,0.915101391559166
SNU-489,11455910,3.799785050507332
SK-N-DZ,637858,1.01149631221124
Kasumi-2,136227924,1.9658135956042504
Namalwa,439501,-2.8468436546580524
HEC-151,6852167,1.7550927798186455
RPMI-8402,168313016,3.4100232859139465
HCC1419,71466445,3.866201948197354
HCC366,135875424,4.513036767183396
SNU-81,5460769,-2.0941921209529575
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
NCI-H1869,46907787,2.861559973778754
HSC-4,135999136,1.7584955345229645
COV644,selumetinib-JQ-1 (4-1 mol-mol),0.9606383383342412
U-251MG,46907787,3.9064535706541945
IST-Mes1,375860,0.4088289358172842
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
HEL 92.1.7,9936388,-4.8155020562106525
DMS 79,9915743,0.1053493686109965
NCI-H1184,selumetinib-JQ-1 (4-1 mol-mol),1.001947758259214
P31/FUJ,135999136,4.068676884464422
SEM,UNC0638-navitoclax (1-1 mol-mol),-2.575766799282578
NCI-H1341,73707398,0.4714728014883233
MPP 89,3689413,-2.191379674666751
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
HGC-27,9915743,-0.5179385932122726
LN-18,11396600,4.155710167267898
MOTN-1,9915743,0.6517075840543033
Peer,BRD-K27188169-navitoclax (2-1 mol-mol),-1.397837045784395
FTC-133,49766530,-1.1381086002707512
Hs 839.T,10302451,3.841231202168181
Pfeiffer,73707398,0.9124583373506832
LOX-IMVI,135875424,4.258043031810949
CCF-STTG1,637858,3.1960196819129343
MEC-1,9936388,-8.61875613599576
Ku812,3689413,-1.935767376067546
MFE-296,135999136,2.110993721878467
SIG-M5,73707398,0.4222046163414817
NCI-H520,selumetinib-JQ-1 (4-1 mol-mol),1.7959695418998267
KP-N-YN,135999136,4.185097541926131
MDA-MB-361,100016,6.5281042722822145
786-O,26596,-1.1841737668988108
AN3-CA,49766530,0.9400447576922468
NCI-H1650,156414,1.3380397033219464
PE/CA-PJ49,241158,3.9020503625286698
MDA-MB-415,327653,3.1618995665355327
SK-MEL-24,44491742,3.9511074387326337
KCL-22,637858,1.7963655240899727
FU-OV-1,637858,1.762395691671764
Lu-99,10231331,1.318316273900534
COR-L105,24180719,3.693037976394381
EKVX,54626689,4.309051265645948
KM12,107970,2.55431308296488
KLE,10231331,5.289162464767698
EJM,12003241,0.5402616975347148
NU-DUL-1,3689413,-2.4087699464815664
Hs 611.T,26596,-1.6290206215335707
PK-1,136227924,2.8943441164421633
TE 441.T,54626689,4.404200006363088
OPM-2,9927531,3.0625153090482757
TE 617.T,107970,1.5986795918546095
PK-45H,136227924,2.93841309707887
ECC12,selumetinib-JQ-1 (4-1 mol-mol),2.1210248258767006
BT 145,24180719,4.17117632834101
NCI-H1355,3689413,0.7312644846226123
SNU-61,73707398,0.7144154314829279
NCI-H446,637858,1.65759101648935
NCI-H2126,24180719,4.020491589071789
HCC1171,644241,2.370755588024315
BL-70,12003241,-2.1974938808167477
786-O,637858,2.2863883731736667
NCI-H2052,54626689,6.545218807685367
HEC-6,46907787,0.920887915413934
BT 248,54626689,4.44361910749143
CAL-51,49766530,0.4609697007955676
SCC-4,5460769,3.1702887923440466
COV362,54626689,4.9523355451502935
L3.3,73707398,1.2944525096848456
NCI-H1563,156414,1.562418155700701
COLO 792,9915743,1.202162575993562
KE-37,11396600,2.928108153981295
NCI-H1395,637858,2.3715473340173774
8505C,241158,4.029404542619069
DK-MG,10302451,2.909618519065636
NCI-H1581,6852167,2.4363894803566777
NCC-StC-K140,241158,1.4895187461892925
JURL-MK1,135999136,1.3235312555861445
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
Aska-SS,9936388,1.048322458845263
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
MFE-319,9936388,3.279926844383342
SNU-213,10302451,1.063572133551757
KMBC-2,9903786,2.1846129600819353
EHEB,10302451,2.5081035375606295
OCI-Ly19,241158,3.0376081259806975
SU-DHL-8,4259181,-1.1396168062766951
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
NCI-H1568,10302451,3.040030486332468
SNU-1066,73707398,1.51937832388092
IPC-298,10231331,-2.263642508285418
NU-DUL-1,100016,4.060799847781438
KYSE-180,10302451,1.5519577455009292
MOLM-13,9927531,3.44947203831576
Panc 05.04,10302451,2.631724593174731
HOS,44491742,4.672695647178855
A-204,262093,2.2081126884410764
SNU-201,6852167,3.1416470109907535
Hs 578Bst,439501,-1.046807547420411
HMC-1-8,selumetinib-JQ-1 (4-1 mol-mol),-0.0708976327611117
A-172,327653,4.415725505090706
MDA-MB-468,11396600,4.2742989673627045
BT 164,135421197,1.9530013508190165
SK-LMS-1,10302451,4.013028906163852
NCI-H929,375860,-0.8805079289764249
OVCAR-4,135999136,4.433648895782621
CML-T1,26596,-2.14043660837674
T98G,135999136,1.5843327150060262
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
NCI-H2023,135421197,2.5449046355332436
SK-HEP-1,262093,3.158620019748703
Sq-1,262093,2.8908130105513856
BICR 18,72967,3.609620563730147
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
SF539,54626689,2.4541626708766855
DBTRG-05MG,439501,-1.6362214385175518
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
SW1783,3689413,0.540292166648154
OCI-AML-3,444795,-5.04160255125036
TE-6,262093,4.180478687873399
HCC1954,439501,-2.308794181663851
SNU-410,4259181,1.1619078924950006
HEC-251,26596,-1.8718311463988424
COR-L47,9903786,1.6785820828918676
NCI-H2342,9915743,3.0177583918562303
LS1034,156414,1.930466609004537
Granta-519,444795,4.599812836973149
TTC-709,11455910,-0.0853911997786654
KYSE-150,135421197,2.7515172040532687
Karpas-620,9929138,4.250879016380974
Mel Ho,10302451,3.2236880748887007
2004,6852167,1.0282813099290709
COLO 800,5460769,0.4868245753357603
HCC1438,26596,-1.656092804302775
GDM-1,10231331,4.684523654952728
SK-LU-1,4259181,0.0552405649133211
COV434,637858,0.809949930350691
A101D,9936388,0.7934880504993692
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
M-07e,637858,0.673950959080143
ONCO-DG-1,5460769,1.9256836095204335
LMSU,9903786,3.928631993031556
COLO 741,3689413,2.799435260821197
Pfeiffer,11396600,1.1420767199469808
SET-2,10302451,3.517530060309579
SNU-899,444795,6.368100900508937
OVK18,10302451,3.76566042423923
COLO 699,135875424,3.78821155380287
KMS-18,10302451,3.935362839755576
P-STS,9915743,0.8915414353493989
SW1353,135875424,4.282925625560305
PE/CA-PJ41 (clone D2),9915743,0.2241511570918921
IGR-1,UNC0638-navitoclax (1-1 mol-mol),0.937988062527938
SW1710,26596,-1.5930178898936072
MKN7,327653,2.5611177198729447
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
U266B1,262093,2.320136156024279
A-549,46907787,5.023259811787708
OV-90,3689413,1.0666322744292105
KYSE-140,135999136,5.49785084344862
Mono-Mac-1,44491742,3.632264372511232
JJN-3,637858,0.9088754309056672
MOLT-16,135875424,2.8305217651964463
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
BT 330,44491742,4.367748851083318
Hs 766T,107970,2.2032041411618652
HOP-62,3689413,-1.4977119259076146
SW982,637858,1.8179065260330984
MDA-MB-468,4259181,-1.7554481906549335
LN-229,168313016,5.156674307088484
SK-CO-1,135999136,4.853872243910513
IST-Mes1,6852167,3.791716512628995
SNU-C1,selumetinib-JQ-1 (4-1 mol-mol),-2.6335235217626702
EKVX,49766530,-0.424915470448776
HT-29,10231331,3.491390747008782
647V,100016,6.109475002217934
HCC44,5460769,-1.4878647509683542
Tm87-16,637858,2.3331403787186673
BxPC-3,9936388,-5.112429278661846
BICR 56,100016,6.239283130221144
Hs 888.T,4259181,0.9050777250600304
MOLP-2,9936388,-6.6933037631173695
SNU-216,9927531,4.928854217015946
A-673,9903786,1.5948741514342302
KMRC-1,12003241,-1.418239320082467
HuH-28,262093,3.3718876693981175
Karpas-299,26596,-3.8097040773311246
CJM [Human melanoma],10302451,4.063448301727013
NCI-H1092,71466445,6.1929235006275585
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
OUMS-23,135421197,2.711287517534292
JHOC-5,9903786,4.996792602991681
Aska-SS,135999136,2.4639426582272796
TALL-1 [Human adult T-ALL],11455910,0.0661503545953694
EPLC-272H,4259181,0.5096759105881317
HuG1-N,107970,2.023608678167257
NCI-H2081,439501,-4.570953887500971
NCI-H647,5460769,0.6003032928308929
KP-N-SI9s,5460769,-0.2609459312778176
HCC1395,439501,-2.37120422712219
HEC-151,168313016,4.881545929029312
HEC-59,9936388,2.590780507756847
TE-15,375860,-0.9577501669745316
OCI-AML-5,49766530,0.2957365675241968
NCI-H1341,46907787,0.7086470221827516
WM1799,12003241,-2.735191284404769
MFE-296,26596,-0.907337078157821
NCI-H2029,12003241,2.5373322791001636
NCI-H2110,135875424,4.423682476800295
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
CL-11,10231331,-1.8481941267603217
KMS-20,11396600,3.251276500206743
RPMI-8402,439501,-3.664200727311063
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
WM1799,439501,-0.7778279608408036
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
HT-1080,135875424,3.167289548700629
HT,168313016,5.111275982915678
NCI-H2342,637858,2.6043516467539662
CAL-33,12003241,-0.8317301463564554
NH-6,73707398,1.0742164546750694
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
TUHR4TKB,3689413,-1.6587483895037962
BT 131,5460769,2.20262518629684
A-375,135421197,1.9818816716343688
8305C,12003241,-1.8647493707838596
HCC827,327653,2.637856228623
JHUEM-2,135999136,3.462043848043772
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
NCI-H838,10302451,3.657499852045878
DMS 53,9927531,3.323341915494568
SNU-119,327653,3.4048649042702364
TOV-21G,241158,3.758877578075152
CGTH-W-1,9936388,2.615768469717637
SK-LMS-1,49766530,-1.7559370930712266
Calu-3,44489367,4.837579529323701
SNU-5,5460769,1.0227075924286728
Panc 08.13,11396600,4.2902573182297665
T-47D,71466445,4.2540654226734596
CHP-126,9915743,1.430510462525058
CW-2,12003241,0.1847256343211754
HCC202,10302451,3.435018280200959
KYSE-450,4259181,0.2433830255631184
BT 328,24180719,4.750415959710981
SNU-119,135875424,4.208481763945608
DMS 454,24180719,3.5949982423424327
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
Ki-JK,9936388,-3.4426986748299955
MES-SA,637858,2.6624965870315505
TE-9,12003241,-0.5375086976849406
Hep 3B2.1-7,262093,2.5027011818139964
BT 147,3689413,1.0613743234478148
BT 172,136227331,3.9802920608276886
HPAC,selumetinib-JQ-1 (4-1 mol-mol),-0.0816962643206643
Hs 729.T,6852167,2.694469174782692
Karpas-422,9915743,0.8862360651040179
BT 147,11396600,2.435185258634128
SUP-HD1,73707398,0.485799200448075
NCI-H1915,5460769,1.211615003674484
HuH-28,439501,-2.3734651091068693
KMRC-1,10302451,2.629362111325239
BT 112,135421197,2.023572470173789
A-204,4259181,0.5128413523484529
RERF-LC-A1,10302451,4.299129878683913
P31/FUJ,136227924,2.3905530687579497
SK-OV-3,3689413,0.6002437290843657
DEL,439501,-2.407341543091591
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
639V,5460769,5.247401600018928
LNCaP clone FGC,262093,3.5120752927452803
SUP-M2,375860,-1.5256283982593837
MeWo,439501,-2.203137437916754
OVISE,11396600,4.241731433198166
A101D,10302451,3.7909822884249498
SK-MEL-5,73707398,1.781035477419176
SNU-216,136227924,2.452598137182288
NOMO-1,9915743,0.4758643096003905
NCI-H2023,439501,-1.9243866702684376
MKN74,168313016,4.440025368788847
LUDLU-1,10302451,2.8134983513482363
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
SNU-8,375860,-0.8346021123643971
DLD-1,3689413,0.9147561458684622
HuCC-T1,UNC0638-navitoclax (1-1 mol-mol),3.2626901265646127
Lu-99,11396600,3.614830317436624
JHH-5,135999136,1.8373103914697355
CMK,44491742,6.009937952525146
AGS,11455910,2.3599070102743274
JJN-3,3689413,0.1640237934246712
GDM-1,9903786,1.637599474321908
HH [Human lymphoma],9915743,0.3869476104558722
Raji,135875424,2.0989109294233264
Hs 683,136227924,2.524769704566026
COLO 792,135421197,2.064004994537627
BT 145,439501,-4.642543329116397
SK-MEL-2,107970,2.2508906285434143
BICR 31,168313016,4.3680397842259095
G-401,11455910,1.3171347053017213
BT 422,156414,1.8271774190955228
HCC44,54626689,3.6701043568009912
OCI-AML-2,46907787,-1.6680050924308902
8305C,6852167,2.0078484699465884
EB1,444795,3.792865279889192
EoL-1,46907787,-4.038494248120017
NCI-H1694,3689413,-2.758320209596303
HOP-92,selumetinib-JQ-1 (4-1 mol-mol),1.8971159146724967
SF539,24180719,2.4860980350614073
Becker,6852167,2.488549626227047
SUIT-2,6852167,4.156327087057675
NCI-H2141,73707398,-0.0854879625434804
SNU-761,selumetinib-JQ-1 (4-1 mol-mol),-0.3894007965128778
NCI-H1838,5460769,4.113464535509182
SNU-601,44491742,3.984168627416036
IGROV-1,439501,-2.1510551928674557
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
NU-DUL-1,44491742,3.737315333639921
NCI-H1793,3689413,2.3725709733273663
U-251MG,135999136,4.081997928047093
NCI-H647,UNC0638-navitoclax (1-1 mol-mol),3.07128640317944
SK-MEL-2,3689413,2.4030655110444767
U-251MG,3689413,0.7299892089467567
BICR 22,54626689,4.975060177279609
M-07e,6852167,2.1940541155208098
SIG-M5,11455910,0.7552766623437589
RCH-ACV,12003241,-2.009657794147886
KYSE-70,24180719,3.52071426185984
IGR-37,6852167,3.6803333790062767
MG-63,637858,1.1304564766926708
BT 271,UNC0638-navitoclax (1-1 mol-mol),2.04696764004419
YH-13,241158,3.687700430080618
FU-OV-1,3689413,-2.180005064661593
MKN7,9903786,5.918197098229428
HCC4006,UNC0638-navitoclax (1-1 mol-mol),-1.371581476675196
JK-1,375860,-0.5573981919442687
HCC202,135398744,6.455993552330763
SK-LMS-1,10231331,6.028475115684305
Hs 578T,9903786,3.085679401941195
IGR-1,135875424,5.003318891233818
SNU-899,6852167,2.8368055986724774
NCI-H2291,selumetinib-JQ-1 (4-1 mol-mol),-0.7266625306171108
MOLT-13,6852167,1.1565895599380966
SNU-C5,9936388,-5.010033217973313
SNU-719,10302451,3.933124965880032
NU-DUL-1,46907787,-2.830192384250456
RD,9915743,0.9845356275865762
NCI-H1395,135999136,4.46612092216275
SK-HEP-1,637858,2.866868896175592
MG-63,11455910,1.9804853910986304
CAL-148,12003241,2.7249507328526015
SNU-423,135999136,4.547106106138672
NB4,9903786,1.7786072365174606
SK-BR-3,107970,1.6836850193480015
SW1088,107970,2.3943763924537147
G-401,44491742,3.951665256591854
LMSU,11396600,3.695024866246392
NCI-H446,73707398,0.6395483632268802
JM-1,24180719,3.5833576580940005
SUP-M2,9927531,2.443296482682693
KYO-1,49766530,-0.7028254429711305
SU-DHL-8,439501,-2.4804073416438626
RERF-LC-MS,12003241,-0.3897829713203344
JMSU-1,6852167,1.4853357753609204
KYSE-30,9936388,2.2895828136918785
BV-173,375860,-0.7007170100715804
2004,12003241,-2.052412032835344
DMS 273,10302451,4.121656528900648
Hs 940.T,selumetinib-JQ-1 (4-1 mol-mol),1.6954490088475127
MCF-7,637858,2.2242194755863856
KYSE-70,26596,-1.4453873864890578
NCI-H1373,73707398,1.6821009682995856
CJM [Human melanoma],UNC0638-navitoclax (1-1 mol-mol),3.5668679369825074
KHM-1B,46907787,-1.0017805456317357
MG-63,135398744,6.808455799902383
Hs 746.T,135875424,4.375354252450309
TE-8,6852167,2.3959021191474448
SNU-8,10231331,0.8787847787611084
SU-DHL-4,9903786,1.90197998733756
JHH-2,637858,0.9882525447375544
CCF-STTG1,4259181,1.4943010127790817
MDA-MB-435S,selumetinib-JQ-1 (4-1 mol-mol),-0.9058827313834622
253J,439501,-2.369438844197353
SNU-1076,9915743,-3.1891763584227775
NCI-H1395,54626689,4.483963070109989
KYSE-140,11455910,1.0441153824583205
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
NCI-H2085,262093,2.713548107137237
TUHR4TKB,107970,3.061138054610261
EM-2,444795,-0.7982281742747948
NCI-H1623,9915743,-1.6977137550638366
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
Calu-3,9927531,4.58448758255864
JHUEM-2,46907787,-0.0354976865727375
NCI-H2081,135999136,1.634974352928294
SK-LU-1,135875424,4.823970968633346
Panc 03.27,439501,-1.8758236187541328
OCI-Ly3,9927531,4.54855652960748
SF126,135999136,1.802588488381459
HEY A8,9915743,1.8632242051136063
Becker,11396600,4.49881996506653
MOLP-8,10231331,1.2198029486879254
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
SW1417,9936388,1.1366395190949656
MDA-MB-157,11396600,3.7386973485738424
U-CH1,44491742,4.471385772399255
639V,9936388,1.6138439311041346
KNS-60,UNC0638-navitoclax (1-1 mol-mol),2.0430869502631475
YD-8,9936388,2.2646667902608724
HEC-59,11396600,4.681293728583163
SNU-1077,4259181,2.3802371330202137
CL-11,135875424,4.310840427091723
IGROV-1,10231331,1.9104831176724932
KMM-1,11455910,2.3238855811198262
RPMI-8402,100016,6.7779334067701145
ECC10,327653,1.2684206514801013
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
ONCO-DG-1,135875424,3.8536123048292175
8305C,11396600,4.152403523001879
UACC-257,selumetinib-JQ-1 (4-1 mol-mol),-0.3941335857847879
Kasumi-2,3689413,-2.6905586087263043
LXF 289,241158,4.717778097263283
NCI-H1395,11455910,1.7673103520073516
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
MOLP-8,49766530,-0.668776240648524
Jurkat,637858,1.7578033949234262
SW48,375860,-0.9823609780883206
HeLa,5460769,5.484643109222549
A-549,100016,7.181380121169662
COLO 800,73707398,1.0528249782433163
JVM-3,49766530,-1.001889961758068
Hs 688(A).T,327653,3.599815702688107
Sq-1,4259181,0.8325863064672886
BT 330,135999136,1.458475788495572
EHEB,11396600,3.4241723821303314
KNS-42,327653,5.121244030514587
BT 187,637858,2.7601807501956337
Hs 729.T,54596490,5.7619879899039095
KYSE-510,6852167,3.606040413694624
SIG-M5,49766530,0.6577937335718277
DLD-1,156414,1.998485037364128
NCI-H1869,selumetinib-JQ-1 (4-1 mol-mol),1.6697033595632398
UACC-257,10302451,3.760959424622009
253J,44491742,4.062821625609178
BICR 16,26596,-0.6914049107649834
BHT-101,107970,2.697716675484313
MHH-NB-11,11455910,-0.4373414457289755
NCI-H727,9903786,3.725485605999375
NU-DHL-1,107970,1.0254507421459336
JL-1,3689413,-0.3699196862305292
HCC2279,135421197,3.588174017039921
SNU-620,9929138,5.350432849489577
Hs 895.T,73707398,1.8635773546339192
HOP-62,71466445,1.9622269092656943
PK-45H,10302451,3.483149431364428
IST-Mes1,4259181,1.4706848514509867
SK-ES-1,11396600,3.1511462884170656
PLC/PRF/5,375860,-0.0784427755583708
PaTu 8988s,327653,3.661431131961154
Caov-3,24180719,3.140093142167815
SNU-878,327653,3.747079580265773
BT 482,11396600,2.553396780600671
IGROV-1,637858,1.814476597989254
SW620,selumetinib-JQ-1 (4-1 mol-mol),-2.137275886686104
SF539,73707398,1.0308821565374424
RVH-421,262093,2.8806904491125
NCI-H2141,135999136,2.014096560063098
Kasumi-1,11455910,3.359505919978685
TOV-112D,444795,5.198010345063251
BT 216,4259181,1.1483081284027674
JHOC-5,439501,-1.8314674512872349
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
HCC2279,44489367,5.633914774729128
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
SNU-761,11455910,-0.2070657020305296
BxPC-3,5460769,-0.1362128387149436
U266B1,12003241,-0.5113173834247196
SNU-5,selumetinib-JQ-1 (4-1 mol-mol),-0.3965065242719394
UM-UC-1,262093,3.285353873808155
IMR-32,46907787,-0.8465098966903165
MEC-1,46907787,-0.7601525986896981
COV434,11455910,1.492860778557748
T3M-10,439501,-3.538112606826756
SNU-886,439501,-0.6078207224909147
MG-63,9936388,-4.191645899593892
K-562,71466445,2.3693775657442373
RPMI-8226,73707398,0.4792823568542893
SNU-899,10302451,2.6572990559771856
KCL-22,24180719,3.5480198411630655
OVCAR-8,262093,3.292567047569706
BT 164,3689413,-2.3779302902052444
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
Peer,11396600,1.9228051784431397
TE 441.T,9936388,-8.412031296278057
VCaP,10302451,3.859651840021036
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
PE/CA-PJ34 (clone C12),24180719,3.969047374225328
YD-38,24180719,4.600103743095947
NCO2,9903786,1.4505958737560818
BT 330,46907787,5.374973233157415
HuNS1,10302451,4.039354414327241
MOLT-3,135999136,2.8520154262430144
THP-1,637858,1.002288461822537
NCI-H1092,9936388,1.337118908669493
JMSU-1,24180719,2.5089168001375155
HCC4006,156414,4.088400381737083
COLO 668,637858,1.0989795984996742
HT-29,637858,2.6707335870409272
Daudi,327653,2.694862581871668
OPM-2,71466445,2.165442844786418
T3M-10,54626689,4.552966806766338
NCI-H716,12003241,-5.132639925352329
COR-L95,46907787,3.807595772412777
A4/Fukuda,135421197,1.440002399326734
Fu97,107970,1.6491316920896912
SNU-5,73707398,1.5532401180341584
ME-1 [Human leukemia],UNC0638-navitoclax (1-1 mol-mol),-2.6124434437691892
HCC827,9915743,-2.5410079672049446
HMCB,10302451,4.070081150685941
Li-7,71466445,3.6770078176216536
HT115,107970,2.245334342149862
MOLP-8,444795,3.9342801961368417
SK-MEL-24,24180719,0.378813651430847
CAL-62,9915743,0.6528059847635581
DMS 114,73707398,1.0730261578873106
NCI-H841,135999136,1.3609604707232876
NB4,135421197,1.336242233620032
HT-1080,4259181,0.789296595746634
M-07e,135999136,1.658429474822417
BT 231,107970,1.486990449957834
NCI-H2030,637858,2.3348665143276843
ST486,9927531,3.885019702146961
DU4475,444795,4.159357115386211
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
SCC-25,6852167,1.4389858944642788
DU4475,241158,3.034259728320883
SNU-182,54626689,4.178954365543633
JHH-4,26596,-1.5147419870530787
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
A-204,6852167,1.599589382352186
SU.86.86,44491742,4.316349403220542
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
SCC-4,10302451,5.608388675584183
NCI-H929,9927531,5.740923779315927
DU4475,9915743,0.8769529722012402
TM-31,136227924,2.988827636595516
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
BT 440,11455910,0.0350443808128442
EC-GI-10,73707398,1.6298474537045162
AMO1,439501,-2.703410930799938
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
Kelly,375860,-0.4375766322385214
NCI-H1651,10302451,3.925825953548281
HCC1395,10302451,3.312939572545873
NCI-H1355,136227924,5.68794295830134
BL-41,44491742,3.779286328341323
SU.86.86,135999136,4.173280321668127
DU4475,UNC0638-navitoclax (1-1 mol-mol),0.9737803597054544
SNU-216,selumetinib-JQ-1 (4-1 mol-mol),1.428202673212368
SNU-601,3689413,0.8443240779543064
HCC38,135999136,4.380203016974773
SUP-HD1,107970,0.5759861128041995
TE-8,10302451,0.966485483628724
ACC-MESO-1,10231331,6.136184274550163
JHH-5,375860,-0.2056318076209378
JHUEM-1,444795,5.327264163388397
MDA-MB-361,10302451,3.796882389957653
SU-DHL-10,49766530,-0.2943285235939838
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
EFO-21,3689413,0.1102098212077115
MOLM-6,644241,-6.412510011256156
SNU-620,49766530,-0.1917979569590051
SK-N-FI,136227924,2.3066593011882084
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
Karpas-299,3689413,-1.6709269792656412
LS1034,375860,0.3009760561874473
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
KYSE-150,9936388,0.0652021177968587
HEC-151,9903786,2.765131251863377
JVM-3,10302451,2.965184799004603
SNU-216,12003241,-2.3730818081536955
Hs 888.T,241158,4.343315425607546
Kelly,10231331,5.16242002724797
HOP-92,637858,1.5659474231121848
IA-LM,9915743,1.455667571666015
NCI-H2081,9903786,1.5566694513779922
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819
UACC-257,439501,-1.398087538451765
SU-DHL-8,10302451,3.070493160453354
NCI-H508,135999136,4.354641124621475
Ri-1,49766530,-2.264065529315868
CHP-126,46907787,-0.1524132064983023
Calu-1,46907787,5.519405311449107
SNU-182,156414,-0.1626152970445549
CAL-54,100016,6.472919480601912
Karpas-299,375860,-0.8505024577562622
NCI-H1693,135421197,1.2995160865472135
CAL-27,241158,4.222061028231435
U-118MG,107970,2.261669486619066
Hs 729.T,5460769,4.220142900655458
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
HCC1438,44491742,5.362050315054713
22Rv1,241158,4.118277920202298
Karpas-299,135999136,1.8576557410346497
SK-N-BE(2),241158,2.5701082208436477
T3M-10,4259181,1.4457109010794826
Hs 766T,135875424,5.942184015876385
Calu-3,3689413,-2.218147351051095
Granta-519,107970,1.5911312599666134
Hs 944.T,9936388,-9.161226763585232
NCI-H1792,9929138,7.3864021797267485
OCI-M1,4259181,0.123787677516806
HT115,73707398,0.748734542291225
AM-38,439501,-2.2075146927882177
SU-DHL-10,46907787,-0.8948479430375792
QGP-1,136227924,3.0535414774537424
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
PE/CA-PJ34 (clone C12),637858,1.319722583622998
SF539,11455910,0.0331728686867912
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
PE/CA-PJ41 (clone D2),9936388,2.7789010886628422
COLO 320,444795,4.368203032924048
ACC-MESO-1,135398744,5.83972457285084
SK-UT-1,375860,0.2310503192742169
VMRC-RCZ,44491742,4.2386816825846285
NCI-H1385,9936388,1.359050451063743
RL95-2,selumetinib-JQ-1 (4-1 mol-mol),-1.1090222735998203
MDA-MB-157,327653,1.3811083957143218
SNU-175,54626689,3.625294864544097
CAS-1,637858,2.6727632637471848
NCI-H28,136227924,2.9733016664554155
LCLC-103H,5460769,4.406822689547097
MDA-MB-453,9927531,3.885109165752666
OE19,135999136,4.619564705221119
BICR 56,10231331,4.370706281036396
HOP-92,9903786,4.828960304549442
CW-2,71466445,2.6360954099135516
IGR-39,241158,5.331256362598503
Aska-SS,135875424,5.860449274469886
AsPC-1,135421197,1.8824248695595285
COLO 684,9903786,4.137443964220156
MOR/CPR,73707398,1.8563625079342585
DEL,10302451,2.7814314514381775
KMS-20,71466445,3.065213582457146
SK-N-BE(2),26596,-1.6881701599106194
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433
D283 Med,9903786,1.479416225891386
KMRC-3,9903786,5.172590154682236
Mino,5460769,1.2525165030578538
Hs 578T,26596,-0.9561374383661984
TUHR14TKB,644241,2.615417426176258
CAL-120,439501,-2.2295565318957955
BT 320,4259181,1.858689674297262
NCI-H2291,637858,3.0474829746086143
SET-2,327653,2.598960189681515
AU565,444795,4.595530435398324
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
KP-N-SI9s,9936388,-6.7356563717129925
WSU-DLCL2,262093,1.9390116112389448
A-549,54626689,6.037159882780096
RERF-LC-Ad2,73707398,1.2471079254460122
TE-11,241158,4.108940957136676
L-540,11396600,2.910168116055403
639V,439501,-2.2821025832606083
A-172,12003241,-1.0086398080644707
NCI-H1339,24180719,4.777839850801867
BT 228,44491742,3.950846154014159
EB1,644241,2.100204883262369
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
JHH-5,4259181,0.4721409889584527
SW1990,135875424,4.251787213143329
JVM-3,11396600,3.007140156358036
RT-112,3689413,0.3015272221175239
A-549,10302451,3.5203591354698016
HCC1500,9927531,5.051014893697188
A-549,73707398,2.11945224002363
LN-229,135875424,3.7186537763136807
LMSU,9927531,5.404187778104352
SIG-M5,9927531,4.880658167161108
EJM,6852167,1.8935710220557025
UACC-62,10302451,4.162006257380555
OV7,439501,-2.8665617033549515
G-401,10302451,3.1015289114526774
M059K,136227924,2.883059674155944
BT 164,11396600,2.523887599451015
EB1,135875424,2.5798652139486262
KYSE-150,135999136,4.969581445777764
RL,107970,2.2198714391244088
DB,49766530,-1.6801310295102778
BL-41,135421197,4.0056146501146195
8505C,10302451,3.51911742997967
SNU-719,3689413,0.5380163789509392
Kasumi-2,375860,-0.7090394918812726
MFE-296,49766530,0.1913665198227111
Becker,73707398,1.456292128842472
RL,439501,-3.24492764026673
OCI-AML-5,10231331,3.33754223031549
BT 422,327653,3.2329647078391046
JHUEM-7,439501,-3.5721158792487646
SNU-478,26596,-1.226862251098003
OCI-Ly19,44491742,4.513227413160856
HCC1937,136227924,3.58866664774513
KYSE-510,107970,2.515593278152379
KCL-22,9903786,2.593050827774072
Mono-Mac-1,100016,3.734497226962008
KMS-20,73707398,-1.0592725192615595
Ci-1,9903786,3.745611899218518
PaTu 8988t,439501,-3.4446792284706347
SNU-1066,135999136,4.400876966814073
COR-L88,selumetinib-JQ-1 (4-1 mol-mol),1.7913504777641114
KALS-1,6852167,3.6016350818751097
Kasumi-2,135398744,8.02054113805855
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
HCC2935,3689413,-0.3223376962809587
NCI-H1915,49766530,3.459700063272212
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
Panc 03.27,9915743,1.9150966993651488
JHH-1,135999136,4.28736281530391
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
EHEB,135875424,3.250653126047009
SNU-182,9936388,-8.600901067529309
HuH-28,135875424,3.694475868133385
HT115,12003241,-0.6699503648785873
HCC2108,71466445,4.412506412183148
BT 482,10302451,4.2072229982706135
COR-L279,72967,3.602139194156965
NCI-H1105,26596,-1.464012997205303
SNU-1033,49766530,-1.347246040659949
UACC-257,3689413,2.9773275321267945
NCI-H929,444795,0.5078215400494521
P12-Ichikawa,26596,-2.168612597742571
PE/CA-PJ49,439501,-2.9475727314168174
NUGC-4,10231331,-2.888773769193711
23132/87,9915743,3.213624563446712
JHH-5,439501,-1.654650544214748
BT 340,selumetinib-JQ-1 (4-1 mol-mol),3.1298101289788223
TE-5,3689413,-3.902523210420284
NCI-H1944,644241,1.8482480993300487
LOX-IMVI,262093,3.0192087839524433
Karpas-422,135421197,2.168063446429243
YD-38,46907787,-0.5393505828045682
OCI-Ly3,444795,3.7741540845121175
RD,135421197,3.4107276707770864
HPB-ALL,136227924,2.35435467065409
TUHR10TKB,9903786,1.579233705567475
OC 314,136227331,3.341110019421027
DMS 114,135398744,6.443015881513616
COLO 684,9936388,-6.416738093665191
NCI-H358,BRD-K27188169-navitoclax (2-1 mol-mol),3.527649094593138
U-BLC1,9915743,-4.280634530876826
SNU-668,73707398,1.6351221445621116
RD,136227924,2.2627633289805424
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507
OCI-M1,71466445,1.3804412160808055
Panc 02.03,10231331,3.962628244123872
COLO 829,6852167,4.832673025771979
HuH-1,26596,4.2639260913768755
KNS-42,44491742,4.252498617041353
NCI-H23,375860,-0.5313938012128813
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
D283 Med,9927531,3.2144716566788745
OVCAR-5,135875424,2.7043210388951007
HPAF-II,12003241,0.935672122739968
U266B1,49766530,0.1325204149265123
SK-MEL-31,54626689,4.672724090516637
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
JMSU-1,46907787,1.0426197937359232
Rh30,9915743,1.5349254277578692
SUP-T11,9927531,4.66163575559017
HT-144,54626689,4.630881451384261
JHUEM-1,168313016,5.6992262147359805
JHH-5,9903786,3.1481910076888684
OE21,439501,-2.897438407377833
NCI-H146,375860,0.4213004900992469
COLO 800,9936388,0.9254157883591568
PaTu 8988s,11455910,0.872430488696118
HT-29,262093,3.4460135622894263
TT,135875424,4.193021061621861
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
HCT 116,6852167,3.4311504829913213
NCI-H1373,selumetinib-JQ-1 (4-1 mol-mol),1.3695812893088852
L3.3,4259181,-1.5745308976200183
HOS,135421197,1.1481730372475163
COV434,49766530,-2.1602854851177495
U2OS,10302451,3.9149293289232343
U-CH1,241158,4.570202527341932
AN3-CA,9936388,-6.467722299824651
BT 444,135421197,2.634348679178173
HSC-4,9903786,4.262681016067309
Mel JuSo,3689413,1.1230560004280308
SNU-869,73707398,1.2954231168780477
CAL-148,10302451,3.8567185397619728
GB-1,644241,3.285062000536014
FU-OV-1,49766530,-1.0180111021842635
Mono-Mac-1,46907787,-0.5681517995940845
SU.86.86,54626689,4.429112000309014
EBC-1,9915743,1.337451785479007
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
MOTN-1,11455910,0.7749413706396605
HPAC,135875424,4.409126746837932
BICR 31,241158,4.31214680273537
NCI-H2081,24180719,4.062007967057392
C2BBe1,26596,5.1914595275269795
VMRC-RCZ,241158,4.939048140887211
COV644,71466445,5.298867896385173
KMS-21-BM,156414,1.1553403018808577
SJSA-1,262093,2.9524375383319468
COLO 829,107970,2.955971944277627
G-361,10231331,-1.1139259320348027
OCI-Ly19,135421197,1.1485789152916004
SNU-719,9915743,1.2257458937302947
RERF-LC-A1,262093,2.373838000571716
TE-5,375860,-0.1603223838203094
NCO2,100016,5.1199760357582385
Daudi,168313016,3.9002026806644734
DBTRG-05MG,73707398,1.7792481673131717
Pfeiffer,71466445,3.089335098136117
GP2d,selumetinib-JQ-1 (4-1 mol-mol),-0.6768305872482345
HEC-251,136227924,4.831338089277502
EFO-27,100016,6.711163327148508
SNU-5,9936388,-5.37483340979982
HCC78,6852167,3.0692566285368157
HCC1500,44491742,3.6723474636183537
SCC-4,11396600,3.496408170179274
OC 314,26596,-2.5716994048265964
LUDLU-1,136227924,3.2639698653649254
EM-2,3689413,-2.767286284866434
OVK18,439501,-1.6105511378028463
Aska-SS,selumetinib-JQ-1 (4-1 mol-mol),-0.4940381618393021
NCI-H929,135421197,1.062377968485951
NCI-H650,26596,-0.9939630725117288
U-87MG ATCC,135875424,4.458869499205082
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
DMS 114,156414,1.696613759181163
HSC-2,3689413,-2.0236874476208353
NUGC-3,71466445,2.3864279046881673
SK-N-AS,9915743,0.9630784924267336
NCI-H1395,3689413,-2.5246792207692073
UM-UC-1,12003241,-2.5301689860244534
TF-1,168313016,4.574809025929095
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
SU-DHL-10,9915743,0.9308124359278332
MES-SA,241158,4.170875918540907
YH-13,3689413,-1.970237829798131
DND-41,135875424,2.6793866497378698
SCC-9,168313016,4.940700460648117
OCI-AML-3,11396600,2.62511537736271
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224
NCI-H2286,136227331,5.6980309243628
G-361,135421197,1.3668023463515628
BT 112,135875424,2.6326015677965087
KATO III,3689413,2.9835896213027673
TE-6,26596,0.4120128768036302
LUDLU-1,54626689,4.6781193223198025
SET-2,9915743,0.156310507538352
HCC44,135421197,1.110305691716081
Becker,46907787,3.975901887649669
SNU-C1,11455910,1.0435411312145502
KO52,10231331,-1.770944789563704
A-375,4259181,-0.8072558556065395
2004,135398744,6.587609936981218
JHOM-1,156414,1.7115419644586811
KP-4,24180719,5.26371468545235
MKN74,241158,4.664529497930215
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
RPMI-7951,9903786,2.3675771120862485
NCI-H661,73707398,1.1965083244926786
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
EoL-1,135875424,2.3813180528282416
SK-MEL-3,46907787,3.879205812014703
MOLT-3,71466445,1.9485978412010911
BT 216,5460769,4.97858517740557
BT 139,10302451,2.4564119741984785
UACC-62,439501,-0.4240195200695472
HEC-59,11455910,1.03172730185298
GI-1,136227924,2.879759291125734
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
Daoy,241158,3.1399206167097966
DMS 114,44491742,4.749496559747659
JURL-MK1,9915743,0.946381424496901
HeLa,12003241,1.4760559160729645
BT 245,644241,2.053411949495115
ACHN,262093,3.108023323173393
KALS-1,3689413,-0.2176182562401838
RPMI-8226,444795,2.5324403629836114
MeWo,26596,2.4666205413872953
Peer,327653,2.3341587781609405
KYSE-410,3689413,0.6720370091874901
NCI-H716,9903786,1.532038090064473
639V,262093,3.248167953384808
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
ESS-1,10231331,5.566440371270769
Karpas-299,11455910,0.3767083594332863
SK-MEL-24,9915743,1.6776285599749
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
BT 172,262093,2.689184232302602
HuP-T3,9903786,4.0743016574038915
22Rv1,44489367,4.4523146967020235
SH-4,439501,-2.6634763397724033
ME-1 [Human leukemia],107970,1.857582457084921
SNU-840,6852167,1.1857689341826607
TM-31,49766530,-2.5083427606022037
BT 159,3689413,0.7549791540054046
KMS-21-BM,9929138,2.832243377547389
KYSE-510,11396600,3.570057014705878
OVCAR-8,100016,5.760214455598188
ESS-1,12003241,-1.211695248693708
SF268,11455910,0.3275538615735771
SNU-1214,9915743,-3.00050567913294
BL-70,46907787,0.0819976049687394
JHH-5,11396600,2.359739892843467
HEC-151,49766530,-0.2709325293810298
COLO 205,136227924,2.4867417586096416
EFE-184,12003241,-0.5797348651994826
TCCSUP,BRD-K27188169-navitoclax (2-1 mol-mol),3.571342544762983
JHOS-2,54626689,4.820692593966466
RERF-LC-Ad2,12003241,0.07971757119013
SK-ES-1,327653,3.091902548838085
TE-8,9915743,1.7914899736385264
Hs 294T,9915743,2.0387924348275734
BT 231,UNC0638-navitoclax (1-1 mol-mol),5.638389329843739
SK-MEL-5,327653,4.002327934975705
PE/CA-PJ15,11455910,0.2163871462693647
HCC2108,439501,-2.3356100476768145
MDA-MB-468,9915743,-0.4692748619853074
Hs 746.T,3689413,-1.6439550226846966
NCI-H1155,11455910,-0.6780769977748015
CCK-81,375860,-0.7586959822706537
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055
T84,44491742,3.592181787537852
KYSE-410,73707398,1.149006405026039
SNG-M,156414,2.487976389206047
HCC-56,49766530,0.5665552829970477
TUHR10TKB,49766530,-0.1624329738440981
Li-7,4259181,-0.2793015764264818
MES-SA,375860,0.0274489129930107
LOX-IMVI,12003241,-2.813518393614124
NCI-H2009,375860,-0.9754800160336818
Reh,11455910,3.330656455417661
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
A-375,439501,-2.387181275139254
SNU-449,54596490,5.440438718305218
GMS-10,262093,2.9524447590849063
Calu-6,12003241,-0.728129558300084
HD-MY-Z,135999136,4.336889602343054
OCI-Ly19,9915743,-0.208935572268568
JIMT-1,3689413,-1.7375587293018775
CAL-85-1,selumetinib-JQ-1 (4-1 mol-mol),0.6836909669956517
NCI-H1339,71466445,4.88090882012996
PSN1,100016,3.987578982943132
Hs 683,26596,-1.91567083647516
ACC-MESO-1,135999136,6.41791740965286
COLO 684,44491742,3.593536773011693
HEC-251,selumetinib-JQ-1 (4-1 mol-mol),0.8388140404115119
EPLC-272H,12003241,-2.3102763219954867
NCI-H2030,6852167,3.664120569274895
KP-N-SI9s,107970,2.3206029022874404
NCI-H2087,9915743,0.7035169318123878
HCT 8,3689413,3.2270836788045054
U-118MG,UNC0638-navitoclax (1-1 mol-mol),2.4042669311771747
KE-39,135421197,0.9510973278490732
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
NCI-H647,selumetinib-JQ-1 (4-1 mol-mol),1.5451877783992325
NCI-H1435,135421197,1.75045264737253
MKN74,73707398,1.2954691116779045
253J-BV,107970,2.4409905185132432
RKO,637858,2.400395947377078
MG-63,6852167,1.3458734698302683
SW1990,168313016,4.40739187693859
SK-N-BE(2),135421197,1.0059955397340807
NCI-H1092,9927531,3.406213307022425
IGR-39,5460769,4.0932684480850074
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
COR-L95,136227924,2.879022500990784
SNU-423,6852167,2.5596210289916765
HL-60,71466445,2.1341422672324732
HCC1143,9903786,3.3387804215378885
RT-4,444795,5.14749831666829
Hs 934.T,49766530,-2.9625051950902455
LP-1,100016,3.986438392754067
JHUEM-7,71466445,4.651705041978002
L-428,9915743,0.0978026688985125
HEL,46907787,-1.2802643066913908
JMSU-1,241158,1.9095752467633784
ACHN,439501,-3.3245140147129684
CAL-51,107970,2.299284460939792
KMRC-3,9936388,-1.673858974154645
ZR-75-1,3689413,2.979171486892431
CW-2,107970,2.3483421716877393
Kelly,73707398,0.4225318745477273
SNU-C5,135999136,4.635904780574041
LOX-IMVI,100016,4.319089113839007
OCI-AML-5,10302451,3.871014497085743
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901
SNU-719,selumetinib-JQ-1 (4-1 mol-mol),-1.673282940163647
LN-18,9927531,5.697950654725697
SUIT-2,637858,2.948083302297865
HuP-T3,637858,1.096014734488476
CAL-51,9877608,5.917079709597661
SCaBER,9903786,2.6079380846248568
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
COLO 741,73707398,1.4336068172676
BT 147,262093,2.7128872808709414
TF-1,49766530,-3.109454480053962
5637,9927531,3.46604374571058
MES-SA,135875424,4.270871924895991
F-36P,71466445,1.2079369849052677
NCI-H661,156414,0.2928474479064595
BT 248,637858,2.256250159493538
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187
HuH-1,168313016,4.434942531625722
Caki-2,135999136,4.889473783004605
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
TUHR10TKB,135421197,3.595491301203154
GP2d,156414,-1.495990520647441
CAL-29,44491742,3.7928020727090392
OVISE,73707398,1.6715872061037895
HOP-62,11396600,3.498863261816077
EFO-21,4259181,0.6056333672996519
HSC-4,73707398,0.9895931551524366
P-STS,11455910,1.4406039312157646
GMS-10,135875424,3.9988471135126633
2004,135999136,4.366970719015835
SK-N-DZ,selumetinib-JQ-1 (4-1 mol-mol),1.491892256324692
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
JHH-5,9915743,-1.119406504769704
KG-1-C,6852167,3.358969778167105
NCI-H841,44491742,3.87806302811964
DMS 53,9903786,1.7776029378286846
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
SIG-M5,12003241,-2.3044245068014826
CA46,11396600,2.515122226404857
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
SNU-1076,135875424,4.991306630113997
SNU-478,4259181,0.4608976650897066
A-204,100016,6.602223097366851
UO-31,9936388,1.3141929110792994
SHP-77,BRD-K27188169-navitoclax (2-1 mol-mol),6.021054144328754
P3HR-1,5460769,3.3454995233869957
MDA-MB-453,71466445,1.9167870178623896
NCI-H2023,3689413,4.096769539099316
NCI-H2009,11396600,4.054693544346837
SNU-407,262093,2.588557756768625
EKVX,73707398,3.029951924279227
HDLM-2,327653,3.054457178723177
TT2609-C02,135421197,3.994443505891966
NCI-H292,4259181,-0.3596950747779806
TE 441.T,26596,-1.4712296697044354
TF-1,5460769,4.30978412133691
CAL-62,26596,-2.09128877077726
TOV-112D,49766530,0.7305238585252054
TE-15,46907787,0.2449943729998491
HL-60,5460769,4.053430435515514
SH-10-TC,375860,-0.0293228358206677
JK-1,10231331,-0.0094076474080567
647V,selumetinib-JQ-1 (4-1 mol-mol),1.0952955161444873
Calu-6,439501,-0.8430638577007564
EoL-1,439501,-3.7702491221703145
MSTO-211H,135421197,0.8053711662366769
TUHR10TKB,107970,2.500440283566812
KCL-22,12003241,-4.05956124354109
THP-1,4259181,-0.8754352887844591
RERF-LC-Ad2,11396600,4.594180065221676
KLE,168313016,5.53335411774071
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
LOU-NH91,24180719,4.451607655435679
SNU-620,11455910,2.08443042552151
JHOS-2,12003241,-0.473680569939606
KMS-34,135999136,4.609338887069151
COLO 699,BRD-K27188169-navitoclax (2-1 mol-mol),-0.1707821345915599
Daudi,136227924,1.3476403322374937
COLO 201,46907787,3.5696726017009364
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
SU-DHL-6,46907787,-0.6700724490980451
HCC1143,6852167,2.667487538311212
MHH-CALL-3,107970,2.3840240428143034
EM-2,44489367,4.304755787656308
MM1.S,135875424,3.0538620465615587
LoVo,73707398,0.5951327141059009
HEL,168313016,4.358661125075543
MSTO-211H,136227924,2.717505566177341
SNU-1214,6852167,3.35319741255355
G-361,4259181,0.5311792597043482
M-07e,9927531,3.229988201288456
SK-CO-1,156414,0.1991331726980137
NCI-H1793,156414,1.6720166250209227
L-1236,100016,5.644363792904431
KE-37,12003241,-1.2024354482149269
MDA-MB-453,73707398,1.1537227860078607
SK-HEP-1,136227924,3.6301481247272287
8305C,selumetinib-JQ-1 (4-1 mol-mol),-1.1248005173903517
UACC-62,12003241,-2.2941993438250865
NH-6,439501,-1.820365577971014
NCI-H1915,54626689,4.527432137143425
OCI-Ly3,71466445,3.621772786062987
BT 482,selumetinib-JQ-1 (4-1 mol-mol),0.6843473878763143
SNU-423,439501,-3.458666497477645
HT-1197,10302451,4.026289624888813
Karpas-422,135875424,4.0020075582939
K-562,54626689,4.3954029102592145
P31/FUJ,107970,2.0437014771117425
NCI-N87,100016,7.118039999797619
PL-21,10302451,3.830293265507133
WM115,9915743,2.6223908273409515
HT-1080,241158,3.7241913217305873
MDA-MB-361,637858,1.7828856282424477
SNU-886,9903786,2.951492144984292
SK-N-MC,241158,3.143336321830594
SiMa,375860,-1.5020105505925594
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
TCC-Pan2,6852167,2.8611295471217533
NCI-H747,136227331,4.187158203356049
Hs 746.T,11396600,2.998642785885706
LCLC-97TM1,49766530,0.6419783818490065
SNG-M,71466445,4.540032899995972
DU145,637858,2.575359401469111
ST486,4259181,0.03160083232378
NCI-H226,46907787,3.460984679843558
AsPC-1,327653,4.351823995090995
NCI-H2110,10302451,3.568351755533758
GMS-10,selumetinib-JQ-1 (4-1 mol-mol),2.191227396741531
SNU-5,24180719,3.696557182410672
NCI-H2444,439501,-0.8074653551260249
Hs 611.T,168313016,4.489282789911296
SUIT-2,selumetinib-JQ-1 (4-1 mol-mol),3.2290404930384637
Hs 936.T,637858,2.404158263720436
NCI-H2087,637858,1.5556640998503009
SNU-878,100016,5.516104284834857
SNU-398,444795,4.655654873396968
BICR 31,10231331,3.776464743887352
TCCSUP,9936388,1.8313124822353004
DND-41,26596,-1.3202555430270588
Kelly,9936388,-6.593577223955802
SNU-119,262093,2.598697839644185
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
SNU-449,100016,6.350050439021361
NCI-H1092,444795,4.269979452389004
IGR-1,10302451,3.763998441817216
G-361,327653,2.592983282576285
JHUEM-2,4259181,-1.5019807031703976
WM266-4,9927531,4.893127770626654
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566
YD-8,135875424,4.059859189077627
SU-DHL-1,11396600,2.533401176626175
HuNS1,262093,2.5146440588932397
NCI-H1339,9927531,5.416434112117517
MKN7,9936388,1.0718801330101393
NCI-H1435,6852167,1.616991513664108
TTC-709,107970,1.8845253707265144
U-118MG,262093,3.0545033004696203
KMRC-1,100016,6.458679548763862
NCI-H69,375860,-0.9936844149430912
COLO 320,262093,2.003306505705094
Panc 03.27,241158,4.5818896655025165
DLD-1,9915743,3.4458544437920784
HT-55,46907787,2.1816340847533824
YKG-1,3689413,0.6324676509110861
KCL-22,46907787,-0.6577650451757896
LOX-IMVI,136227924,2.635687863612288
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
DK-MG,11396600,4.342648785841818
GMS-10,107970,2.1682911780966245
BxPC-3,26596,-1.629746525957504
Jurkat,9929138,6.106641752412507
HCC2218,24180719,3.079134814722543
SK-N-FI,46907787,0.633002527240528
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
L-1236,3689413,-0.1223462388223707
NCI-H1299,6852167,2.875213655534043
UACC-257,73707398,1.7013992717994288
EJM,168313016,4.883313185195125
RT-112,439501,-0.757801709231946
U-251MG,135875424,2.6316918837604613
IGR-39,46907787,4.8604904570412915
FTC-238,selumetinib-JQ-1 (4-1 mol-mol),2.803944259726704
Jurkat,6852167,1.7593049967611742
Hs 294T,5460769,3.362841605128932
CAL-54,9936388,2.642816339395173
BT 145,375860,-0.1157906952672005
OAW28,637858,2.2776250733597085
NCI-H2110,26596,-0.8689069076907829
HMCB,12003241,-2.4987094510650834
GMS-10,9903786,4.533895537186943
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
NCI-H522,136227924,2.2034936459857506
KE-37,135999136,0.9565366137926632
SUP-B15,107970,1.991238175434954
NCI-H2170,6852167,2.6821146878265645
K029AX,135875424,4.978137125833805
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
SNU-503,241158,4.23502512903834
JURL-MK1,100016,3.373338788856286
SK-MEL-3,9915743,2.9768628838576037
BT 248,135421197,1.5349499708791383
DU145,107970,2.74634542230273
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
HEC-265,241158,3.756877585285286
MOLT-16,262093,0.3053132271730923
A-549,3689413,0.7236603744186211
SF268,UNC0638-navitoclax (1-1 mol-mol),2.2886187579463426
SK-MES-1,11455910,0.6501278721551685
SW48,241158,3.5185545260205364
EB1,9915743,-0.0076946910500104
PaTu 8902,10302451,3.9687769441396608
A-204,375860,0.2477180197304712
SNU-423,3689413,-2.448438848320713
PaTu 8988s,107970,1.550826733385026
BT-20,73707398,2.7146143235712747
P31/FUJ,3689413,-2.495432751898851
NCI-H1869,100016,6.8338343579730285
NCI-H1623,26596,-1.1542368606327895
EM-2,71466445,2.363063257631096
SNU-475,241158,4.465385444986592
WSU-DLCL2,selumetinib-JQ-1 (4-1 mol-mol),-0.1705600284579236
SNU-175,375860,-0.9196869368343216
GDM-1,49766530,-5.08643578606908
OV-90,439501,-0.6322605477357213
AU565,9915743,-3.6885201415408098
DMS 454,54626689,3.6179003279879858
SCC-9,135421197,2.7056920215811293
D283 Med,49766530,-3.2280701678526853
KLE,54626689,4.672839373899824
L-363,5460769,3.1855297672006087
NCI-H747,156414,0.8289328165343802
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
BCP-1,9936388,-5.382514367449052
SUP-B15,327653,3.106162842969588
NCI-H358,9903786,1.2866771615699664
Mono-Mac-1,9927531,4.461355065468675
JM-1,3689413,-3.612287026066889
WM983B,5460769,5.3340527249808005
GMS-10,10302451,3.793654439719216
HSC-2,135875424,3.0509908073629397
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
A4/Fukuda,44491742,3.3943913096556444
PL-21,73707398,0.3528693898804576
5637,439501,-2.4129442020826697
KE-39,135875424,3.891762591841876
HMC-1-8,439501,-2.9619639493833247
DMS 114,9927531,5.183306198807951
HSC-3,10302451,2.6157222782287795
IGROV-1,4259181,0.1937358171291443
SYO-1,selumetinib-JQ-1 (4-1 mol-mol),-0.4471349364002282
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
SUP-HD1,11396600,3.836607370981288
WM88,5460769,5.637392858071443
DBTRG-05MG,262093,3.4066291906537645
SIG-M5,10231331,-4.142163395953805
KMS-21-BM,5460769,1.875881845654493
TALL-1 [Human adult T-ALL],375860,-0.0236557250862759
D283 Med,136227924,2.613464686393682
HuH-28,12003241,-1.746609784805712
SNB-75,3689413,0.0039373561000733
COLO 792,241158,4.646846543778487
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
G-292 clone A141B1,10302451,2.810763561923894
U266B1,46907787,1.9154344054077848
JMSU-1,375860,-0.8562191900715512
KMS-11,11455910,-0.6344101562888161
KO52,9927531,4.721929704585103
HSC-3,107970,2.329842902304128
KYSE-510,11455910,0.588334409452975
COV362,6852167,2.529860049737666
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
NCI-H2029,49766530,1.603997264455234
HCC2108,241158,3.0824386157377197
BFTC-905,644241,3.603531566552796
HCT 15,46907787,0.7050921153051607
Daudi,439501,-2.973914496380735
MFE-319,9927531,5.194887870380863
RERF-LC-A1,9903786,4.61839139463389
HuCC-T1,135999136,-3.733945692205328
MKN1,73707398,3.3076884656453283
NCI-H2122,637858,2.372515616710106
H-STS,49766530,-3.13255748664254
NCI-H1650,637858,1.5493828729258998
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094
HCC15,135875424,4.57405525423842
MM1.S,100016,6.180279624553647
HCC1171,327653,2.9925965105482737
NCI-H226,327653,3.133129409572061
Ku812,73707398,0.2962870044778456
SK-N-SH,135999136,3.91639066262896
HEL,9903786,1.206049982415758
SK-N-MC,71466445,2.7140492776165916
OVTOKO,73707398,1.9090953451864836
Calu-1,11396600,3.740782908411944
TYK-nu,71466445,3.026483876560308
BICR 56,9927531,5.497555124114839
SF126,327653,3.680322233248929
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
A4/Fukuda,241158,1.407426277414268
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
NCI-H2030,44491742,2.996823060755576
HCT 8,9936388,2.3288203761031885
A-673,46907787,1.1836850249017303
DEL,6852167,2.99985019228043
MV4-11,44491742,3.928114355026535
HCC1143,637858,1.5767538824178036
NCI-H2170,3689413,3.058757672919766
A2780,12003241,-2.743381978251489
NCI-H322,4259181,-0.0410950856069719
Capan-2,11396600,4.3940876054708005
LOX-IMVI,24180719,3.2847178771546486
HuH-28,selumetinib-JQ-1 (4-1 mol-mol),0.7023038761063913
YH-13,135421197,2.4430977346174165
CAL-78,241158,3.39668217489539
NCI-H1385,44491742,3.386868498663753
Daudi,71466445,1.7957550148901065
MKN1,136227924,3.2741698595271025
KALS-1,9936388,2.309164316423604
SR,44491742,4.371664315658822
UO-31,24180719,1.58391760123463
RL,54626689,3.814725495668137
BFTC-905,6852167,2.9967779321543766
Mino,637858,0.8453968503614813
L-428,UNC0638-navitoclax (1-1 mol-mol),-0.1190030333689591
NU-DUL-1,BRD-K27188169-navitoclax (2-1 mol-mol),-0.4454917865401521
TF-1,UNC0638-navitoclax (1-1 mol-mol),0.2455241341736459
NCI-H1435,12003241,-2.5624704178121274
HPB-ALL,168313016,3.5981845776520047
ACC-MESO-1,9903786,5.156493229165983
KYSE-520,10302451,2.683760674034906
EJM,44491742,4.208016925641279
BT 164,327653,2.84640046206339
KYSE-180,26596,-0.879665743021705
COV362,135421197,3.17227725861234
CHP-126,73707398,0.6128353739948191
LNCaP clone FGC,156414,1.7669501564667316
BT-12,439501,-3.217940129826054
SK-N-AS,49766530,0.7065822517646133
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
COLO 829,9903786,4.931323632089431
SK-N-FI,439501,-4.082548455414269
Hs 852.T,327653,3.018176559338961
Karpas-620,4259181,1.426015705799775
COLO 201,6852167,3.5682572601097116
CCF-STTG1,49766530,2.4939305222304955
HCT 116,135875424,4.043772794114506
YD-38,9903786,2.8631306213752103
KNS-62,107970,2.9855005311621623
SK-LMS-1,54626689,5.075089494785208
KYM-1,54626689,4.141105428633748
BT 286,11455910,-0.3413435906946745
SW1353,71466445,3.3058354165580712
SNU-46,135421197,1.3377995260402369
BICR 6,375860,-0.3964511389825882
Hs 895.T,44491742,4.052136098794782
KATO III,4259181,1.5457239282714792
NCI-H226,262093,3.882477305073409
SNU-182,11396600,3.6909913141994584
HEL,135875424,2.9448279330391927
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
YAPC,262093,3.6115167721531343
BxPC-3,100016,6.453363473458683
KMS-27,262093,2.820550232220946
IGR-37,644241,2.2341406718555814
KO52,73707398,0.5433059802196046
Lu-99,9903786,2.034349953938994
REC-1,637858,3.5079007609087527
RCC10RGB,4259181,1.719089746142662
JHH-2,327653,2.7833537082553055
SNU-478,71466445,3.1088351292941776
MOLM-6,BRD-K27188169-navitoclax (2-1 mol-mol),-1.304104566123336
CCK-81,12003241,-0.505625792514721
BDCM,135421197,0.954440132345953
SNU-466,375860,0.3319976998596873
MOLM-6,156414,-0.040429989059546
MOTN-1,9927531,4.434768269129304
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578
CL-11,107970,1.988288098397546
NCI-H292,49766530,5.348764781206105
GA-10,262093,-0.1751219833238948
Ri-1,262093,1.5615741003890895
SK-MEL-5,9915743,2.239295477459583
BT 498,11396600,3.4855943403203704
KMS-21-BM,44491742,3.2404662940088205
RD,12003241,-0.8502341845781216
Li-7,439501,-2.4815602749889005
MHH-NB-11,136227924,1.3020282745517038
Pfeiffer,9929138,4.431024289942506
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
BT 187,5460769,4.174601592946769
SK-MEL-2,444795,5.015543431579257
SUP-HD1,135999136,4.727855508717699
NCI-H1373,46907787,0.3909534501553842
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
OCI-M1,135421197,1.730627187910493
KE-39,49766530,-2.0647642539816715
HCC15,11455910,-0.3399110905288865
NCI-H2023,262093,3.744435284140356
JeKo-1,156414,1.4830831458310074
NCI-H1184,327653,2.728641844903854
NCI-H2106,135875424,3.1880464092319105
BICR 16,375860,0.0398654341652112
Fu97,46907787,-0.7019075543696672
U2OS,4259181,-0.2674268404210034
HT-1080,107970,2.276862612199837
HuG1-N,6852167,2.3066185552914593
MOLM-13,49766530,-2.4914272268054107
JeKo-1,262093,0.8663217724360005
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
NCI-H1755,9915743,0.4239600926886341
NCI-H2228,46907787,3.0569158272450196
NCI-H292,3689413,1.7536313837601494
HSC-2,9929138,4.82243538291714
DMS 273,49766530,-1.3487399530522592
KO52,136227924,2.4006650771153923
NCI-H2196,100016,7.101599749729703
MDA-MB-453,4259181,0.7923345004369465
TOV-21G,73707398,1.040399662883959
Hs 895.T,24180719,3.877563707745883
SK-CO-1,9903786,1.8148473241522671
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
KYSE-140,49766530,-0.5324613674424623
AsPC-1,439501,-1.6009280184427317
HuH-28,136227924,3.512267666844948
OAW28,4259181,0.9119817479539226
SNU-1076,9936388,-5.0107279938232185
MHH-ES-1,11396600,3.76498087597508
NCI-H2029,107970,1.7716424657793448
VMRC-LCD,156414,1.548496680895589
HEC-1-B,262093,2.9636053597230916
KYSE-510,71466445,4.893287749594832
Rh18,24180719,3.242025504830459
NCI-H2228,10302451,2.892697345966427
DU4475,73707398,1.2053758533745562
A-375,439501,-2.387181275139254
WT2-iPS,9915743,3.010959085060511
U-118MG,439501,-2.7971615553970675
Ishikawa (Heraklio) 02 ER-,241158,3.6664689500376353
MKN74,6852167,3.3368691353125604
BT 271,12003241,-0.5875601678545488
U-BLC1,439501,-3.0504776234222035
23132/87,10302451,3.316540966620256
SKM-1,135875424,3.1648969740603095
NCI-H2122,375860,-0.2915668084843835
SK-MEL-5,10302451,3.6618185056536574
DU4475,156414,1.2292286945344073
RCH-ACV,241158,1.6371386561823098
JHH-6,375860,3.732925459637326
MOLM-13,44491742,3.7695621371445975
SKM-1,12003241,-1.1629643414911237
NCI-H1435,4259181,0.804399177362606
NUGC-3,3689413,0.9569280148265664
TTC-709,6852167,1.9849494908807752
BT-20,135875424,4.4451352594965545
NCI-H1694,71466445,1.7909324236099655
COV644,6852167,1.9451043894831948
NCI-H322,54626689,4.823493280119974
WM983B,11396600,3.738380516099371
CA46,44491742,3.801952242992866
HOS,135875424,3.0466328118467665
IGR-39,375860,-0.5520797955328177
NCI-H1869,4259181,0.9705477170328122
Sq-1,6852167,2.9289319531621327
SNU-1079,135421197,1.0783376836912564
MOLT-13,135421197,0.8546862359015375
SK-MES-1,100016,6.467052003541006
KE-39,439501,-0.0752815835977172
RERF-LC-Ad2,327653,2.6151456371110404
RERF-LC-A1,11455910,0.7727825040667291
SNU-620,5460769,0.532888566426305
CL-11,73707398,0.832008488362177
BT 248,9936388,1.117792201973615
BT-12,135875424,5.671526751726921
BT 131,444795,4.929583132306808
HCC1428,241158,4.858184483095658
NCI-H1838,10302451,2.6735726337808052
NCI-H2126,11396600,4.817248126603388
HeLa,73707398,1.5466980684371698
JMSU-1,135875424,3.6629437314109703
REC-1,9927531,3.800278065681949
CA46,644241,2.374325583681648
Peer,241158,2.2186450937544664
Hs 852.T,168313016,4.522758676040893
JHUEM-1,9929138,5.0527545997933085
Hs 934.T,3689413,-2.375941767618157
Calu-6,3689413,-1.4925549301996452
HT-144,selumetinib-JQ-1 (4-1 mol-mol),-0.2086141141315494
NCI-H2106,444795,4.013902342080577
Panc 05.04,262093,3.3614710639297622
F-36P,9903786,0.2788806994422486
HCC1833,262093,2.988096800875125
Aska-SS,4259181,1.378146825762795
KNS-62,11455910,1.837200886780492
HT-1197,9903786,4.0222787047996915
BICR 18,3689413,0.5803768983412222
Hs 729.T,10302451,3.696071611874436
TC-71,135421197,1.432077175902578
EJM,10302451,3.688285722224437
NCI-H716,24180719,3.6005359501897525
SNU-478,5460769,1.0103147308873888
U266B1,327653,3.490425774646272
BT 271,11396600,2.12554769286952
RERF-LC-A1,9927531,4.243256542635893
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
NCI-H1184,71466445,-0.0738213816478361
K029AX,375860,0.6414495398180249
MDA-MB-453,3689413,0.605092083526794
OVISE,135999136,4.426271635938179
CJM [Human melanoma],5460769,2.7678000793867077
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
SW620,11455910,-0.2228085222725968
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
COLO 800,24180719,0.3914399710999163
SKM-1,327653,2.256314826375049
T24,71466445,5.710927088014398
KMS-26,9903786,0.9658613723306017
HuNS1,26596,-3.648585672469648
MOLM-6,12003241,-5.9234672860619995
BT 172,UNC0638-navitoclax (1-1 mol-mol),1.816912544797352
SNU-216,262093,2.2180002949269793
NCI-H1092,4259181,1.0265302606919988
CAL-12T,262093,3.257362917097833
HD-MY-Z,4259181,0.5589884134551424
SK-MEL-30,6852167,4.680001158379356
Rh30,73707398,0.839071257859524
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
KMRC-20,107970,2.3183049291357953
SCC-4,46907787,0.5455328261501977
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276
TE-5,327653,2.418521663578336
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
ES-2,3689413,-2.830682661734752
SW1990,49766530,-0.1486325613650474
TCCSUP,644241,2.2463977673648823
SHP-77,100016,6.499498313563913
DU145,439501,-2.7485794982467637
SW1353,9903786,3.629285684044714
LOX-IMVI,241158,3.680686115975284
BT 232,136227924,3.5495643934514223
GA-10,selumetinib-JQ-1 (4-1 mol-mol),-0.1687986372090924
LCLC-103H,637858,2.882745745429834
BICR 6,12003241,-1.5069556465481264
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
OCUM-1,26596,0.6196247278484265
SH-4,9903786,3.356674972156618
DBTRG-05MG,4259181,1.5308542109270522
RT-4,5460769,0.3645225539442671
HDLM-2,73707398,0.2540391654131073
SYO-1,12003241,-0.4468506697584958
OCUM-1,9936388,0.7309150474030258
A4/Fukuda,107970,1.5574682195612295
NCI-N87,5460769,3.352422042402732
OCI-Ly10,9915743,3.628362232198514
P3HR-1,135875424,3.923960378133027
LS1034,327653,3.149677799948108
DU145,107970,2.74634542230273
KMS-18,100016,3.3973864073508864
MOLT-16,107970,1.325663053312893
FaDu,44491742,4.0645501932383095
WM88,71466445,3.914580213276338
SNU-1033,11396600,3.651423781511848
CAL-27,26596,-1.6130291256541474
D283 Med,9936388,-6.8022099816120605
BL-70,637858,1.0884199185060726
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
HSC-3,9936388,1.0714511856923938
YKG-1,327653,3.641218936705474
TE-14,9903786,3.4903828938175354
PK-59,444795,4.575943921838248
KYSE-70,9936388,-4.915846401119174
HEC-6,241158,3.593193456057986
TTC-709,73707398,-0.1314880855632042
NCI-H322,73707398,1.8248083553618009
RT-4,135999136,6.151607962032574
DU145,135875424,4.588838795967896
JJN-3,135999136,3.990398552524533
SK-N-BE(2),12003241,-2.145069511983118
PE/CA-PJ34 (clone C12),46907787,4.066257221145479
OS-RC-2,4259181,0.8424139388103674
M-07e,49766530,-2.4452167818324813
BT 224,135421197,2.656676342588309
Hs 944.T,71466445,4.831797191006342
CAL-120,54626689,5.055949677802415
JeKo-1,12003241,-2.1711036059300963
NCI-H1373,49766530,-0.1297725913169194
SW1710,11396600,4.154390829572998
A-375,135875424,3.696378355879961
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
L-363,4259181,0.187048408106301
SNU-423,11455910,2.439649543978504
OC 314,241158,3.741404759579216
EHEB,6852167,1.7579387732994172
Sq-1,5460769,2.958314651359677
GP2d,44491742,5.750365262572418
JM-1,444795,2.4559914793227597
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
GSU,10302451,2.3827257374546886
Hep 3B2.1-7,135875424,3.596529657657783
SNU-878,9936388,-4.0204049031627935
NCI-H1755,54626689,3.5769180352714693
LC-1F,selumetinib-JQ-1 (4-1 mol-mol),2.237558763845896
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
NCI-H358,156414,-1.317355730402675
NCI-H2085,73707398,1.0923484245076107
KP-2,3689413,-1.979504715969029
COR-L95,73707398,1.0347493154641954
SCC-4,49766530,-0.2029842802375615
HuP-T4,135398744,7.1369518257480475
UO-31,12003241,-2.005680138773524
BFTC-909,10302451,3.622269240471498
NCI-H2087,327653,2.6573092193564665
LoVo,6852167,1.8421975016001388
NCI-H1435,444795,6.033920769526426
PLC/PRF/5,3689413,0.4443196233363375
HDLM-2,11396600,2.3384367351946604
MDST8,10302451,4.267643132743765
U-118MG,24180719,4.417025477270802
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
TF-1,26596,-1.8278178688424689
Kasumi-1,12003241,-2.8903721425855284
RCC10RGB,49766530,-1.6086406954404375
NCI-H2141,156414,1.72197296337886
UO-31,54626689,3.95359480209444
COV434,168313016,4.745616441578848
RPMI-7951,9927531,5.17840544344631
SNU-1077,135999136,1.6213426965056292
L-540,439501,-2.6441519340115236
KP-3,439501,-2.4441073658124837
U-CH1,439501,-1.675454590298179
SW1710,46907787,3.5885429995487073
SNU-8,71466445,3.518025690097915
BT 187,44491742,4.194091483119568
Panc 10.05,9927531,5.445272240057394
23132/87,375860,-0.9015552167310936
CGTH-W-1,6852167,2.088295658936421
SW1116,644241,1.8306415261059923
KYO-1,644241,-6.264819027230071
NCI-H211,BRD-K27188169-navitoclax (2-1 mol-mol),-0.0988524329559484
Panc 08.13,135421197,2.5362535902354932
KP-3,9903786,3.3194843074548843
NCI-H2087,135875424,3.0815246928264575
OCI-Ly19,5460769,1.4066182919474557
GI-1,selumetinib-JQ-1 (4-1 mol-mol),2.3155507749392137
M-07e,26596,-2.7882078019466725
Panc 04.03,24180719,4.502790622897018
U-BLC1,136227924,2.288895160726179
KMS-28BM,3689413,-2.3321976244932134
Hs 294T,637858,1.3922470268743958
COR-L88,3689413,0.2810588861379679
JHH-2,107970,2.452158222323847
KNS-81,9936388,2.4620371956354834
SNU-61,11455910,1.387165489844305
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
786-O,12003241,0.5866804436375384
DLD-1,6852167,3.5764523935832835
OV-90,262093,3.163621030526785
NCI-H2122,73707398,2.514369766982023
KMRC-2,241158,4.767496150813131
NCI-H1355,4259181,-0.3138430179747868
SU-DHL-8,selumetinib-JQ-1 (4-1 mol-mol),0.9864241326692214
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767
U-BLC1,135421197,1.4306901409483936
DV-90,135999136,4.944237509825111
SW1417,selumetinib-JQ-1 (4-1 mol-mol),-0.4291556100825567
TYK-nu,637858,1.7482608253094327
C2BBe1,9903786,1.7742124050197758
BT 359,44491742,4.570849750938812
HCC1954,10302451,1.381919447819224
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
697,100016,3.656696343596264
SW982,6852167,2.04801894672205
KYSE-510,3689413,3.0228627584183565
NCI-H358,241158,3.665424345382122
Lu-65,107970,1.8814184481987688
HCC4006,375860,-0.093838404315139
JL-1,135999136,4.159644444432376
SUP-T1,9903786,2.605502996973438
BICR 31,9903786,2.10396775229317
PaTu 8988s,168313016,4.471656567537183
TE-6,73707398,1.658809664747792
OAW42,49766530,2.0594375067340085
KMS-18,26596,-1.560934239345236
HSC-4,11455910,0.337268703123225
GaMG,439501,-0.9687040114702524
OV56,135398744,6.336681474599488
SNU-C2A,44489367,4.3606755880784105
SNU-685,49766530,-2.1503606591822364
JVM-2,6852167,-1.0712990514737957
SK-HEP-1,439501,-2.4482777943885856
KMRC-20,9936388,1.9781775187030703
NCI-H1694,136227924,2.5297757130143887
Lu-99,136227924,2.52697800854745
EM-2,136227924,2.1746228564853864
MDA-MB-435S,3689413,-2.4980053098555404
Hs 578T,5460769,5.961368196562113
SK-MEL-28,135875424,5.515491244041513
IGR-37,135421197,1.178661342091473
SNU-213,10231331,0.6074693800366775
HCC1195,327653,2.9574226117277416
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
SW1990,4259181,-0.3516567866303933
EN,241158,4.188243340516178
KMS-11,46907787,-2.444202993147214
SK-LMS-1,375860,0.2604054406638652
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
OCI-AML-2,327653,2.738179275353154
ESS-1,100016,6.502595194480242
L-428,156414,1.5463646666534006
MEC-1,11455910,-0.0965490267087482
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
GaMG,selumetinib-JQ-1 (4-1 mol-mol),2.933911727916489
NB1,135875424,2.0724069361168
NCI-H1299,10231331,4.726273361560379
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
KYSE-30,156414,3.85489578456772
GCT,644241,2.5275274390262936
Granta-519,44491742,4.018752292224149
NCI-H838,100016,5.521581837907123
WSU-DLCL2,9936388,-6.090870232080744
CML-T1,644241,-4.543158274485358
WM88,637858,1.8355107233516577
NCI-H2087,135421197,1.3607762118240936
NALM-6,168313016,4.005992246679482
PK-59,12003241,-0.8874443449539482
SNU-1214,107970,2.341829699130604
DU145,44491742,3.929497920305024
SNU-398,46907787,3.965707936652475
Hs 839.T,73707398,2.753670018006987
786-O,107970,3.015534830895647
LOX-IMVI,selumetinib-JQ-1 (4-1 mol-mol),0.1243957473600749
JVM-3,637858,0.8696003861837296
639V,73707398,1.241439149904724
NCI-H2052,12003241,-1.5616837194527835
Kelly,439501,-0.837700217244781
NU-DHL-1,9915743,0.5782531397120328
Hs 688(A).T,637858,3.034400874820582
A-204,135999136,4.389692456038631
NB1,12003241,1.4891548799263434
P12-Ichikawa,4259181,-1.1700719944860911
SNU-1214,9936388,-5.365264992891118
Panc 10.05,327653,3.574513043815001
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
HCT 116,5460769,4.292752734346336
BT 328,327653,3.5942697932581344
Panc 10.05,135421197,2.5618075811816277
KMS-12-BM,135999136,1.7056569950210811
T3M-10,135875424,5.0182916898666
P-STS,135421197,0.9430476955578664
MHH-ES-1,439501,-2.339727963154972
SK-N-FI,12003241,-1.9986022359494329
NCI-H2087,3689413,-1.4883160931257695
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706
T-47D,3689413,-1.6434373642176223
8505C,9929138,7.301174384982561
TYK-nu,3689413,-0.8961723591289054
Hs 934.T,439501,-2.1837618207890808
TYK-nu,241158,3.931158179587867
KYSE-450,73707398,1.7321370562114622
Rh18,156414,2.0348797540110093
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
OE33,135421197,1.9963159792783505
SEM,135999136,1.8493753189775255
HeLa,107970,2.289164047292083
DU4475,136227924,1.4993153773488237
EFO-27,136227924,3.515702384882397
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022
CW-2,26596,-0.0212695413567751
NCI-H2087,12003241,-2.8362492565909543
SH-10-TC,26596,-1.1215294696679303
OVCAR-4,6852167,3.1722254779927757
TE-14,375860,-0.5133657303817126
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
NCI-H520,136227924,2.065702540466464
Mono-Mac-1,637858,0.9949100169924338
NCI-H28,12003241,-0.6704965456124867
L-540,444795,4.201661440924783
B-CPAP,135875424,3.307629887397838
COLO 678,135421197,1.7545986410246563
HEC-151,10231331,4.832109833959945
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
OVCAR-8,135398744,6.524120777237468
UACC-62,10231331,-1.3900234436911754
P12-Ichikawa,9927531,3.8027198390435792
KP-4,9936388,-5.247407210845399
VM-CUB-1,49766530,4.3854090079907015
SNU-601,71466445,5.5588944397471085
MHH-CALL-4,135421197,1.0493029833886585
COLO 684,4259181,-0.8601005109751864
HCC2935,156414,-3.3183452375606572
NCC-StC-K140,26596,-2.208339007847408
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
MHH-ES-1,637858,1.480038374938484
DMS 114,241158,3.5080412405177195
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
AGS,100016,6.525427767108566
OCI-M1,135875424,3.745039628073017
KLE,156414,1.5892150248130086
NCI-H2196,49766530,-0.5620796478121586
Daudi,156414,0.7854974484116999
HCC2279,9927531,4.656852539502924
SK-N-FI,4259181,-0.7300767100983097
BV-173,10302451,-0.5891104475601698
SNU-1079,selumetinib-JQ-1 (4-1 mol-mol),-3.26610855773864
CAMA-1,135875424,4.608485379364883
JHUEM-7,107970,1.950560118304485
SNU-8,9915743,2.7412552085538326
BC-3C,11455910,1.805675194715763
MFE-296,327653,3.238444781740251
MM1.S,11455910,0.7825849388460823
LMSU,12003241,-1.0531077396215482
UO-31,73707398,1.1940255314517427
NCI-H446,12003241,-2.472170144252885
Hs 688(A).T,54626689,4.990915712000528
KMS-28BM,107970,1.6529733654048155
SU-DHL-1,46907787,0.92481130470373
RCC10RGB,136227924,3.611686331312014
SK-UT-1,107970,2.916039273405532
SNU-119,4259181,-0.8929687482279648
MDA-MB-435S,262093,2.2230696932896
SNU-245,44491742,4.301989616183203
KP-2,4259181,1.1635750066542332
UACC-62,11396600,2.1673340141549886
HT115,44491742,4.056949016282338
WM1799,9936388,-1.7027793320208122
EHEB,selumetinib-JQ-1 (4-1 mol-mol),-0.0163446257701156
U-937,selumetinib-JQ-1 (4-1 mol-mol),2.241034377001376
NU-DUL-1,439501,-2.935576515069395
Hs 944.T,444795,6.517214631419411
K-562,46907787,1.0881737362577
L-540,168313016,5.054218548454125
RL95-2,71466445,3.2305855648631647
RKO,11396600,3.504834935214814
HCC827,10302451,-2.500583972750256
SK-N-BE(2),107970,2.0125788242050873
KMS-27,444795,4.486378633657878
NCI-H810,4259181,0.1893380308844004
Sq-1,UNC0638-navitoclax (1-1 mol-mol),-0.0941415801553838
PE/CA-PJ34 (clone C12),54596490,5.097353286236204
DLD-1,9903786,2.1877560593252343
DB,9915743,0.3856668875763299
UO-31,10231331,1.601394393410059
KE-37,44489367,4.3644713052658295
SF268,136227331,3.2043124531473945
BT 286,73707398,0.9456567929994184
COLO 684,327653,2.638490754589221
WM115,4259181,1.0090630393378868
BT 179,10231331,5.820683667863652
SK-MEL-24,107970,1.5448155256300662
NCI-H358,10231331,-2.127257720605189
SET-2,49766530,-3.130186221857788
DMS 53,439501,-4.4060490975057105
HuT 78,26596,-1.9929249611117947
RPMI-6666,135999136,3.167235721150589
Malme-3M,24180719,-0.695410475734873
HCC4006,135875424,2.723174656617446
MOLM-6,10231331,-0.5102428611078511
COLO 201,12003241,-1.3508897145637075
CCK-81,241158,4.130700497746359
BT 359,10302451,4.23092370201577
SNU-175,637858,-0.1007556152188427
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
HuNS1,168313016,5.986857407824858
Calu-6,26596,-4.0671398242119965
F-36P,9936388,-5.085386931503238
NCI-H1694,26596,-2.376634499212247
DB,54596490,5.226833912484438
NCI-H838,26596,-1.3070884520917134
DB,135875424,2.935208390580705
BT 422,44491742,4.87231922177064
U-BLC1,135875424,3.992147868924357
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
KYO-1,3689413,-0.0705408923087068
DMS 53,46907787,-0.6821606423951819
HCC1143,439501,-0.7374061663212956
BT 172,26596,1.567138444115151
NCI-H1693,44491742,3.504045241968317
Hs 766T,4259181,0.4904873414900543
L-363,9936388,-7.043187460159181
HL-60,9915743,0.8108920758640651
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
PC-3,637858,2.713540293531518
SU-DHL-1,9915743,1.482861419138649
HCC2279,46907787,1.5309207523287058
SK-MEL-31,4259181,0.9819831348689742
UACC-62,156414,2.6255417580681923
RVH-421,44491742,4.40169374936578
PLC/PRF/5,49766530,1.3653713216930163
RKN,135999136,4.319110081529012
NB1,3689413,-0.0909545830460423
Mel Ho,5460769,6.181973204258103
BT 504,135875424,2.85163619011477
ChaGo-K-1,46907787,2.3551908782612068
8505C,BRD-K27188169-navitoclax (2-1 mol-mol),3.311629115954648
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
MG-63,9903786,3.648237948966595
HCC2218,156414,-3.7494092331236497
HCC2218,439501,-2.1463275405716495
YD-15,11396600,3.950136388858035
T84,135421197,1.1926800486380174
SNU-175,73707398,0.569469638672086
KMS-18,4259181,0.5373331095971873
T84,241158,3.6074169392609665
U-118MG,3689413,-0.7349249104266066
PE/CA-PJ34 (clone C12),73707398,0.9457530769963428
SW982,11455910,2.7333702343206547
Reh,46907787,0.6071639421711836
42-MG-BA,439501,-2.6369598322141967
MHH-ES-1,327653,2.792753552455636
HuNS1,71466445,2.129403545309997
NCI-H1694,156414,1.085717982075386
SNU-899,135999136,4.451212206857688
NCI-H1395,73707398,1.4482642438908118
NCI-H522,439501,-5.784929410118117
C2BBe1,439501,-3.497031397635042
8-MG-BA,44491742,6.487107858540147
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548
HCT 15,9915743,0.5336080219876301
Lu-99,44491742,4.467729937048073
HCC1395,26596,-1.834868374404667
HCC1419,49766530,1.3909719340179874
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
SKM-1,3689413,-2.418262014134033
FTC-133,6852167,4.78859095347106
UM-UC-1,46907787,1.9790385116010816
PE/CA-PJ15,6852167,2.545538398770599
RCC10RGB,3689413,-2.0864832427963336
A-673,327653,2.521292352419487
TE-5,26596,-0.6674646083378311
HEC-108,73707398,1.5484357778063762
NCI-H1581,49766530,-2.147039743069074
NCI-H2087,10302451,3.0804347644462813
KYSE-70,10302451,3.1884398798129525
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
NCI-H322,375860,-0.2770112078497766
HLF,46907787,6.229944229848937
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
JHUEM-7,100016,7.782886537779513
Karpas-299,135875424,2.3425369765707913
SNU-16,11396600,2.12862636556111
WT2-iPS,135875424,4.320167330318722
HEC-6,10302451,3.7773798053956367
Kasumi-2,71466445,1.815897736576068
SK-MEL-3,selumetinib-JQ-1 (4-1 mol-mol),1.624169736782825
SNU-1041,637858,3.0266803479554034
Detroit 562,439501,-2.3410897293820003
HCT 8,107970,2.7615178304694386
MeWo,444795,6.408850279243356
BT 145,10231331,0.0541268159574882
KYSE-30,6852167,3.4266052993567775
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
MOLM-6,107970,1.5916207881460709
YD-10B,12003241,-3.1216797421568847
NCI-H1915,135421197,1.7136891979004163
NCI-H1975,4259181,-0.1828008143345393
U-118MG,10302451,3.818968943715853
NCI-H1793,100016,7.252403961124031
CAL-120,4259181,1.5592783373637074
SK-HEP-1,9936388,2.725726666175631
BT-20,6852167,1.899729475222497
NCI-H2009,49766530,0.9767616789625324
MOTN-1,54596490,5.846399797637999
CAL-51,9929138,6.421072450841616
PL-21,9903786,1.6725311379491856
NCI-H1563,11455910,-0.3468172057796411
NCI-H2029,375860,0.1046660820268347
SK-MEL-1,262093,3.2518519489587785
JHH-4,107970,2.219436256549423
SCC-4,168313016,4.773775305844119
NCI-H2141,375860,-0.119191761966059
SNU-685,73707398,1.5984502695910892
SK-MES-1,selumetinib-JQ-1 (4-1 mol-mol),1.35020527717367
OE21,73707398,1.45276102032063
GCT,241158,3.529930254107966
HCC1428,156414,2.3918754519633754
CCK-81,9936388,-6.1702645083973335
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
HCC1500,9903786,4.21203406645071
HCC1171,136227924,3.688896594319452
SCaBER,327653,3.3904080006606394
EJM,49766530,-0.6352274600767028
HCC1937,44489367,4.382850686343137
U-CH1,9915743,-0.5689803305661224
BFTC-909,9915743,2.0959000942543025
ESS-1,637858,1.315760041448024
HT-55,10302451,2.4391322098866213
ACHN,107970,3.012604712034101
HEC-1-A,6852167,2.216892801119106
NCI-H2405,135421197,1.0087242199460646
KU-19-19,107970,3.004209688555129
769-P,135875424,4.650591407681101
HCC1954,73707398,0.7920047045443592
BT 147,selumetinib-JQ-1 (4-1 mol-mol),1.3824985900887286
BT 187,9936388,1.2853309860246789
LUDLU-1,11455910,1.2851880169886276
SW1271,4259181,0.7411137136724786
MKN45,4259181,2.854305904234322
HL-60,10231331,-1.6804912174653917
HCC2279,selumetinib-JQ-1 (4-1 mol-mol),2.0805029001286517
KMS-18,241158,1.5641269542200231
LCLC-97TM1,135999136,4.356650968290631
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
KMS-34,262093,1.7183791017447037
BT 159,54626689,4.795377463775316
OCI-Ly19,11455910,0.6096382769703742
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
KO52,168313016,6.361073320142098
Ku812,168313016,4.091505378923506
COLO 699,54626689,5.088271659602011
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
MCAS,73707398,1.1782781305000984
ESS-1,49766530,-0.3205579652733103
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
SBC-5,46907787,3.799315463541784
AN3-CA,439501,-3.229124904343767
NCI-H2009,3689413,0.5343246791806224
SNU-C4,637858,2.223101229415045
BICR 16,9903786,3.9167102075651785
SNU-182,10302451,1.4243170989551428
SK-MEL-1,71466445,4.292797719025509
697,4259181,-0.8537492099871785
LS1034,12003241,0.7423322156732435
Hs 746.T,49766530,-0.4715984788298692
ESS-1,46907787,0.8695499024183594
RS4;11,10231331,6.472547503473555
P12-Ichikawa,262093,1.3353925545837786
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
Calu-3,9915743,-3.447731776127472
NCI-H1299,637858,2.0159595809429716
SW1783,136227924,2.7676121780420364
CAS-1,136227924,2.284810237581045
KMS-26,71466445,2.0250779935621868
SK-LMS-1,136227924,4.704854352606181
BT 444,156414,1.6442847888531638
LAMA-84,71466445,3.0064862485124073
MIA PaCa-2,3689413,-2.455927464924985
NCI-H1915,73707398,1.0384692664501904
DMS 273,24180719,3.915275581303962
RERF-LC-MS,100016,6.56071523320666
SBC-5,644241,3.9213876276885458
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
SIG-M5,156414,1.6593645678315314
Sq-1,24180719,4.4280012500269805
Mel Ho,439501,-2.4053312201946055
JK-1,9936388,-6.833225644440661
GP2d,6852167,0.7851862344848514
Hs 294T,selumetinib-JQ-1 (4-1 mol-mol),1.603608430454955
VMRC-LCD,46907787,0.5475756209741912
KP-4,54626689,4.142456533396149
SNU-1076,262093,2.995826964829708
U-251MG,136227924,4.317491880233533
DEL,327653,2.5091773560390553
NCI-H716,136227924,3.096712149885638
KE-39,135421197,0.9510973278490732
Hs 852.T,9903786,1.6008538749226255
A-375,10302451,4.088422063006118
FTC-133,24180719,5.041424864241871
KMS-26,11455910,-0.0860099305648322
T3M-10,3689413,0.3494943823106689
YD-8,9927531,5.007831795650313
WM115,644241,2.021542714802758
MDA-MB-468,135875424,4.133730456333857
KO52,9915743,1.1549502462375985
RKO,10231331,2.816804700080647
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058
JHH-6,3689413,0.376454666699167
KMRC-2,9927531,6.175340087469203
HEC-108,selumetinib-JQ-1 (4-1 mol-mol),4.622936143310662
SET-2,644241,4.42349249378709
NCI-H1915,241158,4.528319937628717
BT 216,11455910,0.3541622799052987
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
KYSE-510,9936388,-2.6451183198904373
EB1,100016,6.112181525197604
DMS 273,44491742,3.7307306463602545
Rh41,UNC0638-navitoclax (1-1 mol-mol),0.2843737570532182
NUGC-4,46907787,-1.879898884008335
SF539,439501,-3.28606941940852
HCC38,107970,1.6777687706047888
Rh18,135875424,2.011591688646641
SNU-1105,10302451,4.249277468468409
A101D,9903786,4.417171452040311
HMCB,637858,1.3431818902192771
NCI-H69,10231331,4.414739108436426
Kasumi-2,12003241,-2.245419673861097
Hs 944.T,26596,-1.3336328172357843
GCT,11455910,0.2932583767108606
DMS 114,5460769,0.4207237171136718
SNU-738,9927531,4.827507825762818
HCC1419,46907787,5.141659597687221
BT 286,11396600,2.040730461375106
WSU-DLCL2,100016,5.8333868406138585
Hs 895.T,262093,3.3540332653039195
MKN74,156414,1.3103031812830657
OE21,135421197,1.5054570422138
Hs 729.T,9915743,2.696415858684256
KMRC-1,54626689,4.972873475873264
NCI-H1395,9927531,4.9557176619227015
CCK-81,4259181,-0.0185863710788798
MSTO-211H,375860,0.0606650448750636
DB,262093,1.243928535741269
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
MOLT-3,375860,-0.9337740552924476
SK-BR-3,136227924,2.8779705448471975
Lu-65,136227924,3.620246561182502
HCC2108,135999136,4.648622110630223
Lu-65,6852167,2.6497392225444103
PE/CA-PJ15,26596,-1.1054075726167758
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
SK-HEP-1,135999136,5.290710201924687
Detroit 562,135421197,1.0926229563125225
NCI-H810,135875424,3.034466151027353
SK-N-DZ,11455910,0.8503332996504234
SK-N-BE(2),11396600,3.067666885131691
KMS-28BM,44491742,3.645458914971546
NCI-H2081,11455910,0.9023670010212674
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
DAN-G,4259181,0.4456475787831931
DU145,6852167,4.203979731076271
TE-6,637858,2.4061460425592203
HT-1080,6852167,3.24608706290334
Hs 688(A).T,UNC0638-navitoclax (1-1 mol-mol),1.6674868425364129
Panc 08.13,9915743,2.266213209948084
CAL-51,10302451,1.350542324147247
COR-L105,9927531,5.197941564874311
MPP 89,241158,4.038106348888228
ES-2,selumetinib-JQ-1 (4-1 mol-mol),3.5375386475265116
OCI-AML-2,6852167,0.5738384365467218
NCI-H526,46907787,-0.1511584481957571
K029AX,3689413,2.968023656376896
UO-31,156414,0.6514349111127984
KO52,135999136,3.8823895578085743
5637,49766530,-2.237904920966697
SNU-1272,9936388,1.7321766128233604
NCI-H1666,135999136,4.367820960898614
LXF 289,24180719,2.719444673565486
SK-ES-1,9903786,1.417242629772361
JK-1,selumetinib-JQ-1 (4-1 mol-mol),-0.917900524349044
OE21,10302451,0.4947890408637831
SNU-423,26596,-1.230407332735001
Hs 852.T,637858,1.5992596099105147
42-MG-BA,3689413,-1.7117650747651572
HCC38,6852167,2.687362191349945
Kasumi-2,73707398,-0.974822208153436
NCI-H1355,156414,1.6377498317213597
MSTO-211H,135999136,4.2061059176098645
TM-31,selumetinib-JQ-1 (4-1 mol-mol),3.4065119528708148
IGROV-1,3689413,-0.3633634632064185
L-428,327653,3.101823728208986
FTC-133,156414,2.701071854154092
Peer,100016,3.808596484759728
HCC2935,46907787,3.142856350749045
CAL-85-1,156414,-0.3486658434502303
KMS-18,selumetinib-JQ-1 (4-1 mol-mol),0.4000748221734009
PK-1,135875424,4.5989103647070655
ZR-75-30,73707398,1.6198674375550512
SNU-407,10231331,0.088671458998178
VMRC-RCW,10302451,2.6470473544508675
BT 444,644241,3.5221227496629663
SU-DHL-10,156414,1.2604313113542105
Hs 934.T,375860,3.709125028692515
JM-1,46907787,-1.9243382261841309
Panc 05.04,73707398,0.929289426406569
HCC1438,11396600,3.772048320050974
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
FTC-238,136227924,2.431059366258334
Calu-3,46907787,0.7618212572232562
HCC78,12003241,-1.0292430450952663
KMS-11,9936388,-7.371852791095938
IM95,5460769,5.308865140220459
HEC-151,73707398,0.6503268944686523
NCI-H841,11455910,0.3569598695245802
WSU-DLCL2,11396600,2.507675324045039
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
CML-T1,73707398,-0.0310412376393591
SK-MEL-31,9936388,2.306732151838548
OVCAR-8,4259181,0.2108264880727851
UM-UC-1,selumetinib-JQ-1 (4-1 mol-mol),0.4959207195366699
TUHR14TKB,9915743,0.9798821424990548
COR-L51,9929138,5.641097380037884
SNU-C2A,24180719,4.032890688004926
SU.86.86,4259181,0.499470171244999
HCC1833,10302451,4.238662713191706
LS123,11396600,3.4015234811291246
Mel Ho,168313016,6.032250687681012
TM-31,44491742,6.007028920174117
OVK18,136227924,2.593591625928113
Rh30,439501,-1.3281255322499272
HuG1-N,54626689,4.564142592647182
MDA-MB-468,107970,1.7140259838975702
SNU-475,107970,3.0030316321993484
SNU-475,73707398,2.6554640747961664
NCC-StC-K140,3689413,-1.9001520150301452
RL95-2,73707398,0.505219001940243
NCI-H2170,selumetinib-JQ-1 (4-1 mol-mol),4.249712356863815
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
J82,5460769,3.931927319993056
GA-10,46907787,-1.6483994380715643
CCF-STTG1,73707398,2.079175010578171
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
HMC-1-8,4259181,0.0513839997710658
Ci-1,11396600,2.9258292979253744
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642
HCC202,262093,3.36035713735401
LCLC-103H,selumetinib-JQ-1 (4-1 mol-mol),2.2778723422083886
NCI-H1755,12003241,-1.003418586049609
NCI-H889,136227924,2.7199111384597447
NCI-H1693,637858,1.99563162890805
SW948,241158,4.5321951743877005
NCI-H520,107970,2.0234591709207397
H-STS,135999136,1.636218584553822
KYSE-450,100016,6.589468110151047
SYO-1,5460769,-0.8579503639796162
COLO 680N,4259181,0.0202986259192109
OPM-2,637858,0.8070227403937857
SU-DHL-6,241158,1.5794519300851928
Caki-1,9927531,5.587911994434885
ST486,24180719,3.812218433679387
NCI-H810,9903786,3.328850282444774
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
EKVX,637858,2.598323376297305
BT 359,135421197,1.2544226030548953
HuH-1,9936388,0.6905848957768463
DB,5460769,1.8834181213891803
KYSE-510,637858,3.0396411206635516
DEL,100016,3.851368536137221
BT 498,3689413,1.8744771197995864
RERF-LC-A1,135398744,8.259619126952485
HuG1-N,3689413,0.3289715107360669
Hs 294T,11455910,1.2626812839087918
BT-20,107970,2.153530404894493
MIA PaCa-2,9915743,0.7812754347673511
OCI-Ly10,11455910,3.348747046731681
RERF-LC-MS,9903786,2.6182355767545213
ECC10,637858,1.1085550148233343
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
SW1116,156414,1.6393126370911288
CFPAC-1,selumetinib-JQ-1 (4-1 mol-mol),1.2285601106700188
Kuramochi,44491742,6.028956148879381
A2058,136227924,2.613575897416718
KYSE-520,136227924,3.1208401396418592
LMSU,26596,2.3008598244356935
Mino,12003241,-3.278689335869641
SNU-119,3689413,-2.887862499697321
A-498,11455910,2.747308138802023
HCC1588,10302451,3.078678072526936
CW-2,selumetinib-JQ-1 (4-1 mol-mol),1.016238653425278
GA-10,135999136,3.782942361648187
WM115,9903786,3.894434750277636
OE33,107970,1.9682278614825048
NCI-H23,241158,1.928803930669148
OUMS-23,6852167,3.800442546300316
SW579,3689413,-0.123080329876746
BT-20,11396600,3.3625164921440884
KE-39,135999136,4.6219900849735325
MDA-MB-157,9927531,5.35009923211275
UO-31,9915743,-0.5228341735607687
JM-1,11455910,-0.0097968256607179
KMS-27,3689413,0.1610585283674763
SNU-46,9903786,2.745048797484884
SYO-1,135875424,3.5152559775635
OPM-2,3689413,-4.501811354570108
YKG-1,10302451,4.0412794748223835
NCI-H446,4259181,-0.6278727967025163
CAL-148,262093,2.3702009846471928
BT 286,644241,2.213968846177929
WM115,10302451,3.6553280898048905
SK-MEL-30,selumetinib-JQ-1 (4-1 mol-mol),-2.43528576724259
8-MG-BA,136227924,3.3968176736472446
DMS 79,UNC0638-navitoclax (1-1 mol-mol),4.220125308149289
SJSA-1,selumetinib-JQ-1 (4-1 mol-mol),1.8964351089823623
GDM-1,5460769,2.283984174479844
LMSU,100016,7.332455698517509
SNU-C2A,4259181,-0.464833946452518
KP-4,241158,1.8280076583022216
Hs 729.T,12003241,-0.5985537077535523
NCI-H1666,BRD-K27188169-navitoclax (2-1 mol-mol),3.659571683686039
Hs 683,100016,6.526692615081327
P12-Ichikawa,11396600,2.4412876679668165
CGTH-W-1,10302451,2.4566200048574265
PLC/PRF/5,selumetinib-JQ-1 (4-1 mol-mol),3.8128877630515614
NCI-H1975,10302451,1.3559914628717409
Hep-G2,6852167,3.060489701170588
NCI-H1869,135999136,1.6552462790975504
Ku812,241158,2.509231607325934
NCI-H28,26596,-2.2516218144459508
SF539,selumetinib-JQ-1 (4-1 mol-mol),1.3049218182358
NCI-H508,9915743,-3.0595011879146967
HDQ-P1,637858,2.3004761888265253
NCI-H1651,637858,3.1417577804963375
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
LOU-NH91,4259181,1.0248896787271708
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385
COLO 678,44491742,3.8306560761300696
P3HR-1,selumetinib-JQ-1 (4-1 mol-mol),3.656805781248008
NCI-H1651,9936388,-1.76189250621897
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
Hep 3B2.1-7,71466445,5.312056535197058
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903
DV-90,46907787,-0.7207800761519887
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
ECC12,44491742,5.882219614933299
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
HCC15,73707398,1.6988346513711203
NCI-H1869,135875424,4.489996634847175
NU-DUL-1,135875424,2.988818183719918
COLO 800,135999136,4.366247169448385
C2BBe1,3689413,0.1296061414739377
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
NCI-H2110,135999136,4.378229186440323
HEC-1-B,444795,4.914613662514923
TE 617.T,135999136,4.164047799222283
JHUEM-7,11455910,0.2186713515547739
SCaBER,100016,6.423492154596734
CAL-54,selumetinib-JQ-1 (4-1 mol-mol),0.710350042212611
Granta-519,3689413,-2.6080640580656977
A101D,262093,3.196770029367663
Lu-99,4259181,-0.6805384637349173
SNU-466,637858,1.1868535051803475
DU4475,168313016,4.82519717161753
JHOC-5,selumetinib-JQ-1 (4-1 mol-mol),2.141197390405602
NU-DUL-1,26596,-3.721309412327892
TOV-112D,136227331,4.785922428339521
KMS-11,54626689,4.332155571981956
EFM-192A,26596,-0.8945052736311969
NCI-H1869,10302451,1.963256574225826
DMS 114,100016,6.89872652787532
Hs 940.T,73707398,1.575879149171109
MKN74,10302451,4.165847653983995
NCI-N87,4259181,-0.3128226187706996
Caki-1,637858,3.2080656123113713
BT-474,49766530,-0.1663339170498422
SBC-5,637858,3.033148612268187
TE-8,BRD-K27188169-navitoclax (2-1 mol-mol),3.903351368243401
BT 416,9903786,2.244954394725016
KG-1-C,262093,3.4811701682583847
Caki-1,136227924,3.8203162456228417
BT 328,11455910,1.1431162062454217
SNU-489,3689413,0.2649172011332545
HCT 116,107970,2.9696327154664126
HCC4006,73707398,1.5270479808510071
HCC38,100016,6.688694515924342
DMS 273,46907787,0.4735517334159472
SEM,637858,0.6523373975707702
Kasumi-2,11455910,-0.3707966959989963
NCI-H2110,262093,4.10340668622513
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
Pfeiffer,156414,0.4848945589525521
A2780,135999136,1.5930192405329104
KP-2,135398744,6.663666573534304
GA-10,4259181,-0.2690364706183594
MCAS,439501,-1.7764971276715424
NCI-H1105,241158,3.2792765444983036
KE-97,10302451,3.3442916828036675
LXF 289,9936388,-5.793518221083613
GA-10,44491742,3.5610264108230365
MKN74,10231331,5.759039673812496
U-BLC1,6852167,1.3413398534081005
CAL-51,73707398,0.7053044464230985
A4/Fukuda,135999136,4.178898868342667
RERF-LC-A1,54626689,4.363358001048379
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
SNU-1214,135421197,1.3172671598461234
U-937,4259181,-0.871929709772469
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
LK-2,10302451,3.925181253698499
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
Pfeiffer,136227924,1.7936916860357504
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
AsPC-1,54626689,5.229882111208764
Ku812,9929138,4.0796690015060095
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
KHM-1B,9915743,0.5787442773030028
MOTN-1,54626689,4.476495641971815
DV-90,10302451,1.181624513697412
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
LP-1,11455910,0.2365094775897044
HCC366,26596,-1.6336746121015082
DU145,3689413,-1.3535401671184424
KYSE-450,49766530,0.7642756518369849
8505C,135421197,0.9629586989681284
A4/Fukuda,637858,0.8198578842358093
HCC1395,9877608,6.36391605144629
TOV-112D,637858,1.8542326975791832
OCI-AML-5,4259181,0.0010032377974649
NU-DHL-1,375860,-1.1724229979544771
TE 617.T,135875424,2.9015039808938483
HuH-6,9929138,4.876929493574036
KYO-1,9903786,1.1587901811719317
AN3-CA,26596,-3.5868272426759584
NCI-H1581,54626689,3.68392931995819
OVK18,327653,2.633798721468076
EBC-1,11455910,1.3767667984766183
SNU-478,9903786,1.906264308135136
MEC-1,54626689,3.788874429365421
SUP-B15,135398744,6.752582090660733
Hs 729.T,UNC0638-navitoclax (1-1 mol-mol),2.435241393916189
RL,selumetinib-JQ-1 (4-1 mol-mol),0.7569589634428372
KP-N-SI9s,3689413,-0.3839516560951015
SNU-886,selumetinib-JQ-1 (4-1 mol-mol),2.185309080254947
NCI-H1792,9903786,2.6645651408291227
UM-UC-3,107970,2.392496715008541
KATO III,135875424,4.043779267428047
RPMI-8226,107970,2.2987962420855617
LS513,10302451,3.84490458936503
GDM-1,24180719,3.303552404087211
HPB-ALL,26596,-2.8269771859665824
J82,107970,2.424996826844534
NCI-H1435,10231331,3.7158203392038103
YH-13,49766530,-0.8723369372860722
P-STS,375860,0.1612218276357334
ST486,100016,6.384120256869386
NCI-H1838,136227924,4.034071845409975
RPMI-7951,46907787,2.690496694685834
AMO1,10302451,3.232615102018798
DMS 273,327653,3.1988672985426847
BT 139,11455910,0.9756266505311688
AN3-CA,selumetinib-JQ-1 (4-1 mol-mol),3.4953796840918763
SNU-387,11455910,4.584937750024463
SF126,46907787,4.091740890071596
HEC-1-A,54596490,4.808755296997763
BICR 22,375860,-0.6251605141105395
EBC-1,168313016,3.7421502425797386
NCO2,selumetinib-JQ-1 (4-1 mol-mol),-1.9216061314069743
SNU-761,10231331,0.4986973787554518
Li-7,168313016,4.344664847370071
UACC-257,637858,2.517971043881924
NCI-H2087,54626689,2.8786913158978664
KMS-18,444795,4.297088429276901
RVH-421,241158,3.9487795616003543
BT 145,3689413,-2.1573583471040827
NCI-H1793,6852167,3.028337837866536
OVCAR-5,24180719,3.7856777895783567
MDA-MB-157,73707398,-0.5856522541525173
DEL,444795,4.321957786836183
PSN1,49766530,-0.1944189543037747
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
TC-71,5460769,1.4458290097671247
IM95,9915743,-0.1388033573785565
COLO 684,9927531,4.094715698749933
NCI-H2171,9915743,0.832341910278816
8505C,100016,6.577733697234268
CAL-85-1,72967,3.75505984138146
MEC-1,9915743,0.3780873784747607
Hs 294T,136227924,2.369017342053728
NCI-H1563,241158,3.759729505660072
Hep-G2,3689413,1.297693127771037
SNU-213,73707398,1.7452345044805029
Hs 839.T,9936388,3.1884497736912567
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094
KYSE-150,10231331,5.9145508836363545
SW48,9915743,2.691515978939234
Sq-1,11396600,4.017113697276402
NCI-H526,136227924,1.9152739000663332
BxPC-3,136227924,2.62858882862477
SNU-61,3689413,-2.128463404187725
KE-97,9915743,-0.9585907230635954
ZR-75-30,4259181,0.9975762137683212
SET-2,135875424,3.0388135878797833
SK-MEL-31,10302451,4.277092998076058
YKG-1,375860,0.0929787084961373
BT 179,9903786,4.337350994333445
Capan-2,UNC0638-navitoclax (1-1 mol-mol),2.1905592054300764
Hs 683,156414,1.79593868877012
LS513,637858,1.4546571063620808
A2780,327653,2.026169684275287
KO52,71466445,2.839981960673523
SNU-1196,100016,6.169672174830197
SW982,375860,-0.2965947785170124
P12-Ichikawa,9936388,-6.7424079460419435
WM1799,6852167,3.2210767792178827
KCL-22,135999136,1.6425661350334857
NCI-H1184,73707398,0.6283107907901586
LS1034,49766530,4.046854400664645
GMS-10,241158,3.9645605442022185
HT-29,10302451,3.535161937635636
WSU-DLCL2,46907787,-1.3675142639317148
A-549,selumetinib-JQ-1 (4-1 mol-mol),1.5948722522654506
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
MKN74,637858,2.2619901111682768
WM266-4,6852167,2.43484592020926
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386
Tm87-16,9936388,1.513062418046636
SF295,100016,6.949657377166824
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
COR-L95,12003241,2.921570030601445
NCI-H292,9927531,4.942242070848643
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
PC-3,135875424,4.657200452224415
Raji,3689413,-1.7827501217470076
HCC1500,49766530,0.4188049276678212
MDA-MB-361,136227924,3.324084435927791
RPMI-8226,9915743,0.7773898345283005
769-P,10302451,1.402599220322161
ZR-75-1,9936388,2.1610264064405977
NCI-H211,44489367,4.490418802909238
MEC-1,24180719,3.2912278477644583
Hs 578T,241158,4.135038700144079
KYSE-510,4259181,-1.303373724971253
TOV-112D,12003241,-0.8504182456561812
Ci-1,9915743,3.2992367606729496
L-540,26596,-2.7361292622141806
JVM-3,54626689,3.5660664871382814
TE 441.T,5460769,2.227250069350157
A-172,107970,2.2406967925449854
JHH-5,637858,1.3205642125836328
HT-55,9936388,-1.3601859214377197
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273
NCI-H1581,327653,2.5433406837267416
SW1990,9936388,2.7870062891486613
UACC-812,135421197,0.8848266315498433
MEC-1,168313016,4.5584742767951125
KNS-62,selumetinib-JQ-1 (4-1 mol-mol),1.6160613728913362
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025
NCI-H747,UNC0638-navitoclax (1-1 mol-mol),0.8720524517922084
MEC-1,3689413,-2.5144055984412903
Hs 578Bst,54626689,4.4109750942390695
BHT-101,9903786,3.039821260092269
SUP-T1,5460769,2.284635628978783
DMS 114,46907787,1.0216495137560369
Hs 578Bst,11396600,3.7098372009722262
Daudi,11396600,1.6595042173405945
PSN1,241158,3.850546493000947
RCC10RGB,135421197,4.393109316582631
TOV-112D,644241,3.1066083987990445
COV434,135875424,2.939089760708004
DEL,49766530,-2.519225091580242
NCI-H1568,12003241,-1.4870303892505918
NCI-H1395,4259181,1.90835331362123
A-253,11455910,0.0705993826212342
DND-41,9915743,1.2658570457354406
Mono-Mac-6,107970,2.698784426617558
MDA-MB-453,24180719,3.640576555720147
NCI-H1105,73707398,1.277952733883997
Panc 02.03,49766530,0.9655059796360064
LC-1/sq-SF,12003241,1.312627912595186
JK-1,644241,-7.211964985196522
769-P,12003241,-0.850847726914325
NCI-H1755,46907787,1.530837440029527
HT-144,262093,3.242537447174441
OPM-2,9915743,0.7579871544404475
SUP-M2,9915743,1.8223517486811256
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
2004,136227924,1.8982400348113204
JK-1,100016,6.141145240463154
CAL-85-1,71466445,4.774774705188815
Hs 746.T,selumetinib-JQ-1 (4-1 mol-mol),1.3690652535230534
SNU-1033,9936388,0.9211545103072076
PSN1,10302451,4.4471631718961335
MKN74,10302451,4.165847653983995
KYSE-30,49766530,-1.4671789919373923
KYSE-30,135999136,4.4123994381842415
NB1,9929138,7.475182637248333
Lu-99,262093,3.013120554949913
SNU-1076,49766530,1.189560796158491
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037
OAW42,54626689,4.5289682618368765
A101D,24180719,3.1670780760682873
SW1271,10302451,1.5832525718610488
OUMS-23,135875424,4.57705137123218
MHH-CALL-4,12003241,-1.7117307202040182
Jurkat,262093,2.316034624316645
Jurkat,UNC0638-navitoclax (1-1 mol-mol),-2.488205497611277
COLO 668,3689413,-2.474838617448709
OCI-AML-5,262093,2.6389627250166825
NCI-H1651,136227924,3.2782738852919966
NCI-H292,5460769,0.0770188109309223
IGR-39,9936388,0.7486960389852466
WM793,49766530,-0.085641441031448
A101D,6852167,3.582205934028784
BT-16,262093,3.676362037858863
A-549,107970,2.6370788506586345
Panc 10.05,3689413,0.9531263048130152
CGTH-W-1,10231331,5.198794225249042
SYO-1,26596,-1.7250044942499454
T3M-10,12003241,-1.1759997048612671
A101D,136227924,2.7929516463081123
LNCaP clone FGC,9927531,4.548275216558741
Hs 944.T,136227331,3.8800196533098847
Granta-519,4259181,-0.7648884727300508
AN3-CA,156414,1.36110068717594
SNU-840,135875424,4.211396947721992
OVK18,107970,2.305543981399572
NCI-H2106,4259181,0.3116133761629641
NCI-H2029,156414,1.6965559140057698
TM-31,439501,-2.1329770748027426
OV7,637858,2.6132506339305888
ChaGo-K-1,6852167,1.9816298194521569
SF295,5460769,2.0646753609737125
BT 228,4259181,1.0401534550854912
SNU-886,135398744,6.3424886084429435
SNU-C2A,26596,-0.6540146277819451
COLO 800,4259181,0.2176234402934261
VMRC-RCW,9903786,3.331782716085826
NCI-H2009,100016,6.24887408197215
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
FU-OV-1,10231331,3.398558944555642
MDA-MB-361,9936388,2.003587918290059
KM12,10302451,1.390637807064829
SK-N-MC,9915743,0.8828684389930763
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482
NCI-H1373,100016,4.430083600999957
NCI-H810,9927531,3.2474997445381693
SK-LMS-1,9927531,4.694028683387814
Aska-SS,73707398,1.256290456128312
YKG-1,241158,4.094206621053088
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
MOLT-3,5460769,-0.5989426440895276
SNU-626,11455910,1.8288059017639848
TOV-112D,44491742,4.330645914345901
NCI-H1693,71466445,4.120869747264166
OVCAR-5,135421197,1.110544860283993
Hs 944.T,9915743,1.2530099192350108
HeLa,5460769,5.484643109222549
BT 333,selumetinib-JQ-1 (4-1 mol-mol),3.898596298326471
Hs 729.T,135999136,2.2512921666618166
HuP-T3,4259181,1.3598984416642497
BT 216,107970,1.6739180929917945
MDA-MB-468,11455910,1.0367745441510958
SK-LU-1,UNC0638-navitoclax (1-1 mol-mol),4.8277080945305375
MFE-319,637858,3.461230658478568
SNU-213,selumetinib-JQ-1 (4-1 mol-mol),1.0193842284675143
WSU-DLCL2,168313016,3.978102745461622
HOS,100016,6.425173790511516
NCI-H520,10302451,3.2587774106229146
SW48,49766530,3.606492941369466
SW1271,156414,2.097129180606755
BT 482,6852167,2.974571022555702
HuP-T3,11455910,1.0919804440303738
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
P31/FUJ,71466445,3.0287439983851225
NCI-H810,136227331,3.856341284870196
AM-38,3689413,-2.9608439081613387
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837
HT-1376,100016,4.270787672820572
CCF-STTG1,54626689,5.020869139068369
SNU-201,637858,3.034279619559701
RD,241158,3.681398849246852
SNU-201,44491742,4.436109231936613
IPC-298,168313016,4.989251523592668
LS1034,136227924,1.69162800732405
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
OVCAR-5,10302451,1.4379569920438735
HCC1954,241158,3.120856344806506
NCI-H1755,10231331,3.436279502262436
SNU-C5,11396600,3.0577499527766316
NCI-H524,12003241,-3.023793196266873
IM95,439501,-2.2673196662301933
KMS-26,168313016,2.9457781921447146
HCC1428,4259181,0.4892648147549973
HT-1080,262093,1.0809900576610223
TCCSUP,3689413,0.6301346851622357
BT 179,11396600,2.8965915614229036
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
WM793,135999136,5.309745002054086
A2058,135421197,3.1634124303989273
NCI-H1734,135875424,3.3840426001662727
HCC1438,10302451,4.112625269368406
KYSE-70,12003241,-1.4257688129039825
MSTO-211H,10231331,1.7809441814393978
DND-41,136227924,1.87568318170164
MKN45,9936388,3.1179555468131235
GCT,46907787,2.5323439300776873
LXF 289,439501,-1.653941874457911
FaDu,54626689,4.128710431878998
COLO 320,9936388,-1.5439590773342686
ALL-SIL,9903786,1.532435199339551
OUMS-23,11455910,4.2280456550760235
Hs 611.T,44491742,3.458740390209698
SNU-869,12003241,1.357086277670327
OCI-Ly3,135875424,3.008011320829632
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
DV-90,136227331,3.915454108317936
SU.86.86,637858,2.2457554549288714
HEY A8,11455910,0.7579063331214974
IA-LM,439501,-4.16745845294267
Hs 578T,9915743,0.6778530093725601
IGR-37,10302451,3.8582187124778256
SCC-4,156414,1.45988580347199
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
SBC-5,11396600,3.6683316442381617
MOR/CPR,selumetinib-JQ-1 (4-1 mol-mol),2.7739348806287945
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
NCI-H2172,73707398,2.7683774259754914
CAL-62,12003241,-1.1507806931187785
JHUEM-7,12003241,-3.5765771521887246
TE-10,3689413,-0.6087813624831553
MSTO-211H,4259181,-0.7585521679245923
SNU-1033,3689413,-2.6391429266703015
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
TTC-709,49766530,-2.0613056502019407
COR-L95,9903786,3.7357721387912513
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
COR-L105,6852167,2.71981320036177
Ri-1,3689413,-2.346816387466721
Hs 578Bst,6852167,5.521965568866905
PSN1,26596,-0.5365301326145567
ES-2,136227924,4.099714373678264
MOLP-2,156414,1.6168750174701296
COLO 205,135999136,4.470292461600089
KYM-1,135999136,4.4173157173390925
NCI-H2196,136227924,2.7386742576768643
42-MG-BA,375860,1.010061771068955
GaMG,9915743,4.602253717337043
SU-DHL-4,46907787,-0.3916382463419708
P3HR-1,444795,4.927433768581791
769-P,439501,-0.7998429700142536
SK-MES-1,UNC0638-navitoclax (1-1 mol-mol),1.0494999959319211
Li-7,11455910,1.362279388286256
FTC-238,49766530,-0.9457086114172378
PANC-1,241158,4.756219321498369
MKN45,135421197,1.3599393151619537
HCC1588,selumetinib-JQ-1 (4-1 mol-mol),-0.6381739990739388
NCO2,9929138,5.425530092389558
8505C,selumetinib-JQ-1 (4-1 mol-mol),0.2956990111735152
SF295,73707398,1.6695998936889058
RL95-2,11455910,0.9076770125519352
NCI-H1694,644241,2.0380000680852035
EFO-21,100016,8.032262329904976
HT-144,3689413,-0.1147563319413739
SaOS-2,5460769,2.263492155098724
Rh18,73707398,1.1064316951658733
Panc 04.03,9927531,5.313421559596226
HEC-59,262093,2.7698106992927007
HeLa,241158,4.038975399720051
SNU-878,3689413,0.601904749344492
COV362,selumetinib-JQ-1 (4-1 mol-mol),4.077044084854786
MDST8,135875424,6.383148165610491
NCI-H28,4259181,-0.5153819717152983
SNU-387,44491742,4.132370196510326
TM-31,327653,3.2329205368266347
OAW28,439501,-0.9322268226633188
Namalwa,375860,-0.654511262615756
ALL-SIL,5460769,0.8731159867521163
SK-MEL-24,12003241,-2.7585414015303424
L3.3,262093,4.054875705556861
CHP-126,9929138,6.335241995637564
JMSU-1,selumetinib-JQ-1 (4-1 mol-mol),2.396136909676299
ONS-76,135421197,2.4329108516652775
Hs 766T,136227924,2.630952750368734
A-172,6852167,3.365866392537541
NCI-H1581,444795,4.04311509968713
KMRC-20,9903786,3.936421872110463
Karpas-422,11455910,0.7211757450052372
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744
MG-63,selumetinib-JQ-1 (4-1 mol-mol),3.254737197001595
A-673,136227924,1.815433973878695
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
TTC-709,24180719,4.144847836584859
HT,11455910,-0.2280059787426213
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
ECC10,6852167,1.422945191083627
JHOS-2,selumetinib-JQ-1 (4-1 mol-mol),3.072081960751537
SNG-M,26596,-1.5448516753437405
TUHR4TKB,12003241,-0.5778416487283387
Calu-1,136227924,3.5665542391568774
T24,49766530,-0.3473877754234792
SUP-HD1,136227924,3.4836971225000735
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
PE/CA-PJ49,10231331,4.972087269175424
HCC4006,327653,2.5941924214272865
CHP-212,637858,1.7500511895355555
KYM-1,12003241,1.54362271248318
CAL-85-1,135999136,4.6165811325196735
Rh41,73707398,0.7299412970985347
SYO-1,9936388,-7.327541769991975
RCH-ACV,444795,3.203280801108019
Hs 888.T,100016,7.920695284419831
SK-MES-1,4259181,0.518582282255732
IMR-32,12003241,0.5902035807991148
AsPC-1,11396600,3.3240147605355506
SNU-C4,46907787,3.840379213773751
NCI-H647,637858,3.278669479288834
NCI-H1299,262093,2.920458315101783
CL-11,49766530,-0.1976824475741571
MOLP-2,71466445,3.5509780826004658
HCC1588,439501,-0.8839537477169336
Hs 746.T,46907787,3.398269102582514
Karpas-299,637858,1.0781855815808754
HuCC-T1,9929138,1.9586255988809151
TCC-Pan2,241158,4.391584480851977
NCI-H2170,375860,0.3943136214520606
HCC1428,10302451,3.907203878611604
NCI-H2172,10302451,4.417347550930714
BT 216,3689413,-0.8248802266685408
HCC1833,71466445,4.001049080223579
NCI-H2029,10302451,4.07303953263125
HCC1171,6852167,6.381123013085841
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
IMR-32,73707398,0.5521746080508468
KMS-12-BM,262093,1.1865999929989532
EM-2,135875424,3.8606951218736287
OVCAR-4,637858,2.0846250774170167
BT 416,107970,2.292868528252604
COLO 829,135421197,3.0893974148285466
BT 333,135999136,1.9230816314921284
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
SCC-25,54626689,4.612651839692497
SW620,439501,-1.8970460757593473
HCC1833,9903786,4.187003338939228
COLO 201,24180719,0.8403044113817764
NCI-H838,5460769,0.2411735941540018
P31/FUJ,100016,5.4217002529902185
SYO-1,4259181,-0.5124750518343509
VMRC-RCW,BRD-K27188169-navitoclax (2-1 mol-mol),1.1900573972855846
JHOS-2,3689413,-2.497853898445669
COLO 792,136227924,2.7402829929938908
G-402,135875424,3.4290798142647776
Mel JuSo,135999136,4.320625379627876
YD-38,12003241,-0.5056624439731239
OV-90,24180719,3.4680495926185633
COR-L51,439501,-3.194299942621501
SNU-1079,11396600,3.205631918167514
NCI-H460,135421197,3.2510260026522233
Becker,439501,-2.817437349005285
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
IA-LM,168313016,4.257474229118996
NCI-H1341,375860,-0.4672550537008356
BT-12,10302451,3.882054819598992
NB1,11455910,-0.1636183381201439
HCC2218,5460769,-0.600250204778271
TYK-nu,11396600,3.490673589764442
GB-1,9915743,1.6867043056533375
OV7,3689413,-5.087599218712134
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
RPMI-7951,54626689,4.364725309097019
SNU-119,26596,2.579410873890194
THP-1,107970,2.0442252682761417
Calu-6,9915743,-0.5707645596602849
NCI-H358,12003241,-1.009244775405437
Hs 766T,637858,2.249517442676159
HCC15,10231331,4.227224330005602
Hs 895.T,9915743,1.4498545473897326
BT 328,3689413,2.3836323832860673
SUP-B15,44491742,3.782518793178516
LK-2,11455910,-0.0454664251663307
KP-N-YN,4259181,2.3669451828988612
MOTN-1,9903786,1.5262783813128549
NCI-H2405,9936388,-0.650835223807707
NUGC-3,10231331,2.721945968034159
RS4;11,439501,-2.445140752441031
TE-15,4259181,-0.9180245906878618
HDLM-2,71466445,2.6757992406645505
NCI-H1373,71466445,6.090116254163269
NCI-H196,439501,-2.4399998682634023
Caki-2,136227924,3.8399348879900854
KYSE-450,12003241,-0.0119879221972118
BICR 16,9915743,1.7576705506596324
Capan-1,135421197,1.617926303344926
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
697,24180719,2.231180317985507
HT-55,selumetinib-JQ-1 (4-1 mol-mol),0.079312954019081
HeLa,9915743,4.03760238390019
DMS 114,12003241,-1.1763340491850245
MFE-296,375860,0.0283845052081567
SNU-1,44491742,4.0790825455255195
MOLP-2,10302451,4.280949044542535
BT 482,49766530,0.6927956114386422
IGR-1,54626689,5.20268151525841
NCI-H1581,107970,2.3968187314483145
Detroit 562,375860,-0.8636251834694404
SNU-738,24180719,3.644922897140592
LNCaP clone FGC,11396600,3.414051330907707
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
HCC1438,135875424,4.418316451963679
NCI-H1869,12003241,-1.5114527115730307
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327
Panc 04.03,9936388,2.385451093408398
JHUEM-7,135875424,3.03961944002969
SNU-1196,10302451,1.5502793512476396
SW48,10302451,2.1638159560649157
ZR-75-30,44491742,3.706511746773907
BT 271,327653,3.0157636823080187
OCI-Ly3,4259181,-0.1616612088591607
ALL-SIL,9929138,4.286241964174987
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
Lu-65,375860,-0.0242259972210493
KYSE-70,327653,3.7336437717951103
JM-1,5460769,0.6255065324989537
AGS,10302451,4.085579699676075
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
SCC-9,73707398,1.5896934234406246
HuT 78,9936388,-7.168553730777331
DND-41,49766530,-2.480417892949832
BT 416,100016,4.165407662771479
SU-DHL-1,5460769,-0.475427190707336
OCI-Ly10,135421197,1.9634913874205968
OPM-2,135421197,1.341685947169011
KMH-2,241158,3.3374557271517
T84,107970,1.2920542062005194
NCI-H2405,10302451,2.493326553695985
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
BT 172,135875424,3.0485083904276933
Hs 944.T,9927531,3.41915171718772
22Rv1,4259181,0.07486128932158
NB1,71466445,1.9975246726713645
IMR-32,26596,-3.972445110403932
MFE-296,4259181,-0.0272818624735243
Jurkat,135875424,3.3200547810241496
SNU-1077,46907787,0.7852146377897988
CCF-STTG1,9915743,3.2198509615239024
KMS-27,156414,1.1434862066422389
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
HCC1806,12003241,-0.1866891199802881
IPC-298,6852167,2.465275757698449
HCC1500,9915743,1.9340540182592263
NB4,637858,1.139031029717768
MKN1,637858,2.106169799801537
SNU-5,11455910,3.529816425197799
Hs 895.T,9936388,3.096853408439268
NCI-H1869,168313016,4.348765145343562
253J-BV,9903786,4.2891414604158395
A-375,135875424,3.696378355879961
NCI-H727,136227924,3.2179651731130585
EC-GI-10,5460769,0.497898829273519
COLO 680N,3689413,-1.68743506325492
COV434,241158,3.2094796403534875
NCI-H810,11396600,2.3533971168912036
NCI-H358,9929138,5.930954019944583
SNU-466,73707398,0.902504461291191
NCI-H1435,5460769,2.24942337838163
KMRC-20,12003241,-0.2043728031762648
769-P,100016,6.594067506922387
CAL-29,135421197,2.48018015495381
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
Mino,11455910,-0.3204403040643599
LoVo,135398744,6.330186357549225
SNU-5,12003241,2.4960585201420247
JMSU-1,44491742,4.046305015990271
JHUEM-1,107970,2.1854656376588415
Caki-1,135421197,2.421962136106705
Caov-3,46907787,0.9279743097720166
KM12,9915743,2.3506580045121948
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
HuH-1,6852167,3.503691591551823
NCI-H28,11455910,-0.4430310622826519
PE/CA-PJ15,135999136,4.2175976064097265
NCI-H2052,selumetinib-JQ-1 (4-1 mol-mol),-0.7577963848142586
OE33,9903786,4.225835285233996
BICR 6,54626689,4.9430607179906
8-MG-BA,selumetinib-JQ-1 (4-1 mol-mol),2.597968943112954
NCI-H1734,49766530,-2.088624168616933
CAL-85-1,262093,2.917494988411318
L-540,135999136,4.377146973519388
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
NCI-H1355,24180719,3.657406095337948
NCI-H526,9929138,5.368953521226413
U-118MG,54626689,4.711558660240095
NCI-H520,375860,-0.3875820486223135
AsPC-1,135999136,4.3448843965381965
JJN-3,107970,1.9663973240446229
A2780,73707398,0.6651600447827565
BT 245,46907787,3.440577921160999
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206
KP-4,644241,3.5135167482418703
KMS-26,3689413,-5.054030253725733
Lu-99,375860,-0.8428045335797242
SK-MEL-5,49766530,5.144736864268162
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115
NCI-H23,44491742,4.066691621644064
LS180,10231331,0.7625893939503741
HEC-265,26596,-1.38176914424549
OCI-AML-3,439501,-3.711408671836436
PF-382,262093,0.5149344400111652
Mel Ho,26596,-0.5803801535189402
Hs 888.Lu,5460769,5.202141251599371
JHOS-2,100016,8.119351788295337
A-549,12003241,-1.903076073453771
NCI-H520,444795,5.008670344858
KHM-1B,6852167,0.7581222087853566
HCC1143,135421197,0.8918606552263807
OCI-AML-2,11455910,0.2624387958343751
Hs 888.T,637858,2.4627454222382235
HSC-4,439501,-1.7709622187792924
Kasumi-1,168313016,3.058088325309781
ST486,selumetinib-JQ-1 (4-1 mol-mol),0.8621591965055626
NCI-H292,6852167,2.409220580223775
DBTRG-05MG,12003241,-1.7775035610862775
Kasumi-2,168313016,3.99242446715415
UM-UC-3,135999136,3.953178744040034
KALS-1,136227331,4.320673828023345
TE-8,12003241,-1.9101664586501004
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
GP2d,24180719,3.2790512744899023
CL-11,439501,-1.1528361936308975
LS180,637858,2.1359320280537704
ST486,241158,1.6334759620227712
SNB-75,5460769,5.271808255832039
JHH-6,49766530,1.0695229920160838
BICR 31,12003241,-1.4237270953299652
RS4;11,9915743,-0.3402304070794544
SNU-182,5460769,4.45196550133433
KHM-1B,156414,1.0383008800592366
IA-LM,71466445,4.189377103287156
A-204,5460769,1.2636887852465275
Karpas-620,327653,1.9362817127308152
TUHR4TKB,26596,-1.9685779873935287
ESS-1,241158,3.69128431914065
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
SW1990,46907787,4.845912107981417
PE/CA-PJ41 (clone D2),135875424,2.9357060771459245
SW1353,439501,-2.4341280198681248
NCI-H28,135421197,1.3178315366428714
CCF-STTG1,9936388,2.748356806633847
HCC95,10302451,2.261306472696935
HOS,327653,3.6084770643772126
A-549,107970,2.6370788506586345
WM983B,439501,-2.1469095584384608
639V,10302451,4.153653577935064
RT-4,71466445,5.089577793908251
SNU-626,3689413,-0.5930983813401607
TE-15,6852167,2.5993041449635794
NCI-H1793,73707398,3.767957109023464
SNU-1077,24180719,3.4105724970727302
NCI-H2405,12003241,-1.91851712943585
PL-21,135398744,6.318867550173511
DV-90,71466445,2.3382409396535384
OV56,46907787,5.709226963672881
NCI-H716,11396600,4.406293438661701
SUP-HD1,327653,2.769714391892401
NCI-H1155,9903786,2.7353298872083984
KP-N-YN,46907787,4.256466884181242
Kasumi-2,9903786,1.7296917357536032
KMS-28BM,6852167,0.671457321927331
SUP-B15,26596,-1.8657043517312688
ONCO-DG-1,selumetinib-JQ-1 (4-1 mol-mol),1.160528859877599
TT,46907787,1.4494674694967729
NCI-H727,44489367,5.9503570299169875
COLO 800,11396600,4.874134738718471
COLO 201,4259181,-1.4500669762010117
DAN-G,241158,3.8198495824160736
PK-45H,6852167,3.230931962142996
PK-59,6852167,1.7961367286330785
BT 440,49766530,1.1711647007099082
SNU-61,6852167,3.859693430343892
OVCAR-5,5460769,4.389197007102137
KMS-27,54626689,4.411427785332684
KP-4,5460769,4.107177099702386
NCI-H1869,637858,2.4827908237252183
HEY A8,49766530,-2.2509342663740566
YKG-1,4259181,0.3868166013965885
Hs 940.T,9936388,1.1653253774918717
NCI-H1184,11455910,0.4610574255043957
NCI-H1693,135999136,1.5965366802541323
NCI-H810,375860,0.3770517333677842
KMS-20,10302451,2.7224697614535662
ECC10,9903786,0.6869958735378703
RKN,327653,3.2518035953304434
TE-8,selumetinib-JQ-1 (4-1 mol-mol),0.5093233831450799
DU145,262093,3.2967412726475187
CGTH-W-1,100016,5.226111530095554
HD-MY-Z,136227924,3.0737298330446103
ZR-75-1,5460769,4.241529452507845
LAMA-84,3689413,-1.3009180368872624
COV434,136227924,1.351853150285656
Hs 746.T,71466445,4.972648672045977
L-428,262093,2.197551267633171
SNU-1196,9903786,3.851159965091799
HuG1-N,5460769,5.358196013663695
MeWo,12003241,-1.7569732997280945
BT 187,107970,1.6658171164192257
MM1.S,439501,-1.8322200924082088
KE-37,46907787,-1.1788296839402306
SW1710,439501,-1.6962022164368444
GA-10,375860,-0.8493314441415308
ONCO-DG-1,107970,2.353407036343958
MEC-1,9903786,1.8402940604427764
NCO2,10231331,-0.4964087143893907
Hep 3B2.1-7,135421197,0.863862977673099
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
NCI-H647,9929138,4.265521593960728
KYSE-450,9915743,1.0249516523129705
CAL-12T,637858,2.037009471526232
MEC-1,UNC0638-navitoclax (1-1 mol-mol),3.101091843102834
DU145,262093,3.2967412726475187
KYSE-140,3689413,0.0626395685413909
PF-382,135875424,3.2130182861195076
HEL 92.1.7,71466445,0.5664416443041054
LN-18,637858,2.819183546851971
BT-20,644241,2.7102093275988133
COV434,327653,2.7172148793284094
COLO 201,439501,-0.4470167142560104
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
NCI-H1568,136227924,3.032081072579533
HSC-3,44489367,4.725999442167047
KE-97,6852167,1.7981479981592747
SK-N-SH,136227924,2.487245372945198
SNU-601,241158,4.328788935254692
JVM-3,135875424,3.424449119356365
U266B1,156414,1.6071696370367765
U-251MG,156414,1.68139049823068
SK-MEL-28,637858,2.5948993681356276
HT-1197,11396600,2.8973650572318213
NCI-H522,135999136,4.552466214525868
COR-L51,12003241,-0.3418570343381517
GSU,9936388,1.1039291708072954
SW1417,3689413,1.8157284329768
NCI-H2030,9936388,0.4850325164954482
SW1710,327653,3.020796751011318
NCI-H1105,637858,0.7238201865125736
Jurkat,444795,4.645488476926674
KNS-81,selumetinib-JQ-1 (4-1 mol-mol),7.110946651223067
ECC12,100016,5.969737428755433
MM1.S,136227924,2.5395832269167027
YD-15,637858,2.2450013527302235
DMS 79,135421197,1.224509473614064
Hs 822.T,241158,6.131081748082957
AML-193,10302451,3.844676833149803
DMS 454,44491742,3.21829880696891
MOTN-1,selumetinib-JQ-1 (4-1 mol-mol),0.9467345984879016
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607
DU145,4259181,1.409412257624231
NCI-H810,107970,1.4646038858189545
SK-N-BE(2),9903786,2.0499315562907627
HCC1419,637858,3.7204958327098416
RKN,73707398,1.136221501718042
CW-2,100016,4.445901991176778
HCC2279,107970,2.1079245815916843
TE-6,10302451,0.423575511897082
KYSE-70,637858,2.812350468450961
TUHR10TKB,262093,3.638427626686601
A2058,46907787,1.6965919931363946
RL,12003241,-0.503691110401914
CCK-81,10231331,1.892878749615724
NCI-H1355,637858,2.3984786151718773
TE-5,136227924,2.0128832307516715
P3HR-1,136227924,2.9304577514896466
BT-474,4259181,0.7470813596666142
ST486,107970,1.035895385995704
KMS-34,100016,4.459610626448404
KHM-1B,9936388,-7.3262126051433425
IM95,3689413,0.7350625809131119
A4/Fukuda,72967,3.695839205584607
KYSE-510,135421197,2.241265348212864
EFE-184,444795,6.4127463450250355
LAMA-84,10231331,-0.5336947695557159
TYK-nu,262093,2.9110323710045285
OAW42,262093,3.645720807716878
NCI-H1703,54626689,4.48380641984727
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
HCC15,9903786,1.5576741113339283
NB4,49766530,-2.04129527445394
UACC-62,46907787,5.687092610783554
BT 444,262093,2.9400297132003623
MSTO-211H,73707398,0.6990065379334892
SNU-216,24180719,2.848757619364884
SNU-201,73707398,1.6082219150055517
CHP-126,439501,-0.4236570710914729
SK-CO-1,241158,4.831010946536929
OCI-AML-2,241158,3.3676277073160237
HCC1438,9927531,4.9957520851932955
PLC/PRF/5,46907787,4.590488786856309
DK-MG,100016,7.056187444773538
SNU-1,6852167,1.5544290188040613
NCI-H1355,46907787,3.837327934735341
OAW42,3689413,0.5201903722679624
OCI-Ly19,136227924,2.004549918496879
COV362,9936388,0.426614716920504
U-118MG,9903786,4.127288494791117
Panc 08.13,44491742,4.265130925236368
MHH-CALL-3,46907787,0.253800682048371
KMBC-2,71466445,4.930861718344141
A-549,637858,3.117280931983567
MG-63,46907787,1.9915589638341744
PE/CA-PJ15,327653,3.705959138945344
HuH-28,UNC0638-navitoclax (1-1 mol-mol),-0.7244825162600496
NCI-H2085,10302451,1.3740847824002096
G-292 clone A141B1,241158,1.9556593894066396
Panc 02.03,3689413,0.2165954212360822
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
HCC1195,637858,2.3009547057481137
HuP-T4,9915743,-1.7741648598156543
DMS 53,637858,1.231022213456641
REC-1,9929138,7.294165808460384
CML-T1,6852167,0.9836314645814764
Hs 822.T,439501,-2.4556830232378712
IGROV-1,135398744,6.402844237905131
KMS-21-BM,3689413,-1.8694843012427496
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
Calu-3,73707398,0.8733315682522698
SF295,9936388,1.8656949469177304
DU4475,10302451,3.9480605085423934
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
BICR 6,439501,-3.4433349442086234
MeWo,6852167,2.944495368954562
LK-2,49766530,3.215264234500344
BFTC-905,12003241,-0.5086689742708943
JHH-5,136227331,4.11271540989167
OCI-Ly3,5460769,0.7293331267323642
RCC10RGB,9903786,5.708919982977709
YD-10B,4259181,-1.8718625004308556
Hs 936.T,100016,5.806135174623166
LCLC-103H,9903786,3.9967722976793696
EoL-1,selumetinib-JQ-1 (4-1 mol-mol),-1.4243084091722091
NCI-H322,107970,2.347963530024278
NCI-H358,46907787,0.0932722717709755
LUDLU-1,26596,-1.0531529741547596
Hs 688(A).T,107970,2.6275562236634173
HCC95,44491742,3.8054910800445994
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
LN-18,100016,6.511039950794577
CAL-33,9927531,3.2885061744461273
SW982,73707398,0.9471359795057472
HH [Human lymphoma],637858,0.9741155601767478
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
NCI-H1299,241158,3.1343803063940996
MHH-NB-11,107970,2.4568673024890604
NCI-H209,9915743,-2.0620663235985797
RERF-LC-MS,135875424,2.839581382146162
TALL-1 [Human adult T-ALL],11396600,2.6371175707819887
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616
KM12,44491742,3.983947326566667
BT 416,6852167,0.3489067839841118
HCT 15,5460769,3.425383237869742
NCI-H526,135421197,1.27710242642961
CFPAC-1,135999136,4.179535980060787
C2BBe1,9936388,0.7937210910014248
Ki-JK,262093,2.27215883158064
BT 112,637858,1.3708104354326625
FTC-133,135999136,5.800253145127344
SK-LU-1,9903786,1.4733207164642357
GSS,637858,1.823205693461285
PSN1,4259181,0.8608268947596887
LoVo,3689413,-0.0015328635235731
Ci-1,107970,1.4916042992052976
SUIT-2,136227924,3.4861054974924133
SU-DHL-8,637858,1.0038553272764972
YH-13,9915743,2.529803461221303
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
SW620,54626689,4.077147643620654
SUP-M2,135875424,2.961544383480745
COR-L51,46907787,1.7446417299481616
SCC-25,10302451,1.3739474591398615
VMRC-LCD,54626689,6.355642452262427
Panc 03.27,73707398,1.02648838548017
Lu-65,49766530,1.0861089243329392
OAW42,9927531,5.261343543721406
HPAC,5460769,1.6003677750846823
THP-1,11396600,3.1299513207633365
NUGC-4,5460769,4.378159421113783
HOP-62,439501,-3.0300699988747333
TUHR14TKB,49766530,-0.541882480263748
Hs 578T,selumetinib-JQ-1 (4-1 mol-mol),1.8752949809426225
Panc 10.05,selumetinib-JQ-1 (4-1 mol-mol),1.8225918521960305
SNU-5,10302451,3.799734936594112
KNS-42,49766530,0.1123105929795226
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
ZR-75-1,135999136,4.466274366376033
ACHN,5460769,0.8804471145118281
HEC-108,135999136,4.441314867436916
CAL-33,3689413,0.5447147166063717
VMRC-RCW,107970,2.4523848142824924
BT 145,26596,-1.6561784022945174
SNU-1272,241158,4.382370259171122
NCI-H810,135999136,1.8085550154613508
HuP-T4,637858,2.2191803891242987
Ri-1,100016,4.838113149785687
SNU-407,375860,-0.2735722372490464
U-BLC1,375860,-0.0684909455881561
DMS 114,136227924,2.8316140416519664
SU-DHL-10,10302451,3.176970574358631
TUHR4TKB,9927531,4.964100941716243
TE 441.T,73707398,2.754590712931621
CJM [Human melanoma],262093,2.9776663734710582
Panc 04.03,10231331,4.944041434313903
NU-DHL-1,136227924,1.2519389073848997
NCI-H1869,9927531,5.985290716685452
WM793,73707398,0.9042820542427616
SHP-77,4259181,-2.0611623813860103
SNU-668,135875424,2.8972214679308084
EoL-1,156414,-3.3085458408804556
J82,9936388,2.8537355622155536
SNU-16,135999136,4.1641097715500495
HEC-108,9903786,3.9980769668892706
HEC-151,9929138,7.082890356746388
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
LP-1,9903786,3.180613462551036
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
KMRC-20,selumetinib-JQ-1 (4-1 mol-mol),2.987450194991694
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
NCI-H322,135875424,4.689474609475431
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
T98G,3689413,-0.3099040936553002
Capan-2,3689413,2.633842483871067
NCI-H2170,11396600,3.579707270807188
WM266-4,12003241,-2.6604387870862745
ACHN,4259181,1.2233693378983428
SCC-9,262093,3.396257832039873
VCaP,262093,1.994503008869617
NCI-H1944,UNC0638-navitoclax (1-1 mol-mol),0.8826171881767358
SNU-899,9915743,1.4111818856730072
U-BLC1,107970,1.5582659561874588
SIG-M5,107970,2.1274244329826417
Mino,327653,2.450086744090126
G-401,135421197,1.4306754302223277
TE-14,100016,6.976624848230786
TCC-Pan2,439501,-0.269334901836468
SCaBER,156414,3.639722880324369
BCP-1,11396600,3.181201903061476
RKN,3689413,-4.085525957083088
DAN-G,12003241,-0.4522104330137063
KP-3,136227924,3.03068470875373
IGROV-1,12003241,-2.0122972114546904
WM88,selumetinib-JQ-1 (4-1 mol-mol),-2.6351532870485017
NCI-H292,44489367,4.492014578968512
LC-1/sq-SF,241158,4.919718305365368
A-549,100016,7.181380121169662
SNU-1041,10302451,3.993130950847062
SUIT-2,73707398,2.4448376326021313
KMRC-2,49766530,0.0425057620545657
CMK,selumetinib-JQ-1 (4-1 mol-mol),0.226926842733127
JHH-5,6852167,3.2228194351334674
Ci-1,49766530,-2.656825005830753
DU4475,12003241,-2.262419788533744
HEL 92.1.7,49766530,-2.6866934842186234
SNU-685,10302451,2.9829097141985583
JVM-2,439501,-2.3079985652377633
NCI-H1734,73707398,0.7636447310811201
MDA-MB-453,135421197,0.8806711164351635
HEY A8,135421197,2.419965019315952
NCI-H1339,241158,4.172701274103716
BT 145,100016,5.857999875396141
SNU-C1,135398744,6.35894151615267
NCI-H810,262093,0.9896842517721274
NCI-H838,12003241,-1.6819169768090954
NCI-H1155,44489367,5.241949335287821
NB1,136227924,2.7984479768491335
HSC-4,136227924,4.2199200707906845
LMSU,135999136,4.828023886470807
Hep 3B2.1-7,9915743,1.8474397407384695
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
YD-38,3689413,0.3954861349850884
TOV-21G,135999136,2.1034760470617138
IM95,11455910,0.766351703140193
Detroit 562,3689413,-1.858060179976838
NCC-StC-K140,439501,-3.4454248624947437
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
OVSAHO,327653,2.515747107547292
DLD-1,439501,-1.8196175209339427
MFE-319,5460769,5.093824644165235
SK-ES-1,UNC0638-navitoclax (1-1 mol-mol),0.7664167233990603
ESS-1,3689413,-0.979855371465586
KP-3,6852167,3.3293836315268805
MDST8,107970,2.8941750874079744
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312
MOLT-13,4259181,0.0040314779304794
NCI-H1869,9936388,1.425696213804551
B-CPAP,12003241,-1.7111954205398938
NCI-H2228,9936388,2.203953103351002
U266B1,637858,0.9424663085199376
HL-60,54626689,4.748043327883289
WM793,168313016,5.214677912138177
MOTN-1,100016,6.2802968176710445
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
SNU-489,54626689,4.575519368934165
GP2d,46907787,2.1457899624672296
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
DK-MG,46907787,1.3821864850113783
T84,9936388,-5.402148456291863
OV56,107970,2.635438984490241
HGC-27,10231331,6.356350936699628
ST486,12003241,-0.1204499968223502
U-118MG,selumetinib-JQ-1 (4-1 mol-mol),4.036114633188371
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
NCI-H1944,107970,2.5235329939917155
SNU-201,3689413,-1.5340531054377644
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
COR-L95,135875424,3.0866900102445816
CL-11,644241,1.6397301100186843
NCI-H2081,135875424,3.067653141346589
COR-L95,54626689,4.626807564914302
PC-14,BRD-K27188169-navitoclax (2-1 mol-mol),0.9936418350863891
OPM-2,136227331,3.7431952210756014
Panc 03.27,9936388,-5.075789023716421
LOX-IMVI,49766530,-3.939815107547984
RT-112,9929138,6.4480300033203095
KE-39,54626689,5.72659105113371
Mono-Mac-6,135421197,1.2337860408769474
MHH-CALL-3,241158,2.355012632546193
OCI-Ly19,26596,-2.6757237263114875
SK-MEL-3,241158,4.338095980194072
AML-193,11455910,0.2037712262055268
DV-90,10231331,-0.8799349916089758
JeKo-1,136227924,2.4041415853814687
BICR 31,11455910,2.0785566961581186
OAW28,12003241,-0.542287488877267
MDST8,375860,-0.0509298762434446
RT-112,4259181,-0.3287525972412779
HCT 15,24180719,3.820109021124781
HEC-151,46907787,1.109021567995486
Hs 940.T,24180719,2.886779013175124
Calu-6,24180719,2.9438266016087886
HCC1954,12003241,-0.7991546925756471
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
LUDLU-1,12003241,-0.5957791848083803
SW982,100016,3.947877721573723
NCI-H838,439501,-0.7442992299750818
SK-N-MC,375860,-0.433233817068978
DLD-1,10302451,3.8037310408669502
YD-15,26596,-1.9516647022251905
NCI-H2228,10231331,2.0160637465796256
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292
KE-37,6852167,0.1803339767594556
NCI-H292,73707398,0.96137499748578
EHEB,73707398,0.3528380726382398
HOP-92,11455910,1.423553791437778
BT 239,241158,3.9563335392907097
M-07e,439501,-3.111960923766982
SF268,136227924,2.8034077121566967
HSC-2,439501,-2.499396675496898
Mino,10302451,2.7399249984312863
SNG-M,637858,1.5780139874200845
SNU-46,6852167,4.045709050144237
ChaGo-K-1,439501,-4.217436880778372
HCC15,9927531,3.758901572486559
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
SNU-423,10302451,3.566969310878258
A-549,9903786,1.8644448309659765
KP-4,12003241,-0.2003950722684058
COR-L105,439501,-1.395093001857319
ZR-75-30,136227924,3.5756469644058613
KNS-81,107970,3.224010672626954
HT115,9927531,5.770411786358663
MES-SA,12003241,-0.7503338761579216
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
HCC1419,262093,3.0653031319463624
B-CPAP,3689413,-2.370401360424748
VMRC-RCZ,107970,2.285336476499746
NCI-H716,9915743,1.329215193121519
HEC-1-A,156414,1.6058347893065534
CCF-STTG1,9936388,2.748356806633847
YD-15,10231331,1.0782876966297934
ESS-1,135875424,3.182582939188363
HT-1376,6852167,4.054024650572562
NCI-H1694,5460769,2.288070088951681
MCAS,135421197,1.955288267695935
SW48,5460769,-0.8804369809799648
Reh,9915743,0.535170068043037
KYSE-450,107970,3.4899067291718717
MOLM-6,11396600,2.3493263787787244
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
T84,11455910,1.5017947925367456
KP-2,44491742,3.9373322425213138
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
SNU-668,439501,-0.7901558289045547
CAL-148,4259181,-0.1870361959408835
CAL-78,11396600,3.713466274420595
OCI-Ly3,168313016,4.115265738534389
MSTO-211H,9903786,1.212702371904443
SK-N-SH,9915743,1.1616840064565594
SK-N-MC,100016,6.319948334432407
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
NCI-H1355,44491742,3.8267579721093905
SF539,444795,3.755252396278318
F-36P,107970,1.5167035192895906
SIG-M5,262093,1.2071251684519244
PE/CA-PJ34 (clone C12),241158,3.3825380068249276
HuH-28,10302451,3.3389802568514257
OCI-Ly3,6852167,1.562357091312624
RL95-2,135875424,3.9099028993279905
BT 422,644241,2.356538089518836
JJN-3,11455910,0.8680436077837121
VM-CUB-1,241158,3.308698579389838
DOV13,11396600,3.62542872436994
SNU-466,439501,-2.48566817429276
RPMI-8226,168313016,3.4366235502594007
HSC-2,375860,-0.5964846661669698
PE/CA-PJ41 (clone D2),9903786,4.971136415817363
TM-31,241158,3.6501345239800216
Panc 05.04,6852167,2.4950969519348685
LMSU,54596490,4.907866417372536
CAL-33,156414,0.5278665840065395
BICR 6,10231331,5.678935014467026
ZR-75-30,10302451,2.034029227265065
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
SK-N-MC,135875424,2.366794730604702
BT 498,262093,3.072055867790356
CA46,12003241,-2.799565618947511
SK-MEL-28,9936388,2.4934378473061902
CAL-33,439501,-2.9579708224622423
Reh,73707398,0.2688632485358125
NCI-H322,12003241,-0.9727084564838948
SNU-216,107970,2.273840953303944
Hs 611.T,136227331,5.417316134562269
OCI-Ly3,11455910,-0.0789783968306418
SNU-719,135421197,0.9792842920964928
A-549,9903786,1.8644448309659765
Hs 934.T,46907787,4.0299623363215975
SJSA-1,107970,2.367498196024735
KPL-1,4259181,1.2075981381395555
SJSA-1,9936388,-5.643627471351419
SCC-9,12003241,-1.125345709331217
WM88,9927531,4.19876481787408
L-540,10231331,4.825518632225075
ECC12,135999136,4.487232125219349
SNU-5,100016,6.769356825304223
U-87MG ATCC,262093,2.7764008714475317
VCaP,6852167,2.151866310697208
COV362,136227331,5.836047268415018
MKN74,9936388,-0.1480822399843773
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
CAL-85-1,3689413,-0.0998650254858705
ECC10,241158,1.496418149137826
HSC-4,10302451,2.384078053411002
HEC-59,136227924,4.443118393205084
SR,168313016,4.7863861467417514
WM1799,135875424,3.6898811613748874
HCC2279,26596,-1.3902688555824585
NCI-H2085,241158,1.210910612126421
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
BICR 31,9936388,2.7244047649519074
RMG-I,11396600,4.055852766131107
EJM,637858,1.0127573104049012
NCI-H1944,100016,8.062523558454052
NCI-H1734,327653,2.957290702730057
HCC38,26596,-1.4255018531390269
RL,44491742,3.724190928980732
ME-1 [Human leukemia],9936388,1.383892450807597
JHOS-2,439501,-1.7810659698963345
KG-1-C,136227924,2.6958486075351944
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
LOX-IMVI,24180719,3.2847178771546486
KG-1-C,12003241,-2.4512871070373476
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335
8505C,11455910,-0.1403664208341097
SEM,73707398,-1.1402705015945305
FTC-133,54626689,4.834884112239084
SYO-1,241158,4.09537808941347
HSC-2,12003241,-2.7433654243875214
BT 416,9915743,-0.2022944112216887
NCI-H2286,327653,1.7676593790329698
COV362,9915743,1.8157277713688496
NCI-H28,262093,2.707398146289125
KYSE-410,BRD-K27188169-navitoclax (2-1 mol-mol),3.7266510041041463
IGROV-1,73707398,0.8848064516600974
BT-549,49766530,-1.005486623843658
JHH-2,135875424,3.057763367956565
SNU-1041,4259181,1.3907235712067347
Rh41,12003241,-2.564539347057637
NCI-H1703,71466445,5.673513655932656
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513
CML-T1,100016,5.302267949835527
LoVo,327653,2.9108064375514604
U-87MG ATCC,9936388,3.5467326028454087
KMS-18,9927531,3.9141727382936624
NU-DUL-1,262093,1.0561136959498525
YH-13,168313016,4.37029301578321
SK-N-DZ,9927531,3.3336857807362392
HMCB,9936388,-4.997946026418023
RPMI-8226,3689413,-0.772061371238599
NCI-H460,135421197,3.2510260026522233
TE-8,3689413,-1.695063922582594
KATO III,11455910,0.859891525831657
MDA-MB-453,6852167,1.219966928776707
CAL-29,9915743,0.4542192657776882
JMSU-1,327653,2.859834874070776
EBC-1,262093,3.282088123658991
SNU-5,26596,-1.206984929364511
NCI-H1869,135875424,4.489996634847175
NCI-H508,156414,-1.5494173849361004
BT-12,9936388,1.0683866861493725
RT-112,375860,-0.4271930456025025
MKN1,46907787,2.3395662903789236
SNU-503,12003241,-0.772187364196845
HuNS1,12003241,-0.810335190638815
BHT-101,44489367,4.393707737329174
KYSE-140,46907787,2.8487460555393453
HSC-3,135421197,2.8710443540281756
Daudi,136227331,3.813653547789358
SNU-761,49766530,-1.6667197408090684
TE-9,135875424,3.7718205892374943
L-1236,49766530,-2.927530009447525
HEC-151,135875424,3.433906350348657
Hep-G2,439501,-0.8010222698535624
NCI-H1105,439501,-2.509690538840725
GMS-10,637858,1.9088173452974475
NALM-6,6852167,-0.0864064217105925
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
SNG-M,5460769,2.9987935080013695
SNU-216,135875424,3.0610068784934885
NCI-H1155,637858,1.7173682170201705
B-CPAP,24180719,2.0507449605485033
SNU-81,327653,3.5323829695882267
NOMO-1,375860,-0.5184264862355304
Hs 578T,136227924,2.600789152961688
CAL-27,6852167,2.441121376612338
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
WM266-4,444795,4.484213962316863
ALL-SIL,168313016,2.945013463521221
23132/87,3689413,0.7778055116853778
GCT,9903786,3.1531512143319396
SNU-81,4259181,-0.3131255720640173
HuP-T3,73707398,1.153693297692098
NCI-H1155,54626689,3.1603722808922248
NCI-H1734,6852167,1.6616243857794395
SNU-601,375860,0.0670595962305998
NCI-H508,4259181,-0.090379313964127
DV-90,135875424,3.100724148145735
G-401,46907787,-0.0293884143124787
Panc 03.27,375860,-0.1725632287380341
KYSE-150,11455910,1.1327678102936536
NCI-H1793,UNC0638-navitoclax (1-1 mol-mol),-2.4732230487504148
Kasumi-1,9936388,-5.775038458721337
WM266-4,644241,2.4444791610838275
ACHN,3689413,-2.388175172833965
NCI-H650,71466445,5.7475497080688065
U-937,10302451,3.755425141733516
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
KYM-1,156414,1.5083149541884115
LoVo,11455910,2.8170443999319574
RPMI-8402,24180719,3.632264594083036
YD-8,107970,2.31722941739338
TE-5,54626689,4.519810715029284
COLO 205,3689413,0.2425510566398385
COV362,UNC0638-navitoclax (1-1 mol-mol),1.9538248312330373
NCI-H1155,262093,2.304592796713043
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
KU-19-19,9936388,2.972521935644637
RERF-LC-A1,241158,3.4003643660710714
LOU-NH91,46907787,1.567116016960845
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544
MDA-MB-361,262093,2.430209495289511
CAL-12T,10302451,-0.1514723125226502
SNU-449,262093,3.0394524195162766
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
NCI-H2081,637858,0.9384843122739523
CJM [Human melanoma],135875424,3.3018695486578573
F-36P,73707398,-0.2227517759229556
Ishikawa (Heraklio) 02 ER-,439501,-2.4484029207577347
NCI-H2087,136227331,3.603331893484652
RPMI-8226,327653,2.456845163980657
SNU-1079,5460769,0.9743779178913314
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457
BT 482,136227924,3.374884803280594
L3.3,3689413,1.7908878640591075
NCI-N87,9903786,2.403456427338335
EFE-184,9936388,2.4089760191608462
CAL-78,46907787,1.7338019226215953
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
NCI-H508,327653,3.0934975234849604
F-36P,439501,-3.1981830153040223
COLO 668,selumetinib-JQ-1 (4-1 mol-mol),2.177290778736977
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
DU4475,375860,-0.8639753216901359
BT-549,135421197,3.4062158650675265
GB-1,327653,3.144088026604962
PE/CA-PJ41 (clone D2),54626689,4.875473167492311
CAL-148,439501,-2.3789265547219647
NCI-H661,24180719,3.917772031076744
MOTN-1,327653,2.846795073413381
JL-1,9936388,-5.012158882257613
Hs 683,107970,1.9317129294379751
LOX-IMVI,439501,-2.207275092585139
MPP 89,11396600,3.423222859590498
Ku812,46907787,-1.7178287271779615
COLO 699,241158,2.9243499322437554
NCI-H1339,107970,3.0174891180051793
SUP-T11,9903786,1.3476542683573176
NH-6,49766530,-1.655296315308959
SU-DHL-8,156414,0.996109901273004
COR-L95,135999136,4.28146486500778
HEL,5460769,3.63888115942649
KPL-1,262093,3.0634356984830298
Mono-Mac-1,9915743,-1.5760754079944657
NCI-H1341,637858,0.954868585664575
SNU-216,637858,1.4153180245301518
BT-474,44491742,4.780448859314668
2004,11396600,3.4880760696639417
SNU-738,73707398,1.1799424413831334
EKVX,11396600,3.2965982260380136
SNU-308,73707398,3.5686803185694327
SNU-119,selumetinib-JQ-1 (4-1 mol-mol),2.003564395289463
MHH-ES-1,5460769,-1.13601039501847
KMS-20,135421197,1.5361253797366796
LK-2,637858,2.9167931054594267
SCaBER,241158,3.991461020169345
NCI-H929,156414,0.5091151756924145
OVISE,54626689,4.712933516379989
SNU-C4,375860,0.622805119835088
OCI-Ly19,71466445,3.5959031231902663
ST486,71466445,2.0454820833353704
DMS 53,100016,7.1608088069035185
SW579,5460769,2.5889118142562197
NCI-H2170,54626689,4.747451158465502
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
HLF,26596,-1.3271956114296155
DU145,3689413,-1.3535401671184424
SK-CO-1,439501,-2.410857533331093
SNU-C4,6852167,3.429186893177276
SU-DHL-1,24180719,4.350105317542874
MHH-CALL-3,54626689,4.965848774112381
SK-MEL-31,241158,3.7616709028064417
KMS-20,135875424,2.456374257858295
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
EFM-192A,136227924,3.313769329286525
SW1271,135875424,3.8663800475620542
PF-382,44489367,4.604182803409816
HuNS1,327653,2.9841027206252693
JHUEM-2,3689413,-0.0908621852790934
CHP-212,135875424,3.192345870347938
Daudi,54626689,2.8292455243221264
SNU-1214,136227924,2.9720785133706213
NU-DHL-1,156414,1.5243299906287209
MSTO-211H,10302451,2.2723798321327826
NCI-H1944,9903786,2.6495499411680785
SNU-C5,6852167,1.7928485717828972
COLO 320,26596,0.3070863795461868
HL-60,136227924,2.3594265520512447
ONCO-DG-1,6852167,2.562401229910015
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854
NCI-H1092,135999136,1.996402787689235
NCI-H1666,10302451,1.573104539002299
KCL-22,10231331,1.7661201425853783
CAL-51,135999136,4.2132345103647015
Calu-6,135398744,6.4194279820254465
EB1,12003241,-4.025525342770554
AN3-CA,9903786,1.5268103297033566
SUP-HD1,54626689,4.441463621812412
VMRC-LCD,135421197,1.103585656826272
KHM-1B,3689413,-2.4012228391908783
NCI-H1339,135421197,3.8934160378835054
ChaGo-K-1,9927531,4.39504142130407
LCLC-103H,135875424,4.227127244707997
YH-13,12003241,-0.7443010060517422
SH-10-TC,262093,3.640204599057082
Raji,9915743,1.7375595717981451
A2780,136227924,2.141563547945887
CAL-85-1,136227331,4.603192424436066
BT 179,637858,3.293610867259511
NCI-H2342,444795,5.031719559259329
RPMI-8226,136227924,2.992898649350054
JM-1,6852167,1.3157742507093588
KYSE-30,327653,3.5492828171510937
TT,9936388,-5.089054710470253
BEN,46907787,0.3993513147154109
RERF-LC-A1,12003241,-0.839480669213789
CAL-33,UNC0638-navitoclax (1-1 mol-mol),2.6190479668064284
P31/FUJ,637858,0.7903103947120294
Hs 578Bst,49766530,-2.7319147514875124
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
HuH-6,444795,4.76302166283974
NCI-H1355,54626689,3.825879941509089
SNU-308,44489367,4.856356872192214
WM88,6852167,1.647257119536929
YD-15,selumetinib-JQ-1 (4-1 mol-mol),1.1872540503704618
RVH-421,136227331,4.595276173623148
SUP-T11,375860,-0.2294135177837117
MKN7,439501,-1.6768390868463443
DMS 273,9936388,3.4086707637717883
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
SH-4,73707398,0.8791045664416594
A-549,9929138,6.139762216307962
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
KE-39,54596490,4.684539429557116
SET-2,156414,0.9354500438685124
LMSU,3689413,-0.2257013593388283
BT 440,44491742,6.048012757107985
HuT 78,11455910,0.0216709312460527
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
BT 112,6852167,2.8502822773493315
RT-112,73707398,0.8744160779523937
BT 112,11455910,0.2027348347828513
BT 271,10231331,3.9566622670383857
ECC12,637858,2.8438650239378793
BT 231,11455910,0.2900866749520439
RERF-LC-Ad1,6852167,4.2610431072057695
Yamato-SS,3689413,-0.7026666605397593
IGR-37,26596,-1.7212662992488197
KYSE-410,26596,0.1189340940832646
Capan-2,107970,2.6741892032296875
KHM-1B,135999136,4.388497598108013
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
PL-21,selumetinib-JQ-1 (4-1 mol-mol),-2.2255955274462287
SK-HEP-1,12003241,-1.7510835313415607
NCI-H1339,44491742,4.759108525431012
IA-LM,135421197,2.370501142960713
NCI-H838,54626689,4.884728791402936
SNU-1033,637858,1.4383513056323138
OCI-Ly3,44491742,3.926689861618192
NCI-H841,UNC0638-navitoclax (1-1 mol-mol),4.479330950981198
Ishikawa (Heraklio) 02 ER-,3689413,0.6231985481364082
BT 145,9915743,0.579862863836084
CHP-126,262093,1.44556631123722
PF-382,6852167,1.6136489506938916
TE-5,644241,2.2121287177414444
NCI-H747,49766530,-2.525329800647816
SNU-216,327653,3.2539044842694183
697,71466445,1.5576237887375004
SK-MEL-3,5460769,5.404359476176559
OCI-AML-3,UNC0638-navitoclax (1-1 mol-mol),2.252668799817522
KNS-60,10231331,6.3329537184020674
NCI-H2029,54626689,4.578538057166338
HPB-ALL,375860,-0.4401336485417012
A4/Fukuda,46907787,-1.6446005772830188
RD,168313016,5.51438068712699
SNU-886,BRD-K27188169-navitoclax (2-1 mol-mol),-4.5731831283745095
WM88,241158,3.766898171789964
DoHH2,10302451,0.9453834851119745
HCC38,10302451,4.063640338050707
Ki-JK,71466445,2.2114493223689693
HCC2279,262093,2.5944321390006397
PaTu 8988t,135875424,4.8815767191826325
ONCO-DG-1,73707398,0.7313986398814263
Jurkat,100016,5.920987823967134
D283 Med,24180719,4.216892125950757
BT 416,73707398,1.2000065788427186
SUP-M2,selumetinib-JQ-1 (4-1 mol-mol),2.7498429004871765
A101D,107970,1.67763505646941
BT 504,73707398,1.4743566299164823
Tm87-16,439501,-3.529895077478111
Hs 729.T,selumetinib-JQ-1 (4-1 mol-mol),4.302811475713859
HCT 15,12003241,-0.9489590343068364
BT 333,136227331,5.5959520749391904
MG-63,327653,2.9545446221362797
Hep 3B2.1-7,9936388,1.3594944323688356
HCC2279,73707398,1.2685600547710263
KP-N-SI9s,46907787,0.1114546179566314
ONCO-DG-1,156414,1.1948780858404957
NCI-H841,135421197,2.4797318977451095
YKG-1,49766530,1.555111020821771
GOS-3,3689413,-2.185831490776692
DMS 53,26596,-0.0361883728556599
SUP-M2,9903786,1.0371489832457852
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
THP-1,71466445,1.634612281146758
EB1,54626689,2.4548321666727255
KU-19-19,135421197,1.2163789616721166
KHM-1B,107970,1.817903354032074
JHH-5,262093,2.961551350403051
JURL-MK1,327653,3.1753414176725374
NCI-H841,637858,1.860990633229084
SK-MEL-3,6852167,3.696781944889267
Ri-1,9903786,-0.2937603570790111
NCI-H292,12003241,-1.027467238096921
NCI-H2052,73707398,1.348162665971746
UM-UC-1,3689413,0.3078714826369425
COLO 699,107970,2.4218490435577613
OVK18,135999136,1.6002328779201676
Sq-1,44491742,3.879734584111586
DU145,637858,2.575359401469111
NALM-6,UNC0638-navitoclax (1-1 mol-mol),-0.3986406964147952
SK-N-AS,10231331,-1.1839301737612744
HPAC,10302451,3.6769046300144543
KYSE-180,44491742,6.4799420322622305
TE-5,UNC0638-navitoclax (1-1 mol-mol),2.6531859620297373
LNCaP clone FGC,107970,2.7706506032666067
COLO 699,4259181,0.3245175779144991
KMH-2,107970,2.222246268833958
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
SF295,3689413,-1.7224429364651286
DMS 53,241158,3.9946484898477936
UACC-62,135999136,5.678520185449006
BHY,12003241,-1.9102935005607824
U-BLC1,46907787,2.215172875838617
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
NCI-H661,444795,4.831383676329662
NCI-H647,136227924,2.9483035397305164
IMR-32,UNC0638-navitoclax (1-1 mol-mol),-0.289591590901736
SiMa,12003241,-0.7003588791224504
G-401,136227924,2.3105932180874365
A-549,12003241,-1.903076073453771
DEL,12003241,1.2715450206031036
BT 504,11396600,2.364157912442885
IM95,135999136,4.354179315277477
HD-MY-Z,10302451,3.8671846767021663
HT-1197,107970,2.1985623382097574
EoL-1,135999136,4.026118373456707
PSN1,6852167,6.331825232579055
Daoy,11455910,0.1226016368388986
HCC1954,4259181,-0.064962892952742
BT 187,11455910,1.1160186893710065
HEL,10302451,3.814274659252608
RL,5460769,2.816259716284544
HCC1143,107970,2.31840177997234
SHP-77,9936388,-4.866558294975543
KMS-12-BM,12003241,-2.27657533610394
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108
JeKo-1,9915743,1.243422351043917
MM1.S,637858,1.1030416488426389
CCF-STTG1,49766530,2.4939305222304955
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
NCI-H1395,9903786,3.8864807174358984
U-118MG,26596,0.614033451908362
NCI-H929,439501,-2.3111413664478513
HCC827,637858,1.7740818571247208
SUIT-2,439501,0.993663636668041
RVH-421,26596,1.0810327973270226
JK-1,3689413,-0.5403816328590246
KU-19-19,136227924,3.1447471190609217
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
KMBC-2,9927531,4.40438479738659
Aska-SS,49766530,-1.4586728518943333
LOX-IMVI,11455910,0.9161498134653596
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
Granta-519,12003241,-2.1147517064841925
T24,327653,3.499336447271142
REC-1,12003241,3.6312404592907614
TE-15,26596,-3.7197158754991615
LP-1,135999136,4.095278648632366
UACC-62,3689413,0.3229546491467058
NCI-H526,135875424,3.753853230919886
PK-45H,241158,4.308454696287406
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
Ci-1,241158,4.072543777825025
OV56,5460769,1.208348663787762
BT 422,262093,2.50169329189886
YAPC,10302451,3.503177254309001
PE/CA-PJ49,11455910,0.6367427486190916
DBTRG-05MG,637858,2.5619452660939146
2004,24180719,3.219492188337677
JHH-1,135875424,4.689279573138962
SCC-9,9927531,5.254709651648818
T3M-10,9927531,5.241044178261577
VM-CUB-1,26596,-2.0768458829121745
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
CJM [Human melanoma],12003241,-0.9609981142913676
786-O,9915743,1.0501009752042196
COR-L51,135999136,4.175528591862206
TT2609-C02,637858,3.064237161486694
SK-MEL-3,135875424,4.254537076795971
VMRC-LCD,168313016,5.458908786396005
ACC-MESO-1,5460769,5.633127442709169
PE/CA-PJ34 (clone C12),375860,-0.361568415532625
KYSE-510,5460769,1.9314900427321815
MIA PaCa-2,9927531,4.662028210048159
CL-11,135421197,1.4144894380219903
Ki-JK,11455910,1.8601225007707891
JHUEM-1,54626689,4.448202323630063
GB-1,46907787,3.428923818572933
TM-31,107970,2.6979475281372944
BT 239,9936388,1.03619999927196
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272
IGROV-1,375860,0.7731558163124775
DK-MG,10231331,4.3753601984660175
NCI-H460,262093,3.3627537421549314
NCI-H1385,444795,4.446664518945096
HuP-T3,439501,-2.469428626730465
NCI-H1915,11396600,3.355120861633073
JHOM-1,107970,2.565801555569848
SU-DHL-8,241158,1.5578201018770153
SNU-387,selumetinib-JQ-1 (4-1 mol-mol),0.6613396146104882
8-MG-BA,4259181,1.4277626204907208
NCI-H929,24180719,3.664799403319753
EC-GI-10,49766530,1.479780900637965
Hs 688(A).T,49766530,-1.7217170265307382
BHY,73707398,1.0886291662008367
SIG-M5,168313016,4.915391806280637
JM-1,156414,0.9517000986854224
IGROV-1,11396600,3.99372654279783
EPLC-272H,262093,2.6585734964122576
SUP-HD1,46907787,0.5577023982990558
HCC15,107970,2.678547076190946
TF-1,107970,2.495705780879279
NALM-6,4259181,-0.6591478009838272
Ku812,375860,-0.7042833930454624
KYSE-70,375860,-0.042936769343065
Daoy,5460769,2.932419907525853
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367
SEM,136227924,1.2424830449991908
RKO,9936388,0.8183869926163714
BT-12,241158,4.014999342891219
HCC1833,241158,3.043564904971582
BL-70,262093,2.9607019791616387
KYSE-150,selumetinib-JQ-1 (4-1 mol-mol),3.5614174256580187
BT 172,644241,2.6400684779055448
NCI-H2085,BRD-K27188169-navitoclax (2-1 mol-mol),-1.203146083937266
Hs 888.T,444795,4.182213673682921
MHH-CALL-4,444795,3.2572985338765084
BT-12,5460769,4.230264663253868
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172
PE/CA-PJ49,168313016,4.508662039314565
RCH-ACV,44491742,3.725167954137364
LS411N,9936388,1.997277136132151
PE/CA-PJ49,375860,-0.7510752719204733
RL95-2,4259181,-1.9396193877623535
LCLC-97TM1,26596,-2.266692800551727
K029AX,100016,6.8355789955685395
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
NCI-H1666,9915743,-2.9000343533744353
SIG-M5,11396600,3.2448183238044255
MM1.S,444795,4.170246109552412
Mel JuSo,135875424,3.5685872974877824
MOLM-13,100016,3.967621300341963
BT 147,135398744,6.518001641470466
BT 320,136227331,4.5584663350036605
Caov-3,44491742,6.286074544034756
Karpas-422,73707398,0.5334637120665475
Hs 729.T,44491742,3.716267531008215
NCI-H1092,11455910,0.2647471022018075
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
WM88,135421197,2.6537583925781054
TCCSUP,135875424,4.238752084680578
L-428,12003241,-0.2572573546541544
Hs 578T,54626689,5.20383473755861
K029AX,12003241,-1.6892437749493532
DAN-G,439501,-2.2705852872142236
Rh41,168313016,3.825560105528655
SNU-840,241158,4.028396774971829
MDA-MB-468,262093,2.5828402827919064
BHY,262093,3.4081401003096548
MKN45,selumetinib-JQ-1 (4-1 mol-mol),3.727544641794376
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
SiMa,168313016,4.596851957301641
KYSE-180,5460769,3.044274290576871
Hs 294T,135999136,4.295347676577794
SK-MEL-24,46907787,2.494372049313226
SW1710,135398744,7.400823424142947
HEC-6,11396600,6.108645448487235
Malme-3M,10231331,-2.99024616185617
HCC1500,3689413,-1.6712109221216571
SK-MEL-3,327653,3.685418998479267
RVH-421,375860,-0.3081604542512128
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
HD-MY-Z,71466445,5.190152829485737
Peer,10302451,1.388599660248698
Panc 08.13,107970,2.2427902977668883
JJN-3,9903786,1.1978093816271655
MG-63,4259181,1.2675663544534232
CW-2,73707398,1.0711790511285473
NCI-H1299,637858,2.0159595809429716
AML-193,4259181,-0.4145932893303466
TE-4,439501,-1.5576935303532289
GDM-1,12003241,-2.0828988572069487
KMH-2,327653,2.6435192789338724
NCI-H889,637858,1.600777353937621
HCC78,4259181,1.2441508772484942
ONCO-DG-1,135999136,1.5915820066692796
Mino,71466445,1.235748115046604
OE21,54626689,4.586584726224223
JM-1,168313016,3.8541200519849017
HuG1-N,135999136,4.33659793669441
SU-DHL-8,135875424,3.290196738895973
COLO 678,4259181,1.135854109347033
OCI-M1,327653,3.224112962070562
NCI-H358,9927531,4.779825407302033
NCI-H520,11396600,3.7776798770198594
BT 504,11455910,0.316004589079872
JURL-MK1,9903786,1.1530539492536125
U266B1,168313016,4.103374457520469
G-401,11396600,3.403558125152034
JURL-MK1,24180719,2.548614204521089
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
HD-MY-Z,107970,2.364477587314304
HCC2108,10231331,3.026437227257123
Mel Ho,46907787,1.2131777756516886
RERF-LC-A1,3689413,-2.1513750225162114
SNU-601,5460769,-0.8674559843471038
SK-OV-3,6852167,3.0870556066687076
HMC-1-8,107970,2.4556526925315754
DEL,136227924,2.1995562608544494
EPLC-272H,3689413,0.721701872436853
HCC1438,327653,3.873621877618888
Hs 729.T,9903786,3.958862053564968
NCI-H1793,9927531,3.368036257397712
TE 441.T,262093,1.5238346929960052
HuT 78,9915743,-0.3205464670121912
MDA-MB-157,136227924,3.402219650297347
G-292 clone A141B1,26596,-0.9634124714344006
OCI-Ly3,100016,3.877117461004623
SF268,5460769,2.7900829317628157
NUGC-4,9936388,-5.886331938622264
SCC-25,135875424,4.102070818018105
SHP-77,11455910,0.1077676986814373
NCI-H1573,9927531,4.21902889327973
WM983B,9927531,5.417064832255327
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
DMS 454,241158,4.171276603162088
TE-1,10302451,2.6320165218762392
NCI-H1563,9927531,5.123884061924823
TE-15,637858,1.9944393508197875
SU-DHL-1,6852167,2.266746993939426
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075
COR-L51,327653,2.7444851925182325
TE 617.T,156414,-2.5018662250676713
TF-1,9915743,0.9371893849348516
ME-1 [Human leukemia],49766530,-2.233463718889399
786-O,selumetinib-JQ-1 (4-1 mol-mol),3.8790698958118006
Yamato-SS,selumetinib-JQ-1 (4-1 mol-mol),-0.2712104381425136
SNU-423,44491742,3.863177146863686
MFE-296,73707398,0.7695687331901435
NCI-H2009,637858,2.463099291034241
Hs 936.T,439501,-0.3006494435216346
NMC-G1,12003241,-0.7597442114064075
Kelly,49766530,-2.0439406855810356
ECC12,439501,0.4068206161036775
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286
BT 416,UNC0638-navitoclax (1-1 mol-mol),-0.0804251161714488
HDQ-P1,9936388,2.1962114210589134
DV-90,644241,1.9963801342029477
LAMA-84,439501,-2.4301107765097525
TE-1,4259181,0.5927596894747944
MOLP-2,12003241,0.9753237716846912
HeLa,6852167,3.9174873228525353
SET-2,selumetinib-JQ-1 (4-1 mol-mol),-0.4291738156644369
WT2-iPS,135421197,2.4533231744799235
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
Calu-3,9929138,6.17100330774615
TUHR14TKB,241158,1.8223582935360012
JeKo-1,73707398,1.0235026447845044
SNU-C5,262093,2.527934317013551
2004,439501,-3.526370090236184
Hs 895.T,136227331,4.438273380824898
SaOS-2,135875424,3.0421388786055727
SW1990,12003241,-1.6004272332343192
D283 Med,9915743,1.368920834577302
TE-9,10302451,6.106147723455812
SNU-182,439501,-3.0072363734756173
Karpas-422,4259181,-1.4276330915263615
P12-Ichikawa,9915743,0.5856133039095079
NCI-H747,46907787,-0.3397749461210398
AML-193,9927531,3.384669993922374
A-253,637858,1.2237702609484895
AM-38,375860,-0.397083991918632
MPP 89,135999136,4.342754015046465
SU-DHL-10,9936388,-7.075176092444515
BT 145,156414,-1.6257906195039402
BT 131,107970,1.8330733391254264
HEL,9936388,-3.337900467930123
OS-RC-2,327653,3.437190963071175
U-937,439501,-2.545607636797326
COLO 678,UNC0638-navitoclax (1-1 mol-mol),1.3905260558490362
NCI-H1341,5460769,4.302850791572325
NCI-H1435,46907787,2.0566854807716317
Caki-2,10302451,2.957054551307016
LAMA-84,262093,2.21531989487936
KCL-22,5460769,3.17116063608923
BT 340,135421197,2.5749512763200824
NCI-H810,100016,4.22640705156995
SF268,10302451,2.8525130095274895
PaTu 8988s,135875424,4.807406911194583
IM95,100016,6.474511795509729
KYSE-450,136227924,3.5350495950730645
BT 231,26596,-1.8186756145502985
NCI-H650,439501,-2.431498086573591
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
NCI-H69,71466445,3.7482174156628263
FTC-238,9927531,3.762159625160711
PK-45H,637858,3.525714653404077
L-428,135999136,4.19516718985733
EFO-27,327653,2.4330037956805133
NCI-H1703,26596,-2.7803694480879857
TT2609-C02,3689413,0.4383684388125656
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
NCI-H2122,135875424,3.891671536757885
SH-4,selumetinib-JQ-1 (4-1 mol-mol),-0.5199709312425982
MG-63,24180719,4.195294954911166
BICR 31,49766530,2.6564815829329236
SNU-869,9936388,1.2557424623780096
Caov-3,135398744,6.775001868991772
EJM,135999136,1.6782155584907743
HCC1833,9927531,4.651328537031639
SU-DHL-10,selumetinib-JQ-1 (4-1 mol-mol),0.722399176579171
MIA PaCa-2,4259181,-0.2210176227464965
22Rv1,9929138,6.22160850617875
SK-N-SH,327653,2.3985684531965887
UO-31,135875424,2.695151327670827
DU145,9915743,3.139044524773344
LUDLU-1,11396600,3.511011158799078
TTC-709,439501,-6.296451607950602
EN,46907787,5.476162929897771
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
BT 422,637858,1.6662329367795623
OV56,73707398,1.090209453559451
HuP-T3,241158,3.8412641522091144
HMCB,327653,2.816846205013027
EoL-1,UNC0638-navitoclax (1-1 mol-mol),-2.9986936858021616
MIA PaCa-2,11396600,3.289038329533777
WSU-DLCL2,73707398,0.2530088858784944
MKN1,9936388,1.1004986908741188
M-07e,107970,1.522491308202342
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
NCI-H889,241158,3.896556371812661
COR-L105,100016,7.1590039780101895
PE/CA-PJ49,107970,2.309472784516984
Mono-Mac-1,135999136,5.618936483472871
SiMa,selumetinib-JQ-1 (4-1 mol-mol),0.2044088203598688
DU4475,49766530,1.1450328858367227
Hs 944.T,135421197,1.7444427011785306
AGS,6852167,3.2110227906181876
Granta-519,10302451,3.667767303482806
KE-39,107970,2.31854003043047
RCC10RGB,439501,-2.548266242367821
PK-1,168313016,5.489792964329215
BT 340,3689413,0.410444406671797
NCI-H2106,136227924,2.8262070038466955
CFPAC-1,100016,6.545938487461667
WM1799,24180719,0.7523091242571477
LOU-NH91,9903786,3.184012464559237
SNU-C1,12003241,0.2452706417287593
Namalwa,11455910,-0.4529585092669797
GB-1,107970,2.4736997234599234
COLO 684,54596490,4.5333934619605
SNU-738,10302451,4.376715699203647
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525
SHP-77,637858,1.6869536628628743
ONS-76,46907787,2.0367347893242247
MES-SA,3689413,1.9720850460136523
LNCaP clone FGC,11455910,0.1396389722474823
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
M-07e,46907787,-1.2673876445941157
NCI-H747,644241,2.028132169133259
TE-1,135421197,1.2529610572902146
EB1,11455910,-1.5299168268702652
SCC-4,9903786,2.916722616299938
IPC-298,241158,3.61817079796593
RERF-LC-A1,selumetinib-JQ-1 (4-1 mol-mol),1.0639220525759086
Panc 05.04,3689413,-0.0862100916213441
JHUEM-7,135421197,2.2083604774336973
HCC1195,9927531,5.131359962593503
KNS-42,9927531,5.582016236081196
IGR-37,241158,3.741796107382708
RERF-LC-Ad1,4259181,1.1969151495318886
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
WM266-4,selumetinib-JQ-1 (4-1 mol-mol),-0.7959266829016844
SNU-886,107970,2.7037771874608034
SHP-77,9903786,4.085318424686739
NCI-H508,46907787,0.2508579246977522
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968
Hs 578Bst,9927531,5.122326242765859
EFO-27,44491742,4.311239061696844
TC-71,241158,3.671280815212322
MOR/CPR,6852167,3.3580650919838537
KYSE-30,136227924,3.298083829392356
WT2-iPS,241158,3.6908045312751145
BICR 56,9903786,4.170821075739504
RL95-2,439501,-2.2732011177914586
NCI-H2291,73707398,1.387885298831554
HD-MY-Z,375860,-0.2550299270549113
MOLP-8,262093,0.615798330418347
MIA PaCa-2,100016,4.223400842588871
MOLM-6,4259181,-0.6414386252476381
F-36P,11396600,3.0952958144122724
JHUEM-2,26596,-3.440401418336309
TUHR14TKB,135421197,2.206090635498825
SK-MEL-2,selumetinib-JQ-1 (4-1 mol-mol),0.1209546449517723
NCI-H716,262093,3.1268134242095735
KE-97,135875424,3.346245315555186
HuG1-N,9903786,2.6577848330965
SK-MEL-24,10302451,3.694685850061357
IPC-298,54626689,6.3444657659191135
NCI-H1666,selumetinib-JQ-1 (4-1 mol-mol),-3.72613020395203
KM12,327653,3.395524528646188
L-363,135875424,3.938515519737711
ACC-MESO-1,439501,-2.1177142805540163
A-172,54626689,5.349866002062792
EM-2,49766530,-1.2569750425961423
BT 231,6852167,2.464272024157972
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
SNU-C2A,262093,2.4515351463373807
HCT 15,4259181,-1.3945666977280595
Hep 3B2.1-7,9903786,2.792162090587101
CAL-12T,selumetinib-JQ-1 (4-1 mol-mol),6.071710843361034
U-BLC1,44491742,3.768443657215341
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
HT-144,637858,2.176874063733469
U266B1,5460769,3.751565438771286
OPM-2,100016,3.804278037815123
NCI-H716,10231331,0.9999723434962392
TE-15,71466445,3.5922640502663077
CCF-STTG1,107970,2.063603625316133
42-MG-BA,selumetinib-JQ-1 (4-1 mol-mol),2.1771764634536734
OVCAR-4,444795,5.182703743158894
NCI-H1734,9915743,-1.4157060227107183
SNU-489,49766530,0.3539258431489716
786-O,135421197,1.9891121265690648
NUGC-4,9903786,1.3800210436357438
SNB-75,4259181,0.0553890152572084
EJM,46907787,1.3360205419537388
NU-DHL-1,49766530,-4.7275009055236445
HT-1080,11396600,2.8023964018444176
AGS,3689413,2.90749290772993
MDA-MB-453,100016,6.0730906594859215
SUP-HD1,135421197,1.0608859931865553
HCC2218,49766530,-1.6679502221604972
OC 314,54626689,3.740918476901323
K-562,241158,3.183928650435804
YD-8,644241,2.56753139102049
MOTN-1,49766530,-1.5651845787849432
HSC-2,135999136,5.308021141561782
Calu-6,637858,1.7699148310431834
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
RPMI-6666,9903786,1.3063050389166864
SNU-1076,44489367,5.145215994281993
NB4,11396600,3.2499354212792646
Mino,262093,1.013010854269816
CCF-STTG1,135999136,5.41297640167708
SHP-77,6852167,3.706975834295729
GCT,71466445,3.865548826740254
SNU-1196,439501,-2.3352671282254303
MOLT-13,26596,-2.4111257577546565
SCC-9,54596490,5.620994411748341
Hs 578T,439501,-3.2814601954597915
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912
NCI-H520,3689413,0.9100551461140616
CGTH-W-1,135875424,4.831147205394264
JJN-3,46907787,-1.5063119607662292
SK-N-AS,12003241,-1.4595382352216486
FTC-238,73707398,0.967863994452516
EPLC-272H,6852167,1.3585565195030245
BT 131,selumetinib-JQ-1 (4-1 mol-mol),2.4613713362199485
Karpas-299,135421197,1.2662606482255232
T24,54596490,5.93576817753399
BICR 56,156414,-1.5673977335728184
JVM-2,9936388,-5.513780712750178
NCI-H1651,9929138,6.746067047112118
NCI-H2023,11396600,4.497397906995783
HCC1806,9903786,3.5202039340354636
A3/Kawakami,241158,1.613723809197875
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
NCI-H1734,135999136,1.9826030882500632
SNU-449,9936388,0.4589950900054629
BICR 31,135875424,5.0736941678127945
COLO 829,selumetinib-JQ-1 (4-1 mol-mol),-0.4824383970487524
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108
TE-11,5460769,-1.6571855134906777
DMS 53,11396600,2.5093833662364107
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
NCI-H2087,24180719,3.2246777209202553
Rh41,3689413,-2.4330549607978984
MM1.S,241158,2.058054746242757
NCI-H522,71466445,4.480637973076106
Hs 766T,selumetinib-JQ-1 (4-1 mol-mol),-1.1904189535424952
OCUM-1,439501,-1.255627556410841
AML-193,644241,1.8416137938925805
JeKo-1,107970,1.751754163116744
SU-DHL-6,10302451,3.370117636140473
KM12,9903786,1.2751766913602836
BT 340,11396600,2.9184379115774375
Panc 10.05,135999136,4.645706759436588
Panc 04.03,49766530,1.2448845141630578
NCI-H1694,9915743,-0.097259817128113
ECC10,9929138,5.792605196564901
L-428,637858,0.9506850141037074
Daoy,54626689,4.380318300965366
SK-MEL-28,11455910,1.7343524639503471
SK-MEL-1,135421197,3.405543423729856
JHUEM-3,327653,4.2565613639882525
HuT 78,375860,-0.3004561584408421
LMSU,9936388,2.8786407463456656
SNU-1066,9936388,2.256482479661346
CAL-78,UNC0638-navitoclax (1-1 mol-mol),-0.0060343846048504
Kasumi-2,439501,-3.441659601561783
HCC1500,11455910,0.2448151005088887
Toledo,24180719,3.70402815117446
MOLM-13,9936388,-7.059788369591511
TUHR14TKB,73707398,1.0008501890108177
MG-63,135875424,4.139194892831929
SK-UT-1,54626689,4.825189757508342
NCI-H747,44491742,4.012258870504445
KYSE-520,135398744,6.453499706252085
SIG-M5,444795,-5.244515717974557
MHH-CALL-4,375860,-0.3474081343117626
MOLT-3,UNC0638-navitoclax (1-1 mol-mol),-1.1342008169918747
BICR 6,4259181,1.0672551037347004
GP2d,3689413,0.2049378471192219
Hs 683,46907787,3.0982371748631325
ECC10,375860,-0.309694131426854
T84,135999136,4.269750359734968
SU-DHL-1,12003241,0.0778318253848937
T98G,54626689,4.664801909720088
MG-63,136227924,3.2795436313273685
SK-BR-3,156414,3.9903950038310354
RS4;11,10302451,3.317269387656833
8505C,6852167,3.356965933736931
G-292 clone A141B1,9903786,2.9519846446825277
QGP-1,6852167,4.211899426816051
Calu-1,107970,2.841948385775343
5637,262093,4.0544390012856235
Li-7,UNC0638-navitoclax (1-1 mol-mol),-0.441208962070896
SK-MEL-24,3689413,0.3993824056710978
TT2609-C02,54626689,4.945116186076299
SNU-C1,71466445,4.306904502290324
SNU-1214,11455910,3.3877834337363124
L-363,136227924,2.122664399399679
BICR 18,46907787,0.7190687661680963
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
NCI-H2171,135875424,2.950178944342904
KMS-27,637858,1.2889744461011985
FaDu,49766530,4.291089764816537
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
COR-L88,72967,3.68051960609927
Aska-SS,9915743,4.6132993472825765
SH-4,24180719,-0.1023367473032153
HGC-27,135421197,0.8927042884556606
KATO III,9915743,3.5253109145888013
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414
NCI-H2110,selumetinib-JQ-1 (4-1 mol-mol),2.5540188828609907
IGROV-1,156414,1.4212019235656712
HCC1954,selumetinib-JQ-1 (4-1 mol-mol),2.098282008016861
SK-MEL-3,44491742,3.867059457044452
UM-UC-3,selumetinib-JQ-1 (4-1 mol-mol),4.140497449686447
Granta-519,439501,-6.00499370561019
A3/Kawakami,46907787,-2.1419759395724296
HCT 15,9927531,3.5842922899079173
LS180,46907787,-0.2837252988913812
COLO 680N,9915743,3.1865022811794006
KG-1-C,49766530,-1.9927650239452297
TE-8,26596,-1.186583847807299
SNU-719,10231331,-1.4600362678469236
SUP-B15,11455910,0.511116887846229
HCC1419,54626689,5.035935803121769
ALL-SIL,44491742,3.700418914769662
NCI-H1666,11396600,3.2365396547508674
NCI-H1563,9936388,1.5935308347912875
HCC1195,9936388,-5.972335548961908
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
SK-BR-3,71466445,3.826803162885657
NCI-H810,12003241,1.7210077749227564
NALM-6,9903786,0.8985317533889718
BT-20,637858,1.5317212374288376
BT 333,73707398,2.80004003661401
NCI-H1339,9903786,4.835064182647526
SNU-478,156414,-1.265366418020168
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
LS123,44491742,4.080361644542357
SK-MEL-28,241158,4.1117452183175445
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
KMS-12-BM,UNC0638-navitoclax (1-1 mol-mol),-0.7236362684252565
NCI-H2196,135875424,2.980052195607556
Capan-2,11455910,0.6528691404413365
NCI-H446,10302451,3.623486069490957
NCI-H2228,327653,3.7326635355564024
TYK-nu,644241,2.6049212423400907
JHH-2,44491742,4.07921218281707
KYSE-150,439501,-2.052967446367251
Hs 578Bst,selumetinib-JQ-1 (4-1 mol-mol),4.806808680835756
HEY A8,439501,-1.1544595971592837
SK-N-BE(2),9915743,0.2330456921975308
SNU-C5,49766530,0.4105480750830131
TE-11,9903786,1.6089543664279713
Kasumi-1,UNC0638-navitoclax (1-1 mol-mol),-1.6460218253730017
CGTH-W-1,4259181,-0.763565573127493
SU-DHL-10,11396600,3.7742694309184297
HCC1937,selumetinib-JQ-1 (4-1 mol-mol),2.308102509236992
SW579,168313016,5.7122133299462945
IGROV-1,156414,1.4212019235656712
HCC38,327653,2.8237453360302576
KYSE-140,9929138,7.103811482735402
NCI-H1944,49766530,4.020768643988838
MDA-MB-435S,10302451,3.892535997624766
JHOC-5,5460769,2.0469189795608447
LNCaP clone FGC,71466445,3.001006325551692
KMS-28BM,644241,0.6061929880948521
IGR-39,44491742,4.786400321878876
OV7,46907787,3.2542167876644466
GA-10,11455910,-1.5757849465302998
HCC1195,135875424,2.5037417223701572
KP-4,135875424,3.69718795810946
BT-474,135421197,1.065092434126716
NH-6,9903786,1.6690533510154009
M-07e,selumetinib-JQ-1 (4-1 mol-mol),-0.078699162510743
GSS,73707398,1.0095081490958464
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384
BT 444,3689413,2.494766939004703
Tm87-16,262093,2.22528250793553
ESS-1,439501,-2.0978778954241215
A-549,12003241,-1.903076073453771
HCC1428,46907787,1.8840160820417653
Mono-Mac-6,11396600,3.7802987218854898
UM-UC-3,156414,2.172219545817744
KYSE-70,3689413,0.9447440025313596
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
SNU-840,4259181,0.9915522893087512
SNU-182,3689413,-3.9177675224777406
NCI-H226,107970,3.317033859610873
SK-MM-2,54626689,4.88986227151498
ACHN,135875424,5.052014083171249
HuP-T3,9927531,4.952379772704904
CAL-85-1,9927531,5.462917800107974
Hs 888.Lu,135875424,4.614690828514689
SK-MEL-1,241158,3.5443731206675646
HCC2935,6852167,2.787674995055815
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
TC-71,73707398,0.9570811163223728
SK-MES-1,136227331,4.390258592428933
ST486,135999136,4.078215309645287
TE-8,156414,0.8617736604769611
DEL,135875424,3.00477413293185
EJM,439501,-2.5591027297640565
CAL-12T,100016,6.470654025405006
NCI-H929,46907787,-2.2229329095691495
Hs 944.T,12003241,-1.584632945920027
HOP-92,262093,2.340026978235907
SU-DHL-8,11396600,1.8138091107788987
Kasumi-2,selumetinib-JQ-1 (4-1 mol-mol),-0.370012591860846
NCI-H2029,9903786,4.7445314067007
U-87MG ATCC,241158,3.8639950646948376
KMS-12-BM,26596,-3.7364157309734822
MHH-CALL-4,262093,0.5666969129517823
Daoy,11396600,3.83670374909926
TE-1,637858,2.0624451168659657
JVM-3,444795,1.4285696310106424
BFTC-909,3689413,0.9841636034152118
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
BT 416,644241,2.228775392817017
NCI-H747,selumetinib-JQ-1 (4-1 mol-mol),-2.0784828379342275
SNU-620,100016,4.241219903285237
BT 145,135999136,1.287616200514186
SK-MM-2,73707398,0.3401468259097277
SK-BR-3,100016,6.79119351825136
BT 231,135999136,1.241486028701245
F-36P,12003241,-0.4333234421592413
786-O,6852167,3.7190668344591025
TC-71,156414,1.5752060003210238
Karpas-299,24180719,3.3752232699178943
HCC38,135875424,3.1024594516018453
DMS 114,9903786,5.060139909585821
KYSE-520,100016,6.554858217735662
NCI-H2052,9936388,2.267249027506278
DU4475,637858,0.6789447912072304
Karpas-299,9903786,1.3697827730065784
RERF-LC-Ad2,135398744,6.529632870190649
HEC-151,135421197,1.9024476201303135
KYO-1,637858,1.4266111239318309
OC 314,UNC0638-navitoclax (1-1 mol-mol),2.3317167150978584
BICR 22,241158,4.423333712203234
KMRC-3,4259181,0.7954133623133547
Hs 888.T,107970,2.2349106200689817
PaTu 8988s,9936388,0.6570193749634515
NCI-H661,262093,3.4983141095274126
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
P12-Ichikawa,156414,1.5852391665710248
BT 159,439501,-3.0773792715975685
KYSE-140,10302451,0.062632955772706
NH-6,26596,-2.8225281366091375
MOLT-3,49766530,-1.2433717650560063
SNU-1041,135875424,4.844300116851518
OS-RC-2,12003241,-1.2099466565873536
Daudi,6852167,0.8630196090584432
COV362,156414,3.3927888347468653
NCI-H2023,4259181,-0.0798035558401368
OCI-AML-2,9915743,0.8292990074766823
RKO,136227924,3.256787131627037
RKO,11455910,0.1271196393609195
MEC-1,135421197,0.4740815920241465
KE-37,375860,-0.9469027157668132
COLO 320,135875424,2.711405074162338
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
WM266-4,71466445,3.9835521920439625
Mino,49766530,-3.2030154452064696
Tm87-16,4259181,0.4584407885070141
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
GCT,selumetinib-JQ-1 (4-1 mol-mol),4.034111871238951
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694
WM88,327653,3.149247099835907
AML-193,444795,4.361597558982522
NCI-H2009,12003241,-1.6852069192913937
LXF 289,6852167,2.2044562779321635
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
Hs 888.Lu,24180719,3.38022367558301
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
OAW28,49766530,-0.5315014966120291
Karpas-620,136227924,3.0310478312116467
RPMI-6666,44491742,4.997277859824789
ME-1 [Human leukemia],100016,5.540349228215307
L-363,375860,-0.3038992932321046
JHUEM-2,100016,5.904304927611702
ZR-75-30,6852167,2.8121433098983037
Hs 688(A).T,644241,2.0149750049986452
WM88,262093,2.979155040217876
NCI-H1694,439501,-3.146903361549278
SNU-8,6852167,2.9028412896879856
OV7,375860,-0.1349693061548985
DBTRG-05MG,107970,3.006907268796323
Caki-1,4259181,2.4269254621819236
SK-N-BE(2),49766530,-3.9007408252768503
Detroit 562,135875424,3.611999355056841
NCI-H2286,241158,1.56895022845318
BT 245,UNC0638-navitoclax (1-1 mol-mol),-0.0358626825022054
Hs 895.T,637858,3.4147376611120186
LS1034,11396600,3.6253356993405266
PSN1,9915743,2.9916709267911084
Hs 888.T,UNC0638-navitoclax (1-1 mol-mol),0.7614125477011823
DV-90,54596490,6.2895799434326
SNU-668,9936388,1.544401750271857
ALL-SIL,71466445,2.2002248480614925
MOLM-6,100016,5.4880920806856865
BT 239,107970,0.200195118514019
SNU-503,9936388,-4.768623005936061
SNU-16,4259181,-2.706381398418005
KMBC-2,107970,2.196231544396115
KMS-18,637858,1.2526171470027732
THP-1,439501,-2.363264407361294
SNU-201,12003241,-1.0113776062533857
UM-UC-3,644241,3.8298846028890745
OVSAHO,168313016,5.470935278602615
DOV13,439501,-2.3645646799051754
COLO 678,262093,3.3030723786800307
OCUM-1,9927531,5.3600518663523244
OVCAR-8,46907787,2.826813590962943
NCI-H1341,135999136,1.7699629004652555
ZR-75-30,107970,2.5357758703425404
NCI-H1435,9915743,-1.162246321840318
SK-MES-1,26596,-0.6489352140411898
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
BT 147,9927531,5.037418148394567
UM-UC-3,11455910,-0.2189764508549214
KO52,637858,1.0718331271712598
AM-38,10302451,3.7847088255145978
BT 224,107970,1.8462444688876551
Caki-1,3689413,-2.406735628687606
HCT 8,12003241,1.3953140594908418
SK-N-BE(2),9927531,3.511797224243287
CHP-126,4259181,-0.3751518469974201
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
DoHH2,327653,-0.1636746029828067
CML-T1,135999136,1.353337094400064
SNU-878,9927531,4.662529833906493
HSC-2,327653,3.1172666689208555
BL-70,100016,3.880189960258483
Daoy,135999136,1.8625758220326087
Jurkat,11455910,1.124658813154621
ESS-1,9915743,1.8900363437156489
EFE-184,135421197,2.5178551703046277
OVCAR-8,6852167,4.329418892564513
NCI-H2009,6852167,1.9075911063810396
A-549,11455910,0.2975953497649719
BT 340,9936388,1.2186667237232216
HCC1143,9936388,-6.988875343339418
SNU-5,135421197,2.4308176065595672
NCI-H2405,107970,2.773049051835492
ECC12,135421197,3.3964396494270357
A-172,4259181,0.7217216416710104
SK-N-BE(2),UNC0638-navitoclax (1-1 mol-mol),-0.3828461387565847
Namalwa,46907787,-1.1716727326146228
U266B1,26596,-3.1243600455967906
COLO 201,9903786,2.3732534001710426
NCI-H1792,9936388,2.616597511132069
T3M-10,10231331,1.7562968841685376
NCI-H23,24180719,4.17621893633888
KM12,49766530,-2.0271084274378373
GSU,73707398,1.504061003792855
AMO1,26596,-3.5101711689538155
HT-144,241158,4.021482220995618
MDA-MB-361,135421197,1.0665899538152213
CAL-51,262093,2.862241975448649
HT-1080,26596,-1.5262132269513464
HCC44,BRD-K27188169-navitoclax (2-1 mol-mol),0.5485670122843167
KU-19-19,135999136,4.912207411852192
Ku812,11455910,-0.1088527514294285
NCI-H2444,156414,2.4052737888176132
AML-193,12003241,-1.5379973109398848
NCI-H647,4259181,0.924115846720778
BT 145,4259181,0.7441300921960503
HCC1569,12003241,1.6977916939082411
NCI-H810,9915743,0.7242422490458518
MOLT-3,26596,-3.757190091597864
Hs 746.T,9903786,3.9786506562957857
KMRC-20,46907787,3.5898907650473855
L3.3,9903786,3.5860218860878263
NCI-H1793,11396600,3.5619281448280233
Panc 04.03,637858,2.9634699724220783
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
A-673,135875424,2.9734448822107886
IGR-37,135999136,4.421370905538769
Panc 08.13,135875424,4.727963468605648
BT 359,selumetinib-JQ-1 (4-1 mol-mol),3.6581943862007416
NCI-H1339,11396600,3.0711399080961934
Daoy,375860,-0.1320421153214505
SW1116,54626689,4.825596947242399
HT,4259181,-1.5614808878704516
PK-59,10302451,2.95389022276854
NCI-H1650,44491742,4.220144565804619
NCI-H2009,135999136,4.285465393980956
NCI-H1869,4259181,0.9705477170328122
LOX-IMVI,375860,0.0693454409370285
JK-1,4259181,0.2041006169508442
RERF-LC-Ad2,444795,4.5594337932678455
SHP-77,10302451,3.8689423401544447
NCC-StC-K140,136227924,1.8113931494957989
IGR-37,9929138,7.412799255181445
PE/CA-PJ49,10302451,1.2868329863340626
PC-3,444795,5.089315637194618
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
Hep 3B2.1-7,12003241,-1.3373877223864783
PaTu 8902,6852167,4.282216220168943
TOV-112D,135875424,3.733970966368142
FU-OV-1,6852167,2.292876265150526
HCC1500,10302451,3.7658874637842135
Reh,4259181,0.2688658389354381
LP-1,12003241,-0.1215623944522291
A3/Kawakami,9915743,1.8122427094959257
LNCaP clone FGC,26596,-2.187376252798695
KP-2,9927531,5.1844073401368735
KYSE-510,44491742,4.7429938042096245
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
NCI-H1184,11396600,3.277329955302312
HEC-59,637858,1.9276997282278596
EM-2,6852167,0.9842346287991872
SW48,439501,-2.266376314928653
ChaGo-K-1,107970,1.9284648709268049
OCI-AML-5,439501,-3.3473386459158583
HCC2935,selumetinib-JQ-1 (4-1 mol-mol),3.5585346140363483
SK-N-DZ,49766530,-5.670578617317044
LS411N,637858,2.7012095970179635
PC-3,136227331,4.235931729378205
Namalwa,44491742,4.1395858329172235
SK-MEL-5,selumetinib-JQ-1 (4-1 mol-mol),2.584301952935506
KALS-1,54626689,4.8560707555478455
DMS 454,262093,2.385432279101096
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
BT-12,4259181,0.5840557445964077
NCI-H1341,327653,2.5295846905015655
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
KMS-20,439501,-3.5751856752548985
NCI-H1869,9927531,5.985290716685452
NCI-H520,11396600,3.7776798770198594
NCI-H1581,136227924,2.9082899651974734
HCC38,46907787,0.4227430281894037
LS1034,3689413,2.145943189168165
COV362,26596,-1.9019545485387068
EFE-184,4259181,0.9634883435103218
647V,3689413,-0.9737590954891844
HH [Human lymphoma],11396600,2.7706503807111575
Kuramochi,46907787,0.743649036621638
VMRC-RCZ,6852167,4.45250121529264
L-363,107970,2.3182024739752123
FaDu,135999136,4.400675161067026
A-673,444795,4.685959151928419
NCI-H226,4259181,1.8377769952921412
NCI-H1155,10302451,3.872107344192631
SNU-213,9915743,1.2181447895342674
SNU-478,135875424,3.766557259457048
HSC-2,6852167,2.0061247190465785
HCC1954,107970,2.2705367149515543
NCI-H1339,5460769,-0.265386406275254
COLO 320,375860,0.3995752770957879
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
LXF 289,9915743,1.5678711489122208
CAL-27,327653,3.557257248242371
PC-3,selumetinib-JQ-1 (4-1 mol-mol),5.329469318289121
OV-90,375860,0.3915953054415123
NCI-H1838,11455910,2.7014431026549386
HEC-59,24180719,4.505272708588429
HOS,9936388,3.3848022689257387
BL-70,10302451,3.7691675443398247
IGROV-1,107970,2.287061680908213
DOV13,637858,2.134745234755602
OVK18,135421197,1.6539511410681966
HuG1-N,12003241,-0.7398422629882291
IGR-39,10302451,3.7276422504611024
BT 228,135421197,1.0231801193279042
BFTC-909,12003241,-0.8371396827795129
SNU-1077,3689413,-1.655364429789056
EKVX,135421197,0.902433297386992
AsPC-1,10231331,1.7826677656602696
Hs 729.T,439501,-2.5302940667967695
NCI-H838,241158,4.193975575812004
SUP-T11,262093,-0.249572082043469
LP-1,11396600,4.222971690174634
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
COLO 800,107970,2.383898658325272
BFTC-905,UNC0638-navitoclax (1-1 mol-mol),2.7149212585440083
TTC-709,136227924,1.406309539576174
TT2609-C02,107970,2.997655912505065
GDM-1,135999136,4.09510969720496
P31/FUJ,9903786,1.0734919883099745
NCI-H1395,439501,0.2163751108150007
SNU-478,6852167,1.935755270387292
SK-N-AS,4259181,-0.3147022482615397
SNU-1272,168313016,6.45685474572034
A-375,73707398,0.8320576726433225
KMS-20,9915743,0.2569666585707142
Peer,10231331,5.411125162137865
NCI-H2023,100016,7.201065180404722
Reh,5460769,-1.7090111602799842
Hs 766T,44491742,4.434347985078199
CL-11,100016,6.945803371228119
RPMI-6666,100016,5.822007631719843
SNU-869,4259181,1.033647746457788
BT 112,73707398,0.9645515230778364
SNU-5,136227924,2.8950932658181876
EFO-27,135875424,4.6207788215281465
G-361,168313016,4.401717934816135
BT 444,12003241,-0.4351069615199688
NCI-H1650,262093,3.0085408028309786
KMS-26,262093,1.018601177342637
HSC-4,4259181,1.301377168384764
HCC38,selumetinib-JQ-1 (4-1 mol-mol),2.765272906318856
NCI-H1944,54596490,4.385480659852923
GI-1,439501,-2.4273681178364837
KMS-26,26596,-2.3246210028506873
HCC44,9929138,6.424680472987345
KNS-60,135875424,4.390614396621118
MPP 89,156414,1.6463851020768565
TE 441.T,9903786,2.9236317230426465
NCI-H1395,46907787,2.4653160178838354
NCI-H2030,135999136,3.784787341236107
NCC-StC-K140,9929138,3.845494861279627
KU-19-19,3689413,0.155027117273248
CA46,637858,0.8997823848237061
CL-11,9903786,2.342392371257784
SF268,107970,1.9571800308435767
MKN74,54626689,6.992029114848977
RCC10RGB,241158,4.984223152954295
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
JMSU-1,9915743,-1.579364390846883
G-361,11455910,0.6100431250643066
MOLT-3,444795,4.052546401379371
NCI-H520,71466445,4.442767515504577
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
NCI-H2170,11455910,0.541639462195205
PANC-1,46907787,0.0989885994051276
KM12,12003241,1.1245278791827416
U2OS,10231331,1.781161622423505
KHM-1B,selumetinib-JQ-1 (4-1 mol-mol),-1.6661106827496956
KP-N-SI9s,12003241,-1.3670670210068214
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
Sq-1,100016,4.274424361552861
WM88,168313016,5.2919128740723265
GB-1,637858,2.4866943846346072
NCI-H358,375860,-0.8161593688614527
TE-10,4259181,-1.9859765021225648
U-251MG,6852167,3.572430046092572
SUP-B15,5460769,1.5557801555914603
KO52,107970,1.5787465596439585
MOTN-1,444795,4.717239973457594
SK-MEL-30,135421197,2.8284209456564025
WM88,10302451,3.9540346970245337
G-401,375860,-0.2910974790080222
SK-BR-3,327653,3.1347096083864816
LS180,11455910,2.088798844266998
SNU-685,168313016,6.404851942189217
NU-DHL-1,100016,6.7557445252971355
HDLM-2,168313016,4.65822549892325
NCI-H441,71466445,4.182727047603201
TYK-nu,46907787,2.3666645247212346
LAMA-84,12003241,-5.010316876482206
Detroit 562,6852167,2.213470028027015
NCI-H2170,9936388,-3.7757464775618104
697,439501,-3.82474204489092
K-562,44491742,3.373435641850853
Sq-1,439501,0.4738250943054584
Daoy,44489367,5.617390271902998
DU145,135999136,4.106502655585601
MKN74,168313016,4.440025368788847
K-562,9903786,3.6050720376028105
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
SK-LMS-1,262093,2.881429058515633
GOS-3,241158,4.584939515140501
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
KMBC-2,156414,2.2596369338990976
MOLP-2,5460769,4.105160520991768
OVSAHO,444795,4.551054343981997
GaMG,26596,-1.3647461579215698
NCI-H1755,44491742,6.2867569407900215
MOLP-8,9936388,3.4211096692910052
KMS-28BM,26596,-2.75100842761318
CAL-85-1,6852167,1.6238122656389518
SET-2,439501,-3.519167585481613
B-CPAP,46907787,3.372107688619731
KYSE-150,12003241,-0.8115897611031261
HT-144,9936388,0.7271233653710654
KMS-11,375860,-0.7431294237893198
MOR/CPR,71466445,4.247289487065976
TYK-nu,135999136,4.524317210504986
HCC366,BRD-K27188169-navitoclax (2-1 mol-mol),3.586818183472054
HOS,9903786,4.58127571794388
BHT-101,26596,-0.678699585519716
RKN,49766530,-3.8574490235665584
KMS-27,100016,3.811410813700335
PE/CA-PJ49,selumetinib-JQ-1 (4-1 mol-mol),1.4139822071582016
JURL-MK1,44491742,4.045631279535998
UO-31,135999136,3.536527795891914
NH-6,9915743,0.850347452828082
D283 Med,327653,2.8736593168933786
SK-ES-1,100016,7.4795645853927475
BT 271,73707398,1.1660432005744914
Hs 578T,46907787,2.2226344570292915
SR,selumetinib-JQ-1 (4-1 mol-mol),2.1481021926688695
DU145,selumetinib-JQ-1 (4-1 mol-mol),3.7436181665569137
COR-L105,156414,4.037454349539868
MDA-MB-231,637858,2.969194389696412
NCI-H2170,71466445,3.990901852662392
Pfeiffer,444795,1.9683094418573817
NCI-H2452,637858,1.8545349692582156
8-MG-BA,24180719,4.246646703044828
RT-4,9929138,7.578104590024713
CGTH-W-1,49766530,-0.0096054874021786
SR,637858,1.3694084425594049
HEC-265,375860,-0.1308592558386561
BT 330,12003241,-0.9920089469814386
LK-2,136227924,2.893153940116167
BICR 22,71466445,3.433479198461154
A-549,439501,-2.483005959928592
Hs 683,241158,4.572594529470727
HLF,44491742,4.796533392480472
BT 112,262093,1.8523945417932268
SNU-201,136227924,3.0451171975506903
RCH-ACV,73707398,0.2793180424503238
RKN,637858,2.0099352926359533
NCI-H2171,9927531,3.1501077196413783
U-CH1,12003241,2.634808409336574
8505C,49766530,-3.896310533039643
WM266-4,156414,1.6191743084759036
PF-382,9903786,1.7632578420268197
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008
VMRC-RCW,44491742,5.061613878025198
WM115,49766530,-0.6421157759153451
NCI-H838,637858,3.1822824792904467
JHH-2,9927531,4.777538001331337
SNU-601,262093,2.665583006952994
BC-3C,10302451,3.564024501759527
NCI-H2087,444795,4.628154500266454
SW1271,9915743,1.6128868969613257
Hs 936.T,9903786,5.166198075920313
SNU-1196,9936388,1.7924578695982027
NCI-H2052,439501,-0.5583326091598753
TC-71,71466445,3.509629418813805
CAL-148,168313016,4.8531346041528165
NCI-H1869,9903786,3.8309501172404734
NCI-H2029,9915743,1.4952182425439322
HCC2935,637858,2.581193307800251
WM983B,46907787,1.5249847323988268
P-STS,10302451,3.885100498730175
SNG-M,6852167,3.692235384021515
K-562,439501,-2.3563528898814905
SNU-899,9903786,2.4739971743095497
RPMI-8402,6852167,1.2289989467414018
639V,107970,2.3280826917079667
HT-1197,5460769,3.9110228695560223
UM-UC-3,46907787,4.913925621865414
HT-144,49766530,0.4974871030439343
NCI-H1092,54596490,4.303629834820445
HT-1376,327653,3.1831063450087265
TE-11,262093,3.7294474830562336
MCF-7,168313016,4.48999133855647
Karpas-620,3689413,-2.001578563648977
BICR 16,12003241,-0.754422743943259
BICR 56,135421197,3.0441014153106893
SK-LMS-1,26596,1.8216060443410544
U-118MG,49766530,0.4314667015324968
JVM-3,UNC0638-navitoclax (1-1 mol-mol),0.2477073978511914
FaDu,11396600,3.202627424323668
Kuramochi,135875424,3.969220594462324
5637,100016,5.253062593048346
NCI-H2291,49766530,-0.0984213660928805
OCI-M1,11396600,3.110541819968075
PE/CA-PJ15,637858,2.2671736383658985
YD-10B,135999136,5.8909279281917994
MKN74,262093,3.405035629450505
SU-DHL-10,24180719,4.172021817266092
RS4;11,3689413,-2.3954384764538528
Ku812,6852167,2.7508092991832016
BT-549,327653,2.9888914918454854
CAMA-1,135421197,1.145586441403014
BT 131,44491742,4.605626488786133
MCF-7,327653,2.921277434210666
SNU-182,135999136,4.249172509573539
U-118MG,11396600,3.770930746611021
HDLM-2,9903786,0.9941602221273084
KMS-34,444795,1.6495761438437055
JURL-MK1,54626689,4.535381768416785
SNU-308,156414,-0.0512353312380724
RCH-ACV,136227331,3.661348982396994
JJN-3,327653,3.1728287046324386
SaOS-2,644241,2.5011234622868415
OE21,selumetinib-JQ-1 (4-1 mol-mol),-0.1930020472631329
SU-DHL-8,12003241,-0.8632235676270862
RPMI-6666,135421197,1.415232327318222
NCI-H1666,73707398,0.9789960895675976
HuT 78,9903786,-0.2471360619469426
G-402,4259181,1.0577669619122276
KG-1-C,241158,4.3112514697697355
NCI-H2286,71466445,4.093392952146547
BT-12,11455910,1.8698034646141068
SNU-1214,156414,-3.2304362437665812
SW579,9927531,5.20286248500357
MOLM-6,49766530,0.2890752826418397
JHOS-2,135875424,4.409473105758524
RCH-ACV,BRD-K27188169-navitoclax (2-1 mol-mol),-0.4738742154532085
Mel Ho,71466445,3.8263355015421503
NCI-H2444,11396600,3.7702875929264312
T3M-10,107970,2.164377602054981
NCI-H1299,selumetinib-JQ-1 (4-1 mol-mol),1.4480114642409152
OVK18,24180719,3.6742518622215186
SK-N-SH,135421197,1.303640254483224
Caki-2,3689413,-0.1901377653832866
NCI-H647,44491742,3.8006488884614527
RT-112,11396600,5.757660560625734
SW1271,46907787,1.639327018501732
NCI-H929,selumetinib-JQ-1 (4-1 mol-mol),-1.4418974567272833
Ki-JK,3689413,-3.396353931218892
SNU-C2A,10302451,2.484478658072876
BT 172,100016,6.450201924949107
UO-31,3689413,-5.037713706278837
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
SNU-601,9903786,4.302030389769322
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
KMH-2,4259181,-1.7257445215614664
NU-DHL-1,26596,-3.470221600864271
JHUEM-7,136227924,2.4332957155572688
MG-63,3689413,-2.4336894587390323
2004,5460769,0.3983589325904631
ME-1 [Human leukemia],135421197,1.4857901642413922
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
CFPAC-1,6852167,4.928120613967257
KMS-27,5460769,1.7009983096984826
253J,12003241,-2.2004462353623775
NH-6,135421197,0.8889429247891555
LOU-NH91,135875424,2.9424536382603215
NCI-H2228,9903786,2.418550241736446
KE-39,12003241,0.559414259019648
OCI-AML-5,selumetinib-JQ-1 (4-1 mol-mol),-0.0288655863231173
RERF-LC-A1,375860,-0.507812876154058
SNU-1214,11396600,3.7056462791365847
Hs 839.T,136227924,4.248389123686858
EPLC-272H,46907787,-0.1418313335798283
NCI-H1339,49766530,0.922676999768476
697,9929138,3.2982563407186447
KYSE-520,135875424,4.420553116763078
TUHR10TKB,BRD-K27188169-navitoclax (2-1 mol-mol),-1.316014143631707
DLD-1,46907787,1.2209217762946305
OCI-AML-5,135421197,2.371407792163204
YAPC,327653,3.117178905090827
SNU-1,selumetinib-JQ-1 (4-1 mol-mol),-0.6922648212512231
EFM-192A,3689413,0.6464751811970497
KP-4,439501,-3.618807292682963
SW1353,107970,3.000498774882463
BICR 18,9936388,2.6183672071363175
HCC4006,135421197,1.321900660308596
KYO-1,BRD-K27188169-navitoclax (2-1 mol-mol),4.264535140392017
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
CAL-148,26596,-0.995899107261143
NCI-H1975,156414,-4.584489477313673
HuH-1,9915743,2.131122478495969
Panc 04.03,54626689,4.659724899973851
TALL-1 [Human adult T-ALL],262093,1.1652608151765906
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
SCC-4,241158,1.6483761097046987
HCC1395,9929138,7.007797451102856
MOLP-8,135875424,3.0291075959050233
K-562,375860,-0.3542925626582329
Hs 746.T,9915743,2.055973723979153
NCI-H2126,637858,2.592215073021411
AN3-CA,71466445,5.096273299698095
U-937,135875424,3.4051518074460487
Tm87-16,135421197,2.3570280625350057
HEC-59,3689413,-1.7900495461220194
CAL-78,9903786,2.899593269782219
JHOM-1,135999136,4.389225693013997
OS-RC-2,44491742,4.539389041576503
MKN74,71466445,3.93940813882303
HuCC-T1,135875424,4.122331591088892
SNU-216,375860,0.5464638688972412
SU-DHL-10,4259181,-0.5480239066602804
MCF-7,6852167,1.253402776787036
M059K,9903786,3.785857349201863
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
BT 333,135421197,2.652327815352438
SNU-216,9915743,-0.7074992417120266
HCC2935,73707398,1.6520031559057071
KYSE-140,11396600,4.836880334492914
SUP-T11,327653,-0.0983618163081044
CW-2,5460769,1.6725505189692909
CCK-81,107970,2.3373477232254443
LAMA-84,241158,2.9700972782798636
BT 248,4259181,0.8166391520482507
MOLP-8,168313016,3.7646553629166304
SW620,12003241,-2.6864351641930155
MHH-NB-11,9936388,-5.109130573397568
ONS-76,135875424,3.856833286433643
TC-71,439501,-2.5028085406649336
VMRC-RCW,3689413,-0.2709078941714827
SW579,11455910,0.492813014431951
Calu-1,637858,1.6711749737628838
TE-11,73707398,1.9159507910668552
NCI-H1703,11455910,0.7967317937160228
SNU-C1,9915743,1.8965789747873807
BT 330,107970,1.6746237285504426
A-549,135421197,2.4799819746704075
HCC1171,107970,2.4719782408323385
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
MOLM-13,107970,2.204740997332017
HCC1428,11396600,5.584589218980949
JJN-3,11396600,3.2077193233266375
KMS-27,375860,-1.142960082705596
SIG-M5,9903786,1.9849552317824917
BT 172,327653,3.4070255129044114
TOV-21G,selumetinib-JQ-1 (4-1 mol-mol),-0.6067316586875464
MSTO-211H,3689413,-2.1873545800685865
GSS,3689413,-0.0459197992618788
IGROV-1,135875424,3.3275053166921347
MCAS,5460769,1.176961037581758
U-251MG,262093,3.13898838464472
Hs 934.T,107970,1.693270868560192
PC-3,73707398,4.033617880786533
NU-DHL-1,135999136,3.842512591140382
CAL-54,644241,2.4540588983104628
NCI-H510A,26596,-3.9165599075217994
IGR-1,9936388,-6.544031744867033
HCC202,71466445,5.615992482141614
GaMG,BRD-K27188169-navitoclax (2-1 mol-mol),4.031909809581955
UACC-62,54626689,4.6707261131257365
SNU-503,6852167,3.0647211041019986
BV-173,100016,4.070459829867503
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
T-47D,73707398,1.257680639100872
COR-L105,10231331,1.4114577114599935
HD-MY-Z,135875424,4.008559842592383
Hs 888.Lu,54626689,4.866459108879175
NCI-H841,156414,1.5063589508923476
PE/CA-PJ49,4259181,0.0577258955195342
SH-4,107970,1.9075532691951709
Ri-1,241158,1.4314385956610491
MDA-MB-435S,4259181,-1.4410759013373908
BHY,UNC0638-navitoclax (1-1 mol-mol),4.480092938546525
G-361,11396600,3.133964518585525
K029AX,5460769,3.760325914422788
NCI-H1581,135421197,1.183263993717128
BICR 18,135875424,4.8231575753624645
TE-5,6852167,1.6333591981161106
KMS-26,54626689,3.66942330100015
Yamato-SS,107970,2.6475909059700284
SNU-8,44491742,5.735879763811486
DBTRG-05MG,168313016,5.178980190186753
BT 131,135999136,1.5410915865018433
GOS-3,637858,2.327239346274226
Peer,44491742,1.9885349932687044
NCI-H1155,327653,1.739205993239167
BC-3C,241158,4.191862782565103
TCCSUP,156414,2.0603521073886952
Kelly,9927531,6.376471657693257
42-MG-BA,5460769,1.54562912999154
NCI-H1944,241158,4.952217480031954
YAPC,5460769,2.316930709954587
SW1783,24180719,4.7795575092347535
CCF-STTG1,135999136,5.41297640167708
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
UM-UC-3,100016,5.625806405184742
BICR 22,6852167,2.9570859917106533
LMSU,156414,1.5302250641749746
OE21,71466445,1.981156974013709
NCI-H69,5460769,3.1019087351608037
A-172,71466445,4.063203501420166
LP-1,136227924,2.2350423658008416
PC-3,9927531,5.366538449676758
SNU-C2A,73707398,0.9848565358771032
GI-1,46907787,1.730990455077524
Caki-2,4259181,2.3809189293534017
NCI-H1573,44491742,3.554417916622067
EHEB,135421197,1.2947733633872678
HH [Human lymphoma],selumetinib-JQ-1 (4-1 mol-mol),0.1451973449780448
KNS-81,439501,-1.422452321432204
SUIT-2,4259181,1.8331520084863369
HCC2279,637858,2.02122620769869
COLO 829,24180719,0.7010526091354425
BT 216,49766530,0.8435993289862541
DU145,selumetinib-JQ-1 (4-1 mol-mol),3.7436181665569137
NCI-H1155,375860,-1.1401166336200168
RPMI-8402,11455910,1.2135317922717286
MOLT-16,BRD-K27188169-navitoclax (2-1 mol-mol),-1.192342551776464
GCT,327653,3.242786384875356
KP-2,439501,-0.3502086047975351
AML-193,54626689,3.941845874506918
KYSE-30,262093,2.7328983938102693
DU145,439501,-2.7485794982467637
MDST8,12003241,0.3559193403256231
COR-L105,11455910,0.425998653780944
BHT-101,6852167,2.0914160274610616
Hs 578T,168313016,4.885965287193478
KP-N-SI9s,11396600,4.554176657358924
DMS 53,54626689,3.4293190582260333
GI-1,375860,-0.0355977916209161
HeLa,3689413,0.6540693787829278
NCI-H1703,24180719,3.271820785032152
DB,637858,0.9550301785887676
Calu-3,156414,-2.1411931104090964
SET-2,54626689,4.509616884336031
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
NCI-H929,10231331,2.673485705852421
PK-59,107970,2.298393992220364
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
RCH-ACV,46907787,-0.324822109365263
COLO 829,136227924,3.354215786550203
NCI-H929,71466445,3.0733288534415233
23132/87,26596,-1.073494997011525
MOLT-16,327653,2.613678241642498
RCC10RGB,44491742,5.1484686760969645
CHP-126,10302451,3.625484511715841
CAL-54,637858,1.3720795157109595
TALL-1 [Human adult T-ALL],4259181,-0.2599925665535982
G-361,241158,1.6882284990551055
ZR-75-30,262093,3.223282782718559
SNG-M,135421197,2.4480650600360705
CCF-STTG1,637858,3.1960196819129343
IGR-1,11455910,1.3265797692921302
RMG-I,637858,1.5920986883450186
SW579,136227331,4.609326652979714
PF-382,46907787,-1.0517755055208098
Hep 3B2.1-7,10302451,4.252461968415576
BT 231,selumetinib-JQ-1 (4-1 mol-mol),1.4143353306589224
P12-Ichikawa,46907787,-0.81199339168832
HCC15,637858,3.032734575357801
LCLC-103H,107970,2.8448254128571224
SNU-16,6852167,2.2118089271790033
NCI-H2286,3689413,-2.1479799329428437
BL-70,168313016,3.7978075808944967
Peer,439501,-2.3355144214927614
CAL-85-1,10231331,1.6707948774111965
BT 172,11396600,2.88874233952659
SET-2,135999136,1.840217367729006
YD-8,73707398,1.1339237170250962
EHEB,12003241,-2.0597430880681062
JHUEM-1,12003241,-0.7244634318456832
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
CAL-33,26596,-1.0071366013877838
MOLM-13,375860,-1.005106987112833
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
HOS,9927531,4.717123870748892
U2OS,100016,5.485609538675787
IGROV-1,241158,3.288496474515495
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
HEC-151,100016,5.913951457428463
SF539,12003241,-2.026733754371074
NCI-H1651,5460769,-1.7567427214342684
SNG-M,327653,3.199895940413603
NCI-H2405,327653,4.67741902123664
FTC-133,135398744,6.510037604259866
DB,135421197,1.3227021747573118
NCI-H1299,3689413,-0.9598507897960026
U-BLC1,637858,1.4857976283615233
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
TE-4,6852167,1.583100276013206
BT 139,136227924,3.476406727957654
U-251MG,444795,4.461152799118872
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
BT 271,3689413,-0.1683301005825848
SNU-1041,selumetinib-JQ-1 (4-1 mol-mol),3.895658717247031
SK-N-FI,107970,1.709574109633146
U-251MG,73707398,1.5280990364669664
KMS-28BM,168313016,3.3868967811757313
A-253,54626689,4.837207991804877
KMRC-2,54596490,5.045398582154487
NCI-H2452,6852167,1.5258165813873172
697,9936388,-7.51713340803998
Caki-1,73707398,2.0691913303307023
COR-L95,5460769,3.3963309413836815
NCI-H1581,135999136,1.6076711322789656
KHM-1B,44491742,4.066156285625521
OE21,26596,-3.6158126221637823
SF295,9929138,4.960030945136907
Mono-Mac-6,9915743,0.3878185063656593
SW1417,327653,3.3016307661200925
KMRC-2,UNC0638-navitoclax (1-1 mol-mol),2.5258787536181515
SKM-1,26596,-4.237929506963809
HCC4006,107970,2.1045056981388246
NCI-H146,439501,-3.5641402563292393
COLO 684,9915743,1.4008131015785188
NCI-H1944,11455910,-0.1007611933414571
HGC-27,136227924,2.541882907814414
DMS 454,9915743,0.9542388658928032
SK-MEL-3,9936388,1.3818026560314072
HCC1569,54626689,4.381005988397351
MDA-MB-468,439501,-1.8794738155702295
Rh41,BRD-K27188169-navitoclax (2-1 mol-mol),5.081389054580924
Pfeiffer,4259181,-0.2784459130692439
MIA PaCa-2,637858,1.1483651516118356
SK-MEL-31,11455910,3.802034948643962
KCL-22,9936388,-5.415966351243413
TE 617.T,73707398,0.9549107621752264
HuG1-N,11455910,1.8248856097934676
BT 271,136227924,1.335352033885486
DK-MG,107970,2.306444626900634
HuG1-N,46907787,3.257301518744958
NCI-H1693,9936388,1.0326729048127057
RERF-LC-Ad1,637858,2.9001668968564953
SK-N-BE(2),11455910,1.253525820715845
BT 172,156414,1.0602728240220436
SW579,439501,-3.952222233094387
GP2d,10302451,0.1765662972629052
M059K,10302451,3.367449874877144
RKO,262093,2.7220373961576834
J82,6852167,3.3420386373293685
Mel JuSo,10302451,3.755800024002333
AML-193,3689413,-0.2908308590674514
JHUEM-3,135421197,1.4304571308518408
YD-10B,375860,-0.7327340587593554
BT 504,135999136,1.8570291523116993
RERF-LC-MS,9936388,-8.273067767637817
AGS,262093,2.7795414492690953
NCI-H747,12003241,-1.9291719472544329
VMRC-RCW,135875424,3.9669138059560063
Hep-G2,135421197,1.3335693407455125
NCI-H1341,9915743,0.2650285979263042
HCC1195,3689413,-0.7365828236328352
TT,71466445,5.02784430072311
JHH-4,135421197,2.467716742231404
A-549,9903786,1.8644448309659765
HL-60,selumetinib-JQ-1 (4-1 mol-mol),-1.2129549912844606
MOLT-16,3689413,-0.0606324778239056
U-87MG ATCC,107970,2.4278638259024965
PK-59,135875424,3.737021018611698
DMS 454,637858,1.6809233286791794
HCT 116,637858,2.500606444102258
HL-60,100016,6.415560767920564
EKVX,24180719,3.2050087927697004
RT-4,24180719,5.152911409441223
LoVo,135875424,3.182508442374063
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
ECC10,3689413,0.143670384150019
NCI-H1915,637858,1.260114577354328
COR-L95,439501,-1.1523844892623298
UACC-812,11396600,4.679415745859403
SNU-46,10302451,2.4087587881907324
KMRC-1,644241,4.9037113640465035
IGROV-1,6852167,1.5305143027352028
J82,11455910,0.4504251564245444
EN,135875424,5.104378760772923
COLO 320,49766530,-1.8814026432492763
YD-15,12003241,-1.418070390851184
TYK-nu,6852167,3.6852222689466223
BL-70,24180719,3.1504599403729947
HCC2279,439501,-2.2925635815610006
SW1271,6852167,3.737297660761554
Jurkat,5460769,1.807388363251775
HOS,107970,2.981785279093002
ESS-1,135421197,2.603718676668537
AML-193,168313016,4.844735989269703
PK-1,5460769,3.319049240944118
DEL,44491742,3.848906849757271
D283 Med,241158,3.4452599332241616
KALS-1,44491742,4.207872917974877
MIA PaCa-2,439501,-4.331404793236993
HCC1500,135875424,3.5744445956281483
VM-CUB-1,439501,-2.2859816602677077
HT,11396600,2.79137838927363
ME-1 [Human leukemia],439501,-0.373146825712067
HCC1954,156414,-0.6903981351926928
SNU-761,439501,-2.8080514994136
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
TE-5,44491742,3.7855362982761194
SNU-61,135421197,1.1046098427392648
NCI-H1435,3689413,0.9860334604053864
TE-1,73707398,1.1292781016966351
HOS,4259181,0.2461191052601901
KG-1-C,73707398,3.866855838885212
JK-1,156414,0.0859453244387242
T-47D,135875424,2.636297002166631
SK-MES-1,135421197,1.0053632050719472
KMM-1,10302451,4.497512097117774
OV-90,71466445,5.236644798872222
Hs 888.Lu,100016,7.863224005148367
COLO 792,9936388,1.0587943491174894
SU-DHL-8,444795,3.428161639013317
SCaBER,26596,-1.7174475471543391
VMRC-RCZ,11455910,2.4109500553955487
KMS-34,439501,-2.83193731194203
BT 139,54626689,5.014806632611532
Fu97,9903786,2.3049271395078827
Malme-3M,46907787,0.0437822426845402
BT 228,9915743,2.3964891014052943
KMS-21-BM,49766530,-1.7820478851785848
KMH-2,375860,-0.9905938635036066
Rh18,4259181,0.3186625896881334
CAL-27,selumetinib-JQ-1 (4-1 mol-mol),-0.7476694829756971
JHUEM-2,11396600,2.4680372971734372
UACC-62,135875424,4.412505043477628
AGS,73707398,1.7385666104641533
DV-90,444795,4.1768333505010435
SW1710,54626689,4.898779962093531
BT 228,3689413,-1.5659127438457598
COLO 680N,selumetinib-JQ-1 (4-1 mol-mol),3.283056644335128
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
SW1417,44491742,4.02538714893742
BT-12,637858,1.7766399417002317
Hs 729.T,262093,3.080256577751834
SBC-5,26596,-2.1907470722084414
SR,71466445,1.8572383863538957
A-549,10231331,2.044831055629592
SNU-C5,135875424,2.310166721767538
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
TE-14,9915743,-2.4468727006504483
KM12,5460769,1.9442092441204395
TE-4,136227924,2.9171247501964945
MOR/CPR,26596,-0.9539590783160214
8-MG-BA,135421197,2.5937417683499526
OCI-M1,10302451,3.881215030976717
NCI-H1105,156414,2.2634806702955768
COLO 829,439501,-1.3241633043003287
RKO,46907787,4.104881837237831
KP-N-YN,44491742,4.254136072994776
NCI-H650,136227924,4.852289363773007
CAL-51,4259181,-0.5132501801478601
NCI-H2172,9936388,1.8105409817982183
SW1710,6852167,3.088497738849751
Granta-519,11396600,3.399615682634249
SHP-77,439501,-1.6083465101803276
HCT 15,637858,1.0268362607747696
AGS,107970,2.300813331206164
HuH-28,168313016,4.3836924047698
TE 617.T,4259181,-1.3173271639424509
UO-31,241158,4.2784384777828866
TALL-1 [Human adult T-ALL],9927531,3.369458546084366
PL-21,11455910,0.5383649206422021
JMSU-1,5460769,-1.1957562952388658
CAL-12T,135421197,3.5670485271085868
JHUEM-1,375860,-0.7048271059992764
SH-10-TC,241158,4.192657349891415
Karpas-299,9915743,0.0717302917443794
G-402,10302451,2.796814888628964
HCC827,4259181,1.5760084140568134
CL-11,12003241,-0.9595086367475664
Hep-G2,168313016,5.1281820641860545
Jurkat,4259181,-1.4685498518927522
JHUEM-1,46907787,1.7226050110198932
HCC2218,44491742,3.8267338846087497
K029AX,135421197,2.4286138926915175
OCI-M1,49766530,0.2650302716544968
BT-16,9903786,2.8143760707131347
DMS 79,9936388,0.9891135195416976
Panc 02.03,135875424,4.996461687769912
TUHR10TKB,UNC0638-navitoclax (1-1 mol-mol),-2.6605756335280297
BT 231,4259181,0.6722298764653775
JL-1,10302451,3.780690005321544
BT 422,9927531,5.2521428794559
SNU-C2A,107970,2.380782463123486
Sq-1,9936388,1.5257442738884122
HT-144,439501,-0.7742465567172142
KMS-21-BM,168313016,1.80428760603686
COLO 699,44491742,4.375917041754564
CAL-85-1,644241,2.606352757440632
SK-CO-1,3689413,1.2567954519757167
RERF-LC-Ad2,49766530,0.0972135502095861
KMS-26,9936388,-7.293063549205381
LK-2,71466445,4.119295136707602
647V,637858,1.2035591572726518
SaOS-2,100016,6.565789067704999
JHH-1,4259181,0.0366010748409238
NCI-H2170,12003241,-0.7011198558518746
SCC-4,73707398,1.0055389356954705
IGR-37,UNC0638-navitoclax (1-1 mol-mol),2.547238827516404
KYSE-30,9929138,6.4382239569963255
JHH-4,9936388,-5.466111968240916
ONS-76,637858,2.646425044184718
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
Mino,4259181,-0.1308029844207646
SW1353,375860,-0.9837699886394528
BFTC-905,10231331,1.5129291743987272
UACC-257,10231331,-1.074340029980585
PE/CA-PJ34 (clone C12),selumetinib-JQ-1 (4-1 mol-mol),1.4884609912866928
HCT 15,107970,1.6751321182254142
NCI-H647,71466445,5.041902875168557
MV4-11,9903786,0.7441932169203459
HPB-ALL,439501,-2.479146853758179
NCI-H1755,6852167,2.94649587469227
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
KMS-12-BM,24180719,3.687281269749717
RPMI-7951,selumetinib-JQ-1 (4-1 mol-mol),1.1039196671614755
Toledo,11455910,1.8011509430224568
SK-LMS-1,12003241,-1.0710207153229787
HCT 8,9927531,4.796707314113722
PC-3,11455910,0.8033042289278307
BxPC-3,10302451,2.105262518783424
HuP-T4,4259181,0.3179741116426117
SBC-5,375860,-0.6399303579455221
Lu-65,11455910,0.1308260352372195
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
CAL-62,439501,-2.324492116544492
NCI-H522,262093,3.0660845932794656
EN,637858,2.5142942932116252
KMS-18,107970,2.023216397694573
MOLM-13,54626689,4.673711949381485
TOV-112D,46907787,4.171399533980788
Hs 729.T,11396600,3.2923365887008966
A2780,11396600,2.9320615716687564
KYM-1,11396600,3.5240556474022737
SK-MES-1,54626689,4.736636064579195
KP-4,46907787,2.8983323327312185
BT 239,10302451,3.768420544812393
COR-L47,439501,-2.8835443741058437
SCaBER,135421197,2.9143213088501794
ECC12,9903786,2.9866335342643953
COLO 201,9929138,6.828783569682717
HMC-1-8,136227924,3.367197210687835
Ku812,439501,-2.3195298765386587
BT 444,135875424,3.072023667711102
HCC1954,44489367,4.4147435467815805
CMK,136227924,3.317343215770968
NCI-H1838,46907787,3.3230363809861667
P3HR-1,71466445,2.8786541215857264
COLO 800,136227924,2.9949932078985437
MG-63,49766530,-2.6108444064120686
NCI-H2009,107970,2.2954238398166344
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
DMS 53,12003241,-1.7395700319118894
JHOC-5,637858,2.3474009196061973
U-CH1,637858,2.937039052046479
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
Rh41,6852167,0.2858028091905864
LN-229,4259181,-0.7508188735233954
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
HuH-28,241158,2.528595827749566
Ci-1,4259181,0.2080497901890623
OCI-Ly3,135398744,6.408015135669225
Hs 683,24180719,3.5923230228392953
NCI-H2405,71466445,6.20734018076787
EFO-27,637858,1.802850970746332
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
SK-N-BE(2),9936388,-4.085977969956083
HCC2935,12003241,-0.8324751754872037
LP-1,71466445,2.285503887885024
OV-90,selumetinib-JQ-1 (4-1 mol-mol),-0.755409659671859
MCAS,49766530,-0.3094916991443784
L3.3,439501,-0.248470622878828
A-549,46907787,5.023259811787708
MDA-MB-453,54626689,4.438407624810902
SNU-449,135398744,6.632733291537939
NCI-H2106,49766530,-2.15877326131524
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
LS1034,9936388,-2.448497321625194
KE-97,135999136,1.4589784549040783
PSN1,327653,3.415730458851978
LS1034,135875424,4.8820481204382995
Karpas-422,26596,-1.4945297758647662
RT-112,9903786,2.0638797497197237
KP-3,73707398,1.3853432761584183
SNU-1105,71466445,6.046955371467825
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
NCI-H1563,54626689,4.184786337516801
KP-N-SI9s,73707398,0.6857954039664277
BT 232,54596490,5.37904940780473
SNG-M,135398744,7.8429611595155055
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
OCI-AML-5,107970,2.8114256045372
JHUEM-1,644241,3.1376628194237446
OAW28,44491742,4.754653012158477
RS4;11,BRD-K27188169-navitoclax (2-1 mol-mol),-1.4495220882625608
NB1,375860,-0.2400015719415603
BT 159,4259181,0.9611359841951334
LC-1/sq-SF,10302451,3.3793809491586764
NCI-H747,637858,1.7302074070773383
HCT 15,262093,3.178837249101228
SNU-182,10231331,3.169558165272788
Kelly,3689413,-0.2906048821836837
P12-Ichikawa,10302451,3.489810984245078
SNU-478,3689413,0.4137881438833174
COR-L95,10302451,3.773437494355592
FTC-238,12003241,-0.6060695245587711
JL-1,9903786,5.3673726170242455
PaTu 8902,9903786,4.041497343746548
NCI-H747,135875424,3.2442393754776178
SNU-620,24180719,3.566465527367131
NCI-H1339,375860,-0.3541433845632409
NCI-N87,6852167,1.8373876080574163
NCI-H28,156414,1.3812121222696463
NCI-H2030,439501,-1.2331748188079374
NCI-H2171,26596,-1.7584148860978708
KMS-34,9903786,0.5468687794140459
FaDu,135421197,1.369051763273762
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
COLO 699,49766530,0.7999690356188136
HuH-1,637858,3.115781360028532
SR,327653,3.5781508881575426
NCI-H211,49766530,-2.3844555763934707
DND-41,UNC0638-navitoclax (1-1 mol-mol),-0.950622126966266
TALL-1 [Human adult T-ALL],73707398,0.2643947199828666
G-401,156414,1.0662464633968871
HCC2218,72967,3.841314233742601
NCI-H2106,107970,2.258654621274229
SNU-626,6852167,3.646098015968206
L-1236,9915743,1.4582710578381164
LNCaP clone FGC,selumetinib-JQ-1 (4-1 mol-mol),0.1140146745231702
KMS-28BM,selumetinib-JQ-1 (4-1 mol-mol),-2.4132470490315883
TE-6,156414,-0.6190347638694889
DB,375860,-1.6620763038884403
KMS-20,49766530,-1.2962307066769267
SUP-M2,12003241,0.982076040273681
BT 428,136227331,3.9646009077151456
HCC1419,11396600,4.111721753411411
GSS,24180719,2.7345917663435975
BFTC-905,10302451,3.466344338322821
MKN74,selumetinib-JQ-1 (4-1 mol-mol),1.7394351663824423
ONS-76,49766530,-0.8397126534273769
NCI-H1666,439501,-0.7596014001034053
HOP-62,107970,2.340316246371355
M059K,selumetinib-JQ-1 (4-1 mol-mol),1.7015071354964328
KYSE-510,selumetinib-JQ-1 (4-1 mol-mol),4.587608539341743
SNU-16,selumetinib-JQ-1 (4-1 mol-mol),-0.036968234082151
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
BT 164,5460769,1.5184738603275272
KMS-20,4259181,-0.0713242382704696
SNU-466,327653,2.6893389012281834
BT 164,241158,4.083914381884583
2004,136227331,4.391518238587266
253J-BV,135421197,3.2645583108657217
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
5637,3689413,-0.8929275995994026
PaTu 8988t,6852167,4.186106645973286
JHH-1,168313016,4.409492948023239
WSU-DLCL2,327653,2.070157362085428
SW1271,9936388,2.2656701786136315
JHUEM-1,637858,1.3497979097457864
IGR-39,439501,-2.7155182926460832
T24,637858,2.492000159283808
TE-14,9936388,-5.01118425035393
SNU-620,BRD-K27188169-navitoclax (2-1 mol-mol),3.09696399261744
BT 416,26596,-1.7367305778393065
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
HT,327653,2.456712877727426
KHM-1B,10302451,3.4740404834517156
Panc 02.03,637858,2.766769284687194
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
HEY A8,24180719,3.3084910976376105
U-937,637858,1.48880900039916
NCI-H2122,10302451,3.7465874333262654
NCI-H1703,11396600,3.3181128171686254
MHH-CALL-4,9936388,-7.2015851477673785
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207
YD-10B,10302451,-1.3287756961511683
NCI-H211,156414,1.061128990416998
Hs 683,262093,3.4514070525670295
BT 131,11455910,0.493476636285018
NCI-H23,12003241,-0.7384604538146603
KMS-12-BM,49766530,-2.33896572420352
NCI-H1299,73707398,1.237381568912588
CCF-STTG1,12003241,0.9586959919868534
MES-SA,9936388,2.5692609882827964
KMS-11,9927531,3.9884073246481058
A-375,9915743,2.060034252561476
YD-8,6852167,2.601588502277786
HGC-27,54596490,4.386231335265865
LAMA-84,100016,4.28644111913654
HCC1833,46907787,1.8265768936236628
KMH-2,9929138,5.036636108742583
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
KMM-1,107970,3.424252998103548
NCI-H2196,UNC0638-navitoclax (1-1 mol-mol),0.6687398915022545
JJN-3,selumetinib-JQ-1 (4-1 mol-mol),-0.4237843202351842
TUHR10TKB,selumetinib-JQ-1 (4-1 mol-mol),2.5341436510751754
Hs 852.T,444795,5.030337936357497
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
MOLM-6,136227924,2.6719988051227386
PK-1,10302451,3.287223466177899
NCI-H1395,5460769,5.87662281780079
PaTu 8988s,644241,1.4748860636178889
SNU-869,439501,0.8866471334792935
TCCSUP,6852167,2.775293027732918
BC-3C,327653,4.094698905019423
BT 231,3689413,-1.816097223149399
OCUM-1,UNC0638-navitoclax (1-1 mol-mol),0.1567632695939746
SF126,9903786,3.79320485000813
NCI-H1395,107970,2.4345825548290265
BT 248,439501,-2.3411963573363104
Peer,UNC0638-navitoclax (1-1 mol-mol),-1.4165935954052693
HCT 8,11455910,0.923477323038918
BFTC-909,54626689,4.365294423210906
U-251MG,44491742,4.097928635737581
HLF,637858,2.3340457243469905
Hs 294T,327653,3.611148476495374
SNU-245,9936388,-0.9809692402129652
Calu-6,6852167,4.13886535210474
LUDLU-1,3689413,3.1550499386231325
SNU-398,73707398,0.6638278244633883
MIA PaCa-2,135999136,4.438724153803844
KP-N-YN,136227924,3.0572578369433376
HCC1937,262093,4.048076592606387
LNCaP clone FGC,46907787,-0.4203114771143783
BT 444,136227331,4.190644654212499
CAMA-1,4259181,0.5315390076391365
GP2d,100016,6.428285689025714
COR-L51,11455910,-0.1708653149441187
OE19,73707398,1.8381430425163503
NCI-H841,46907787,3.457668599276525
RCH-ACV,262093,0.7174466036111895
KMS-18,46907787,-0.0444535065961487
L-540,3689413,0.298858834558217
TE 441.T,156414,0.839328879560188
Hs 578T,6852167,0.7100294177326232
SNU-201,10302451,2.8885993041273643
F-36P,11455910,-0.4221924181382917
MDA-MB-231,3689413,-0.2652306492331258
L-540,9915743,0.3390225663294273
EoL-1,9929138,2.1880692859665984
BHT-101,11396600,4.367853211267109
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
DND-41,3689413,-2.0667644412480755
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
KE-97,73707398,0.8488233877842626
TM-31,4259181,1.8515749843690743
DV-90,3689413,0.3888446743511712
MDA-MB-361,107970,1.8583499456777055
NCI-H2405,selumetinib-JQ-1 (4-1 mol-mol),-0.5847662551268008
CAL-27,135421197,2.124038194027939
NCI-H1299,49766530,-0.517142624612936
KYM-1,136227924,2.3887987595454594
RERF-LC-A1,444795,5.084978113439599
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
FTC-238,241158,3.997303742735551
NCI-H146,44491742,2.6808030102351323
NMC-G1,107970,2.528467571568031
L-363,11455910,-0.1325866927171838
SNU-466,24180719,4.487288552600118
PC-14,9915743,-2.4249555987147615
MHH-CALL-4,11396600,2.799931622192491
MES-SA,6852167,3.4530557014146024
SNU-878,24180719,3.680298461653599
NCI-H1734,selumetinib-JQ-1 (4-1 mol-mol),-1.5307267440702577
KP-3,10231331,4.79345932538097
HT,637858,1.2510770253025525
KE-39,24180719,4.116999771545502
FTC-238,26596,-1.757502878688391
SU-DHL-1,168313016,5.361416197440646
NU-DHL-1,637858,-0.1721952663561851
HCC1395,3689413,-0.620515875859175
HEY A8,637858,2.557883541626409
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
MDST8,26596,-1.25574590011264
NCI-H1155,44491742,3.896429855213272
Daoy,10302451,4.756484214423896
ZR-75-1,73707398,1.0303983431454184
HD-MY-Z,selumetinib-JQ-1 (4-1 mol-mol),0.9792895483914368
TUHR4TKB,135421197,2.8220761476999665
EFO-21,168313016,4.418933774560441
A-673,6852167,1.8255345198368305
CML-T1,71466445,2.0221424049362033
T84,9915743,0.6360721322539938
KNS-60,262093,2.4239806824503876
Hs 683,9903786,4.056971165383086
Hs 578T,71466445,2.0883073445743574
2004,44491742,4.273676019695118
A3/Kawakami,4259181,0.5157779937872828
A2780,10231331,0.3686619766312378
ES-2,49766530,-3.8492688352561055
MDA-MB-361,375860,2.2561583319189773
SK-MM-2,12003241,0.4022958113963022
BFTC-909,637858,2.264716830291231
AsPC-1,73707398,2.3690176063372888
Raji,10302451,3.856690135156121
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
JJN-3,26596,-2.098638975777458
NCI-H1651,26596,-1.4213694669265446
BICR 18,375860,-0.1292020331481549
MDST8,6852167,1.3374988720553735
SNB-75,241158,4.443207850412388
IGR-37,11396600,3.951317160447081
SK-BR-3,9936388,-7.247395712922041
Hs 683,11396600,3.438921740314131
Lu-65,135421197,2.266142941564523
SNU-398,9915743,1.0980624705271882
Panc 03.27,12003241,-0.3666669100111787
Becker,selumetinib-JQ-1 (4-1 mol-mol),4.188822961792769
LNCaP clone FGC,9903786,4.486079979714403
HEC-59,12003241,-0.4049011737939335
SK-OV-3,24180719,3.148638094054939
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503
OE33,637858,2.678273035808489
BT 216,135875424,2.865998902674901
A2058,375860,-0.1531874219729508
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
SNU-C1,46907787,0.1536504661582554
KO52,11396600,3.051627581840025
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
786-O,241158,3.701389818055655
U266B1,136227924,2.814695997301776
NCI-H841,6852167,3.0459288620836964
BT 328,241158,5.267624320159163
PL-21,26596,-4.324956328818882
Hs 895.T,5460769,5.961347926985583
RERF-LC-A1,10231331,6.3240202906005045
NCI-H1563,100016,6.550294719377214
EFO-27,156414,2.3785601677308215
MOLP-8,637858,0.6022882265593398
MEC-1,5460769,1.3276972601062724
EFM-192A,10302451,2.636572550550667
SR,136227924,2.657612515566446
TT2609-C02,54596490,5.109876516053897
HEC-151,5460769,2.7656616945667
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
HLF,73707398,1.1086250249858645
COLO 668,10302451,4.094573947065704
SK-MEL-5,9903786,4.335376265950657
HPAF-II,10302451,3.631982907327204
RMG-I,6852167,3.689813828532847
NCI-H211,375860,-0.4774994527633157
Peer,135398744,6.7016638444522325
HuH-1,4259181,-0.1704791553622929
BICR 16,73707398,1.1623092103049966
NOMO-1,73707398,0.2786764614411772
LNCaP clone FGC,439501,-2.4937134944398176
NCI-H2081,156414,1.7676788858922157
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
NCI-H460,73707398,3.251551904382877
CCK-81,637858,1.7536647831614909
LN-229,6852167,3.506524715278259
SK-MEL-3,3689413,0.509275079548213
HCC2218,10302451,2.366058376925374
ALL-SIL,262093,0.6753795238054565
SK-MEL-24,439501,0.5144696508733063
WM266-4,241158,3.707551482011516
NCI-H661,168313016,5.326553105852446
MDA-MB-453,262093,2.6969191096415113
OE21,6852167,2.0185127581228763
T24,5460769,2.1302621758873435
HCC2279,49766530,-1.2949504069495965
CAL-29,439501,-2.337192610313779
SNU-1214,24180719,2.9494589381604026
A2780,241158,1.61479428578643
NCI-H1666,100016,7.086863626956854
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
NCI-H1092,6852167,4.811360661328789
HCC1195,241158,3.21939431238571
BT 139,3689413,1.1435542954681734
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
HuH-6,439501,-1.8507525220603604
MPP 89,107970,1.974109057124115
639V,136227924,2.8924456476929605
OCI-Ly19,3689413,0.0585798733039559
Kasumi-1,10302451,0.677780573615616
JHUEM-1,26596,-1.2940313289426515
Rh41,46907787,-1.0296946770791056
KE-39,44491742,3.945663107977575
EPLC-272H,49766530,0.3578946183960979
SK-MEL-3,135421197,1.515093492040075
GB-1,241158,3.739869791827646
Hs 936.T,3689413,1.174689206695868
SNU-869,136227924,3.0372027283613505
CAL-78,9936388,2.7062290727666816
JVM-3,12003241,-2.550977818363364
NCI-H841,4259181,0.3090048316145359
KYSE-450,54626689,5.089860588921688
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
SNU-119,49766530,-2.6347810345662785
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
OVK18,5460769,2.4178106376045516
J82,selumetinib-JQ-1 (4-1 mol-mol),4.77504788089244
HSC-2,46907787,4.2296699665196344
JL-1,selumetinib-JQ-1 (4-1 mol-mol),2.2145378518156345
253J-BV,12003241,-1.283652626050959
EFE-184,9915743,2.640815176926095
SNU-620,44491742,4.13195678155616
SNU-899,168313016,4.812796828917726
Pfeiffer,3689413,-4.622184503253435
SNU-1076,44491742,5.119632622149795
MKN1,UNC0638-navitoclax (1-1 mol-mol),3.1350259693808926
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
SNU-620,107970,2.1644257311198936
NCI-H1563,9903786,2.6215320097996684
IGROV-1,71466445,2.3758001916617797
BT 164,6852167,3.560765959786231
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
BT 216,71466445,4.739477596582892
DU4475,644241,1.8384373512088976
UACC-62,9936388,3.097569174421774
A4/Fukuda,135875424,2.943838777845953
HD-MY-Z,46907787,2.2677015455494187
HEY A8,107970,2.371695678258084
HEC-108,4259181,0.4931043474853455
NCI-H1573,12003241,0.8925202340822594
OCI-M1,46907787,-0.947970936826993
NCI-H520,46907787,1.4915843927881316
SU-DHL-1,11455910,0.1271925880707346
DND-41,11455910,1.0422963026529204
OCI-Ly3,9936388,-6.9188564775194035
L-363,168313016,3.838439815056608
BT 139,156414,0.911612783306993
ESS-1,5460769,-0.3251379363550979
KMBC-2,3689413,-0.0193871140642154
HuH-28,73707398,0.8791610389008363
VCaP,135421197,0.8808099569732696
ST486,11455910,-0.3463533308218484
MG-63,107970,2.132030955920877
NCI-H460,439501,-2.362377537788676
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
SK-MEL-3,4259181,0.967538636263607
NCI-H520,644241,4.472644159305388
HCC1806,241158,4.195325698193969
SCC-4,644241,1.8790035097217737
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
WM266-4,11455910,-0.4355783836702207
COLO 678,100016,6.808142270815235
G-402,262093,2.972927806454912
EM-2,439501,-2.360437246727397
HCC44,11455910,-0.4907181791415154
MHH-NB-11,4259181,-2.6012580075129494
JHOM-1,637858,3.172765266389714
SNU-601,10302451,3.762945529134958
RPMI-6666,24180719,3.48215874438346
HOS,73707398,3.147958849673515
CJM [Human melanoma],135421197,2.95523092671823
SW948,10231331,-0.4116197219649379
HOP-62,262093,4.19078744138027
AsPC-1,24180719,3.701309063973522
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
A-375,107970,2.3829956966560664
TE-5,100016,6.463093527046919
MHH-CALL-4,73707398,0.4741930113136588
NCI-H1651,168313016,5.365886513418571
SNU-1,168313016,4.634706136735533
JVM-3,135421197,0.8439957558117435
HCC44,12003241,-2.184153343310603
NCI-H1944,3689413,3.2556823925737395
Mel Ho,241158,4.052373465177995
P31/FUJ,26596,-2.2448149587984836
KMRC-20,4259181,0.4653117276954742
BT 416,44491742,4.3969888889672415
TF-1,71466445,1.6305537519060282
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
ES-2,54626689,4.486863219854404
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096
Hs 888.T,selumetinib-JQ-1 (4-1 mol-mol),4.1803685038079665
SNU-5,46907787,-0.3928354111783015
PF-382,selumetinib-JQ-1 (4-1 mol-mol),-1.2412031100333754
NCI-H1339,135875424,4.767141568633495
DB,46907787,-0.5328399527377402
786-O,54626689,4.241906872411121
IPC-298,135875424,4.836826203485717
UM-UC-3,444795,4.9683698067712365
HDQ-P1,3689413,0.8200542052424229
IMR-32,49766530,-2.845366137118504
Hs 683,135421197,1.945110581550152
RKO,4259181,-0.4049041326260317
HT115,3689413,1.0252939168322983
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
MSTO-211H,9915743,-1.0722844498490078
HCT 8,6852167,4.092945222972044
PSN1,262093,2.941975220157323
SET-2,136227924,2.6175155289445646
SW1783,73707398,1.417049584359394
OE33,11455910,2.709307324033481
JeKo-1,327653,2.5433327541113333
SW48,73707398,0.6331221198690845
SU-DHL-10,3689413,-0.1067642786236739
SNU-1,9915743,0.7760871972168086
NCI-H810,135398744,5.260119762115652
ONCO-DG-1,9903786,3.737117521186133
PF-382,135421197,0.9667662585436329
LCLC-103H,4259181,1.0955663651185623
Detroit 562,26596,-2.098444949143179
KYSE-510,73707398,1.7707709875360005
Namalwa,107970,1.960491610604563
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
K029AX,11396600,4.390484410073567
Hs 839.T,4259181,2.177978802351787
LOX-IMVI,9915743,1.7866984805438202
SK-N-DZ,9915743,0.9921777316804312
VCaP,73707398,0.7017253624246395
SNU-685,136227924,3.487679457544809
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
NCI-H2052,10302451,3.419992680957008
NCI-H446,54626689,4.134256079285674
Sq-1,644241,2.9163264724433136
M-07e,10302451,3.6544835870370815
SNU-1105,3689413,0.7210916116253745
NCI-H2170,637858,3.3845898272276016
SK-N-MC,637858,1.08432841840482
HCT 15,3689413,1.3698068653375808
SNU-620,10302451,2.660381585705483
ML-1 [Human thyroid carcinoma],375860,0.003862862725961
RPMI-6666,107970,2.181327963925534
CL-11,241158,4.171275148838918
SH-10-TC,135999136,5.659373349051974
KE-37,262093,1.3419761733864255
23132/87,439501,-2.5239735825770797
MHH-NB-11,10302451,3.700428006456128
Mino,136227924,1.7493984310197022
Kasumi-1,444795,4.080394330066641
RT-112,637858,2.10625188542633
TM-31,10302451,3.782179608043209
HOP-62,12003241,-2.147728480634193
NCI-H1734,11455910,0.8885636438539928
OAW42,9936388,-0.5306764798725707
Lu-99,100016,4.341210602126273
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
HCC1588,3689413,0.6550602760333641
SU-DHL-1,107970,1.234326472603969
NCI-H2405,46907787,0.6159609614456228
EM-2,327653,2.703948215233707
HT,71466445,4.097100218112886
Jurkat,49766530,-1.3206088246448346
Calu-3,107970,1.816322424399714
SK-BR-3,3689413,-0.6055139082378386
SCLC-21H,selumetinib-JQ-1 (4-1 mol-mol),-0.3063993577138266
OE21,12003241,-2.4283256435660205
OVK18,12003241,-0.5661348884613613
Hs 888.T,10302451,3.1676099375521263
IMR-32,11455910,-0.0063621760742968
NCI-H1755,637858,1.863634433373937
ALL-SIL,10302451,-1.1728976190372558
LXF 289,135398744,6.087135496005038
HT115,44489367,4.290876709778966
HuP-T4,156414,-2.045710295199573
HCC1954,11396600,4.077392960060392
SW1417,135875424,4.272780059645497
Ki-JK,637858,0.6675155607453573
SUP-M2,135421197,0.9814934118096088
DB,4259181,-1.103754913039793
CAL-51,9929138,6.421072450841616
NCI-H841,375860,-0.3820365701601304
A-253,3689413,0.6147211160043753
SUP-M2,UNC0638-navitoclax (1-1 mol-mol),0.3542006408694472
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
SNU-1079,6852167,2.2180229891841723
L-540,49766530,-0.200470626398811
KE-39,9915743,-0.5446321163343049
L-540,46907787,-0.1213280736644094
Hs 294T,156414,1.7651646794166465
KMS-18,439501,-2.5838956635173287
DLD-1,262093,2.7792650333384072
HT,26596,-2.1592273986948394
EN,10302451,3.9663070096792303
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
NCI-H226,BRD-K27188169-navitoclax (2-1 mol-mol),3.945266063582221
MDST8,439501,-2.351670240427255
MPP 89,26596,0.6612538021834572
IMR-32,262093,1.1917781979548805
WM266-4,107970,2.3123576759858
BT 164,49766530,-0.4702645034832948
JHOM-1,6852167,2.88456787030296
U-BLC1,11396600,3.266285635126102
HuH-1,100016,6.427674645277276
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
SK-N-MC,9903786,1.1605258193445984
PK-1,10231331,4.583437812683764
OV7,selumetinib-JQ-1 (4-1 mol-mol),3.65742971657535
NCI-H838,6852167,2.9602564244495713
JHOM-1,11455910,0.6774290111714439
ME-1 [Human leukemia],selumetinib-JQ-1 (4-1 mol-mol),-1.5743329708103595
NMC-G1,UNC0638-navitoclax (1-1 mol-mol),2.0372459349033716
COR-L95,375860,0.21091681928276
SW1573,54626689,3.958399976383255
PK-45H,262093,3.1651162159981765
NB1,9936388,-7.943927579353001
T3M-10,10302451,2.8903780681865636
EN,12003241,3.248318270429482
BT 320,644241,3.936570500455286
Lu-99,12003241,-1.7463019078510122
Kasumi-1,135875424,2.9305214666609904
IPC-298,4259181,-0.8006210931556415
Hs 888.T,54626689,4.7169294925106025
HCC1833,73707398,0.9424461947301042
ME-1 [Human leukemia],241158,1.6111961137085613
SU-DHL-1,26596,-2.3613305357908625
KMRC-3,156414,2.3420261536798663
RMG-I,5460769,4.854195851393806
SKM-1,168313016,3.949913306453134
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
MKN1,selumetinib-JQ-1 (4-1 mol-mol),4.262768356267428
ACHN,637858,2.369370305211161
CAL-27,9915743,-3.4733954540635015
RPMI-6666,262093,3.187153978804494
NCI-H526,637858,1.1191066667687413
DMS 454,136227331,4.3527556098556275
BT 159,11396600,2.8148026318928054
YAPC,9929138,5.651296587688524
MCAS,4259181,0.6276233805104566
NCI-H1944,135875424,3.314930841291418
SNU-1077,44489367,4.954217803557541
IGROV-1,3689413,-0.3633634632064185
U-CH1,6852167,2.6187781142325823
JJN-3,262093,2.0717593866365847
SW1417,107970,2.060618552310012
NCI-H1694,135875424,2.6288634269875075
KE-97,637858,1.152191846926287
SNU-449,73707398,1.8238531786702632
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
HCC366,637858,2.347165295871174
Hs 888.Lu,10302451,3.51710263851651
HCC1143,9915743,0.7364353129897024
BT 224,9927531,6.091778203420535
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
SK-ES-1,107970,2.2840745570981738
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978
MOLP-2,375860,-0.2269367011336988
BT 164,135999136,1.3864420097377277
RL,11396600,2.7344364548427413
SW1271,136227924,3.2074421772411372
ONCO-DG-1,12003241,-0.5849918543503058
DEL,73707398,-0.3093051259140468
OE33,44491742,5.719021846419829
DMS 114,11396600,3.971117414652232
NCI-H2452,262093,3.2163720661137942
LNCaP clone FGC,135999136,2.023158565172241
Ci-1,9927531,4.406404304601132
RL95-2,241158,2.957107105755342
JVM-2,10231331,-1.0631945813970318
SJSA-1,73707398,1.3784617669206425
SYO-1,9903786,1.9235940661883033
NUGC-3,10302451,1.9926087789716964
EFO-21,241158,5.404342041267148
Mel JuSo,11455910,0.951920968650534
SF268,262093,3.1286411170758113
SK-MM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.4426024400590536
BT 248,444795,4.817055384579841
NB1,10231331,2.218353261890846
MDA-MB-435S,241158,4.325248822766316
NUGC-3,4259181,-1.671238825802355
NCI-H1581,637858,1.6649755773360142
MV4-11,262093,1.4019245337963713
SHP-77,73707398,1.2877058560034058
KP-N-YN,54626689,4.960149402588451
TE-6,136227331,4.078918341903366
G-292 clone A141B1,4259181,1.2731839652194843
BHY,3689413,1.273700268174745
BxPC-3,375860,-1.018881063070817
Panc 03.27,54596490,4.426950175549895
697,10302451,0.2291087598985289
NB1,46907787,2.2087209713335736
HMC-1-8,6852167,2.3465845176332953
CAL-54,24180719,3.055306580078546
NCI-H524,9936388,-8.40858165815813
CAL-85-1,168313016,5.825760446908126
OAW28,11396600,3.5740319462685535
YD-10B,26596,-1.4003119054370567
KP-2,156414,1.9292190738661952
BT 179,135875424,3.093650685325698
42-MG-BA,135875424,2.570592080360526
DV-90,44491742,3.389036842154366
BT 159,136227924,3.541986211057949
NCI-H2286,49766530,-2.3239391037136654
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
SK-N-MC,11396600,3.4054376977010485
M-07e,11396600,2.6873765044270463
SW1710,4259181,0.6388275128085489
HEC-108,9929138,6.458847770997077
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
OVTOKO,6852167,2.7499655001384995
SU.86.86,73707398,1.5768997133892455
Karpas-620,9903786,4.2683089971609265
NB4,26596,-4.43915063636903
KMRC-2,168313016,5.0095238893407315
SW48,3689413,2.066117060158584
CAL-33,4259181,-0.7192046491947381
KMBC-2,12003241,-0.070536665370705
NCI-H1651,selumetinib-JQ-1 (4-1 mol-mol),4.513797591593027
PC-3,107970,3.1728973881319753
NCI-H1793,135421197,3.9424142241593145
TE-5,9936388,-0.0111298591303443
A-549,136227924,3.1395144761786486
OVCAR-5,46907787,2.1714346553006862
VMRC-RCZ,12003241,-1.8843773680512867
HPB-ALL,73707398,0.3017873739761496
SNU-81,73707398,1.1294477244846828
NCI-H1792,135421197,1.9377775784144329
HT115,9915743,-3.7208520870958286
RL,49766530,-2.7332300451243294
HLF,4259181,0.3097123752626088
EM-2,11455910,-0.237589126916505
U-CH1,3689413,0.3133886953072482
CAL-12T,107970,2.601314081604761
NCI-H1355,6852167,2.860107026969785
SNU-1041,12003241,-1.3076188477929267
TE-11,135875424,3.5127349276031996
SUIT-2,241158,4.373615531607702
C2BBe1,135421197,0.6239864918667269
HCC2108,3689413,-1.830632797435868
BT-549,9903786,2.513972936103366
DND-41,73707398,-1.2139974872607189
SK-MEL-3,11396600,4.278325283702902
IPC-298,12003241,-0.6695697613758284
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
IGROV-1,241158,3.288496474515495
HCC44,71466445,3.444849178593719
Hs 746.T,44491742,3.728027076014932
NCI-H1734,9903786,1.4575898804478404
BT 159,241158,4.193201486638546
EC-GI-10,selumetinib-JQ-1 (4-1 mol-mol),4.048995652828291
HCC1569,5460769,3.8365065781624255
SNU-449,54626689,4.585589968636992
NCI-H1944,24180719,4.907268975851754
HEC-108,135875424,4.07561778301408
NCI-H209,9927531,3.5477571143466156
HEC-265,637858,2.1532926189030386
HCC44,375860,-0.7535444730887934
KMS-18,12003241,-1.9143210957947092
HCC1143,135875424,3.1375636080090925
A-549,9929138,6.139762216307962
KMS-26,135875424,3.4699512465530713
NCI-H69,6852167,1.728526971731107
HEC-6,100016,5.931518422248653
MOLT-16,10302451,3.2248246991129985
SET-2,444795,4.329364706689898
SNU-1214,10231331,0.2722984048431807
U-118MG,637858,2.0304539500460015
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186
BT 422,3689413,0.8456322118691856
P-STS,3689413,0.8859178339084445
MHH-ES-1,4259181,-2.005736185062781
OCI-AML-5,3689413,0.2797126247075585
ONCO-DG-1,10302451,1.357943287176287
HDLM-2,UNC0638-navitoclax (1-1 mol-mol),-2.911208376881327
MOLP-2,54626689,5.197362662891135
CAL-51,10302451,1.350542324147247
ME-1 [Human leukemia],4259181,1.0162660070131528
Hs 683,135999136,4.01183659290713
Panc 02.03,24180719,3.694319415808187
HeLa,3689413,0.6540693787829278
SNU-1041,107970,2.962273906034501
KNS-81,11455910,2.3157999192593888
KMH-2,9915743,0.5597932998699471
JVM-3,135999136,1.5770128380468875
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
NCI-H838,9936388,2.922779996332477
LK-2,439501,-2.6408972828107053
F-36P,UNC0638-navitoclax (1-1 mol-mol),0.5889836911302547
SNU-878,UNC0638-navitoclax (1-1 mol-mol),-0.9446051430967974
HCC202,73707398,1.13633679828289
NCI-H23,135421197,1.340316450445973
NU-DHL-1,10302451,2.2542174061675055
SNG-M,9915743,0.6282873859108726
COLO 829,9936388,-8.135727269739062
SNU-449,4259181,0.6587440570439733
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
KNS-42,10302451,3.728146529938257
Li-7,156414,1.35161341660602
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205
BT 224,12003241,-0.3430722292852487
SK-CO-1,444795,5.109688629113172
DK-MG,135875424,4.206439943890902
JHOM-1,3689413,0.7537035675764964
IGR-39,9915743,0.9113402553932568
NCI-H1341,107970,1.14679418621191
SCC-25,168313016,4.190269075253486
NCI-H28,439501,-2.3815897212946333
CAMA-1,327653,2.753376635525665
TUHR10TKB,136227331,3.9944328984652975
SNU-1105,10231331,2.3119647781894272
KMS-21-BM,11455910,-0.3641448488710944
GB-1,54626689,4.27693354733002
BICR 18,6852167,2.321701706128057
PE/CA-PJ15,9915743,-1.4704662389348668
SNU-626,9903786,4.459436811322819
BT 164,375860,0.1283909632199744
NCI-H322,637858,2.9009451409256273
CJM [Human melanoma],9936388,-7.628341639171254
U-937,6852167,1.5283780064526906
SH-10-TC,4259181,1.4387365857426029
JHUEM-3,107970,1.8006750209945723
PLC/PRF/5,439501,-1.8160204684239925
Yamato-SS,135421197,2.276835379752713
SNU-8,46907787,1.495459042873151
HEY A8,54626689,5.83297345931857
Hs 944.T,5460769,2.3296902245035995
NCI-H1703,135421197,2.2444093773538043
TE-9,5460769,0.3621954570930285
Becker,135999136,4.331325475055123
CAS-1,107970,2.1962069806486326
SK-MEL-1,4259181,0.7052646872097644
ES-2,375860,0.1597186252009672
BT 422,10302451,4.143225986408294
HCC1806,5460769,-0.192100809913994
NCI-H1650,9903786,2.8320144189469385
NCI-H2110,168313016,5.8271641700116215
DB,11396600,2.484814775765491
NCI-H2291,5460769,2.25244251110153
RPMI-8226,439501,-1.9239295318483216
ZR-75-30,156414,-3.885096329656602
SYO-1,6852167,2.5720443571070546
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
SNU-878,26596,-1.9589890224119235
EBC-1,6852167,1.79353662478517
HGC-27,135398744,6.47323705988127
COLO 684,262093,1.418781406629004
SNU-738,54626689,4.568369397903385
DU145,5460769,5.167808415466422
B-CPAP,439501,-2.790842155958922
MES-SA,73707398,1.87604618350638
JM-1,9927531,4.0230036766634125
DLD-1,73707398,0.9462775715159254
NCI-H2228,4259181,0.2163071151070651
Raji,26596,-2.574302974428465
MFE-319,54596490,4.465210230923051
OAW42,439501,-3.627774271274344
HCC1588,26596,-1.1478060280369464
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
CHP-212,9903786,1.1399886841606115
G-361,637858,1.6464472873206493
SNU-1,156414,1.4754796967551809
TE-8,135875424,3.858903579459316
SUP-B15,UNC0638-navitoclax (1-1 mol-mol),-1.2738444623015683
SNU-C1,11396600,2.8735657781270003
A-204,327653,2.705970152182007
SUP-B15,439501,-4.354200278672526
COV362,107970,1.7647317871906374
HCC44,73707398,1.5654778950043116
BT 330,637858,2.906999129152924
JHUEM-1,135421197,1.216827050882974
LMSU,241158,4.2548793295703025
LS123,444795,4.324297623780839
Rh41,136227924,2.134040377876842
KMS-18,6852167,1.1752786516202087
WM983B,49766530,2.209591976361656
BT 228,5460769,3.1734234469755775
BT 428,selumetinib-JQ-1 (4-1 mol-mol),-0.8814562357404941
A-549,135999136,3.721733527600953
SK-N-FI,327653,2.9446631388146383
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
KMS-28BM,241158,0.8736847772336357
EB1,135421197,0.2915543489276729
HCC1419,44491742,3.720252057260251
NCI-H2196,11455910,0.991466046593156
JIMT-1,49766530,-0.5672366381322033
COLO 792,24180719,3.7164928233513033
DLD-1,241158,4.313425488580076
DOV13,135875424,3.915299469104102
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
KNS-81,73707398,1.6579800817235788
HCC1806,168313016,5.712077143573756
HCC1569,4259181,0.6490126665134603
P31/FUJ,44489367,5.126164790260484
SNU-449,135421197,1.7191553190938056
Raji,54626689,5.170364825272944
MDA-MB-157,375860,0.0174110406826079
JM-1,135999136,3.9281924738089016
SNU-1033,262093,2.351645391909522
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
SK-ES-1,644241,2.5960462683298067
NCI-H2023,73707398,2.6726280968603287
C2BBe1,4259181,0.796166800859259
MPP 89,10302451,3.6853052068561816
Hs 940.T,46907787,1.3777694831541
DU145,375860,0.0587895300626014
A-375,6852167,3.704250523230319
Lu-65,26596,-0.6076566338784338
IPC-298,9915743,1.3514375802174825
NCI-H1869,9903786,3.8309501172404734
HuT 78,135875424,3.0458075465752694
DMS 273,6852167,2.1769146352356707
A4/Fukuda,100016,4.8831896191852096
JVM-2,637858,1.463406475028887
BT 228,156414,1.710173414440736
TUHR10TKB,10302451,3.6459208870681774
JHUEM-3,156414,0.1798690531293942
LNCaP clone FGC,135421197,1.5055395740527522
COLO 699,9903786,3.444453349709646
WSU-DLCL2,375860,-1.1401457482447963
NCI-H1755,107970,2.3148125135378548
SNU-213,262093,3.638008939275064
TT,5460769,2.0834356012703155
HuT 78,46907787,-2.3061129610788833
P3HR-1,9915743,1.4210240305197754
HeLa,selumetinib-JQ-1 (4-1 mol-mol),4.321478137399501
BHY,637858,2.0345881350811297
M059K,135999136,4.281587930141844
BEN,9915743,3.139870035792778
L3.3,6852167,2.807934515358382
KNS-81,156414,2.524016739930243
KMS-12-BM,637858,0.99115660334439
CAL-51,135421197,1.6266864976107616
DU145,54596490,4.798915584619797
TCCSUP,100016,6.5110410318476575
NCI-H1944,135421197,1.84181744698867
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
HCC78,3689413,0.9109498190296136
KCL-22,9929138,6.476952108797493
SK-N-DZ,3689413,-4.934308383981231
LOX-IMVI,5460769,1.2475955137176375
Hs 688(A).T,24180719,4.499880750867179
HCC202,3689413,-1.588009861739516
U-937,11396600,2.847104167418143
KYSE-180,375860,-0.0718407094344544
NU-DUL-1,168313016,3.4848851465403667
Rh30,637858,1.50729974182792
SK-LMS-1,637858,2.4121207019199074
LK-2,9903786,3.191424869539257
NH-6,UNC0638-navitoclax (1-1 mol-mol),0.3961901525390363
A-204,9936388,1.1921952776349394
EFO-27,24180719,4.15462806748021
GCT,439501,-2.020397475807145
DLD-1,135875424,4.314785833755313
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
OAW28,9915743,2.8675584787684456
MHH-CALL-3,6852167,2.761241961167472
HT-55,327653,2.92353631762882
SaOS-2,26596,-1.8442798913702467
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
IMR-32,135875424,2.969458523828033
LS1034,73707398,1.4627229109682227
SK-N-AS,637858,1.2070263661617462
BT-20,100016,6.680150665921765
SR,54626689,4.807386792276117
JHH-2,375860,0.4544273736853194
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
G-401,9903786,2.8038927126182327
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
RL,4259181,0.4203356092825316
SNU-182,644241,1.5546173589165062
LOX-IMVI,107970,2.2116293322990264
KMRC-2,12003241,-1.7913952791170802
SK-N-MC,107970,1.887698358378098
B-CPAP,4259181,0.2789779013360439
HCC2108,44489367,5.96526198558648
HD-MY-Z,439501,-3.7474534787438714
JHUEM-3,9927531,4.734556698770441
HCC78,10302451,3.668800940704608
A-253,135875424,3.168681324917889
KO52,24180719,3.93533100976642
HCC202,637858,1.2638902875992883
HD-MY-Z,49766530,-2.787165933045758
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
JK-1,9929138,4.47533502757398
NCI-H2081,73707398,0.6809572071185331
Hs 940.T,10302451,2.168659720829093
Karpas-620,54626689,4.953675786442807
OAW28,10302451,2.68651474445359
DEL,5460769,1.5827510666329687
SNU-1,135421197,1.7958722609417297
KATO III,135421197,1.1737614873683315
EN,327653,3.831719900381987
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
KMRC-1,107970,3.035071998795665
Granta-519,9927531,4.885085469625254
YD-8,9903786,2.667696713101927
MOLT-16,375860,-0.5978036063438881
SNU-423,241158,3.874082799654454
KMS-27,11455910,0.2864489394234576
NOMO-1,12003241,-0.5951695723430065
SEM,71466445,-0.7002004774951326
KMS-27,73707398,0.1300509584750546
CAL-29,12003241,-0.9586511485623302
WM983B,262093,4.372812176554698
CAL-85-1,135421197,1.4377656539975323
CAS-1,439501,-3.1948113083897223
SK-LU-1,439501,-0.3728808637534341
BT-549,9936388,-4.888200161073446
MOLM-13,11455910,-0.3133362084586128
NCI-H2110,107970,2.6685379556569297
OVK18,73707398,0.6900312181003939
NCI-H522,241158,3.3210308536521156
U-251MG,11396600,2.977650858137137
JHOC-5,136227924,3.178485175637893
MSTO-211H,100016,4.243846732059744
SNU-1105,9936388,-0.2458072651641521
NCI-H2196,54626689,4.218847448418183
NCI-H460,11455910,1.4134750909778395
AsPC-1,3689413,-2.062701377390924
HPAC,637858,2.270663033055596
Ri-1,73707398,0.2154037021026328
BT-20,241158,4.666874417516415
TE 617.T,168313016,4.349421247778161
HCC202,135421197,1.3435596040644655
SK-LMS-1,3689413,-2.0473825870324935
SNU-81,3689413,1.1974270464491454
OCI-AML-5,12003241,0.3941324977706439
OVTOKO,107970,2.3329176858745164
MDST8,9936388,-2.5080849755955485
Hs 888.T,5460769,6.095978340264565
RPMI-8226,135875424,2.066297647502018
PLC/PRF/5,107970,2.9757983230893092
TE-10,107970,2.363675844497519
HCC38,73707398,0.9482703589784276
CAL-51,168313016,5.819136604546001
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
RVH-421,24180719,1.644818701894013
HMC-1-8,46907787,0.1330345715933646
Ishikawa (Heraklio) 02 ER-,135999136,1.8759825202501337
MOLM-13,11396600,-0.7885098330267027
BT 444,10231331,2.8828813905739388
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
NCI-H1568,9936388,-8.53108348301746
Hs 766T,9915743,-0.5263602870781319
MOLM-6,444795,3.219828752375847
YD-38,439501,-2.4363640234681347
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
RERF-LC-MS,4259181,-1.273108977623296
NCI-H358,selumetinib-JQ-1 (4-1 mol-mol),-0.8434190935752972
LoVo,11396600,2.965288622606591
Capan-1,9936388,2.896402107939059
COV362,12003241,-1.5516185540299623
HT-144,644241,2.394177436899907
HCC2218,168313016,4.988518158983073
LOU-NH91,3689413,0.742189593443008
CML-T1,9915743,1.9836361869709076
NCI-H2291,6852167,4.73681316056411
RPMI-7951,6852167,2.0077345898162675
Hs 746.T,10302451,3.5755968540448704
SIG-M5,100016,4.056618507771364
SNU-1196,46907787,4.641039727024587
CAL-33,135421197,1.5184759141231294
KNS-60,241158,2.203041444596406
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472
LP-1,241158,2.0926541088677055
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
NCI-H1838,156414,0.9997225683484908
Rh30,10302451,2.982588909550782
PL-21,107970,1.3819465807660944
A2780,11455910,-0.8495199814745813
BT 504,439501,-3.1394850364876907
KYSE-30,439501,-2.11333824600192
SYO-1,107970,2.1888093094332217
SK-ES-1,26596,-2.5080764618558775
SK-ES-1,262093,1.8712503240297784
COLO 201,73707398,0.9936334998071072
G-402,168313016,4.5360377997320915
TF-1,9903786,1.2296708534399408
FTC-238,262093,2.848255562611525
SCC-4,3689413,-0.212283545233458
42-MG-BA,241158,3.541250292338109
MG-63,135999136,4.46138735599139
A2058,selumetinib-JQ-1 (4-1 mol-mol),1.8047869257512583
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
Daoy,49766530,-2.465455878883475
MOLP-8,135398744,7.476327693514706
MeWo,49766530,4.570214778123743
YAPC,135398744,6.484368053683043
KO52,4259181,-1.031664922111082
SK-N-FI,71466445,2.6055268332428563
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
SK-MM-2,135875424,1.809957653015655
A-204,135421197,1.5277781833550137
MM1.S,26596,-1.4234323398175248
NCI-H508,375860,-0.1999863020255136
NCI-H747,9927531,5.010482166224782
IGR-1,26596,-0.0620943147126713
Mino,135875424,2.8874232883749578
TE-15,135421197,1.6096072932868513
HCC827,73707398,1.1622787671814725
HCC44,168313016,4.333593878585594
CW-2,136227924,3.283467391951437
RPMI-8226,49766530,-1.9522692121049856
M-07e,262093,1.9323160486424649
SNU-475,6852167,2.5801440708134193
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
Ri-1,156414,0.7366105303424468
SK-HEP-1,11396600,5.84824704867975
HCC1395,262093,3.7391779193808254
YD-10B,24180719,2.309682934798808
Li-7,637858,2.0676196467006447
Calu-6,100016,6.484915939204548
COV434,10302451,3.159485757996385
SNU-1076,9903786,2.0917140595670585
CL-11,136227924,2.4405671689998027
NCI-H1869,262093,3.2234761574881485
HPAC,327653,3.5480126625924804
OE21,637858,2.675555960290433
GaMG,10302451,4.686034849330264
Sq-1,135999136,4.253718800618169
TCCSUP,54626689,3.911629715273472
LS1034,10231331,-0.9247771776372667
Detroit 562,168313016,4.3016363208247235
DB,11455910,-0.1853401051603744
HPB-ALL,selumetinib-JQ-1 (4-1 mol-mol),1.6760902542091598
BT 245,3689413,-2.318316316051159
KMBC-2,73707398,1.4795418187244096
KMS-26,637858,-0.2587644829981909
B-CPAP,73707398,1.14773007898321
HMC-1-8,135999136,4.399756896007318
KP-2,73707398,2.475309032034208
SNU-423,637858,2.0123731637810875
OCI-AML-2,49766530,-2.1429855478008975
PE/CA-PJ15,9927531,4.562949408871821
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
HCC95,375860,1.218591942556542
Rh41,135875424,2.4863940955705517
JJN-3,9915743,0.8433303744027496
OCUM-1,375860,-0.572394584794254
M059K,135421197,3.1464794228942488
SNU-C2A,100016,6.499335908465164
M-07e,3689413,-2.11596462386005
EB1,637858,0.8330107296865988
NCI-H1435,11396600,4.531231464370408
KNS-62,UNC0638-navitoclax (1-1 mol-mol),3.437270318122968
MOR/CPR,9936388,-5.6462813856837055
CAL-51,9915743,1.1260994347217144
Hs 934.T,241158,5.288609584609173
HCC1569,11396600,3.770118441175883
WM266-4,44491742,3.776227470260235
SNU-16,168313016,4.402991610313933
TE 617.T,selumetinib-JQ-1 (4-1 mol-mol),1.4912652874419787
BxPC-3,439501,-2.27553783948146
NU-DUL-1,11396600,2.3602642092623753
COLO 800,54626689,5.6516946961985175
JHUEM-2,6852167,1.1461018937250853
NCI-H1184,375860,0.2561611360303955
NCC-StC-K140,9927531,5.259562635251384
ZR-75-1,327653,3.194009791572073
NCI-H2106,54626689,3.940367731220507
HCC2108,4259181,0.1536721114746798
PE/CA-PJ15,9903786,2.2611792207171484
PE/CA-PJ49,49766530,3.753784618730391
NCI-H322,9903786,4.921113869322727
BT 504,262093,2.380431698547906
22Rv1,9903786,3.2246012387786536
SNU-886,375860,-0.100716733121392
NCI-H2405,24180719,2.6118252586505113
8305C,3689413,-2.5688983672154575
SF295,10302451,4.330260751201553
JVM-2,375860,-0.3585152251232266
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
VMRC-RCW,135421197,2.019130008458573
MDA-MB-435S,375860,0.073459033352106
HEL 92.1.7,12003241,-0.5838184983387604
GI-1,11455910,0.5064796295845606
WM983B,24180719,-0.3073697815298015
SUP-T11,439501,-2.327064015434822
SNU-626,BRD-K27188169-navitoclax (2-1 mol-mol),2.798301591450071
QGP-1,100016,6.909688760762285
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
MHH-CALL-3,selumetinib-JQ-1 (4-1 mol-mol),2.581245013728603
NCI-H1838,6852167,2.848861882071558
COLO 829,73707398,1.647067774146123
HCC4006,6852167,2.5349173961292206
VM-CUB-1,135875424,5.069346685135383
GA-10,5460769,2.1295302547958976
MOR/CPR,4259181,0.2734993531272701
KMS-27,11396600,3.3340163467465573
GaMG,9936388,1.1516041835416544
SNU-1077,262093,2.74279505858148
Capan-1,9915743,1.7686030457629929
ALL-SIL,9927531,4.600523700119875
SNU-182,107970,2.1936630998991262
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
LS513,12003241,-0.5342180043119649
HuG1-N,156414,1.680497486867769
42-MG-BA,327653,3.7293022074682343
RERF-LC-A1,135999136,1.9235315107843012
CA46,135421197,1.13174100448049
L-428,24180719,3.2253016178343925
Mono-Mac-6,71466445,2.7223789510878524
TE-4,10231331,0.3803992395266883
JURL-MK1,11396600,3.824773747794518
NCI-H1339,6852167,2.7157240163412206
A-498,10302451,3.720340150939392
NCI-H716,71466445,4.25396332421541
ESS-1,444795,3.9723378710264985
SCC-9,135875424,4.9754653396039314
NCI-H660,4259181,0.4292897010686547
FTC-238,9915743,0.6345085116820538
Mono-Mac-1,136227924,2.2269797620359864
CAMA-1,3689413,0.0263776901636627
CAL-78,107970,2.506185199590124
JK-1,241158,1.4435433616658495
NCI-H524,3689413,-3.856889937044058
LXF 289,46907787,-0.1426698074457199
KYSE-140,327653,3.149359454040081
B-CPAP,49766530,-2.4408790709837396
Hs 578Bst,UNC0638-navitoclax (1-1 mol-mol),2.7234983149900964
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
RD,135875424,4.367894980695875
HPAF-II,136227924,3.1547615754637
RERF-LC-MS,46907787,3.883745984979501
NCI-H660,375860,0.3780778676190657
MEC-1,135875424,2.225432824256911
SUP-T1,107970,1.556646477102781
Detroit 562,selumetinib-JQ-1 (4-1 mol-mol),1.562753151865237
DU145,135875424,4.588838795967896
TE 617.T,10302451,0.2926739718102283
Panc 05.04,637858,2.56001931031159
Capan-2,54626689,4.713216544454884
NCI-H1435,135398744,6.3008870427516115
KM12,9936388,-6.571860760975573
Karpas-422,5460769,4.127517160029383
TE-8,107970,2.3283260801611916
MDA-MB-468,49766530,0.7158760984187301
MEC-1,12003241,-2.6195126554486223
KMRC-1,6852167,3.0099217565414693
TE-11,6852167,2.6244902782026966
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
SF539,3689413,-2.2250008276513107
KU-19-19,637858,2.3404288739792314
GDM-1,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2415593278739456
MOLM-13,10231331,1.9024628033326092
MFE-296,11455910,1.116173433967265
SNU-C1,327653,3.4971944416112795
EoL-1,49766530,-3.8413897802106014
Panc 04.03,12003241,0.3752932920389255
SNU-761,637858,1.643402740657157
AML-193,10231331,0.6322489911417504
NCI-N87,26596,-0.8687464208841552
KMRC-1,3689413,-1.8207429228817171
NCI-H1651,135999136,5.817346187949403
BT 231,637858,1.9874949933256931
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
Caov-3,4259181,0.2335996818142696
Li-7,9936388,-1.419334332710526
BT 440,439501,-2.9388364994679614
MKN74,11455910,0.5314790476879293
OCI-M1,54626689,4.522261035968461
8-MG-BA,9903786,3.978061546376923
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
SK-MES-1,444795,5.062530202812243
NCI-H441,73707398,1.0117211394398191
BT 444,327653,3.660965582464104
HOP-62,136227331,3.5608481617611165
MIA PaCa-2,375860,-0.6403278633855397
T-47D,136227924,3.374798567013006
OCI-Ly3,637858,0.9478393577089198
C2BBe1,44491742,3.6465315929226967
CW-2,262093,1.6035183288099986
LS180,439501,-1.9142457865624176
GA-10,3689413,-4.87834364200375
COLO 800,637858,1.9254657398660469
SBC-5,9927531,4.452264212548339
GaMG,4259181,0.737386892829234
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359
PE/CA-PJ34 (clone C12),3689413,1.240876822848384
VCaP,9915743,0.8539213695890696
NCI-H1694,135999136,3.5133999051844795
LAMA-84,4259181,-2.0546008756255767
NCI-H727,168313016,5.705554517808247
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
SNU-1033,375860,2.3566426851273063
HCT 8,439501,1.4071558312094663
L-363,71466445,2.316676755012692
CCF-STTG1,3689413,0.3028996084806184
769-P,156414,6.134448587786172
BICR 18,156414,1.618645532999343
MCAS,135398744,6.37399282177603
PE/CA-PJ15,44491742,3.9025986426144934
JHH-6,135875424,5.397184820434736
HuP-T3,327653,2.4979616286385573
KMS-11,44491742,3.7132617808424704
KALS-1,11396600,3.671510042060093
TE-1,12003241,-0.9529252226933594
HCC2218,3689413,-1.7582350299108729
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
NCI-H889,135875424,4.039374159627762
RCH-ACV,4259181,-1.0090631503985652
LOU-NH91,439501,-1.197324809082114
A-549,9929138,6.139762216307962
G-361,26596,-1.652088739985509
SNU-1214,100016,6.334633199659308
COLO 320,11396600,2.8347180367361235
TE-10,135999136,5.59737351740663
DMS 53,262093,1.90510022371224
SW620,637858,2.50208407243828
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
HT-55,135999136,4.374145297422013
KMRC-20,11396600,4.3348303945761835
Hs 822.T,3689413,-2.285857937794557
UACC-257,4259181,0.0904604772087934
SaOS-2,54596490,5.687426160237218
SW1710,9903786,3.726951851848614
SF268,26596,0.6172202345506846
SU-DHL-4,10302451,0.5258227793179377
G-401,71466445,3.182548969694367
BT 179,5460769,5.470437683574026
5637,241158,3.580140863644883
AsPC-1,10302451,4.160835682979353
AM-38,26596,-1.378118107802664
LNCaP clone FGC,54626689,4.472345767671783
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
HDLM-2,26596,-1.5696156753174118
BFTC-909,73707398,1.325657316242966
HCC95,12003241,-0.8735704800502477
SF539,9936388,-8.641778658087059
HDLM-2,5460769,4.226839303780804
SUP-T11,44491742,3.738526329456195
SNU-489,6852167,4.263249412846992
LCLC-97TM1,156414,1.5907536031970133
SNU-668,6852167,2.3843814312201603
KMBC-2,9936388,2.279378439007598
DU145,49766530,-0.0443271676579987
MOLP-2,selumetinib-JQ-1 (4-1 mol-mol),0.6007356900304069
LOX-IMVI,10302451,1.9959018084394209
HCC1500,54596490,4.413271545106012
COV644,637858,1.9905836123238367
MHH-NB-11,9903786,1.7813974868905205
NU-DUL-1,71466445,1.0857622618478715
SK-N-BE(2),71466445,2.4935058531452414
A-673,156414,1.4246196000990916
MeWo,9915743,1.4031179966359888
NCI-H2196,10231331,5.621753201885216
MFE-319,375860,0.1651753747878266
KMRC-20,637858,2.2731698678706027
KMS-18,UNC0638-navitoclax (1-1 mol-mol),-0.0148454242506128
BT 145,46907787,3.740968952451874
KMS-34,375860,-1.1418796151741155
DMS 114,10302451,3.9352333210903625
CAL-54,46907787,-1.4297052290573224
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
NCI-H661,71466445,2.1620252686029646
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
NCI-H446,9915743,1.175250953167702
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
SUP-T11,156414,0.8844395337826703
SNU-245,327653,2.306144869873458
HSC-2,54626689,4.515369195352833
HOP-62,10231331,1.3709968490270463
SIG-M5,241158,3.2994951506114827
KMS-34,44491742,2.8856017326933965
SH-10-TC,46907787,1.9589503619322264
HCC44,262093,3.638344184210184
NCI-H1355,5460769,3.1635335423218907
WSU-DLCL2,9903786,-0.2732990105431844
Mono-Mac-1,168313016,3.482496352370787
SNU-1272,3689413,0.1489687776606243
Caov-3,327653,2.7768695220445685
253J,49766530,0.1673174329767313
OCI-Ly3,12003241,-1.5890645032871102
HCC1195,11455910,0.2918122154241095
KYO-1,9927531,4.747865514161547
CAL-120,UNC0638-navitoclax (1-1 mol-mol),1.6079379957846396
MCAS,107970,2.3689234635005274
K-562,637858,1.3097643671251342
FaDu,5460769,4.852166639687207
NCI-H510A,9927531,4.438228286684184
Ishikawa (Heraklio) 02 ER-,135875424,3.942443711237878
VCaP,9903786,1.7887289169146705
HGC-27,262093,2.210004437321543
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
TE 617.T,10231331,2.9787791726298183
LP-1,6852167,-0.3749906746995474
JHOS-2,9915743,3.2140989729370273
CAS-1,644241,2.086999477594296
L-540,5460769,1.6720211707369994
MES-SA,selumetinib-JQ-1 (4-1 mol-mol),3.9352065939881538
Hs 683,375860,-0.6026673211862823
BT 330,5460769,2.587250000288721
WSU-DLCL2,49766530,-5.110358860052542
Lu-99,135421197,1.2736591779946078
LS513,327653,2.653571852634388
COV434,71466445,1.9159359610911857
NCI-H747,100016,6.898929440027426
KMS-34,11396600,-3.5704564556839227
TE-6,136227924,2.9118612520968803
SNU-1076,11396600,4.278437683696295
HEC-265,4259181,0.9428766197604146
SNU-407,46907787,-0.6820147293264143
MHH-CALL-4,UNC0638-navitoclax (1-1 mol-mol),-1.5087642797213563
COR-L47,9936388,-7.709676320407029
KMBC-2,5460769,1.880103554481412
WT2-iPS,54626689,4.986091442505818
G-292 clone A141B1,10231331,4.526878083033799
NCI-H2085,9936388,2.2479758965135828
KE-97,439501,-2.4280531684579896
CMK,5460769,4.702047832953649
BT 286,327653,3.383263992676688
KMS-18,327653,1.4419845630654913
NCI-H2405,10231331,-2.5791985337557155
Hs 934.T,156414,1.5290679569214394
RPMI-8402,262093,1.1284769386432876
BT 245,9936388,0.9041726045525886
SNU-738,107970,3.0367586938493756
SNU-16,444795,3.455599253564167
Hs 683,327653,4.055715527758498
HCC366,11396600,4.932418286549936
NCI-H2444,136227924,3.2293818919988153
Toledo,444795,4.36576066611392
SW982,241158,3.5394445387006948
OAW28,262093,2.853078829548121
Ku812,10302451,-2.0253572962014617
NCI-H2452,136227924,3.4253193575490695
CCF-STTG1,24180719,5.187179011089803
RPMI-8402,selumetinib-JQ-1 (4-1 mol-mol),1.0607904490994169
HeLa,375860,-0.2411971223696274
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963
IGR-37,439501,-2.841973609481132
EoL-1,262093,0.636688142118246
NCI-H358,644241,2.2506762746858144
HL-60,135421197,1.9226353151764572
GaMG,6852167,2.8661941087752445
SK-ES-1,9927531,4.061932878113416
Rh18,49766530,-3.897407053636511
CAS-1,3689413,-1.7594128574941137
NCI-N87,262093,3.0008468279122607
NCI-H1339,327653,3.7168174136495735
L-540,262093,1.75189061264014
LN-229,12003241,-0.983315383516156
NCI-H1703,637858,1.360095781311221
SNU-489,4259181,1.5212826565077282
Sq-1,444795,5.017643579289032
PC-14,637858,2.799364880868444
WM115,71466445,4.303064097958205
8305C,136227924,2.5381850582467913
SH-10-TC,selumetinib-JQ-1 (4-1 mol-mol),1.9837436435885376
PE/CA-PJ41 (clone D2),136227331,5.555158250699494
HEC-1-A,26596,-0.4494032602178983
SNU-308,6852167,3.364672579284096
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
SF268,11396600,2.843144767793207
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
HT-55,10231331,1.030153906918628
NCI-H838,9903786,3.3354692149309124
JHUEM-3,375860,-0.3399174798307714
OAW28,49766530,-0.5315014966120291
OCI-AML-5,168313016,4.3654687962480345
BT 359,439501,-2.266223118686084
TYK-nu,439501,-2.468535707905716
BT 224,3689413,1.7352583151087375
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
ES-2,637858,2.4124737052825975
OCUM-1,12003241,-0.8918432074998596
HSC-4,44491742,4.173988284907792
TE-6,135875424,3.6628772269399192
CML-T1,24180719,2.7823494948279373
NCI-H1299,439501,-2.475221299124019
Daudi,49766530,-5.535187194073846
BT 245,262093,2.3897148405812536
OCI-Ly3,135421197,2.144739759882478
BT 159,135421197,3.0775929354078926
NU-DUL-1,444795,2.712125699604821
YD-15,135875424,3.8226191901992377
NCI-H1573,644241,1.7880619305370915
MHH-ES-1,136227924,2.293763722118734
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
MFE-319,73707398,1.6772690272757178
SNU-213,327653,3.9341238423164127
AML-193,6852167,1.3321437801414788
TALL-1 [Human adult T-ALL],327653,2.1585656138598424
EBC-1,637858,1.730597013869335
TE-15,100016,6.263488161224716
SNU-C5,444795,4.656078466363809
ESS-1,4259181,0.7076598943715965
EB1,UNC0638-navitoclax (1-1 mol-mol),1.198480968859453
SNU-475,4259181,0.9455014217250642
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
YD-38,637858,1.9824428087241075
HCC1954,9915743,-1.9238050645061189
SJSA-1,375860,-0.2161052387707686
BT 239,11396600,1.7772646645104542
TUHR4TKB,375860,-0.0991772019420722
HEC-151,9915743,1.4580340601681427
SEM,9927531,4.847523560791686
697,327653,2.345786210451013
HT,156414,0.9679138644870768
KMS-27,44491742,4.7290458888071765
SK-N-SH,6852167,2.0581991902600913
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
BT 320,156414,4.178952757446285
PF-382,241158,3.333523301157689
KMS-21-BM,439501,-2.3809491999533003
L-540,UNC0638-navitoclax (1-1 mol-mol),-0.1391755381050462
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
OCUM-1,10231331,-2.6467056337525183
SW1116,4259181,0.852960615063059
SK-N-FI,9903786,1.217997719739724
BT 359,136227924,4.313964424354799
RL,71466445,2.5949033766521037
Karpas-422,46907787,-1.7872558374884018
P-STS,262093,0.957741648186898
ST486,10302451,3.4096383084955004
H-STS,73707398,1.2106724937411937
DB,168313016,4.30064233178
HT-1376,9936388,2.4935299933788957
COLO 792,439501,-2.3600745539186994
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
IGR-1,439501,-2.7516642734120307
DMS 273,71466445,2.157471967137961
T3M-10,73707398,1.864351117774127
NCI-H1581,439501,-2.58240650687765
HEC-59,selumetinib-JQ-1 (4-1 mol-mol),2.9499197232125907
SW1710,10302451,1.3013355107012203
BV-173,4259181,-0.0019973314195643
SU-DHL-1,71466445,3.7763473385017994
HuH-6,4259181,-0.1636677698512317
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
HCC366,71466445,5.760220768448806
HD-MY-Z,241158,3.745964403533247
KYO-1,11396600,3.3836130470467736
SK-OV-3,73707398,1.4890038437616029
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
GI-1,100016,6.475829804009189
CHP-126,11396600,3.667072533638785
BT 131,6852167,4.417190549255619
SUIT-2,3689413,0.4029780891432681
UO-31,637858,2.23783587214263
A2780,156414,1.0391092981452308
HMCB,375860,-0.2087542288186852
CJM [Human melanoma],100016,5.681499096329984
JIMT-1,4259181,-0.6325464626851699
HCC1428,135421197,1.8247359563067895
RVH-421,10231331,1.0693585699310195
Lu-99,selumetinib-JQ-1 (4-1 mol-mol),1.3184696740871884
PE/CA-PJ34 (clone C12),135875424,2.9771289784544934
COV434,4259181,-1.451446052468279
G-401,24180719,3.4290114124184568
BT 179,6852167,5.751557945891216
NCI-H1155,135421197,0.9372585927098024
HMC-1-8,26596,-1.609914747159897
BT 187,73707398,1.309358111635466
SUP-M2,107970,1.4120118261465122
COLO 684,241158,2.662003234974788
DU145,12003241,-2.0135691280208876
GI-1,24180719,4.422456488672885
SW1990,3689413,-1.271257676680656
KMS-34,UNC0638-navitoclax (1-1 mol-mol),-1.1659764168057434
KMS-34,136227924,2.5847633588950147
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
NCI-H2087,11396600,3.1581134421925
MDA-MB-231,49766530,-1.3973718691388817
HEL 92.1.7,11396600,3.6147449573871735
HSC-3,46907787,0.9324024386936162
NCI-H441,107970,2.428065240863963
Karpas-422,selumetinib-JQ-1 (4-1 mol-mol),-0.3387810810596827
OUMS-23,3689413,0.7829309194563772
KMS-11,6852167,1.1613595325638657
Karpas-620,135398744,5.497457460597933
Hs 852.T,6852167,1.5153309311291714
NCI-H522,135875424,3.5456342124976445
NCI-H1299,3689413,-0.9598507897960026
CAL-27,439501,-1.3320445705497543
Panc 03.27,100016,6.730276002902577
OAW28,12003241,-0.542287488877267
DMS 114,4259181,0.0455858036720845
NCI-H2196,73707398,1.0531590450327926
VMRC-RCZ,136227331,4.757387304339598
HCC1419,10302451,2.8904756214047556
KMS-34,135875424,2.166327494960368
HCC1500,71466445,3.970736335461394
HuH-6,9903786,2.683606252138214
SCC-25,46907787,-0.5502677293335551
Jurkat,46907787,-0.5839129118288405
OCI-AML-2,375860,-0.4546682587094939
PLC/PRF/5,637858,2.297656828654134
NCI-H2444,262093,2.966539403917491
AsPC-1,44491742,4.429887143828186
EB1,9927531,2.850216647233053
JM-1,9903786,1.587415218469425
BT 482,73707398,1.2920921662182432
AN3-CA,444795,3.791626271347074
OVISE,12003241,-0.8183931153803442
BT 231,46907787,1.384655777142133
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
COR-L88,11396600,3.064115551453064
L-428,241158,3.279588979368862
NUGC-3,135421197,1.602671962705462
HuP-T3,46907787,1.2763139172323097
HCC38,12003241,1.828137629090711
U-BLC1,UNC0638-navitoclax (1-1 mol-mol),0.3786430687179207
Namalwa,9903786,1.5886639412240358
BT-20,9936388,-7.739336729410493
PC-3,46907787,4.432628398195534
D283 Med,10302451,2.6795990859409695
MDST8,71466445,2.0942740576673593
OAW42,73707398,1.7425852441434224
UACC-257,644241,2.4588334794775615
LK-2,135875424,3.2650387901291844
MHH-ES-1,12003241,-1.3957716684214538
T-47D,135999136,4.653802376085038
NCI-H520,9915743,1.4167224147327635
SK-N-FI,selumetinib-JQ-1 (4-1 mol-mol),1.2619141801436582
MDA-MB-453,107970,2.0242856345207834
SNU-213,12003241,-1.127561281071067
HOS,262093,1.0531886567175572
NCI-H1693,9927531,4.77981113730065
EB1,156414,0.9475806167822072
MDA-MB-415,107970,1.9761217126753423
KMS-20,12003241,-1.6984779188581272
Panc 04.03,439501,0.3022334331499904
KE-37,54626689,4.502064320425672
HEL 92.1.7,9903786,1.7249056875700772
NCI-H1755,9903786,1.073033240421295
RERF-LC-A1,4259181,-0.0269897105807535
NCI-H1623,6852167,1.7873387390250663
CML-T1,11455910,-0.3388293365451558
KP-4,49766530,-2.33091907235806
MHH-ES-1,375860,-0.6305847513048299
OV56,135421197,2.071998378530058
VMRC-LCD,6852167,3.4717019465216037
SNU-899,11396600,4.052340052261649
BT 131,135875424,2.7884599516406094
NCI-H929,262093,-0.1267697569252451
CAL-78,156414,2.419390315202125
SUIT-2,6852167,4.156327087057675
DoHH2,6852167,2.322695414326351
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
TT,3689413,3.828584328493261
OVCAR-5,439501,-2.798423639950905
KMS-12-BM,100016,3.5545657198194873
KE-39,9915743,-0.5446321163343049
MOLT-13,11396600,2.919023807687231
OE21,11396600,3.3249407167750284
MKN74,136227331,4.503917554589063
HCC1588,262093,3.0584960901544833
OVSAHO,135999136,4.44889825660089
BT 239,72967,3.6652679956846272
RCH-ACV,71466445,1.275442483005524
ECC12,4259181,-1.5873031517089868
PL-21,637858,1.6083768268340104
EM-2,241158,2.6622179540907283
A3/Kawakami,71466445,1.2297175943082674
Panc 10.05,9936388,0.6007373562986975
ONCO-DG-1,49766530,-2.0037340634863
KMRC-3,11396600,3.674088989428189
NCI-H1915,44491742,3.914803792289667
SU-DHL-1,262093,1.7952973078733698
Granta-519,9915743,0.9460784198503543
JHH-1,107970,2.971432436185186
DMS 454,375860,-1.1674942929403889
H-STS,5460769,1.2422964505231244
SEM,selumetinib-JQ-1 (4-1 mol-mol),-1.6081049960911422
SNU-886,156414,1.8221946579264756
SNU-407,9915743,0.256973573653406
SW1417,5460769,5.65335320943634
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
NCI-H1650,73707398,0.7010144240165336
P-STS,327653,2.8911465905529674
BT 179,107970,1.72684325120686
RL,46907787,-0.3277939634463202
SEM,444795,1.9334021981472231
LNCaP clone FGC,54596490,4.35808730811733
YD-15,9915743,-2.405110430781952
KYSE-520,241158,6.053168866324876
COLO 668,100016,7.809114037996309
SH-4,12003241,-2.3432697923698083
NCI-H1694,10302451,3.86716164825304
MOLM-13,4259181,-1.5110532495146267
DMS 53,selumetinib-JQ-1 (4-1 mol-mol),0.0293599246560963
IGR-1,136227924,2.467918205864833
BT 216,135999136,1.3001577329115062
F-36P,10302451,3.5545884157395604
HL-60,107970,1.8158418564078016
Rh41,5460769,3.320988700800296
COLO 680N,136227924,3.1124323049819003
Hs 294T,135875424,4.177071063974562
WM88,107970,2.1698352778486987
MDA-MB-157,107970,2.1200224507121868
NCI-H2141,135421197,1.2037655567537868
T3M-10,327653,3.9520223783948185
CAL-12T,9903786,2.474655504914218
TCCSUP,135999136,4.392620213932673
NCI-H2029,9927531,4.454841105841318
L-363,135421197,1.89182184034138
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
CAL-85-1,44491742,3.820376025852422
SIG-M5,637858,1.0348469848357038
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
BT 179,136227924,3.760107948072088
MDA-MB-453,9903786,4.505035222499518
MOLP-2,4259181,0.166016027920661
BT 239,5460769,-1.3091160600101754
NCI-H1623,241158,4.3681147628536445
SNU-5,107970,2.4514742036829484
SK-MM-2,26596,0.072150738405161
DMS 79,4259181,0.3860900214886335
TE-4,10302451,0.8279627071260693
AGS,71466445,4.414686930362743
SNU-878,135999136,4.61740204433434
SW1271,24180719,4.447587763279296
SW948,135421197,1.7477185084776832
JM-1,12003241,0.2073989775302392
NCI-H1703,136227924,2.979921585365296
EB1,71466445,3.091644056319097
OPM-2,136227924,1.7425170628423947
AN3-CA,135421197,1.808403236431818
LCLC-97TM1,9903786,1.8016114643921617
KE-97,100016,5.841816758085698
KMS-21-BM,135875424,2.842121058769458
Mino,100016,3.8828597807205023
J82,4259181,0.7909526857706146
OE33,168313016,4.477619540995002
NCI-H1793,9936388,1.8612470505024563
COLO 792,11396600,4.429975159558261
KMS-18,11396600,2.8169219147606066
SHP-77,135999136,1.876778796417732
GOS-3,107970,2.255442380434802
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
HCC2935,10302451,0.5371939191045066
EFO-21,54626689,4.7612011017508085
BICR 16,262093,3.685769886928711
NCI-H2030,10302451,2.0984974298740484
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
IGROV-1,11455910,-0.2792640061206097
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
KE-97,46907787,-0.8205560600274511
G-402,644241,3.1791014891654457
BT 333,11455910,0.8481846232713552
WSU-DLCL2,439501,-2.4187850283326933
SK-MES-1,49766530,1.8908947653330492
NCI-H520,439501,-2.5978412941351405
BHY,44491742,4.864491079150181
VMRC-RCZ,3689413,-1.2845787687356065
OCI-Ly19,107970,1.7406149998809803
UACC-257,6852167,4.471876231491938
BT 248,5460769,4.810999932000391
SNU-C1,135875424,3.0946795282474007
BT-20,54596490,5.325824832549944
TYK-nu,73707398,1.0785188405280586
NCI-H2106,73707398,-1.2347656307302788
OCI-Ly19,262093,1.0490468502028176
VM-CUB-1,10302451,1.2041316516547516
HT-144,6852167,3.604976607540464
A-375,12003241,-1.2978704743837648
Hs 944.T,241158,3.718025513554267
SK-N-AS,11455910,1.0183707360563456
G-402,9903786,2.6546356785146084
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
DU4475,4259181,-0.0830563562754407
COR-L105,135421197,1.9442341701951136
OCI-Ly19,11396600,4.160001255842617
SK-MES-1,644241,1.6292140413735792
KMS-11,637858,0.3400135149620736
SF126,12003241,-0.8562047407383144
NCI-H211,54626689,4.283049952749316
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
Panc 08.13,73707398,1.0210763814613335
T24,54626689,4.454161702427286
SNU-216,156414,-1.34829160644196
TC-71,selumetinib-JQ-1 (4-1 mol-mol),4.262945722459713
SNU-308,637858,3.38776683487698
Jurkat,135999136,1.446686093818366
BT 131,644241,1.8188461332217016
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
MOTN-1,26596,-3.629503770216574
MFE-296,5460769,1.1407160363759563
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
CAL-85-1,135875424,4.15034145684821
LN-229,136227924,2.284287102346984
KMS-27,selumetinib-JQ-1 (4-1 mol-mol),-2.808360563321437
SK-MEL-2,262093,3.2801506390546225
SIG-M5,3689413,0.233032105010129
NCI-H2141,46907787,2.646319689052489
TYK-nu,11455910,0.7161463243688381
KMS-27,10231331,-2.582639088661463
MOLP-8,4259181,0.2540996075245788
DV-90,11455910,-0.2128562796551693
COLO 684,11396600,2.8933753280460186
HCC44,46907787,-1.085630650739563
ALL-SIL,136227924,2.439460537978413
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
SEM,262093,0.379936046646312
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
SU.86.86,156414,2.3553345636516148
TE-10,12003241,-0.2960597839275556
TE-14,5460769,2.4898485363417917
BT 239,54626689,4.3043594859771
SK-MEL-30,439501,-0.2056245952948021
KP-N-YN,637858,1.0855268631392891
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
NCI-H1755,168313016,6.160193768284492
HMCB,135421197,2.011360494635396
COR-L95,11455910,1.0154509596480157
NCI-H647,107970,2.33869745071115
SNU-1,71466445,4.2359794223935054
Sq-1,9903786,4.063753255024067
YD-38,6852167,2.552467124707018
Kasumi-1,49766530,0.877947367225252
KE-39,10231331,4.477976749120646
NCI-H2141,9936388,-7.734442160433386
RPMI-7951,156414,1.6471654307541064
RKN,12003241,-0.3350096455718494
BT 131,135421197,1.356520545497568
Tm87-16,71466445,3.970710704905261
647V,375860,-0.1505103622979239
SR,6852167,3.3054095897845777
ONCO-DG-1,11396600,3.950887665043145
PLC/PRF/5,241158,3.973842744350964
KMS-28BM,49766530,-3.0196417815888124
YD-8,54626689,4.483773401424057
NCI-H747,135999136,4.34177986775996
LN-18,6852167,3.0256445999301045
NCI-H1184,12003241,-1.9901297280698445
SNU-8,5460769,4.64495536055113
NCI-H650,135999136,1.5977473869198309
SW1116,12003241,0.0582707461824652
MOLM-13,262093,0.9014616367149992
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
KMS-34,73707398,0.3733285965494264
HT,9915743,0.0669624214071764
PaTu 8988s,9927531,5.1297297992623605
DMS 273,135875424,3.231864587804135
NCI-H1666,10231331,-2.5582241272853667
HT-144,135421197,3.272729024645835
SNU-489,9903786,5.534401948294785
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
KYSE-70,71466445,4.079477869375345
Ki-JK,46907787,-0.7224055491880652
TE-9,73707398,1.6638503318233642
SNU-1105,selumetinib-JQ-1 (4-1 mol-mol),2.4835806832746035
JVM-3,375860,-1.2196327473464486
5637,26596,-2.698358850803536
HMC-1-8,10302451,3.7891789370584967
DK-MG,135398744,6.3715043377255665
SU-DHL-8,UNC0638-navitoclax (1-1 mol-mol),2.2079034151849246
MOTN-1,24180719,3.5804113680618177
HCT 15,10302451,3.496013643332504
EJM,241158,2.554123806651753
Kasumi-2,327653,2.4977161394914953
SNU-685,135421197,3.6677204832747976
Hs 611.T,6852167,0.4305744814723918
TE-15,156414,-3.941980071268382
SK-N-FI,241158,3.5219656608107455
SNG-M,9936388,-6.347266548904431
NCI-H838,327653,3.747496502125908
HuH-28,49766530,-2.3300741099072937
KMS-34,107970,1.9427085752985964
KPL-1,644241,3.1412957180316656
Hs 578T,24180719,3.880022267469775
RPMI-7951,4259181,-0.293226545536714
Ri-1,327653,2.467525677033306
HCC1588,10231331,-1.6927312799094765
TE-9,4259181,-2.1230941225382325
P31/FUJ,9915743,-0.8907797257006451
BICR 16,439501,-3.169207556484136
NCI-H929,3689413,-2.331613234092956
SUP-B15,49766530,-0.1643365136132614
SH-4,241158,4.950630413385666
YD-15,9903786,1.471025688701345
QGP-1,4259181,-0.6804082450631646
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
Kasumi-2,9915743,-0.5759730647314978
BT 330,9936388,0.9619236718444248
TE-4,107970,2.372527622902973
ST486,5460769,4.068144147085423
SUP-HD1,241158,3.1145793783464257
LS1034,10302451,3.8027433677682545
NCI-H1869,11396600,4.813854369313605
JHUEM-2,9936388,-5.407825047744209
H-STS,439501,-3.713409181758543
A-673,11396600,2.723776149104898
UM-UC-3,136227331,3.94021080809034
FU-OV-1,327653,2.5930307991109784
SNU-C5,3689413,0.7822461761518839
BC-3C,644241,2.777421268835519
NCI-H1869,375860,1.5517292037743613
SNU-C1,9903786,1.6227295920089169
253J-BV,439501,-2.3122827098315515
BT 440,262093,2.750742554492899
MDA-MB-468,156414,1.2288207962265136
Caov-3,3689413,1.9135377903432256
JHUEM-7,4259181,0.2879228284005847
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
NCI-H1694,73707398,-0.8924536531071223
NCI-H2444,9927531,4.993346804303282
SF268,9915743,0.6317459379603247
SNU-423,107970,2.9468491759606303
SEM,11455910,-0.3463344343386808
BC-3C,26596,-0.2711171382512473
BT 179,26596,-0.8233770737136159
CMK,24180719,3.713899777107303
OPM-2,12003241,-2.9738714531294232
A-204,71466445,3.8139873570598497
L-363,73707398,0.3951176028003356
CA46,439501,-3.521132637790176
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
CAL-62,375860,-0.9840760104927472
Kuramochi,262093,3.1885659706851026
G-361,107970,2.5078993960458917
AN3-CA,12003241,-2.637522524679412
PSN1,9903786,4.143013374018909
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
NCI-H522,26596,-2.5500947066960276
BFTC-905,54626689,4.852775852436906
JHUEM-3,6852167,2.2177056670449105
KMRC-2,3689413,-1.0505298927618916
FTC-238,3689413,-2.1600357182012493
EFO-27,136227331,4.702115323060179
JM-1,135421197,0.410328587733175
T3M-10,24180719,4.031714486734796
LCLC-103H,6852167,4.45978228332794
A2058,26596,-1.435799382276171
Mono-Mac-1,12003241,-3.167077714646063
K-562,100016,4.034095210213227
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
COLO 699,136227924,2.9902058739506385
CJM [Human melanoma],49766530,-0.5091083947600985
SK-UT-1,44491742,5.121507877742128
HD-MY-Z,10231331,1.3407827449085772
LS123,selumetinib-JQ-1 (4-1 mol-mol),1.505935551015269
KCL-22,6852167,2.500162547183108
BT 139,637858,2.313744051526735
THP-1,9903786,3.0926145703043852
BT 231,262093,2.1267355779539043
FaDu,135875424,3.054249321596862
BEN,selumetinib-JQ-1 (4-1 mol-mol),2.435867815788394
U-BLC1,156414,-4.628968432164774
BT 232,135999136,1.8601306956722656
Ku812,49766530,-2.390671573618507
OCUM-1,6852167,3.0808075947415237
BT 416,9936388,-4.783265609756594
MOLP-8,241158,1.846975252387852
KNS-60,107970,2.476032725637248
SK-LMS-1,44491742,4.239159149665423
PE/CA-PJ34 (clone C12),26596,-1.1037163261022582
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
Karpas-299,11396600,2.5931923649102804
SK-HEP-1,4259181,0.3926762831937545
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
KNS-62,4259181,0.7585731297182399
Becker,4259181,1.0240306217869668
LMSU,135875424,4.495921610081383
BT 271,4259181,0.1680419141045905
LCLC-97TM1,10302451,3.3699574981481217
Mono-Mac-1,24180719,2.2518396015404174
KP-N-SI9s,9903786,1.8487391330719625
T3M-10,46907787,3.0112486695528085
VMRC-LCD,637858,1.7836003197528063
NCI-H647,12003241,-2.504495302724225
U-937,327653,2.9204709055129365
BT 159,46907787,3.605654998165969
HCC1954,26596,-1.6295363665710343
OVCAR-4,135875424,4.627520209049134
JHH-5,24180719,3.7018419367807978
BT 504,26596,-1.373211017914528
REC-1,9936388,3.0128299108104306
BICR 18,49766530,0.9372744186265172
DoHH2,73707398,-1.1852671026116226
SaOS-2,375860,-0.2844076074043694
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
NCI-H1915,selumetinib-JQ-1 (4-1 mol-mol),1.3677022548996522
NCI-H1869,11396600,4.813854369313605
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
NCI-H1944,6852167,2.052569965143729
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
JHUEM-1,135999136,1.801917523699696
MOLM-13,444795,-0.8871401586886155
LNCaP clone FGC,24180719,3.4893851088457266
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
NCI-H1299,9936388,-0.1781231784373126
PaTu 8988s,11396600,3.1820503715354276
OE21,241158,4.080451555980482
ZR-75-1,71466445,5.023248156123476
KMS-20,9929138,5.867169727564362
TE-10,11396600,3.9393585387483334
RCH-ACV,6852167,1.1883730851322674
PK-45H,10231331,1.1390548984492337
U-251MG,54626689,4.612715526261494
SNU-719,637858,2.2997289437945487
MDA-MB-453,168313016,4.163913885489913
NB4,73707398,0.2702647975206608
SF126,4259181,0.0859599023411325
HCC95,241158,6.17490433758637
ACHN,9915743,1.4221547150387026
NCI-H1341,10302451,3.6932298221436737
HMCB,9903786,3.962700823971229
KMS-18,44491742,4.313842675965846
KMBC-2,439501,-3.686477603107828
KG-1-C,9903786,3.898193715125589
F-36P,262093,1.6746033026960565
NCI-H2452,107970,2.3345640718356364
WM266-4,10231331,-1.2915436879792983
SNU-387,135875424,4.7667426399208965
EFO-27,10302451,6.465018307145316
KMS-21-BM,73707398,-1.1120298197741494
BT 340,73707398,1.0135826425077856
HL-60,637858,1.467320754534128
LS513,9936388,-5.267981088058912
JHUEM-3,9915743,-0.9592300023642776
SNU-8,9903786,3.356408381726989
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
NCI-H508,439501,-0.5256588079382335
U-CH1,selumetinib-JQ-1 (4-1 mol-mol),2.130676998880085
T24,9936388,-4.864379366787304
CHP-212,100016,6.525746829388361
NCI-H1703,44491742,4.242219664453596
T98G,9936388,2.8447022467541956
HCT 116,9936388,2.1629557808045146
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
NH-6,11396600,3.28881859897494
AU565,11455910,2.266336610800082
TE-6,24180719,4.124910489654677
PC-3,100016,6.704789318152335
HuP-T3,135421197,1.625440100707307
TE 441.T,11455910,0.1965703482136005
HDLM-2,136227924,3.1256787357030937
SNU-398,241158,1.6033958932567285
GA-10,26596,-3.772659675473913
HT,135421197,1.8590236680580152
JHH-1,49766530,-0.2614910303747365
WM115,54596490,4.400808012137458
NCI-H358,100016,4.0854531303861155
SW1353,168313016,6.218366310793427
BT 239,11455910,0.8577205226551546
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
RERF-LC-MS,24180719,3.6010609924552455
NCI-H2171,10302451,3.986494326049399
OCI-Ly3,9903786,0.6513092256101434
HT,9936388,-5.879912313959706
LOX-IMVI,3689413,-4.023880524547255
CAMA-1,9936388,-3.1372789388983944
22Rv1,9915743,0.4549229080465418
HCC-56,11396600,3.807461388056502
NU-DHL-1,71466445,1.452037118148276
VM-CUB-1,136227924,2.7643713240945016
KE-39,54626689,5.72659105113371
PaTu 8902,3689413,3.662647678116459
Caov-3,439501,-0.6475406712801833
UM-UC-1,439501,-2.7541191906970224
MOLM-13,5460769,1.2989705913507943
DU145,9915743,3.139044524773344
Hs 611.T,5460769,0.2348324565646969
SNU-C5,136227331,4.384397979730017
SUP-T1,439501,-1.5599134432816564
SNU-175,26596,-1.9837379159345812
RL95-2,11396600,6.018951630956894
SF539,46907787,0.2074640579250286
HD-MY-Z,12003241,-2.342795911905131
MKN74,136227331,4.503917554589063
SKM-1,439501,-2.678240610691138
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
A-673,54626689,4.6393725921997415
NCI-H727,49766530,1.5110740555461553
OCI-Ly3,10302451,3.8277705801604656
JHH-5,11455910,0.7201597489902917
DND-41,100016,5.882204784714585
SW982,135875424,6.1479470083270735
Li-7,6852167,0.9733642966109146
L3.3,26596,-0.871586326159775
NCI-H1869,10302451,1.963256574225826
EM-2,9936388,-5.706813199670236
NCI-H522,3689413,-4.273368850016072
OE21,135875424,4.2322811376256
G-401,135999136,2.1711954992798987
RD-ES,439501,-2.2858768035402623
KMRC-3,135875424,5.901870515016819
NCI-H69,136227924,3.1937315471147443
SUIT-2,3689413,0.4029780891432681
SNU-213,9936388,2.0534039631402994
TOV-21G,375860,1.331316468880544
NCI-H1693,644241,2.15020513902518
SW620,107970,2.8176179958695053
CAMA-1,439501,-1.1821357093397586
LS1034,439501,-2.506043270280418
TT,73707398,1.721245202435463
NCI-H508,26596,-1.5060721880179218
NCI-H1341,10231331,3.946004914876153
SW982,4259181,0.6436142208790868
GSS,241158,4.1367730610069975
MHH-CALL-3,375860,-0.1586420227897289
SUP-T1,136227924,2.470227214750311
MHH-CALL-3,71466445,3.985305904868944
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
U-937,49766530,0.8721430649798465
Ishikawa (Heraklio) 02 ER-,73707398,1.818794277396009
SW48,9903786,0.6824641791663469
JHH-5,135421197,0.9598662644879212
SNU-398,9903786,4.103035354116066
TE-8,9927531,4.6696791278322625
AGS,135999136,4.507616922311627
KATO III,9927531,6.301212923475331
SK-MEL-3,637858,2.888806865252382
DK-MG,637858,2.2775491010161724
AsPC-1,262093,3.2992304028365926
NCI-H1915,3689413,1.3727527679359948
NCI-H2172,24180719,4.347081195006066
RS4;11,375860,-1.0420029340567167
MeWo,11396600,3.146503563655223
BT 172,136227924,2.3975770198101545
BT 330,241158,3.9809433714442166
T-47D,5460769,6.397053715460356
LS123,135999136,4.314561511385293
NCI-H1623,9903786,3.0418604220511436
MJ,9915743,1.766638415426978
Hs 766T,73707398,0.9103087119029484
TALL-1 [Human adult T-ALL],444795,3.2400868280054995
OUMS-23,637858,2.1150816031372655
MFE-319,11396600,2.9869741461400956
SNU-61,46907787,2.0753699666277936
HuP-T4,6852167,1.1747824212222648
NCI-H446,44491742,5.101744314169451
TC-71,375860,-0.373501612035207
CJM [Human melanoma],46907787,4.250483968066917
JHUEM-2,327653,2.730949132575015
EPLC-272H,135421197,1.5481264659951517
BICR 31,4259181,2.3774772051226685
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
BICR 16,100016,8.634217681257812
JVM-3,73707398,-0.2600677123452043
SW1417,4259181,-0.0767370011258741
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
HLF,136227924,2.390310427445978
NCI-H1650,135875424,3.5061044557480865
OCI-AML-5,73707398,0.4979905922815086
BT-16,5460769,2.094030868827637
TE 441.T,12003241,-1.1939319008466374
EJM,3689413,-2.394173462666658
Rh30,9929138,6.636453392237079
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
MEC-1,10302451,2.9779050160540144
FU-OV-1,46907787,-0.0188806347407138
Karpas-422,136227924,2.027369566350396
NCI-H520,44491742,3.7897459257936057
HEC-1-A,637858,1.7638389780998065
MOLT-16,5460769,0.1124317409166702
RERF-LC-Ad2,selumetinib-JQ-1 (4-1 mol-mol),5.304471125852225
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
KP-N-SI9s,439501,-2.735040326022903
CCK-81,9929138,5.48307425077135
Hs 852.T,11455910,5.310115560593476
Calu-3,6852167,1.946679158570884
JHUEM-3,5460769,0.399281620663996
IM95,135875424,4.902055922324696
Kasumi-1,6852167,0.8999296873470045
CAL-29,9936388,1.3417151621152168
OC 314,9903786,3.545915763256713
SNU-387,637858,3.1289218700109696
LK-2,3689413,0.6891361192494543
Reh,136227924,1.9009503552795357
Ki-JK,11396600,1.9069544068718032
DND-41,107970,1.5227826017057635
DU145,136227331,5.067250261949365
NCI-H2081,UNC0638-navitoclax (1-1 mol-mol),0.8615686531760992
Hs 683,136227331,4.5546400151434066
OVK18,11396600,3.420105685661315
NUGC-3,9936388,-6.309971467031446
SK-N-AS,135999136,3.841880719801881
BT 330,327653,3.419413627791973
JHUEM-2,262093,2.369625461390079
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
SNU-601,135421197,1.035367817666236
KMS-34,241158,1.191579890053919
SNU-601,135875424,2.726240370483818
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
IMR-32,327653,2.318153172774913
MCAS,12003241,0.5308085719616568
COLO 320,241158,3.262543389019309
SW948,136227924,2.9576701343794145
SEM,9903786,1.5227669871926164
SET-2,UNC0638-navitoclax (1-1 mol-mol),-0.0926361698206657
CAL-51,135875424,4.33643967165441
NCI-H1563,73707398,1.563728239277783
TE-9,375860,-0.8213044409878748
HCC1833,12003241,-0.598038454038546
ECC12,5460769,2.2219131741447913
TE-8,327653,2.91040693421224
SK-CO-1,9915743,2.0474134916136184
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
TE 441.T,3689413,-1.0112421393817166
LAMA-84,327653,2.986202595396493
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068
647V,6852167,2.725026978750747
COR-L88,135421197,1.3679822518227
SNG-M,135999136,4.445666300574397
WSU-DLCL2,26596,-2.173424611684264
SW1710,9936388,-6.272511442902443
SK-UT-1,135875424,3.143376991018657
BT-12,selumetinib-JQ-1 (4-1 mol-mol),3.32378383442081
HMCB,selumetinib-JQ-1 (4-1 mol-mol),1.6185777798994516
VCaP,156414,1.5741450298899773
OAW28,3689413,-1.4375749125930504
Karpas-620,5460769,3.7991710121936304
Daudi,5460769,0.2326576177581661
SK-LU-1,107970,2.349132829745335
MKN1,9927531,4.774967251580727
NCI-H292,9903786,2.498172259524573
CHP-212,46907787,-1.3675859090756428
RKO,9915743,2.8851858618766957
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
HGC-27,4259181,-1.3994815184637035
NCI-H1623,10302451,3.5735543079001553
HMCB,439501,-1.1140754693945072
HEC-251,100016,6.174926130166858
SNU-761,444795,4.765225896641203
NCI-H838,10231331,6.376756175674043
NCI-H292,9936388,-1.1579069678838152
BICR 22,12003241,-0.4808187565312439
Ri-1,107970,1.039511049799593
SU-DHL-8,71466445,1.823428220748298
NCI-H526,selumetinib-JQ-1 (4-1 mol-mol),1.4934874607418576
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
RL95-2,107970,2.164613856567184
KMS-20,5460769,-0.4034471516809727
MOLM-13,73707398,-1.293008226929777
LAMA-84,46907787,-0.5709891402685436
HuCC-T1,10302451,3.2341520564219666
MM1.S,135999136,4.602725766791159
EHEB,9915743,0.5785876427148751
RERF-LC-A1,100016,6.9126876628990885
DoHH2,444795,2.4065428115339005
SYO-1,9915743,2.525873666544599
SNU-1079,49766530,-2.354055789977545
U266B1,135398744,6.53135676756175
OPM-2,327653,2.4944005218311984
NCI-H1792,135875424,3.896639880830057
HuG1-N,439501,-1.480081510168686
ACC-MESO-1,BRD-K27188169-navitoclax (2-1 mol-mol),3.904500927832786
COLO 741,11455910,3.212603536123838
MHH-ES-1,135999136,1.7507962768732164
TT2609-C02,12003241,-1.0431647024866548
BICR 16,107970,2.422420093451505
BT 504,selumetinib-JQ-1 (4-1 mol-mol),2.8147645186457964
JHH-2,selumetinib-JQ-1 (4-1 mol-mol),2.106213738968382
HCC4006,46907787,3.5860575166232933
U-BLC1,26596,-0.9383285983925695
Daoy,107970,2.72954505874123
MDA-MB-157,9903786,1.458865596348786
KYM-1,6852167,2.766391322477695
JVM-3,327653,2.8356821004059967
KMS-20,375860,-0.5673020428522673
G-401,3689413,-2.428789331956376
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
Hs 578Bst,135875424,2.7019998595734327
HuH-28,11396600,3.662277898501366
BV-173,26596,-4.295505465502321
MEC-1,6852167,1.6745748203448447
NCI-H460,637858,3.384702960830197
NCI-H2110,44491742,4.139827167651669
ESS-1,375860,-0.234699059648963
OAW28,73707398,1.2451215877479735
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802
A-375,73707398,0.8320576726433225
NCI-H460,73707398,3.251551904382877
BICR 31,24180719,3.9564262696237096
EFO-21,26596,2.967643494346353
DB,71466445,1.8837270144082423
FTC-238,637858,1.114636329944604
NCI-H2087,136227924,2.807670387816286
HPAF-II,3689413,1.4854609616797476
M-07e,100016,5.065678373530031
PE/CA-PJ41 (clone D2),439501,-0.7748943226504631
KMS-27,135875424,3.062949478876591
SNU-738,9936388,-4.72034190751593
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904
EJM,136227924,2.8681258655198367
Hs 888.Lu,selumetinib-JQ-1 (4-1 mol-mol),2.5380306208890744
DMS 114,54626689,5.669117563720445
NCO2,12003241,-5.3551857747003
EJM,71466445,3.872070794685453
HPAC,10231331,1.4659578196353913
IGROV-1,168313016,4.807199318661473
Kasumi-1,73707398,-0.5667763623156434
PC-14,3689413,2.901459905806189
TOV-21G,262093,3.1318910470351327
Namalwa,26596,-3.71974803891978
SNU-C5,637858,1.288200676644884
CAL-78,12003241,-1.8526248382085972
SBC-5,444795,4.741830288065925
SKM-1,637858,0.6023395164344832
KMS-34,156414,0.8867581295421252
EoL-1,135421197,0.8401357676850814
EM-2,10231331,-1.453053484988338
KMH-2,135999136,4.261603598420712
AsPC-1,49766530,-1.5554439905221051
DND-41,5460769,0.7297318325246287
NCI-H522,44491742,4.766943404170333
SU.86.86,136227924,3.0459574781144014
LS1034,46907787,3.4253315978668084
OCI-AML-3,11455910,-0.2153245710553746
JJN-3,10302451,3.2491275640758905
NCI-H2228,UNC0638-navitoclax (1-1 mol-mol),2.5874541495767933
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
SBC-5,241158,4.402731015442316
KMS-34,BRD-K27188169-navitoclax (2-1 mol-mol),-1.281856432496571
253J,375860,-0.8253978695794215
SIG-M5,136227924,2.112174988724855
NCI-H196,6852167,3.0057734574295765
MOLT-3,156414,1.112574242693939
NCI-H446,selumetinib-JQ-1 (4-1 mol-mol),1.746581196190114
AML-193,136227924,2.0129973822753735
VCaP,11396600,5.246887519153865
SW948,4259181,0.2292867461834122
SUP-HD1,4259181,0.3829881633856215
SNU-878,135421197,4.562979063002288
NCI-H2085,9903786,1.6610112484663062
NCI-H1623,5460769,3.63452416726077
ALL-SIL,135421197,0.8278001934093618
SUP-T11,11455910,1.655670582891713
SNU-387,10302451,4.6164991918458345
CL-11,9915743,1.17704113749316
SCaBER,135875424,4.404727092025364
KP-N-SI9s,71466445,1.8589750237088865
COV362,100016,7.994124175315401
YD-38,9915743,-2.811758020987732
SYO-1,100016,3.831378840669671
Detroit 562,262093,3.439277279464399
NCI-H2291,71466445,5.58813492621218
SW620,9903786,1.7872370567942188
TE-10,9936388,-5.117656284676294
A-253,9903786,4.10726286628635
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
Hep 3B2.1-7,3689413,-0.8676280815745859
NCI-H1573,selumetinib-JQ-1 (4-1 mol-mol),-2.008096563094489
CML-T1,375860,-0.8039918924580166
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
SNU-407,136227924,2.9703344519672785
SCaBER,selumetinib-JQ-1 (4-1 mol-mol),-0.5555159454375147
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
SNU-620,26596,-1.49043613544065
NU-DUL-1,9936388,-7.007510974926655
KMS-27,9915743,0.5712823893171636
ECC10,54626689,2.3098687462339424
WM1799,3689413,0.6160914431487012
HCC4006,444795,4.934994268877888
GaMG,11455910,1.9778197277547145
MOLT-16,26596,-3.5703441979693245
NCI-H2291,100016,7.4079580735543695
DMS 114,637858,1.7824394886832768
LS180,262093,3.1953995116592826
RL,6852167,1.9852892386197472
COLO 201,9936388,0.7010349840122784
HCC1500,135421197,1.2704457907642457
OV7,10302451,4.138234745374046
GSU,135421197,3.362120533278017
GMS-10,135999136,4.793570328652181
COR-L51,5460769,2.8872461015254913
TOV-112D,10302451,4.162111646950722
JVM-3,9929138,5.001902882551054
HT-29,135421197,2.624845390114819
P3HR-1,241158,4.4514160234357725
OS-RC-2,selumetinib-JQ-1 (4-1 mol-mol),3.295482739639699
HCC1833,49766530,-1.3796186102265957
OCI-AML-3,136227331,4.0355343672890935
HuH-1,73707398,2.2911867225031712
JJN-3,44491742,4.04042701265084
BT 440,135999136,2.163125999503531
HuG1-N,71466445,4.414199948526064
KPL-1,156414,2.530967902679832
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
JHUEM-3,4259181,0.9034843084512042
NCI-H661,5460769,1.0320957244219937
HCC1143,12003241,-0.0421467164139253
SNU-C1,136227924,2.406947195401098
DEL,11396600,2.9496069557825155
MKN1,3689413,-2.0686117581954537
RPMI-8402,26596,-2.3009998991377274
HT-1080,9927531,5.0886456677015595
LS180,136227924,2.415770069388299
SK-MES-1,262093,3.241171035364572
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
SNU-738,135421197,2.9898433759416396
HT-1080,73707398,1.432665893023954
HCC1833,6852167,3.1486831435900164
CAL-148,3689413,0.1534272524825109
NCI-H211,5460769,0.8923450706014173
COV434,3689413,-2.336562516768729
SK-N-SH,375860,-1.202026834926373
PL-21,241158,4.28297897809028
Kasumi-2,6852167,0.8229890671000598
SNU-761,54626689,4.37718848317912
NCI-H1563,9915743,0.028314904661926
A-549,73707398,2.11945224002363
BL-70,11455910,0.0297014164053517
RKO,375860,-0.2095842697906711
YD-15,375860,-0.9866922587532774
LCLC-97TM1,6852167,1.822160840349085
Rh41,439501,-3.728538784636516
SR,9915743,2.3691370724807985
UACC-62,24180719,0.4884305020103158
NCI-H1650,444795,5.080138888321433
HCC2218,107970,1.4999859497279118
A101D,135875424,4.8786521946508214
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
BT-474,UNC0638-navitoclax (1-1 mol-mol),3.2058314272138477
SNU-245,3689413,-1.9631171858613183
CAL-54,135421197,1.5931766951689923
PE/CA-PJ49,6852167,2.2001528743044094
BT-16,3689413,5.62862969112265
RPMI-7951,BRD-K27188169-navitoclax (2-1 mol-mol),3.4218571512591915
SNU-489,637858,3.5025780458402784
WM983B,12003241,-2.729936813041864
CAL-54,49766530,-3.2730005692653803
CAL-85-1,9915743,-0.3969926925010483
THP-1,168313016,4.49092647714658
JHUEM-3,24180719,2.8866781738980296
SK-MEL-2,54626689,4.994958580964683
NCI-H2052,262093,2.885672555371676
CHP-126,637858,1.208684782865996
DV-90,637858,1.0178013462705249
OUMS-23,327653,3.655730641174575
KLE,46907787,0.6768942529427939
IM95,156414,5.105742065185946
BT 340,637858,3.4610486275881147
NCI-H647,327653,3.987842659559465
Tm87-16,136227924,1.7990989939748585
Calu-1,11455910,4.249423837752583
LUDLU-1,5460769,4.034100561481378
NCI-N87,10302451,0.4744399528749561
MHH-CALL-3,49766530,-2.9861059393678766
SNU-761,107970,2.2170986122907177
U-BLC1,3689413,-0.8991596677439855
CCK-81,73707398,0.5234113847041482
Granta-519,156414,1.3767921664113123
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
BT-20,135999136,4.456503311518702
SNU-668,4259181,-0.218852080929754
JVM-2,26596,-2.43180743148247
Hs 852.T,73707398,0.5669652099288242
Panc 10.05,46907787,2.9074392738010384
Detroit 562,12003241,-1.0092858141729106
SK-MEL-1,44489367,4.41779299292988
DMS 79,3689413,-2.460389219665011
MOLP-8,12003241,-1.4499361325619826
AM-38,444795,-4.814022989676893
SNU-1196,327653,3.765750014421376
OC 314,262093,2.2402315645095054
OCUM-1,11455910,0.0490190969024124
J82,135875424,4.806406086619794
SNG-M,11455910,-0.2567139520485192
Pfeiffer,46907787,-2.4243616059921864
L3.3,135421197,2.5730452840447415
HCC2218,327653,1.357600314803345
TF-1,262093,2.2730814154629573
MHH-CALL-3,135875424,3.7440034297864258
Reh,9936388,-7.618651347698478
HuT 78,UNC0638-navitoclax (1-1 mol-mol),0.0082226538693411
NCI-H146,135999136,1.6477982136645704
SNU-5,9929138,6.321300531012286
Daoy,12003241,1.232177667394707
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798
SNU-5,4259181,-0.7448784030448398
HCC2218,136227924,2.978872567688762
KYSE-30,10302451,4.500697624442922
RERF-LC-MS,107970,3.001301355490032
MG-63,439501,-2.9607530024491515
CGTH-W-1,637858,2.9183826473094125
Hs 940.T,439501,-3.345771956263442
AN3-CA,73707398,0.9328233137559012
22Rv1,5460769,4.1007004291064675
MOTN-1,168313016,3.9664362294048954
OV-90,73707398,1.9025325058972111
SNU-C1,9927531,4.924275506690927
MDA-MB-453,637858,1.2138352699902215
EFO-27,4259181,1.8274060730963064
BICR 31,5460769,3.9433617709959696
SNU-410,644241,3.406569838152794
Fu97,439501,-2.2730678806091924
GB-1,11396600,3.609932395636561
Jurkat,12003241,-1.1785607025510931
SNU-213,107970,2.2765725167688045
JHUEM-1,49766530,0.8981374764595749
AN3-CA,10302451,3.617635565971862
PE/CA-PJ15,262093,3.193957949465754
NCI-H1395,9915743,5.704472879097531
Panc 02.03,327653,3.634511095206161
NCI-H1869,100016,6.8338343579730285
Daudi,73707398,-0.7942959168982594
HCC1171,selumetinib-JQ-1 (4-1 mol-mol),0.606022356375209
C2BBe1,107970,1.6421664588143934
Calu-6,444795,4.794697273365938
NCI-H2029,135421197,1.9497380661453336
MIA PaCa-2,6852167,2.446025976555517
HT-1376,10302451,2.517064396144774
EFO-21,135875424,5.187448577491803
RERF-LC-MS,135999136,4.400683337930441
NCI-H146,107970,1.621489555747201
JHUEM-2,637858,1.722532316890112
MOLT-16,135999136,3.319237148517738
SCaBER,637858,2.007494552130968
LS180,107970,2.4480125060803077
AN3-CA,24180719,3.691546686395667
YD-10B,5460769,-2.041920161211882
COR-L51,3689413,-2.4511139859333526
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
QGP-1,12003241,-0.3742156649429844
Peer,4259181,-1.5408877519068418
IGROV-1,44491742,4.406671418311328
RMG-I,135875424,4.352584072598887
Hs 294T,262093,3.0816217922662146
NCI-H28,3689413,-1.886606090231827
GDM-1,637858,1.427006767911647
SUP-T11,3689413,-2.394245997939745
CAL-78,135875424,3.436960606583848
TE-8,10231331,3.463708070242339
BT 228,46907787,3.432433507540363
SUP-B15,136227924,1.2725004934322246
NB4,135875424,3.6399380221617936
HuT 78,107970,1.6472037116063474
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
HCC827,262093,3.007487219518493
KYSE-140,10231331,3.095458864415077
AU565,637858,2.0174799842455364
NCI-H1869,3689413,-0.7267032921286074
BHY,168313016,5.174584951343697
NH-6,9927531,5.219237358239311
SNU-5,9903786,3.415136592873371
Pfeiffer,135421197,0.665786429706454
TE-11,9915743,-1.3132877910831091
CML-T1,11396600,3.3654395371867425
SNU-308,9877608,6.965514964870985
SK-MES-1,156414,0.4265793069571684
JIMT-1,262093,3.7926345151691208
JeKo-1,168313016,4.381746397495715
GP2d,49766530,0.1592380212690584
KYSE-140,262093,3.0131352463234906
T84,9903786,2.2055003104833553
BT 112,selumetinib-JQ-1 (4-1 mol-mol),2.692883041543946
NCI-H1155,3689413,-1.8427844176402348
HH [Human lymphoma],12003241,0.3736289232405389
OCI-Ly3,73707398,0.607106430835092
MM1.S,10302451,3.7035556434363808
NCI-H889,73707398,0.8984121723552707
VMRC-RCW,73707398,1.1041967608217782
SW579,135875424,4.01544080394069
Hs 688(A).T,135875424,5.335047490558406
JHUEM-2,10302451,3.19057171364304
UACC-62,107970,2.9897447341876764
YD-38,4259181,0.0281637492495702
RS4;11,UNC0638-navitoclax (1-1 mol-mol),-2.225017135965684
SF126,135875424,4.31417208102172
CHP-212,3689413,0.1952243777291655
MOLT-13,135875424,3.0994865086023125
TYK-nu,135875424,3.095355061385467
HCC1195,54626689,4.495229788085953
DMS 114,26596,-1.464727194464046
CAL-54,9903786,1.6300874124823186
NCI-N87,135875424,4.206412745126992
CAS-1,73707398,1.243178259930861
QGP-1,10231331,-2.309455655415662
NCI-H1703,9915743,0.7424925656484964
HEC-151,4259181,-0.935569196791714
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
GCT,156414,1.5367233529561777
HPAC,107970,2.120634105202459
22Rv1,135421197,1.1830541259797036
SR,9936388,-6.002984450827545
MDA-MB-453,241158,3.8848602363142697
RPMI-8226,11455910,-0.3031686531040117
TUHR4TKB,73707398,1.120933989488566
HT-1376,9915743,2.2155128053194777
A-375,selumetinib-JQ-1 (4-1 mol-mol),1.0912668350631578
RL95-2,262093,3.494468986300009
HEY A8,10231331,1.7101627370208758
ST486,9903786,1.7386739001111973
HT-1197,6852167,3.650905767737215
Daudi,375860,-0.7416229308895455
NCI-H209,439501,-3.220511958386942
LS513,5460769,-0.3272270852290284
TT,439501,-2.411064207621025
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
SNU-61,136227924,2.341371828887226
HCC1395,135421197,5.533531628940142
HT,73707398,0.4062242987529652
NCI-H1155,selumetinib-JQ-1 (4-1 mol-mol),-0.0960210384523843
Calu-6,10231331,0.6339980155000304
NCI-H2081,375860,-0.0986689884250349
COR-L105,12003241,-1.8759508779616432
OCI-Ly19,10302451,3.771055498510201
EM-2,637858,1.4868695241377077
SNU-16,156414,1.3810749136744684
SU-DHL-10,241158,3.096931304704652
MHH-CALL-3,4259181,0.8022730547571968
SUP-T1,44491742,3.5302085503569782
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
NCI-H889,44491742,5.742464384520159
AN3-CA,54626689,5.185402039214214
NCI-H1666,644241,2.338416658672265
SNU-46,73707398,1.3670817300424394
NCI-H716,4259181,-1.4668256372956798
GSU,3689413,3.217966232949248
TE-6,9927531,3.995869764794834
COR-L95,4259181,0.8580425806970188
SNU-719,439501,-0.6056911297010781
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
A2780,6852167,1.374383856311773
PK-59,262093,2.249881918634125
Rh18,439501,-2.3237711161162102
T24,11455910,0.9790559747688146
SNU-119,136227924,3.0573258202750253
PE/CA-PJ15,46907787,3.628617033804344
NCI-H2052,107970,2.4120996569563253
LS1034,54626689,4.683612598558961
NCI-H929,9936388,-5.492803140929198
NCI-H1869,637858,2.4827908237252183
Ku812,156414,-0.0936884682974776
SNU-16,54596490,4.1031320340534485
OCI-Ly10,selumetinib-JQ-1 (4-1 mol-mol),0.8556530157943396
BT 359,136227331,5.057853288307873
HuT 78,10231331,-3.0866153075416376
HT-144,4259181,0.9881663979403672
NCO2,9915743,0.6795436219303662
SCaBER,6852167,2.743013640713377
OCI-Ly10,4259181,0.7781113389195214
Calu-3,327653,2.745193676578601
JHH-4,71466445,3.279742837129593
HCC1806,49766530,4.996924493962182
KO52,9903786,1.3206822748757847
NCI-H23,10302451,3.1322195915738167
NCI-H2286,135875424,2.580791603996685
SNU-878,6852167,1.5277093469935394
COLO 684,439501,-2.1381820034562944
OCI-AML-2,4259181,-1.46222192980106
HT,3689413,-1.9551613931391472
YAPC,73707398,1.1307339717786768
PF-382,5460769,-0.5383889446594711
OVCAR-8,241158,4.09430351942766
Panc 02.03,136227924,3.0839082623333387
RERF-LC-MS,439501,-1.3704502050640626
MKN1,11396600,3.1092750639740903
A-375,3689413,-0.7182003405560186
KYSE-30,4259181,0.866671634934387
HDLM-2,46907787,1.6560945810392764
HDLM-2,241158,2.746701613084659
BT 482,4259181,1.1102562042329451
GCT,135398744,7.690422491741855
SH-10-TC,5460769,3.8511006484967223
JVM-3,136227924,1.9937281150641608
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
5637,24180719,2.238388335608301
PC-14,selumetinib-JQ-1 (4-1 mol-mol),0.1857937435498048
MOLT-13,100016,6.122983577816604
COV644,4259181,0.9348750432369554
H-STS,100016,5.985929376611731
Hs 766T,3689413,1.3725594081850794
SaOS-2,3689413,0.0712794264513353
Karpas-620,71466445,4.078861741332925
YKG-1,10231331,5.270675851444794
SNU-C5,71466445,3.9202067188972616
JHUEM-1,3689413,0.044302486666068
SK-N-MC,136227924,2.70298794492574
SK-N-DZ,439501,-4.085743704417651
HuT 78,10302451,3.5523158684911764
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
SNU-423,10231331,4.762188035854746
NCI-H2196,9915743,2.494227946954125
HCT 15,327653,3.42482892968062
CCF-STTG1,107970,2.063603625316133
NCI-H929,136227924,1.899057841083653
SK-N-FI,10231331,0.8741467482588007
RKO,10302451,3.926970734642152
TE-6,168313016,5.611200236172772
HEC-1-A,selumetinib-JQ-1 (4-1 mol-mol),1.220922111320793
G-402,5460769,1.138003238352945
DK-MG,5460769,1.2841485986218522
OVCAR-5,6852167,4.045184483405561
BT 216,136227924,4.751796234635162
786-O,10302451,3.590808927034644
NCI-H526,3689413,-2.6230284067277725
KHM-1B,135421197,0.982032972009238
YH-13,46907787,2.497821160225489
HCC38,3689413,-2.099341250488443
MHH-NB-11,9915743,1.606610900960874
JHH-6,637858,3.376480637337269
OC 314,10302451,3.0087201367098033
HGC-27,11396600,2.081101267240524
HuP-T4,73707398,0.9905638319288622
CCF-STTG1,selumetinib-JQ-1 (4-1 mol-mol),4.9623301985248265
BT 164,156414,0.5587758047388703
NCI-H23,4259181,0.0190895573933118
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
Panc 10.05,44491742,3.75595275347319
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
COLO 205,10231331,-0.6755418094368107
RERF-LC-MS,375860,-0.2896823379882159
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
HCC2935,9915743,-3.080711335255353
SaOS-2,107970,2.235066344736828
NCI-H2087,644241,1.6454264321046088
HD-MY-Z,9903786,3.5223384929798187
Mono-Mac-6,4259181,0.7662701795751813
NU-DHL-1,46907787,-1.3567156835247356
SK-HEP-1,135421197,3.339831791709741
JHH-5,100016,5.964491744827364
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
WM115,3689413,-0.1044392328624619
Hs 746.T,9927531,5.239357337613853
HL-60,46907787,-0.5362964011669514
MDA-MB-231,135421197,1.4675791065879262
NCI-H2126,241158,6.024338101753431
HCC2218,26596,-0.1880453521462128
Toledo,107970,3.124947759529639
NCI-H23,6852167,1.7818977710975086
J82,136227924,3.3108045260668564
5637,135999136,4.088875596610543
Ki-JK,44489367,4.331606835471221
KMS-27,135999136,1.9595465875821207
IGR-1,9903786,4.216869468062427
COR-L105,135875424,4.584511127602178
KP-N-YN,5460769,4.0809724038992705
KATO III,9936388,1.2982183156620934
SNU-475,5460769,3.649857099977848
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384
NCI-H446,UNC0638-navitoclax (1-1 mol-mol),2.1887843348128917
SK-MES-1,44491742,3.681896184622424
COLO 678,327653,2.991494950010625
SNU-503,100016,6.601678520618542
HCC1588,24180719,3.6997723249870385
CCF-STTG1,10302451,5.711005870244634
OCI-M1,3689413,0.2396810105329112
SNU-878,selumetinib-JQ-1 (4-1 mol-mol),-0.4766929338153627
SNU-626,4259181,1.842335226683514
RERF-LC-MS,168313016,4.277512101574917
Daudi,12003241,-4.903510386182724
SNU-899,3689413,3.063297937380225
HuP-T4,3689413,-0.6711491165828569
HCT 116,73707398,3.627883589581251
SK-UT-1,4259181,0.5247904304596981
CAL-51,44489367,4.725330666921359
DB,selumetinib-JQ-1 (4-1 mol-mol),0.9497259010838596
JURL-MK1,10231331,-1.884478324211451
SK-N-AS,26596,-3.589406361417691
Karpas-620,135421197,3.2232508043122587
NCI-H1793,selumetinib-JQ-1 (4-1 mol-mol),2.732859806890437
SW1417,12003241,-2.0835943723769184
MOLM-16,26596,-3.9817084754511782
RD,10231331,0.5766168645235544
JHUEM-1,73707398,0.9079210855488236
ONS-76,73707398,1.7098056225756528
Capan-1,selumetinib-JQ-1 (4-1 mol-mol),1.4038636121829502
HCC38,136227924,2.8991930932960983
AsPC-1,135999136,4.3448843965381965
SW1990,54626689,4.474747694138227
KYSE-30,11396600,3.6948052468539654
LoVo,241158,4.012317425862525
HCC4006,10302451,-1.0524765865485184
HEY A8,9936388,2.7984735931283153
SUP-T11,26596,-3.766256771827544
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
BT-16,selumetinib-JQ-1 (4-1 mol-mol),4.014507447561005
DAN-G,135999136,4.415198368400697
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
SUP-T1,6852167,1.0606596994017583
DK-MG,168313016,4.410305787145771
JHUEM-2,9915743,-0.2350251959157376
Karpas-422,10302451,2.97293319769233
NCI-H2126,135421197,2.0437497253057137
OCI-Ly19,9903786,1.1452071440663905
HCC1438,9903786,3.876774477069639
EFM-192A,44491742,3.8805374650465905
NCI-H889,3689413,1.8557298697874456
BT-474,9915743,-4.144721850714229
DEL,UNC0638-navitoclax (1-1 mol-mol),2.6998299925711127
BT 286,262093,2.2473217807206916
COV434,73707398,-0.7309489415917809
KMRC-2,9936388,3.0990467374612813
TYK-nu,107970,2.1879195811758683
BICR 6,9915743,0.967897294058306
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
COLO 678,73707398,1.0849189454014951
Pfeiffer,9915743,-1.0333729924514143
TE-15,10302451,0.955725633878595
TCCSUP,439501,-2.3382973857263893
BT 224,241158,4.18453017300662
NCI-H460,9903786,4.057661845653794
MV4-11,73707398,-1.799925362976645
BT 286,135999136,1.5966853845263294
Namalwa,71466445,4.063090897069234
FaDu,11455910,0.0548486967941132
LCLC-97TM1,24180719,3.1823264447338837
AsPC-1,44491742,4.429887143828186
KMS-26,73707398,0.2889997068369305
YD-8,11455910,2.3608003231552717
TM-31,9936388,3.1233644325895185
MFE-296,241158,3.7425746941518327
DAN-G,9927531,4.82875872277198
TYK-nu,44491742,3.839739340970965
UM-UC-3,241158,3.872560584721575
Capan-2,12003241,-1.76044802004158
IPC-298,9936388,2.329968749108903
CCK-81,9915743,-3.5525770077735555
PK-59,73707398,1.1955784126278513
YD-10B,637858,1.786914568759276
TTC-709,4259181,-0.3591071255089544
HuCC-T1,12003241,-1.0945393222434805
OCI-AML-3,156414,1.0676156487977742
COLO 680N,168313016,5.234421894550309
TT,6852167,2.4660311659605125
HCC-56,9927531,5.667739973718857
BT 504,327653,3.327628019841459
Caki-1,6852167,4.352231289432342
SW1088,73707398,1.711259788893634
G-292 clone A141B1,selumetinib-JQ-1 (4-1 mol-mol),2.4558837946594307
COV644,135875424,4.838301094582854
NCI-H2030,136227924,3.923759704530775
Tm87-16,375860,0.3575465541966368
DMS 53,49766530,-0.8601617685974926
KYSE-30,11455910,0.7960710883386756
HuH-28,44489367,4.3287624589651035
JIMT-1,107970,2.57313135077594
EJM,26596,-3.57565028157041
QGP-1,49766530,0.3270238560259029
SK-BR-3,375860,-0.5619604471367267
KYSE-140,4259181,-1.5506571157207716
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218
BT 286,12003241,-0.6969940125697452
OAW42,10302451,3.168446299952244
CML-T1,135421197,0.9317392273651705
Hs 294T,26596,-0.6328702993813093
BICR 22,26596,-1.8883514509946957
HEC-151,107970,2.3284041079322497
THP-1,54626689,3.8462325652796423
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
SNU-1041,73707398,1.6372848153968225
NCI-H1385,439501,-0.294435314613152
CAL-12T,44489367,4.339447480612273
Hs 683,4259181,-0.0189213214010426
NCI-H69,135421197,1.0126694729048382
NALM-6,selumetinib-JQ-1 (4-1 mol-mol),-2.6623327843481035
BT 320,135875424,3.1120862947515255
HeLa,selumetinib-JQ-1 (4-1 mol-mol),4.321478137399501
MOLM-6,9915743,0.4708635426992801
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
SH-10-TC,637858,3.386044080916751
DMS 273,136227924,2.538513279360657
KP-N-YN,6852167,3.160535826824463
Sq-1,9915743,-0.0182413792869356
Panc 04.03,168313016,6.087789512449841
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
Hs 934.T,44491742,4.305764247310721
CGTH-W-1,73707398,1.5502915494771807
BT 228,10231331,4.437777613633079
ACC-MESO-1,135875424,3.861508499056134
PaTu 8902,135421197,2.3024316473658004
RS4;11,9903786,1.046136748247593
CAL-27,136227924,2.2169431722835324
GSU,100016,6.3262103117900805
PaTu 8988t,107970,2.530920724052233
U-937,444795,3.85111190930368
MG-63,241158,3.962785624190749
22Rv1,439501,-2.2106497946316175
Reh,100016,6.483959173055827
NCI-H2452,9927531,4.529523169776047
BDCM,9915743,-0.0089573294150241
MFE-319,107970,2.9739758734328774
Hs 294T,12003241,-1.502620378279095
L-428,54626689,4.378954152796482
SK-N-MC,262093,3.06312964755372
NCI-H2122,4259181,0.8798448055972885
SBC-5,4259181,0.3536055110585087
T98G,135421197,2.3831918060045663
KLE,637858,1.7560393431403896
SNU-1214,241158,4.530958895072107
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659
WM983B,9915743,1.863557730328146
BT 139,9936388,1.6173516252245872
Karpas-620,644241,2.657067982766826
H-STS,4259181,0.3091139042767585
SUP-M2,241158,1.5646629177764024
MeWo,73707398,1.0654051497037464
NCI-H526,262093,1.015946009419874
GP2d,11455910,0.6533370320075141
NCI-H2122,439501,-2.460326379579743
BICR 56,5460769,-1.0977162863448868
KMRC-2,439501,-1.138228475309333
SiMa,4259181,-0.990958559837322
LOU-NH91,10302451,4.426232341068122
MeWo,3689413,1.920191181250088
NCI-H2081,71466445,4.38598643785932
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
HEC-6,5460769,3.976458521596205
DMS 114,9915743,2.4307544773783465
OV-90,135999136,4.339682590853578
OCI-AML-2,73707398,0.2295184114128151
LMSU,5460769,3.9630418347665857
BHT-101,168313016,4.350384619812103
23132/87,9903786,3.7145887754512414
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
SNU-1076,637858,2.268139092050385
NCI-H1568,71466445,4.632148673172368
RD,44491742,4.422595956491757
SW48,262093,2.726859331273406
Fu97,9936388,-0.0217982395537123
786-O,375860,-0.1367440745191159
L-540,73707398,0.7518551251866028
GP2d,UNC0638-navitoclax (1-1 mol-mol),-2.07499994680321
HOP-92,10302451,3.9702293485609457
AGS,439501,-2.3986338247622148
BICR 6,262093,3.032842470666603
BT 422,439501,-3.455801521940444
ME-1 [Human leukemia],637858,0.3716421428475518
RERF-LC-A1,644241,2.932089965738435
KMS-28BM,9903786,-0.1585542654155638
SK-MM-2,6852167,1.7319631304035736
MKN74,71466445,3.93940813882303
CAL-62,241158,3.704320848974484
OV7,135421197,2.579158372442756
CMK,UNC0638-navitoclax (1-1 mol-mol),-0.1141456937981058
IA-LM,10302451,4.177351274859187
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
Granta-519,637858,1.0013506713179747
CAL-148,107970,2.288238614109801
NCI-H1666,9936388,0.7507462468701122
KE-39,9936388,1.1689372039333712
RL95-2,100016,4.898266673475204
TYK-nu,327653,3.2225765861053506
SNU-899,9929138,5.051227774447189
BT 328,9903786,4.817171686681598
SNU-668,136227924,2.8591825047695925
Pfeiffer,12003241,-4.957665380544675
HCC44,135999136,4.053989707945556
ESS-1,71466445,5.77037971840281
Li-7,375860,-0.9891534259719538
BL-41,3689413,2.890540357567194
MG-63,100016,6.791496028485962
ST486,49766530,-3.0199322417978065
Rh41,241158,2.6802066493092154
MEC-1,44491742,3.700583986314622
G-402,100016,6.451749665500501
KYM-1,107970,2.300725596971748
AsPC-1,262093,3.2992304028365926
MOLT-16,135421197,0.9266017011835492
DV-90,UNC0638-navitoclax (1-1 mol-mol),1.6997014306077862
TE-6,BRD-K27188169-navitoclax (2-1 mol-mol),3.6644648098972072
NCI-H446,100016,4.920277084242614
NCI-H661,107970,2.2398777867932473
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
HuCC-T1,107970,2.387051685262573
PK-59,selumetinib-JQ-1 (4-1 mol-mol),1.6048028888022474
KYSE-520,selumetinib-JQ-1 (4-1 mol-mol),3.0817543061531434
NCI-H1650,4259181,0.5942836331714245
HCC38,135421197,1.646244202411993
HEC-251,46907787,-0.5109395446508497
TE-6,11455910,0.2232951915413818
Karpas-620,9927531,5.121600131108068
ECC12,11455910,2.320558491794217
NCI-H520,selumetinib-JQ-1 (4-1 mol-mol),1.7959695418998267
NCI-H1915,UNC0638-navitoclax (1-1 mol-mol),1.0243351798341758
Sq-1,135875424,4.0365326385362055
NCI-H441,6852167,5.036797338049703
EC-GI-10,327653,3.618269807161223
NCI-H23,107970,2.3320218632275096
YD-15,10302451,0.0740355498774049
L3.3,375860,0.2158630030269858
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
Caov-3,107970,2.358306338723641
SK-LMS-1,24180719,4.466013942579335
SW579,UNC0638-navitoclax (1-1 mol-mol),1.075742965744335
HD-MY-Z,3689413,-2.31640912661536
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
Calu-1,49766530,-2.4151861357185056
MeWo,644241,2.094796596283421
A-498,135875424,4.978423270774445
NU-DUL-1,9903786,0.8090083924855098
G-292 clone A141B1,136227924,3.074698527992838
A2058,241158,4.224104807378981
BxPC-3,73707398,1.0061551215696194
BFTC-909,375860,-1.1901103647211757
UM-UC-3,4259181,0.3214411925726369
SNU-620,375860,-1.000717785037884
GOS-3,135875424,4.516628943420056
JK-1,136227924,1.8733417156502243
JM-1,10302451,3.097435274235228
KMRC-2,135875424,4.786513298485674
Daudi,135875424,2.734623655159311
HL-60,9936388,-5.148540194165726
HGC-27,46907787,1.268146898786742
Karpas-620,100016,5.312019885835398
BT 248,12003241,-0.5635987052840526
DU4475,327653,2.541237154607322
Ishikawa (Heraklio) 02 ER-,6852167,3.9423721034653423
CAL-33,73707398,0.9500271465517623
DK-MG,375860,-0.3429837018274142
EC-GI-10,4259181,1.6950184604495684
ONCO-DG-1,26596,-2.0057166886721625
KYSE-140,73707398,1.695660009720789
Hs 822.T,selumetinib-JQ-1 (4-1 mol-mol),3.901287400786403
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
HEC-1-A,135421197,1.5855088638754589
Ishikawa (Heraklio) 02 ER-,9936388,-5.11124273822625
SNU-899,135421197,3.636870006524017
ChaGo-K-1,10231331,4.797062827822195
NUGC-4,136227924,2.1432448607030308
BICR 18,selumetinib-JQ-1 (4-1 mol-mol),2.0446383498260534
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
HCC15,644241,2.326085716096255
RCC10RGB,54626689,5.11978438920743
Hs 888.T,73707398,2.4412256310996026
SK-HEP-1,73707398,1.730256970360003
MOLT-16,637858,0.9912301542753724
SUIT-2,10302451,3.8519201138639
NCI-H889,26596,-2.687353168028847
OE33,9936388,2.0912313369341287
A-375,71466445,4.407690807388674
MG-63,71466445,6.092565154113904
SNU-1079,24180719,1.6141219894609071
EM-2,135421197,1.083301811797457
SW1783,135875424,4.794068332474245
JMSU-1,9936388,-5.635407745986741
COR-L105,73707398,2.56355231698926
HuT 78,637858,0.0090449520272635
COLO 668,135398744,8.327897360354253
NCI-H526,24180719,3.591354250057624
UM-UC-3,375860,0.617293660275221
CAL-51,444795,5.053001195278548
OV7,135999136,1.588038297711629
UM-UC-3,439501,-1.7316159115926524
SK-N-AS,100016,6.379811774246359
DLD-1,54626689,4.853059608644546
TE-14,4259181,-3.298060588196884
NH-6,44491742,4.075747370877145
SK-N-AS,241158,4.128008478186768
HCC1937,5460769,4.797106987757637
Hs 940.T,6852167,2.7181130284574793
U-CH1,156414,-1.9415090197307168
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
BT 416,5460769,1.3706696040691966
BFTC-909,439501,-2.4866456286351095
NCI-H2029,11396600,2.8760485463291334
NCI-H460,4259181,-0.2054535095090753
GMS-10,12003241,-0.439124949180571
SNU-1066,135421197,3.020792561550821
NCI-H2106,327653,1.9858546242154949
TE 441.T,9927531,5.546705362793043
HPB-ALL,135875424,3.2013409363750474
T3M-10,UNC0638-navitoclax (1-1 mol-mol),0.7914868615478301
NCI-H211,327653,2.6447070202366776
SUIT-2,262093,4.049104877248936
NCI-H1563,3689413,0.532874202175122
NCI-H69,46907787,1.1887394251634753
ZR-75-1,11396600,4.04408078338515
MKN1,6852167,2.386061639562249
A2780,9915743,1.3754925129164983
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
BT 482,UNC0638-navitoclax (1-1 mol-mol),2.1366376160225227
NCI-H2030,12003241,-1.1383124397984303
RERF-LC-Ad1,136227924,3.427007002266959
ESS-1,327653,3.2040700098938837
SK-N-BE(2),444795,4.243523725164084
LS513,BRD-K27188169-navitoclax (2-1 mol-mol),3.65610110113228
JHH-2,439501,-1.6705307194191004
Hs 611.T,136227924,1.5120677878583844
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
OCI-Ly10,9903786,3.2654189555082493
SF295,46907787,3.23145207595968
KNS-81,11396600,3.683177466862877
PANC-1,26596,-1.3824156046290312
ZR-75-30,637858,1.9303975734710028
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
SK-CO-1,73707398,0.894037962240185
RS4;11,54626689,4.296710447471879
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
MOLP-8,100016,7.090961588333011
SNU-489,46907787,5.700655422231745
NH-6,135875424,3.8228230929419182
COV434,6852167,2.2026969386230397
MM1.S,46907787,-0.8682718758201811
SK-MES-1,46907787,1.4035137131204831
DOV13,BRD-K27188169-navitoclax (2-1 mol-mol),4.625405186200569
OV7,26596,0.3804702126499801
Aska-SS,10302451,3.2025437422649796
THP-1,26596,-4.239434805167959
TE-10,selumetinib-JQ-1 (4-1 mol-mol),1.1375794894339473
TYK-nu,9936388,2.2854724724454254
8505C,11396600,3.6355990729160306
Hs 746.T,100016,6.2249168538435
BT 482,156414,1.6572125651700018
KLE,3689413,-1.503166424361693
MPP 89,12003241,-0.4822573033051652
G-292 clone A141B1,135999136,4.156911102982334
SUP-T1,637858,0.5136167225072658
Rh18,10302451,3.686530291048044
JM-1,54596490,4.858476490911798
NUGC-4,439501,-0.6746997916086527
BT 228,selumetinib-JQ-1 (4-1 mol-mol),2.3416360255070523
ESS-1,11455910,0.1046831634026344
F-36P,44491742,3.961170859118446
EC-GI-10,156414,-0.2987346529077731
C2BBe1,11455910,0.6579710467185694
HCC1833,4259181,-0.2637882544292723
VCaP,135875424,4.074355595909067
MOLM-6,327653,2.4462105990382694
YD-10B,439501,-2.459950710231521
WM793,selumetinib-JQ-1 (4-1 mol-mol),1.649848066078306
MM1.S,9903786,2.841249590923514
CAL-12T,135875424,4.193322146667977
M-07e,10231331,3.7072976059744134
SW1353,11455910,2.4581078683414765
Sq-1,selumetinib-JQ-1 (4-1 mol-mol),1.2922884384093536
HLF,71466445,3.5325302047070295
NCI-H1568,6852167,2.376266672184036
MOLP-2,3689413,-0.0389139812968664
NCI-H838,44491742,4.734730430776703
BICR 16,135875424,5.068625182385868
WSU-DLCL2,9929138,4.197789309677048
SK-ES-1,4259181,-0.7252819561793736
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
MDA-MB-435S,444795,6.789363212656908
JMSU-1,10302451,2.622801309403871
BICR 18,73707398,1.6642895703320195
SNU-201,9903786,3.5619464236544336
YD-15,71466445,5.119296595757631
U-BLC1,168313016,5.063255605681815
SU.86.86,107970,2.3526522734553685
OAW28,135999136,1.5944266420299655
NCO2,46907787,-1.209980225717052
TALL-1 [Human adult T-ALL],241158,1.7102872988706168
KYSE-180,9903786,3.667884143051944
NCI-H146,327653,2.704686127708374
GCT,135875424,3.965319619265028
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
HD-MY-Z,156414,1.5591920607935952
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
TCC-Pan2,9936388,2.201514810862402
SNU-761,11396600,3.454843575520041
KP-4,9927531,4.133132471869078
NCI-H522,9927531,4.749051096908956
HCC202,9936388,1.0165680238121546
SW1116,6852167,3.995945836747335
NCI-H358,9915743,-2.527498846949541
TTC-709,9929138,5.828368594409336
NCI-H2110,4259181,-0.2511035825060961
BL-70,9915743,2.1180817838790658
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
SNU-1077,327653,3.4488214544204108
BICR 56,12003241,-1.3308187474558526
SW982,9903786,2.8939777098979333
VMRC-RCZ,327653,3.628374275379161
HEC-151,241158,3.682505125351082
BT 228,54626689,4.388884846293327
NCI-N87,136227924,3.040461203265333
Hs 766T,5460769,5.317456208461946
786-O,262093,3.537658086729407
SK-BR-3,637858,1.5595701631801446
OAW42,46907787,3.3206761920396164
B-CPAP,BRD-K27188169-navitoclax (2-1 mol-mol),4.542627193137736
SNB-75,46907787,3.565520882453274
OE21,375860,-0.7347528974131474
TE-10,24180719,3.7319153909050424
NCI-H1339,3689413,0.3064961832206241
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
SU.86.86,49766530,0.3418469510818301
KALS-1,136227924,3.4972882997363257
KE-97,241158,3.4100000813842013
JHUEM-7,10302451,1.7373663186818131
KYM-1,24180719,4.117840338964858
OVCAR-8,49766530,-0.1649030183556315
KU-19-19,241158,4.34083218708613
TOV-112D,439501,-4.317689883213593
697,241158,1.4573107535842036
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
KYSE-150,6852167,4.365388047600905
EJM,4259181,-0.0332233948997356
WM115,100016,7.477930972064711
BICR 16,136227924,2.8848408076895393
D283 Med,73707398,0.757498039182734
BxPC-3,24180719,3.164671730334926
TT2609-C02,49766530,0.6648763661012455
KYSE-70,107970,2.5727619321994353
DLD-1,327653,3.308553284717408
TUHR10TKB,135875424,4.420218264862005
MOLP-8,6852167,0.8455390099609336
HEL 92.1.7,44491742,4.540639923778426
EC-GI-10,135999136,4.467618898798576
Hs 839.T,49766530,-2.6127392720366296
LoVo,9936388,-7.372990206557469
UM-UC-3,3689413,2.922700003558909
KE-39,136227331,5.536038659908766
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
CAL-54,156414,1.1305015543844827
NCI-H28,11396600,3.4580715977014185
NCI-H1568,5460769,1.1324377767406906
KE-39,44491742,3.945663107977575
KE-37,637858,0.6902429951487689
ST486,73707398,-1.0150997686400067
HT-1197,444795,4.721186439495217
OV7,107970,1.7001806684569305
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
SK-CO-1,12003241,-0.9578793579943758
Calu-6,262093,3.3052566234761116
BT 145,9927531,3.3032194302925557
UACC-257,9903786,4.920300978966239
NCI-H650,637858,2.5210776011499236
HCC2218,9927531,0.7764965952119703
OCI-Ly3,3689413,-2.743608446400997
Panc 10.05,444795,4.847688722639358
Mel Ho,11396600,5.196544531499117
IGR-39,12003241,-1.2962824425712205
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
HOP-62,135421197,0.8812919220198131
JIMT-1,375860,-0.7058390896374014
NCI-H1650,11455910,2.7994234029229372
DMS 114,107970,2.840444077880968
TF-1,375860,-0.3667631401948379
Hs 611.T,135421197,0.2639365806220374
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
BL-70,375860,-0.623761093700038
786-O,439501,-3.5974319595711832
G-401,241158,1.9889661714459972
COLO 678,9927531,4.922936078042476
DMS 114,439501,-3.85283118857385
SW1990,136227924,4.2742525725591864
8305C,9903786,1.7590562865334185
SNU-61,4259181,0.2985440005718957
L-363,6852167,1.3812859143740928
M-07e,UNC0638-navitoclax (1-1 mol-mol),-0.772569020368213
Reh,BRD-K27188169-navitoclax (2-1 mol-mol),2.907049079895175
ONCO-DG-1,46907787,0.8121949091079932
KMS-27,9929138,5.026853283311406
NCI-H1355,135999136,1.691805478061882
Panc 04.03,44491742,4.30815140156182
KE-97,71466445,2.322380108520085
NCI-H28,637858,1.7357637542615616
SF268,46907787,2.334109792042798
SNU-1105,5460769,2.875284182310896
NCI-H2405,9903786,2.53791171783736
NCI-H2452,46907787,3.091101876271566
A-204,3689413,-1.831192826185156
F-36P,54626689,5.186614622996473
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
OE33,24180719,3.6753594192286583
COR-L105,3689413,-2.1605707630353708
SNU-C1,156414,1.7952824452797074
Mono-Mac-1,26596,-2.0508737654950036
VM-CUB-1,4259181,-1.4163454013046757
LMSU,10302451,4.092585001279765
RKO,6852167,3.601912647929868
PaTu 8988s,UNC0638-navitoclax (1-1 mol-mol),1.233216645790841
SIG-M5,135875424,3.9161233057534584
OE33,5460769,3.7320924588923465
HeLa,73707398,1.5466980684371698
Sq-1,11455910,0.8534874445635723
SEM,327653,3.0255719016474605
ZR-75-1,11455910,1.4286794272371928
OCI-AML-2,10302451,2.7563880016120113
BT 232,46907787,4.9227176505536665
A-673,26596,-3.820628112159822
SK-N-AS,46907787,2.030774624984343
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653
CJM [Human melanoma],54626689,4.401218331353684
TOV-21G,327653,2.366074038804648
BT 139,135999136,1.5889963250911243
FTC-238,54626689,5.819145402995468
QGP-1,439501,-1.697500396570699
RVH-421,10302451,3.790601078841018
M059K,4259181,1.0338081724694033
KP-N-SI9s,4259181,-0.1617576819472535
DMS 53,4259181,0.5080002769116885
KMS-11,156414,0.7669613928251784
TOV-112D,54626689,4.435468202188779
KMRC-1,135875424,5.075329697898493
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854
BC-3C,107970,3.022957216824654
Hs 746.T,54626689,4.6397128820346545
KYSE-410,107970,2.1635571527834676
BT 239,439501,-3.505235897057165
BT-16,73707398,1.7491627069246496
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
WM88,12003241,-2.725037582616198
RS4;11,262093,0.7375601612159237
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
HCC1588,135421197,1.0846790192354827
DMS 79,135999136,2.6080032011939953
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
COLO 684,135421197,1.6241995142011054
TF-1,327653,3.0642738579154383
SK-UT-1,135421197,2.4956722116312813
CCK-81,11396600,4.135348832339609
A-253,selumetinib-JQ-1 (4-1 mol-mol),3.3006041735860476
SF539,135875424,2.4028504168317473
NCC-StC-K140,11396600,-1.2265429504727747
COLO 741,9936388,-5.068982881561057
KYSE-450,135421197,2.3081928088852774
COLO 684,54626689,4.469799738159948
Mel Ho,375860,-0.1475069462998833
SH-10-TC,73707398,1.591598537302804
SW1990,11455910,1.2583427289615488
SK-MEL-30,241158,4.095934000449828
SNU-738,4259181,-0.68989187934339
A-549,54626689,6.037159882780096
DAN-G,11396600,4.828113333823666
SW48,9936388,-6.68623848822316
NCI-H1838,135875424,4.369975669876832
NCC-StC-K140,10231331,-1.373872117719025
COR-L105,54626689,5.0742986339862926
TE-8,262093,2.355811133795261
SNU-423,262093,3.077382051759327
KALS-1,UNC0638-navitoclax (1-1 mol-mol),2.8792786842803673
NCI-H716,10302451,3.670682861692165
LS513,73707398,0.9593843362718174
PE/CA-PJ49,5460769,0.8323029326456293
Rh41,375860,-1.1822425747894922
PE/CA-PJ41 (clone D2),5460769,2.5777137088305184
MDA-MB-361,9903786,4.233301337396568
JHH-4,168313016,4.720247698392662
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
SNU-1041,136227924,4.256354114890169
OV56,11455910,2.728140912842352
A2780,5460769,-5.6757466443406575
SCC-4,107970,2.410783645873977
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
OV56,49766530,0.3841868356522632
COV362,46907787,3.641146774847172
EM-2,100016,3.5566389909433913
WM115,44491742,3.78432787650886
SNU-C2A,135421197,5.231431749442163
OUMS-23,71466445,3.24844223945163
KLE,444795,4.58251515525995
HDQ-P1,73707398,1.4216828244439217
PL-21,10231331,-1.2621716252501856
Mono-Mac-6,49766530,-0.8039148598736047
SK-N-SH,26596,-3.7665654883669664
SNU-119,644241,2.7771526168962084
A-549,439501,-2.483005959928592
THP-1,49766530,-1.885819657206308
NMC-G1,9936388,2.483063894359811
JK-1,135999136,1.835652515578062
SF539,644241,2.736795870753983
KP-2,71466445,5.055512681465278
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
SNU-840,46907787,4.423017532961323
SK-MM-2,100016,6.381158442456996
HCC1954,54626689,4.571580953633881
HEC-151,327653,2.9802978395573123
786-O,11396600,5.6652705596340045
AU565,439501,-2.8703859168743384
FTC-238,6852167,3.2631212459606864
MCF-7,135421197,1.272552449753212
OE21,10231331,0.7094072975995727
OE21,44491742,3.708692446594154
RMG-I,73707398,0.9592777542588656
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
NCI-H2029,44491742,3.631304430303769
SNU-1066,5460769,2.0075693464583817
NALM-6,11396600,2.9362643003919975
RMG-I,107970,2.2198175714732535
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
NCI-H1666,11455910,-0.2695956952552506
COV644,9915743,2.089583867030486
WM983B,136227924,4.383113443662036
M059K,262093,3.1968962336594644
CFPAC-1,73707398,2.9085605361845213
NCI-H2110,327653,3.7242823172188815
JHH-1,5460769,4.810019702724217
T84,11396600,3.8176066701556097
SNU-5,10231331,1.1538331312223369
HCC2108,637858,1.810315688111992
LC-1/sq-SF,54626689,5.5430759849304465
LN-229,10302451,3.828508416143536
DB,439501,-2.823022710491889
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
SK-N-AS,439501,-3.01819280603901
PLC/PRF/5,9915743,4.0648434850392
Hs 294T,375860,-0.214003047287039
MKN7,49766530,-2.7589304585779493
KMRC-3,637858,0.9671022653811864
RERF-LC-A1,6852167,3.5109914497052928
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434
SNU-C4,135875424,3.2044136454561896
RL95-2,10231331,-1.47553780419568
SNU-1033,44491742,3.84113608449774
NCI-H838,71466445,4.919843327137771
DMS 114,3689413,-0.1355634310043713
NCI-H2110,24180719,4.287105919201185
A-673,262093,2.1198375376891705
KCL-22,136227924,2.6502010503693016
LS1034,9903786,3.887461634575776
NCI-H520,637858,1.8177885969386705
NCI-H1435,107970,2.287499744924415
DLD-1,9927531,4.358823264887286
BxPC-3,3689413,-0.056748072256038
RL,327653,2.642918590817601
Rh30,9903786,2.553175737800522
LUDLU-1,6852167,2.262101031306484
ZR-75-1,262093,2.676837097800324
SNU-668,12003241,-0.9113554646183494
TALL-1 [Human adult T-ALL],3689413,-2.1948693605087577
Hs 578Bst,10302451,3.7780341903913848
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
EM-2,9927531,3.4413075859413556
CJM [Human melanoma],107970,2.889297820732489
HOS,11455910,0.0895853773471224
KMS-26,12003241,-3.93647753580664
SW1990,73707398,1.200617797087527
SK-ES-1,49766530,-2.1156842470602037
BT 286,637858,1.913556569209282
BT 504,136227331,4.427068433279088
KCL-22,444795,4.537075802103081
SNU-738,12003241,0.0747510600230264
TE-4,4259181,-3.177196127545685
RD,26596,-1.141843302094684
UO-31,107970,1.930629959385541
WM88,9915743,1.087537207724937
SNU-449,9915743,1.6643053553641087
HT,12003241,2.790793152125299
SNU-869,327653,3.749735139585272
TOV-112D,156414,1.328569515035358
OCI-AML-3,6852167,1.22318237293595
ESS-1,107970,3.021792385864846
NCI-H1793,644241,1.969414301495338
Detroit 562,4259181,0.0640792531234673
Kasumi-2,26596,-3.0246532529835273
HGC-27,644241,1.74526015473942
NCI-H522,46907787,0.5375692456309028
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
HDQ-P1,136227924,3.063540067223108
NCI-H1944,10302451,3.756494167528543
Toledo,10302451,4.132316597371657
SNU-1272,4259181,2.0481969958420683
GCT,54626689,4.450582447187649
LP-1,135875424,2.677692696582144
SUP-T11,10302451,3.4427567109360573
Rh41,44491742,3.4583513797459537
NCI-H508,10231331,1.5621495524149538
SIG-M5,54626689,4.599183359939461
IGR-39,107970,3.0190333972500913
SK-MES-1,241158,4.574622502408226
COR-L88,9929138,3.603535907252336
LUDLU-1,644241,2.818954515130764
Panc 04.03,241158,4.444137488799797
IA-LM,4259181,2.3536383664390734
EFO-27,9915743,1.432055126276498
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
SW1463,439501,-0.3046644173954531
MOLM-6,UNC0638-navitoclax (1-1 mol-mol),-2.357780415242804
SW1417,136227924,2.767989145735224
Hs 746.T,637858,1.1882246907154543
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
CCF-STTG1,3689413,0.3028996084806184
BT 359,135875424,3.201120817115183
WM115,5460769,2.9023963298546507
SNU-423,9936388,-4.810408284387772
JHOM-1,9915743,4.157597716548686
Fu97,71466445,1.7619679258294287
CCF-STTG1,10231331,5.780092265996196
697,9927531,2.816043229727806
FaDu,136227331,3.76397674876245
OVISE,637858,1.8122421616924396
GOS-3,73707398,2.285638026393688
SJSA-1,9903786,3.6249544402257863
G-402,241158,3.7257491741278512
NCI-H322,11455910,0.5525831103614591
L-1236,73707398,0.6462128656528482
FTC-133,262093,3.024825063724614
NU-DUL-1,10231331,-2.9477670322701885
SCaBER,135999136,5.810928777589949
AML-193,5460769,4.1891717596196205
JHH-1,262093,3.2882358665123426
JMSU-1,637858,1.632608270796334
HCC1419,439501,-1.0086934548500974
SUIT-2,10231331,3.5504785260208473
Ci-1,12003241,-0.8991759784993727
HCC1419,107970,2.3261217172500306
Mono-Mac-1,156414,-0.6734994653601284
NCI-H522,10302451,3.5044820085806645
TE 617.T,375860,-0.5164864785345091
RD,3689413,-1.0823038646320762
NCI-H2170,444795,4.456748853500419
HuH-1,12003241,0.2926250163716364
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
GSU,107970,2.406623240528259
Panc 08.13,4259181,0.6585404981574742
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592
PC-14,156414,-5.707063313851652
BT 224,selumetinib-JQ-1 (4-1 mol-mol),4.743283040381324
253J-BV,4259181,-2.41881896756534
OUMS-23,262093,2.6847920209845886
Hs 822.T,107970,2.3652889622874405
NCI-H2172,637858,5.647730401907311
OE19,9915743,-1.6834349992839135
Hs 888.Lu,9915743,1.135469165316104
A-549,44491742,4.437272986024
CAL-85-1,4259181,0.3435211839049084
Hs 934.T,selumetinib-JQ-1 (4-1 mol-mol),3.438166448048175
NCI-H2029,135999136,4.497237183301633
AU565,135421197,1.4743648854968991
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
BICR 16,10302451,3.722394392304981
Peer,49766530,-3.815848082576589
THP-1,375860,-0.8916673896492482
VMRC-RCZ,439501,0.1982663120150432
SNU-478,135421197,1.3858416930524595
T98G,9903786,3.9737183240681153
SK-MEL-5,135875424,3.6602054011582137
MeWo,9927531,4.558706173548934
SNU-C4,44491742,4.387584080211158
SK-LMS-1,107970,3.0105847397664403
VMRC-LCD,26596,-2.205960208364449
DEL,135999136,3.877926825133574
NCI-H1944,135999136,3.9999259167921544
HCC4006,11455910,0.2919573550060502
LN-18,107970,2.3088219916705857
JHOS-2,73707398,4.073232258082221
NCI-H1355,12003241,-2.4294292569102436
KYSE-140,241158,3.465086029728998
LS411N,10302451,4.220534629483678
HEL,4259181,-1.3539346499127438
JIMT-1,10302451,2.8331671466366957
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
L-428,135875424,2.6389964210598937
BHT-101,375860,-0.7386088763195126
SNU-387,3689413,-0.310852459101112
TE 441.T,444795,4.4291459900533185
HPB-ALL,4259181,-0.2921614648601848
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
HPB-ALL,46907787,1.131077875050485
HOP-92,107970,1.9922027058608
253J-BV,241158,5.2277807850188
OVCAR-5,11396600,3.059623725203541
NCI-H1105,107970,2.297291340192952
NCI-H2172,107970,2.7119922666869276
JJN-3,136227924,1.2624051766932831
TOV-112D,11396600,3.358650381716018
SK-MEL-3,135999136,4.927599963416982
LUDLU-1,135421197,2.9427726224498274
SNU-61,49766530,-2.178873950286192
RS4;11,12003241,-1.5224166820052676
NCI-H1734,26596,-1.406622025931408
DND-41,444795,3.8247123815588817
TE-14,6852167,2.6176714040781977
NCI-H526,135999136,1.5678365159824872
KM12,3689413,0.1387513220516042
NCI-H2106,11455910,1.3355909303164284
COLO 678,135999136,4.397967779172533
IA-LM,9936388,2.150111055311291
MHH-NB-11,9927531,4.251740517213762
CMK,135421197,2.3308084532247935
COLO 800,327653,4.002837585261912
EFO-27,5460769,4.47484627366887
LOX-IMVI,637858,1.7619736168396252
DB,107970,1.6169184615127037
MOLM-6,24180719,3.778271052013941
COLO 205,4259181,0.4383947336306227
SK-LU-1,241158,4.950718472920296
Karpas-299,100016,4.52969889794102
EFO-27,241158,4.165561573655071
BC-3C,9915743,1.1334859275806484
LK-2,12003241,-1.6123297720888603
SNU-899,4259181,0.9668668372242236
CAL-62,73707398,1.6928009125846106
IPC-298,5460769,5.755627361996784
KMM-1,selumetinib-JQ-1 (4-1 mol-mol),2.602303806396768
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
647V,135875424,4.107222785717565
Rh41,637858,1.4614866227185788
SK-N-BE(2),327653,1.124959303799422
YD-38,11455910,1.5894943212861383
SUP-B15,135999136,1.810963396419892
HT115,6852167,3.3430367149018596
BCP-1,46907787,-0.5507438894309143
SK-MEL-1,selumetinib-JQ-1 (4-1 mol-mol),-2.2090163573526653
SNU-503,637858,3.226228036596522
Pfeiffer,168313016,4.585441539484118
CFPAC-1,107970,2.8345957706781544
HuP-T4,5460769,3.995973336692885
MHH-CALL-3,444795,2.920512667470236
EFO-27,9927531,5.387402639259967
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301
MOLP-8,26596,-2.4791577040777812
SNU-245,49766530,-2.046420200198333
TM-31,375860,0.1832837483799453
HT-55,241158,4.257763680370867
GA-10,168313016,4.160019409093505
YD-38,136227924,2.6123275605059075
OCI-Ly3,375860,-1.0546671004791963
Fu97,26596,-2.255904398728495
HT-1080,10231331,3.574558984410994
SNU-213,5460769,1.7717518807864931
NCI-H196,3689413,0.3068410473600975
Rh41,9903786,2.3999141751709763
Hs 852.T,71466445,3.0340826390115985
JVM-3,241158,1.7213635489720556
GOS-3,262093,3.1165245547903804
HuH-6,637858,1.0144806827186308
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
RD,375860,-0.3090206369308591
COLO 668,54626689,4.52164494325761
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
Ku812,selumetinib-JQ-1 (4-1 mol-mol),-3.4448372792658857
NCI-H841,3689413,-2.418219785730911
Panc 04.03,5460769,2.0457621674825224
FTC-133,73707398,1.7335394908123083
NCI-H1793,11455910,0.5323419140009732
LMSU,44491742,4.063120482610564
Mono-Mac-1,selumetinib-JQ-1 (4-1 mol-mol),0.1381126547939459
BT 482,439501,-3.1816156321337186
HEL 92.1.7,135421197,1.9345150408297491
OVISE,10302451,2.747913318530857
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
HPB-ALL,44491742,4.0686707496415835
SU-DHL-1,9936388,0.846879508636978
NCI-H524,9915743,-0.1513844458241534
SUP-HD1,26596,-3.617348161498389
Mino,135398744,6.764750512167438
OE19,10302451,2.815743510977312
OCI-AML-2,10231331,-3.616941439793987
NCI-H2141,3689413,-3.646913366295815
MJ,11455910,1.0370030045754386
HuT 78,49766530,-1.6423396691241603
MOLM-13,156414,-0.1970532812518614
NCI-H1666,9927531,4.532813040549954
RPMI-8226,637858,0.6587174282897974
JJN-3,54626689,5.947770911187968
Hs 934.T,9936388,1.629687666609809
U-937,644241,2.838998182644169
OCI-AML-2,135999136,3.9689816560897184
EFE-184,44491742,4.212174395306579
Karpas-620,136227331,4.429067996401553
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
YD-10B,241158,3.886933806831691
A-673,107970,1.5652885370840817
KMH-2,73707398,0.2398101632779203
SK-MES-1,9915743,0.4302153441445988
BT-549,24180719,4.750015939259711
BT 216,10302451,3.7888700603694785
WM1799,637858,1.7330510519637692
LAMA-84,9936388,-4.994244165866005
HCC1588,11455910,1.225245370216729
EBC-1,439501,-0.4192565995990754
Hs 888.T,439501,-5.801037223256167
NCI-H520,439501,-2.5978412941351405
RCC10RGB,10302451,3.839480938635774
NCI-H2444,selumetinib-JQ-1 (4-1 mol-mol),1.4268472301227464
NCO2,4259181,-1.6856701146210389
CFPAC-1,10302451,2.7378299397254366
NCI-H1869,54626689,4.973681232735932
SNU-182,444795,4.399798471090252
T24,26596,0.1047033051772514
MHH-NB-11,6852167,2.4645742623243856
NCI-H1435,327653,3.0967015068004637
Malme-3M,136227331,3.99929328678972
SK-MEL-1,3689413,2.3373069635982495
MOLM-6,46907787,0.3486946401183053
IGR-37,107970,2.921312490724966
GA-10,49766530,-5.511762261884949
CML-T1,136227924,1.8923919385229255
Hs 766T,71466445,5.502653015711173
RCH-ACV,24180719,3.4330934492594523
SK-CO-1,49766530,2.416603727276247
KE-39,11396600,3.848773124810753
U-118MG,100016,6.712569444944465
KMS-12-BM,54626689,3.649325161583167
A4/Fukuda,9927531,3.7257201794253776
NCI-H1105,12003241,2.305570238632079
MFE-296,selumetinib-JQ-1 (4-1 mol-mol),3.490518746009096
MKN74,439501,-1.7547166912858625
RPMI-6666,156414,3.6582096652616096
HPAF-II,135421197,2.4273877762947933
RL95-2,9903786,1.393609544351605
KNS-62,6852167,4.622267495378103
HEC-1-A,100016,7.347183870003149
BT 172,107970,1.9169413056630975
CAL-85-1,11455910,0.9235836598300894
K-562,11396600,3.7562155275673415
Kasumi-1,135421197,1.491198054618576
MOTN-1,136227924,2.565430053126423
WM983B,11455910,0.7348895690575076
JHH-1,selumetinib-JQ-1 (4-1 mol-mol),2.2841827224917206
SK-MEL-30,135875424,4.398067233460652
HPAC,3689413,3.007667333136724
A-673,10302451,3.0176041071951345
BT 232,9936388,1.379095675434134
TYK-nu,49766530,-1.9829356479605205
A-253,49766530,4.327253973822055
EKVX,327653,3.480417258353757
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
SNU-685,10231331,4.963116273787337
KMS-11,10302451,3.186469993884299
HCC1588,9927531,4.588881343798492
Malme-3M,49766530,0.5606234787009209
KMS-28BM,444795,2.369177528845911
MOLT-16,9903786,1.2441798518109255
BHT-101,12003241,-0.6402723165837827
NCI-H1651,135875424,3.2371114243146453
HD-MY-Z,444795,4.361137066373933
TUHR14TKB,3689413,-1.483434528636918
LN-229,637858,1.9749871629178417
IGROV-1,637858,1.814476597989254
C2BBe1,262093,2.5609927987470753
IMR-32,5460769,-1.03513215878617
U-BLC1,10231331,-1.9285312072374636
NCI-H2171,439501,-3.0635131055453924
Ci-1,637858,1.188374489474976
BHT-101,241158,3.8603827087696105
SF268,375860,0.7372350800509891
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
MHH-ES-1,26596,-2.3851189142163176
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
YKG-1,135421197,3.1079510852519343
HCC4006,9915743,-2.0110769744346824
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
253J-BV,11396600,3.6309884615301953
KYSE-180,262093,4.394400122480356
Panc 10.05,54596490,4.364006655792474
KYSE-140,135875424,3.5989722346209927
MOLT-16,156414,0.7801911907074802
CAL-120,11455910,1.9217151174360485
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
MV4-11,10302451,1.7320919236125134
Hs 746.T,10231331,1.9624435442246329
DU145,136227331,5.067250261949365
LS180,100016,6.005443229591697
LS180,6852167,2.255231171645259
MKN7,3689413,-1.1623045029840038
ONCO-DG-1,44489367,5.194114258179244
A-204,241158,3.4037902568157823
NCI-H1573,100016,4.561614919470221
769-P,9903786,3.979605140448373
HD-MY-Z,135421197,1.63491304477545
BT 228,241158,4.2850908556877405
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
NALM-6,49766530,-2.146531352978819
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
TF-1,637858,1.984492436193965
NCI-H446,262093,1.6387081415954237
SUP-B15,3689413,-0.2664359486303652
KE-37,156414,0.759529623484987
COR-L105,262093,2.940873643596252
Panc 10.05,262093,2.3686778047262327
NCI-H2172,241158,6.148791775116968
NCI-H2126,439501,-1.6048735298353825
RCH-ACV,UNC0638-navitoclax (1-1 mol-mol),-0.6973432503183749
KMS-11,439501,-0.5953872178744132
HCC1395,24180719,4.262412177650308
Hs 611.T,135875424,2.7263445003410536
EBC-1,54626689,5.851246538358325
8505C,637858,1.946970263384462
SK-MES-1,5460769,2.678686049759102
MOTN-1,135875424,3.06502770536401
HCC1937,11455910,2.342196786755475
SK-MEL-28,3689413,3.3385356968233744
253J,637858,2.279095666502017
BT-20,262093,3.15256529620894
SaOS-2,44491742,4.263847553999534
SNU-601,26596,-1.2729418504176535
PE/CA-PJ41 (clone D2),107970,2.3655447470564774
NUGC-3,11396600,3.780901195469807
TUHR4TKB,selumetinib-JQ-1 (4-1 mol-mol),2.4543426930881647
KMM-1,9936388,3.2700380564057543
MDA-MB-415,168313016,6.365347791419527
NCI-H520,3689413,0.9100551461140616
RPMI-8402,9903786,1.556072952295762
Panc 08.13,9936388,-1.7608820575386173
NCI-H1623,135875424,3.67415188779786
A-549,135999136,3.721733527600953
NCI-H1105,4259181,0.6146385538816125
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
NCI-H716,73707398,1.3705255443510411
SW1990,156414,1.6914107782596666
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251
BT 416,637858,2.044208431747075
SNU-398,71466445,4.422743395241771
NCI-H508,6852167,2.6729418239485128
KNS-60,26596,-3.4190498423081026
KYSE-180,selumetinib-JQ-1 (4-1 mol-mol),4.706272098527088
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
RKN,107970,2.600341318615175
TE 441.T,9915743,0.2395120621423657
EHEB,49766530,-1.6427312921557593
HCC4006,100016,6.421907923076987
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
Ri-1,4259181,-1.255290292535843
EN,444795,5.084994921875901
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
HD-MY-Z,9915743,1.384717362630253
M059K,439501,-3.0131166353991703
IM95,71466445,4.20194665159327
HL-60,3689413,0.2723590351268871
NU-DHL-1,135875424,2.8057790902603665
SNU-1272,73707398,1.7046938678660917
WM115,11396600,2.8854117577089378
NCI-H441,439501,1.4166866147967416
SW1271,73707398,1.637161284255629
KYO-1,156414,0.9411257556473772
BV-173,135421197,1.3396067648225152
UACC-257,9927531,4.918712273550195
KM12,46907787,3.704464245999132
EN,644241,6.348339111845882
YAPC,637858,2.16601707981449
FU-OV-1,9936388,1.7648084748519457
T3M-10,262093,3.0314849196691704
BT 428,46907787,0.0171893573997719
LS411N,136227924,3.1900427132689724
HD-MY-Z,637858,1.3208525061915146
SK-N-DZ,107970,1.1338188802465183
HuH-6,46907787,2.171713572401701
NH-6,107970,1.549749994663037
HEC-251,327653,2.909784100810203
SK-MEL-1,11455910,2.3970626759922418
SW620,135999136,4.224661895270989
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633
JHH-2,135999136,4.591945581603726
DK-MG,241158,3.78846931925535
42-MG-BA,6852167,2.433379256165192
KMS-11,135421197,1.6070380180755417
NCI-H1694,9927531,4.024250624925043
Karpas-422,44491742,3.8079113446891424
NCI-H1651,24180719,3.8056650039704047
YD-10B,262093,3.599984263013195
JeKo-1,selumetinib-JQ-1 (4-1 mol-mol),2.6629730147631587
NCI-H1869,136227924,3.4575085361719955
HT-55,6852167,1.7657334784571834
MDA-MB-361,168313016,4.301877723932002
SNU-1077,136227924,3.612132735883527
NCI-H508,12003241,-0.6008293317473488
MHH-CALL-4,4259181,0.5177558135201623
JHH-4,54626689,4.603491854161989
MOLP-8,71466445,1.892906464336944
TE-9,3689413,4.927394449121957
HMCB,136227924,3.0347930044007643
BT 231,10302451,3.095881087225805
NCI-H1666,46907787,0.6812473543243156
Kuramochi,168313016,6.466034723760261
23132/87,73707398,1.3488452767175056
CCK-81,71466445,2.0404974765306085
HOP-62,9927531,4.3195662996069855
HSC-3,9915743,0.268265478867946
HDQ-P1,135421197,5.294865947723562
OCI-AML-3,3689413,-2.4390268193517275
CAL-27,73707398,1.0723780770878542
SK-MEL-24,11455910,1.6031217504483102
KMBC-2,135421197,1.90199423292403
HEC-6,136227924,2.983713037764577
NCI-H1792,26596,-3.036610435257371
OCI-AML-2,3689413,-0.7025216224577658
LCLC-103H,439501,-2.3624899744714956
HCC1395,44489367,5.389676649360524
CHP-126,241158,4.488407239110937
HT-29,73707398,3.199725729582929
JHH-1,3689413,-2.4023532817808304
AN3-CA,9915743,2.510213815091878
SNU-C5,46907787,2.7707191723433673
NCI-H747,4259181,0.8302255965965687
DK-MG,262093,3.1450288318092596
NB4,100016,6.294523599868374
TYK-nu,9915743,1.635959733436141
KMS-20,135398744,7.132407790781497
COR-L95,107970,2.0048060228155333
SNU-C5,375860,0.3015760011094635
NCI-H1105,375860,-0.1286391946208893
RL95-2,9915743,-0.1806547920270402
OVK18,9936388,-8.646346484628276
SNU-449,241158,4.010766929552104
253J-BV,135999136,-5.377455212980044
NCI-H1703,9903786,2.5255687748265903
KYSE-70,9915743,1.2522553618909642
Pfeiffer,49766530,-5.33360369117745
KU-19-19,10231331,0.2937024112037242
SK-N-AS,11396600,3.143624411786837
SNU-719,6852167,2.8569668843128606
NCI-H2085,637858,1.2687999057722932
LCLC-97TM1,3689413,0.1289764847745495
769-P,135421197,1.1178294524098082
TE 441.T,135875424,2.9590043348173225
MEC-1,26596,-1.4944057602934653
NCI-H1869,71466445,5.354012834432668
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
SW48,11455910,-0.1633281652990052
Mel Ho,3689413,0.6432726542837045
EoL-1,10231331,-2.1863910131139326
8305C,439501,-2.556096692618791
Hs 611.T,9915743,-0.4075331774048215
BT 359,11396600,2.03647677274721
NCI-H520,156414,1.990276073985292
MFE-319,6852167,3.5625471714915395
ST486,168313016,3.7452740241785847
BT 422,241158,4.557316478619076
UACC-62,73707398,1.6592602760990676
SNU-1,10302451,3.250909305490784
CAL-27,10302451,1.505930195385636
LP-1,10302451,3.6686554467714574
BT 147,9903786,1.444914560684451
BICR 16,46907787,2.015388722243017
L-428,375860,-0.9643395664590056
COR-L47,46907787,1.5571447931043088
KMS-18,9915743,2.162276720334097
TUHR4TKB,49766530,-1.753828688422756
Hs 940.T,11396600,4.001977527096724
HCC1569,73707398,0.8159586298539813
KO52,327653,2.901066573817011
NCI-H520,168313016,4.384348437846953
NUGC-4,selumetinib-JQ-1 (4-1 mol-mol),-2.3807316373780716
NCI-H1650,6852167,3.0026725356195336
OVK18,241158,3.4460864967100195
SNU-C4,262093,3.503220082312251
IST-Mes1,24180719,3.838804357743771
OV56,9903786,4.181691762553772
YKG-1,44491742,4.005192115909779
YD-38,100016,6.21667674155364
SUP-T11,24180719,2.870555565285409
MDA-MB-468,135421197,1.1227139239966792
PLC/PRF/5,54626689,4.565474707676091
TE-14,selumetinib-JQ-1 (4-1 mol-mol),0.562522938991472
HeLa,10302451,4.286472451875936
HSC-3,9903786,2.4966748748730025
HCC2935,54626689,4.781952262322412
F-36P,135398744,6.4039586130062505
NCI-H522,11455910,0.4156799864056491
SF126,3689413,-2.3760985230108584
SKM-1,9936388,-5.746280121163761
JHH-1,136227924,2.990976056622349
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
SUP-HD1,637858,0.8989263915132222
SNU-601,156414,1.6952343284910505
G-402,439501,-3.32986520483416
LOU-NH91,100016,8.416108067142021
MHH-CALL-3,3689413,-1.9959162007922513
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
RKO,135421197,1.472175761257966
U-251MG,439501,-1.7120275668154334
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
SNU-601,12003241,-1.174156148938379
A2058,4259181,-0.6082432544796528
SNU-16,54626689,2.624508737817753
L3.3,11455910,1.84757483649511
MKN7,46907787,4.340343416812888
SNU-387,46907787,2.091267871629519
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
Daudi,9927531,3.2507934675389447
KYO-1,10231331,0.1625334489701108
BT 320,11455910,4.86644863423661
YAPC,12003241,-0.7644111057992425
TCCSUP,selumetinib-JQ-1 (4-1 mol-mol),2.2207378270123725
BT 239,637858,1.534947650301569
NCI-H1092,327653,2.585630282314354
BT 328,262093,2.379096363022233
EPLC-272H,9929138,6.961893442416843
NCI-H647,135875424,4.395312958272854
HPAC,6852167,3.682014733747655
NCI-H2172,135421197,1.3346129669572484
Lu-65,10231331,-0.1827270457349836
NCI-H661,135999136,1.375733620998009
OVTOKO,5460769,2.45887134191899
KP-2,46907787,4.229874958784046
NCI-H747,136227924,2.5739387589966265
SK-MEL-1,54626689,4.627988024732575
KP-3,135421197,0.5862918255078794
REC-1,44491742,3.8136752597353953
CGTH-W-1,9903786,1.99445591465905
Aska-SS,6852167,0.8511531756898867
SNU-685,4259181,0.9546595561294612
GOS-3,10302451,4.10350760632464
Hep-G2,135875424,4.631021258019282
DMS 79,375860,3.7186272317869102
WM266-4,262093,1.7934582046103504
SNU-878,4259181,-0.5553008083361718
CAL-148,5460769,1.0209449875435856
RPMI-6666,135875424,3.217067635076314
ONS-76,44489367,4.840464292002439
CA46,71466445,1.6737757590775906
Mono-Mac-6,262093,3.4687299225305535
COLO 792,9903786,2.6845883070851277
COLO 792,135999136,4.1263704306141795
SK-MEL-24,4259181,0.7896386879367492
Hs 688(A).T,241158,4.491821627446691
MOR/CPR,135421197,2.970176340421023
DAN-G,73707398,1.7178798930780177
CAL-78,135999136,4.505947344605436
NCI-H2228,3689413,-0.2908814661872257
PaTu 8988s,10231331,2.3383323035983787
NCI-H2122,136227924,3.797810316623325
ZR-75-1,135875424,4.30667404331582
NCI-H838,selumetinib-JQ-1 (4-1 mol-mol),5.188205394228317
GDM-1,107970,1.974801043927804
KYSE-30,46907787,3.978537949893093
EFE-184,selumetinib-JQ-1 (4-1 mol-mol),1.6324969446710622
SK-MM-2,136227924,3.42367167276636
D283 Med,12003241,-3.4539176227720794
DMS 53,327653,2.8933864584670217
HEL,135421197,2.810551353794614
HCT 8,10302451,3.901700462546551
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
SW1710,375860,-0.2472901912164723
NCI-H526,168313016,5.326869674802652
CAMA-1,262093,3.184417935809398
CAL-51,156414,1.13799157004995
ZR-75-30,100016,8.126082181881081
NB1,327653,2.937642307777295
LK-2,156414,1.7745779166627789
Hs 578Bst,73707398,1.3431993476303796
BT 112,241158,4.111283984788845
A-204,439501,-3.495173266920804
TE 441.T,11396600,2.898111820402536
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
BT 428,9927531,4.812195201637174
BT 286,49766530,0.4498348011542866
SU-DHL-8,9936388,-6.541298738392362
KMS-18,375860,0.187704093925913
SNU-C5,54626689,4.318668290208523
Calu-1,9936388,2.4202012833379016
SK-ES-1,241158,2.8136344339249275
H-STS,11396600,3.334455384541719
HCC1438,262093,5.151605944522477
NCI-H1944,327653,4.691187068736962
NCI-H2106,selumetinib-JQ-1 (4-1 mol-mol),-0.56613539512018
PLC/PRF/5,11396600,2.8035721911913645
NCI-H1623,136227924,2.959018127447204
HuP-T3,12003241,-0.2833744856936582
MDA-MB-453,9915743,0.2126089191242519
ZR-75-30,9903786,5.791062866548605
HCT 116,4259181,1.0304730701082
YAPC,11455910,1.8317787914833017
SNU-761,6852167,3.092817272087504
NCI-H358,6852167,2.3300376258618294
Calu-3,11455910,0.8473272312384381
P12-Ichikawa,9903786,1.487769039842012
GSU,selumetinib-JQ-1 (4-1 mol-mol),-0.4114270930139164
MDST8,262093,2.389063867163299
MKN74,46907787,3.0385379880903542
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
KMS-20,3689413,-1.644811207648459
SNU-61,10302451,2.848073588995495
NCI-H1869,9936388,1.425696213804551
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
MOLT-13,5460769,4.221123357906427
SUIT-2,9936388,2.2499280975506393
BICR 56,11455910,1.513170236314074
BT 172,135999136,1.8952925369851452
DMS 79,6852167,4.014161600338899
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
SUP-T1,4259181,-1.9215317609188305
SUP-T1,135999136,2.1938595349455885
VCaP,637858,1.896853411256556
HEC-1-A,49766530,-0.9816829149963144
HL-60,11455910,0.6593265039247426
786-O,9936388,-0.7628994518050997
IST-Mes1,327653,2.848745693869025
EFO-21,156414,3.642961879439636
TCCSUP,10302451,3.6876382718765206
OVCAR-8,135999136,4.416830472376433
SK-MEL-28,262093,2.757579366484628
Li-7,49766530,4.425008044849751
NCI-H2009,135421197,1.5480281661357902
SCC-25,49766530,-2.1571219685765195
SaOS-2,637858,1.716758511666406
NCI-H2052,5460769,4.5383671359434254
NCI-H520,444795,5.008670344858
JeKo-1,71466445,3.0601358929071605
PE/CA-PJ34 (clone C12),327653,3.4791017722352815
HCC1806,73707398,1.2659800646796615
Hs 611.T,24180719,3.465286559859583
K029AX,168313016,6.147743390869082
SNU-5,262093,3.3115328447566723
SK-HEP-1,46907787,5.1061569205326505
NCI-H810,136227924,1.6901408020045232
TE 617.T,262093,2.7005370454000004
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
Lu-65,5460769,3.7972822070130494
Ki-JK,100016,3.514869011895543
MOLT-13,11455910,1.8534554613452228
LC-1/sq-SF,6852167,3.913772365452576
HCC1438,168313016,6.342901339897561
UO-31,11455910,0.6340600347677866
PSN1,3689413,-0.2980036400640658
SW1353,5460769,4.513460705614206
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
U-BLC1,9903786,1.0981923916711085
HT-55,54626689,5.010364400461222
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
NCI-H1355,136227331,3.624687432922337
G-401,73707398,0.5507155331982622
MHH-CALL-3,44491742,4.228181381617403
HCC15,12003241,-1.0460858766179792
NUGC-4,10302451,-0.3779920067585693
NCI-H1581,9903786,1.8918310652044057
SNU-C2A,156414,1.9531845574719549
